Clustering O 0 0.08051221072673798
of O 0 0.02466263435781002
missense O 0 0.049827467650175095
mutations O 0 0.016459668055176735
in O 0 0.010281427763402462
the O 0 0.018454479053616524
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.011767634190618992
in O 0 0.0067301285453140736
a O 0 0.009669910185039043
sporadic B-Disease 1 0.7791323661804199
T I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
cell I-Disease 1 0.9965845346450806
leukaemia I-Disease 1 0.9999998807907104
. O 0 0.044115569442510605

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.10672801733016968
A B-Disease 1 0.9999974966049194
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.007174185011535883
is O 0 0.005255918949842453
a O 0 0.0074843307957053185
recessive B-Disease 1 0.9333630800247192
multi I-Disease 1 0.9999984502792358
- I-Disease 1 1.0
system I-Disease 1 0.9979199767112732
disorder I-Disease 1 1.0
caused O 1 0.9563930034637451
by O 0 0.007639158517122269
mutations O 0 0.009066523984074593
in O 0 0.0054044234566390514
the O 0 0.008180525153875351
ATM O 0 0.06688123941421509
gene O 0 0.011512977071106434
at O 0 0.012812236323952675
11q22 O 1 0.989166796207428
- O 1 0.9999641180038452
q23 O 1 0.9992526173591614
( O 0 0.01821117289364338
ref O 1 0.9812697172164917
. O 0 0.01765240915119648
3 O 0 0.028443751856684685
) O 0 0.02379322610795498
. O 0 0.03177230432629585

The O 0 0.023468470200896263
risk O 0 0.025491219013929367
of O 0 0.018833976238965988
cancer B-Disease 1 1.0
, O 0 0.061273299157619476
especially O 0 0.06976720690727234
lymphoid B-Disease 1 0.9999998807907104
neoplasias I-Disease 1 0.9999988079071045
, O 0 0.00874628871679306
is O 0 0.006114447955042124
substantially O 0 0.010748163796961308
elevated O 0 0.027801770716905594
in O 0 0.0065741450525820255
A B-Disease 1 0.9999837875366211
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9981911778450012
and O 0 0.005760213825851679
has O 0 0.0058178408071398735
long O 0 0.007377294357866049
been O 0 0.005113205406814814
associated O 0 0.007424111943691969
with O 0 0.011012610048055649
chromosomal O 1 0.9999126195907593
instability O 1 0.9999966621398926
. O 0 0.09941238909959793

By O 0 0.029239382594823837
analysing O 0 0.07712393999099731
tumour B-Disease 1 0.9999979734420776
DNA O 0 0.018083201721310616
from O 0 0.008355565369129181
patients O 0 0.01394104678183794
with O 0 0.00650385394692421
sporadic B-Disease 1 0.7049106955528259
T I-Disease 1 1.0
- I-Disease 1 0.9999974966049194
cell I-Disease 0 0.2807815670967102
prolymphocytic I-Disease 1 0.9999877214431763
leukaemia I-Disease 1 1.0
( O 1 0.8611838221549988
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999996423721313
) O 0 0.010891124606132507
, O 0 0.007593113463371992
a O 0 0.008173957467079163
rare O 0 0.016086526215076447
clonal B-Disease 1 0.9929157495498657
malignancy I-Disease 1 0.9999985694885254
with O 0 0.0068246363662183285
similarities O 0 0.008155245333909988
to O 0 0.0047410763800144196
a O 0 0.007276549004018307
mature B-Disease 1 0.8562448024749756
T I-Disease 1 1.0
- I-Disease 1 0.9999980926513672
cell I-Disease 1 0.5353731513023376
leukaemia I-Disease 1 0.9999977350234985
seen O 0 0.007070587016642094
in O 0 0.006334790028631687
A B-Disease 1 0.9998698234558105
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 0.008016512729227543
we O 0 0.005089648067951202
demonstrate O 0 0.008047658018767834
a O 0 0.006192602217197418
high O 0 0.008541547693312168
frequency O 0 0.0070599401369690895
of O 0 0.008077824488282204
ATM O 0 0.09262185543775558
mutations O 0 0.014688568189740181
in O 0 0.017137493938207626
T B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
PLL I-Disease 1 0.9999759197235107
. O 0 0.05063427984714508

In O 0 0.019924024119973183
marked O 0 0.019740765914320946
contrast O 0 0.010667397640645504
to O 0 0.0060350787825882435
the O 0 0.007579205557703972
ATM O 0 0.03177424892783165
mutation O 0 0.009165429510176182
pattern O 0 0.006808198988437653
in O 0 0.0058362106792628765
A B-Disease 1 0.9999419450759888
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
, O 0 0.007164928130805492
the O 0 0.006501472555100918
most O 0 0.005597792100161314
frequent O 0 0.009238881058990955
nucleotide O 0 0.01022433489561081
changes O 0 0.005383382551372051
in O 0 0.007047552615404129
this O 0 0.010075902566313744
leukaemia B-Disease 1 0.9999997615814209
were O 0 0.015369683504104614
missense O 0 0.06173204258084297
mutations O 0 0.034862928092479706
. O 0 0.03342645242810249

These O 0 0.01778360642492771
clustered O 0 0.02616586908698082
in O 0 0.008258734829723835
the O 0 0.007933542132377625
region O 0 0.008285907097160816
corresponding O 0 0.007174307014793158
to O 0 0.006109913811087608
the O 0 0.008675395511090755
kinase O 0 0.04632166028022766
domain O 0 0.012004941701889038
, O 0 0.00692371092736721
which O 0 0.0045385053381323814
is O 0 0.004398915451020002
highly O 0 0.008745446801185608
conserved O 0 0.009372401982545853
in O 0 0.007698065135627985
ATM O 1 0.9046337604522705
- O 1 0.9832194447517395
related O 0 0.012625151313841343
proteins O 0 0.012085886672139168
in O 0 0.00943942740559578
mouse O 0 0.03227059543132782
, O 0 0.014750807546079159
yeast O 0 0.03500938415527344
and O 0 0.021130654960870743
Drosophila O 0 0.06728924065828323
. O 0 0.04000353068113327

The O 0 0.028366582468152046
resulting O 0 0.029009848833084106
amino O 0 0.03095531091094017
- O 1 0.9998517036437988
acid O 0 0.04555422067642212
substitutions O 0 0.019267389550805092
are O 0 0.004199541173875332
predicted O 0 0.00944626983255148
to O 0 0.006485371850430965
interfere O 0 0.011800351552665234
with O 0 0.008877826854586601
ATP O 1 0.99993896484375
binding O 0 0.017655277624726295
or O 0 0.013538017868995667
substrate O 0 0.03233826905488968
recognition O 0 0.03116879053413868
. O 0 0.034556448459625244

Two O 0 0.017400529235601425
of O 0 0.016029322519898415
seventeen O 0 0.044853538274765015
mutated O 1 0.9504123330116272
T B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999798536300659
PLL I-Disease 1 0.9980504512786865
samples O 0 0.015142619609832764
had O 0 0.010686807334423065
a O 0 0.008606634102761745
previously O 0 0.010669197887182236
reported O 0 0.012775643728673458
A B-Disease 1 0.9926508069038391
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999996423721313
allele O 0 0.0691094920039177
. O 0 0.03994308412075043

In O 0 0.02328653261065483
contrast O 0 0.020830459892749786
, O 0 0.010630281642079353
no O 0 0.008706856518983841
mutations O 0 0.008404199033975601
were O 0 0.004589140880852938
detected O 0 0.007630422245711088
in O 0 0.0048625352792441845
the O 0 0.007988915778696537
p53 O 0 0.025286614894866943
gene O 0 0.008242635987699032
, O 0 0.005143806803971529
suggesting O 0 0.00674059521406889
that O 0 0.0037674892228096724
this O 0 0.007418239954859018
tumour B-Disease 1 1.0
suppressor O 1 0.9999992847442627
is O 0 0.007913781329989433
not O 0 0.005188890732824802
frequently O 0 0.008337410166859627
altered O 0 0.01142965815961361
in O 0 0.008449070155620575
this O 0 0.014179227873682976
leukaemia B-Disease 1 0.9999995231628418
. O 0 0.033787623047828674

Occasional O 0 0.0738920122385025
missense O 0 0.07004871219396591
mutations O 0 0.021235942840576172
in O 0 0.010591330006718636
ATM O 0 0.03050306998193264
were O 0 0.005857803393155336
also O 0 0.006827015429735184
found O 0 0.005570427048951387
in O 0 0.007266491651535034
tumour B-Disease 1 0.9999997615814209
DNA O 0 0.00929871667176485
from O 0 0.005781739950180054
patients O 0 0.017409997060894966
with O 0 0.006553852465003729
B B-Disease 1 0.9999842643737793
- I-Disease 1 0.9998483657836914
cell I-Disease 0 0.02417685091495514
non I-Disease 1 0.7110561728477478
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 0 0.48168015480041504
B B-Disease 1 0.9999895095825195
- I-Disease 1 0.9998360872268677
NHL I-Disease 0 0.20269568264484406
) O 0 0.007778629660606384
and O 0 0.006892339792102575
a O 0 0.011448532342910767
B B-Disease 1 0.9997808337211609
- I-Disease 1 0.9998513460159302
NHL I-Disease 1 0.9685865044593811
cell O 0 0.045044369995594025
line O 0 0.04140524938702583
. O 0 0.031151896342635155

The O 0 0.021166527643799782
evidence O 0 0.010833850130438805
of O 0 0.006773166358470917
a O 0 0.006992651149630547
significant O 0 0.005372667219489813
proportion O 0 0.005959017667919397
of O 0 0.005371699575334787
loss O 1 0.9272457957267761
- O 1 0.9999825954437256
of O 0 0.01870550401508808
- O 1 0.9999889135360718
function O 0 0.007659030146896839
mutations O 0 0.006504913792014122
and O 0 0.004354041535407305
a O 0 0.005551180336624384
complete O 0 0.007793806958943605
absence O 0 0.008313002064824104
of O 0 0.005094778724014759
the O 0 0.005857130512595177
normal O 0 0.008057783357799053
copy O 0 0.01249575987458229
of O 0 0.008704629726707935
ATM O 0 0.02460707165300846
in O 0 0.006355862598866224
the O 0 0.007462260313332081
majority O 0 0.008117755874991417
of O 0 0.011032789014279842
mutated O 1 0.9414894580841064
tumours B-Disease 1 1.0
establishes O 1 0.999588668346405
somatic O 1 0.9926568865776062
inactivation O 1 0.999812662601471
of O 0 0.009492157958447933
this O 0 0.007053137291222811
gene O 0 0.0077399201691150665
in O 0 0.005017430521547794
the O 0 0.007024847902357578
pathogenesis O 1 0.9955527186393738
of O 0 0.009684034623205662
sporadic B-Disease 1 0.9966861605644226
T I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
PLL I-Disease 1 0.9999876022338867
and O 0 0.009849874302744865
suggests O 0 0.010231686756014824
that O 0 0.005972106475383043
ATM O 0 0.025430483743548393
acts O 0 0.008914167992770672
as O 0 0.009852536022663116
a O 0 0.04270071163773537
tumour B-Disease 1 1.0
suppressor O 1 0.9999967813491821
. O 0 0.048300571739673615

As O 0 0.02203253097832203
constitutional O 0 0.023052528500556946
DNA O 0 0.017707746475934982
was O 0 0.012833832763135433
not O 0 0.006648899521678686
available O 0 0.007591404020786285
, O 0 0.006729714572429657
a O 0 0.010557899251580238
putative O 0 0.29886966943740845
hereditary O 1 0.9999884366989136
predisposition O 1 0.9999936819076538
to O 1 0.5801567435264587
T B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
PLL I-Disease 1 0.9999668598175049
will O 0 0.011395876295864582
require O 0 0.010307195596396923
further O 0 0.010419243015348911
investigation O 0 0.01812109723687172
. O 0 0.016151107847690582
. O 0 0.026382923126220703

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.97569340467453
kinase O 1 0.6611252427101135
is O 0 0.010341856628656387
involved O 0 0.0073651704005897045
in O 0 0.005283741280436516
the O 0 0.005795598961412907
modulation O 0 0.013579255901277065
of O 0 0.007949928753077984
the O 0 0.01461645308881998
Ca2 O 1 0.9999502897262573
+ O 1 0.994707465171814
homeostasis O 1 0.999018669128418
in O 0 0.029321497306227684
skeletal O 1 0.9999998807907104
muscle O 1 0.9999990463256836
cells O 0 0.1535860151052475
. O 0 0.03445510193705559

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.017186999320983887
, O 0 0.007866390980780125
the O 0 0.006802993360906839
most O 0 0.00669149961322546
prevalent O 1 0.9999926090240479
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9592927098274231
adults O 1 0.8748407363891602
, O 0 0.007365316618233919
is O 0 0.0052446178160607815
caused O 0 0.009336089715361595
by O 0 0.005006734281778336
( O 0 0.010311350226402283
CTG O 1 0.9999973773956299
) O 0 0.010338963009417057
n O 0 0.01897122710943222
- O 1 0.6668875813484192
repeat O 0 0.01674945279955864
expansion O 0 0.012499530799686909
in O 0 0.006375041324645281
a O 0 0.007907666265964508
gene O 0 0.008898640982806683
encoding O 0 0.009129432030022144
a O 0 0.010040839202702045
protein O 0 0.01822498068213463
kinase O 0 0.043750323355197906
( O 0 0.022016098722815514
DM B-Disease 1 1.0
protein O 0 0.04113318398594856
kinase O 0 0.36161258816719055
; O 0 0.02044188790023327
DMPK O 1 0.9999856948852539
) O 0 0.010657486505806446
and O 0 0.008712583221495152
involves O 0 0.011355454102158546
changes O 0 0.0101556945592165
in O 0 0.011710114777088165
cytoarchitecture O 1 0.996421217918396
and O 0 0.021007895469665527
ion O 1 0.9971766471862793
homeostasis O 1 0.9997095465660095
. O 0 0.05026819929480553

To O 0 0.02126835286617279
obtain O 0 0.020372824743390083
clues O 0 0.017445728182792664
to O 0 0.007507415022701025
the O 0 0.007747512310743332
normal O 0 0.008413196541368961
biological O 0 0.009782563894987106
role O 0 0.00866253487765789
of O 0 0.008371442556381226
DMPK O 1 0.9999076128005981
in O 0 0.010451662354171276
cellular O 1 0.9881870150566101
ion O 1 0.9955291152000427
homeostasis O 1 0.9995903372764587
, O 0 0.009319934993982315
we O 0 0.005157237406820059
have O 0 0.0036391334142535925
compared O 0 0.006232074461877346
the O 0 0.008860762231051922
resting O 1 0.9748309254646301
[ O 1 0.5956217646598816
Ca2 O 1 0.9999837875366211
+ O 1 0.9725863933563232
] O 0 0.025595368817448616
i O 0 0.013827343471348286
, O 0 0.007919007912278175
the O 0 0.006623381748795509
amplitude O 0 0.01335379108786583
and O 0 0.0061421566642820835
shape O 0 0.01196926087141037
of O 0 0.011923848651349545
depolarization O 1 0.9999982118606567
- O 1 1.0
induced O 1 0.9999998807907104
Ca2 O 1 0.9999992847442627
+ O 1 0.9904428124427795
transients O 0 0.0827912911772728
, O 0 0.009244312532246113
and O 0 0.005214577075093985
the O 0 0.006341125816106796
content O 0 0.007906603626906872
of O 0 0.009334519505500793
ATP O 1 0.9999961853027344
- O 1 0.9998310804367065
driven O 0 0.02898404374718666
ion O 0 0.04086105525493622
pumps O 0 0.04097852483391762
in O 0 0.01344635896384716
cultured O 1 0.5596649050712585
skeletal O 1 0.9999560117721558
muscle O 1 0.9952087998390198
cells O 0 0.01180655974894762
of O 0 0.008018544875085354
wild O 0 0.01364470086991787
- O 1 0.9987194538116455
type O 0 0.013353860937058926
and O 0 0.009350706823170185
DMPK O 1 0.9999926090240479
[ O 1 0.8832336664199829
- O 1 0.9999994039535522
/ O 1 0.9999934434890747
- O 1 0.999994158744812
] O 0 0.44232842326164246
knockout O 1 0.9950437545776367
mice O 0 0.05341533571481705
. O 0 0.03775643929839134

In O 0 0.03077700361609459
vitro O 0 0.061414118856191635
- O 1 0.9255138635635376
differentiated O 0 0.15098853409290314
DMPK O 1 0.9999663829803467
[ O 1 0.844947874546051
- O 1 0.9999994039535522
/ O 1 0.9999853372573853
- O 1 0.9998376369476318
] O 0 0.03599964827299118
myotubes O 0 0.05159774422645569
exhibit O 0 0.01815974712371826
a O 0 0.00989754032343626
higher O 0 0.012036127038300037
resting O 1 0.9681295156478882
[ O 1 0.5647953152656555
Ca2 O 1 0.9999758005142212
+ O 1 0.9046732187271118
] O 0 0.023814644664525986
i O 0 0.010773051530122757
than O 0 0.004562931135296822
do O 0 0.005244731437414885
wild O 0 0.011917077004909515
- O 1 0.999123752117157
type O 0 0.03925996273756027
myotubes O 1 0.7367589473724365
because O 0 0.005446946248412132
of O 0 0.004586821887642145
an O 0 0.004719954915344715
altered O 0 0.009297337383031845
open O 0 0.008456519804894924
probability O 0 0.006389131303876638
of O 0 0.006490470375865698
voltage O 0 0.020729592069983482
- O 1 0.9981725215911865
dependent O 0 0.019393837079405785
l O 1 0.9834692478179932
- O 1 0.999487042427063
type O 0 0.09184511750936508
Ca2 O 1 0.9909624457359314
+ O 0 0.1411578357219696
and O 0 0.024022966623306274
Na O 1 0.9999890327453613
+ O 0 0.0701027661561966
channels O 0 0.03737276792526245
. O 0 0.03893586993217468

The O 0 0.03834957256913185
mutant O 0 0.06892295181751251
myotubes O 1 0.9205740690231323
exhibit O 0 0.02786811999976635
smaller O 0 0.015751006081700325
and O 0 0.011077681556344032
slower O 0 0.025986742228269577
Ca2 O 1 0.9656469821929932
+ O 0 0.028935790061950684
responses O 0 0.013146054930984974
upon O 0 0.012503664009273052
triggering O 0 0.020607352256774902
by O 0 0.010158902034163475
acetylcholine O 0 0.03429342806339264
or O 0 0.010369536466896534
high O 0 0.022399529814720154
external O 0 0.04725033417344093
K O 1 0.998458981513977
+ O 0 0.07826897501945496
. O 0 0.039248768240213394

In O 0 0.02181989699602127
addition O 0 0.014586588367819786
, O 0 0.00931961927562952
we O 0 0.005142157897353172
observed O 0 0.004801768343895674
that O 0 0.004117956385016441
these O 0 0.006299864500761032
Ca2 O 1 0.9985347986221313
+ O 1 0.9194701910018921
transients O 0 0.33577993512153625
partially O 0 0.024466825649142265
result O 0 0.008073283359408379
from O 0 0.006445616018027067
an O 0 0.006355058401823044
influx O 0 0.0176387932151556
of O 0 0.011200600303709507
extracellular O 0 0.2927486002445221
Ca2 O 1 0.9612084031105042
+ O 0 0.02372715249657631
through O 0 0.009597035124897957
the O 0 0.012819983065128326
l O 1 0.9991121888160706
- O 1 0.9999790191650391
type O 1 0.6801311373710632
Ca2 O 1 0.9888269901275635
+ O 0 0.07405095547437668
channel O 0 0.05475721135735512
. O 0 0.04198163002729416

Neither O 0 0.03343401476740837
the O 0 0.015249645337462425
content O 0 0.010852727107703686
nor O 0 0.009393765591084957
the O 0 0.006708456203341484
activity O 0 0.007348963059484959
of O 0 0.010590015910565853
Na O 1 0.9999998807907104
+ O 1 0.9991087317466736
/ O 1 0.9991992115974426
K O 1 0.8142619729042053
+ O 0 0.09430088102817535
ATPase O 1 0.7933652400970459
and O 0 0.026685837656259537
sarcoplasmic O 1 0.9999935626983643
reticulum O 1 0.9999980926513672
Ca2 O 1 0.9999957084655762
+ O 1 0.9995821118354797
- O 1 0.9999672174453735
ATPase O 1 0.973997950553894
are O 0 0.008813216350972652
affected O 0 0.014129539020359516
by O 0 0.01314585655927658
DMPK O 1 0.9999922513961792
absence O 0 0.2821739614009857
. O 0 0.037890978157520294

In O 0 0.022286424413323402
conclusion O 0 0.020050929859280586
, O 0 0.009145708754658699
our O 0 0.007502445485442877
data O 0 0.005782321095466614
suggest O 0 0.006462038494646549
that O 0 0.005647994577884674
DMPK O 1 0.9962518811225891
is O 0 0.0074291289784014225
involved O 0 0.006961767561733723
in O 0 0.006293008569628
modulating O 0 0.021760456264019012
the O 0 0.007479083724319935
initial O 0 0.00938602164387703
events O 0 0.007569467183202505
of O 0 0.0084780128672719
excitation O 1 0.6491748094558716
- O 1 0.9999867677688599
contraction O 1 0.7924417853355408
coupling O 0 0.03850112482905388
in O 0 0.021637095138430595
skeletal O 1 0.9999997615814209
muscle O 1 0.9999988079071045
. O 0 0.024188222363591194
. O 0 0.034628305584192276

Constitutional O 0 0.25605010986328125
RB1 O 1 0.9999997615814209
- O 1 0.9999140501022339
gene O 0 0.02555914595723152
mutations O 0 0.017668085172772408
in O 0 0.01191441435366869
patients O 1 0.7391864061355591
with O 0 0.012678892351686954
isolated O 0 0.06734395027160645
unilateral B-Disease 1 0.8115079402923584
retinoblastoma I-Disease 1 0.9999996423721313
. O 0 0.05339374020695686

In O 0 0.01844359189271927
most O 0 0.013995213434100151
patients O 0 0.09896418452262878
with O 0 0.008280383422970772
isolated O 0 0.03667743504047394
unilateral B-Disease 1 0.9724799394607544
retinoblastoma I-Disease 1 1.0
, O 1 0.9969509840011597
tumor B-Disease 1 0.9999998807907104
development O 0 0.017714090645313263
is O 0 0.008913207799196243
initiated O 0 0.018020715564489365
by O 0 0.009092126972973347
somatic O 0 0.029285704717040062
inactivation O 1 0.8504441976547241
of O 0 0.010548089630901814
both O 0 0.00805786345154047
alleles O 0 0.015158651396632195
of O 0 0.010609406977891922
the O 0 0.023260997608304024
RB1 O 1 0.9999992847442627
gene O 0 0.040672071278095245
. O 0 0.035688720643520355

However O 0 0.013848088681697845
, O 0 0.007703800220042467
some O 0 0.0043832105584442616
of O 0 0.005807138979434967
these O 0 0.005038703791797161
patients O 1 0.9288026094436646
can O 0 0.008428441360592842
transmit O 1 0.8812385201454163
retinoblastoma B-Disease 1 0.9999998807907104
predisposition O 1 0.9999699592590332
to O 0 0.01441535260528326
their O 0 0.016887260600924492
offspring O 0 0.037623368203639984
. O 0 0.03167552128434181

To O 0 0.017188401892781258
determine O 0 0.010916224680840969
the O 0 0.007735205348581076
frequency O 0 0.00887147244066
and O 0 0.005486425012350082
nature O 0 0.006343596149235964
of O 0 0.006422108504921198
constitutional O 0 0.0625089704990387
RB1 O 1 1.0
- O 1 0.9999995231628418
gene O 0 0.015484257601201534
mutations O 0 0.009143773466348648
in O 0 0.006718778051435947
patients O 0 0.1411510556936264
with O 0 0.006561780348420143
isolated O 0 0.01805470511317253
unilateral B-Disease 0 0.4819168150424957
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 0.008371755480766296
we O 0 0.005615013185888529
analyzed O 0 0.008733201771974564
DNA O 0 0.007947733625769615
from O 0 0.007568647153675556
peripheral O 1 0.9999704360961914
blood O 1 0.9777801632881165
and O 0 0.011358560062944889
from O 0 0.04916730895638466
tumor B-Disease 1 1.0
tissue O 1 0.9999904632568359
. O 0 0.04241457208991051

The O 0 0.020984694361686707
analysis O 0 0.013856765814125538
of O 0 0.014047740958631039
tumors B-Disease 1 0.9998601675033569
from O 0 0.009098943322896957
54 O 0 0.021794261410832405
( O 0 0.010873452760279179
71 O 0 0.023257605731487274
% O 0 0.008596768602728844
) O 0 0.006482960190623999
of O 0 0.009244373999536037
76 O 0 0.03770405426621437
informative O 0 0.03580876812338829
patients O 0 0.04292386397719383
showed O 0 0.013445182703435421
loss O 0 0.015009840950369835
of O 0 0.009516389109194279
constitutional O 0 0.0843425989151001
heterozygosity O 1 1.0
( O 1 0.9966817498207092
LOH O 1 1.0
) O 0 0.02680271863937378
at O 0 0.031193193048238754
intragenic O 1 0.9681403636932373
loci O 0 0.06939242780208588
. O 0 0.03914526104927063

Three O 0 0.02253197692334652
of O 0 0.01759364828467369
13 O 0 0.031646184623241425
uninformative O 1 0.999907374382019
patients O 1 0.99720698595047
had O 0 0.020769232884049416
constitutional O 0 0.0400177463889122
deletions O 1 0.6297045350074768
. O 0 0.04347199946641922

For O 0 0.02483479678630829
39 O 0 0.03177018463611603
randomly O 0 0.01969040371477604
selected O 0 0.025100868195295334
tumors B-Disease 1 0.9997169375419617
, O 0 0.016793666407465935
SSCP O 1 0.9999902248382568
, O 0 0.021990783512592316
hetero O 1 0.9999982118606567
- O 1 0.9999597072601318
duplex O 0 0.35017523169517517
analysis O 0 0.010280176065862179
, O 0 0.008407839573919773
sequencing O 0 0.01286187581717968
, O 0 0.008108298294246197
and O 0 0.007905062288045883
Southern O 0 0.013456685468554497
blot O 1 0.5572437644004822
analysis O 0 0.009734679013490677
were O 0 0.005110779777169228
used O 0 0.006287076976150274
to O 0 0.009336812421679497
identify O 0 0.019723759964108467
mutations O 0 0.025977088138461113
. O 0 0.028196731582283974

Mutations O 0 0.03638197109103203
were O 0 0.009739925153553486
detected O 0 0.011932561174035072
in O 0 0.007829149253666401
21 O 0 0.014267011545598507
( O 0 0.01091744378209114
91 O 0 0.022081779316067696
% O 0 0.009236158803105354
) O 0 0.008848575875163078
of O 0 0.011005612090229988
23 O 0 0.04069221019744873
tumors B-Disease 1 0.9999997615814209
with O 1 0.6911507844924927
LOH O 1 1.0
. O 0 0.0575278140604496

In O 0 0.023436909541487694
6 O 0 0.026736728847026825
( O 0 0.013648713007569313
38 O 0 0.01948488876223564
% O 0 0.009480311535298824
) O 0 0.00687424885109067
of O 0 0.007950372993946075
16 O 0 0.020169315859675407
tumors B-Disease 1 0.999998927116394
without O 0 0.025971753522753716
LOH O 1 1.0
, O 0 0.011542192660272121
one O 0 0.009092144668102264
mutation O 0 0.011685517616569996
was O 0 0.009207334369421005
detected O 0 0.008765608072280884
, O 0 0.005385673604905605
and O 0 0.003907199949026108
in O 0 0.0044869021512568
9 O 0 0.008675706572830677
( O 0 0.007338331080973148
56 O 0 0.012976687401533127
% O 0 0.006196947302669287
) O 0 0.005805660504847765
of O 0 0.006184577941894531
the O 0 0.010378210805356503
tumors B-Disease 1 0.9999998807907104
without O 0 0.438821941614151
LOH O 1 1.0
, O 0 0.014652730897068977
both O 0 0.008939804509282112
mutations O 0 0.011949416249990463
were O 0 0.0077667152509093285
found O 0 0.012443176470696926
. O 0 0.02223241701722145

Thus O 0 0.023997444659471512
, O 0 0.010787294246256351
a O 0 0.009192313067615032
total O 0 0.007888796739280224
of O 0 0.007776105310767889
45 O 0 0.01231310423463583
mutations O 0 0.008218379691243172
were O 0 0.004318602383136749
identified O 0 0.007152053993195295
in O 0 0.008047913201153278
tumors B-Disease 1 0.9999939203262329
of O 0 0.01630614884197712
36 O 1 0.6989281177520752
patients O 1 0.9999150037765503
. O 0 0.031825531274080276

Thirty O 0 0.05258312076330185
- O 0 0.04520035907626152
nine O 0 0.011491074226796627
of O 0 0.007630812004208565
the O 0 0.008164036087691784
mutations O 0 0.011958557181060314
- O 0 0.36617979407310486
including O 0 0.006764530204236507
34 O 0 0.01359447930008173
small O 0 0.00791096594184637
mutations O 0 0.007631693501025438
, O 0 0.006054250057786703
2 O 0 0.00875893235206604
large O 0 0.008432707749307156
structural O 0 0.27145063877105713
alterations O 0 0.028842991217970848
, O 0 0.008270345628261566
and O 0 0.007553082890808582
hypermethylation O 1 0.9887864589691162
in O 0 0.009400157257914543
3 O 0 0.3320300579071045
tumors O 1 0.9999998807907104
- O 1 0.9990743398666382
were O 0 0.006508323363959789
not O 0 0.004455979913473129
detected O 0 0.007442861795425415
in O 0 0.005072424188256264
the O 0 0.00946328416466713
corresponding O 0 0.016654370352625847
peripheral O 1 0.9999803304672241
blood O 1 0.9715057015419006
DNA O 0 0.03725157678127289
. O 0 0.029955077916383743

In O 0 0.023254355415701866
6 O 0 0.024998018518090248
( O 0 0.013926095329225063
17 O 0 0.016047893092036247
% O 0 0.00905041303485632
) O 0 0.005955135449767113
of O 0 0.005410326644778252
the O 0 0.0066690570674836636
36 O 0 0.017150308936834335
patients O 0 0.49627962708473206
, O 0 0.006714174523949623
a O 0 0.008186724968254566
mutation O 0 0.009890468791127205
was O 0 0.007922377437353134
detected O 0 0.0069144973531365395
in O 0 0.0044686985202133656
constitutional O 0 0.008607015013694763
DNA O 0 0.008450843393802643
, O 0 0.004689142573624849
and O 0 0.0038026401307433844
1 O 0 0.006703241262584925
of O 0 0.004508354235440493
these O 0 0.0035282245371490717
mutations O 0 0.005612143315374851
is O 0 0.003575800685212016
known O 0 0.004538103938102722
to O 0 0.0037878784351050854
be O 0 0.0037990726996213198
associated O 0 0.006178840063512325
with O 0 0.007506963796913624
reduced O 0 0.09638535976409912
expressivity O 1 0.9999942779541016
. O 0 0.0325104184448719

The O 0 0.0217895470559597
presence O 0 0.015529443509876728
of O 0 0.009150687605142593
a O 0 0.009337641298770905
constitutional O 0 0.012924887239933014
mutation O 0 0.010881763882935047
was O 0 0.007862499915063381
not O 0 0.004214709624648094
associated O 0 0.004512581042945385
with O 0 0.0033606423530727625
an O 0 0.004239700268954039
early O 0 0.009286507964134216
age O 0 0.012727572582662106
at O 0 0.01700657233595848
treatment O 1 0.9872236251831055
. O 0 0.031011734157800674

In O 0 0.025516068562865257
1 O 0 0.028696522116661072
patient O 1 0.6275591254234314
, O 0 0.01748185232281685
somatic O 1 0.766376256942749
mosaicism O 1 0.9999452829360962
was O 0 0.01771731860935688
demonstrated O 0 0.012988901697099209
by O 0 0.00627621915191412
molecular O 0 0.010755877941846848
analysis O 0 0.00653289258480072
of O 0 0.006130652502179146
DNA O 0 0.01004666555672884
and O 0 0.007248231675475836
RNA O 0 0.019833823665976524
from O 0 0.013198429718613625
peripheral O 1 0.999988317489624
blood O 1 0.9680408239364624
. O 0 0.029941393062472343

In O 0 0.02013993449509144
2 O 0 0.023825643584132195
patients O 0 0.025939663872122765
without O 0 0.006415023002773523
a O 0 0.00852737296372652
detectable O 1 0.6134339570999146
mutation O 0 0.012830548919737339
in O 0 0.008787755854427814
peripheral O 1 0.9999994039535522
blood O 1 0.9980500936508179
, O 0 0.015437433496117592
mosaicism O 1 0.9999878406524658
was O 0 0.012553717941045761
suggested O 0 0.008036892861127853
because O 0 0.0047125546261668205
1 O 0 0.007862513884902
of O 0 0.0055123683996498585
the O 0 0.008048666641116142
patients O 1 0.9999513626098633
showed O 1 0.9982696771621704
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.010338450782001019
the O 0 0.008458110503852367
other O 0 0.006101519335061312
later O 0 0.013318290933966637
developed O 0 0.02217268757522106
bilateral B-Disease 0 0.11006857454776764
retinoblastoma I-Disease 1 0.9999879598617554
. O 0 0.04492603987455368

In O 0 0.025766687467694283
conclusion O 0 0.020388027653098106
, O 0 0.00971163623034954
our O 0 0.009481861256062984
results O 0 0.009139582514762878
emphasize O 0 0.014943609945476055
that O 0 0.004607570823282003
the O 0 0.008246156387031078
manifestation O 1 0.833888828754425
and O 0 0.012120853178203106
transmissibility O 1 0.999941349029541
of O 0 0.03313182294368744
retinoblastoma B-Disease 1 0.9999983310699463
depend O 0 0.008607447147369385
on O 0 0.005219487007707357
the O 0 0.004912382457405329
nature O 0 0.004972837399691343
of O 0 0.003763275220990181
the O 0 0.005180560052394867
first O 0 0.007375579793006182
mutation O 0 0.00715312734246254
, O 0 0.004012042190879583
its O 0 0.003628486767411232
time O 0 0.003671869169920683
in O 0 0.00381667073816061
development O 0 0.005069241393357515
, O 0 0.004080654587596655
and O 0 0.0032730151433497667
the O 0 0.003547030733898282
number O 0 0.0030378815717995167
and O 0 0.0033378361258655787
types O 0 0.0040017045103013515
of O 0 0.004623705521225929
cells O 0 0.006493573542684317
that O 0 0.004071678966283798
are O 0 0.004561930429190397
affected O 0 0.010153016075491905
. O 0 0.010879618115723133
. O 0 0.02228127233684063

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.02527795173227787
the I-Disease 0 0.11933460831642151
fifth I-Disease 1 0.9998489618301392
component I-Disease 1 0.9697561860084534
of I-Disease 0 0.014305529184639454
complement I-Disease 0 0.027402574196457863
in O 0 0.015063795261085033
man O 0 0.03645329549908638
. O 0 0.03253401443362236

I O 0 0.12981154024600983
. O 0 0.06502947211265564

Clinical O 1 0.9993584752082825
, O 0 0.02397945150732994
immunochemical O 1 0.999875545501709
, O 0 0.013478213921189308
and O 0 0.011052983812987804
family O 0 0.01996799185872078
studies O 0 0.017464710399508476
. O 0 0.026499690487980843

The O 0 0.022817155346274376
first O 0 0.01581752300262451
recognized O 0 0.015065507963299751
human O 0 0.012269074097275734
kindred O 1 0.9999861717224121
with O 1 0.6922556757926941
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.988108217716217
the I-Disease 1 0.7632863521575928
fifth I-Disease 1 0.999882698059082
component I-Disease 1 0.5977640151977539
of I-Disease 0 0.011128113605082035
complement I-Disease 1 0.7460729479789734
( O 0 0.0339115671813488
C5 O 1 0.9999979734420776
) O 0 0.015967443585395813
is O 0 0.01570068672299385
described O 0 0.027949463576078415
. O 0 0.027203571051359177

The O 0 0.0286128968000412
proband O 0 0.18829253315925598
, O 0 0.00985193531960249
a O 0 0.008768906816840172
20 O 0 0.01236958708614111
- O 1 0.7343835830688477
year O 0 0.009505752474069595
- O 1 0.9784138202667236
old O 0 0.016377616673707962
black O 0 0.014494584873318672
female O 0 0.015183037146925926
with O 1 0.7213703393936157
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.999792754650116
age O 1 0.7502767443656921
11 O 0 0.01919068954885006
, O 0 0.014957409352064133
lacked O 1 0.9723148941993713
serum O 1 0.9999998807907104
hemolytic O 1 1.0
complement O 1 0.9929128289222717
activity O 0 0.014449425972998142
, O 0 0.010441184043884277
even O 0 0.011476058512926102
during O 0 0.021208370104432106
remission O 1 0.9983866214752197
. O 0 0.0340113639831543

C5 O 1 0.9999852180480957
was O 0 0.05085008963942528
undetectable O 1 0.9864472150802612
in O 0 0.013496828265488148
her O 0 0.019860416650772095
serum O 1 0.9884288907051086
by O 0 0.008321097120642662
both O 0 0.010093139484524727
immunodiffusion O 1 0.9999780654907227
and O 0 0.4053078293800354
hemolytic O 1 1.0
assays O 1 0.5042538046836853
. O 0 0.04361823946237564

Other O 0 0.019766420125961304
complement O 0 0.03099219687283039
components O 0 0.018694592639803886
were O 0 0.0064527844078838825
normal O 0 0.007528530899435282
during O 0 0.0110128503292799
remission O 1 0.998469889163971
of O 1 0.8617268800735474
lupus O 1 1.0
, O 1 0.980595588684082
but O 0 0.018868697807192802
C1 O 1 1.0
, O 0 0.021672632545232773
C4 O 1 0.9999940395355225
, O 0 0.02038157358765602
C2 O 1 0.9999998807907104
, O 0 0.012455604039132595
and O 0 0.013044594787061214
C3 O 1 0.9999997615814209
levels O 0 0.02688635140657425
fell O 1 0.9790815114974976
during O 0 0.04051574692130089
exacerbations O 1 0.9999986886978149
. O 0 0.04953838884830475

A O 0 0.03693636506795883
younger O 0 0.0317416749894619
half O 0 0.02043316140770912
- O 1 0.9955105781555176
sister O 0 0.019464991986751556
, O 0 0.0067473603412508965
who O 0 0.006696395576000214
had O 0 0.005513371434062719
no O 0 0.007286193314939737
underlying O 1 0.9999901056289673
disease O 1 1.0
, O 1 0.5551067590713501
was O 1 0.5093255639076233
also O 0 0.0063259233720600605
found O 0 0.004999883007258177
to O 0 0.00771537609398365
lack O 0 0.01939254254102707
immunochemically O 1 0.9999972581863403
detectable O 1 0.9999709129333496
C5 O 1 0.9999799728393555
. O 0 0.04961325600743294

By O 0 0.0395718589425087
hemolytic O 1 1.0
assay O 1 0.8305323123931885
, O 0 0.0152136767283082
she O 0 0.012963134795427322
exhibited O 0 0.018001483753323555
1 O 0 0.01706210896372795
- O 1 0.604638397693634
2 O 0 0.010410789400339127
% O 0 0.0048114531673491
of O 0 0.00455113360658288
the O 0 0.005535419099032879
normal O 0 0.011552865616977215
serum O 1 0.9999504089355469
C5 O 1 0.9999972581863403
level O 0 0.012785582803189754
and O 0 0.008896984159946442
normal O 0 0.01056168507784605
concentrations O 0 0.01262081228196621
of O 0 0.007726031821221113
other O 0 0.008525107987225056
complement O 0 0.03257350996136665
components O 0 0.03535151481628418
. O 0 0.03194860741496086

C5 O 1 0.9996583461761475
levels O 0 0.020001258701086044
of O 0 0.01159247662872076
other O 0 0.00693857204169035
family O 0 0.008180780336260796
members O 0 0.004958468023687601
were O 0 0.0036358677316457033
either O 0 0.003813765710219741
normal O 0 0.004586986731737852
or O 0 0.0039582219906151295
approximately O 0 0.00553582888096571
half O 0 0.007752271834760904
- O 1 0.923970103263855
normal O 0 0.007567680906504393
, O 0 0.006361102219671011
consistent O 0 0.010095807723701
with O 0 0.008829501457512379
autosomal O 1 0.9891308546066284
codominant O 1 0.9998509883880615
inheritance O 0 0.02591032348573208
of O 0 0.007793829310685396
the O 0 0.010839829221367836
gene O 0 0.020929263904690742
determining O 0 0.47663551568984985
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.38498184084892273

Normal O 1 0.5379301309585571
hemolytic O 1 1.0
titers O 1 0.9999661445617676
were O 0 0.013514069840312004
restored O 0 0.019811300560832024
to O 0 0.007897594012320042
both O 0 0.007967465557157993
homozygous O 0 0.09873178601264954
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 1 0.7342584133148193
C5D B-Disease 1 1.0
) O 0 0.02057665027678013
sera O 0 0.4356243312358856
by O 0 0.008148067630827427
addition O 0 0.011489687487483025
of O 0 0.011631946079432964
highly O 0 0.0280118677765131
purified O 1 0.9580036997795105
human O 0 0.04188884049654007
C5 O 1 0.9998905658721924
. O 0 0.05941995978355408

In O 0 0.02566133625805378
specific O 0 0.022951800376176834
C5 O 1 0.9999980926513672
titrations O 1 0.9998003840446472
, O 0 0.011623446829617023
however O 0 0.006385228596627712
, O 0 0.006066650152206421
it O 0 0.004500930197536945
was O 0 0.0076641300693154335
noted O 0 0.00595802953466773
that O 0 0.003676146734505892
when O 0 0.0050600748509168625
limited O 0 0.007429076358675957
amounts O 0 0.008249050937592983
of O 0 0.010149900801479816
C5 O 1 0.999849796295166
were O 0 0.00861942209303379
assayed O 0 0.024891244247555733
in O 0 0.005686120130121708
the O 0 0.005506489425897598
presence O 0 0.006125823128968477
of O 0 0.007223866879940033
low O 0 0.012580364011228085
dilutions O 0 0.300462543964386
of O 0 0.009145587682723999
either O 0 0.012630156241357327
C5D B-Disease 1 1.0
serum O 1 0.9999663829803467
, O 0 0.016034534201025963
curving O 0 0.027845002710819244
rather O 0 0.008142766542732716
than O 0 0.006627203896641731
linear O 0 0.014687704853713512
dose O 1 0.9799394607543945
- O 1 0.9943490624427795
response O 0 0.009631969034671783
plots O 0 0.010722629725933075
were O 0 0.0052676089107990265
consistently O 0 0.010649490170180798
obtained O 0 0.008995377458631992
, O 0 0.007129258010536432
suggesting O 0 0.010733324103057384
some O 0 0.009308627806603909
inhibitory O 0 0.032558538019657135
effect O 0 0.02478882111608982
. O 0 0.028790263459086418

Further O 0 0.021492015570402145
studies O 0 0.013986228965222836
suggested O 0 0.009805681183934212
that O 0 0.006053948309272528
low O 0 0.014566539786756039
dilutions O 0 0.397291362285614
of O 0 0.014553498476743698
C5D B-Disease 1 1.0
serum O 1 0.9998013377189636
contain O 0 0.013014638796448708
a O 0 0.011811267584562302
factor O 0 0.019942330196499825
( O 0 0.007258674129843712
or O 0 0.006968370638787746
factors O 0 0.0067559052258729935
) O 0 0.006079688668251038
interfering O 0 0.008792862296104431
at O 0 0.006710664834827185
some O 0 0.0036909410264343023
step O 0 0.007620456162840128
in O 0 0.005894789472222328
the O 0 0.01103453803807497
hemolytic O 1 1.0
assay O 1 0.9832726716995239
of O 0 0.09964025765657425
C5 O 1 0.9999985694885254
, O 0 0.011567948386073112
rather O 0 0.008647958748042583
than O 0 0.006470769643783569
a O 0 0.01273928489536047
true O 0 0.02899530716240406
C5 O 1 0.9999986886978149
inhibitor O 1 0.9999533891677856
or O 0 0.027013016864657402
inactivator O 1 0.9951643943786621
. O 0 0.043954767286777496

Of O 0 0.02736847661435604
clinical O 1 0.9387325644493103
interest O 0 0.010550239123404026
are O 0 0.0046324110589921474
( O 0 0.006497325375676155
a O 0 0.006415528245270252
) O 0 0.005341355223208666
the O 0 0.006228879559785128
documentation O 0 0.012325635179877281
of O 0 0.012319356203079224
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999964237213135
vasculitis B-Disease 1 1.0
, O 1 0.9997815489768982
and O 1 0.9999732971191406
arthritis B-Disease 1 1.0
in O 0 0.054075032472610474
an O 0 0.010727670043706894
individual O 0 0.01213579997420311
lacking O 1 0.999798595905304
C5 O 1 0.9999998807907104
( O 0 0.010316870175302029
and O 0 0.0069563137367367744
its O 0 0.00847094226628542
biologic O 1 0.9911724925041199
functions O 0 0.009649123065173626
) O 0 0.007037012372165918
, O 0 0.005890230182558298
and O 0 0.005443006753921509
( O 0 0.008937296457588673
b O 0 0.07307184487581253
) O 0 0.0070572891272604465
a O 0 0.008611077442765236
remarkable O 0 0.016145911067724228
propensity O 1 0.6337956190109253
to O 0 0.017556868493556976
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.011959598399698734
the O 0 0.016553828492760658
proband O 1 0.9996685981750488
, O 0 0.008516180329024792
even O 0 0.005721320863813162
during O 0 0.007082860451191664
periods O 0 0.00822953786700964
of O 0 0.008086975663900375
low O 0 0.018464773893356323
- O 1 0.9939171671867371
dose O 0 0.06031350791454315
or O 0 0.009269614703953266
alternate O 0 0.01910039223730564
- O 1 0.9991652965545654
day O 0 0.04324256628751755
corticosteroid O 1 0.9999983310699463
therapy O 1 0.9999442100524902
. O 0 0.04140036925673485

Other O 0 0.01737125962972641
observations O 0 0.02049570344388485
indicate O 0 0.00985571276396513
that O 0 0.005294581409543753
the O 0 0.008627424016594887
C5D B-Disease 1 0.9999926090240479
state O 0 0.006277794949710369
is O 0 0.006723212078213692
compatible O 0 0.01269474346190691
with O 0 0.006191035732626915
normal O 0 0.010411537252366543
coagulation O 1 0.9997275471687317
function O 0 0.006738903000950813
and O 0 0.005335129797458649
the O 0 0.005372973624616861
capacity O 0 0.009962214156985283
to O 0 0.008668705821037292
mount O 0 0.04093720391392708
a O 0 0.020744305104017258
neutrophilic O 1 0.9999998807907104
leukocytosis O 1 0.9999998807907104
during O 1 0.9998550415039062
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.02970571257174015
. O 0 0.0368550680577755

Susceptibility O 1 0.9995465874671936
to O 0 0.22734898328781128
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9159196615219116
twins O 1 0.9972768425941467
: O 0 0.011328719556331635
the O 0 0.007867583073675632
role O 0 0.00800669752061367
of O 0 0.007267220877110958
genes O 0 0.009734919294714928
, O 0 0.016124093905091286
HLA O 1 1.0
, O 0 0.010721741244196892
and O 0 0.009194093756377697
the O 0 0.013948126696050167
environment O 0 0.03057025372982025
. O 0 0.03147304803133011

OBJECTIVE O 0 0.043671779334545135
To O 0 0.012113165110349655
determine O 0 0.008105908520519733
the O 0 0.007457931526005268
relative O 0 0.011444997042417526
effects O 0 0.01014578714966774
of O 0 0.007186023984104395
genetic O 0 0.009410322643816471
and O 0 0.005609402898699045
environmental O 0 0.011406432837247849
factors O 0 0.007357776165008545
in O 0 0.007618076633661985
susceptibility O 1 0.9999920129776001
to O 1 0.995537519454956
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999939203262329
AS B-Disease 1 0.9999784231185913
) O 0 0.026955243200063705
. O 0 0.03718830272555351

METHODS O 0 0.03853706642985344
Twins O 0 0.042457424104213715
with O 0 0.010953345336019993
AS B-Disease 0 0.012896157801151276
were O 0 0.0046469904482364655
identified O 0 0.005354488734155893
from O 0 0.003468524431809783
the O 0 0.005889655090868473
Royal O 0 0.23980921506881714
National O 1 0.9689287543296814
Hospital O 1 1.0
for O 1 0.9999512434005737
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9998692274093628
. O 0 0.039942916482686996

Clinical O 1 0.9978228807449341
and O 0 0.023155363276600838
radiographic O 1 0.9998939037322998
examinations O 0 0.17128638923168182
were O 0 0.006981144659221172
performed O 0 0.007550334092229605
to O 0 0.005095211323350668
establish O 0 0.010325315408408642
diagnoses O 1 0.9999970197677612
, O 0 0.01669415831565857
and O 1 0.5187044143676758
disease O 1 1.0
severity O 1 1.0
was O 1 0.9890783429145813
assessed O 0 0.016353217884898186
using O 0 0.008558852598071098
a O 0 0.010279370471835136
combination O 0 0.014751785434782505
of O 0 0.010186951607465744
validated O 0 0.03217161446809769
scoring O 0 0.026897994801402092
systems O 0 0.03886476159095764
. O 0 0.03717009723186493

HLA O 1 0.9999963045120239
typing O 0 0.11325112730264664
for O 0 0.024458402767777443
HLA O 1 1.0
- O 1 0.9999970197677612
B27 O 1 0.9997252821922302
, O 0 0.024530969560146332
HLA O 1 1.0
- O 1 0.999970555305481
B60 O 1 0.9794607162475586
, O 0 0.010967974551022053
and O 0 0.014208600856363773
HLA O 1 1.0
- O 1 1.0
DR1 O 1 0.9999977350234985
was O 0 0.01717188023030758
performed O 0 0.013210982084274292
by O 0 0.008064698427915573
polymerase O 0 0.02688317373394966
chain O 0 0.015491039492189884
reaction O 0 0.009501191787421703
with O 0 0.006115035619586706
sequence O 0 0.00871879979968071
- O 0 0.032378919422626495
specific O 0 0.008599198423326015
primers O 0 0.02374991588294506
, O 0 0.008948960341513157
and O 0 0.009510031901299953
zygosity O 1 0.9207083582878113
was O 0 0.01803482696413994
assessed O 0 0.022731956094503403
using O 0 0.021038584411144257
microsatellite O 1 0.9450159668922424
markers O 0 0.06135687977075577
. O 0 0.0346069373190403

Genetic O 0 0.03426850587129593
and O 0 0.01443115808069706
environmental O 0 0.015686772763729095
variance O 0 0.012404166162014008
components O 0 0.012451499700546265
were O 0 0.004572518635541201
assessed O 0 0.008311815559864044
with O 0 0.00487458286806941
the O 0 0.006480466574430466
program O 0 0.014006642624735832
Mx O 1 0.9999449253082275
, O 0 0.006627100519835949
using O 0 0.004689561668783426
data O 0 0.003601944074034691
from O 0 0.0027287104167044163
this O 0 0.002584756352007389
and O 0 0.0035973216872662306
previous O 0 0.004757127724587917
studies O 0 0.0055601769126951694
of O 0 0.006218586582690477
twins O 1 0.6701353192329407
with O 0 0.010634624399244785
AS B-Disease 1 0.9384473562240601
. O 0 0.02777685411274433

RESULTS O 0 0.031870462000370026
Six O 0 0.016557825729250908
of O 0 0.01185351237654686
8 O 0 0.024593772366642952
monozygotic O 1 0.998846173286438
( O 0 0.04942809417843819
MZ O 1 1.0
) O 0 0.01720787212252617
twin O 0 0.08019320666790009
pairs O 0 0.014281543903052807
were O 0 0.008601808920502663
disease O 1 0.9999974966049194
concordant O 1 0.9974995255470276
, O 0 0.006796591449528933
compared O 0 0.006290188524872065
with O 0 0.004671113565564156
4 O 0 0.008702495135366917
of O 0 0.0073754750192165375
15 O 0 0.015430223196744919
B27 O 1 0.9132574796676636
- O 1 0.8769741654396057
positive O 0 0.018893130123615265
dizygotic O 1 0.9824106693267822
( O 0 0.02228287234902382
DZ O 1 0.9999884366989136
) O 0 0.015080368146300316
twin O 0 0.03546991944313049
pairs O 0 0.01333747897297144
( O 0 0.009108131751418114
27 O 0 0.015935318544507027
% O 0 0.008075540885329247
) O 0 0.005982149858027697
and O 0 0.004839003551751375
4 O 0 0.008540364913642406
of O 0 0.008170993998646736
32 O 0 0.020645832642912865
DZ O 1 0.9999951124191284
twin O 0 0.4824892282485962
pairs O 0 0.015498082153499126
overall O 0 0.014054769650101662
( O 0 0.009135210886597633
12 O 0 0.011769031174480915
. O 0 0.008089730516076088
5 O 0 0.015346993692219257
% O 0 0.013691436499357224
) O 0 0.01712866686284542
. O 0 0.024599332362413406

Nonsignificant O 1 0.9767370820045471
increases O 0 0.021294046193361282
in O 0 0.01071072556078434
similarity O 0 0.011633329093456268
with O 0 0.004812979139387608
regard O 0 0.006164927035570145
to O 0 0.0045676808804273605
age O 0 0.010617529973387718
at O 1 0.984927773475647
disease O 1 1.0
onset O 1 1.0
and O 0 0.006364128086715937
all O 0 0.0034053672570735216
of O 0 0.005395910236984491
the O 0 0.13192147016525269
disease O 1 1.0
severity O 1 0.9999926090240479
scores O 0 0.012813839130103588
assessed O 0 0.01186639815568924
were O 0 0.004937837831676006
noted O 0 0.008273127488791943
in O 0 0.010563509538769722
disease O 1 0.9999998807907104
- O 1 0.9999998807907104
concordant O 1 0.9999738931655884
MZ O 1 1.0
twins O 0 0.43912601470947266
compared O 0 0.022774716839194298
with O 0 0.021308301016688347
concordant O 1 0.9847603440284729
DZ O 1 0.9999986886978149
twins O 1 0.965698778629303
. O 0 0.05768250301480293

HLA O 1 1.0
- O 1 0.9999973773956299
B27 O 1 0.9926839470863342
and O 0 0.012583006173372269
B60 O 0 0.14380139112472534
were O 0 0.005603310186415911
associated O 0 0.004880173597484827
with O 0 0.004253112245351076
the O 0 0.008755381219089031
disease O 1 0.9999998807907104
in O 0 0.03309578821063042
probands O 1 0.9999985694885254
, O 0 0.005754656158387661
and O 0 0.003843737533316016
the O 0 0.005247887223958969
rate O 0 0.006027651485055685
of O 0 0.008676240220665932
disease O 1 0.9999949932098389
concordance O 1 0.982660710811615
was O 0 0.01758744940161705
significantly O 0 0.011583651416003704
increased O 0 0.011811274103820324
among O 0 0.013482538983225822
DZ O 1 0.999998927116394
twin O 1 0.5528096556663513
pairs O 0 0.009574946947395802
in O 0 0.00459884200245142
which O 0 0.004237619694322348
the O 0 0.0071729752235114574
co O 1 0.9982445240020752
- O 1 0.999982476234436
twin O 1 0.86435467004776
was O 0 0.009886443614959717
positive O 0 0.006612760480493307
for O 0 0.006005380302667618
both O 0 0.008873703889548779
B27 O 1 0.9854429960250854
and O 0 0.02426101267337799
DR1 O 1 0.9999477863311768
. O 0 0.04145490378141403

Additive O 0 0.08945762366056442
genetic O 0 0.023999366909265518
effects O 0 0.01464427262544632
were O 0 0.005386924836784601
estimated O 0 0.007911871187388897
to O 0 0.005773544777184725
contribute O 0 0.011788636445999146
97 O 0 0.022846313193440437
% O 0 0.007703713607043028
of O 0 0.00646375585347414
the O 0 0.007350604981184006
population O 0 0.008385511115193367
variance O 0 0.020311182364821434
. O 0 0.024098165333271027

CONCLUSION O 0 0.05788237228989601
Susceptibility O 1 0.5379389524459839
to O 0 0.013404750265181065
AS B-Disease 0 0.017009131610393524
is O 0 0.007896525785326958
largely O 0 0.007581193931400776
genetically O 0 0.008716530166566372
determined O 0 0.006773531902581453
, O 0 0.004713487811386585
and O 0 0.0038732632528990507
the O 0 0.004568062257021666
environmental O 0 0.010277303867042065
trigger O 0 0.03158502280712128
for O 0 0.007775086909532547
the O 1 0.8402092456817627
disease O 1 1.0
is O 0 0.017714006826281548
probably O 0 0.023652037605643272
ubiquitous O 1 0.8193709254264832
. O 0 0.031587887555360794

HLA O 1 1.0
- O 1 0.9998254179954529
B27 O 0 0.0802759975194931
accounts O 0 0.012712026946246624
for O 0 0.006363175809383392
a O 0 0.006555876694619656
minority O 0 0.006409615743905306
of O 0 0.004953315947204828
the O 0 0.007200019434094429
overall O 0 0.074007049202919
genetic O 0 0.09297947585582733
susceptibility O 1 0.9956756234169006
to O 0 0.014720519073307514
AS B-Disease 0 0.40140947699546814
. O 0 0.03601052239537239

Cell O 0 0.08185304701328278
cycle O 0 0.04856773465871811
- O 0 0.48210659623146057
dependent O 0 0.025845680385828018
colocalization O 0 0.17365756630897522
of O 0 0.017617488279938698
BARD1 O 1 0.9999986886978149
and O 0 0.022523831576108932
BRCA1 O 1 0.9998726844787598
proteins O 0 0.01499879639595747
in O 0 0.011289148591458797
discrete O 0 0.025432270020246506
nuclear O 0 0.032025646418333054
domains O 0 0.04401211068034172
. O 0 0.03394176810979843

Germ O 1 0.9999864101409912
- O 1 0.9991650581359863
line O 0 0.025415269657969475
mutations O 0 0.015085595659911633
of O 0 0.008521554060280323
the O 0 0.011310543864965439
BRCA1 O 1 0.9999232292175293
gene O 0 0.013021628372371197
predispose O 0 0.11629234999418259
women O 0 0.007558181881904602
to O 0 0.005000784993171692
early O 0 0.01099137868732214
- O 1 0.9999997615814209
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999891519546509
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.011697489768266678
compromising O 1 0.8737010955810547
the O 0 0.011593169532716274
genes O 0 0.013531987555325031
presumptive O 1 0.9999748468399048
function O 0 0.011688402853906155
as O 0 0.011868618428707123
a O 0 0.025323564186692238
tumor B-Disease 1 0.9999994039535522
suppressor O 1 0.9998273849487305
. O 0 0.04809773713350296

Although O 0 0.021895593032240868
the O 0 0.017865121364593506
biochemical O 0 0.035338882356882095
properties O 0 0.021723410114645958
of O 0 0.01647743210196495
BRCA1 O 1 0.9999929666519165
polypeptides O 0 0.0348718985915184
are O 0 0.0050412677228450775
not O 0 0.004402074497193098
understood O 0 0.006842704955488443
, O 0 0.005092903506010771
their O 0 0.004676057491451502
expression O 0 0.007877704687416553
pattern O 0 0.01031425129622221
and O 0 0.008730924688279629
subcellular O 0 0.03142022714018822
localization O 0 0.021581072360277176
suggest O 0 0.008141126483678818
a O 0 0.007613499648869038
role O 0 0.009911353699862957
in O 0 0.009466583840548992
cell O 0 0.05255661532282829
- O 1 0.9992479681968689
cycle O 0 0.027247224003076553
regulation O 0 0.032381322234869
. O 0 0.03209953382611275

When O 0 0.04706534370779991
resting O 1 0.9928104281425476
cells O 0 0.022566745057702065
are O 0 0.008106646127998829
induced O 1 0.7076348662376404
to O 0 0.010652792640030384
proliferate O 0 0.027798045426607132
, O 0 0.00786637607961893
the O 0 0.0077518317848443985
steady O 0 0.015205277130007744
- O 0 0.02208460122346878
state O 0 0.005291333422064781
levels O 0 0.0066110072657465935
of O 0 0.007469122763723135
BRCA1 O 0 0.48105207085609436
increase O 0 0.007061086129397154
in O 0 0.006820481736212969
late O 0 0.018437905237078667
G1 O 1 0.9999068975448608
and O 0 0.008221151307225227
reach O 0 0.00929713062942028
a O 0 0.008417855016887188
maximum O 0 0.01317940279841423
during O 0 0.01790798455476761
S O 1 0.971906304359436
phase O 0 0.050605084747076035
. O 0 0.037615831941366196

Moreover O 0 0.03499745577573776
, O 0 0.013668916188180447
in O 0 0.012228365987539291
S O 1 0.9974479675292969
phase O 0 0.3349400460720062
cells O 0 0.019270047545433044
, O 0 0.014627556316554546
BRCA1 O 1 0.9976907968521118
polypeptides O 0 0.031610552221536636
are O 0 0.007240087725222111
hyperphosphorylated O 0 0.361083447933197
and O 0 0.010064523667097092
accumulate O 0 0.022269664332270622
into O 0 0.012151875533163548
discrete O 0 0.027163533493876457
subnuclear O 1 0.9893636703491211
foci O 1 0.9962064027786255
termed O 1 0.6348237991333008
" O 0 0.034285154193639755
BRCA1 O 1 0.9997730851173401
nuclear O 0 0.05681002885103226
dots O 0 0.08954133093357086
. O 0 0.04774188622832298

" O 0 0.04826045781373978
BRCA1 O 1 0.9999003410339355
associates O 0 0.29256731271743774
in O 0 0.013896462507545948
vivo O 0 0.0295614805072546
with O 0 0.009310442954301834
a O 0 0.012702037580311298
structurally O 1 0.7238901257514954
related O 0 0.021171804517507553
protein O 0 0.02536488138139248
termed O 1 0.5376287698745728
BARD1 O 1 0.9999788999557495
. O 0 0.04703573137521744

Here O 0 0.019765647128224373
we O 0 0.00920788198709488
show O 0 0.008654709905385971
that O 0 0.0036647426895797253
the O 0 0.00605801260098815
steady O 0 0.012336588464677334
- O 0 0.0265737883746624
state O 0 0.0060479892417788506
levels O 0 0.006713481619954109
of O 0 0.007319344207644463
BARD1 O 1 0.9998722076416016
, O 0 0.0073213716968894005
unlike O 0 0.006990419700741768
those O 0 0.004592830315232277
of O 0 0.0071996236220002174
BRCA1 O 1 0.9998729228973389
, O 0 0.007320553530007601
remain O 0 0.008961529470980167
relatively O 0 0.009103832766413689
constant O 0 0.013011325150728226
during O 0 0.01662861928343773
cell O 0 0.10039841383695602
cycle O 0 0.03957821801304817
progression O 1 0.640974223613739
. O 0 0.03665570914745331

However O 0 0.024039968848228455
, O 0 0.01831956021487713
immunostaining O 1 0.8414255380630493
revealed O 0 0.019136516377329826
that O 0 0.010984041728079319
BARD1 O 1 0.998713493347168
resides O 0 0.03848639875650406
within O 0 0.013954994268715382
BRCA1 O 1 0.9788574576377869
nuclear O 0 0.019233670085668564
dots O 0 0.022704144939780235
during O 0 0.011651852168142796
S O 1 0.6423218846321106
phase O 0 0.014283147640526295
of O 0 0.006111437454819679
the O 0 0.007747050374746323
cell O 0 0.016722209751605988
cycle O 0 0.009873252362012863
, O 0 0.005737896542996168
but O 0 0.0038970194291323423
not O 0 0.0036193288397043943
during O 0 0.009571678005158901
the O 0 0.016096098348498344
G1 O 1 0.9999942779541016
phase O 0 0.06552928686141968
. O 0 0.039501167833805084

Nevertheless O 0 0.059358853846788406
, O 0 0.027890754863619804
BARD1 O 1 0.9996993541717529
polypeptides O 0 0.038434263318777084
are O 0 0.006341445259749889
found O 0 0.006322093773633242
exclusively O 0 0.008097432553768158
in O 0 0.004731078632175922
the O 0 0.0058390055783092976
nuclear O 0 0.009752851910889149
fractions O 0 0.012780130840837955
of O 0 0.00742122158408165
both O 0 0.010445855557918549
G1 O 1 0.9999978542327881
- O 1 0.9995390176773071
and O 0 0.01779066026210785
S O 1 0.9999569654464722
- O 1 0.9999732971191406
phase O 0 0.07945045828819275
cells O 0 0.03772156313061714
. O 0 0.03440925478935242

Therefore O 0 0.030436603352427483
, O 0 0.0178687684237957
progression O 0 0.03354339674115181
to O 0 0.012168426997959614
S O 1 0.9993705153465271
phase O 0 0.026846859604120255
is O 0 0.009872674942016602
accompanied O 0 0.016083477064967155
by O 0 0.00615739356726408
the O 0 0.008640925399959087
aggregation O 0 0.018823429942131042
of O 0 0.012539121322333813
nuclear O 0 0.033572372049093246
BARD1 O 1 0.9972225427627563
polypeptides O 0 0.05638381466269493
into O 0 0.029442084953188896
BRCA1 O 1 0.9971022009849548
nuclear O 0 0.05138508230447769
dots O 0 0.0742197260260582
. O 0 0.03924160078167915

This O 0 0.024469418451189995
cell O 0 0.03689945861697197
cycle O 0 0.03311038017272949
- O 1 0.5679361820220947
dependent O 0 0.020158179104328156
colocalization O 0 0.12892501056194305
of O 0 0.017633434385061264
BARD1 O 1 0.9999986886978149
and O 0 0.02181190811097622
BRCA1 O 1 0.9997007846832275
indicates O 0 0.014313668012619019
a O 0 0.009285543113946915
role O 0 0.010798340663313866
for O 0 0.009011928923428059
BARD1 O 1 0.9998551607131958
in O 0 0.017232147976756096
BRCA1 O 1 0.9999998807907104
- O 1 1.0
mediated O 1 0.9999904632568359
tumor B-Disease 1 0.9999998807907104
suppression O 1 0.9999574422836304
. O 0 0.054255735129117966

Ethnic O 0 0.02750552073121071
differences O 0 0.015280351042747498
in O 0 0.012010077014565468
the O 0 0.01704656332731247
HFE O 1 0.9999500513076782
codon O 0 0.0555717870593071
282 O 1 0.9816793203353882
( O 0 0.08748950809240341
Cys O 1 1.0
/ O 1 0.9999988079071045
Tyr O 1 0.9999996423721313
) O 0 0.03770924359560013
polymorphism O 0 0.0729277953505516
. O 0 0.04759224131703377

Recent O 0 0.019943958148360252
studies O 0 0.009757855907082558
have O 0 0.004323805216699839
shown O 0 0.0064054508693516254
that O 0 0.008245427161455154
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.01601581834256649
is O 0 0.006431249901652336
likely O 0 0.006167054176330566
to O 0 0.004590814467519522
be O 0 0.004058897960931063
caused O 0 0.00768844410777092
by O 0 0.005123602692037821
homozygosity O 0 0.354619562625885
for O 0 0.0077953040599823
a O 0 0.012650391086935997
Cys282Tyr O 1 0.9989199638366699
mutation O 0 0.012969610281288624
in O 0 0.008071285672485828
the O 0 0.013673247769474983
HFE O 1 0.9999955892562866
gene O 0 0.023088786751031876
located O 0 0.024700826033949852
4 O 0 0.031021425500512123
. O 0 0.029810404404997826

5 O 0 0.07938485592603683
Mb O 1 0.9648115634918213
telomeric O 1 0.8904752135276794
to O 0 0.042404308915138245
HLA O 1 1.0
- O 1 0.99992835521698
A O 0 0.05526990443468094
. O 0 0.03570715710520744

Population O 0 0.019881192594766617
studies O 0 0.013580565340816975
of O 0 0.009331485256552696
this O 0 0.006688205990940332
polymorphism O 0 0.016621267423033714
are O 0 0.004324379842728376
facilitated O 0 0.010727882385253906
by O 0 0.0047249929048120975
the O 0 0.005724495276808739
fact O 0 0.006052783690392971
that O 0 0.004382445476949215
the O 0 0.009419172070920467
Cys282Tyr O 1 0.9960636496543884
mutation O 0 0.017792636528611183
creates O 0 0.02026265859603882
a O 0 0.018045935779809952
Rsal O 1 0.9995784163475037
restriction O 0 0.03223276510834694
site O 0 0.03600183501839638
. O 0 0.0303492471575737

We O 0 0.018670707941055298
have O 0 0.008119084872305393
studied O 0 0.012414409779012203
the O 0 0.010202426463365555
codon O 0 0.028583573177456856
282 O 0 0.4007934331893921
( O 0 0.043543774634599686
Cys O 1 1.0
/ O 1 0.9999994039535522
Tyr O 1 0.9999997615814209
) O 0 0.021087095141410828
polymorphism O 0 0.02685069479048252
in O 0 0.009728522971272469
different O 0 0.006698730867356062
ethnic O 0 0.013238927349448204
groups O 0 0.0140723567456007
. O 0 0.025625422596931458

In O 0 0.020277120172977448
agreement O 0 0.01625788025557995
with O 0 0.009883765131235123
previous O 0 0.012401157990098
observations O 0 0.016097456216812134
the O 0 0.012964660301804543
Tyr O 1 0.9999995231628418
allele O 0 0.027442103251814842
appeared O 0 0.010324664413928986
to O 0 0.006722345948219299
be O 0 0.005855714902281761
rare O 0 0.009505415335297585
or O 0 0.0062022884376347065
absent O 0 0.014326387085020542
in O 0 0.008656563237309456
Asiatic O 1 0.9999821186065674
( O 0 0.012810524553060532
Indian O 0 0.015406965278089046
, O 0 0.011556396260857582
Chinese O 0 0.02082265168428421
) O 0 0.017000529915094376
populations O 0 0.02121507190167904
. O 0 0.03159727901220322

The O 0 0.02653539925813675
highest O 0 0.03142375871539116
allele O 0 0.031705256551504135
frequency O 0 0.015452479012310505
( O 0 0.008767841383814812
7 O 0 0.01226204913109541
. O 0 0.00671255262568593
5 O 0 0.01147095300257206
% O 0 0.008344067260622978
) O 0 0.007429775316268206
was O 0 0.01152023021131754
found O 0 0.008166562765836716
in O 0 0.012699393555521965
Swedes O 0 0.05033762753009796
. O 0 0.029830506071448326

Saamis O 1 0.99543297290802
( O 0 0.01971038430929184
2 O 0 0.021993093192577362
% O 0 0.011270338669419289
) O 0 0.008538959547877312
and O 0 0.008267494849860668
Mordvinians O 1 0.9924874305725098
( O 0 0.008000442758202553
1 O 0 0.010860007256269455
. O 0 0.005635401234030724
8 O 0 0.010058775544166565
% O 0 0.006265687756240368
) O 0 0.006254134699702263
had O 0 0.007613669149577618
significantly O 0 0.009138883091509342
lower O 0 0.010874426923692226
frequencies O 0 0.008507182821631432
of O 0 0.009427334181964397
the O 0 0.0187312513589859
Tyr O 1 0.9999984502792358
allele O 0 0.07972042262554169
. O 0 0.04086434468626976

Comparisons O 0 0.03930177539587021
with O 0 0.017121806740760803
allele O 0 0.024705491960048676
frequencies O 0 0.010881040245294571
based O 0 0.00929170474410057
on O 0 0.0075060403905808926
prevalence O 0 0.018864411860704422
estimates O 0 0.010113995522260666
of O 0 0.010354319587349892
HH B-Disease 1 1.0
showed O 0 0.012305288575589657
some O 0 0.005669733043760061
disagreements O 0 0.011904661543667316
with O 0 0.0070026046596467495
the O 0 0.009648684412240982
RFLP O 1 0.9382638335227966
data O 0 0.011866726912558079
, O 0 0.011089622974395752
particularly O 0 0.013229306787252426
in O 0 0.015090483240783215
Finns O 0 0.10614319890737534
. O 0 0.03337204456329346

The O 0 0.03649282827973366
newly O 0 0.05151933431625366
described O 0 0.0373721569776535
HFE O 1 0.9999984502792358
marker O 1 0.6911632418632507
provides O 0 0.015232132747769356
a O 0 0.00797351635992527
new O 0 0.0068650804460048676
approach O 0 0.0055855317041277885
to O 0 0.0037897902075201273
the O 0 0.004893110599368811
screening O 0 0.011176892556250095
of O 0 0.010639813728630543
HH B-Disease 1 1.0
as O 0 0.006712495815008879
well O 0 0.005055259447544813
as O 0 0.004018991254270077
studies O 0 0.004215764347463846
of O 0 0.0038720346055924892
the O 0 0.004498093854635954
relationship O 0 0.006268654949963093
between O 0 0.005948508623987436
the O 0 0.012228505685925484
HFE O 1 1.0
Tyr O 1 1.0
allele O 0 0.11843004822731018
and O 0 0.013399642892181873
different O 0 0.013866269960999489
disorders O 1 0.9999998807907104
including O 1 0.9236536026000977
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999529123306274
dominant I-Disease 1 0.9999954700469971
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.028591537848114967
with O 0 0.010425498709082603
a O 0 0.012895733118057251
missense O 0 0.02768198773264885
mutation O 0 0.01664348505437374
encoding O 0 0.019097862765192986
Gly23 O 1 0.9999587535858154
- O 1 0.9999992847442627
- O 1 0.9999947547912598
> O 1 0.9974647760391235
Val O 1 0.9984536170959473
in O 0 0.02370040863752365
neurophysin O 1 0.9999055862426758
II O 1 0.9999964237213135
. O 0 0.04700499400496483

Autosomal B-Disease 1 0.9997908473014832
dominant I-Disease 1 0.9999711513519287
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999486207962036
ADNDI B-Disease 1 1.0
) O 0 0.011026340536773205
is O 0 0.00836052093654871
an O 0 0.020499831065535545
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999992847442627
by O 0 0.21382136642932892
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9602460861206055
the O 1 0.7456272840499878
magnocellular O 1 0.9999978542327881
neurons O 0 0.02457232028245926
of O 0 0.009652427397668362
the O 0 0.009803756140172482
hypothalamus O 0 0.3908883035182953
leading O 0 0.018671004101634026
to O 0 0.007482715416699648
decreased O 0 0.011827612295746803
ability O 0 0.006696541793644428
to O 0 0.005526179447770119
produce O 0 0.008742734789848328
the O 0 0.011007007211446762
hormone O 1 0.9616120457649231
arginine O 1 0.9598501920700073
vasopressin O 1 0.9998339414596558
( O 0 0.08460918813943863
AVP O 1 0.9999964237213135
) O 0 0.03675531595945358
. O 0 0.038008663803339005

Affected O 0 0.027782585471868515
individuals O 0 0.007405922748148441
are O 0 0.004017537459731102
not O 0 0.005687525030225515
symptomatic O 1 0.9999982118606567
at O 0 0.19181738793849945
birth O 1 0.5461862683296204
, O 0 0.006030771881341934
but O 0 0.004640120547264814
usually O 0 0.007621292490512133
develop O 1 0.6495360136032104
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 1 0.5266542434692383
1 O 0 0.24084194004535675
- O 1 0.9996743202209473
6 O 0 0.030655134469270706
yr O 1 0.9561611413955688
of O 0 0.024826252833008766
age O 0 0.03518027067184448
. O 0 0.036445252597332

The O 0 0.02859012968838215
genetic O 0 0.02246655896306038
locus O 0 0.034393180161714554
of O 0 0.009371251799166203
the O 0 0.012717463076114655
disease O 1 0.9999969005584717
is O 0 0.008325166068971157
the O 0 0.012963331304490566
AVP O 1 1.0
- O 1 0.9999996423721313
neurophysin O 1 0.999995231628418
II O 1 1.0
( O 0 0.021417343989014626
NPII O 1 0.9999934434890747
) O 0 0.0111137880012393
gene O 0 0.008540812879800797
, O 0 0.006327568553388119
and O 0 0.00624661473557353
mutations O 0 0.007185135968029499
that O 0 0.0044145481660962105
cause O 1 0.9734731316566467
ADNDI B-Disease 1 0.9999998807907104
have O 0 0.004645274952054024
been O 0 0.0039622588083148
found O 0 0.0031961805652827024
in O 0 0.0032856690231710672
both O 0 0.003536428790539503
the O 0 0.004941296763718128
signal O 0 0.009888960979878902
peptide O 0 0.012903881259262562
of O 0 0.006330229341983795
the O 0 0.011019415222108364
prepro O 1 0.9999746084213257
- O 1 0.9999998807907104
AVP O 1 1.0
- O 1 0.9999979734420776
NPII O 1 0.9999872446060181
precursor O 0 0.04429568350315094
and O 0 0.01610172539949417
within O 0 0.021412093192338943
NPII O 1 0.9995715022087097
itself O 0 0.04268909618258476
. O 0 0.032495830208063126

An O 0 0.02827116847038269
affected O 0 0.025559695437550545
girl O 0 0.03285566717386246
who O 0 0.011121179908514023
presented O 0 0.012017390690743923
at O 0 0.008738371543586254
9 O 0 0.01031236257404089
months O 0 0.00719465920701623
of O 0 0.006209849379956722
age O 0 0.008001835085451603
and O 0 0.005869176704436541
her O 0 0.009254563599824905
similarly O 0 0.01183395180851221
affected O 0 0.012396725825965405
younger O 1 0.500929594039917
brother O 1 0.6296376585960388
and O 0 0.0064833504147827625
father O 0 0.013306623324751854
were O 0 0.0032972199842333794
all O 0 0.0034166653640568256
found O 0 0.0031148307025432587
to O 0 0.0039013810455799103
have O 0 0.003542608115822077
a O 0 0.007005974184721708
novel O 0 0.01699388585984707
missense O 0 0.022352280095219612
mutation O 0 0.013913804665207863
( O 0 0.011983715929090977
G1758 O 1 0.9993882179260254
- O 1 0.9999980926513672
- O 1 0.9999986886978149
> O 1 0.9998948574066162
T O 1 0.9997038245201111
) O 0 0.010916790924966335
encoding O 0 0.012424733489751816
the O 0 0.010638213716447353
amino O 0 0.016356047242879868
acid O 0 0.024411780759692192
substitution O 0 0.03084600903093815
Gly23 O 1 0.9999479055404663
- O 1 0.9999980926513672
- O 1 0.9999934434890747
> O 1 0.9904943704605103
Val O 1 0.9809600114822388
within O 0 0.036568526178598404
NPII O 1 0.9976364374160767
. O 0 0.04963003844022751

The O 0 0.03022065944969654
mutation O 0 0.026708733290433884
was O 0 0.017312193289399147
confirmed O 0 0.01298514287918806
by O 0 0.00905164610594511
restriction O 0 0.026234718039631844
endonuclease O 0 0.20274974405765533
analysis O 0 0.03102179244160652
. O 0 0.03656436875462532

A O 0 0.1450926810503006
T1 O 1 0.999995231628418
- O 1 0.9186846613883972
weighted O 0 0.03989465907216072
magnetic O 0 0.02710883878171444
resonance O 0 0.026682868599891663
imaging O 0 0.027490708976984024
of O 0 0.011563445441424847
the O 0 0.014198891818523407
fathers O 1 0.9854244589805603
pituitary O 1 1.0
gland O 1 0.9999997615814209
demonstrates O 1 0.9474748373031616
an O 0 0.033291589468717575
attenuated O 1 0.9999959468841553
posterior O 1 0.9999967813491821
pituitary O 1 1.0
bright O 1 0.9999834299087524
spot O 1 0.9219963550567627
. O 0 0.04496349021792412

This O 0 0.02306254953145981
mutation O 0 0.024338750168681145
may O 0 0.009004895575344563
be O 0 0.005506787449121475
valuable O 0 0.011444112285971642
for O 0 0.005778607912361622
developing O 0 0.010049483738839626
models O 0 0.012214988470077515
of O 0 0.01191659364849329
dominantly B-Disease 1 0.9999998807907104
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.01320702861994505
as O 0 0.007005814462900162
the O 0 0.006116293836385012
early O 0 0.006867942400276661
age O 0 0.007437051273882389
of O 0 0.007680215872824192
onset O 1 0.9999998807907104
of O 1 0.9662127494812012
symptoms O 1 1.0
suggests O 0 0.020675484091043472
that O 0 0.0038119868841022253
this O 0 0.0044969236478209496
mutation O 0 0.00937116239219904
may O 0 0.0053859795443713665
be O 0 0.0045974282547831535
particularly O 0 0.008986406028270721
deleterious O 0 0.021293101832270622
to O 0 0.01043192483484745
the O 0 0.0173910241574049
magnocellular O 1 0.9999921321868896
neuron O 1 0.999481737613678
. O 0 0.03018873743712902
. O 0 0.03780391812324524

Frequent O 0 0.059325531125068665
inactivation O 1 0.9903029799461365
of O 0 0.03996851295232773
PTEN O 1 0.9999998807907104
/ O 1 0.9999856948852539
MMAC1 O 1 0.9999954700469971
in O 0 0.02905781753361225
primary O 1 0.9999756813049316
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7604315876960754

Sporadic B-Disease 1 0.999974250793457
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.015060337260365486
the O 0 0.008789210580289364
most O 0 0.007332306355237961
common O 0 0.008500524796545506
male B-Disease 0 0.20162883400917053
cancer I-Disease 1 0.9999969005584717
in O 0 0.0050896042957901955
the O 0 0.005282521713525057
Western O 0 0.007969497703015804
world O 0 0.009603436104953289
, O 0 0.004871581215411425
yet O 0 0.003948051482439041
many O 0 0.0022018621675670147
of O 0 0.0033759032376110554
the O 0 0.004271167796105146
major O 0 0.007253305055201054
genetic O 0 0.0060457829385995865
events O 0 0.004419701639562845
involved O 0 0.0036615682765841484
in O 0 0.003439798019826412
the O 0 0.005029718857258558
progression O 0 0.011651303619146347
of O 0 0.004742428660392761
this O 0 0.004617354366928339
often O 0 0.006756668910384178
fatal O 1 0.9999997615814209
cancer B-Disease 1 1.0
remain O 0 0.011240532621741295
to O 0 0.010282176546752453
be O 0 0.011631989851593971
elucidated O 0 0.15685948729515076
. O 0 0.029753955081105232

Numerous O 0 0.041208505630493164
cytogenetic O 1 0.9255068302154541
and O 0 0.018596339970827103
allelotype O 1 0.9987801909446716
studies O 0 0.009667924605309963
have O 0 0.005239763762801886
reported O 0 0.00838426686823368
frequent O 0 0.008586208336055279
loss O 0 0.014689818024635315
of O 0 0.009775037877261639
heterozygosity O 1 0.9999934434890747
on O 0 0.012150002643465996
chromosomal O 1 0.9402083158493042
arm O 1 0.9998375177383423
10q O 1 0.9999256134033203
in O 0 0.04088004678487778
sporadic B-Disease 1 0.999996542930603
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7473359107971191

Deletion O 0 0.07651104778051376
mapping O 0 0.03682173416018486
studies O 0 0.015820113942027092
have O 0 0.008906340226531029
unambiguously O 0 0.023754991590976715
identified O 0 0.00807849783450365
a O 0 0.007630425971001387
region O 0 0.00862062443047762
of O 0 0.008800678886473179
chromosome O 0 0.019991662353277206
10q23 O 1 0.7881210446357727
to O 0 0.006561706308275461
be O 0 0.004919139202684164
the O 0 0.006322562228888273
minimal O 0 0.014314258471131325
area O 0 0.012889094650745392
of O 0 0.0131702134385705
loss O 1 0.8801590800285339
. O 0 0.029756471514701843

A O 0 0.04030618816614151
new O 0 0.031495872884988785
tumor B-Disease 1 0.9999775886535645
suppressor O 1 0.9997265934944153
gene O 0 0.021588686853647232
, O 0 0.01923106610774994
PTEN O 1 0.9999998807907104
/ O 1 0.9999957084655762
MMAC1 O 1 0.9999940395355225
, O 0 0.01271874364465475
was O 0 0.012700110673904419
isolated O 0 0.012902448885142803
recently O 0 0.010026464238762856
at O 0 0.00681406632065773
this O 0 0.0036174512933939695
region O 0 0.006864996161311865
of O 0 0.00770594784989953
chromosome O 0 0.01776064746081829
10q23 O 1 0.91462641954422
and O 0 0.005905842874199152
found O 0 0.004359065555036068
to O 0 0.004993783310055733
be O 0 0.005550232715904713
inactivated O 0 0.03918631747364998
by O 0 0.005434148944914341
mutation O 0 0.008374408818781376
in O 0 0.0060236272402107716
three O 0 0.021336643025279045
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999945163726807
lines O 0 0.0429278165102005
. O 0 0.03070170432329178

We O 0 0.028946612030267715
screened O 0 0.053793009370565414
80 O 0 0.4166196882724762
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999994039535522
by O 0 0.014452999457716942
microsatellite O 1 0.9663728475570679
analysis O 0 0.011610624380409718
and O 0 0.008348259143531322
found O 0 0.008379688486456871
chromosome O 0 0.016627002507448196
10q23 O 0 0.1254746913909912
to O 0 0.0074952030554413795
be O 0 0.006777935195714235
deleted O 0 0.016937844455242157
in O 0 0.009552935138344765
23 O 0 0.020257337018847466
cases O 0 0.01750635914504528
. O 0 0.024353813380002975

We O 0 0.022816931828856468
then O 0 0.01712135039269924
proceeded O 0 0.02127450332045555
with O 0 0.006708881817758083
sequence O 0 0.006325567606836557
analysis O 0 0.004664438311010599
of O 0 0.005093439482152462
the O 0 0.008511382155120373
entire O 0 0.028258200734853745
PTEN O 1 0.9999998807907104
/ O 1 0.9999799728393555
MMAC1 O 1 0.9999958276748657
coding O 0 0.1271730214357376
region O 0 0.014071200974285603
and O 0 0.009208395145833492
tested O 0 0.013610056601464748
for O 0 0.009870694018900394
homozygous O 0 0.023676592856645584
deletion O 0 0.01896965689957142
with O 0 0.008337047882378101
new O 0 0.014271452091634274
intragenic O 1 0.9854633808135986
markers O 0 0.016334662213921547
in O 0 0.006069946102797985
these O 0 0.0040963622741401196
23 O 0 0.010670576244592667
cases O 0 0.007219990249723196
with O 0 0.00840845238417387
10q23 O 1 0.991482138633728
loss O 1 0.5117672085762024
of O 0 0.02988595888018608
heterozygosity O 1 0.9999263286590576
. O 0 0.0424116887152195

The O 0 0.02214895561337471
identification O 0 0.015211211517453194
of O 0 0.008897337131202221
the O 0 0.008975923992693424
second O 0 0.01798320934176445
mutational O 1 0.9980182647705078
event O 0 0.014066945761442184
in O 0 0.007175142876803875
10 O 0 0.008987483568489552
( O 0 0.008510780520737171
43 O 0 0.018603947013616562
% O 0 0.012277108617126942
) O 0 0.01894596964120865
tumors B-Disease 1 0.9999805688858032
establishes O 1 0.9997531771659851
PTEN O 1 1.0
/ O 1 0.9999961853027344
MMAC1 O 1 0.9999229907989502
as O 0 0.01150631532073021
a O 0 0.012848914600908756
main O 0 0.01720643788576126
inactivation O 0 0.06223287060856819
target O 0 0.0126299187541008
of O 0 0.009819084778428078
10q O 1 0.6253328919410706
loss O 0 0.047001585364341736
in O 0 0.013271438889205456
sporadic B-Disease 1 0.9999943971633911
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.4464271366596222
. O 0 0.032848652452230453

Risk O 0 0.20330893993377686
reversals O 0 0.05086848884820938
in O 0 0.0150977848097682
predictive O 0 0.039634864777326584
testing O 0 0.04161030426621437
for O 0 0.3803081512451172
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.1039738580584526

The O 0 0.020916083827614784
first O 0 0.016674701124429703
predictive O 0 0.026531953364610672
testing O 0 0.016012338921427727
for O 0 0.016912074759602547
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9960902333259583
HD B-Disease 1 0.9999948740005493
) O 0 0.010983436368405819
was O 0 0.009789429605007172
based O 0 0.006280981469899416
on O 0 0.004323912318795919
analysis O 0 0.005396959371864796
of O 0 0.006381429731845856
linked O 0 0.013118862174451351
polymorphic O 0 0.08891014754772186
DNA O 0 0.0135432044044137
markers O 0 0.012250302359461784
to O 0 0.006511085666716099
estimate O 0 0.007860914804041386
the O 0 0.00657786475494504
likelihood O 0 0.010958533734083176
of O 0 0.009037370793521404
inheriting O 0 0.4501016438007355
the O 0 0.013000663369894028
mutation O 0 0.019178379327058792
for O 0 0.01742667146027088
HD B-Disease 1 0.9858500361442566
. O 0 0.041364219039678574

Limits O 0 0.024134593084454536
to O 0 0.013047921471297741
accuracy O 0 0.01591789536178112
included O 0 0.011293397285044193
recombination O 0 0.014175969175994396
between O 0 0.006196950562298298
the O 0 0.006682183127850294
DNA O 0 0.00998216588050127
markers O 0 0.01083241868764162
and O 0 0.005818999372422695
the O 0 0.007618755102157593
mutation O 0 0.011775534600019455
, O 0 0.008994171395897865
pedigree O 1 0.5279381275177002
structure O 0 0.01082848571240902
, O 0 0.006146413739770651
and O 0 0.005471736658364534
whether O 0 0.005892079323530197
DNA O 0 0.007849453948438168
samples O 0 0.006939134560525417
were O 0 0.004598735366016626
available O 0 0.007005914580076933
from O 0 0.008128921501338482
family O 0 0.014216268435120583
members O 0 0.013649032451212406
. O 0 0.026973698288202286

With O 0 0.014370477758347988
direct O 0 0.011262069456279278
tests O 0 0.008092409931123257
for O 0 0.004956950433552265
the O 0 0.008419790305197239
HD B-Disease 1 0.9999291896820068
mutation O 0 0.013784094713628292
, O 0 0.0052399723790585995
we O 0 0.003230369882658124
have O 0 0.0025501747149974108
assessed O 0 0.0063424003310501575
the O 0 0.004375169053673744
accuracy O 0 0.007147646974772215
of O 0 0.005176087375730276
results O 0 0.00618335697799921
obtained O 0 0.005784415639936924
by O 0 0.004927890375256538
linkage O 0 0.014076857827603817
approaches O 0 0.010519289411604404
when O 0 0.006435854360461235
requested O 0 0.010415811091661453
to O 0 0.005220408085733652
do O 0 0.0038972138427197933
so O 0 0.0035122008994221687
by O 0 0.003958425484597683
the O 0 0.0063555678352713585
test O 0 0.013377994298934937
individuals O 0 0.010998455807566643
. O 0 0.022935498505830765

For O 0 0.01604493521153927
six O 0 0.011389079503715038
such O 0 0.006556227803230286
individuals O 0 0.004856917075812817
, O 0 0.00499701825901866
there O 0 0.004132943693548441
was O 0 0.007662317715585232
significant O 0 0.009226868860423565
disparity O 0 0.018073037266731262
between O 0 0.008377213031053543
the O 0 0.012268333695828915
tests O 0 0.025003667920827866
. O 0 0.028954997658729553

Three O 0 0.018376655876636505
went O 0 0.01539271418005228
from O 0 0.007282690145075321
a O 0 0.008458038792014122
decreased O 0 0.015358676202595234
risk O 0 0.007056551519781351
to O 0 0.004332045093178749
an O 0 0.004534768406301737
increased O 0 0.008225767873227596
risk O 0 0.03902309015393257
, O 0 0.004987560212612152
while O 0 0.00415050471201539
in O 0 0.0032466454431414604
another O 0 0.004440749995410442
three O 0 0.004376700147986412
the O 0 0.007948948070406914
risk O 0 0.076481394469738
was O 0 0.2068381905555725
decreased O 0 0.31386539340019226
. O 0 0.03139977157115936

Knowledge O 0 0.02666356973350048
of O 0 0.010688341222703457
the O 0 0.00887559074908495
potential O 0 0.01008044183254242
reasons O 0 0.007152029313147068
for O 0 0.003985904622823
these O 0 0.0025156093761324883
changes O 0 0.003321906551718712
in O 0 0.0037464189808815718
results O 0 0.004962852690368891
and O 0 0.0039035568479448557
impact O 0 0.005884113721549511
of O 0 0.004939084406942129
these O 0 0.003916118294000626
risk O 0 0.010890727862715721
reversals O 1 0.5804064869880676
on O 0 0.00513828219845891
both O 0 0.005011844448745251
patients O 1 0.8426048159599304
and O 0 0.004569923505187035
the O 0 0.005800705868750811
counseling O 1 0.9921667575836182
team O 0 0.009674391709268093
can O 0 0.004693417809903622
assist O 0 0.009153584949672222
in O 0 0.004294573329389095
the O 0 0.004941494204103947
development O 0 0.005810337606817484
of O 0 0.005058963783085346
strategies O 0 0.008501116186380386
for O 0 0.004131248686462641
the O 0 0.006480696611106396
prevention O 1 0.9999113082885742
and O 0 0.005773012991994619
, O 0 0.00484441127628088
where O 0 0.003655915381386876
necessary O 0 0.004489692859351635
, O 0 0.004067310597747564
management O 0 0.007377262692898512
of O 0 0.005070680286735296
a O 0 0.010561286471784115
risk O 1 0.5625649690628052
reversal O 0 0.013891576789319515
in O 0 0.005909539293497801
any O 0 0.006518252193927765
predictive O 0 0.018209684640169144
testing O 0 0.015945550054311752
program O 0 0.01797872968018055
. O 0 0.014911889098584652
. O 0 0.024534860625863075

A O 0 0.04765252768993378
novel O 0 0.0407305508852005
common O 0 0.021862098947167397
missense O 0 0.04405267536640167
mutation O 0 0.022993963211774826
G301C O 0 0.03691301867365837
in O 0 0.00929751805961132
the O 0 0.011491183191537857
N O 0 0.044836461544036865
- O 1 0.9993405938148499
acetylgalactosamine O 1 0.9991094470024109
- O 1 0.9999361038208008
6 O 0 0.06616353988647461
- O 1 0.9999610185623169
sulfate O 1 0.9999682903289795
sulfatase O 1 0.9999755620956421
gene O 0 0.030503151938319206
in O 0 0.026453761383891106
mucopolysaccharidosis B-Disease 1 0.9999823570251465
IVA I-Disease 1 0.9999997615814209
. O 0 0.05722128227353096

Mucopolysaccharidosis B-Disease 1 0.9999912977218628
IVA I-Disease 1 1.0
( O 0 0.06441953033208847
MPS B-Disease 1 0.9999194145202637
IVA I-Disease 1 1.0
) O 0 0.013229736126959324
is O 0 0.008036399260163307
an O 0 0.01091830525547266
autosomal B-Disease 1 0.9999852180480957
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9997311234474182
by O 0 0.007192929275333881
a O 0 0.02939273603260517
genetic B-Disease 1 0.9395191669464111
defect I-Disease 1 0.9999837875366211
in O 0 0.010657374747097492
N O 0 0.42268988490104675
- O 1 0.9955282807350159
acetylgalactosamine O 1 0.9980593323707581
- O 1 0.9997652173042297
6 O 0 0.0920741856098175
- O 1 0.999995231628418
sulfate O 1 0.9999991655349731
sulfatase O 1 0.9999997615814209
( O 0 0.2624642550945282
GALNS O 1 0.9999970197677612
) O 0 0.03360273689031601
. O 0 0.033835988491773605

In O 0 0.017718249931931496
previous O 0 0.013707798905670643
studies O 0 0.010157079435884953
, O 0 0.005902864504605532
we O 0 0.0035825688391923904
have O 0 0.0026851121801882982
found O 0 0.0029208529740571976
two O 0 0.0031009626109153032
common O 0 0.004794232081621885
mutations O 0 0.007285090629011393
in O 0 0.00705512473359704
Caucasians O 1 0.9990555644035339
and O 0 0.009976658038794994
Japanese O 1 0.5222671627998352
, O 0 0.01462279912084341
respectively O 0 0.022906910628080368
. O 0 0.024736454710364342

To O 0 0.03252705559134483
characterize O 0 0.0465262196958065
the O 0 0.022254835814237595
mutational O 1 0.8778128027915955
spectrum O 0 0.02613144740462303
in O 0 0.00870230607688427
various O 0 0.005653219297528267
ethnic O 0 0.007574896328151226
groups O 0 0.004553484730422497
, O 0 0.0060219718143343925
mutations O 0 0.006553250830620527
in O 0 0.0044743954204022884
the O 0 0.007026251871138811
GALNS O 1 0.9999946355819702
gene O 0 0.009327379055321217
in O 0 0.007656775414943695
Colombian O 0 0.037182796746492386
MPS B-Disease 1 0.9998792409896851
IVA I-Disease 1 1.0
patients O 1 0.9998539686203003
were O 0 0.0074039604514837265
investigated O 0 0.013070809654891491
, O 0 0.007597506046295166
and O 0 0.0066929650492966175
genetic O 0 0.009221271611750126
backgrounds O 0 0.009012317284941673
were O 0 0.005017315968871117
extensively O 0 0.0103714345023036
analyzed O 0 0.008346546441316605
to O 0 0.005496083293110132
identify O 0 0.008136175572872162
racial O 0 0.008136829361319542
origin O 0 0.006157779134809971
, O 0 0.006246732547879219
based O 0 0.007084087934345007
on O 0 0.007532721385359764
mitochondrial O 0 0.014119592495262623
DNA O 0 0.015998192131519318
( O 0 0.014949796721339226
mtDNA O 0 0.02403702586889267
) O 0 0.01612422987818718
lineages O 0 0.03389576077461243
. O 0 0.025950375944375992

Three O 0 0.02716309390962124
novel O 0 0.03744383528828621
missense O 0 0.04861321672797203
mutations O 0 0.015605424530804157
never O 0 0.01177925243973732
identified O 0 0.00741724343970418
previously O 0 0.0076130460947752
in O 0 0.005107103381305933
other O 0 0.0037264255806803703
populations O 0 0.0049070329405367374
and O 0 0.004510293714702129
found O 0 0.004282730631530285
in O 0 0.004507776815444231
16 O 0 0.006948015186935663
out O 0 0.0065145110711455345
of O 0 0.007395652588456869
19 O 0 0.016188299283385277
Colombian O 0 0.03963448107242584
MPS B-Disease 1 0.9341798424720764
IVA I-Disease 1 1.0
unrelated O 0 0.03869172930717468
alleles O 0 0.02618221938610077
account O 0 0.015058017335832119
for O 0 0.013173870742321014
84 O 0 0.05521412938833237
. O 0 0.033120423555374146

2 O 0 0.03633255884051323
% O 0 0.014751140028238297
of O 0 0.010706542991101742
the O 0 0.011980786919593811
alleles O 0 0.018604738637804985
in O 0 0.010562152601778507
this O 0 0.010308869183063507
study O 0 0.02077493630349636
. O 0 0.02721048705279827

The O 0 0.05318300798535347
G301C O 0 0.4463791251182556
and O 0 0.030492467805743217
S162F O 0 0.4908545911312103
mutations O 0 0.0234660767018795
account O 0 0.015164637938141823
for O 0 0.013914267532527447
68 O 0 0.04853834956884384
. O 0 0.03543166443705559

4 O 0 0.050972454249858856
% O 0 0.024845343083143234
and O 0 0.019952984526753426
10 O 0 0.028225019574165344
. O 0 0.0355769619345665

5 O 0 0.032465122640132904
% O 0 0.014770042151212692
of O 0 0.011810466647148132
mutations O 0 0.015180491842329502
, O 0 0.008206883445382118
respectively O 0 0.010133122093975544
, O 0 0.007340196520090103
whereas O 0 0.007990716025233269
the O 0 0.00869088526815176
remaining O 0 0.015152137726545334
F69V O 1 0.9998713731765747
is O 0 0.009437822736799717
limited O 0 0.010127189569175243
to O 0 0.009268722496926785
a O 0 0.013431747443974018
single O 0 0.02368655987083912
allele O 0 0.04936212673783302
. O 0 0.03366059437394142

The O 0 0.043453436344861984
skewed O 0 0.05439632385969162
prevalence O 0 0.07345470786094666
of O 0 0.01823885180056095
G301C O 1 0.8650577068328857
in O 0 0.010352682322263718
only O 0 0.009116026572883129
Colombian O 0 0.03588574752211571
patients O 1 0.6875560283660889
and O 0 0.008447944186627865
haplotype O 0 0.02535916306078434
analysis O 0 0.008380794897675514
by O 0 0.006714079529047012
restriction O 0 0.01627250760793686
fragment O 0 0.022180715575814247
length O 0 0.013449267484247684
polymorphisms O 0 0.01712845265865326
in O 0 0.007204809691756964
the O 0 0.010983441025018692
GALNS O 1 0.9999737739562988
gene O 0 0.01234972570091486
suggest O 0 0.009763422422111034
that O 0 0.00623832643032074
G301C O 0 0.10815150290727615
originated O 0 0.013514355756342411
from O 0 0.007367059122771025
a O 0 0.012512545101344585
common O 0 0.015204562805593014
ancestor O 0 0.036019958555698395
. O 0 0.03043186292052269

Investigation O 0 0.032284047454595566
of O 0 0.014636498875916004
the O 0 0.011305499821901321
genetic O 0 0.010517412796616554
background O 0 0.010281112976372242
by O 0 0.004737351555377245
means O 0 0.006612478289753199
of O 0 0.007026191800832748
mtDNA O 0 0.013069197535514832
lineages O 0 0.009313060902059078
indicate O 0 0.005219383165240288
that O 0 0.0028366348706185818
all O 0 0.0035017759073525667
our O 0 0.007403108291327953
patients O 0 0.36046504974365234
are O 0 0.00394758814945817
probably O 0 0.008500163443386555
of O 0 0.007828382775187492
native O 0 0.01617911458015442
American O 0 0.03347339853644371
descent O 0 0.060966119170188904

Low O 0 0.044173695147037506
frequency O 0 0.023203179240226746
of O 0 0.02077852189540863
BRCA1 O 1 0.9528682231903076
germline O 0 0.047730859369039536
mutations O 0 0.013346492312848568
in O 0 0.007652566768229008
45 O 0 0.018974468111991882
German O 1 0.9999779462814331
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9034580588340759
. O 0 0.03597414493560791

In O 0 0.017936401069164276
this O 0 0.007040952332317829
study O 0 0.007179610896855593
we O 0 0.004573970567435026
investigated O 0 0.0103847561404109
45 O 0 0.0157095268368721
German O 1 0.9995538592338562
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.024078886955976486
for O 0 0.013040002435445786
germline O 1 0.6773435473442078
mutations O 0 0.016829349100589752
in O 0 0.009227007627487183
the O 0 0.01747776009142399
BRCA1 O 1 0.9999672174453735
gene O 0 0.030012229457497597
. O 0 0.03115474432706833

We O 0 0.017981434240937233
identified O 0 0.013968425802886486
four O 0 0.012628206983208656
germline O 0 0.02635992132127285
mutations O 0 0.010813713073730469
in O 0 0.006447488442063332
three O 0 0.009888759814202785
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.006654205732047558
and O 0 0.004148512613028288
in O 0 0.004219414666295052
one O 0 0.02612466551363468
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9723072648048401
. O 0 0.005645477678626776
among O 0 0.005018806550651789
these O 0 0.002626787405461073
were O 0 0.003326453734189272
one O 0 0.006221734918653965
frameshift O 0 0.430570513010025
mutation O 0 0.009931100532412529
, O 0 0.005916400346904993
one O 0 0.0065409038215875626
nonsense O 0 0.0949624627828598
mutation O 0 0.009841298684477806
, O 0 0.00579525763168931
one O 0 0.006066793575882912
novel O 0 0.01464884914457798
splice O 0 0.03522038459777832
site O 0 0.016577761620283127
mutation O 0 0.013812657445669174
, O 0 0.00821303017437458
and O 0 0.008372912183403969
one O 0 0.013441527262330055
missense O 0 0.04424435645341873
mutation O 0 0.0339101143181324
. O 0 0.03267281875014305

The O 0 0.036854371428489685
missense O 0 0.0527433417737484
mutation O 0 0.02587798982858658
was O 0 0.015507804229855537
also O 0 0.010034816339612007
found O 0 0.008531776256859303
in O 0 0.010168544948101044
2 O 0 0.02474840357899666
. O 0 0.02934926375746727

8 O 0 0.029098663479089737
% O 0 0.011962112970650196
of O 0 0.007233102340251207
the O 0 0.006038173567503691
general O 0 0.00838822778314352
population O 0 0.004807434044778347
, O 0 0.004431472159922123
suggesting O 0 0.005551372654736042
that O 0 0.002841508248820901
it O 0 0.0033617985900491476
is O 0 0.005558853503316641
not O 0 0.007835214026272297
disease O 1 0.9999990463256836
associated O 0 0.03422573581337929
. O 0 0.027048582211136818

The O 0 0.01981445588171482
average O 0 0.018117055296897888
age O 0 0.013955664820969105
of O 0 0.024463512003421783
disease O 1 1.0
onset O 1 1.0
in O 0 0.011020449921488762
those O 0 0.007542937994003296
families O 0 0.013090581633150578
harbouring O 1 0.9999932050704956
causative O 1 0.9999969005584717
mutations O 0 0.02087206020951271
was O 0 0.01817917637526989
between O 0 0.012895647436380386
32 O 0 0.03291977196931839
. O 0 0.026184139773249626

3 O 0 0.06249590590596199
and O 0 0.038001663982868195
37 O 0 0.06860394775867462
. O 0 0.04711827635765076

4 O 0 0.03723375126719475
years O 0 0.015521969646215439
, O 0 0.010664960369467735
whereas O 0 0.011247911490499973
the O 0 0.00879458338022232
family O 0 0.014220453798770905
harbouring O 1 0.9433845281600952
the O 0 0.012589192017912865
missense O 0 0.05083715543150902
mutation O 0 0.012311932630836964
had O 0 0.006844967603683472
an O 0 0.005824844818562269
average O 0 0.008056151680648327
age O 0 0.008715116418898106
of O 0 0.008471486158668995
onset O 1 0.9999840259552002
of O 0 0.023654425516724586
51 O 1 0.6400519609451294
. O 0 0.03413083031773567

2 O 0 0.07587332278490067
years O 0 0.052221886813640594
. O 0 0.051121439784765244

These O 0 0.014240734279155731
findings O 0 0.014757814817130566
show O 0 0.011081714183092117
that O 0 0.009202905930578709
BRCA1 O 1 0.995610773563385
is O 0 0.007923632860183716
implicated O 0 0.01427463162690401
in O 0 0.005063302349299192
a O 0 0.005803946405649185
small O 0 0.005722764413803816
fraction O 0 0.011013275012373924
of O 0 0.026921145617961884
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.014986895956099033
suggesting O 0 0.009899353608489037
the O 0 0.0061084553599357605
involvement O 0 0.008549073711037636
of O 0 0.006763908546417952
another O 0 0.01572783663868904
susceptibility O 1 0.999954104423523
gene O 0 0.025054622441530228
( O 0 0.02260609343647957
s O 1 0.575867772102356
) O 0 0.04586898535490036

Paternal O 1 0.9672734141349792
transmission O 1 0.9917502999305725
of O 1 0.9999520778656006
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999918937683105

We O 0 0.01977284625172615
report O 0 0.013855566270649433
a O 0 0.012065425515174866
rare O 0 0.012269731611013412
case O 0 0.010725049301981926
of O 0 0.01496997568756342
paternally O 1 0.9999996423721313
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 1 0.6114703416824341
. O 0 0.04627778008580208

The O 0 0.031301163136959076
proband O 0 0.21210640668869019
is O 0 0.01097953598946333
a O 0 0.010026795789599419
23 O 0 0.012217947281897068
year O 0 0.009217174723744392
old O 0 0.02292085625231266
, O 0 0.013729330152273178
mentally B-Disease 1 0.9999984502792358
retarded I-Disease 1 0.9999970197677612
male O 1 0.9965516328811646
who O 1 0.9999258518218994
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9994074106216431

He O 0 0.027064166963100433
presented O 0 0.0279957577586174
with O 0 0.07028549909591675
respiratory O 1 1.0
and O 1 0.8924617767333984
feeding O 1 0.9886115193367004
difficulties O 1 0.9999420642852783
at O 1 0.9037948250770569
birth O 1 0.8497876524925232
. O 0 0.03165138140320778

His O 0 0.04269469901919365
two O 0 0.023769017308950424
sibs O 1 0.999984860420227
suffer O 1 0.999913215637207
from O 0 0.1300523728132248
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.9488745331764221

Their O 0 0.01882403902709484
late O 0 0.018706027418375015
father O 0 0.01490328274667263
had O 0 0.006362439598888159
the O 0 0.005824016872793436
adult O 0 0.009575209580361843
type O 0 0.013245823793113232
of O 0 0.01608402095735073
DM B-Disease 1 1.0
, O 0 0.012977102771401405
with O 0 0.009752899408340454
onset O 1 0.9999862909317017
around O 0 0.015219671651721
30 O 0 0.018933232873678207
years O 0 0.02309596538543701
. O 0 0.028285283595323563

Only O 0 0.014765714295208454
six O 0 0.01026215311139822
other O 0 0.0048637487925589085
cases O 0 0.005450124852359295
of O 0 0.006237031426280737
paternal O 1 0.905495285987854
transmission O 1 0.9992049336433411
of O 1 0.9999966621398926
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 1 0.5175526142120361
been O 0 0.011531360447406769
reported O 0 0.015982352197170258
recently O 0 0.028556490316987038
. O 0 0.023480841889977455

We O 0 0.016937121748924255
review O 0 0.01656895875930786
the O 0 0.010902157053351402
sex O 0 0.013367632403969765
related O 0 0.009454081766307354
effects O 0 0.010996589437127113
on O 0 0.009364843368530273
transmission O 1 0.9497759342193604
of O 1 0.9974416494369507
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.999233603477478

Decreased O 0 0.05034366250038147
fertility O 0 0.037465423345565796
of O 0 0.01274705957621336
males O 0 0.012543337419629097
with O 0 0.009780495427548885
adult O 1 0.7168278694152832
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.37932059168815613
contraction O 0 0.494716614484787
of O 0 0.008028891868889332
the O 0 0.008250647224485874
repeat O 0 0.01530760433524847
upon O 0 0.009673252701759338
male O 0 0.014176209457218647
transmission O 0 0.016451532021164894
contribute O 0 0.008846990764141083
to O 0 0.005002310965210199
the O 0 0.005337880924344063
almost O 0 0.006769235245883465
absent O 0 0.013006857596337795
occurrence O 0 0.010673074051737785
of O 0 0.008744987659156322
paternal O 1 0.9589980244636536
transmission O 1 0.9963321089744568
of O 1 0.9999158382415771
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9983966946601868

Also O 0 0.024923274293541908
the O 0 0.014775805175304413
fathers O 0 0.018819468095898628
of O 0 0.008210353553295135
the O 0 0.010227013379335403
reported O 0 0.022090673446655273
congenitally O 1 0.9999716281890869
affected O 0 0.02261434495449066
children O 0 0.01144892442971468
showed O 0 0.008264939300715923
, O 0 0.005230813752859831
on O 0 0.004966103006154299
average O 0 0.008883114904165268
, O 0 0.007909438572824001
shorter O 0 0.0173202995210886
CTG O 1 0.9993168115615845
repeat O 0 0.02105708420276642
lengths O 0 0.016402961686253548
and O 0 0.00643269345164299
hence O 0 0.009946879930794239
less O 0 0.009094963781535625
severe O 1 1.0
clinical O 1 1.0
symptoms O 1 1.0
than O 0 0.008337528444826603
the O 0 0.00967756099998951
mothers O 0 0.018959935754537582
of O 0 0.0095681082457304
children O 0 0.14630886912345886
with O 1 0.9944413304328918
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9996644258499146

We O 0 0.01749078370630741
conclude O 0 0.02034963294863701
that O 0 0.007669470738619566
paternal O 0 0.025789448991417885
transmission O 1 0.6798663139343262
of O 1 0.9991587400436401
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9992945194244385
rare O 1 0.9620158672332764
and O 0 0.00950988195836544
preferentially O 0 0.020680107176303864
occurs O 0 0.007438719738274813
with O 0 0.005840621888637543
onset O 1 0.9999949932098389
of O 0 0.2855977416038513
DM B-Disease 1 1.0
past O 0 0.015011701732873917
30 O 0 0.012420754879713058
years O 0 0.00811086781322956
in O 0 0.006806944962590933
the O 0 0.009481789544224739
father O 0 0.023561658337712288
. O 0 0.017009977251291275
. O 0 0.027445605024695396

The O 0 0.05002683773636818
RB1 O 1 0.9999890327453613
gene O 0 0.02529800496995449
mutation O 0 0.017430424690246582
in O 0 0.00808587484061718
a O 0 0.011660394258797169
child O 0 0.4059220552444458
with O 0 0.18116262555122375
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.3892725110054016

The O 0 0.0482696108520031
RB1 O 1 0.9999947547912598
gene O 0 0.030014682561159134
mutation O 0 0.021753208711743355
was O 0 0.01328493282198906
investigated O 0 0.01256030984222889
in O 0 0.006354323588311672
a O 0 0.008206409402191639
child O 0 0.04865378513932228
with O 0 0.018938597291707993
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999998807907104
using O 0 0.011690682731568813
DNA O 0 0.012404294684529305
obtained O 0 0.007567135617136955
from O 0 0.004571257159113884
both O 0 0.00551196513697505
the O 0 0.00967507716268301
pineal B-Disease 1 0.999982476234436
and I-Disease 0 0.14936891198158264
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.6178951859474182
the O 1 0.7075459957122803
patient O 1 0.9999892711639404
. O 0 0.03654787689447403

A O 0 0.06049921736121178
nonsense O 0 0.05886945500969887
mutation O 0 0.029425473883748055
in O 0 0.015465839765965939
exon O 0 0.046954430639743805
17 O 0 0.0217567291110754
( O 0 0.013990214094519615
codon O 0 0.028231922537088394
556 O 0 0.034903399646282196
) O 0 0.008479099720716476
of O 0 0.007784388959407806
the O 0 0.010380513966083527
RB1 O 1 0.9999996423721313
gene O 0 0.011136334389448166
was O 0 0.009202412329614162
found O 0 0.0041107432916760445
to O 0 0.003916482906788588
be O 0 0.0031147063709795475
present O 0 0.00559424189850688
homozygously O 0 0.031606391072273254
in O 0 0.0054765320383012295
both O 0 0.005807553883641958
the O 0 0.009305717423558235
retinal B-Disease 1 0.9999971389770508
and I-Disease 0 0.016059041023254395
the I-Disease 0 0.20721589028835297
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.052446477115154266

The O 0 0.024313384667038918
same O 0 0.015595083124935627
mutation O 0 0.018161926418542862
was O 0 0.013248092494904995
present O 0 0.01146976463496685
heterozygously O 1 0.5469153523445129
in O 0 0.007367049343883991
the O 0 0.006903030909597874
DNA O 0 0.00680159218609333
from O 0 0.003904367331415415
the O 0 0.004868156276643276
constitutional O 0 0.008064882829785347
cells O 0 0.007018697913736105
of O 0 0.005515110678970814
the O 0 0.007601079996675253
patient O 1 0.9995757937431335
, O 0 0.008388904854655266
proving O 0 0.030087726190686226
it O 0 0.0048773521557450294
to O 0 0.004913764540106058
be O 0 0.005316197406500578
of O 0 0.009393997490406036
germline O 0 0.04384250193834305
origin O 0 0.01957809180021286
. O 0 0.027188370004296303

The O 0 0.021681828424334526
initial O 0 0.02492309734225273
mutation O 0 0.017480917274951935
was O 0 0.010602273978292942
shown O 0 0.006912448443472385
to O 0 0.005907853599637747
have O 0 0.004153124522417784
occurred O 0 0.006862655747681856
in O 0 0.006346807815134525
the O 0 0.012743472121655941
paternally O 1 0.9653725624084473
derived O 0 0.03433651104569435
RB1 O 1 0.9999821186065674
allele O 0 0.089992955327034
. O 0 0.04791003465652466

The O 0 0.027627920731902122
mutation O 0 0.019395174458622932
is O 0 0.007545180153101683
in O 0 0.004997718147933483
an O 0 0.005134576465934515
area O 0 0.0064055416733026505
of O 0 0.0051269237883389
the O 0 0.005698921158909798
gene O 0 0.00533823249861598
that O 0 0.003403697395697236
encodes O 0 0.008987615816295147
the O 0 0.005896326620131731
protein O 0 0.01034125778824091
- O 0 0.36104509234428406
binding O 0 0.008127694949507713
region O 0 0.007179412990808487
known O 0 0.005018325522542
as O 0 0.004036271013319492
the O 0 0.006182187236845493
pocket O 1 0.999903678894043
region O 0 0.0072649577632546425
and O 0 0.004472734406590462
has O 0 0.004474901128560305
been O 0 0.004033158998936415
detected O 0 0.005688436329364777
in O 0 0.003793464507907629
other O 0 0.003660375252366066
cases O 0 0.00675632618367672
of O 0 0.013654695823788643
retinoblastoma B-Disease 1 0.9999998807907104
. O 0 0.01949087344110012
. O 0 0.03184190392494202

Low O 0 0.036539968103170395
levels O 0 0.014160791411995888
of O 0 0.010843521915376186
beta O 0 0.03685936704277992
hexosaminidase O 1 0.781665027141571
A O 0 0.013031481765210629
in O 0 0.007851731963455677
healthy O 0 0.011553039774298668
individuals O 0 0.004913619719445705
with O 0 0.007571771275252104
apparent O 1 0.9999933242797852
deficiency O 1 1.0
of O 1 0.9914957284927368
this O 0 0.0290350504219532
enzyme O 0 0.05225503072142601
. O 0 0.030875908210873604

Appreciable O 0 0.34933599829673767
beta O 0 0.0952499732375145
hexosaminidase O 1 0.8639334440231323
A O 0 0.02686803974211216
( O 0 0.01722358912229538
hex O 0 0.04095654562115669
A O 0 0.015450999140739441
) O 0 0.007455210667103529
activity O 0 0.00604157242923975
has O 0 0.004586983006447554
been O 0 0.003841729834675789
detected O 0 0.007459336891770363
in O 0 0.007062126416712999
cultured O 1 0.9996685981750488
skin O 1 1.0
fibroblasts O 1 0.9999998807907104
and O 1 0.999904990196228
melanoma B-Disease 1 1.0
tissue O 1 0.9999997615814209
from O 0 0.012788194231688976
healthy O 0 0.2589218318462372
individuals O 0 0.005294129718095064
previously O 0 0.008764149621129036
reported O 0 0.00731315603479743
as O 0 0.007204645778983831
having O 0 0.0729924663901329
deficiency B-Disease 1 1.0
of I-Disease 0 0.2754990756511688
hex I-Disease 1 0.9917795062065125
A I-Disease 0 0.015887189656496048
activity O 0 0.008065489120781422
indistinguishable O 0 0.011139936745166779
from O 0 0.0033036686945706606
that O 0 0.002585612004622817
of O 0 0.00453907810151577
patients O 0 0.48212361335754395
with O 1 0.7900725603103638
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9998654127120972
TSD B-Disease 1 1.0
) O 0 0.03809473291039467
. O 0 0.04036874696612358

Identification O 0 0.04625546187162399
and O 0 0.02462008409202099
quantitation O 0 0.2707024812698364
of O 0 0.020865902304649353
hex O 0 0.19682452082633972
A O 0 0.02488495595753193
, O 0 0.01377770397812128
amounting O 0 0.027411434799432755
to O 0 0.016127143055200577
3 O 0 0.02810146100819111
. O 0 0.027641747146844864

5 O 0 0.04891243204474449
% O 0 0.03377123549580574
- O 1 0.9909148812294006
6 O 0 0.0489492192864418
. O 0 0.03889729082584381

9 O 0 0.035628218203783035
% O 0 0.013367366977036
of O 0 0.009845806285738945
total O 0 0.012485401704907417
beta O 0 0.14490549266338348
hexosaminidase O 1 0.9740033745765686
activity O 0 0.01210051029920578
, O 0 0.007378742564469576
has O 0 0.005827281158417463
been O 0 0.005608339328318834
obtained O 0 0.008774247020483017
by O 0 0.008438649587333202
cellulose O 1 0.9999532699584961
acetate O 1 0.9999948740005493
gel O 1 0.9999738931655884
electrophoresis O 1 0.7418366074562073
, O 0 0.01883356086909771
DEAE O 1 0.9999963045120239
- O 1 0.9999973773956299
cellulose O 1 0.9999374151229858
ion O 1 0.9656488299369812
- O 1 0.9859814643859863
exchange O 0 0.018367784097790718
chromatography O 0 0.08491562306880951
, O 0 0.017764117568731308
radial O 1 0.6122997403144836
immunodiffusion O 1 0.9993525147438049
, O 0 0.021299246698617935
and O 0 0.01983988657593727
radioimmunoassay O 1 0.9943695664405823
. O 0 0.03877061977982521

Previous O 0 0.033111102879047394
family O 0 0.020046519115567207
studies O 0 0.01001146249473095
suggested O 0 0.007006378844380379
that O 0 0.003670646110549569
these O 0 0.0028575852047652006
individuals O 0 0.003207717789337039
may O 0 0.004720407538115978
be O 0 0.005169606767594814
compound O 0 0.018618689849972725
heterozygotes O 0 0.036075152456760406
for O 0 0.00620563980191946
the O 0 0.009377866052091122
common O 0 0.013109932653605938
mutant O 1 0.5600873231887817
TSD B-Disease 1 0.9999998807907104
gene O 0 0.013979879207909107
and O 0 0.00816378928720951
a O 0 0.010099888779222965
rare O 0 0.018009888008236885
( O 0 0.015121216885745525
allelic O 1 0.994530975818634
) O 0 0.019726883620023727
mutant O 0 0.047525085508823395
gene O 0 0.028057677671313286
. O 0 0.03143678978085518

Thus O 0 0.02453867346048355
, O 0 0.011854834854602814
the O 0 0.010726971551775932
postulated O 0 0.023955555632710457
rate O 0 0.012214712798595428
mutant O 0 0.02621958591043949
gene O 0 0.011500529944896698
appears O 0 0.008651413023471832
to O 0 0.005019040312618017
code O 0 0.005990063305944204
for O 0 0.004602698143571615
the O 0 0.005765718873590231
expression O 0 0.006995208561420441
of O 0 0.008240590803325176
low O 0 0.014242501929402351
amounts O 0 0.011257313191890717
of O 0 0.013751539401710033
hex O 0 0.06688258051872253
A O 0 0.04350460693240166
. O 0 0.03910505771636963

Heterozygotes O 0 0.16308966279029846
for O 0 0.016135580837726593
the O 0 0.014587238430976868
rare O 0 0.029002347961068153
mutant O 0 0.2069629728794098
may O 0 0.010402480140328407
be O 0 0.006574462167918682
indistinguishable O 0 0.018950780853629112
from O 0 0.009019618853926659
heterozygotes O 0 0.03245137631893158
for O 0 0.0099596893414855
the O 0 0.015541328117251396
common O 0 0.027115479111671448
TSD B-Disease 1 0.9999997615814209
mutant O 1 0.9401877522468567
. O 0 0.05279742181301117

However O 0 0.020107261836528778
, O 0 0.012325135990977287
direct O 0 0.01276442687958479
visualization O 0 0.034140150994062424
and O 0 0.013148081488907337
quantitation O 1 0.9266018271446228
of O 0 0.011916819028556347
hex O 0 0.05498447269201279
A O 0 0.011320642195641994
by O 0 0.00476309098303318
the O 0 0.005408771801739931
methods O 0 0.005130850709974766
described O 0 0.006598195992410183
may O 0 0.005372996907681227
prevent O 0 0.007790600415319204
false O 0 0.012375494465231895
- O 1 0.9999889135360718
positive O 0 0.013306623324751854
prenatal O 1 0.9999887943267822
diagnosis O 1 0.9999918937683105
of O 0 0.34236010909080505
TSD B-Disease 1 1.0
in O 0 0.014653804711997509
fetuses O 1 0.6354982256889343
having O 0 0.009999328292906284
the O 0 0.009863147512078285
incomplete O 0 0.016890564933419228
hex B-Disease 1 0.7625161409378052
A I-Disease 1 0.8253087997436523
deficiency I-Disease 1 1.0
of O 0 0.012257222086191177
the O 0 0.018047615885734558
type O 0 0.34370580315589905
described O 0 0.009857350029051304
in O 0 0.006586987525224686
the O 0 0.009440532885491848
four O 0 0.01428751926869154
healthy O 0 0.03787834942340851
individuals O 0 0.027992017567157745

The O 0 0.05032983422279358
tumor B-Disease 1 0.9999840259552002
suppressor O 1 0.9998880624771118
gene O 0 0.041558366268873215
Smad4 O 1 0.999991774559021
/ O 1 0.9998900890350342
Dpc4 O 1 0.9962194561958313
is O 0 0.009288148954510689
required O 0 0.00819657277315855
for O 0 0.008208738639950752
gastrulation O 1 0.9815335869789124
and O 0 0.00911994744092226
later O 0 0.010410740971565247
for O 0 0.009366976097226143
anterior O 1 0.995625376701355
development O 0 0.012933925725519657
of O 0 0.01091370265930891
the O 0 0.018246639519929886
mouse O 1 0.6847558617591858
embryo O 0 0.04096561297774315
. O 0 0.03244785591959953

Mutations O 0 0.03559887036681175
in O 0 0.013421528041362762
the O 0 0.01677418313920498
SMAD4 O 1 0.9999996423721313
/ O 1 0.9999991655349731
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999943971633911
gene O 0 0.014644203707575798
, O 0 0.007714028004556894
a O 0 0.008615371771156788
key O 0 0.01207813061773777
signal O 0 0.01645810715854168
transducer O 0 0.027655167505145073
in O 0 0.007739774417132139
most O 0 0.009189890697598457
TGFbeta O 1 0.999994158744812
- O 1 0.9999938011169434
related O 0 0.017698997631669044
pathways O 0 0.01481008529663086
, O 0 0.005555041134357452
are O 0 0.002831685356795788
involved O 0 0.0045939418487250805
in O 0 0.004747826140373945
50 O 0 0.010101987048983574
% O 0 0.010519740171730518
of O 0 0.023375391960144043
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.04689234122633934

Homozygous O 0 0.3483659625053406
Smad4 O 1 0.9998272061347961
mutant O 1 0.9779165387153625
mice O 1 0.6379749774932861
die O 0 0.19564072787761688
before O 0 0.017289722338318825
day O 0 0.02126622200012207
7 O 0 0.03390900418162346
. O 0 0.030630912631750107

5 O 0 0.06146189942955971
of O 0 0.04347968474030495
embryogenesis O 0 0.4621477425098419
. O 0 0.057265546172857285

Mutant O 0 0.07224707305431366
embryos O 0 0.024863937869668007
have O 0 0.009270832873880863
reduced O 0 0.013372299261391163
size O 0 0.012165446765720844
, O 0 0.008159836754202843
fail O 0 0.012712528929114342
to O 0 0.008123347535729408
gastrulate O 1 0.525263786315918
or O 0 0.008056235499680042
express O 0 0.014239783398807049
a O 0 0.012379644438624382
mesodermal O 1 0.9998809099197388
marker O 1 0.9751763939857483
, O 0 0.010407046414911747
and O 0 0.008614855818450451
show O 0 0.016455359756946564
abnormal O 1 0.6083253026008606
visceral O 1 0.999953031539917
endoderm O 1 0.9999995231628418
development O 1 0.6240189671516418
. O 0 0.04059714078903198

Growth B-Disease 1 0.7131619453430176
retardation I-Disease 1 0.9999470710754395
of O 0 0.016765646636486053
the O 0 0.19532814621925354
Smad4 O 1 1.0
- O 1 0.9999997615814209
deficient O 1 0.9963520765304565
embryos O 0 0.013021372258663177
results O 0 0.007800517603754997
from O 0 0.007405676878988743
reduced O 0 0.013447510078549385
cell O 0 0.019083015620708466
proliferation O 0 0.020942073315382004
rather O 0 0.009455698542296886
than O 0 0.009209839627146721
increased O 0 0.02080618031322956
apoptosis O 0 0.06399838626384735
. O 0 0.0390583835542202

Aggregation O 0 0.06242580711841583
of O 0 0.027536120265722275
mutant O 0 0.3740085959434509
Smad4 O 1 0.9999918937683105
ES O 1 0.9999361038208008
cells O 0 0.022405128926038742
with O 0 0.012890173122286797
wild O 0 0.022630814462900162
- O 1 0.9983952641487122
type O 0 0.04875066131353378
tetraploid O 0 0.08573771268129349
morulae O 1 0.9776178002357483
rescues O 1 0.6542195081710815
the O 0 0.034966807812452316
gastrulation B-Disease 1 0.9999935626983643
defect I-Disease 1 0.9999837875366211
. O 0 0.05319647863507271

These O 0 0.017031580209732056
results O 0 0.01193530485033989
indicate O 0 0.010249153710901737
that O 0 0.007083585485816002
Smad4 O 1 0.7125452160835266
is O 0 0.007536965422332287
initially O 0 0.00939335860311985
required O 0 0.005189053248614073
for O 0 0.004087485373020172
the O 0 0.006115047726780176
differentiation O 0 0.011717446148395538
of O 0 0.007427328731864691
the O 0 0.011299883015453815
visceral O 1 0.9999963045120239
endoderm O 1 0.9999936819076538
and O 0 0.008176637813448906
that O 0 0.005583880003541708
the O 0 0.010166216641664505
gastrulation B-Disease 1 0.999961256980896
defect I-Disease 1 0.9975326061248779
in O 0 0.00891063455492258
the O 0 0.011651731096208096
epiblast O 1 0.9999866485595703
is O 0 0.009151440113782883
secondary O 0 0.014495437033474445
and O 0 0.010182134807109833
non O 1 0.5643466114997864
- O 1 0.9999932050704956
cell O 0 0.033935852348804474
autonomous O 0 0.037453509867191315
. O 0 0.03152250498533249

Rescued O 0 0.08753477782011032
embryos O 0 0.03603426739573479
show O 0 0.02858375571668148
severe O 1 0.9999984502792358
anterior O 1 0.9999998807907104
truncations O 1 0.9999998807907104
, O 0 0.017422767356038094
indicating O 0 0.014046591706573963
a O 0 0.009813237003982067
second O 0 0.011174351908266544
important O 0 0.006938926409929991
role O 0 0.00875367596745491
for O 0 0.009033894166350365
Smad4 O 1 0.998698353767395
in O 0 0.017306653782725334
anterior O 1 0.999997615814209
patterning O 1 0.9999951124191284
during O 1 0.9108763337135315
embryogenesis O 1 0.9998118281364441
. O 0 0.04781634733080864

Prevalence O 1 0.9102737903594971
of O 0 0.02982284687459469
p16 O 1 0.9918988943099976
and O 0 0.0198163203895092
CDK4 O 1 0.9999926090240479
germline O 0 0.36077195405960083
mutations O 0 0.01567476987838745
in O 0 0.010502463206648827
48 O 1 0.9105437397956848
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999960660934448
families O 0 0.019274936988949776
in O 0 0.015425535850226879
France O 0 0.037505537271499634
. O 0 0.028719153255224228

The O 0 0.04134000837802887
French O 1 0.96601802110672
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.9455811977386475
Group O 0 0.11058356612920761
. O 0 0.03556860610842705

Germline O 0 0.25149407982826233
mutations O 0 0.026286087930202484
in O 0 0.01116505078971386
the O 0 0.013113530352711678
p16 O 1 0.9780040979385376
and O 0 0.012640519067645073
CDK4 O 1 0.9999947547912598
genes O 0 0.00869037676602602
have O 0 0.003452461678534746
been O 0 0.003858530893921852
reported O 0 0.004370962735265493
in O 0 0.003725256770849228
a O 0 0.006147823762148619
subset O 0 0.015175553038716316
of O 0 0.012670526280999184
melanoma B-Disease 1 1.0
pedigrees O 1 0.9997333884239197
, O 0 0.007527526933699846
but O 0 0.005315037909895182
their O 0 0.005500325467437506
prevalence O 1 0.976033091545105
is O 0 0.005919273477047682
not O 0 0.0053690350614488125
well O 0 0.00924852304160595
known O 0 0.01665702648460865
. O 0 0.02293800376355648

We O 0 0.024528123438358307
searched O 0 0.03009115718305111
for O 0 0.010778514668345451
such O 0 0.009117905050516129
germline O 0 0.0267717894166708
mutations O 0 0.0094292052090168
in O 0 0.00699784466996789
48 O 0 0.01844446361064911
French O 1 0.9997727274894714
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999668598175049
families O 0 0.008104207925498486
selected O 0 0.007534725591540337
according O 0 0.003941036760807037
to O 0 0.003909985069185495
two O 0 0.0037945278454571962
major O 0 0.006701046600937843
criteria O 0 0.006315597333014011
families O 0 0.004388193134218454
with O 0 0.0035226631443947554
at O 0 0.0046681128442287445
least O 0 0.0037373602390289307
three O 0 0.0037166026886552572
affected O 0 0.005517357960343361
members O 0 0.005094869993627071
( O 0 0.007599836215376854
n O 0 0.015697428956627846
= O 0 0.019766870886087418
20 O 0 0.010029304772615433
) O 0 0.006842487957328558
or O 0 0.00494049908593297
families O 0 0.004541310481727123
with O 0 0.003410578705370426
two O 0 0.003523333230987191
affected O 0 0.005113680846989155
members O 0 0.0034967081155627966
, O 0 0.003609300358220935
one O 0 0.002916637109592557
of O 0 0.003247191896662116
them O 0 0.0031115885358303785
affected O 0 0.004836671054363251
before O 0 0.004018438048660755
the O 0 0.003981485031545162
age O 0 0.0059449453838169575
of O 0 0.0046613579615950584
50 O 0 0.009042700752615929
( O 0 0.007483955938369036
n O 0 0.015464214608073235
= O 0 0.020460965111851692
28 O 0 0.0131855309009552
) O 0 0.006696383003145456
, O 0 0.006094129290431738
and O 0 0.005538212601095438
one O 0 0.007029433269053698
additional O 0 0.010685155168175697
minor O 0 0.0875977948307991
criterion O 1 0.986280083656311
. O 0 0.03227463364601135

Sixteen O 0 0.06170669570565224
different O 0 0.020216701552271843
p16 O 1 0.746059000492096
germline O 0 0.21757908165454865
mutations O 0 0.013760698959231377
were O 0 0.0055581447668373585
found O 0 0.0044841887429356575
in O 0 0.004709617234766483
21 O 0 0.008973437361419201
families O 0 0.005459455773234367
, O 0 0.005719341337680817
while O 0 0.005071131978183985
one O 0 0.006956119555979967
germline O 0 0.16012918949127197
mutation O 0 0.014343736693263054
, O 0 0.0093905134126544
Arg24His O 1 0.999816358089447
, O 0 0.008659400045871735
was O 0 0.010102057829499245
detected O 0 0.011349872685968876
in O 0 0.008536005392670631
the O 0 0.014295069500803947
CDK4 O 1 0.9999747276306152
gene O 0 0.029786499217152596
. O 0 0.029156707227230072

The O 0 0.02655421756207943
frequency O 0 0.02230658195912838
of O 0 0.017996124923229218
p16 O 1 0.6638960242271423
gene O 0 0.01705307699739933
mutation O 0 0.01225978508591652
in O 0 0.005664993543177843
our O 0 0.007283034734427929
sample O 0 0.008020123466849327
( O 0 0.007088335230946541
44 O 0 0.014104188419878483
% O 0 0.007305298466235399
) O 0 0.005324005149304867
is O 0 0.00461950246244669
among O 0 0.004554889630526304
the O 0 0.0053510768339037895
highest O 0 0.00905455369502306
rates O 0 0.005853058770298958
yet O 0 0.005779671017080545
reported O 0 0.006337347440421581
and O 0 0.004773881286382675
the O 0 0.008420244790613651
CDK4 O 1 0.9999942779541016
mutation O 0 0.011224232614040375
is O 0 0.005593318957835436
the O 0 0.0070162490010261536
second O 0 0.012248484417796135
mutation O 0 0.011591094546020031
detected O 0 0.010548492893576622
in O 0 0.006431998685002327
this O 0 0.007313331589102745
gene O 0 0.015079070813953876
worldwide O 0 0.023679228499531746
. O 0 0.02805262617766857

In O 0 0.021513737738132477
summary O 0 0.024910015985369682
, O 0 0.009933440014719963
our O 0 0.008526768535375595
results O 0 0.008152030408382416
show O 0 0.00798354484140873
frequent O 0 0.008737170137465
involvement O 0 0.009240775369107723
of O 0 0.0067056892439723015
the O 0 0.009716267697513103
p16 O 1 0.9816550016403198
gene O 0 0.012568067759275436
in O 0 0.010751338675618172
familial B-Disease 1 0.9999998807907104
melanoma I-Disease 1 1.0
and O 0 0.01847025565803051
confirm O 0 0.008499476127326488
the O 0 0.0063737910240888596
role O 0 0.00713477935642004
of O 0 0.006052244454622269
the O 0 0.008603419177234173
CDK4 O 1 0.999980092048645
gene O 0 0.009797083213925362
as O 0 0.007835890166461468
a O 0 0.033209532499313354
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 0.9999977350234985
gene O 0 0.026447825133800507
. O 0 0.020297855138778687
. O 0 0.030942028388381004

Progression O 0 0.2605378031730652
of O 0 0.029004711657762527
somatic O 0 0.4736270010471344
CTG O 1 0.9999485015869141
repeat O 0 0.033400699496269226
length O 0 0.01589733175933361
heterogeneity O 0 0.025798942893743515
in O 0 0.007264932617545128
the O 0 0.01069053914397955
blood O 1 0.5634691715240479
cells O 0 0.026251697912812233
of O 1 0.9081687927246094
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.4661637842655182

The O 0 0.02170984074473381
genetic O 0 0.01582583226263523
basis O 0 0.010721670463681221
of O 0 0.06014992296695709
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.017335517331957817
is O 0 0.0077717360109090805
the O 0 0.008019925095140934
expansion O 0 0.014028217643499374
of O 0 0.010244499891996384
an O 0 0.012518887408077717
unstable O 1 0.9988951086997986
CTG O 1 0.9999854564666748
repeat O 0 0.02402324602007866
in O 0 0.010041005909442902
the O 0 0.010458854958415031
34 O 0 0.020217612385749817
UTR O 0 0.0603112056851387
of O 0 0.011760362423956394
the O 0 0.01830269768834114
DM B-Disease 1 1.0
protein O 0 0.035908665508031845
kinase O 0 0.04934023320674896
gene O 0 0.01712140254676342
on O 0 0.01651587337255478
chromosome O 0 0.031104302033782005
19 O 0 0.03472970053553581
. O 0 0.036899134516716

One O 0 0.01626081019639969
of O 0 0.009243988431990147
the O 0 0.007639078423380852
principal O 0 0.01226759422570467
features O 0 0.008586476556956768
of O 0 0.006895316764712334
the O 0 0.09241781383752823
DM B-Disease 1 1.0
mutation O 0 0.0840378925204277
is O 0 0.006640131119638681
an O 0 0.006147713400423527
extraordinarily O 0 0.03289403021335602
high O 0 0.009303782135248184
level O 0 0.007193031255155802
of O 0 0.008352745324373245
somatic O 1 0.5375422239303589
mosaicism O 1 0.9999740123748779
, O 0 0.008046154864132404
due O 0 0.0055730342864990234
to O 0 0.004949171561747789
an O 0 0.004971761256456375
extremely O 0 0.00820946041494608
high O 0 0.008740788325667381
degree O 0 0.00916223879903555
of O 0 0.00824797060340643
somatic O 0 0.12349103391170502
instability O 0 0.2618386447429657
both O 0 0.0062172990292310715
within O 0 0.0056464471854269505
and O 0 0.006190451793372631
between O 0 0.006790629588067532
different O 0 0.008930970914661884
tissues O 0 0.0693705752491951
. O 0 0.02668004296720028

This O 0 0.025269053876399994
instability O 0 0.056345392018556595
appears O 0 0.01620432175695896
to O 0 0.007941411808133125
be O 0 0.004964991007000208
biased O 0 0.008689356967806816
towards O 0 0.0063752345740795135
further O 0 0.005492641590535641
expansion O 0 0.00923248566687107
and O 0 0.005428044591099024
continuous O 0 0.00741245923563838
throughout O 0 0.005234799813479185
the O 0 0.004984355065971613
life O 0 0.005439822096377611
of O 0 0.0038529213052242994
an O 0 0.004118046723306179
individual O 0 0.004676876589655876
, O 0 0.00449287798255682
features O 0 0.005315103102475405
that O 0 0.0024401831906288862
could O 0 0.0028615824412554502
be O 0 0.002812543185427785
associated O 0 0.0038537816144526005
with O 0 0.0036033696960657835
the O 0 0.005692469887435436
progressive O 0 0.09053146839141846
nature O 0 0.008647464215755463
of O 0 0.01210811734199524
the O 1 0.9099060893058777
disease O 1 1.0
. O 0 0.04065706208348274

Although O 0 0.023847542703151703
increasing O 0 0.017678888514637947
measured O 0 0.016502462327480316
allele O 0 0.021624663844704628
size O 0 0.014551365748047829
between O 0 0.009637783281505108
patients O 1 0.6513314247131348
clearly O 0 0.012080405838787556
correlates O 0 0.016265012323856354
with O 0 0.004758256487548351
an O 0 0.005617792718112469
increased O 0 0.008966401219367981
severity O 1 0.9991424083709717
of O 1 0.7969186305999756
symptoms O 1 1.0
and O 0 0.005986223462969065
an O 0 0.004768491722643375
earlier O 0 0.006317039951682091
age O 0 0.007940690033137798
of O 0 0.0078051029704511166
onset O 1 0.9999995231628418
, O 0 0.00661869253963232
this O 0 0.00473060691729188
correlation O 0 0.007952871732413769
is O 0 0.004144194535911083
not O 0 0.0029014605097472668
precise O 0 0.005618219263851643
and O 0 0.004753340966999531
measured O 0 0.00865795835852623
allele O 0 0.013698803260922432
length O 0 0.007429684512317181
cannot O 0 0.0048823002725839615
be O 0 0.0032277298159897327
used O 0 0.003542062360793352
as O 0 0.0034771994687616825
an O 0 0.0045327311381697655
accurate O 0 0.009539720602333546
predictor O 0 0.02161109820008278
of O 0 0.008131212554872036
age O 0 0.014026925899088383
of O 0 0.019121825695037842
onset O 1 0.9999998807907104
. O 0 0.041879307478666306

In O 0 0.018985943868756294
order O 0 0.012391158379614353
to O 0 0.008251629769802094
further O 0 0.008616313338279724
characterize O 0 0.017018429934978485
the O 0 0.008808336220681667
dynamics O 0 0.023058006539940834
of O 0 0.02031651698052883
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.9997029900550842
somatic O 1 0.9888068437576294
instability O 1 0.9345974326133728
, O 0 0.00928293727338314
we O 0 0.006432242691516876
have O 0 0.004186305217444897
studied O 0 0.008965706452727318
repeat O 0 0.012711070477962494
length O 0 0.006716134026646614
changes O 0 0.004829327575862408
over O 0 0.004788256715983152
time O 0 0.005795104429125786
in O 0 0.008997584693133831
111 O 1 0.9999022483825684
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999995231628418
with O 0 0.012033257633447647
varying O 0 0.015431882813572884
clinical O 1 0.9999994039535522
severity O 1 0.9999970197677612
and O 0 0.07792751491069794
CTG O 1 0.9999974966049194
repeat O 0 0.02899787761271
size O 0 0.012104774825274944
over O 0 0.006657023914158344
time O 0 0.005472769495099783
intervals O 0 0.008287293836474419
of O 0 0.007219661958515644
1 O 0 0.015215097926557064
- O 1 0.8033686280250549
7 O 0 0.02109612338244915
years O 0 0.020293425768613815
. O 0 0.0268770232796669

We O 0 0.017591603100299835
have O 0 0.00615817541256547
found O 0 0.006205298937857151
a O 0 0.0074868034571409225
direct O 0 0.009037772193551064
progression O 0 0.014408213086426258
of O 0 0.006348967086523771
the O 0 0.0069085280410945415
size O 0 0.011747688986361027
heterogeneity O 0 0.017947329208254814
over O 0 0.007478311657905579
time O 0 0.006651022937148809
related O 0 0.0066371941938996315
to O 0 0.006131431553512812
initial O 0 0.015614224597811699
CTG O 1 0.999678373336792
repeat O 0 0.021683581173419952
size O 0 0.012832141481339931
and O 0 0.006492033135145903
the O 0 0.006133547518402338
time O 0 0.007882088422775269
interval O 0 0.01428304798901081
and O 0 0.007186524569988251
always O 0 0.010029351338744164
biased O 0 0.01603294536471367
towards O 0 0.01408854965120554
further O 0 0.015116238966584206
expansion O 0 0.035284969955682755
. O 0 0.03648858889937401

Attempts O 0 0.034301165491342545
to O 0 0.014967408962547779
mathematically O 0 0.026478629559278488
model O 0 0.01614077389240265
the O 0 0.01007886789739132
dynamics O 0 0.016634810715913773
have O 0 0.005270832683891058
proved O 0 0.010618231259286404
only O 0 0.005133066792041063
partially O 0 0.012306217104196548
successful O 0 0.00906375702470541
suggesting O 0 0.006848124787211418
that O 0 0.0024955973494797945
individual O 0 0.003234130097553134
specific O 0 0.003539723576977849
genetic O 0 0.005786385387182236
and O 0 0.007305930368602276
/ O 1 0.9999896287918091
or O 0 0.00656847283244133
environmental O 0 0.013622783124446869
factors O 0 0.006315442267805338
also O 0 0.005096369422972202
play O 0 0.006189434323459864
a O 0 0.007475248072296381
role O 0 0.01071518287062645
in O 0 0.01206816453486681
somatic O 1 0.6844285726547241
mosaicism O 1 0.9999674558639526
. O 0 0.023464536294341087
. O 0 0.031475428491830826

Aspartylglucosaminuria B-Disease 1 0.999812662601471
among O 0 0.035390473902225494
Palestinian O 0 0.039201561361551285
Arabs O 0 0.04962605983018875
. O 0 0.04573013633489609

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9739263653755188
AGU B-Disease 1 1.0
) O 0 0.015385807491838932
is O 0 0.009014330804347992
a O 0 0.011100972071290016
rare O 0 0.3807174563407898
disorder B-Disease 1 1.0
of I-Disease 1 0.9997863173484802
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999731779098511
caused O 0 0.24606728553771973
by O 0 0.007162727415561676
the O 0 0.02424897626042366
deficiency B-Disease 1 1.0
of I-Disease 0 0.12506262958049774
the I-Disease 1 0.9209120273590088
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9988151788711548
aspartylglucosaminidase I-Disease 1 0.999998927116394
( O 1 0.6166366338729858
AGA O 1 0.9999998807907104
) O 0 0.032675620168447495
. O 0 0.03771129623055458

AGU B-Disease 1 1.0
is O 0 0.023971829563379288
inherited O 1 0.996547281742096
as O 0 0.009174575097858906
an O 0 0.022093622013926506
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999997615814209
and O 0 0.4362306594848633
occurs O 0 0.007085962686687708
with O 0 0.00444286921992898
a O 0 0.006383667234331369
high O 0 0.008149100467562675
frequency O 0 0.005955189000815153
in O 0 0.005217511672526598
Finland O 0 0.014576301909983158
because O 0 0.0056130001321434975
of O 0 0.006645974703133106
a O 0 0.013456059619784355
founder O 1 0.998238205909729
effect O 0 0.024668782949447632
. O 0 0.026930678635835648

While O 0 0.02237275429069996
very O 0 0.011767351999878883
few O 0 0.010288719087839127
patients O 1 0.9196168780326843
with O 0 0.019370991736650467
AGU B-Disease 1 1.0
have O 0 0.004704474471509457
been O 0 0.004027264192700386
reported O 0 0.004876410122960806
from O 0 0.004112862050533295
non O 0 0.010369952768087387
- O 1 0.9986768364906311
Finnish O 1 0.5451720356941223
origin O 0 0.006606467068195343
, O 0 0.005547712091356516
we O 0 0.005672956816852093
diagnosed O 1 0.9999995231628418
the O 0 0.036237236112356186
disorder O 1 1.0
in O 0 0.061609890311956406
8 O 0 0.18924836814403534
patients O 1 0.8412396311759949
originating O 0 0.009686006233096123
from O 0 0.006337059661746025
3 O 0 0.011629698798060417
unrelated O 0 0.011148963123559952
families O 0 0.005592907778918743
, O 0 0.004332674201577902
all O 0 0.0034396497067064047
Palestinian O 0 0.0073349857702851295
Arabs O 0 0.00817373488098383
from O 0 0.005744031630456448
the O 0 0.0075897942297160625
region O 0 0.011856171302497387
of O 0 0.014520117081701756
Jerusalem O 0 0.1245155856013298
. O 0 0.030963096767663956

The O 0 0.030196504667401314
clinical O 1 0.9999010562896729
diagnosis O 1 0.9999997615814209
of O 1 0.9990432858467102
AGU B-Disease 1 1.0
is O 0 0.07420103251934052
often O 0 0.006535334978252649
difficult O 0 0.0062281242571771145
, O 0 0.0043387687765061855
in O 0 0.003336456371471286
particular O 0 0.003610941581428051
early O 0 0.0036314032040536404
in O 0 0.002905119676142931
the O 0 0.0036482324358075857
course O 0 0.005502582062035799
of O 0 0.0038420455530285835
the O 0 0.03804059699177742
disease O 1 0.9999998807907104
, O 0 0.004187847953289747
and O 0 0.002895183628425002
most O 0 0.0027472719084471464
of O 0 0.00382734602317214
the O 0 0.006629250943660736
patients O 1 0.9997724890708923
are O 0 0.004135174211114645
diagnosed O 1 0.9999998807907104
after O 0 0.006897975690662861
the O 0 0.006311528850346804
age O 0 0.008473007008433342
of O 0 0.008750908076763153
5 O 0 0.015920840203762054
years O 0 0.018239198252558708
. O 0 0.02364228293299675

However O 0 0.01667124405503273
, O 0 0.01008302066475153
since O 0 0.008202978409826756
these O 0 0.0065419478341937065
patients O 1 0.9575878977775574
excrete O 1 0.9987342953681946
early O 0 0.007841067388653755
large O 0 0.005341697484254837
amounts O 0 0.005468299612402916
of O 0 0.0066265384666621685
aspartylglucosamine O 1 0.961287260055542
in O 0 0.008720844984054565
urine O 0 0.014946783892810345
, O 0 0.007603990379720926
biochemical O 0 0.018547015264630318
screening O 0 0.013796045444905758
is O 0 0.0063870614394545555
easy O 0 0.01249376405030489
by O 0 0.008576528169214725
urine O 0 0.031715791672468185
chromatography O 1 0.8777425289154053
. O 0 0.020799942314624786
. O 0 0.02873324230313301

Detection O 0 0.056653089821338654
of O 0 0.01953078992664814
heterozygous O 0 0.02449139580130577
carriers O 0 0.016225524246692657
of O 0 0.008908984251320362
the O 0 0.017351029440760612
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.07669727504253387
ATM O 1 0.9835202097892761
) O 0 0.011932319961488247
gene O 0 0.010845409706234932
by O 0 0.009863155893981457
G2 O 1 0.9999955892562866
phase O 0 0.055381353944540024
chromosomal O 0 0.3918025493621826
radiosensitivity O 1 0.9995061159133911
of O 0 0.47958245873451233
peripheral O 1 1.0
blood O 1 0.9999927282333374
lymphocytes O 1 0.9999899864196777
. O 0 0.047135550528764725

In O 0 0.042202260345220566
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.021054459735751152
A B-Disease 1 0.9999933242797852
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.015594175085425377
patients O 1 0.9012535214424133
, O 0 0.006921728141605854
mutations O 0 0.005946292541921139
in O 0 0.0037939974572509527
a O 0 0.005157755687832832
single O 0 0.007181891705840826
gene O 0 0.007017261814326048
, O 0 0.005565927363932133
ATM O 0 0.01948787271976471
, O 0 0.004302790388464928
result O 0 0.0033377348445355892
in O 0 0.004403822589665651
an O 0 0.037975311279296875
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.5534704327583313
embraces O 1 0.9982224106788635
a O 0 0.009886257350444794
variety O 0 0.008464147336781025
of O 0 0.00788716971874237
clinical O 1 0.9990918636322021
features O 0 0.014480778947472572
and O 0 0.009708247147500515
manifests O 1 0.8489256501197815
extreme O 1 0.8996613621711731
radiosensitivity O 1 0.9997937083244324
and O 0 0.008216160349547863
a O 0 0.008728119544684887
strong O 0 0.012177682481706142
pre O 1 0.9987875819206238
- O 1 0.9999853372573853
disposition O 1 0.8900685906410217
to O 0 0.026659075170755386
malignancy B-Disease 1 0.9999966621398926
. O 0 0.04230254143476486

Heterozygotes O 0 0.0913594663143158
for O 0 0.014934061095118523
the O 0 0.015704041346907616
ATM O 1 0.6598432660102844
gene O 0 0.010295198298990726
have O 0 0.004181048832833767
no O 0 0.004915212746709585
clinical O 0 0.012276957742869854
expression O 0 0.005850362591445446
of O 0 0.006283051334321499
A B-Disease 1 0.9999982118606567
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 0.006811265833675861
may O 0 0.006547205615788698
be O 0 0.007713411469012499
cancer B-Disease 1 0.9999986886978149
prone O 1 0.9918420314788818
with O 0 0.006454197224229574
a O 0 0.009557719342410564
moderate O 0 0.02134341560304165
increase O 0 0.008864084258675575
in O 0 0.00993405468761921
in O 0 0.015239501371979713
vitro O 0 0.06306090205907822
radiosensitivity O 1 0.9635253548622131
. O 0 0.03793966770172119

We O 0 0.01919025182723999
performed O 0 0.019850924611091614
a O 0 0.017191002145409584
blind O 0 0.03205171972513199
chromosomal O 0 0.022713227197527885
analysis O 0 0.011257481761276722
on O 0 0.01163976639509201
G2 O 1 1.0
- O 1 0.9999933242797852
phase O 0 0.05035708099603653
lymphocytes O 0 0.03426807001233101
from O 0 0.007692687213420868
7 O 0 0.013686426915228367
unrelated O 0 0.01483412366360426
A B-Disease 1 0.9977606534957886
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.7242637872695923
, O 0 0.008033016696572304
13 O 0 0.011365849524736404
obligate O 0 0.02149149589240551
A B-Disease 1 0.9996989965438843
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.9822744131088257
( O 0 0.007869265042245388
parents O 0 0.006286320276558399
of O 0 0.005411307327449322
the O 0 0.007221227046102285
patients O 1 0.999594509601593
) O 0 0.005657348781824112
, O 0 0.0047182305715978146
and O 0 0.004020873457193375
14 O 0 0.006267772056162357
normal O 0 0.005607254803180695
controls O 0 0.009158816188573837
following O 0 0.008328615687787533
X O 1 0.9959738850593567
- O 1 0.9911689758300781
irradiation O 0 0.02408796362578869
with O 0 0.010188562795519829
1 O 0 0.020052166655659676
Gy O 1 0.9992309808731079
in O 0 0.007960500195622444
order O 0 0.007470501586794853
to O 0 0.00726308673620224
evaluate O 0 0.017933722585439682
this O 0 0.008949780836701393
cytogenetic O 0 0.04254157096147537
method O 0 0.009522057138383389
as O 0 0.0078359330072999
a O 0 0.010081898421049118
tool O 0 0.01719953492283821
for O 0 0.009130635298788548
detection O 0 0.02259594388306141
of O 0 0.017240192741155624
ATM O 1 0.9991169571876526
carriers O 0 0.09062255173921585
. O 0 0.03173106908798218

Both O 0 0.02548063173890114
A B-Disease 1 0.9853707551956177
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 1 0.9998052716255188
and O 0 0.015653029084205627
heterozygotes O 0 0.27346181869506836
showed O 0 0.011926928535103798
significantly O 0 0.00827561505138874
increased O 0 0.006546498741954565
levels O 0 0.0059683858416974545
of O 0 0.00807078368961811
radiation O 1 0.9999922513961792
- O 1 1.0
induced O 1 0.9999991655349731
chromatid O 1 0.9999994039535522
damage O 1 0.9514585137367249
relative O 0 0.011844237335026264
to O 0 0.006222657859325409
that O 0 0.004916983190923929
of O 0 0.008076769299805164
normal O 0 0.014347638934850693
controls O 0 0.0294256079941988
. O 0 0.02814314141869545

These O 0 0.013962149620056152
results O 0 0.01087187323719263
show O 0 0.007353534922003746
that O 0 0.004416492767632008
the O 0 0.00927736982703209
G2 O 1 1.0
- O 1 0.999981164932251
phase O 0 0.2744119465351105
chromosomal O 1 0.8262837529182434
radiosensitivity O 1 0.9999003410339355
assay O 0 0.02963673509657383
can O 0 0.005576787982136011
be O 0 0.003528422676026821
used O 0 0.004065335262566805
for O 0 0.0036210226826369762
the O 0 0.004929777700453997
detection O 0 0.01307008322328329
of O 0 0.009478628635406494
A B-Disease 1 0.9999487400054932
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
heterozygotes O 1 0.9768682718276978
. O 0 0.04823637008666992

In O 0 0.02085690200328827
combination O 0 0.01886221021413803
with O 0 0.008644398301839828
molecular O 0 0.016219114884734154
genetic O 0 0.009305549785494804
analyses O 0 0.009016300551593304
, O 0 0.0049318852834403515
this O 0 0.003380674635991454
test O 0 0.007284234743565321
may O 0 0.0036259826738387346
be O 0 0.0028463194612413645
of O 0 0.0034640326630324125
value O 0 0.003889683401212096
in O 0 0.0035020518116652966
studies O 0 0.004477467853575945
of O 0 0.00543171213939786
familial B-Disease 1 0.9998663663864136
and I-Disease 0 0.013430844061076641
sporadic I-Disease 1 0.9835477471351624
cancers I-Disease 1 0.9999995231628418
aimed O 0 0.022479288280010223
at O 0 0.008541139774024487
determination O 0 0.010941367596387863
of O 0 0.006409983150660992
the O 0 0.006126807536929846
potential O 0 0.007671883795410395
involvement O 0 0.00985175371170044
of O 0 0.007499740459024906
ATM O 1 0.962807297706604
mutations O 0 0.012029159814119339
in O 0 0.010382520966231823
tumor B-Disease 1 1.0
risk O 1 0.9873321652412415
or O 0 0.01013480219990015
development O 0 0.016257483512163162
. O 0 0.0164256040006876
. O 0 0.026332726702094078

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999998807907104
: O 0 0.01814224384725094
identification O 0 0.01416714396327734
and O 0 0.00792290922254324
detection O 0 0.014244056306779385
of O 0 0.010582164861261845
founder O 1 0.9999915361404419
- O 1 0.9999326467514038
effect O 0 0.01025578286498785
mutations O 0 0.008833249099552631
in O 0 0.005441984627395868
the O 0 0.008104019798338413
ATM O 0 0.28089088201522827
gene O 0 0.012398794293403625
in O 0 0.008544334210455418
ethnic O 0 0.012518863193690777
populations O 0 0.01743442751467228
. O 0 0.027191421017050743

To O 0 0.018235573545098305
facilitate O 0 0.017158566042780876
the O 0 0.009612402878701687
evaluation O 0 0.016851436346769333
of O 0 0.010793916881084442
ATM O 1 0.9833093285560608
heterozygotes O 1 0.672456681728363
for O 0 0.007972419261932373
susceptibility O 0 0.2135162353515625
to O 0 0.0057697417214512825
other O 0 0.005526989698410034
diseases O 1 0.9999992847442627
, O 0 0.004308247938752174
such O 0 0.004157232586294413
as O 1 0.9980973601341248
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.020287098363041878
we O 0 0.004646369256079197
have O 0 0.0035240263678133488
attempted O 0 0.008120582439005375
to O 0 0.005012433975934982
define O 0 0.007902855984866619
the O 0 0.005876737646758556
most O 0 0.0058099254965782166
common O 0 0.006107918918132782
mutations O 0 0.007240601349622011
and O 0 0.004124357830733061
their O 0 0.003842200618237257
frequencies O 0 0.006888548377901316
in O 0 0.00884612649679184
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.01727290265262127
A B-Disease 1 0.9999932050704956
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.014253579080104828
homozygotes O 0 0.05846806988120079
from O 0 0.010095775127410889
10 O 0 0.013962503522634506
ethnic O 0 0.013296921737492085
populations O 0 0.01966007985174656
. O 0 0.029694227501749992

Both O 0 0.025069277733564377
genomic O 0 0.0433044359087944
mutations O 0 0.018306128680706024
and O 0 0.008136117830872536
their O 0 0.007906397804617882
effects O 0 0.014163202606141567
on O 0 0.012895756401121616
cDNA O 0 0.04173106700181961
were O 0 0.014692888595163822
characterized O 0 0.033686790615320206
. O 0 0.029261693358421326

Protein O 0 0.062315043061971664
- O 1 0.7059293985366821
truncation O 0 0.04959343001246452
testing O 0 0.019691724330186844
of O 0 0.01174195483326912
the O 0 0.013354877941310406
entire O 0 0.021438099443912506
ATM O 0 0.044958993792533875
cDNA O 0 0.04128439351916313
detected O 0 0.023169569671154022
92 O 0 0.03734030947089195
( O 0 0.016561321914196014
66 O 0 0.031857576221227646
% O 0 0.014683006331324577
) O 0 0.015235129743814468
truncating O 0 0.04928521439433098
mutations O 0 0.016821272671222687
in O 0 0.010596413165330887
140 O 0 0.03496807813644409
mutant O 0 0.059799924492836
alleles O 0 0.04881826415657997
screened O 0 0.06166764348745346
. O 0 0.03754900395870209

The O 0 0.030096355825662613
haplotyping O 1 0.9557142853736877
of O 0 0.013783225789666176
patients O 1 0.9851470589637756
with O 0 0.007882865145802498
identical O 0 0.013857305981218815
mutations O 0 0.00980153027921915
indicates O 0 0.007426460273563862
that O 0 0.0035021489020437002
almost O 0 0.003638469846919179
all O 0 0.002515128580853343
of O 0 0.003311594482511282
these O 0 0.002172390930354595
represent O 0 0.004121114499866962
common O 0 0.004301037173718214
ancestry O 0 0.006211583036929369
and O 0 0.004179762210696936
that O 0 0.003590939799323678
very O 0 0.004818115383386612
few O 0 0.008266572840511799
spontaneously O 0 0.028457172214984894
recurring O 1 0.9971089959144592
ATM O 1 0.999545156955719
mutations O 0 0.025207707658410072
exist O 0 0.017265837639570236
. O 0 0.026375455781817436

Assays O 0 0.07179281860589981
requiring O 0 0.025541936978697777
minimal O 0 0.020946307107806206
amounts O 0 0.011754910461604595
of O 0 0.008615017868578434
genomic O 0 0.019417649134993553
DNA O 0 0.010426724329590797
were O 0 0.004695881623774767
designed O 0 0.008941199630498886
to O 0 0.004906881600618362
allow O 0 0.007046328391879797
rapid O 0 0.015481777489185333
screening O 0 0.014664149843156338
for O 0 0.007704124785959721
common O 0 0.011055058799684048
ethnic O 0 0.01408372726291418
mutations O 0 0.02510174736380577
. O 0 0.02796352282166481

These O 0 0.020167384296655655
rapid O 0 0.033294208347797394
assays O 0 0.032056696712970734
detected O 0 0.021713821217417717
mutations O 0 0.012947793118655682
in O 0 0.007547779940068722
76 O 0 0.022232837975025177
% O 0 0.009014297276735306
of O 0 0.008340529166162014
Costa O 0 0.05622377246618271
Rican O 1 0.7734807729721069
patients O 1 0.998171329498291
( O 0 0.009793896228075027
3 O 0 0.01152709499001503
) O 0 0.006134102586656809
, O 0 0.005001551005989313
50 O 0 0.006958129350095987
% O 0 0.004830468911677599
of O 0 0.005620371550321579
Norwegian O 0 0.029872208833694458
patients O 1 0.9872688055038452
( O 0 0.008035657927393913
1 O 0 0.010334783233702183
) O 0 0.0057082935236394405
, O 0 0.005023456644266844
25 O 0 0.0067148711532354355
% O 0 0.004538360517472029
of O 0 0.005936222150921822
Polish O 1 0.9997392296791077
patients O 1 0.9998769760131836
( O 0 0.010419636033475399
4 O 0 0.01328863576054573
) O 0 0.006576412357389927
, O 0 0.00509447930380702
and O 0 0.00416218675673008
14 O 0 0.006044295616447926
% O 0 0.0051772561855614185
of O 0 0.005450109485536814
Italian O 1 0.9997327923774719
patients O 1 0.9999713897705078
( O 0 0.012966735288500786
1 O 0 0.02468516118824482
) O 0 0.006673202849924564
, O 0 0.005458070896565914
as O 0 0.004340972285717726
well O 0 0.0040400284342467785
as O 0 0.004859653767198324
in O 0 0.0064283981919288635
patients O 0 0.05949592962861061
of O 0 0.010571186430752277
Amish O 1 0.9989325404167175
/ O 1 0.9996472597122192
Mennonite O 0 0.36885616183280945
and O 0 0.013751060701906681
Irish O 0 0.024025753140449524
English O 0 0.02060304954648018
backgrounds O 0 0.02995694801211357
. O 0 0.026257850229740143

Additional O 0 0.033900320529937744
mutations O 0 0.0233866386115551
were O 0 0.007457742001861334
observed O 0 0.0075972722843289375
in O 0 0.00840923935174942
Japanese O 0 0.02090355008840561
, O 0 0.011533725075423717
Utah O 0 0.024862660095095634
Mormon O 0 0.025838928297162056
, O 0 0.009772314690053463
and O 0 0.009492984041571617
African O 0 0.023283854126930237
American O 0 0.05807105451822281
patients O 1 0.9964836835861206
. O 0 0.03457849472761154

These O 0 0.01776321977376938
assays O 0 0.02434343658387661
should O 0 0.007280428893864155
facilitate O 0 0.010431368835270405
screening O 0 0.012254762463271618
for O 0 0.0074993399903178215
A B-Disease 1 0.999617338180542
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.3824811279773712
in O 0 0.007914222776889801
the O 0 0.00927241425961256
populations O 0 0.009676731191575527
studied O 0 0.018061397597193718
. O 0 0.01498451828956604
. O 0 0.024594135582447052

The O 0 0.03607697784900665
von B-Disease 1 0.9930207133293152
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999998807907104
suppressor O 1 0.9999738931655884
gene O 0 0.013121739029884338
is O 0 0.006275463849306107
required O 0 0.006133980583399534
for O 0 0.007486669812351465
cell O 0 0.01670699752867222
cycle O 0 0.017327826470136642
exit O 0 0.02406401000916958
upon O 0 0.02422233484685421
serum O 1 0.9939141869544983
withdrawal O 0 0.05662085860967636
. O 0 0.034380942583084106

The O 0 0.031550128012895584
inactivation O 0 0.08279585093259811
of O 0 0.014834366738796234
the O 0 0.017236880958080292
von B-Disease 1 0.997262716293335
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999997615814209
Lindau I-Disease 1 0.9999996423721313
( I-Disease 0 0.03405015915632248
VHL I-Disease 1 0.9999997615814209
) I-Disease 0 0.03162841871380806
tumor I-Disease 1 0.9999969005584717
suppressor O 1 0.9999748468399048
gene O 0 0.021884044632315636
predisposes O 1 0.9448449015617371
affected O 0 0.008899915032088757
individuals O 0 0.0038375912699848413
to O 0 0.004143921192735434
the O 0 0.006177127361297607
human O 1 0.9743829369544983
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9934456944465637
is O 0 0.006571508478373289
associated O 0 0.006017942447215319
with O 0 0.006340501829981804
sporadic B-Disease 1 0.9985989928245544
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999887943267822
RCC B-Disease 1 1.0
) O 0 0.10433989763259888
and O 0 0.03172231465578079
brain B-Disease 1 0.999715268611908
hemangioblastomas I-Disease 1 0.9999661445617676
. O 0 0.044048916548490524

VHL O 1 0.9999932050704956
- O 1 0.993525505065918
negative O 0 0.031794000416994095
786 O 1 0.9999421834945679
- O 1 0.9999984502792358
0 O 0 0.22968104481697083
RCC B-Disease 1 0.9999998807907104
cells O 0 0.018814213573932648
are O 0 0.006619052961468697
tumorigenic O 0 0.29182931780815125
in O 0 0.011694981716573238
nude O 1 0.998007595539093
mice O 0 0.02594752050936222
which O 0 0.00669143395498395
is O 0 0.006303190719336271
suppressed O 0 0.014491588808596134
by O 0 0.006275915540754795
the O 0 0.011259776540100574
reintroduction O 0 0.15606936812400818
of O 0 0.029059406369924545
VHL B-Disease 1 0.9999992847442627
. O 0 0.04603436216711998

Remarkably O 0 0.128945454955101
, O 0 0.014639697968959808
this O 0 0.007776400074362755
occurs O 0 0.007545051164925098
without O 0 0.005545613821595907
affecting O 0 0.007145102135837078
the O 0 0.005732093937695026
growth O 0 0.00861305557191372
rate O 0 0.006964850705116987
and O 0 0.005772044416517019
cell O 0 0.01199204009026289
cycle O 0 0.010395905934274197
profile O 0 0.012254110537469387
of O 0 0.006642031017690897
these O 0 0.005419350229203701
cells O 0 0.009988303296267986
in O 0 0.009717622771859169
culture O 0 0.025065073743462563
. O 0 0.03059869445860386

The O 0 0.03139309585094452
786 O 1 0.9992222785949707
- O 1 0.9998443126678467
0 O 0 0.02875630371272564
cell O 0 0.01718919165432453
line O 0 0.010911190882325172
, O 0 0.006285450421273708
like O 0 0.006736746057868004
many O 0 0.006929733324795961
cancer B-Disease 1 1.0
cells O 0 0.012317684479057789
, O 0 0.0068247620947659016
fails O 0 0.013276885263621807
to O 0 0.006689726375043392
exit O 0 0.013161614537239075
the O 0 0.0095510333776474
cell O 0 0.01791011169552803
cycle O 0 0.020495757460594177
upon O 0 0.019514353945851326
serum O 1 0.9980005621910095
withdrawal O 0 0.06041666120290756
. O 0 0.03979784622788429

Here O 0 0.02501591108739376
, O 0 0.011624667793512344
it O 0 0.0066610476933419704
is O 0 0.005759247113019228
shown O 0 0.005722693167626858
that O 0 0.0035288012586534023
reintroduction O 0 0.01368655450642109
of O 0 0.0056466455571353436
the O 0 0.006632410921156406
wild O 0 0.015913408249616623
- O 1 0.9999510049819946
type O 1 0.7398894429206848
VHL B-Disease 1 0.9999727010726929
gene O 0 0.016936516389250755
restores O 0 0.029923655092716217
the O 0 0.007042949087917805
ability O 0 0.009435638785362244
of O 0 0.011910093948245049
VHL O 1 1.0
- O 1 0.9999998807907104
negative O 1 0.9924753308296204
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.013153070583939552
to O 0 0.007958590984344482
exit O 0 0.015369981527328491
the O 0 0.008664076216518879
cell O 0 0.014270111918449402
cycle O 0 0.013106546364724636
and O 0 0.009511338546872139
enter O 0 0.02682892419397831
G0 O 1 0.9999995231628418
/ O 1 0.9997323155403137
quiescence O 1 0.9783204793930054
in O 0 0.022170113399624825
low O 0 0.05128362029790878
serum O 1 0.9849975109100342
. O 0 0.04563997685909271

Both O 0 0.034909624606370926
VHL O 1 0.999997615814209
- O 1 0.9926837086677551
positive O 0 0.015267694368958473
and O 0 0.01385942567139864
VHL O 1 1.0
- O 1 0.9999988079071045
negative O 0 0.03669329360127449
RCC B-Disease 1 1.0
cells O 0 0.01769992709159851
exit O 0 0.019071198999881744
the O 0 0.011456574313342571
cell O 0 0.01927284337580204
cycle O 0 0.015314262360334396
by O 0 0.010595163330435753
contact O 0 0.025320056825876236
inhibition O 0 0.0766470804810524
. O 0 0.03397681564092636

The O 0 0.05312902852892876
cyclin O 1 0.9995988011360168
- O 1 0.999705970287323
dependent O 0 0.04146873205900192
kinase O 1 0.9363182187080383
inhibitor O 1 0.9766684174537659
, O 0 0.016130343079566956
p27 O 1 0.9887374639511108
, O 0 0.013298604637384415
accumulates O 0 0.03982631862163544
upon O 0 0.013622386381030083
serum O 1 0.9998588562011719
withdrawal O 0 0.12776052951812744
, O 0 0.0072167301550507545
only O 0 0.0041131372563540936
in O 0 0.00416953768581152
the O 0 0.004954477306455374
presence O 0 0.008209072053432465
of O 0 0.009295935742557049
VHL B-Disease 1 0.9999996423721313
, O 0 0.008365127258002758
as O 0 0.005763925611972809
a O 0 0.0067590209655463696
result O 0 0.005271873436868191
of O 0 0.0050430758856236935
the O 0 0.0076597826555371284
stabilization O 0 0.08583236485719681
of O 0 0.009631823748350143
the O 0 0.014453394338488579
protein O 0 0.02367648482322693
. O 0 0.02375573106110096

We O 0 0.015525628812611103
propose O 0 0.017827510833740234
that O 0 0.004855180159211159
the O 0 0.006184288766235113
loss O 0 0.010523657314479351
of O 0 0.0070930286310613155
wild O 0 0.05392680689692497
- O 1 0.9999997615814209
type O 1 0.9917205572128296
VHL B-Disease 1 0.9999936819076538
gene O 0 0.011011873371899128
results O 0 0.006889168173074722
in O 0 0.004807665012776852
a O 0 0.006173978094011545
specific O 0 0.00695070018991828
cellular O 0 0.14500364661216736
defect O 1 0.9668228030204773
in O 0 0.011323902755975723
serum O 1 0.9999969005584717
- O 1 0.9999767541885376
dependent O 0 0.01149359904229641
growth O 0 0.009155601263046265
control O 0 0.00966581143438816
, O 0 0.006608927622437477
which O 0 0.005959989503026009
may O 0 0.008826022036373615
initiate O 1 0.9218076467514038
tumor B-Disease 1 0.9999997615814209
formation O 1 0.7345871329307556
. O 0 0.035102393478155136

This O 0 0.021679213270545006
is O 0 0.013858693651854992
corrected O 0 0.022949758917093277
by O 0 0.006361686624586582
the O 0 0.006285152863711119
reintroduction O 0 0.020517360419034958
of O 0 0.008529490791261196
wild O 0 0.01714048907160759
- O 1 0.9999986886978149
type O 1 0.9810848236083984
VHL B-Disease 1 0.9999995231628418
, O 0 0.017784662544727325
implicating O 1 0.9971956014633179
VHL B-Disease 1 0.9999890327453613
as O 0 0.010091643780469894
the O 0 0.008915675804018974
first O 0 0.02583550103008747
tumor B-Disease 1 0.9999995231628418
suppressor O 1 0.9954251646995544
involved O 0 0.00610576244071126
in O 0 0.004237808287143707
the O 0 0.0046155862510204315
regulation O 0 0.006321633234620094
of O 0 0.005226051900535822
cell O 0 0.011891568079590797
cycle O 0 0.010478267446160316
exit O 0 0.01162216067314148
, O 0 0.005424992647022009
which O 0 0.003476545214653015
is O 0 0.0032955827191472054
consistent O 0 0.0051719737239181995
with O 0 0.004221934359520674
its O 0 0.006566935684531927
gatekeeper O 1 0.9999030828475952
function O 0 0.007075826171785593
in O 0 0.006796777714043856
the O 0 0.03441222012042999
kidney O 1 1.0
. O 0 0.018645839765667915
. O 0 0.0241368617862463

Piebaldism B-Disease 1 0.9999974966049194
with O 0 0.15275833010673523
deafness B-Disease 1 1.0
: O 0 0.02270967699587345
molecular O 0 0.01794184371829033
evidence O 0 0.007573437876999378
for O 0 0.007292897906154394
an O 0 0.0131504712626338
expanded O 1 0.9933699369430542
syndrome O 1 1.0
. O 0 0.05971865355968475

In O 0 0.02062392234802246
a O 0 0.015545276924967766
South O 0 0.0202572550624609
African O 0 0.01793644204735756
girl O 0 0.02222527749836445
of O 0 0.012046524323523045
Xhosa O 1 0.9999924898147583
stock O 0 0.10751834511756897
with O 0 0.009756067767739296
severe O 1 0.9999995231628418
piebaldism B-Disease 1 0.9999998807907104
and O 1 0.9966446161270142
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.6473642587661743
identified O 0 0.015505940653383732
a O 0 0.013196318410336971
novel O 0 0.02258496917784214
missense O 0 0.028728874400258064
substitution O 0 0.015195746906101704
at O 0 0.010021515190601349
a O 0 0.00838775560259819
highly O 0 0.012514984235167503
conserved O 0 0.015944411978125572
residue O 0 0.016350211575627327
in O 0 0.007834351621568203
the O 0 0.010726905427873135
intracellular O 0 0.03451100364327431
kinase O 0 0.027005918323993683
domain O 0 0.012665659189224243
of O 0 0.009343395940959454
the O 0 0.016420744359493256
KIT O 1 1.0
proto O 1 0.9999998807907104
- O 1 0.9999997615814209
oncogene O 1 0.9999974966049194
, O 0 0.03631399944424629
R796G O 1 0.8396345973014832
. O 0 0.0475706085562706

Though O 0 0.03812913969159126
auditory B-Disease 1 0.8293169140815735
anomalies I-Disease 0 0.07005967944860458
have O 0 0.007070356514304876
been O 0 0.005905349738895893
observed O 0 0.006186249665915966
in O 0 0.004717657342553139
mice O 0 0.00948118045926094
with O 0 0.0052175018936395645
dominant O 0 0.046876274049282074
white O 1 0.5864946246147156
spotting O 1 0.9999649524688721
( O 1 0.5411814451217651
W O 1 0.9999997615814209
) O 0 0.008844754658639431
due O 0 0.00763020571321249
to O 0 0.009176794439554214
KIT O 1 0.9999994039535522
mutations O 0 0.020294934511184692
, O 0 0.017963668331503868
deafness B-Disease 1 1.0
is O 0 0.008191678673028946
not O 0 0.005269068293273449
typical O 0 0.010328894481062889
in O 0 0.00776210380718112
human O 0 0.012867998331785202
piebaldism B-Disease 1 0.9999024868011475
. O 0 0.03387715667486191

Thus O 0 0.022631140425801277
, O 0 0.009590321220457554
the O 0 0.008037121035158634
occurrence O 0 0.01606236957013607
of O 0 0.14934049546718597
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.37041231989860535
this O 0 0.009603146463632584
patient O 1 0.9652166366577148
extends O 0 0.02280893176794052
considerably O 0 0.015796750783920288
the O 0 0.008144618943333626
phenotypic O 0 0.016981033608317375
range O 0 0.010254571214318275
of O 0 0.008239354938268661
piebaldism B-Disease 1 0.5785011649131775
due O 0 0.009391024708747864
to O 0 0.01085993554443121
KIT O 1 0.9999949932098389
gene O 0 0.013351373374462128
mutation O 0 0.010159879922866821
in O 0 0.005511099938303232
humans O 0 0.006943147163838148
and O 0 0.007111421786248684
tightens O 1 0.9425632953643799
the O 0 0.00843003299087286
clinical O 1 0.9529240727424622
similarity O 0 0.013223680667579174
between O 0 0.008513721637427807
piebaldism B-Disease 1 0.9734488725662231
and O 0 0.006040020380169153
the O 0 0.005884027108550072
various O 0 0.0042355479672551155
forms O 0 0.008015860803425312
of O 1 0.9900934100151062
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9804748892784119
. O 0 0.0381607711315155

Cycloheximide O 1 0.8861148357391357
facilitates O 0 0.049048230051994324
the O 0 0.015543092973530293
identification O 0 0.0149651188403368
of O 0 0.01184327807277441
aberrant O 0 0.07663876563310623
transcripts O 0 0.01865800842642784
resulting O 0 0.009623652324080467
from O 0 0.00576820969581604
a O 0 0.008886563591659069
novel O 0 0.020974302664399147
splice O 0 0.3626314699649811
- O 1 0.8808488249778748
site O 0 0.01651996374130249
mutation O 0 0.012429437600076199
in O 0 0.008597186766564846
COL17A1 O 1 0.9742669463157654
in O 0 0.008889234624803066
a O 0 0.01206350326538086
patient O 1 0.9641160368919373
with O 0 0.019680753350257874
generalized O 1 0.9999985694885254
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.40974292159080505

Patients O 1 0.9909467697143555
with O 0 0.029112812131643295
generalized O 1 0.9999978542327881
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.01834709197282791
show O 0 0.014289285987615585
decreased O 0 0.015122388489544392
expression O 0 0.011648479849100113
of O 0 0.013597163371741772
type O 1 0.9999713897705078
XVII O 1 1.0
collagen O 1 1.0
, O 0 0.021524036303162575
a O 0 0.02216600440442562
transmembrane O 1 0.9887793064117432
hemidesmosomal O 1 0.9972946047782898
protein O 0 0.02281687594950199
encoded O 0 0.018246280029416084
by O 0 0.015572458505630493
COL17A1 O 1 0.9992388486862183
. O 0 0.040154892951250076

This O 0 0.0179620198905468
report O 0 0.01322086714208126
documents O 0 0.010857740417122841
a O 0 0.010169072076678276
novel O 0 0.017913416028022766
splice O 1 0.5514417290687561
- O 1 0.9886271357536316
site O 0 0.016653776168823242
mutation O 0 0.012204671278595924
in O 0 0.007580569013953209
COL17A1 O 1 0.9935694932937622
in O 0 0.007143833674490452
a O 0 0.01008792407810688
patient O 1 0.9182695150375366
with O 0 0.01168092992156744
generalized O 1 0.9999984502792358
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 1 0.5321502685546875
and O 0 0.008236776106059551
applies O 0 0.009189612232148647
a O 0 0.007292431779205799
new O 0 0.007944554090499878
methodology O 0 0.010359206236898899
to O 0 0.006398492492735386
define O 0 0.010704835876822472
and O 0 0.00775814289227128
characterize O 0 0.020004520192742348
the O 0 0.01236262172460556
resulting O 0 0.021245844662189484
mRNA O 0 0.04074419289827347
splice O 0 0.08223047852516174
variants O 0 0.04563754424452782
. O 0 0.03632793948054314

Mutational O 0 0.2399223893880844
analysis O 0 0.027140678837895393
of O 0 0.019497394561767578
COL17A1 O 1 0.9852932095527649
identified O 0 0.016657141968607903
a O 0 0.017911722883582115
maternally O 1 0.986748218536377
inherited O 1 0.9999972581863403
G O 1 0.9999979734420776
- O 1 0.9995250701904297
to O 0 0.012007339857518673
- O 1 0.99997878074646
T O 1 0.9997292160987854
transversion O 0 0.049404192715883255
at O 0 0.010821979492902756
the O 0 0.009619759395718575
- O 1 0.8172672390937805
1 O 0 0.014811325818300247
position O 0 0.015004328452050686
of O 0 0.016042465344071388
exon O 0 0.0705316960811615
32 O 0 0.050051406025886536
. O 0 0.03808535262942314

This O 0 0.029448285698890686
acceptor O 0 0.0612788088619709
splice O 0 0.4270424544811249
- O 1 0.9333454966545105
site O 0 0.021128591150045395
mutation O 0 0.016231711953878403
led O 0 0.010435977019369602
to O 0 0.005702937487512827
the O 0 0.00699923001229763
formation O 0 0.010159770026803017
of O 0 0.009034590795636177
aberrant O 0 0.027716144919395447
transcripts O 0 0.015355173498392105
present O 0 0.00969961378723383
at O 0 0.011107878759503365
extremely O 0 0.016451718285679817
low O 0 0.023878736421465874
levels O 0 0.019782250747084618
. O 0 0.02637421526014805

Based O 0 0.023564763367176056
on O 0 0.01109384372830391
our O 0 0.010936358012259007
recent O 0 0.009963060729205608
finding O 0 0.012041405774652958
that O 0 0.008690282702445984
cycloheximide O 1 0.9981963038444519
stabilized O 1 0.9986997842788696
mutant O 0 0.3799889385700226
COL17A1 O 1 0.9999548196792603
transcripts O 0 0.027859007939696312
in O 0 0.0122159318998456
keratinocytes O 0 0.04515210911631584
homozygous O 0 0.022959141060709953
for O 0 0.009780789725482464
a O 0 0.013541114516556263
frameshift O 1 0.9702666401863098
mutation O 0 0.015238085761666298
, O 0 0.007528537884354591
the O 0 0.006040231790393591
effects O 0 0.009250192902982235
of O 0 0.0065436395816504955
the O 0 0.010989290662109852
splice O 1 0.9008779525756836
- O 1 0.982805073261261
site O 0 0.017454011365771294
mutation O 0 0.013185492716729641
on O 0 0.009004895575344563
splicing O 0 0.017974724993109703
of O 0 0.012688888236880302
COL17A1 O 1 0.9946150183677673
transcripts O 0 0.020858949050307274
were O 0 0.007136238738894463
determined O 0 0.01141352765262127
using O 0 0.009035125374794006
reverse O 0 0.02765464037656784
transcriptase O 0 0.058690592646598816
polymerase O 0 0.047893550246953964
chain O 0 0.027392689138650894
reaction O 0 0.014403358101844788
of O 0 0.010243339464068413
total O 0 0.013091986998915672
RNA O 0 0.02631928212940693
from O 0 0.015385699458420277
keratinocytes O 0 0.06856842339038849
incubated O 0 0.051011823117733
for O 0 0.01908225007355213
2 O 0 0.03380795940756798
. O 0 0.03197978064417839

5 O 0 0.044270578771829605
h O 0 0.045708540827035904
in O 0 0.008986133150756359
the O 0 0.00806825514882803
presence O 0 0.0076439096592366695
or O 0 0.0056096529588103294
absence O 0 0.010312727652490139
of O 0 0.008520280942320824
10 O 0 0.01613612473011017
microg O 1 0.9996309280395508
cycloheximide O 1 0.9995574355125427
per O 0 0.03478986769914627
ml O 1 0.8872008919715881
. O 0 0.042224470525979996

Using O 0 0.018793370574712753
this O 0 0.009352208115160465
approach O 0 0.01354067400097847
, O 0 0.009445601142942905
an O 0 0.010149708949029446
abnormally O 0 0.10223890095949173
spliced O 0 0.03125559166073799
transcript O 0 0.02188253216445446
was O 0 0.010679179802536964
identified O 0 0.007471049670130014
that O 0 0.003958485554903746
contains O 0 0.006225066725164652
an O 0 0.005896756891161203
extra O 0 0.01530833076685667
264 O 0 0.028160443529486656
bases O 0 0.019132697954773903
upstream O 0 0.018293293192982674
from O 0 0.00920061580836773
exon O 0 0.03328423202037811
32 O 0 0.016966769471764565
, O 0 0.008526155725121498
resulting O 0 0.008147519081830978
in O 0 0.007385119795799255
a O 0 0.013068189844489098
premature O 0 0.2417728453874588
termination O 1 0.6420735716819763
codon O 0 0.04098367691040039
27 O 0 0.0355704203248024
bp O 0 0.04477832466363907
downstream O 0 0.027311835438013077
from O 0 0.013804864138364792
the O 0 0.01834220066666603
cryptic O 0 0.06838157773017883
splice O 0 0.15535373985767365
site O 0 0.04320977255702019
. O 0 0.033861227333545685

Three O 0 0.020927267149090767
other O 0 0.01179544348269701
splice O 0 0.03962969034910202
variants O 0 0.016443872824311256
, O 0 0.008552510291337967
including O 0 0.006129923276603222
one O 0 0.006182756274938583
derived O 0 0.006143184844404459
from O 0 0.004553043749183416
the O 0 0.00735004898160696
skipping O 0 0.02391577884554863
of O 0 0.010778600350022316
exon O 0 0.044626884162425995
32 O 0 0.01955587975680828
, O 0 0.009829585440456867
were O 0 0.008820930495858192
also O 0 0.0130675183609128
identified O 0 0.02060830220580101
. O 0 0.02640034817159176

These O 0 0.012907672673463821
results O 0 0.0127228032797575
indicate O 0 0.009544800966978073
the O 0 0.008197844959795475
usefulness O 0 0.02253158949315548
of O 0 0.011562998406589031
cycloheximide O 1 0.9999967813491821
treatment O 1 0.9893605709075928
in O 0 0.007831735536456108
evaluating O 0 0.016218628734350204
the O 0 0.00802771095186472
abnormal O 0 0.0114778783172369
processing O 0 0.009329326450824738
of O 0 0.006381448358297348
mRNA O 0 0.010917481034994125
due O 0 0.006738527212291956
to O 0 0.007688323967158794
splice O 0 0.04230880364775658
- O 1 0.8082916736602783
site O 0 0.015385625883936882
mutations O 0 0.010183923877775669
, O 0 0.006240416783839464
because O 0 0.005973301362246275
( O 0 0.007879560813307762
i O 0 0.011230419389903545
) O 0 0.009684291668236256
aberrant O 0 0.024194683879613876
splicing O 0 0.02128281444311142
often O 0 0.006544935517013073
generates O 0 0.016183096915483475
a O 0 0.010786582715809345
premature O 0 0.06602740287780762
termination O 1 0.7132891416549683
codon O 0 0.025838539004325867
, O 0 0.010492159053683281
( O 0 0.011584785766899586
ii O 1 0.9979294538497925
) O 0 0.008439662866294384
transcripts O 0 0.014486797153949738
with O 0 0.009062600322067738
premature O 1 0.8419492244720459
termination O 1 0.902878999710083
codons O 0 0.017958763986825943
can O 0 0.004702010191977024
occur O 0 0.0046455636620521545
at O 0 0.007064366713166237
low O 0 0.009316880255937576
or O 0 0.005630417261272669
undetectable O 1 0.9822604060173035
levels O 0 0.006723365280777216
due O 0 0.005270537920296192
to O 0 0.006673579104244709
nonsense O 0 0.026956355199217796
- O 1 0.993224561214447
mediated O 0 0.022836735472083092
mRNA O 0 0.01760278083384037
decay O 0 0.01708553358912468
, O 0 0.008068935014307499
and O 0 0.006538217421621084
( O 0 0.00862511619925499
iii O 1 0.9992324113845825
) O 0 0.005592223722487688
the O 0 0.0052438760176301
levels O 0 0.005192993208765984
of O 0 0.004392428323626518
these O 0 0.0032502368558198214
transcripts O 0 0.008350232616066933
can O 0 0.00417585764080286
be O 0 0.004597126506268978
increased O 0 0.008667344227433205
by O 0 0.010804729536175728
cycloheximide O 1 0.9526296257972717
. O 0 0.03328157961368561

A O 0 0.04901614785194397
deletion O 0 0.056162163615226746
mutation O 0 0.024390045553445816
in O 0 0.011666885577142239
COL17A1 O 1 0.9987748265266418
in O 0 0.008470933884382248
five O 0 0.00958713237196207
Austrian O 0 0.19164463877677917
families O 0 0.011696734465658665
with O 0 0.01233665831387043
generalized O 1 0.9999772310256958
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 1 0.6837129592895508
propagation O 0 0.03817255422472954
of O 0 0.017041075974702835
an O 0 0.019901057705283165
ancestral O 0 0.4539698660373688
allele O 0 0.0769638866186142
. O 0 0.04084956273436546

Patients O 1 0.9920672178268433
with O 0 0.0286099836230278
generalized O 1 0.9999985694885254
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.16295090317726135
a O 0 0.016581442207098007
usually O 0 0.013009770773351192
nonlethal O 0 0.03245479613542557
form O 0 0.01216164417564869
of O 0 0.019346831366419792
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.014641541987657547
have O 0 0.007406830321997404
generalized O 0 0.14703243970870972
blistering B-Disease 1 0.9999887943267822
, O 1 0.978571355342865
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9990144968032837
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 1 0.9989014863967896
and O 1 0.9994608759880066
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.438932865858078

Skin B-Disease 1 1.0
fragility I-Disease 1 0.999998927116394
in O 0 0.012894724495708942
most O 0 0.007760821841657162
cases O 0 0.006820516660809517
is O 0 0.00453891372308135
due O 0 0.005176612641662359
to O 0 0.005250751040875912
mutations O 0 0.005804952699691057
in O 0 0.00432071927934885
the O 0 0.006167346611618996
gene O 0 0.009065435267984867
encoding O 0 0.015961503610014915
type O 1 0.9785430431365967
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.922636091709137
COL17A1 O 1 0.9999991655349731
) O 0 0.03450606018304825
. O 0 0.0381486602127552

Recently O 0 0.03577608987689018
, O 0 0.01205646526068449
we O 0 0.0069857812486588955
reported O 0 0.008166350424289703
five O 0 0.006790803279727697
Austrian O 0 0.039927031844854355
families O 0 0.01161364559084177
with O 0 0.01325284969061613
generalized O 1 0.9999984502792358
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.27629441022872925
share O 0 0.017361389473080635
the O 0 0.01293373666703701
same O 0 0.019472410902380943
COL17A1 O 1 0.9999759197235107
mutation O 0 0.047223854809999466
. O 0 0.03407012298703194

Affected O 0 0.03129468113183975
individuals O 0 0.009569472633302212
in O 0 0.0068364436738193035
three O 0 0.00597156397998333
families O 0 0.0066627394407987595
are O 0 0.003469623625278473
homozygous O 0 0.01324559934437275
for O 0 0.00857274979352951
4003delTC O 1 0.999646782875061
, O 0 0.009037960320711136
whereas O 0 0.008378052152693272
those O 0 0.0038850523997098207
in O 0 0.004789911210536957
two O 0 0.0044840662740170956
others O 0 0.00759931793436408
are O 0 0.007082371041178703
compound O 0 0.03580683842301369
heterozygotes O 1 0.9637576341629028
. O 0 0.03350096940994263

To O 0 0.018589768558740616
determine O 0 0.012233207002282143
if O 0 0.006768541876226664
the O 0 0.0068661668337881565
occurrence O 0 0.012061594985425472
of O 0 0.008706753142178059
4003delTC O 1 0.9856104254722595
in O 0 0.008365717716515064
these O 0 0.005241327453404665
unrelated O 0 0.01258801855146885
families O 0 0.009344464167952538
signifies O 0 0.045047398656606674
propagation O 0 0.01608707569539547
of O 0 0.007825560867786407
an O 0 0.008321348577737808
ancestral O 0 0.41268160939216614
allele O 0 0.018321359530091286
or O 0 0.0070143756456673145
a O 0 0.010791354812681675
mutational O 1 0.999956488609314
hot O 1 0.939696192741394
spot O 0 0.030229581519961357
, O 0 0.011346561834216118
haplotypes O 0 0.018434159457683563
were O 0 0.005717814899981022
determined O 0 0.008182010613381863
for O 0 0.006147474516183138
polymorphisms O 0 0.014247805811464787
both O 0 0.00658064428716898
within O 0 0.009434521198272705
and O 0 0.01645902544260025
flanking O 1 0.9996453523635864
COL17A1 O 1 0.9999984502792358
. O 0 0.04653735086321831

Five O 0 0.040401194244623184
intragenic O 1 0.7410640120506287
polymorphisms O 0 0.03234636038541794
were O 0 0.009507700800895691
chosen O 0 0.011833126656711102
based O 0 0.009533753618597984
on O 0 0.00918695516884327
their O 0 0.01325981691479683
informativeness O 1 0.9647939205169678
. O 0 0.03459204360842705

One O 0 0.019290948286652565
of O 0 0.01006749365478754
these O 0 0.0055021564476192
, O 0 0.006088408175855875
not O 0 0.0038783703930675983
previously O 0 0.0075257448479533195
reported O 0 0.0073622423224151134
, O 0 0.006422851234674454
was O 0 0.010043010115623474
2988 O 1 0.7567955255508423
A O 0 0.014768454246222973
or O 0 0.00915160495787859
C O 0 0.07575271278619766
that O 0 0.005820000544190407
introduces O 0 0.018603188917040825
a O 0 0.008775142021477222
new O 0 0.009492624551057816
restriction O 0 0.015101438388228416
site O 0 0.01572793908417225
for O 0 0.013789878226816654
Eco0109 O 1 0.9665759205818176
I O 0 0.05220124125480652
. O 0 0.03408012166619301

All O 0 0.02279024012386799
the O 0 0.022399937734007835
4003delTC O 1 0.8586797118186951
alleles O 0 0.024874521419405937
showed O 0 0.013397978618741035
the O 0 0.008026658557355404
same O 0 0.008429055102169514
haplotype O 0 0.023668328300118446
for O 0 0.00841476023197174
these O 0 0.006770857609808445
five O 0 0.014630874618887901
polymorphic O 0 0.08799527585506439
markers O 0 0.05861096829175949
. O 0 0.041632842272520065

Fourteen O 0 0.09300894290208817
microsatellite O 1 0.7792186141014099
polymorphisms O 0 0.030201345682144165
were O 0 0.007921496406197548
selected O 0 0.009881669655442238
based O 0 0.0066686468198895454
on O 0 0.005106422118842602
their O 0 0.004981078673154116
high O 0 0.011754590086638927
heterozygosity O 1 0.9840206503868103
and O 0 0.005402872804552317
their O 0 0.004792714491486549
location O 0 0.007962522096931934
within O 0 0.00797392800450325
10q23 O 1 0.99637371301651
- O 1 0.9999643564224243
q25 O 1 0.9983617663383484
near O 0 0.05197989195585251
COL17A1 O 1 0.9998158812522888
. O 0 0.04438284412026405

Three O 0 0.023619286715984344
families O 0 0.02018802985548973
shared O 0 0.025433896109461784
microsatellite O 1 0.9555023908615112
polymorphisms O 0 0.03022017702460289
covering O 0 0.020334742963314056
at O 0 0.00892487820237875
most O 0 0.0065091922879219055
19 O 0 0.014394717290997505
cM O 0 0.023659108206629753
, O 0 0.0066324700601398945
whereas O 0 0.006178219337016344
the O 0 0.005647566635161638
others O 0 0.0060881017707288265
shared O 0 0.00842338241636753
smaller O 0 0.006734021939337254
regions O 0 0.004714686889201403
consistent O 0 0.0065020667389035225
with O 0 0.005371330305933952
cross O 0 0.01094385888427496
- O 1 0.8079206943511963
over O 0 0.0063954805955290794
events O 0 0.0060959793627262115
during O 0 0.00660296343266964
passage O 0 0.0076685016974806786
of O 0 0.005394789390265942
this O 0 0.004793895408511162
mutation O 0 0.009126664139330387
through O 0 0.0066802650690078735
several O 0 0.009749533608555794
generations O 0 0.026896610856056213
. O 0 0.024225909262895584

These O 0 0.01683100499212742
results O 0 0.012678963132202625
indicate O 0 0.01016660500317812
that O 0 0.006984199862927198
4003delTC O 0 0.3778257369995117
occurs O 0 0.008504971861839294
on O 0 0.007378848735243082
a O 0 0.01110896747559309
single O 0 0.01771477982401848
ancestral O 0 0.041660793125629425
allele O 0 0.03931397944688797
. O 0 0.019865764304995537
. O 0 0.031781479716300964

The O 0 0.05750472471117973
haptoglobin O 1 0.9997789263725281
- O 1 0.9994282126426697
gene O 0 0.025648077949881554
deletion O 0 0.03509272634983063
responsible O 0 0.019665947183966637
for O 0 0.018647298216819763
anhaptoglobinemia B-Disease 1 0.9994438290596008
. O 0 0.039653144776821136

We O 0 0.018726620823144913
have O 0 0.007414782419800758
found O 0 0.006453612819314003
an O 0 0.007615200709551573
allelic O 0 0.03377927839756012
deletion O 0 0.020951099693775177
of O 0 0.00914948619902134
the O 0 0.01341918669641018
haptoglobin O 1 0.9999985694885254
( O 0 0.01744598150253296
Hp O 1 0.9995601773262024
) O 0 0.010205604135990143
gene O 0 0.008293362334370613
from O 0 0.0052060652524232864
an O 0 0.007248849608004093
individual O 0 0.00978216715157032
with O 0 0.015606449916958809
anhaptoglobinemia B-Disease 1 0.9993940591812134
. O 0 0.03561806306242943

The O 0 0.042808182537555695
Hp O 1 0.8099837303161621
gene O 0 0.02678121067583561
cluster O 0 0.025615539401769638
consists O 0 0.015998994931578636
of O 0 0.008499488234519958
coding O 0 0.016724076122045517
regions O 0 0.0064346687868237495
of O 0 0.005740121938288212
the O 0 0.007766786962747574
alpha O 0 0.21447618305683136
chain O 0 0.02322733774781227
and O 0 0.007308147847652435
beta O 0 0.017216002568602562
chain O 0 0.01378333568572998
of O 0 0.006147163454443216
the O 0 0.00850432738661766
haptoglobin O 1 0.9995296001434326
gene O 0 0.01408400572836399
( O 0 0.010995986871421337
Hp O 1 0.9706605672836304
) O 0 0.0066639455035328865
and O 0 0.004874587524682283
of O 0 0.004699563141912222
the O 0 0.006579079199582338
alpha O 0 0.06784568727016449
chain O 0 0.01792413368821144
and O 0 0.007109321188181639
beta O 0 0.018940100446343422
chain O 0 0.013380932621657848
of O 0 0.006656068377196789
the O 0 0.010144895873963833
haptoglobin O 1 0.999504566192627
- O 1 0.9977560639381409
related O 0 0.013473509810864925
gene O 0 0.012630775570869446
( O 0 0.012659948319196701
Hpr O 1 0.9999814033508301
) O 0 0.008367902599275112
, O 0 0.00677335262298584
in O 0 0.006351681426167488
tandem O 0 0.020239688456058502
from O 0 0.006733473390340805
the O 0 0.010420536622405052
5 O 0 0.019613279029726982
side O 0 0.024631913751363754
. O 0 0.027080344036221504

Southern O 0 0.05909929797053337
blot O 1 0.9952475428581238
and O 0 0.018337439745664597
PCR O 0 0.04535480961203575
analyses O 0 0.015313089825212955
have O 0 0.00476921396329999
indicated O 0 0.006838797125965357
that O 0 0.003139810636639595
the O 0 0.004177759867161512
individual O 0 0.005137460771948099
with O 0 0.007055408786982298
anhaptoglobinemia B-Disease 1 0.9949710369110107
was O 0 0.012816966511309147
homozygous O 0 0.01589985378086567
for O 0 0.005425584502518177
the O 0 0.007612621411681175
gene O 0 0.008372587151825428
deletion O 0 0.012540985830128193
and O 0 0.004123529884964228
that O 0 0.0027318098582327366
the O 0 0.004879442509263754
gene O 0 0.00711040198802948
deletion O 0 0.011878744699060917
was O 0 0.0071701779961586
included O 0 0.005335815250873566
at O 0 0.004399469587951899
least O 0 0.003484318032860756
from O 0 0.004317712038755417
the O 0 0.0070443726144731045
promoter O 0 0.03493121638894081
region O 0 0.010573729872703552
of O 0 0.010254716500639915
Hp O 1 0.9542043805122375
to O 0 0.014958974905312061
Hpr O 1 0.9993219375610352
alpha O 0 0.02306528575718403
but O 0 0.005950532853603363
not O 0 0.004803739953786135
to O 0 0.009679391048848629
Hpr O 1 0.9997939467430115
beta O 1 0.766521155834198
( O 0 0.024435171857476234
Hpdel O 1 0.9994497895240784
) O 0 0.028738152235746384
. O 0 0.03130744770169258

In O 0 0.020302996039390564
addition O 0 0.013477110303938389
, O 0 0.007131590973585844
we O 0 0.004370538983494043
found O 0 0.004021702334284782
seven O 0 0.004430943634361029
individuals O 0 0.003349101869389415
with O 0 0.004454943351447582
hypohaptoglobinemia B-Disease 1 0.9958617687225342
in O 0 0.004279129207134247
three O 0 0.0041000209748744965
families O 0 0.004609672352671623
, O 0 0.003796395380049944
and O 0 0.0035999335814267397
the O 0 0.00506445299834013
genotypes O 0 0.015212390571832657
of O 0 0.004743763245642185
six O 0 0.005136593710631132
of O 0 0.004111192189157009
the O 0 0.0046854461543262005
seven O 0 0.004409154877066612
individuals O 0 0.0029110792092978954
were O 0 0.00331607973203063
found O 0 0.003608275204896927
to O 0 0.0051340945065021515
be O 0 0.008474137634038925
Hp2 O 1 0.9999953508377075
/ O 1 0.9999872446060181
Hpdel O 1 0.9995823502540588
. O 0 0.04311737045645714

The O 0 0.03362173214554787
phenotypes O 0 0.053905051201581955
and O 0 0.015023564919829369
genotypes O 0 0.06425870209932327
in O 0 0.006725193001329899
one O 0 0.005237253848463297
of O 0 0.004098901059478521
these O 0 0.002662465674802661
three O 0 0.0033084952738136053
families O 0 0.004346255213022232
showed O 0 0.005485139787197113
the O 0 0.00450934749096632
father O 0 0.008525777608156204
to O 0 0.004825978074222803
be O 0 0.006201471667736769
hypohaptoglobinemic B-Disease 1 0.9988620281219482
( O 0 0.011994228698313236
Hp2 O 1 0.9984326958656311
) O 0 0.010383854620158672
and O 0 0.010795509442687035
Hp2 O 1 0.9999949932098389
/ O 1 0.9999792575836182
Hpdel O 1 0.9993127584457397
, O 0 0.009386102668941021
the O 0 0.007290761452168226
mother O 0 0.010145225562155247
to O 0 0.005474443547427654
be O 0 0.0055372281931340694
Hp2 O 1 0.9951005578041077
- O 1 0.9937236905097961
1 O 0 0.013334416784346104
and O 0 0.009723657742142677
Hp1 O 1 0.9999939203262329
/ O 1 0.9999641180038452
Hp2 O 1 0.9964693784713745
, O 0 0.006486739031970501
one O 0 0.0040519204922020435
of O 0 0.003915139939635992
the O 0 0.004411736503243446
two O 0 0.0034944473300129175
children O 0 0.004529010038822889
to O 0 0.004087718203663826
be O 0 0.00466863764449954
hypohaptoglobinemic B-Disease 1 0.994642972946167
( O 0 0.01049721147865057
Hp2 O 1 0.9991481304168701
) O 0 0.009040094912052155
and O 0 0.009811795316636562
Hp2 O 1 0.9999842643737793
/ O 1 0.999966025352478
Hpdel O 1 0.9998176693916321
, O 0 0.00867595337331295
and O 0 0.006049904506653547
the O 0 0.005936927627772093
other O 0 0.0039366804994642735
child O 0 0.007347919978201389
to O 0 0.004873898345977068
be O 0 0.00557426642626524
Hp1 O 1 0.951393723487854
and O 0 0.01307826116681099
Hp1 O 1 0.9999977350234985
/ O 1 0.9999724626541138
Hpdel O 1 0.9997972846031189
, O 0 0.011561838909983635
showing O 0 0.011967693455517292
an O 0 0.008755877614021301
anomalous O 0 0.029119592159986496
inheritance O 0 0.02261539362370968
of O 0 0.010931762866675854
Hp O 1 0.9999960660934448
phenotypes O 1 0.6306007504463196
in O 0 0.008953338488936424
the O 0 0.011494146659970284
child O 0 0.04057377576828003
with O 0 0.017779424786567688
Hp1 O 1 0.9998847246170044
. O 0 0.03563457354903221

The O 0 0.04213862493634224
Hp2 O 1 0.9999904632568359
/ O 1 0.9999598264694214
Hpdel O 1 0.9972599744796753
individuals O 0 0.008196713402867317
had O 0 0.007228902541100979
an O 0 0.006003274116665125
extremely O 0 0.008507399819791317
low O 0 0.009736076928675175
level O 0 0.00710636330768466
of O 0 0.006508918013423681
Hp O 1 0.9900908470153809
( O 0 0.008558034896850586
mean O 0 0.010756841860711575
+ O 0 0.0417892262339592
/ O 1 0.9296684861183167
- O 1 0.9984025359153748
SD O 1 0.9989277720451355
= O 0 0.028961453586816788
0 O 0 0.021715685725212097
. O 0 0.0128093296661973
049 O 1 0.9933496117591858
+ O 1 0.5324774980545044
/ O 1 0.8565768599510193
- O 0 0.23658014833927155
0 O 0 0.02045624330639839
. O 0 0.011139307171106339
043 O 1 0.9755285382270813
mg O 1 0.9999953508377075
/ O 1 0.9995597004890442
ml O 1 0.9994813799858093
; O 0 0.014106390066444874
n O 0 0.020892757922410965
= O 0 0.022055761888623238
6 O 0 0.012843828648328781
) O 0 0.006481615360826254
, O 0 0.005510901566594839
compared O 0 0.004516090732067823
with O 0 0.0034392245579510927
the O 0 0.004899855703115463
level O 0 0.006457123439759016
( O 0 0.005135809071362019
1 O 0 0.007986444979906082
. O 0 0.005627188365906477
64 O 0 0.018653504550457
+ O 0 0.14846061170101166
/ O 1 0.8412361145019531
- O 1 0.526177167892456
1 O 0 0.016357535496354103
. O 0 0.011506175622344017
07 O 1 0.9945706725120544
mg O 1 0.999995231628418
/ O 1 0.99974125623703
ml O 1 0.9942876696586609
) O 0 0.011607500724494457
obtained O 0 0.010265350341796875
from O 0 0.00745657691732049
52 O 0 0.02047121152281761
healthy O 0 0.02120458520948887
volunteers O 0 0.022125594317913055
having O 0 0.015106729231774807
phenotype O 1 0.9735400080680847
Hp2 O 1 0.999929666519165
, O 0 0.010650822892785072
whereas O 0 0.011067346669733524
the O 0 0.011125894263386726
serum O 1 0.9977380037307739
Hp O 1 0.994604766368866
level O 0 0.008723655715584755
of O 0 0.005231811664998531
an O 0 0.005873022601008415
individual O 0 0.007336735725402832
with O 0 0.010455332696437836
Hp1 O 1 0.9999994039535522
/ O 1 0.9999958276748657
Hpdel O 1 0.9999431371688843
was O 0 0.03367399424314499
0 O 0 0.044465307146310806
. O 0 0.03521139174699783

50 O 0 0.05880898982286453
mg O 1 0.9999983310699463
/ O 1 0.9999909400939941
ml O 1 0.9999746084213257
, O 0 0.011407616548240185
which O 0 0.00577126769348979
was O 0 0.007210200652480125
approximately O 0 0.005635822657495737
half O 0 0.0046741049736738205
the O 0 0.004208224825561047
level O 0 0.006171029526740313
of O 0 0.00605156272649765
Hp O 1 0.6945016980171204
in O 0 0.007785934954881668
control O 0 0.012688719667494297
sera O 1 0.9449145197868347
from O 0 0.006977173034101725
the O 0 0.009257939644157887
Hp1 O 1 0.999961256980896
phenotype O 0 0.14506982266902924
( O 0 0.00996031891554594
1 O 0 0.012887323275208473
. O 0 0.007510559633374214
26 O 0 0.01760859601199627
+ O 0 0.05373421311378479
/ O 0 0.399657666683197
- O 0 0.10646248608827591
0 O 0 0.015309697017073631
. O 0 0.007857576943933964
33 O 0 0.02199735678732395
mg O 1 0.9997515082359314
/ O 1 0.9984230995178223
ml O 1 0.996839165687561
; O 0 0.015046147629618645
n O 0 0.02286127582192421
= O 0 0.024549243971705437
9 O 0 0.016178667545318604
) O 0 0.00784219428896904
, O 0 0.006992155220359564
showing O 0 0.009024166502058506
a O 0 0.010574229061603546
gene O 0 0.020377764478325844
- O 1 0.9998716115951538
dosage O 1 0.9906862378120422
effect O 0 0.02687063440680504
. O 0 0.02874833345413208

The O 0 0.026465674862265587
other O 0 0.013778467662632465
allele O 0 0.033263325691223145
( O 0 0.014772819355130196
Hp2 O 1 0.9786524176597595
) O 0 0.008664170280098915
of O 0 0.005653248634189367
individuals O 0 0.004247450269758701
with O 0 0.007542795967310667
Hp2 O 1 0.9999998807907104
/ O 1 0.9999996423721313
Hpdel O 1 0.9999916553497314
was O 0 0.010927608236670494
found O 0 0.004689009394496679
to O 0 0.0037743677385151386
have O 0 0.002567647024989128
, O 0 0.003484192071482539
in O 0 0.003040257841348648
all O 0 0.003724658628925681
exons O 0 0.013059255667030811
, O 0 0.006695621646940708
no O 0 0.007266945205628872
mutation O 0 0.010420733131468296
, O 0 0.0071815308183431625
by O 0 0.006875837687402964
DNA O 0 0.01885824091732502
sequencing O 0 0.03629763796925545
. O 0 0.028583543375134468

On O 0 0.015451507642865181
the O 0 0.009731044061481953
basis O 0 0.00588148133829236
of O 0 0.005088024772703648
the O 0 0.004963912069797516
present O 0 0.005873401649296284
study O 0 0.00565966684371233
, O 0 0.0044318255968391895
the O 0 0.0053701251745224
mechanism O 0 0.0083217928186059
of O 0 0.007644249126315117
anhaptoglobinemia B-Disease 1 0.9978610873222351
and O 0 0.006287595257163048
the O 0 0.006327968090772629
mechanism O 0 0.010301773436367512
of O 0 0.008169947192072868
anomalous O 0 0.06130918115377426
inheritance O 0 0.46053630113601685
of O 0 0.027025314047932625
Hp O 1 0.9999988079071045
phenotypes O 1 0.848709762096405
were O 0 0.010993711650371552
well O 0 0.01557919941842556
explained O 0 0.030421976000070572
. O 0 0.0308223906904459

However O 0 0.02298605442047119
, O 0 0.0155830392614007
the O 0 0.013308306224644184
mechanism O 0 0.022765139117836952
of O 0 0.018289601430296898
hypohaptoglobinemia B-Disease 1 0.9996808767318726
remains O 0 0.1068420261144638
unknown O 0 0.0722283348441124

ATM O 0 0.45045942068099976
mutations O 0 0.02970762550830841
and O 0 0.013844138011336327
phenotypes O 0 0.04007431119680405
in O 0 0.022917134687304497
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.011957434937357903
in O 0 0.006661789957433939
the O 0 0.007551406044512987
British O 0 0.013089301064610481
Isles O 0 0.027761857956647873
: O 0 0.008517453446984291
expression O 0 0.00787947978824377
of O 0 0.007377939764410257
mutant O 0 0.029358040541410446
ATM O 0 0.11258265376091003
and O 0 0.004709113854914904
the O 0 0.005760082975029945
risk O 0 0.009333972819149494
of O 0 0.22716516256332397
leukemia B-Disease 1 1.0
, O 1 1.0
lymphoma B-Disease 1 1.0
, O 1 0.999995231628418
and O 1 0.9999914169311523
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.18526691198349

We O 0 0.018428094685077667
report O 0 0.014634071849286556
the O 0 0.010848013684153557
spectrum O 0 0.01762966811656952
of O 0 0.009489296935498714
59 O 0 0.02718430943787098
ATM O 0 0.047782931476831436
mutations O 0 0.011135410517454147
observed O 0 0.006837638095021248
in O 0 0.010218164883553982
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.019572556018829346
A B-Disease 1 0.9999966621398926
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.01397709921002388
patients O 0 0.018961098045110703
in O 0 0.007841857150197029
the O 0 0.010728479363024235
British O 0 0.024879610165953636
Isles O 0 0.24783235788345337
. O 0 0.035748325288295746

Of O 0 0.03169744461774826
51 O 0 0.051336705684661865
ATM O 0 0.25143563747406006
mutations O 0 0.017183929681777954
identified O 0 0.010207709856331348
in O 0 0.0061929961666464806
families O 0 0.0060140653513371944
native O 0 0.006129194516688585
to O 0 0.004972817841917276
the O 0 0.005785515531897545
British O 0 0.01090278010815382
Isles O 0 0.02053149789571762
, O 0 0.0063840546645224094
11 O 0 0.0075511634349823
were O 0 0.0054733892902731895
founder O 1 0.7205411791801453
mutations O 0 0.008675280958414078
, O 0 0.005028960760682821
and O 0 0.004508705344051123
2 O 0 0.00635144067928195
of O 0 0.004559938330203295
these O 0 0.0032989303581416607
11 O 0 0.009694751352071762
conferred O 0 0.018767036497592926
a O 0 0.012216075323522091
milder O 1 0.983153760433197
clinical O 1 0.9998041987419128
phenotype O 0 0.12585951387882233
with O 0 0.007374930661171675
respect O 0 0.008443598635494709
to O 0 0.00870603695511818
both O 0 0.012624901719391346
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9996501207351685
cellular O 1 0.9999908208847046
features O 0 0.06511352956295013
. O 0 0.03786608576774597

We O 0 0.015252115204930305
report O 0 0.009294521994888783
, O 0 0.0056386301293969154
in O 0 0.004214391112327576
two O 0 0.004788856953382492
A B-Disease 1 0.9868720769882202
- I-Disease 1 1.0
T I-Disease 1 0.9999995231628418
families O 0 0.008479411713778973
, O 0 0.005979723762720823
an O 0 0.0070454333908855915
ATM O 0 0.03161880001425743
mutation O 0 0.013142615556716919
( O 0 0.010751865804195404
7271T O 1 0.9977152347564697
- O 1 0.9999991655349731
- O 1 0.9999991655349731
> O 1 0.9999887943267822
G O 1 0.9998277425765991
) O 0 0.007546951062977314
that O 0 0.0038874666206538677
may O 0 0.003822583705186844
be O 0 0.002923034131526947
associated O 0 0.003729343879967928
with O 0 0.0025185442063957453
an O 0 0.0031606785487383604
increased O 0 0.005090492777526379
risk O 1 0.6849915981292725
of O 1 0.9661088585853577
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.008697276003658772
both O 0 0.0071945637464523315
homozygotes O 1 0.9986791014671326
and O 0 0.012057754211127758
heterozygotes O 1 0.9865857362747192
( O 0 0.008783134631812572
relative O 0 0.010835240595042706
risk O 0 0.009201825596392155
12 O 0 0.008163931779563427
. O 0 0.005168893374502659
7 O 0 0.010905531235039234
; O 0 0.010807981714606285
P O 1 0.8495649099349976
= O 0 0.026751380413770676
. O 0 0.010562682524323463
0025 O 1 0.9996836185455322
) O 0 0.010225546546280384
, O 0 0.006144603248685598
although O 0 0.004338471218943596
there O 0 0.002896744990721345
is O 0 0.0031824414618313313
a O 0 0.004516572691500187
less O 0 0.005721423774957657
severe O 1 0.9999951124191284
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 0.02761261537671089
in O 0 0.005466707516461611
terms O 0 0.004945629276335239
of O 0 0.005215897224843502
the O 0 0.006555249914526939
degree O 0 0.01672009378671646
of O 1 0.7985721826553345
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.99671870470047

This O 0 0.021719077602028847
mutation O 0 0.02854912355542183
( O 0 0.018938502296805382
7271T O 1 0.9962998032569885
- O 1 0.9999984502792358
- O 1 0.9999991655349731
> O 1 0.999957799911499
G O 1 0.9981635212898254
) O 0 0.009795163758099079
also O 0 0.006322846282273531
allows O 0 0.005102426744997501
expression O 0 0.004571795463562012
of O 0 0.004728324711322784
full O 0 0.01024513877928257
- O 1 0.9919958114624023
length O 0 0.011425678618252277
ATM O 0 0.02830873429775238
protein O 0 0.008222034201025963
at O 0 0.006816054228693247
a O 0 0.005503716878592968
level O 0 0.006805635988712311
comparable O 0 0.008806204423308372
with O 0 0.0045261993072927
that O 0 0.004202261567115784
in O 0 0.008701877668499947
unaffected O 0 0.05300280451774597
individuals O 0 0.012977847829461098
. O 0 0.024511272087693214

In O 0 0.019064251333475113
addition O 0 0.013496981002390385
, O 0 0.006278777029365301
we O 0 0.003675472689792514
have O 0 0.0025493649300187826
studied O 0 0.006453896872699261
18 O 0 0.007477087434381247
A B-Disease 1 0.9988141059875488
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9954040050506592
, O 0 0.005910261534154415
in O 0 0.004822965245693922
15 O 0 0.0059191216714680195
families O 0 0.004524428863078356
, O 0 0.004255843348801136
who O 0 0.007812344003468752
developed O 1 0.9801550507545471
leukemia B-Disease 1 1.0
, O 1 0.9999536275863647
lymphoma B-Disease 1 1.0
, O 1 0.9974445104598999
preleukemic O 1 1.0
T O 1 1.0
- O 1 0.9999984502792358
cell O 0 0.03428134694695473
proliferation O 0 0.30763593316078186
, O 0 0.014913143590092659
or O 1 0.997077465057373
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9888367652893066
mostly O 0 0.011879527941346169
in O 0 0.015188721008598804
childhood O 1 0.9995397329330444
. O 0 0.03053496591746807

A O 0 0.028976676985621452
wide O 0 0.01910184882581234
variety O 0 0.01428104005753994
of O 0 0.012286676093935966
ATM O 1 0.9198355674743652
mutation O 0 0.014108086936175823
types O 0 0.007987081073224545
, O 0 0.006345352157950401
including O 0 0.006721785757690668
missense O 0 0.021321412175893784
mutations O 0 0.0080848578363657
and O 0 0.005192737095057964
in O 0 0.007376431487500668
- O 1 0.9999953508377075
frame O 0 0.059049177914857864
deletions O 0 0.01973133534193039
, O 0 0.006764846853911877
were O 0 0.004385431297123432
seen O 0 0.006826592609286308
in O 0 0.005856439471244812
these O 0 0.0061456747353076935
patients O 1 0.7318778038024902
. O 0 0.023180905729532242

We O 0 0.018305998295545578
also O 0 0.009680020622909069
show O 0 0.007513605989515781
that O 0 0.003586387261748314
25 O 0 0.006144026294350624
% O 0 0.004171719774603844
of O 0 0.0034370175562798977
all O 0 0.004231080878525972
A B-Disease 1 0.9961357712745667
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.724401593208313
carried O 0 0.008254951797425747
in O 0 0.008974048309028149
- O 1 0.9944657683372498
frame O 0 0.023382142186164856
deletions O 0 0.02432815171778202
or O 0 0.009212781675159931
missense O 0 0.024494757875800133
mutations O 0 0.00870487280189991
, O 0 0.004199214279651642
many O 0 0.002484804717823863
of O 0 0.003420749446377158
which O 0 0.0029110820032656193
were O 0 0.0027030378114432096
also O 0 0.003775262739509344
associated O 0 0.004301462788134813
with O 0 0.00411732355132699
expression O 0 0.009151759557425976
of O 0 0.011283560656011105
mutant O 1 0.9637768864631653
ATM O 1 0.9989144802093506
protein O 0 0.03590618073940277
. O 0 0.030545104295015335

The O 0 0.03299478814005852
DMPK O 1 0.9979123473167419
gene O 0 0.019384801387786865
of O 0 0.01402566023170948
severely O 1 0.9999923706054688
affected O 1 0.9999943971633911
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9971389770507812
hypermethylated O 1 0.9999997615814209
proximal O 1 0.9999690055847168
to O 0 0.013812657445669174
the O 0 0.014991114847362041
largely O 0 0.020585613325238228
expanded O 0 0.0442054346203804
CTG O 1 0.9996956586837769
repeat O 0 0.08369409292936325
. O 0 0.04570068046450615

Using O 0 0.02514825202524662
methylation O 0 0.03736107796430588
- O 1 0.9806380271911621
sensitive O 0 0.022700699046254158
restriction O 0 0.020492717623710632
enzymes O 0 0.014881758019328117
, O 0 0.008233987726271152
we O 0 0.005662055220454931
characterized O 0 0.009659044444561005
the O 0 0.007179227191954851
methylation O 0 0.013054456561803818
pattern O 0 0.008561641909182072
on O 0 0.005565133411437273
the O 0 0.006184813100844622
5 O 0 0.009148682467639446
side O 0 0.008397814817726612
of O 0 0.006780407391488552
the O 0 0.009523938409984112
CTG O 1 0.9998513460159302
repeat O 0 0.019397452473640442
in O 0 0.0071875546127557755
the O 0 0.010110538452863693
DMPK O 1 0.9997361302375793
gene O 0 0.009574761614203453
of O 0 0.006021886132657528
normal O 0 0.00570012116804719
individuals O 0 0.0036336241755634546
and O 0 0.005270692519843578
of O 0 0.007904315367341042
patients O 1 0.9999730587005615
affected O 1 0.8512769341468811
with O 1 0.9841049313545227
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.231974259018898
showing O 0 0.02043936774134636
expansions O 0 0.027112668380141258
of O 0 0.014418860897421837
the O 0 0.0170451570302248
repetitive O 0 0.09999913722276688
sequence O 0 0.023706525564193726
. O 0 0.031782958656549454

The O 0 0.03699202463030815
gene O 0 0.024908093735575676
segment O 0 0.02597424015402794
analyzed O 0 0.018789617344737053
corresponds O 0 0.016397234052419662
to O 0 0.009136500768363476
the O 0 0.014719926752150059
genomic O 0 0.040505778044462204
SacI O 1 0.9996979236602783
- O 1 0.9995096921920776
HindIII O 1 0.7834463715553284
fragment O 0 0.035607170313596725
carrying O 0 0.01972765475511551
exons O 0 0.034992024302482605
11 O 0 0.027943801134824753
- O 1 0.941588819026947
15 O 0 0.03294745460152626
. O 0 0.03555877134203911

There O 0 0.027232354506850243
is O 0 0.019616413861513138
constitutive O 0 0.046845443546772
methylation O 0 0.025094594806432724
in O 0 0.012372918426990509
intron O 1 0.9825718402862549
12 O 0 0.013289934024214745
at O 0 0.009616234339773655
restriction O 0 0.01080843061208725
sites O 0 0.008704723790287971
of O 0 0.009041009470820427
SacII O 1 0.9970942735671997
and O 0 0.012059764005243778
HhaI O 1 0.9972510933876038
, O 0 0.012119644321501255
localized O 0 0.021299658343195915
1 O 0 0.0138670913875103
, O 0 0.011648931540548801
159 O 0 0.03204547241330147
- O 1 0.8986926078796387
1 O 0 0.01795470342040062
, O 0 0.011486385948956013
232 O 0 0.03065900318324566
bp O 0 0.026795130223035812
upstream O 0 0.015656622126698494
of O 0 0.008108309470117092
the O 0 0.010386093519628048
CTG O 1 0.9999910593032837
repeat O 0 0.04182502254843712
, O 0 0.0077832723036408424
whereas O 0 0.006942439824342728
most O 0 0.004348942544311285
, O 0 0.004248784855008125
if O 0 0.0028041412588208914
not O 0 0.0024226359091699123
all O 0 0.002521878806874156
, O 0 0.0031107747927308083
of O 0 0.0029463781975209713
the O 0 0.003450268879532814
other O 0 0.0028244731947779655
sites O 0 0.004587477073073387
of O 0 0.0061690062284469604
SacII O 1 0.9995949864387512
, O 0 0.011599450372159481
HhaI O 1 0.9996122717857361
, O 0 0.009395633824169636
and O 0 0.008477294817566872
HpaII O 1 0.9075948596000671
in O 0 0.006073243450373411
this O 0 0.004561183974146843
region O 0 0.007314059417694807
are O 0 0.004831899423152208
unmethylated O 0 0.03485524654388428
, O 0 0.005938990972936153
in O 0 0.004831388592720032
normal O 0 0.004878442268818617
individuals O 0 0.003191844094544649
and O 0 0.004107699263840914
most O 0 0.005061340052634478
of O 0 0.008052528835833073
the O 0 0.017263557761907578
patients O 1 0.9999600648880005
. O 0 0.03001849167048931

In O 0 0.014102622866630554
a O 0 0.010447166860103607
number O 0 0.005581735633313656
of O 0 0.006399371661245823
young O 0 0.012093625962734222
and O 0 0.010519498027861118
severely O 1 0.9999997615814209
affected O 1 0.998455286026001
patients O 1 0.9999939203262329
, O 0 0.00784696638584137
however O 0 0.004850155673921108
, O 0 0.005233414936810732
complete O 0 0.008321159519255161
methylation O 0 0.009405531920492649
of O 0 0.004961072932928801
these O 0 0.00359588791616261
restriction O 0 0.007277148775756359
sites O 0 0.006408486049622297
was O 0 0.0076186396181583405
found O 0 0.004701171535998583
in O 0 0.0058029829524457455
the O 0 0.010409826412796974
mutated O 0 0.05073830485343933
allele O 0 0.04841772839426994
. O 0 0.03752710670232773

In O 0 0.014412196353077888
most O 0 0.007235024124383926
of O 0 0.006126859225332737
these O 0 0.004167353734374046
patients O 0 0.36513301730155945
, O 0 0.004174374975264072
the O 0 0.005196728743612766
onset O 1 0.9999986886978149
of O 0 0.19678278267383575
the O 1 0.9999728202819824
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9894425868988037

Preliminary O 0 0.045634202659130096
in O 0 0.024715110659599304
vivo O 0 0.07453304529190063
footprinting O 1 0.5828867554664612
data O 0 0.01191890798509121
gave O 0 0.00988699495792389
evidence O 0 0.005370971281081438
for O 0 0.005894015077501535
protein O 0 0.010517487302422523
- O 1 0.6844888925552368
DNA O 0 0.009323813952505589
contact O 0 0.006289497017860413
in O 0 0.004235877655446529
normal O 0 0.0054716248996555805
genes O 0 0.0060440353117883205
at O 0 0.007122318726032972
an O 0 0.008267652243375778
Sp1 O 1 0.999524712562561
consensus O 0 0.0162106491625309
binding O 0 0.014000301249325275
site O 0 0.01329239271581173
upstream O 0 0.01453656330704689
of O 0 0.008260175585746765
the O 0 0.010608017444610596
CTG O 1 0.9999747276306152
repeat O 0 0.01906915009021759
and O 0 0.005914908833801746
for O 0 0.005078979302197695
a O 0 0.005820268765091896
significant O 0 0.006193964276462793
reduction O 0 0.007577642798423767
of O 0 0.004646655637770891
this O 0 0.0036057287361472845
interaction O 0 0.00630387756973505
in O 0 0.004964067600667477
cells O 0 0.007184578105807304
with O 0 0.0073798783123493195
a O 0 0.015111404471099377
hypermethylated O 1 0.9999687671661377
DMPK O 1 0.9999982118606567
gene O 0 0.02621590532362461
. O 0 0.018046675249934196
. O 0 0.023793881759047508

The O 0 0.052143387496471405
hemochromatosis B-Disease 1 1.0
gene O 0 0.02372055873274803
product O 0 0.02189898118376732
complexes O 0 0.021450551226735115
with O 0 0.008401661179959774
the O 0 0.012850094586610794
transferrin O 1 0.9998866319656372
receptor O 0 0.030719714239239693
and O 0 0.014469703659415245
lowers O 1 0.5980938076972961
its O 0 0.012479052878916264
affinity O 0 0.023760154843330383
for O 0 0.015911765396595
ligand O 0 0.06336220353841782
binding O 0 0.03660428896546364
. O 0 0.03149337321519852

We O 0 0.023802509531378746
recently O 0 0.021969495341181755
reported O 0 0.012304876931011677
the O 0 0.008688568137586117
positional O 0 0.025534093379974365
cloning O 0 0.014856236055493355
of O 0 0.00800924189388752
a O 0 0.009147713892161846
candidate O 0 0.014176877215504646
gene O 0 0.015109914354979992
for O 0 0.01667875051498413
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999984502792358
HFE O 1 1.0
. O 0 0.06319554150104523

The O 0 0.026666412129998207
gene O 0 0.01670246385037899
product O 0 0.013156808912754059
, O 0 0.007663494907319546
a O 0 0.006729493848979473
member O 0 0.00644692312926054
of O 0 0.0050880517810583115
the O 0 0.006330931559205055
major O 0 0.11137500405311584
histocompatibility O 1 1.0
complex O 0 0.2766115367412567
class O 1 0.7055673003196716
I O 1 0.9617956876754761
- O 1 0.9931569695472717
like O 0 0.009592159651219845
family O 0 0.00981131847947836
, O 0 0.005729029420763254
was O 0 0.006577524356544018
found O 0 0.00414676358923316
to O 0 0.003523473162204027
have O 0 0.003084963420405984
a O 0 0.006631301715970039
mutation O 0 0.01122696790844202
, O 0 0.011350889690220356
Cys O 1 0.9999982118606567
- O 1 0.9998639822006226
282 O 1 0.9971655011177063
- O 1 0.999998927116394
- O 1 0.9999918937683105
> O 1 0.9999103546142578
Tyr O 1 0.9999986886978149
( O 0 0.023122575134038925
C282Y O 1 0.861913800239563
) O 0 0.011537558399140835
, O 0 0.007801983505487442
in O 0 0.006853316444903612
85 O 0 0.020016882568597794
% O 0 0.011105405166745186
of O 0 0.016392165794968605
patient O 1 0.9960185885429382
chromosomes O 0 0.04679431393742561
. O 0 0.0360562689602375

This O 0 0.025059759616851807
mutation O 0 0.030263150110840797
eliminates O 0 0.036536894738674164
the O 0 0.012582069262862206
ability O 0 0.011990685015916824
of O 0 0.010957850143313408
HFE O 1 0.9999253749847412
to O 0 0.010107762180268764
associate O 0 0.015830140560865402
with O 0 0.010572982020676136
beta2 O 1 0.9999912977218628
- O 1 0.9999985694885254
microglobulin O 1 0.9999163150787354
( O 0 0.01604708656668663
beta2m O 1 0.9744880199432373
) O 0 0.010970302857458591
and O 0 0.009588291868567467
prevents O 0 0.21167589724063873
cell O 1 0.9281813502311707
- O 1 0.9999791383743286
surface O 0 0.024682164192199707
expression O 0 0.024873292073607445
. O 0 0.029962560161948204

A O 0 0.03584829717874527
second O 0 0.026524268090724945
mutation O 0 0.01554176490753889
that O 0 0.005423989146947861
has O 0 0.005297641269862652
no O 0 0.005177550949156284
effect O 0 0.007186186965554953
on O 0 0.008539291098713875
beta2m O 1 0.9903749823570251
association O 0 0.019324254244565964
, O 0 0.011568854562938213
H63D O 1 0.9999943971633911
, O 0 0.00959361344575882
was O 0 0.009631478227674961
found O 0 0.005241667851805687
in O 0 0.004009107127785683
eight O 0 0.005108620505779982
out O 0 0.005431387107819319
of O 0 0.00605740724131465
nine O 0 0.011239663697779179
patients O 0 0.04719660431146622
heterozygous O 0 0.016015715897083282
for O 0 0.008669083006680012
the O 0 0.016213994473218918
C282Y O 1 0.9992056488990784
mutant O 0 0.0933966115117073
. O 0 0.03968467935919762

In O 0 0.01878160610795021
this O 0 0.008870448917150497
report O 0 0.010384795255959034
, O 0 0.007621602155268192
we O 0 0.0057958923280239105
demonstrate O 0 0.010280587710440159
in O 0 0.008761407807469368
cultured O 0 0.03015754371881485
293 O 0 0.3823249042034149
cells O 0 0.024608463048934937
overexpressing O 1 0.9713165163993835
wild O 0 0.0239946898072958
- O 1 0.999760091304779
type O 0 0.02547299675643444
or O 0 0.013386864215135574
mutant O 1 0.5392564535140991
HFE O 1 0.9999936819076538
proteins O 0 0.009515894576907158
that O 0 0.0037331972271203995
both O 0 0.0035598487593233585
the O 0 0.005713232792913914
wild O 0 0.012065784074366093
- O 1 0.999813973903656
type O 0 0.02274758368730545
and O 0 0.011578104458749294
H63D O 1 0.9999997615814209
HFE O 1 0.9999997615814209
proteins O 0 0.017431611195206642
form O 0 0.011326936073601246
stable O 0 0.01960240676999092
complexes O 0 0.0189078226685524
with O 0 0.007999051362276077
the O 0 0.014431815594434738
transferrin O 1 0.9999957084655762
receptor O 1 0.8455533385276794
( O 0 0.03260918706655502
TfR O 1 0.9999066591262817
) O 0 0.03297685459256172
. O 0 0.039823371917009354

The O 0 0.038118876516819
C282Y O 1 0.8223924040794373
mutation O 0 0.028152257204055786
nearly O 0 0.014525623060762882
completely O 0 0.015054147690534592
prevents O 0 0.014088481664657593
the O 0 0.008537942543625832
association O 0 0.011538869701325893
of O 0 0.009259120561182499
the O 0 0.013962220400571823
mutant O 1 0.9024174213409424
HFE O 1 0.9999996423721313
protein O 0 0.01988561451435089
with O 0 0.011588236317038536
the O 0 0.022223496809601784
TfR O 1 0.9996057152748108
. O 0 0.04263092204928398

Studies O 0 0.020504377782344818
on O 0 0.014764993451535702
cell O 0 0.02673114277422428
- O 1 0.9637117981910706
associated O 0 0.013375760987401009
transferrin O 0 0.20712947845458984
at O 0 0.012844299897551537
37 O 0 0.01734182797372341
degrees O 0 0.016698408871889114
C O 0 0.02569396048784256
suggest O 0 0.00710664875805378
that O 0 0.00413098931312561
the O 0 0.007252010516822338
overexpressed O 0 0.04169563204050064
wild O 0 0.016989314928650856
- O 1 0.9999722242355347
type O 1 0.8141390085220337
HFE O 1 0.9999969005584717
protein O 0 0.019394684582948685
decreases O 0 0.017073486000299454
the O 0 0.011021619662642479
affinity O 0 0.016969528049230576
of O 0 0.010822332464158535
the O 0 0.016790755093097687
TfR O 1 0.9998859167098999
for O 0 0.031959932297468185
transferrin O 1 0.9995900988578796
. O 0 0.05193557217717171

The O 0 0.03963873162865639
overexpressed O 1 0.999413013458252
H63D O 1 0.9999974966049194
protein O 0 0.01723163016140461
does O 0 0.006998335476964712
not O 0 0.0038987542502582073
have O 0 0.002776028588414192
this O 0 0.003287301631644368
effect O 0 0.004920063074678183
, O 0 0.005015878472477198
providing O 0 0.0059127951972186565
the O 0 0.004894105717539787
first O 0 0.0063989716582000256
direct O 0 0.005812548100948334
evidence O 0 0.004525522235780954
for O 0 0.004737204872071743
a O 0 0.00810107123106718
functional O 0 0.017165925353765488
consequence O 0 0.014207945205271244
of O 0 0.011264968663454056
the O 0 0.020991699770092964
H63D O 1 0.9999977350234985
mutation O 0 0.04638155922293663
. O 0 0.03697745129466057

Addition O 0 0.025947123765945435
of O 0 0.017564354464411736
soluble O 1 0.8503310084342957
wild O 0 0.027333641424775124
- O 1 0.9999977350234985
type O 1 0.9924262762069702
HFE O 1 1.0
/ O 1 0.9999896287918091
beta2m O 1 0.9996834993362427
heterodimers O 1 0.9983748197555542
to O 0 0.017373858019709587
cultured O 0 0.04351219907402992
cells O 0 0.014871479012072086
also O 0 0.008575951680541039
decreased O 0 0.011196545325219631
the O 0 0.008589841425418854
apparent O 0 0.013858185149729252
affinity O 0 0.01381456758826971
of O 0 0.006646128371357918
the O 0 0.008721387945115566
TfR O 1 0.9878900647163391
for O 0 0.007169305346906185
its O 0 0.008522681891918182
ligand O 0 0.022946646437048912
under O 0 0.010071062482893467
steady O 0 0.022322766482830048
- O 0 0.4121082127094269
state O 0 0.006194775458425283
conditions O 0 0.007772213779389858
, O 0 0.005455679725855589
both O 0 0.0047562699764966965
in O 0 0.006748472340404987
293 O 1 0.8837291598320007
cells O 0 0.01446325983852148
and O 0 0.011826069094240665
in O 0 0.018350541591644287
HeLa O 1 0.9999974966049194
cells O 0 0.040293850004673004
. O 0 0.035640016198158264

Furthermore O 0 0.03803717717528343
, O 0 0.014751910232007504
at O 0 0.012694965116679668
4 O 0 0.015135867521166801
degrees O 0 0.017806624993681908
C O 0 0.061030007898807526
, O 0 0.008835796266794205
the O 0 0.00912946742027998
added O 0 0.013828151859343052
soluble O 0 0.12268592417240143
complex O 0 0.01856735534965992
of O 0 0.01898133009672165
HFE O 1 1.0
/ O 1 0.9999746084213257
beta2m O 1 0.9976761937141418
inhibited O 0 0.048727575689554214
binding O 0 0.02153005450963974
of O 0 0.016250116750597954
transferrin O 1 0.7069882750511169
to O 0 0.021966101601719856
HeLa O 1 0.9999749660491943
cell O 0 0.03974055126309395
TfR O 1 0.8313396573066711
in O 0 0.012127067893743515
a O 0 0.01785426400601864
concentration O 1 0.8493141531944275
- O 1 0.9991388320922852
dependent O 0 0.03467944264411926
manner O 0 0.034005388617515564
. O 0 0.028041211888194084

Scatchard O 0 0.12476785480976105
plots O 0 0.030268650501966476
of O 0 0.01072995737195015
these O 0 0.0052328589372336864
data O 0 0.006047795061022043
indicate O 0 0.0056264461018145084
that O 0 0.0036441199481487274
the O 0 0.006333127152174711
added O 0 0.01544263120740652
heterodimer O 1 0.9913405776023865
substantially O 0 0.019835131242871284
reduced O 0 0.012370435521006584
the O 0 0.010335221886634827
affinity O 0 0.018019365146756172
of O 0 0.015309329144656658
TfR O 1 0.9999746084213257
for O 0 0.027148909866809845
transferrin O 1 0.9996510744094849
. O 0 0.05080538988113403

These O 0 0.014172326773405075
results O 0 0.012396025471389294
establish O 0 0.012810595333576202
a O 0 0.010130315087735653
molecular O 0 0.015444304794073105
link O 0 0.013274792581796646
between O 0 0.009424075484275818
HFE O 1 0.9999896287918091
and O 0 0.006999926175922155
a O 0 0.008101467043161392
key O 0 0.010257312096655369
protein O 0 0.00781302060931921
involved O 0 0.005995133426040411
in O 0 0.0068679749965667725
iron O 1 0.9997727274894714
transport O 0 0.015093949623405933
, O 0 0.008356109261512756
the O 0 0.00916137732565403
TfR O 1 0.9999651908874512
, O 0 0.007539141457527876
and O 0 0.005461304448544979
raise O 0 0.00820295512676239
the O 0 0.005410850513726473
possibility O 0 0.007007776293903589
that O 0 0.003972543403506279
alterations O 0 0.010232914239168167
in O 0 0.0044523426331579685
this O 0 0.004508405923843384
regulatory O 0 0.011209688149392605
mechanism O 0 0.008988410234451294
may O 0 0.005573023576289415
play O 0 0.005399611778557301
a O 0 0.006494364235550165
role O 0 0.007414683699607849
in O 0 0.0060745906084775925
the O 0 0.009677013382315636
pathogenesis O 1 0.9999986886978149
of O 1 0.9974230527877808
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9990135431289673
. O 0 0.04409417882561684

Genomic O 0 0.057708967477083206
organization O 0 0.022676387801766396
of O 0 0.013694294728338718
the O 0 0.019463980570435524
UBE3A O 1 0.9999997615814209
/ O 1 0.9999983310699463
E6 O 1 0.9999992847442627
- O 1 0.9999983310699463
AP O 1 0.9880433082580566
gene O 0 0.01914684846997261
and O 0 0.012828114442527294
related O 0 0.02018876187503338
pseudogenes O 0 0.22513175010681152
. O 0 0.03286008909344673

The O 0 0.056879326701164246
UBE3A O 1 0.9920064806938171
gene O 0 0.031940098851919174
encodes O 0 0.031641069799661636
the O 0 0.018732290714979172
E6 O 1 0.9987000226974487
- O 1 0.9998185038566589
AP O 1 0.9371788501739502
ubiquitin O 1 0.9716504216194153
- O 1 0.9987590312957764
protein O 0 0.020272033289074898
ligase O 0 0.02979853004217148
and O 0 0.008109698072075844
has O 0 0.007148881442844868
recently O 0 0.009152763523161411
been O 0 0.0045083630830049515
shown O 0 0.004359907936304808
to O 0 0.0035239022690802813
be O 0 0.004303480498492718
mutated O 0 0.018146906048059464
in O 1 0.6852617263793945
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.9954828023910522
lack O 1 0.99601811170578
15q11 O 1 0.9999998807907104
- O 1 0.9999997615814209
q13 O 1 0.9964427351951599
deletions O 0 0.041567474603652954
or O 0 0.013969008810818195
chromosome O 0 0.02482713758945465
15 O 0 0.02573363296687603
paternal O 1 0.9774696230888367
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999960660934448
. O 0 0.05753426253795624

Previous O 0 0.05394802242517471
UBE3A O 1 0.9936478734016418
cDNA O 0 0.05566718801856041
analysis O 0 0.014372536912560463
has O 0 0.009355513378977776
shown O 0 0.008599084801971912
a O 0 0.010257630608975887
coding O 0 0.018884187564253807
region O 0 0.012499789707362652
of O 0 0.011083140969276428
approximately O 0 0.01799895614385605
2 O 0 0.02899426780641079
. O 0 0.028490319848060608

6 O 0 0.05559210106730461
kb O 0 0.0779685378074646
and O 0 0.012814311310648918
a O 0 0.014485025778412819
3 O 0 0.0197835024446249
- O 1 0.9978284239768982
untranslated O 1 0.9923182725906372
region O 0 0.0185418501496315
( O 0 0.014344322495162487
UTR O 1 0.98686683177948
) O 0 0.01147825550287962
of O 0 0.012551714666187763
< O 0 0.2890666723251343
50 O 0 0.019040539860725403
bp O 0 0.029186395928263664
, O 0 0.010913846082985401
whereas O 0 0.009322057478129864
Northern O 0 0.008376387879252434
analysis O 0 0.005676428321748972
has O 0 0.005893400404602289
indicated O 0 0.007994435727596283
mRNA O 0 0.01144229993224144
sizes O 0 0.009663820266723633
of O 0 0.007772221229970455
5 O 0 0.017705414444208145
- O 1 0.9961650371551514
8 O 0 0.037743840366601944
kb O 0 0.46703800559043884
. O 0 0.037589240819215775

We O 0 0.020000314339995384
have O 0 0.008875415660440922
analyzed O 0 0.01643962971866131
additional O 0 0.011904596351087093
cDNA O 0 0.03416495770215988
clones O 0 0.028739603236317635
and O 0 0.006745226215571165
provide O 0 0.006510952953249216
evidence O 0 0.005226367153227329
for O 0 0.004891181364655495
an O 0 0.0069513386115431786
additional O 0 0.015459161251783371
0 O 0 0.031496793031692505
. O 0 0.02899133414030075

5 O 0 0.03915879502892494
kb O 0 0.06245972216129303
of O 0 0.016729604452848434
5 O 0 0.02390296384692192
- O 1 0.9907586574554443
UTR O 1 0.9913288354873657
and O 0 0.014702417887747288
> O 0 0.0751875564455986
2 O 0 0.020848937332630157
kb O 0 0.04838140308856964
of O 0 0.015546945855021477
3 O 0 0.03283834829926491
- O 1 0.9972165822982788
UTR O 1 0.9972656965255737
. O 0 0.04334922879934311

We O 0 0.015680700540542603
have O 0 0.007147795520722866
established O 0 0.010485459119081497
the O 0 0.008090143091976643
genomic O 0 0.016651244834065437
organization O 0 0.011453469283878803
of O 0 0.010667447000741959
UBE3A O 1 0.9999972581863403
and O 0 0.009032554924488068
the O 0 0.009130467660725117
sequence O 0 0.009456823579967022
of O 0 0.013623153790831566
intron O 1 0.9999754428863525
- O 1 0.9998026490211487
exon O 0 0.18812434375286102
borders O 0 0.03713729605078697
. O 0 0.037019602954387665

We O 0 0.020505787804722786
have O 0 0.008351907134056091
also O 0 0.010321379639208317
mapped O 0 0.01719503290951252
two O 0 0.007217864505946636
highly O 0 0.015434143133461475
homologous O 0 0.0226602703332901
processed O 0 0.017090074717998505
pseudogenes O 0 0.034019727259874344
, O 0 0.014580631628632545
UBE3AP1 O 1 0.9999758005142212
and O 0 0.012663471512496471
UBE3AP2 O 1 0.9998849630355835
, O 0 0.007365609053522348
to O 0 0.005976283457130194
chromosomes O 0 0.01037021167576313
2 O 0 0.009295378811657429
and O 0 0.006099293008446693
21 O 0 0.010089552961289883
, O 0 0.007160537876188755
respectively O 0 0.007953140884637833
, O 0 0.0063365427777171135
and O 0 0.006124699953943491
determined O 0 0.008909017778933048
their O 0 0.008621741086244583
genomic O 0 0.02838844619691372
organization O 0 0.023589089512825012
. O 0 0.02993306890130043

These O 0 0.014339160174131393
results O 0 0.012051946483552456
will O 0 0.007037595845758915
form O 0 0.0057465070858597755
the O 0 0.004588562063872814
basis O 0 0.004290902055799961
for O 0 0.0048682489432394505
studies O 0 0.007739122025668621
of O 0 0.00865988340228796
mutation O 0 0.016911670565605164
and O 0 0.01201518252491951
imprinting O 1 0.9767693877220154
of O 0 0.036568012088537216
UBE3A O 1 0.999998927116394
. O 0 0.0461777038872242

Mutation O 0 0.05350007116794586
spectrum O 0 0.03660773113369942
and O 0 0.017066046595573425
genotype O 1 0.8757840991020203
- O 1 0.9996368885040283
phenotype O 0 0.05104595050215721
analyses O 0 0.018625209107995033
in O 0 0.014600733295083046
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9669574499130249
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.13972808420658112
two O 0 0.016247017309069633
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9896969199180603
germline O 1 1.0
PTEN O 1 1.0
mutation O 1 0.697128415107727
. O 0 0.04248523339629173

The O 0 0.08822326362133026
tumour B-Disease 1 1.0
suppressor O 1 0.9999996423721313
gene O 1 0.6634563207626343
PTEN O 1 0.9999880790710449
, O 0 0.01763668842613697
which O 0 0.010581590235233307
maps O 0 0.022380191832780838
to O 0 0.017385706305503845
10q23 O 0 0.35749971866607666
. O 0 0.03504427894949913

3 O 0 0.04015625640749931
and O 0 0.019063450396060944
encodes O 0 0.029924238100647926
a O 0 0.018696043640375137
403 O 0 0.05174771696329117
amino O 0 0.022946877405047417
acid O 0 0.02684888429939747
dual O 0 0.02959049679338932
specificity O 0 0.058192480355501175
phosphatase O 1 0.9989660978317261
( O 0 0.017283782362937927
protein O 0 0.021405285224318504
tyrosine O 0 0.047652918845415115
phosphatase O 1 0.9980915188789368
; O 0 0.016180312260985374
PTPase O 1 0.9996646642684937
) O 0 0.009578841738402843
, O 0 0.008363715372979641
was O 0 0.008097114972770214
shown O 0 0.005559272598475218
recently O 0 0.007582528050988913
to O 0 0.005034680012613535
play O 0 0.005846711341291666
a O 0 0.0078005362302064896
broad O 0 0.011333175003528595
role O 0 0.011818365193903446
in O 0 0.011529595591127872
human O 0 0.02498069778084755
malignancy B-Disease 1 0.9999992847442627
. O 0 0.04542956501245499

Somatic O 1 0.9890232086181641
PTEN O 1 0.9999277591705322
deletions O 0 0.05815787613391876
and O 0 0.014670572243630886
mutations O 0 0.012655526399612427
were O 0 0.004580090753734112
observed O 0 0.005184742622077465
in O 0 0.005477560218423605
sporadic B-Disease 0 0.19075699150562286
breast I-Disease 1 1.0
, I-Disease 1 0.5562949180603027
brain I-Disease 1 0.9999920129776001
, I-Disease 1 0.9868691563606262
prostate I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999823570251465
lines O 0 0.010204525664448738
and O 0 0.004812576808035374
in O 0 0.004331547301262617
several O 0 0.004622494801878929
primary O 0 0.013279465958476067
tumours B-Disease 1 0.9999860525131226
such O 0 0.006607556249946356
as O 0 0.0479876771569252
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9932676553726196

In O 0 0.02313888818025589
addition O 0 0.019844774156808853
, O 0 0.01722109690308571
PTEN O 1 0.9998735189437866
was O 0 0.01549405138939619
identified O 0 0.009249528869986534
as O 0 0.006925481837242842
the O 0 0.008354379795491695
susceptibility O 0 0.02486208826303482
gene O 0 0.007632856257259846
for O 0 0.005348610691726208
two O 0 0.009426506236195564
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997311234474182
CD B-Disease 1 0.9999901056289673
; O 0 0.029866930097341537
MIM O 1 0.9999995231628418
158350 O 1 0.996218740940094
) O 0 0.01376345194876194
and O 0 0.013771827332675457
Bannayan B-Disease 1 0.9999740123748779
- I-Disease 1 0.9999974966049194
Zonana I-Disease 1 0.999998927116394
( I-Disease 0 0.029779434204101562
BZS I-Disease 1 0.9996780157089233
) I-Disease 0 0.017366871237754822
or I-Disease 0 0.014741107821464539
Ruvalcaba I-Disease 1 0.9999393224716187
- I-Disease 1 0.9999957084655762
Riley I-Disease 1 0.9999697208404541
- I-Disease 1 0.9999998807907104
Smith I-Disease 1 0.999996542930603
syndrome I-Disease 1 1.0
( O 1 0.9996144771575928
MIM O 1 1.0
153480 O 1 0.9999997615814209
) O 0 0.04076245799660683
. O 0 0.041680242866277695

Constitutive O 0 0.10020660609006882
DNA O 0 0.026633815839886665
from O 0 0.012043505907058716
37 O 0 0.02368021383881569
CD B-Disease 0 0.03241652250289917
families O 0 0.01112954132258892
and O 0 0.008536424487829208
seven O 0 0.014980512671172619
BZS B-Disease 1 0.9996875524520874
families O 0 0.016039365902543068
was O 0 0.018469713628292084
screened O 0 0.029906895011663437
for O 0 0.018917540088295937
germline O 1 0.9984537363052368
PTEN O 1 0.9999988079071045
mutations O 0 0.059036169201135635
. O 0 0.041208088397979736

PTEN O 1 0.9999681711196899
mutations O 0 0.026879392564296722
were O 0 0.008009295910596848
identified O 0 0.0072408108972013
in O 0 0.0048088147304952145
30 O 0 0.007386402692645788
of O 0 0.006572070997208357
37 O 0 0.013375343754887581
( O 0 0.008704839274287224
81 O 0 0.030641941353678703
% O 0 0.009095856919884682
) O 0 0.009392008185386658
CD B-Disease 0 0.029929179698228836
families O 0 0.009575567208230495
, O 0 0.0072298296727240086
including O 0 0.005755463615059853
missense O 0 0.018378600478172302
and O 0 0.008412795141339302
nonsense O 0 0.028437362983822823
point O 0 0.01346703339368105
mutations O 0 0.013015716336667538
, O 0 0.010107667185366154
deletions O 0 0.02206798456609249
, O 0 0.01123484130948782
insertions O 0 0.028298022225499153
, O 0 0.009326294995844364
a O 0 0.012744312174618244
deletion O 1 0.6123668551445007
/ O 1 0.9965167045593262
insertion O 0 0.03606444597244263
and O 0 0.015297215431928635
splice O 0 0.2791745662689209
site O 0 0.032970089465379715
mutations O 0 0.031085511669516563
. O 0 0.029865283519029617

These O 0 0.01847049966454506
mutations O 0 0.014683598652482033
were O 0 0.005963928531855345
scattered O 0 0.007562969345599413
over O 0 0.005171350669115782
the O 0 0.005009709391742945
entire O 0 0.008937688544392586
length O 0 0.008123218081891537
of O 0 0.008729125373065472
PTEN O 1 0.9999977350234985
, O 0 0.005998185835778713
with O 0 0.004043865483254194
the O 0 0.0046754274517297745
exception O 0 0.005546073894947767
of O 0 0.004088632762432098
the O 0 0.004673244897276163
first O 0 0.006547733210027218
, O 0 0.0067031485959887505
fourth O 0 0.015094219706952572
and O 0 0.00850394181907177
last O 0 0.018448468297719955
exons O 0 0.04298357293009758
. O 0 0.027370722964406013

A O 0 0.04880315437912941
hot O 0 0.058168407529592514
spot O 0 0.03508366271853447
for O 0 0.01769302971661091
PTEN O 1 0.9998657703399658
mutation O 0 0.01992913708090782
in O 0 0.011045277118682861
CD B-Disease 0 0.03740277886390686
was O 0 0.013349613174796104
identified O 0 0.008973561227321625
in O 0 0.00702012050896883
exon O 0 0.02461347170174122
5 O 0 0.009383154101669788
that O 0 0.004232335370033979
contains O 0 0.006756858434528112
the O 0 0.008877319283783436
PTPase O 1 0.9991232752799988
core O 0 0.0403582826256752
motif O 0 0.02762388437986374
, O 0 0.007118108682334423
with O 0 0.0048327199183404446
13 O 0 0.007576918229460716
of O 0 0.005629872437566519
30 O 0 0.008257094770669937
( O 0 0.008139077574014664
43 O 0 0.01646328717470169
% O 0 0.008994520641863346
) O 0 0.009836147539317608
CD B-Disease 0 0.04797295108437538
mutations O 0 0.015501675195991993
identified O 0 0.009621553122997284
in O 0 0.008111163042485714
this O 0 0.011697027832269669
exon O 0 0.0718177855014801
. O 0 0.034591902047395706

Seven O 0 0.023170283064246178
of O 0 0.011518959887325764
30 O 0 0.012900990433990955
( O 0 0.009722165763378143
23 O 0 0.013914063572883606
% O 0 0.007762087043374777
) O 0 0.0052351877093315125
were O 0 0.003305473132058978
within O 0 0.003446631133556366
the O 0 0.005897472612559795
core O 0 0.018958618864417076
motif O 0 0.02828780934214592
, O 0 0.006303124595433474
the O 0 0.00579637847840786
majority O 0 0.005435856059193611
( O 0 0.004144538659602404
five O 0 0.003604169934988022
of O 0 0.003910686820745468
seven O 0 0.005313928704708815
) O 0 0.00477396696805954
of O 0 0.00446583516895771
which O 0 0.003951692953705788
were O 0 0.005102644674479961
missense O 0 0.018875187262892723
mutations O 0 0.009137079119682312
, O 0 0.005946343299001455
possibly O 0 0.008369080722332
pointing O 0 0.00835840217769146
to O 0 0.004649174865335226
the O 0 0.0065541379153728485
functional O 0 0.012843654491007328
significance O 0 0.011492320336401463
of O 0 0.0073933848179876804
this O 0 0.007881440222263336
region O 0 0.017850395292043686
. O 0 0.02250281162559986

Germline O 1 0.9994670748710632
PTEN O 1 0.999958872795105
mutations O 0 0.02349966950714588
were O 0 0.007644032593816519
identified O 0 0.0072890291921794415
in O 0 0.004902422893792391
four O 0 0.004783577751368284
of O 0 0.0058425189927220345
seven O 0 0.00897643156349659
( O 0 0.01028717402368784
57 O 0 0.025732317939400673
% O 0 0.0150325708091259
) O 0 0.020802391692996025
BZS B-Disease 1 0.998492956161499
families O 0 0.02635493315756321
studied O 0 0.039179202169179916
. O 0 0.035542502999305725

Interestingly O 0 0.070576973259449
, O 0 0.016121113672852516
none O 0 0.012502097524702549
of O 0 0.007831701077520847
these O 0 0.006259824149310589
mutations O 0 0.008988646790385246
was O 0 0.008302269503474236
observed O 0 0.007959079928696156
in O 0 0.008776536211371422
the O 0 0.01560927927494049
PTPase O 1 0.9999264478683472
core O 1 0.931321382522583
motif O 1 0.6331735849380493
. O 0 0.0399058572947979

It O 0 0.016175851225852966
is O 0 0.008876707404851913
also O 0 0.008178512565791607
worthy O 0 0.016268888488411903
of O 0 0.006296820472925901
note O 0 0.007179382722824812
that O 0 0.003324942197650671
a O 0 0.005411234684288502
single O 0 0.007572423201054335
nonsense O 0 0.01483955979347229
point O 0 0.008738636039197445
mutation O 0 0.0100401621311903
, O 0 0.008197503164410591
R233X O 1 0.942244827747345
, O 0 0.007783378940075636
was O 0 0.008536010049283504
observed O 0 0.006717183161526918
in O 0 0.005776488222181797
the O 0 0.008194736205041409
germline O 0 0.02452837862074375
DNA O 0 0.010952198877930641
from O 0 0.005714855156838894
two O 0 0.005610020365566015
unrelated O 0 0.01623447611927986
CD B-Disease 0 0.03607762232422829
families O 0 0.012684779241681099
and O 0 0.01182461529970169
one O 0 0.02117959037423134
BZS B-Disease 1 0.9999592304229736
family O 0 0.04160480573773384
. O 0 0.03792969509959221

Genotype O 1 0.9994848966598511
- O 1 0.9999659061431885
phenotype O 1 0.544826865196228
studies O 0 0.0112438490614295
were O 0 0.004909390117973089
not O 0 0.004668527282774448
performed O 0 0.007532882504165173
on O 0 0.005320501513779163
this O 0 0.004637508187443018
small O 0 0.0076218550093472
group O 0 0.012215448543429375
of O 0 0.014519229531288147
BZS B-Disease 1 0.9999297857284546
families O 0 0.03176955506205559
. O 0 0.033525221049785614

However O 0 0.02689925767481327
, O 0 0.02188788913190365
genotype O 0 0.26144054532051086
- O 1 0.9915208220481873
phenotype O 0 0.035173896700143814
analysis O 0 0.01242816261947155
inthe O 0 0.0546899288892746
group O 0 0.012418841943144798
of O 0 0.00896120723336935
CD B-Disease 1 0.6701106429100037
families O 0 0.008541321381926537
revealed O 0 0.008164893835783005
two O 0 0.004014916252344847
possible O 0 0.0048079476691782475
associations O 0 0.0071340021677315235
worthy O 0 0.014038815163075924
of O 0 0.0070186578668653965
follow O 0 0.011996788904070854
- O 1 0.8728030920028687
up O 0 0.012747803702950478
in O 0 0.009021736681461334
independent O 0 0.015236804261803627
analyses O 0 0.03210125118494034
. O 0 0.026000021025538445

The O 0 0.018446562811732292
first O 0 0.015083695761859417
was O 0 0.01258059497922659
an O 0 0.007329197134822607
association O 0 0.009412561543285847
noted O 0 0.006646222434937954
in O 0 0.004988490603864193
the O 0 0.005657719448208809
group O 0 0.0065673780627548695
of O 0 0.006021483335644007
CD B-Disease 1 0.7748109102249146
families O 0 0.011438912712037563
with O 0 0.18898124992847443
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.33065545558929443

A O 0 0.038209013640880585
correlation O 0 0.026872172951698303
was O 0 0.01316105853766203
observed O 0 0.007567476015537977
between O 0 0.00510083232074976
the O 0 0.0072651635855436325
presence O 0 0.010353928431868553
/ O 1 0.7389018535614014
absence O 0 0.01139046996831894
of O 0 0.008671090006828308
a O 0 0.01386402640491724
PTEN O 1 0.9999953508377075
mutation O 0 0.011987370438873768
and O 0 0.005784882232546806
the O 0 0.006269881501793861
type O 0 0.01202993094921112
of O 0 0.01074974611401558
breast O 1 1.0
involvement O 1 0.9737188220024109
( O 0 0.031191907823085785
unaffected O 1 0.9992181062698364
versus O 1 0.9995291233062744
benign O 1 0.9999998807907104
versus O 1 0.9999997615814209
malignant O 1 1.0
) O 0 0.03900574520230293
. O 0 0.03838236629962921

Specifically O 0 0.024582277983427048
and O 0 0.009655513800680637
more O 0 0.005647663027048111
directly O 0 0.006048635113984346
, O 0 0.004688025917857885
an O 0 0.004930285271257162
association O 0 0.012582946568727493
was O 0 0.010355140082538128
also O 0 0.00477697653695941
observed O 0 0.0048348442651331425
between O 0 0.0033999113366007805
the O 0 0.0035258850548416376
presence O 0 0.0043782880529761314
of O 0 0.004968459717929363
a O 0 0.0105171799659729
PTEN O 1 0.9999998807907104
mutation O 1 0.9799962043762207
and O 1 0.999687671661377
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9893741011619568

Secondly O 1 0.6426960825920105
, O 0 0.014474763534963131
there O 0 0.006868483033031225
appeared O 0 0.008361849002540112
to O 0 0.005064109340310097
be O 0 0.004301484674215317
an O 0 0.006536944303661585
interdependent O 1 0.673003613948822
association O 0 0.01403658278286457
between O 0 0.007818999700248241
mutations O 0 0.011104295961558819
upstream O 0 0.012318705208599567
and O 0 0.006210010964423418
within O 0 0.004947701469063759
the O 0 0.009460173547267914
PTPase O 1 0.9998745918273926
core O 1 0.6549437046051025
motif O 0 0.05407080054283142
, O 0 0.008338679559528828
the O 0 0.008331750519573689
core O 0 0.019710613414645195
motif O 0 0.02240978740155697
containing O 0 0.008784666657447815
the O 0 0.00543680414557457
majority O 0 0.005923787131905556
of O 0 0.006712094880640507
missense O 0 0.02583722211420536
mutations O 0 0.00842214748263359
, O 0 0.005042664241045713
and O 0 0.003895007772371173
the O 0 0.004568479023873806
involvement O 0 0.006719732191413641
of O 0 0.0038759945891797543
all O 0 0.0034619555808603764
major O 0 0.016951045021414757
organ O 1 0.9998051524162292
systems O 1 0.8663865923881531
( O 0 0.007380032446235418
central O 0 0.008864992298185825
nervous O 0 0.2221904844045639
system O 0 0.01192964892834425
, O 0 0.12961430847644806
thyroid O 1 1.0
, O 1 0.9997556805610657
breast O 1 1.0
, O 1 0.9999915361404419
skin O 1 1.0
and O 1 0.9999998807907104
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9985862970352173
. O 0 0.04068480804562569

However O 0 0.02348119206726551
, O 0 0.013000449165701866
these O 0 0.005679402966052294
observations O 0 0.008891141973435879
would O 0 0.005383952520787716
need O 0 0.005615220870822668
to O 0 0.005012300796806812
be O 0 0.004427921958267689
confirmed O 0 0.00655759172514081
by O 0 0.0039490326307713985
studying O 0 0.008759519085288048
a O 0 0.007154054939746857
larger O 0 0.008480020798742771
number O 0 0.005648501217365265
of O 0 0.010227448306977749
CD B-Disease 0 0.24138805270195007
families O 0 0.02193092182278633
. O 0 0.02741476520895958

Molecular O 1 0.6983352899551392
defects O 1 0.9983502626419067
leading O 0 0.017488732933998108
to O 0 0.008392778225243092
human O 0 0.00908372737467289
complement B-Disease 1 0.9986542463302612
component I-Disease 1 0.9999998807907104
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.01284141093492508
an O 0 0.012669852003455162
African O 1 0.9772385358810425
- O 1 0.9999771118164062
American O 0 0.025631187483668327
family O 0 0.02899221144616604
. O 0 0.028003456071019173

Complement B-Disease 1 0.9141284227371216
component I-Disease 1 0.999997615814209
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9997885823249817
C6D B-Disease 1 1.0
) O 0 0.016809619963169098
was O 0 0.27067986130714417
diagnosed O 1 0.9999713897705078
in O 0 0.005593001376837492
a O 0 0.008114324882626534
16 O 0 0.010939106345176697
- O 1 0.904754638671875
year O 0 0.00918692909181118
- O 1 0.956928551197052
old O 0 0.016574755311012268
African O 0 0.016281303018331528
- O 1 0.9417372345924377
American O 0 0.016977524384856224
male O 0 0.02525639533996582
with O 0 0.05600033700466156
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.7996641397476196

The O 0 0.032812297344207764
patients O 1 0.992302417755127
father O 0 0.022708706557750702
and O 0 0.00663402583450079
two O 0 0.0054570147767663
brothers O 0 0.014498203061521053
also O 0 0.005745055619627237
had O 0 0.009374070912599564
C6D B-Disease 1 0.9999982118606567
, O 0 0.005759214051067829
but O 0 0.0036630993708968163
gave O 0 0.006016238126903772
no O 0 0.003762141801416874
history O 0 0.007099855691194534
of O 0 0.011038778349757195
meningitis B-Disease 1 1.0
or O 0 0.24471083283424377
other O 0 0.014238056726753712
neisserial B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.040467094630002975

By O 0 0.021402044221758842
using O 0 0.018737440928816795
exon O 0 0.058479104191064835
- O 0 0.2346043884754181
specific O 0 0.013070600107312202
polymerase O 0 0.03550203517079353
chain O 0 0.022092977538704872
reaction O 0 0.014694378711283207
( O 0 0.012589049525558949
PCR O 0 0.047678764909505844
) O 0 0.012655442580580711
/ O 0 0.22320851683616638
single O 0 0.01707044616341591
- O 1 0.8786005973815918
strand O 0 0.027752310037612915
conformation O 0 0.02713218331336975
polymorphism O 0 0.02298998460173607
as O 0 0.008856844156980515
a O 0 0.010822807438671589
screening O 0 0.01803654059767723
step O 0 0.014996252954006195
and O 0 0.009349117055535316
nucleotide O 0 0.012471886351704597
sequencing O 0 0.010604575276374817
of O 0 0.007132985163480043
target O 0 0.009697983972728252
exons O 0 0.014934699051082134
, O 0 0.006160811986774206
we O 0 0.004642548970878124
determined O 0 0.005912980064749718
that O 0 0.0034161913208663464
the O 0 0.006502671167254448
proband O 1 0.7592453360557556
was O 0 0.010812479071319103
a O 0 0.010447826236486435
compound O 0 0.032831739634275436
heterozygote O 0 0.08675188571214676
for O 0 0.010685215704143047
two O 0 0.015186337754130363
C6 O 1 0.9999959468841553
gene O 0 0.0369921438395977
mutations O 0 0.03889201581478119
. O 0 0.0337555818259716

The O 0 0.025721430778503418
first O 0 0.021404162049293518
, O 0 0.01635861024260521
1195delC O 0 0.05957251787185669
located O 0 0.016411690041422844
in O 0 0.010051139630377293
exon O 0 0.035951774567365646
7 O 0 0.015628686174750328
, O 0 0.008323820307850838
is O 0 0.005715610925108194
a O 0 0.008795276284217834
novel O 0 0.013492334634065628
mutation O 0 0.010069817304611206
, O 0 0.005463957786560059
while O 0 0.00480578513815999
the O 0 0.005835128948092461
second O 0 0.010206674225628376
, O 0 0.009749648161232471
1936delG O 0 0.03446197509765625
in O 0 0.01032489724457264
exon O 0 0.03165863826870918
12 O 0 0.011054406873881817
, O 0 0.0068686483427882195
has O 0 0.005292794667184353
been O 0 0.004496974870562553
described O 0 0.005999098531901836
before O 0 0.005333535373210907
to O 0 0.006254114210605621
cause O 0 0.035154663026332855
C6D B-Disease 1 0.9999312162399292
in O 0 0.006605197209864855
an O 0 0.007142356596887112
unrelated O 0 0.01435457356274128
African O 0 0.08543696999549866
- O 1 0.9994940757751465
American O 0 0.020183060318231583
individual O 0 0.0166721660643816
. O 0 0.027350548654794693

Both O 0 0.023542683571577072
mutations O 0 0.021484795957803726
result O 0 0.01124189980328083
in O 0 0.011778331361711025
premature O 1 0.8828191161155701
termination O 1 0.9983646273612976
codons O 0 0.0644359290599823
and O 0 0.03650188073515892
C6 O 1 0.9999980926513672
null O 0 0.12337300926446915
alleles O 0 0.08752693235874176
. O 0 0.04910598695278168

Allele O 0 0.17065097391605377
- O 1 0.8843153119087219
specific O 0 0.015110715292394161
PCR O 0 0.03466150909662247
indicated O 0 0.013279448263347149
that O 0 0.005554777570068836
the O 0 0.009307757019996643
probands O 0 0.19354288280010223
two O 0 0.008189504966139793
brothers O 0 0.01740848831832409
also O 0 0.009223390370607376
inherited O 1 0.9918157458305359
the O 0 0.01019622664898634
1195delC O 1 0.9995809197425842
mutation O 0 0.01187120284885168
from O 0 0.005894710775464773
their O 0 0.005932286381721497
heterozygous O 0 0.014784657396376133
mother O 0 0.012905326671898365
and O 0 0.006208237260580063
the O 0 0.009595902636647224
1936delG O 1 0.9984795451164246
mutation O 0 0.013461397029459476
from O 0 0.006846094969660044
their O 0 0.008230339735746384
homozygous O 0 0.027813531458377838
father O 0 0.05085431784391403
. O 0 0.01792346127331257
. O 0 0.028290273621678352

PAX6 O 1 0.9997418522834778
mutations O 0 0.09277274459600449
reviewed O 0 0.07796478271484375
. O 0 0.06070009246468544

Mutations O 0 0.04717718064785004
in O 0 0.021123919636011124
PAX6 O 1 0.999270498752594
are O 0 0.0053061614744365215
responsible O 0 0.0066314940340816975
for O 0 0.005099750589579344
human O 0 0.007351165171712637
aniridia B-Disease 1 0.9999998807907104
and O 0 0.006197670008987188
have O 0 0.003395689418539405
also O 0 0.0030990943778306246
been O 0 0.0029933054465800524
found O 0 0.0029887380078434944
in O 0 0.0037082198541611433
patients O 0 0.42878544330596924
with O 0 0.006237983237951994
Peters B-Disease 1 0.9999995231628418
anomaly I-Disease 1 0.9999979734420776
, O 0 0.0911940336227417
with O 1 0.9847564101219177
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9995169639587402
with O 1 0.9192951917648315
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.14627385139465332
and O 0 0.010031212121248245
with O 0 0.01161061879247427
isolated B-Disease 1 0.9989257454872131
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.2613666355609894

No O 0 0.030709929764270782
locus O 0 0.04131469130516052
other O 0 0.00857581477612257
than O 0 0.010241387411952019
chromosome O 0 0.02157137542963028
11p13 O 0 0.4602923095226288
has O 0 0.009343678131699562
been O 0 0.007492708973586559
implicated O 0 0.016545237973332405
in O 0 0.00986270047724247
aniridia B-Disease 1 0.9999996423721313
, O 0 0.012074057012796402
and O 0 0.012413294054567814
PAX6 O 1 0.9999995231628418
is O 0 0.007386759389191866
clearly O 0 0.0076571376994252205
the O 0 0.00504309544339776
major O 0 0.008984367363154888
, O 0 0.005114687606692314
if O 0 0.00392452348023653
not O 0 0.003646638011559844
only O 0 0.004726001992821693
, O 0 0.009688197635114193
gene O 0 0.014416748657822609
responsible O 0 0.018812021240592003
. O 0 0.023767724633216858

Twenty O 0 0.057384829968214035
- O 0 0.04428001865744591
eight O 0 0.013256935402750969
percent O 0 0.011717423796653748
of O 0 0.00860315840691328
identified O 0 0.012929598800837994
PAX6 O 1 0.9999759197235107
mutations O 0 0.014083648100495338
are O 0 0.00626725610345602
C O 1 0.9998518228530884
- O 1 0.9999948740005493
T O 1 0.9979518055915833
changes O 0 0.012685602530837059
at O 0 0.016090158373117447
CpG O 0 0.060823965817689896
dinucleotides O 0 0.2489156723022461
, O 0 0.011267578229308128
20 O 0 0.010647094808518887
% O 0 0.006779090501368046
are O 0 0.0038160451222211123
splicing O 0 0.013175904750823975
errors O 0 0.009697288274765015
, O 0 0.005517253186553717
and O 0 0.004303427413105965
more O 0 0.0036666200030595064
than O 0 0.003912841901183128
30 O 0 0.00858531054109335
% O 0 0.007155542261898518
are O 0 0.005328116938471794
deletion O 0 0.019960492849349976
or O 0 0.011852388270199299
insertion O 0 0.03702428936958313
events O 0 0.022524524480104446
. O 0 0.03132497891783714

There O 0 0.016333622857928276
is O 0 0.010815530084073544
a O 0 0.01089706365019083
noticeably O 0 0.07440787553787231
elevated O 1 0.8301506042480469
level O 0 0.009992359206080437
of O 0 0.007130422163754702
mutation O 0 0.007897787727415562
in O 0 0.005359550938010216
the O 0 0.006833643652498722
paired O 0 0.014872120693325996
domain O 0 0.009827962145209312
compared O 0 0.0068727643229067326
with O 0 0.004268772900104523
the O 0 0.00590905174612999
rest O 0 0.010336625389754772
of O 0 0.008834628388285637
the O 0 0.012867683544754982
gene O 0 0.024469293653964996
. O 0 0.027546245604753494

Increased O 0 0.03745242580771446
mutation O 0 0.024807849898934364
in O 0 0.010991981253027916
the O 0 0.01382786501199007
homeodomain O 1 0.999007523059845
is O 0 0.010266896337270737
accounted O 0 0.013718918897211552
for O 0 0.006417346186935902
by O 0 0.0077463616617023945
the O 0 0.014271466061472893
hypermutable O 1 0.997431218624115
CpG O 1 0.7968564033508301
dinucleotide O 1 0.939907968044281
in O 0 0.02687208727002144
codon O 0 0.06170446425676346
240 O 0 0.07350412011146545
. O 0 0.04565728083252907

Very O 0 0.016423193737864494
nearly O 0 0.01186751015484333
all O 0 0.006631066091358662
mutations O 0 0.007406153716146946
appear O 0 0.004810846410691738
to O 0 0.0050211502239108086
cause O 0 0.012337576597929
loss O 0 0.28732743859291077
of O 0 0.005581364501267672
function O 0 0.005215140990912914
of O 0 0.0052271331660449505
the O 0 0.007978932000696659
mutant O 0 0.2563742399215698
allele O 0 0.0176437608897686
, O 0 0.005829759873449802
and O 0 0.0038954901974648237
more O 0 0.003140642074868083
than O 0 0.0040792846120893955
80 O 0 0.00856686756014824
% O 0 0.006758535280823708
of O 0 0.008831121027469635
exonic O 1 0.9450470209121704
substitutions O 0 0.022196508944034576
result O 0 0.011605826206505299
in O 0 0.014561106450855732
nonsense O 0 0.04926576092839241
codons O 0 0.0560893677175045
. O 0 0.037761397659778595

In O 0 0.021276157349348068
a O 0 0.015973828732967377
gene O 0 0.010710569098591805
with O 0 0.0076807173900306225
such O 0 0.00629701092839241
extraordinarily O 0 0.08696944266557693
high O 0 0.012662689201533794
sequence O 0 0.008160855621099472
conservation O 0 0.00915875006467104
throughout O 0 0.005464429035782814
evolution O 0 0.007912934757769108
, O 0 0.0057426318526268005
there O 0 0.00407377490773797
are O 0 0.0034814749378710985
presumed O 0 0.017425697296857834
undiscovered O 1 0.9853469133377075
missense O 0 0.10266879200935364
mutations O 0 0.014641905203461647
, O 0 0.007787828333675861
these O 0 0.004124790895730257
are O 0 0.0035360862966626883
hypothesized O 0 0.009911878034472466
to O 0 0.004305654671043158
exist O 0 0.0040358612313866615
in O 0 0.0046569970436394215
as O 0 0.007236106786876917
- O 1 0.9885568618774414
yet O 0 0.011930402368307114
unidentified O 0 0.026551084592938423
phenotypes O 0 0.044245053082704544
. O 0 0.015657100826501846
. O 0 0.02530360221862793

Genetic O 0 0.058816004544496536
heterogeneity O 0 0.061652857810258865
and O 0 0.018463484942913055
penetrance O 0 0.06699834764003754
analysis O 0 0.010318565182387829
of O 0 0.008906550705432892
the O 0 0.012698807753622532
BRCA1 O 1 0.9999357461929321
and O 0 0.014268512837588787
BRCA2 O 1 0.9999797344207764
genes O 0 0.0165708065032959
in O 1 0.5713793039321899
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.4949146807193756
. O 0 0.02927957847714424

The O 1 0.9850172400474548
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999850988388062
Consortium O 1 0.9807060956954956
. O 0 0.04715285450220108

The O 0 0.026434965431690216
contribution O 0 0.027741611003875732
of O 0 0.016333477571606636
BRCA1 O 1 0.999786913394928
and O 0 0.011027722619473934
BRCA2 O 1 0.9999973773956299
to O 0 0.1770891547203064
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9997699856758118
assessed O 0 0.020759696140885353
by O 0 0.0058469162322580814
linkage O 0 0.016955893486738205
and O 0 0.006980391219258308
mutation O 0 0.007556822616606951
analysis O 0 0.0049540577456355095
in O 0 0.0053169443272054195
237 O 0 0.022226260975003242
families O 0 0.0062946961261332035
, O 0 0.0042891898192465305
each O 0 0.002716638147830963
with O 0 0.0027016361709684134
at O 0 0.003878474934026599
least O 0 0.002779042813926935
four O 0 0.0039881509728729725
cases O 0 0.004390237387269735
of O 0 0.04883630946278572
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.007612304296344519
collected O 0 0.00723717175424099
by O 0 0.0064135282300412655
the O 0 0.11401160061359406
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999841451644897
Consortium O 1 0.8882547616958618
. O 0 0.04330023005604744

Families O 0 0.026143549010157585
were O 0 0.00911872461438179
included O 0 0.007869197987020016
without O 0 0.004647983703762293
regard O 0 0.0058016846887767315
to O 0 0.004240823909640312
the O 0 0.005057245492935181
occurrence O 0 0.011115851812064648
of O 0 0.20514512062072754
ovarian B-Disease 1 1.0
or I-Disease 1 0.7661292552947998
other I-Disease 0 0.01956360787153244
cancers I-Disease 1 0.9999992847442627
. O 0 0.028890833258628845

Overall O 1 0.7465298175811768
, O 0 0.10655305534601212
disease O 1 0.9999980926513672
was O 0 0.1975555270910263
linked O 0 0.01665901578962803
to O 0 0.009679509326815605
BRCA1 O 1 0.9768317341804504
in O 0 0.005658148322254419
an O 0 0.004627628717571497
estimated O 0 0.007227146998047829
52 O 0 0.01288481242954731
% O 0 0.00591845391318202
of O 0 0.004922644235193729
families O 0 0.00552707863971591
, O 0 0.005178513471037149
to O 0 0.006357576698064804
BRCA2 O 0 0.2192162424325943
in O 0 0.006086429115384817
32 O 0 0.010920596309006214
% O 0 0.006237654946744442
of O 0 0.005547225475311279
families O 0 0.005951910279691219
, O 0 0.004344319924712181
and O 0 0.0034250158350914717
to O 0 0.004471936728805304
neither O 0 0.006654265336692333
gene O 0 0.005063197109848261
in O 0 0.00452726474031806
16 O 0 0.008352388627827168
% O 0 0.006946863606572151
( O 0 0.006514868699014187
95 O 0 0.015438077040016651
% O 0 0.009091027081012726
confidence O 0 0.015511658042669296
interval O 0 0.02078714594244957
[ O 0 0.02616446278989315
CI O 1 0.9999712705612183
] O 0 0.02585631236433983
6 O 0 0.01659931056201458
% O 0 0.011776566505432129
- O 1 0.5758219957351685
28 O 0 0.014700229279696941
% O 0 0.009933209978044033
) O 0 0.00786278210580349
, O 0 0.008789032697677612
suggesting O 0 0.015218649059534073
other O 0 0.010490486398339272
predisposition O 1 0.97383052110672
genes O 0 0.02708440274000168
. O 0 0.03092854470014572

The O 0 0.026340140029788017
majority O 0 0.015957916155457497
( O 0 0.011289521120488644
81 O 0 0.02541656792163849
% O 0 0.006892835255712271
) O 0 0.0053695086389780045
of O 0 0.0060388981364667416
the O 0 0.012599852867424488
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.013256311416625977
were O 0 0.005831282585859299
due O 0 0.006820368580520153
to O 0 0.007987299002707005
BRCA1 O 1 0.9955669045448303
, O 0 0.005733347497880459
with O 0 0.004960126243531704
most O 0 0.004518201109021902
others O 0 0.005457811988890171
( O 0 0.006712447851896286
14 O 0 0.009641789831221104
% O 0 0.008162894286215305
) O 0 0.00994172040373087
due O 0 0.014140423387289047
to O 0 0.02392999827861786
BRCA2 O 1 0.9982175230979919
. O 0 0.0354396216571331

Conversely O 0 0.05726274102926254
, O 0 0.014082628302276134
the O 0 0.008613462559878826
majority O 0 0.008197813294827938
of O 0 0.0062211621552705765
families O 0 0.005906287580728531
with O 0 0.005327453371137381
male B-Disease 0 0.011661636643111706
and I-Disease 0 0.011841799132525921
female I-Disease 1 0.9999767541885376
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.00663853669539094
due O 0 0.007649206556379795
to O 0 0.011627419851720333
BRCA2 O 1 0.9999315738677979
( O 0 0.015618424862623215
76 O 1 0.9073473811149597
% O 0 0.018499258905649185
) O 0 0.021059198305010796
. O 0 0.029400072991847992

The O 0 0.025105450302362442
largest O 0 0.027258388698101044
proportion O 0 0.016922954469919205
( O 0 0.01060654129832983
67 O 0 0.02120298333466053
% O 0 0.008325126953423023
) O 0 0.005801687482744455
of O 0 0.00571737764403224
families O 0 0.005519168451428413
due O 0 0.0051173060201108456
to O 0 0.005245905835181475
other O 0 0.004445981699973345
genes O 0 0.004767152946442366
was O 0 0.005819739308208227
found O 0 0.003963064402341843
in O 0 0.003418455133214593
families O 0 0.0037261454854160547
with O 0 0.0027903325390070677
four O 0 0.0037042757030576468
or O 0 0.003330677282065153
five O 0 0.003883753437548876
cases O 0 0.005080188624560833
of O 0 0.009015391580760479
female O 1 0.9999977350234985
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.01922563463449478
. O 0 0.029365578666329384

These O 0 0.013365305960178375
estimates O 0 0.014157197438180447
were O 0 0.006655605044215918
not O 0 0.005966467317193747
substantially O 0 0.013398873619735241
affected O 0 0.008153106085956097
either O 0 0.005221336614340544
by O 0 0.004418202210217714
changing O 0 0.009097645990550518
the O 0 0.008914575912058353
assumed O 0 0.020564483478665352
penetrance O 1 0.6955700516700745
model O 0 0.015579596161842346
for O 0 0.01027680467814207
BRCA1 O 1 0.9865227341651917
or O 0 0.005643757060170174
by O 0 0.004448071122169495
including O 0 0.00604592077434063
or O 0 0.008431998081505299
excluding O 0 0.1024007797241211
BRCA1 O 1 0.9999735355377197
mutation O 0 0.021999165415763855
data O 0 0.015641622245311737
. O 0 0.023965608328580856

Among O 0 0.019713709130883217
those O 0 0.008467225357890129
families O 0 0.009430141188204288
with O 0 0.008562940172851086
disease O 1 0.9999998807907104
due O 0 0.17683333158493042
to O 0 0.01213211938738823
BRCA1 O 1 0.9999866485595703
that O 0 0.0036900609266012907
were O 0 0.003677771659567952
tested O 0 0.007208677940070629
by O 0 0.0031328455079346895
one O 0 0.003474289085716009
of O 0 0.0036655734293162823
the O 0 0.004793772008270025
standard O 0 0.008617250248789787
screening O 0 0.011247476562857628
methods O 0 0.006209608633071184
, O 0 0.00637744041159749
mutations O 0 0.006161997094750404
were O 0 0.0034019185695797205
detected O 0 0.0067891925573349
in O 0 0.0040265414863824844
the O 0 0.005861047189682722
coding O 0 0.014881652779877186
sequence O 0 0.00696517713367939
or O 0 0.0060120136477053165
splice O 0 0.019325420260429382
sites O 0 0.005837721284478903
in O 0 0.003982748836278915
an O 0 0.005289618857204914
estimated O 0 0.009214035235345364
63 O 0 0.01693672500550747
% O 0 0.008309952914714813
( O 0 0.008345394395291805
95 O 0 0.019838504493236542
% O 0 0.01336367055773735
CI O 1 0.9966488480567932
51 O 0 0.030903717502951622
% O 0 0.015214018523693085
- O 1 0.9932593703269958
77 O 0 0.04362545907497406
% O 0 0.018382694572210312
) O 0 0.02147763967514038
. O 0 0.027288276702165604

The O 0 0.027559464797377586
estimated O 0 0.02214290201663971
sensitivity O 0 0.02421250380575657
was O 0 0.014536481350660324
identical O 0 0.010419012047350407
for O 0 0.005554938688874245
direct O 0 0.008163033053278923
sequencing O 0 0.014019384048879147
and O 0 0.008300982415676117
other O 0 0.007189552765339613
techniques O 0 0.020244812592864037
. O 0 0.026157602667808533

The O 0 0.03764726221561432
penetrance O 1 0.7240774631500244
of O 0 0.026354778558015823
BRCA2 O 1 0.9999792575836182
was O 0 0.015021723695099354
estimated O 0 0.010040863417088985
by O 0 0.006122412625700235
maximizing O 0 0.02444666624069214
the O 0 0.01164429821074009
LOD O 1 0.9984328150749207
score O 0 0.014185729436576366
in O 0 0.011019550263881683
BRCA2 O 1 0.9999929666519165
- O 1 0.9999862909317017
mutation O 0 0.013516727834939957
families O 0 0.006608495954424143
, O 0 0.005603395402431488
over O 0 0.004865166265517473
all O 0 0.006740696728229523
possible O 0 0.013573545962572098
penetrance O 1 0.6638432145118713
functions O 0 0.025651736184954643
. O 0 0.03475334867835045

The O 0 0.02002248913049698
estimated O 0 0.01694190315902233
cumulative O 0 0.022802412509918213
risk O 0 0.020750848576426506
of O 0 0.06854930520057678
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.4360131323337555
28 O 0 0.0205676332116127
% O 0 0.01015122327953577
( O 0 0.010147074237465858
95 O 0 0.02331535518169403
% O 0 0.01599257066845894
CI O 1 0.9901976585388184
9 O 0 0.022175747901201248
% O 0 0.01349250040948391
- O 0 0.06692598760128021
44 O 0 0.01731821522116661
% O 0 0.008062335662543774
) O 0 0.005693390034139156
by O 0 0.004083578009158373
age O 0 0.00706722354516387
50 O 0 0.008250857703387737
years O 0 0.006145342253148556
and O 0 0.005772472359240055
84 O 0 0.017353786155581474
% O 0 0.007415304891765118
( O 0 0.007354969624429941
95 O 0 0.016649823635816574
% O 0 0.011223205365240574
CI O 1 0.9972816705703735
43 O 0 0.02213871106505394
% O 0 0.01048982422798872
- O 0 0.296941339969635
95 O 0 0.01823299005627632
% O 0 0.008086058311164379
) O 0 0.00667479308322072
by O 0 0.005691481754183769
age O 0 0.012475221417844296
70 O 0 0.02059786580502987
years O 0 0.021787390112876892
. O 0 0.02958480268716812

The O 0 0.033234450966119766
corresponding O 1 0.995697021484375
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999977350234985
were O 0 0.02140014059841633
0 O 0 0.04394460842013359
. O 0 0.036592546850442886

4 O 0 0.03983275964856148
% O 0 0.018686912953853607
( O 0 0.012909051962196827
95 O 0 0.027377024292945862
% O 0 0.01509378757327795
CI O 1 0.9968337416648865
0 O 0 0.021354900673031807
% O 0 0.012196666561067104
- O 1 0.7277952432632446
1 O 0 0.013289998285472393
% O 0 0.006549036130309105
) O 0 0.00481318449601531
by O 0 0.0034888458903878927
age O 0 0.0063218120485544205
50 O 0 0.007018711417913437
years O 0 0.004771366715431213
and O 0 0.004598909988999367
27 O 0 0.009180845692753792
% O 0 0.006111952941864729
( O 0 0.006941714324057102
95 O 0 0.015512616373598576
% O 0 0.012759999372065067
CI O 1 0.997174859046936
0 O 0 0.018143849447369576
% O 0 0.010181265883147717
- O 0 0.2025853842496872
47 O 0 0.018227702006697655
% O 0 0.008760148659348488
) O 0 0.006697639357298613
by O 0 0.0057633440010249615
age O 0 0.011908999644219875
70 O 0 0.02013256959617138
years O 0 0.019006630405783653
. O 0 0.02727460488677025

The O 0 0.022520167753100395
lifetime O 0 0.051567260175943375
risk O 1 0.6751390099525452
of O 1 0.9898567199707031
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.20433321595191956
similar O 0 0.004814316984266043
to O 0 0.004229819402098656
the O 0 0.0051155393011868
risk O 0 0.02332211472094059
in O 0 0.007864151149988174
BRCA1 O 1 0.9999994039535522
carriers O 1 0.8714643716812134
, O 0 0.006099383346736431
but O 0 0.003958812449127436
there O 0 0.003227048786357045
was O 0 0.0061132474802434444
some O 0 0.003538751509040594
suggestion O 0 0.008720794692635536
of O 0 0.005155497696250677
a O 0 0.007475409656763077
lower O 0 0.011040153913199902
risk O 0 0.012541760690510273
in O 0 0.010677974671125412
BRCA2 O 1 0.9999794960021973
carriers O 1 0.9209738373756409
< O 1 0.9196107983589172
50 O 0 0.017087016254663467
years O 0 0.013181119225919247
of O 0 0.013990359380841255
age O 0 0.028895646333694458
. O 0 0.02926163747906685

Eye B-Disease 1 0.9999762773513794
movement I-Disease 0 0.07317060232162476
abnormalities I-Disease 1 0.9936977028846741
correlate O 0 0.02547537535429001
with O 0 0.00957458931952715
genotype O 0 0.344096839427948
in O 0 0.012416129931807518
autosomal O 1 0.9999988079071045
dominant O 1 1.0
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999430179595947
. O 0 0.04166426509618759

We O 0 0.018889278173446655
compared O 0 0.021966993808746338
horizontal O 0 0.03978276997804642
eye O 1 0.9988526105880737
movements O 0 0.01592758111655712
( O 0 0.012688207440078259
visually O 0 0.04345553740859032
guided O 1 0.5488290190696716
saccades O 1 0.9999966621398926
, O 0 0.01543368585407734
antisaccades O 1 0.9957172274589539
, O 0 0.009553356096148491
and O 0 0.008470316417515278
smooth O 0 0.01853880286216736
pursuit O 0 0.06005415320396423
) O 0 0.00703703286126256
in O 0 0.005331606138497591
control O 0 0.0081577617675066
subjects O 0 0.010830405168235302
( O 0 0.008320904336869717
n O 0 0.017829280346632004
= O 0 0.018377764150500298
14 O 0 0.011572780087590218
) O 0 0.00681651895865798
and O 0 0.005988240707665682
patients O 0 0.009182026609778404
with O 0 0.004182748030871153
three O 0 0.004655932076275349
forms O 0 0.0055384282022714615
of O 0 0.008509037084877491
autosomal O 1 0.9999819993972778
dominant O 1 0.9999645948410034
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.999974250793457
I I-Disease 1 0.9980837106704712
spinocerebellar B-Disease 1 0.9999997615814209
ataxias I-Disease 1 0.9995904564857483
1 I-Disease 0 0.01999554969370365
and I-Disease 0 0.0087154945358634
2 I-Disease 0 0.013881071470677853
( O 0 0.011181140318512917
SCA1 B-Disease 1 0.9994204044342041
, O 0 0.01131809689104557
n O 0 0.020052092149853706
= O 0 0.02215902879834175
11 O 0 0.015539395622909069
; O 0 0.014317488297820091
SCA2 B-Disease 1 0.9018749594688416
, O 0 0.014102151617407799
n O 0 0.02065160684287548
= O 0 0.023159872740507126
10 O 0 0.010838204063475132
) O 0 0.008382768370211124
and O 0 0.010786214843392372
SCA3 B-Disease 1 0.999998927116394
/ O 1 0.99985671043396
Machado B-Disease 1 0.9999905824661255
- I-Disease 1 0.999998927116394
Joseph I-Disease 1 0.999737560749054
disease I-Disease 1 0.9999998807907104
( O 0 0.4699070453643799
MJD B-Disease 1 1.0
) O 0 0.013644765131175518
( O 0 0.013189167715609074
n O 0 0.02675093337893486
= O 0 0.03412167727947235
16 O 0 0.024928787723183632
) O 0 0.020380882546305656
. O 0 0.029136471450328827

In O 0 0.03881785273551941
SCA1 B-Disease 1 0.9996476173400879
, O 0 0.027035443112254143
saccade O 1 0.962113618850708
amplitude O 0 0.035485539585351944
was O 0 0.018572229892015457
significantly O 0 0.016116522252559662
increased O 0 0.012514146976172924
, O 0 0.011128817684948444
resulting O 0 0.012334137223660946
in O 0 0.016032831743359566
hypermetria B-Disease 1 0.9955902099609375
. O 0 0.03963790461421013

The O 0 0.028820758685469627
smooth O 0 0.04040951654314995
pursuit O 0 0.05685410648584366
gain O 0 0.03149949759244919
was O 0 0.062252555042505264
decreased O 0 0.08624505251646042
. O 0 0.030483417212963104

In O 0 0.04630278795957565
SCA2 B-Disease 1 0.9994813799858093
, O 0 0.031011030077934265
saccade O 1 0.9692593216896057
velocity O 0 0.04121476411819458
was O 0 0.034336451441049576
markedly O 0 0.05935573950409889
decreased O 0 0.05522480607032776
. O 0 0.04410308226943016

The O 0 0.021117018535733223
percentage O 0 0.016566501930356026
of O 0 0.009565641172230244
errors O 0 0.01310142781585455
in O 0 0.008603260852396488
antisaccades O 1 0.999836802482605
was O 0 0.01684936136007309
greatly O 0 0.0118643119931221
increased O 0 0.007925199344754219
and O 0 0.005953828804194927
was O 0 0.008084452711045742
significantly O 0 0.009576095268130302
correlated O 0 0.011351349763572216
with O 0 0.006034967489540577
age O 0 0.02166520431637764
at O 1 0.9740622043609619
disease O 1 1.0
onset O 1 1.0
. O 0 0.24619024991989136

In O 0 0.021293869242072105
addition O 0 0.014500588178634644
, O 0 0.009100370109081268
a O 0 0.008918816223740578
correlation O 0 0.01075105369091034
between O 0 0.007447812240570784
smooth O 0 0.015917204320430756
pursuit O 0 0.025138026103377342
gain O 0 0.010878689587116241
and O 0 0.005711207166314125
the O 0 0.005244620144367218
number O 0 0.005375124514102936
of O 0 0.008936319500207901
trinucleotide O 1 0.9999457597732544
repeats O 0 0.032082315534353256
was O 0 0.022830946370959282
found O 0 0.01806396059691906
. O 0 0.025312652811408043

In O 0 0.037043239921331406
SCA3 B-Disease 1 0.9999966621398926
, O 0 0.02560459077358246
gaze B-Disease 1 0.9984134435653687
- I-Disease 1 0.9999963045120239
evoked I-Disease 1 0.9998227953910828
nystagmus I-Disease 1 0.9999918937683105
was O 0 0.019385581836104393
often O 0 0.006972915027290583
present O 0 0.007150597404688597
as O 0 0.006970069836825132
was O 0 0.019670793786644936
saccade O 1 0.9998039603233337
hypometria O 1 0.9954206347465515
and O 0 0.010545453056693077
smooth O 0 0.02369002252817154
pursuit O 0 0.22315841913223267
gain O 0 0.02425268292427063
was O 0 0.04100218415260315
markedly O 0 0.16957300901412964
decreased O 0 0.07518147677183151
. O 0 0.033665433526039124

Three O 0 0.024659229442477226
major O 0 0.02443363331258297
criteria O 0 0.020346226170659065
, O 0 0.017918208613991737
saccade O 1 0.9231881499290466
amplitude O 0 0.033743903040885925
, O 0 0.015934621915221214
saccade O 1 0.9160187840461731
velocity O 0 0.016865378245711327
, O 0 0.008351718075573444
and O 0 0.005847454071044922
presence O 0 0.008857074193656445
of O 0 0.010772720910608768
gaze B-Disease 1 0.9998047947883606
- I-Disease 1 0.9999995231628418
evoked I-Disease 1 0.9998149275779724
nystagmus I-Disease 1 0.9999743700027466
, O 0 0.00882207602262497
permitted O 0 0.008400607854127884
the O 0 0.007664851378649473
correct O 0 0.010235540568828583
assignment O 0 0.012539669871330261
of O 0 0.005876924376934767
90 O 0 0.0080600930377841
% O 0 0.005223328247666359
of O 0 0.004926716443151236
the O 0 0.007732778787612915
SCA1 B-Disease 1 0.9999173879623413
, O 0 0.007298682816326618
90 O 0 0.00912753026932478
% O 0 0.005524175241589546
of O 0 0.0051482003182172775
the O 0 0.0083626639097929
SCA2 B-Disease 1 0.9999793767929077
, O 0 0.00682919193059206
and O 0 0.005162232555449009
93 O 0 0.014096948318183422
% O 0 0.005860502365976572
of O 0 0.004635986872017384
the O 0 0.006836537271738052
patients O 1 0.993614137172699
with O 0 0.008248484693467617
SCA3 B-Disease 1 1.0
to O 0 0.00621255487203598
their O 0 0.0051606460474431515
genetically O 0 0.010059209540486336
confirmed O 0 0.008244086988270283
patient O 1 0.7819669246673584
group O 0 0.009078972972929478
and O 0 0.005839542951434851
, O 0 0.0053206877782940865
therefore O 0 0.004909774288535118
, O 0 0.004490844439715147
may O 0 0.005128179211169481
help O 0 0.009698285721242428
orient O 0 0.03826850280165672
diagnoses O 1 0.9855048060417175
of O 0 0.013284572400152683
SCA1 B-Disease 1 0.9999997615814209
, O 0 0.024507736787199974
SCA2 B-Disease 1 0.9999988079071045
, O 0 0.00938024278730154
and O 0 0.00812553521245718
SCA3 B-Disease 1 0.9999967813491821
at O 0 0.010621834546327591
early O 0 0.010471407324075699
clinical O 0 0.03205202519893646
stages O 0 0.014100594446063042
of O 0 0.010443361476063728
the O 0 0.0993342474102974
diseases O 1 1.0
. O 0 0.019530054181814194
. O 0 0.02745930477976799

Genetic O 0 0.029939079657197
basis O 0 0.013652320019900799
and O 0 0.01229009497910738
molecular O 0 0.01857668161392212
mechanism O 0 0.02227003313601017
for O 1 0.8225655555725098
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9997454285621643

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.7484432458877563
more O 0 0.008652313612401485
than O 0 0.007256161887198687
300 O 0 0.014744862914085388
, O 0 0.010750374756753445
000 O 0 0.02693246491253376
sudden O 0 0.06746431440114975
deaths O 0 0.012779987417161465
each O 0 0.00530796404927969
year O 0 0.008443785831332207
in O 0 0.008455903269350529
the O 0 0.014097067527472973
USA O 0 0.05268248915672302
alone O 0 0.03179141879081726
. O 0 0.026183458045125008

In O 0 0.01662161760032177
approximately O 0 0.01349117886275053
5 O 0 0.017267057672142982
- O 0 0.060938410460948944
12 O 0 0.009602746926248074
% O 0 0.005895510781556368
of O 0 0.004692669026553631
these O 0 0.003398257540538907
cases O 0 0.004675644915550947
, O 0 0.003918354865163565
there O 0 0.002547505311667919
are O 0 0.0019970436114817858
no O 0 0.004614913836121559
demonstrable O 1 0.9999973773956299
cardiac O 1 1.0
or O 1 0.9743990302085876
non O 1 0.999998927116394
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9566436409950256
to O 0 0.005719151347875595
account O 0 0.005435928236693144
for O 0 0.003917567431926727
the O 0 0.0055254013277590275
episode O 0 0.010208274237811565
, O 0 0.005064722616225481
which O 0 0.0037783035077154636
is O 0 0.004178440663963556
therefore O 0 0.005263772793114185
classified O 0 0.011972915381193161
as O 0 0.08501946181058884
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999998807907104
IVF B-Disease 1 1.0
) O 0 0.031934645026922226
. O 0 0.03492007777094841

A O 0 0.027305172756314278
distinct O 0 0.01397689338773489
group O 0 0.014090588316321373
of O 0 0.012996049597859383
IVF B-Disease 1 1.0
patients O 1 0.999996542930603
has O 0 0.0072790030390024185
been O 0 0.0041884686797857285
found O 0 0.0034899981692433357
to O 0 0.0033615778665989637
present O 0 0.004995330702513456
with O 0 0.004906800109893084
a O 0 0.011450759135186672
characteristic O 1 0.5041767954826355
electrocardiographic O 1 0.9999593496322632
pattern O 0 0.04593717306852341
. O 0 0.0337989442050457

Because O 0 0.014929963275790215
of O 0 0.009676693938672543
the O 0 0.008845874108374119
small O 0 0.0073868995532393456
size O 0 0.007894657552242279
of O 0 0.005048294551670551
most O 0 0.005212998948991299
pedigrees O 0 0.013381249271333218
and O 0 0.0044042025692760944
the O 0 0.0061537944711744785
high O 0 0.015923194587230682
incidence O 1 0.9827985167503357
of O 0 0.00976310484111309
sudden B-Disease 1 0.9999860525131226
death I-Disease 1 0.901573896408081
, O 0 0.007112404797226191
however O 0 0.005434819031506777
, O 0 0.006288143806159496
molecular O 0 0.008756481111049652
genetic O 0 0.006421737838536501
studies O 0 0.0062539535574615
of O 0 0.00763660715892911
IVF B-Disease 1 0.9999935626983643
have O 0 0.005900257267057896
not O 0 0.005468605551868677
yet O 0 0.008489777334034443
been O 0 0.007849722169339657
done O 0 0.017495019361376762
. O 0 0.02488279901444912

Because O 0 0.038260407745838165
IVF B-Disease 1 1.0
causes O 1 0.9999994039535522
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999973773956299
, O 0 0.009919666685163975
we O 0 0.006881978362798691
investigated O 0 0.010687217116355896
whether O 0 0.007830026559531689
malfunction O 1 0.8934692144393921
of O 0 0.00970308668911457
ion O 0 0.04185677692294121
channels O 0 0.010716624557971954
could O 0 0.007338938303291798
cause O 0 0.01067044585943222
the O 0 0.009705414064228535
disorder O 1 0.9999912977218628
by O 0 0.005792868323624134
studying O 0 0.011449924670159817
mutations O 0 0.009494242258369923
in O 0 0.005936317145824432
the O 0 0.011089446023106575
cardiac O 1 0.9999998807907104
sodium O 1 0.998724639415741
channel O 0 0.034412868320941925
gene O 0 0.0350533165037632
SCN5A O 1 0.9985195994377136
. O 0 0.0432160310447216

We O 0 0.01803474873304367
have O 0 0.008309520781040192
now O 0 0.009841048158705235
identified O 0 0.008140425197780132
a O 0 0.009457948617637157
missense O 0 0.025121809914708138
mutation O 0 0.01190770324319601
, O 0 0.006173112895339727
a O 0 0.009847782552242279
splice O 1 0.9885962605476379
- O 1 0.9999549388885498
donor O 0 0.15679329633712769
mutation O 0 0.011659982614219189
, O 0 0.006183696910738945
and O 0 0.0057472893968224525
a O 0 0.008686388842761517
frameshift O 1 0.5730330348014832
mutation O 0 0.010599118657410145
in O 0 0.005977351684123278
the O 0 0.007523046340793371
coding O 0 0.015658827498555183
region O 0 0.009260979481041431
of O 0 0.010289321653544903
SCN5A O 1 0.9999610185623169
in O 0 0.010847155004739761
three O 0 0.012802951037883759
IVF B-Disease 1 0.9998809099197388
families O 0 0.027994951233267784
. O 0 0.028423480689525604

We O 0 0.018287915736436844
show O 0 0.012599948793649673
that O 0 0.0076901610009372234
sodium O 0 0.02005573734641075
channels O 0 0.007052974309772253
with O 0 0.005879588890820742
the O 0 0.007807426154613495
missense O 0 0.02333199605345726
mutation O 0 0.014140994288027287
recover O 0 0.21494407951831818
from O 0 0.009915987960994244
inactivation O 1 0.9965519905090332
more O 0 0.007226558867841959
rapidly O 0 0.012096645310521126
than O 0 0.004629045724868774
normal O 0 0.00461442768573761
and O 0 0.0038357307203114033
that O 0 0.0034429121296852827
the O 0 0.006984236650168896
frameshift O 1 0.6498630046844482
mutation O 0 0.01370189432054758
causes O 0 0.012761217541992664
the O 0 0.009067397564649582
sodium O 0 0.03260034695267677
channel O 0 0.010832607746124268
to O 0 0.006079527083784342
be O 0 0.00652014184743166
non O 0 0.022505246102809906
- O 1 0.9993891716003418
functional O 0 0.047131262719631195
. O 0 0.03223499655723572

Our O 0 0.027353979647159576
results O 0 0.01471855491399765
indicate O 0 0.00864227395504713
that O 0 0.005239080172032118
mutations O 0 0.008854944258928299
in O 0 0.008126595988869667
cardiac O 1 1.0
ion O 1 0.9999988079071045
- O 1 0.9999972581863403
channel O 0 0.01473227608948946
genes O 0 0.007843151688575745
contribute O 0 0.007987730205059052
to O 0 0.00527375191450119
the O 0 0.006743072997778654
risk O 0 0.010260438546538353
of O 0 0.009603871963918209
developing O 1 0.9305738806724548
IVF B-Disease 1 0.9999997615814209
. O 0 0.021312043070793152
. O 0 0.029725445434451103

Molecular O 0 0.06142927706241608
heterogeneity O 0 0.06611713767051697
in O 0 0.02432859316468239
mucopolysaccharidosis B-Disease 1 0.9999881982803345
IVA I-Disease 1 1.0
in O 0 0.015368575230240822
Australia O 0 0.016755659133195877
and O 0 0.008824103511869907
Northern O 0 0.011900356039404869
Ireland O 0 0.014310370199382305
: O 0 0.010333905927836895
nine O 0 0.012453857809305191
novel O 0 0.017796969041228294
mutations O 0 0.01085387822240591
including O 0 0.007573434617370367
T312S O 1 0.9528464078903198
, O 0 0.00842100940644741
a O 0 0.008727457374334335
common O 0 0.008862948045134544
allele O 0 0.016559457406401634
that O 0 0.00822050217539072
confers O 1 0.997192919254303
a O 0 0.2660335302352905
mild O 1 0.9999992847442627
phenotype O 1 0.9998133778572083
. O 0 0.04324817284941673

Mucopolysaccharidosis B-Disease 1 0.999996542930603
IVA I-Disease 1 1.0
( O 0 0.10935714840888977
MPS B-Disease 1 0.9999129772186279
IVA I-Disease 1 1.0
) O 0 0.013077312149107456
is O 0 0.008947979658842087
an O 0 0.009770072996616364
autosomal B-Disease 1 0.9999678134918213
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9998408555984497
by O 0 0.007794972509145737
a O 0 0.01631130464375019
genetic B-Disease 1 0.9237246513366699
defect I-Disease 1 0.9999910593032837
in O 0 0.011938240379095078
N O 1 0.5760414600372314
- O 1 0.9996403455734253
acetylgalactosamine O 1 0.9994378685951233
- O 1 0.9998672008514404
6 O 0 0.05120185390114784
- O 1 0.9999924898147583
sulfate O 1 0.9999980926513672
sulfatase O 1 0.9999992847442627
( O 0 0.15411372482776642
GALNS O 1 0.9999951124191284
) O 0 0.03648809716105461
. O 0 0.04260878264904022

Previous O 0 0.027737148106098175
studies O 0 0.015637453645467758
of O 0 0.010475696995854378
patients O 0 0.026908431202173233
from O 0 0.0060060834512114525
a O 0 0.008412369526922703
British O 0 0.08031013607978821
- O 1 0.993716299533844
Irish O 0 0.01128515787422657
population O 0 0.004644754342734814
showed O 0 0.0059243482537567616
that O 0 0.003308531828224659
the O 0 0.006726343184709549
I113F O 1 0.9926322102546692
mutation O 0 0.009996011853218079
is O 0 0.004606315866112709
the O 0 0.004864679183810949
most O 0 0.004403581377118826
common O 0 0.00424278574064374
single O 0 0.006435193121433258
mutation O 0 0.00827006809413433
among O 0 0.008924828842282295
MPS B-Disease 1 0.9999821186065674
IVA I-Disease 1 1.0
patients O 1 0.9999996423721313
and O 0 0.016127172857522964
produces O 0 0.07735483348369598
a O 0 0.0276828370988369
severe O 1 0.9999998807907104
clinical O 1 1.0
phenotype O 1 0.9999923706054688
. O 0 0.04800340533256531

We O 0 0.021451519802212715
studied O 0 0.020408738404512405
mutations O 0 0.013689141720533371
in O 0 0.006460761651396751
the O 0 0.00935616996139288
GALNS O 1 0.999618649482727
gene O 0 0.009934589266777039
from O 0 0.006925281137228012
23 O 0 0.01122515369206667
additional O 0 0.012459641322493553
MPS B-Disease 1 0.9996463060379028
IVA I-Disease 1 1.0
patients O 1 0.9999706745147705
( O 0 0.009967993013560772
15 O 0 0.010221251286566257
from O 0 0.006462268065661192
Australia O 0 0.009797301143407822
, O 0 0.00610776524990797
8 O 0 0.006807982921600342
from O 0 0.004458099603652954
Northern O 0 0.0074170115403831005
Ireland O 0 0.008320766501128674
) O 0 0.005109190009534359
, O 0 0.004041657783091068
with O 0 0.003443762892857194
various O 0 0.004961101338267326
clinical O 1 0.9999862909317017
phenotypes O 1 0.9999929666519165
( O 0 0.23154222965240479
severe O 1 0.9999990463256836
, O 0 0.009235790930688381
16 O 0 0.010225005447864532
cases O 0 0.006516343913972378
; O 0 0.006448853760957718
intermediate O 0 0.01322852075099945
, O 0 0.0062566036358475685
4 O 0 0.009967352263629436
cases O 0 0.007399517577141523
; O 0 0.008381539024412632
mild O 1 0.9976732134819031
, O 0 0.010737775824964046
3 O 0 0.01686568558216095
cases O 0 0.013454609550535679
) O 0 0.017116142436861992
. O 0 0.027300093322992325

We O 0 0.01497866865247488
found O 0 0.010007153265178204
two O 0 0.00651923380792141
common O 0 0.007946041412651539
mutations O 0 0.008734655566513538
that O 0 0.0038848973345011473
together O 0 0.006302373018115759
accounted O 0 0.009767143987119198
for O 0 0.005390160251408815
32 O 0 0.010667960159480572
% O 0 0.005726248491555452
of O 0 0.005375363864004612
the O 0 0.007569151930510998
44 O 0 0.017767736688256264
unrelated O 0 0.017088279128074646
alleles O 0 0.01592663861811161
in O 0 0.009913993068039417
these O 0 0.010185818187892437
patients O 1 0.8527505993843079
. O 0 0.027061767876148224

One O 0 0.023012688383460045
is O 0 0.012408892624080181
the O 0 0.01382980216294527
T312S O 1 0.9943247437477112
mutation O 0 0.01702175848186016
, O 0 0.008279972709715366
a O 0 0.009409069083631039
novel O 0 0.015232649631798267
mutation O 0 0.010811347514390945
found O 0 0.005778593942523003
exclusively O 0 0.010846908204257488
in O 0 0.010283835232257843
milder O 1 0.9994003772735596
patients O 1 0.9999001026153564
. O 0 0.03403038904070854

The O 0 0.021077141165733337
other O 0 0.00836693961173296
is O 0 0.007584637962281704
the O 0 0.007762945722788572
previously O 0 0.0118445735424757
described O 0 0.012592416256666183
I113F O 1 0.7265949845314026
that O 0 0.007483760826289654
produces O 0 0.021337119862437248
a O 0 0.022542934864759445
severe O 1 0.9999992847442627
phenotype O 1 0.9999724626541138
. O 0 0.04403608664870262

The O 0 0.041766125708818436
I113F O 1 0.8780372142791748
and O 0 0.018027592450380325
T312S O 0 0.36901500821113586
mutations O 0 0.015109865926206112
accounted O 0 0.013364361599087715
for O 0 0.006289872340857983
8 O 0 0.010622439906001091
( O 0 0.006492069456726313
18 O 0 0.008090106770396233
% O 0 0.006046063266694546
) O 0 0.00522896321490407
and O 0 0.005052688531577587
6 O 0 0.009897265583276749
( O 0 0.007196246646344662
14 O 0 0.010571695864200592
% O 0 0.0069624995812773705
) O 0 0.005870548076927662
of O 0 0.007962108589708805
44 O 0 0.017852116376161575
unrelated O 0 0.019856378436088562
alleles O 0 0.022502953186631203
, O 0 0.013602345250546932
respectively O 0 0.02410893142223358
. O 0 0.027115317061543465

The O 0 0.025746766477823257
relatively O 0 0.020286602899432182
high O 0 0.027190539985895157
residual O 1 0.9909396171569824
GALNS O 1 0.9999804496765137
activity O 0 0.016010832041502
seen O 0 0.013070168904960155
when O 0 0.010727042332291603
the O 0 0.013515163213014603
T312S O 1 0.7083494067192078
mutant O 0 0.04114583134651184
cDNA O 0 0.03823995962738991
is O 0 0.014412453398108482
overexpressed O 0 0.045182500034570694
in O 0 0.010274384170770645
mutant O 0 0.025985712185502052
cells O 0 0.010642184875905514
provides O 0 0.008235051296651363
an O 0 0.005091007333248854
explanation O 0 0.007617211900651455
for O 0 0.005376883782446384
the O 0 0.00902597513049841
mild O 1 0.9999969005584717
phenotype O 1 0.9998527765274048
in O 0 0.013337917625904083
patients O 1 0.9987094402313232
with O 0 0.009919128380715847
this O 0 0.011994709260761738
mutation O 0 0.03146931156516075
. O 0 0.027925416827201843

The O 0 0.0243931133300066
distribution O 0 0.0156977828592062
and O 0 0.00820751953870058
relative O 0 0.009823755361139774
frequencies O 0 0.00728536257520318
of O 0 0.006079293321818113
the O 0 0.008471308276057243
I113F O 1 0.975196361541748
and O 0 0.010810939595103264
T312S O 1 0.9932465553283691
mutations O 0 0.01211206428706646
in O 0 0.006431682035326958
Australia O 0 0.010547323152422905
corresponded O 0 0.011648227460682392
to O 0 0.00522979162633419
those O 0 0.0034910428803414106
observed O 0 0.004141871351748705
in O 0 0.004190495703369379
Northern O 0 0.006620069500058889
Ireland O 0 0.00729753915220499
and O 0 0.003941481467336416
are O 0 0.0024851211346685886
unique O 0 0.0037087465170770884
to O 0 0.0028712842613458633
these O 0 0.0020781722851097584
two O 0 0.0028821551240980625
populations O 0 0.003644726239144802
, O 0 0.003998756408691406
suggesting O 0 0.004748653154820204
that O 0 0.0028330087661743164
both O 0 0.0038670646026730537
mutations O 0 0.005894454196095467
were O 0 0.003720824606716633
probably O 0 0.005870671011507511
introduced O 0 0.006846604403108358
to O 0 0.005125627852976322
Australia O 0 0.00856870599091053
by O 0 0.005268791224807501
Irish O 0 0.010413323529064655
migrants O 0 0.0091289933770895
during O 0 0.009548750706017017
the O 0 0.011963194236159325
19th O 0 0.032046571373939514
century O 0 0.03542185202240944
. O 0 0.028577525168657303

Haplotype O 0 0.09512176364660263
analysis O 0 0.022307245060801506
using O 0 0.01538214460015297
6 O 0 0.029562165960669518
RFLPs O 0 0.05604873225092888
provides O 0 0.014591790735721588
additional O 0 0.008680752478539944
data O 0 0.006480423733592033
that O 0 0.0042418912053108215
the O 0 0.009954786859452724
I113F O 1 0.9592078328132629
mutation O 0 0.014672847464680672
originated O 0 0.012123720720410347
from O 0 0.007196240592747927
a O 0 0.011102850548923016
common O 0 0.01400082092732191
ancestor O 0 0.03472132608294487
. O 0 0.026768548414111137

The O 0 0.023027554154396057
other O 0 0.010656023398041725
9 O 0 0.018670104444026947
novel O 0 0.01641429029405117
mutations O 0 0.00975669827312231
identified O 0 0.005349732004106045
in O 0 0.004148268140852451
these O 0 0.003537275828421116
23 O 0 0.011018776334822178
patients O 0 0.030640579760074615
were O 0 0.004223949741572142
each O 0 0.003933162894099951
limited O 0 0.006231418810784817
to O 0 0.006785213015973568
a O 0 0.00987505167722702
single O 0 0.016067329794168472
family O 0 0.024472709745168686
. O 0 0.025081554427742958

These O 0 0.014638452790677547
data O 0 0.009557683952152729
provide O 0 0.009403764270246029
further O 0 0.007184265647083521
evidence O 0 0.006070003379136324
for O 0 0.006264939904212952
extensive O 0 0.01373264193534851
allelic O 1 0.8151277303695679
heterogeneity O 0 0.18114829063415527
in O 0 0.014005389995872974
MPS B-Disease 1 0.996496856212616
IVA I-Disease 1 1.0
in O 0 0.013393964618444443
British O 0 0.43545058369636536
- O 1 0.9999927282333374
Irish O 0 0.19514955580234528
patients O 1 0.7333650588989258
and O 0 0.0048780436627566814
provide O 0 0.005688525270670652
evidence O 0 0.004176096059381962
for O 0 0.0038711007218807936
their O 0 0.003736209822818637
transmission O 0 0.007266319822520018
to O 0 0.004516043700277805
Australia O 0 0.006883278954774141
by O 0 0.004963936284184456
British O 0 0.01714833825826645
- O 1 0.9985242486000061
Irish O 0 0.019348766654729843
migrants O 0 0.014627039432525635
. O 0 0.014798512682318687
. O 0 0.021578678861260414

Identification O 0 0.030663155019283295
of O 0 0.01773897372186184
constitutional O 0 0.036463413387537
WT1 O 1 0.9999984502792358
mutations O 0 0.019549518823623657
, O 0 0.008676929399371147
in O 0 0.008039538748562336
patients O 0 0.11403632164001465
with O 0 0.007945883087813854
isolated O 1 0.9966188669204712
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 1 0.5585630536079407
and O 0 0.007604461628943682
analysis O 0 0.006536582019180059
of O 0 0.010198690928518772
genotype O 1 0.9998464584350586
/ O 1 0.9999849796295166
phenotype O 0 0.29505035281181335
correlations O 0 0.016746852546930313
by O 0 0.006011038552969694
use O 0 0.006513035856187344
of O 0 0.007877682335674763
a O 0 0.013871687464416027
computerized O 0 0.32248201966285706
mutation O 0 0.028625858947634697
database O 0 0.03867534175515175
. O 0 0.03487370163202286

Constitutional O 0 0.04150578752160072
mutations O 0 0.02428930439054966
of O 0 0.013050549663603306
the O 0 0.01643805019557476
WT1 O 1 0.9999786615371704
gene O 0 0.01553893368691206
, O 0 0.009020322002470493
encoding O 0 0.012506336905062199
a O 0 0.014771480113267899
zinc O 1 0.9999994039535522
- O 1 0.9999837875366211
finger O 1 0.7361100912094116
transcription O 0 0.018697643652558327
factor O 0 0.013662244193255901
involved O 0 0.010028225369751453
in O 0 0.012622975744307041
renal O 1 1.0
and O 1 0.9618473052978516
gonadal O 1 1.0
development O 1 0.6695172786712646
, O 0 0.006129902321845293
are O 0 0.002636160934343934
found O 0 0.0029692898970097303
in O 0 0.003192878793925047
most O 0 0.0037839096039533615
patients O 0 0.019376931712031364
with O 0 0.00739944726228714
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999906063079834
DDS B-Disease 1 1.0
) O 0 0.012202337384223938
, O 0 0.009845675900578499
or O 0 0.011259319260716438
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999990463256836
DMS B-Disease 1 1.0
) O 0 0.012688111513853073
associated O 0 0.008472534827888012
with O 0 0.007667521480470896
pseudohermaphroditism B-Disease 1 0.9999998807907104
and O 0 0.3767577111721039
/ O 1 0.9999997615814209
or O 1 0.987851083278656
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9857397675514221
WT B-Disease 1 0.9999998807907104
) O 0 0.03902984783053398
. O 0 0.04326889291405678

Most O 0 0.02906774915754795
mutations O 0 0.024228887632489204
in O 0 0.0190870501101017
DDS B-Disease 1 1.0
patients O 1 0.9999550580978394
lie O 0 0.028918655589222908
in O 0 0.011272772215306759
exon O 0 0.07027323544025421
8 O 0 0.018323516473174095
or O 0 0.01079678162932396
exon O 0 0.029885679483413696
9 O 0 0.015461556613445282
, O 0 0.010061359964311123
encoding O 0 0.018520323559641838
zinc O 1 0.9998630285263062
finger O 1 0.5554577112197876
2 O 0 0.016035767272114754
or O 0 0.011497566476464272
zinc O 1 0.9999995231628418
finger O 1 0.9903292655944824
3 O 0 0.01225269678980112
, O 0 0.006913627032190561
respectively O 0 0.007602763827890158
, O 0 0.005768762435764074
with O 0 0.004520521964877844
a O 0 0.00792443472892046
hot O 1 0.8233529329299927
spot O 0 0.05683709681034088
( O 0 0.012510601431131363
R394W O 1 0.6550512313842773
) O 0 0.01300875935703516
in O 0 0.013881705701351166
exon O 0 0.06051233783364296
9 O 0 0.039174582809209824
. O 0 0.03165970370173454

We O 0 0.01670234650373459
analyzed O 0 0.01567384973168373
a O 0 0.007269188761711121
series O 0 0.008518271148204803
of O 0 0.006481768563389778
24 O 0 0.011994312517344952
patients O 0 0.1957016885280609
, O 0 0.0049297986552119255
10 O 0 0.006354034878313541
with O 0 0.0057442463003098965
isolated B-Disease 1 0.5228148698806763
DMS I-Disease 1 1.0
( O 1 0.9212364554405212
IDMS B-Disease 1 1.0
) O 0 0.009981836192309856
, O 0 0.007166383787989616
10 O 0 0.008441826328635216
with O 0 0.008134313859045506
DDS B-Disease 1 1.0
, O 0 0.008484167978167534
and O 0 0.007613488472998142
4 O 0 0.011671428568661213
with O 0 0.011145338416099548
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9990432858467102
/ O 1 0.9999995231628418
or O 0 0.3426826000213623
WT B-Disease 1 0.9999991655349731
. O 0 0.05686193332076073

We O 0 0.029229922220110893
report O 0 0.02373427525162697
WT1 O 1 0.989874005317688
heterozygous O 0 0.03229209780693054
mutations O 0 0.01461058109998703
in O 0 0.007976644672453403
16 O 0 0.015540816821157932
patients O 0 0.42982181906700134
, O 0 0.0073233675211668015
4 O 0 0.010257650166749954
of O 0 0.007374742534011602
whom O 0 0.01260909903794527
presented O 0 0.021761631593108177
with O 0 0.023182930424809456
IDMS B-Disease 1 0.9999998807907104
. O 0 0.04284064844250679

One O 0 0.025173597037792206
male O 0 0.019576167687773705
and O 0 0.009558148682117462
two O 0 0.008693481795489788
female O 0 0.05864487588405609
IDMS B-Disease 1 1.0
patients O 1 0.9999793767929077
with O 1 0.5250075459480286
WT1 O 1 1.0
mutations O 1 0.9975054860115051
underwent O 1 1.0
normal O 0 0.12447819858789444
puberty O 1 0.9926114678382874
. O 0 0.04107814282178879

Two O 0 0.021403886377811432
mutations O 0 0.01889723166823387
associated O 0 0.009889693930745125
with O 0 0.010960775427520275
IDMS B-Disease 1 0.9999998807907104
are O 0 0.003997826017439365
different O 0 0.00277215288951993
from O 0 0.0035960928071290255
those O 0 0.004276011139154434
described O 0 0.008885697461664677
in O 0 0.023686371743679047
DDS B-Disease 1 1.0
patients O 1 0.9999990463256836
. O 0 0.042250990867614746

No O 0 0.0439864806830883
WT1 O 1 0.9999830722808838
mutations O 0 0.02226440981030464
were O 0 0.008129129186272621
detected O 0 0.011198330670595169
in O 0 0.006535480730235577
the O 0 0.0067131598480045795
six O 0 0.008677671663463116
other O 0 0.009344702586531639
IDMS B-Disease 1 1.0
patients O 1 0.9998180270195007
, O 0 0.009772629477083683
suggesting O 0 0.011482595466077328
genetic O 0 0.010578121989965439
heterogeneity O 0 0.16122053563594818
of O 0 0.01346917636692524
this O 0 0.015757855027914047
disease O 1 0.9999996423721313
. O 0 0.0365479476749897

We O 0 0.0307313222438097
analyzed O 0 0.04666181281208992
genotype O 1 0.8313853144645691
/ O 1 0.9995688796043396
phenotype O 0 0.4793197512626648
correlations O 0 0.023987172171473503
, O 0 0.00916400644928217
on O 0 0.0061437529511749744
the O 0 0.0054977694526314735
basis O 0 0.004762666765600443
of O 0 0.00575589993968606
the O 0 0.006312647368758917
constitution O 0 0.010027528740465641
of O 0 0.00875956192612648
a O 0 0.015241469256579876
WT1 O 1 0.9997888207435608
mutation O 0 0.01593662053346634
database O 0 0.010196755640208721
of O 0 0.009220123291015625
84 O 1 0.7419908046722412
germ O 1 0.9999998807907104
- O 1 0.9999914169311523
line O 0 0.018422948196530342
mutations O 0 0.010006039403378963
, O 0 0.005382486619055271
to O 0 0.005157393403351307
compare O 0 0.007628328166902065
the O 0 0.0050143226981163025
distribution O 0 0.005555873271077871
and O 0 0.0051984842866659164
type O 0 0.008537635207176208
of O 0 0.0066905999556183815
mutations O 0 0.00795808620750904
, O 0 0.005197056569159031
according O 0 0.004180712625384331
to O 0 0.00552001129835844
the O 0 0.00869369599968195
different O 0 0.009670527651906013
symptoms O 1 0.9997236132621765
. O 0 0.02936042658984661

This O 0 0.017441093921661377
demonstrated O 0 0.023685887455940247
( O 0 0.012843883596360683
1 O 0 0.014889126643538475
) O 0 0.007373534142971039
the O 0 0.006723170168697834
association O 0 0.008545797318220139
between O 0 0.005615037400275469
mutations O 0 0.006984960753470659
in O 0 0.00479128398001194
exons O 0 0.013689350336790085
8 O 0 0.010016289539635181
and O 0 0.005697067826986313
9 O 0 0.011634019203484058
and O 0 0.009632287546992302
DMS B-Disease 1 0.9999998807907104
; O 0 0.010607677511870861
( O 0 0.008611450903117657
2 O 0 0.012086085975170135
) O 0 0.007198400795459747
among O 0 0.008158200420439243
patients O 0 0.4396461248397827
with O 0 0.00984192918986082
DMS B-Disease 1 1.0
, O 0 0.007295774295926094
a O 0 0.007315492257475853
higher O 0 0.0073302313685417175
frequency O 0 0.006753537338227034
of O 0 0.007130301557481289
exon O 0 0.028077298775315285
8 O 0 0.01512897852808237
mutations O 0 0.010592403821647167
among O 0 0.00810971762984991
46 O 0 0.018038123846054077
, O 0 0.014209828339517117
XY O 1 0.9999994039535522
patients O 1 0.9780492186546326
with O 0 0.008342806249856949
female O 0 0.016932470723986626
phenotype O 0 0.021250911056995392
than O 0 0.0063844905234873295
among O 0 0.007398852147161961
46 O 0 0.01587560959160328
, O 0 0.012339970096945763
XY O 1 0.9999992847442627
patients O 1 0.840535044670105
with O 0 0.006420593708753586
sexual O 0 0.009098952636122704
ambiguity O 0 0.017298564314842224
or O 0 0.008113594725728035
male O 0 0.1811472475528717
phenotype O 1 0.9855824708938599
; O 0 0.007758334279060364
and O 0 0.005659435875713825
( O 0 0.007370826788246632
3 O 0 0.009879856370389462
) O 0 0.006686608772724867
statistically O 0 0.006955632008612156
significant O 0 0.004490136168897152
evidence O 0 0.004460623487830162
that O 0 0.0036426554434001446
mutations O 0 0.005670813377946615
in O 0 0.004779316950589418
exons O 0 0.014388845302164555
8 O 0 0.0116883534938097
and O 0 0.007589640095829964
9 O 0 0.015084936283528805
preferentially O 0 0.021552879363298416
affect O 0 0.013631966896355152
amino O 0 0.011968482285737991
acids O 0 0.010974369011819363
with O 0 0.006122923921793699
different O 0 0.005460706539452076
functions O 0 0.010781687684357166
. O 0 0.012426826171576977
. O 0 0.02286374568939209

The O 0 0.047114040702581406
185delAG O 1 0.9998476505279541
BRCA1 O 1 0.9998809099197388
mutation O 0 0.026730623096227646
originated O 0 0.01819119043648243
before O 0 0.010358952917158604
the O 0 0.00853034108877182
dispersion O 0 0.016917800530791283
of O 0 0.007166316267102957
Jews O 0 0.00856799352914095
in O 0 0.005325671751052141
the O 0 0.0069438316859304905
diaspora O 0 0.014938452281057835
and O 0 0.006920583546161652
is O 0 0.006126972381025553
not O 0 0.0055611287243664265
limited O 0 0.011962885037064552
to O 0 0.016595568507909775
Ashkenazim O 0 0.11092220991849899
. O 0 0.03815971687436104

The O 0 0.0336124524474144
185delAG O 1 0.9256090521812439
mutation O 0 0.022936664521694183
in O 0 0.013707825914025307
BRCA1 O 1 0.9998183846473694
is O 0 0.00801219791173935
detected O 0 0.010111140087246895
in O 0 0.006681229919195175
Ashkenazi O 0 0.020329182967543602
Jews O 0 0.00809856690466404
both O 0 0.004473518580198288
in O 0 0.007155433297157288
familial B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.7835652232170105
in O 0 0.008087164722383022
the O 0 0.009791344404220581
general O 0 0.01779887266457081
population O 0 0.012564285658299923
. O 0 0.024722259491682053

All O 0 0.03007761761546135
tested O 0 0.047457918524742126
Ashkenazi O 0 0.4190642535686493
mutation O 0 0.027801020070910454
carriers O 0 0.023555612191557884
share O 0 0.012029307894408703
the O 0 0.009023468010127544
same O 0 0.008234391920268536
allelic O 0 0.04169853404164314
pattern O 0 0.01826685108244419
at O 0 0.015303428284823895
the O 0 0.01983468607068062
BRCA1 O 1 0.9998966455459595
locus O 1 0.9946911931037903
. O 0 0.03964043781161308

Our O 0 0.02802749164402485
previous O 0 0.0154363252222538
study O 0 0.011315557174384594
showed O 0 0.008181175217032433
that O 0 0.004078070167452097
this O 0 0.005393287632614374
Ashkenazi O 1 0.9415709376335144
mutation O 0 0.012396831065416336
also O 0 0.007341495715081692
occurs O 0 0.005440977402031422
in O 0 0.004492792766541243
Iraqi O 0 0.00818824302405119
Jews O 0 0.007096589542925358
with O 0 0.005084280390292406
a O 0 0.00936763547360897
similar O 0 0.013284864835441113
allelic O 1 0.9922481775283813
pattern O 0 0.03419177606701851
. O 0 0.0321321003139019

We O 0 0.01741139404475689
extended O 0 0.016120189800858498
our O 0 0.008926507085561752
analysis O 0 0.006594008766114712
to O 0 0.004914477933198214
other O 0 0.005860396660864353
non O 0 0.015345833264291286
- O 1 0.9972034692764282
Ashkenazi O 0 0.05388413369655609
subsets O 0 0.033351730555295944
354 O 0 0.040150195360183716
of O 0 0.013047651387751102
Moroccan O 0 0.030916830524802208
origin O 0 0.010000182315707207
, O 0 0.010312712751328945
200 O 0 0.021621165797114372
Yemenites O 0 0.3550155460834503
and O 0 0.012298856861889362
150 O 0 0.02130024880170822
Iranian O 0 0.025697946548461914
Jews O 0 0.029518257826566696
. O 0 0.02725774608552456

Heteroduplex O 1 0.6593453884124756
analysis O 0 0.024511579424142838
complemented O 0 0.030881578102707863
by O 0 0.008697083219885826
direct O 0 0.011099552735686302
DNA O 0 0.013436046428978443
sequencing O 0 0.017335955053567886
of O 0 0.011763344518840313
abnormally O 0 0.22424182295799255
migrating O 0 0.023115552961826324
bands O 0 0.02274719625711441
were O 0 0.01274188794195652
employed O 0 0.03259235993027687
. O 0 0.029024014249444008

Four O 0 0.01844894513487816
of O 0 0.011896779760718346
Moroccan O 0 0.02307807467877865
origin O 0 0.00803418643772602
( O 0 0.0077829002402722836
1 O 0 0.010512326844036579
. O 0 0.006306282710283995
1 O 0 0.010051723569631577
% O 0 0.006781682372093201
) O 0 0.005393809638917446
and O 0 0.004321638029068708
none O 0 0.005796412471681833
of O 0 0.006037701852619648
the O 0 0.010034419596195221
Yemenites O 1 0.9999271631240845
or O 0 0.008239572867751122
Iranians O 0 0.01463830191642046
was O 0 0.011869036592543125
a O 0 0.011096830479800701
carrier O 0 0.033874716609716415
of O 0 0.012402273714542389
the O 0 0.018348660320043564
185delAG O 1 0.999757707118988
mutation O 0 0.046611227095127106
. O 0 0.032079361379146576

BRCA1 O 1 0.9998144507408142
allelic O 0 0.46827033162117004
patterns O 0 0.01659802719950676
were O 0 0.006471474654972553
determined O 0 0.0072918240912258625
for O 0 0.0043404195457696915
four O 0 0.004672096110880375
of O 0 0.004026719368994236
these O 0 0.0026588127948343754
individuals O 0 0.00249708304181695
and O 0 0.0030006631277501583
for O 0 0.003909253049641848
12 O 0 0.007408846169710159
additional O 0 0.009137151762843132
non O 0 0.018392866477370262
- O 1 0.991104006767273
Ashkenazi O 0 0.32282713055610657
185delAG O 0 0.3694242238998413
mutation O 0 0.01914866641163826
carriers O 0 0.018838509917259216
who O 0 0.011757408268749714
had O 1 0.9440314769744873
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7672387361526489

Six O 0 0.03679032623767853
non O 0 0.04014598950743675
- O 1 0.9989092350006104
Ashkenazi O 0 0.038877371698617935
individuals O 0 0.007842546328902245
shared O 0 0.010006293654441833
the O 0 0.007773170247673988
common O 0 0.009981025941669941
Ashkenazi O 1 0.9999357461929321
haplotype O 1 0.9605866074562073
, O 0 0.006891742814332247
four O 0 0.005596985574811697
had O 0 0.005703845992684364
a O 0 0.005366280674934387
closely O 0 0.005645226687192917
related O 0 0.00591990677639842
pattern O 0 0.0059584048576653
, O 0 0.004137483891099691
and O 0 0.004255144391208887
the O 0 0.005416652653366327
rest O 0 0.009262551553547382
( O 0 0.008480718359351158
n O 0 0.018051810562610626
= O 0 0.021396666765213013
6 O 0 0.016593055799603462
) O 0 0.00965331681072712
displayed O 0 0.015072260051965714
a O 0 0.012861690483987331
distinct O 0 0.020229356363415718
BRCA1 O 1 0.9999052286148071
allelic O 1 0.9994685053825378
pattern O 0 0.07658608257770538
. O 0 0.03535649925470352

We O 0 0.0220277551561594
conclude O 0 0.02195187844336033
that O 0 0.008174530230462551
the O 0 0.015885066241025925
185delAG O 1 0.9999443292617798
BRCA1 O 1 0.9999921321868896
mutation O 0 0.017456015571951866
occurs O 0 0.007703946437686682
in O 0 0.004696622025221586
some O 0 0.004564278293401003
non O 0 0.03566029667854309
- O 1 0.9999645948410034
Ashkenazi O 0 0.21689699590206146
populations O 0 0.007430155295878649
at O 0 0.007965540513396263
rates O 0 0.007963682524859905
comparable O 0 0.011064853519201279
with O 0 0.006003402639180422
that O 0 0.0065543618984520435
of O 0 0.014483739621937275
Ashkenazim O 1 0.965735673904419
. O 0 0.03299269825220108

The O 0 0.023271743208169937
majority O 0 0.015222659334540367
of O 0 0.011448103934526443
Jewish O 0 0.01957891508936882
185delAG O 1 0.999910831451416
mutation O 0 0.02069578692317009
carriers O 0 0.01865391433238983
have O 0 0.005204731598496437
a O 0 0.00883923377841711
common O 0 0.009776699356734753
allelic O 1 0.9329098463058472
pattern O 0 0.0156487375497818
, O 0 0.008015541359782219
supporting O 0 0.010094469413161278
the O 0 0.007981293834745884
founder O 1 0.9571759700775146
effect O 0 0.009245360270142555
notion O 0 0.010058843530714512
, O 0 0.0056435782462358475
but O 0 0.0045124562457203865
dating O 0 0.0069101303815841675
the O 0 0.004924318753182888
mutations O 0 0.0054085105657577515
origin O 0 0.002911723917350173
to O 0 0.003761806059628725
an O 0 0.004355916753411293
earlier O 0 0.006673348601907492
date O 0 0.00836496613919735
than O 0 0.005997281987220049
currently O 0 0.012870004400610924
estimated O 0 0.019141389057040215
. O 0 0.02532520331442356

However O 0 0.0214203093200922
, O 0 0.010312377475202084
the O 0 0.008192665874958038
different O 0 0.00500949053093791
allelic O 0 0.025715157389640808
pattern O 0 0.011627324856817722
at O 0 0.009443268179893494
the O 0 0.010868806391954422
BRCA1 O 1 0.9999868869781494
locus O 1 0.7933493852615356
even O 0 0.0069742691703140736
in O 0 0.005188348703086376
some O 0 0.004272238817065954
Jewish O 0 0.011392494663596153
mutation O 0 0.01317646261304617
carriers O 0 0.024626929312944412
, O 0 0.0070030223578214645
might O 0 0.007020107004791498
suggest O 0 0.006067472510039806
that O 0 0.0040418533608317375
the O 0 0.008015178143978119
mutation O 0 0.012862209230661392
arose O 0 0.0148147689178586
independently O 0 0.012644032016396523
. O 0 0.014245943166315556
. O 0 0.021463928744196892

Crystal O 0 0.06768280267715454
structure O 0 0.026923896744847298
of O 0 0.016188381239771843
the O 0 0.023934893310070038
hemochromatosis B-Disease 1 1.0
protein O 1 0.9908860921859741
HFE O 1 0.9999998807907104
and O 0 0.013338018208742142
characterization O 0 0.018823396414518356
of O 0 0.009864293038845062
its O 0 0.010863471776247025
interaction O 0 0.01646207459270954
with O 0 0.01623501628637314
transferrin O 1 0.9999467134475708
receptor O 0 0.0731062963604927
. O 0 0.04259861260652542

HFE O 1 0.9994868040084839
is O 0 0.017868729308247566
an O 0 0.016995279118418694
MHC O 1 0.9999997615814209
- O 1 0.9999958276748657
related O 0 0.014110447838902473
protein O 0 0.009723850525915623
that O 0 0.004490694496780634
is O 0 0.005259769503027201
mutated O 0 0.0125792371109128
in O 0 0.005155615508556366
the O 0 0.01056571677327156
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999703168869019

HFE O 1 0.9997851252555847
binds O 0 0.07363827526569366
to O 0 0.02681410126388073
transferrin O 1 0.9993690848350525
receptor O 0 0.25585395097732544
( O 0 0.028009675443172455
TfR O 1 0.9999105930328369
) O 0 0.014070517383515835
and O 0 0.009815414436161518
reduces O 0 0.01619785465300083
its O 0 0.009680163115262985
affinity O 0 0.016603924334049225
for O 0 0.011316762305796146
iron O 1 0.9999902248382568
- O 1 0.9999226331710815
loaded O 0 0.0528094545006752
transferrin O 1 0.944774866104126
, O 0 0.026899730786681175
implicating O 1 0.9932833909988403
HFE O 1 0.9999998807907104
in O 0 0.22007228434085846
iron O 1 0.9999998807907104
metabolism O 1 0.9967879056930542
. O 0 0.03570066764950752

The O 0 0.05232365429401398
2 O 0 0.05627170577645302
. O 0 0.044027335941791534

6 O 0 0.04784499853849411
A O 0 0.03345197066664696
crystal O 0 0.0478091686964035
structure O 0 0.02252991870045662
of O 0 0.01709038019180298
HFE O 1 0.9999866485595703
reveals O 0 0.025392714887857437
the O 0 0.008723198436200619
locations O 0 0.009473132900893688
of O 0 0.011616288684308529
hemochromatosis B-Disease 1 1.0
mutations O 0 0.03272990882396698
and O 0 0.007625538855791092
a O 0 0.015516726300120354
patch O 1 0.9999988079071045
of O 0 0.016679182648658752
histidines O 1 0.9996907711029053
that O 0 0.004859928507357836
could O 0 0.004283311776816845
be O 0 0.003176169702783227
involved O 0 0.0051599848084151745
in O 0 0.008304539136588573
pH O 1 0.9999949932098389
- O 1 0.9999910593032837
dependent O 0 0.026805119588971138
interactions O 0 0.02165100909769535
. O 0 0.02330346778035164

We O 0 0.02070719376206398
also O 0 0.013841800391674042
demonstrate O 0 0.01785348728299141
that O 0 0.01257387362420559
soluble O 1 0.9964491128921509
TfR O 1 0.9999585151672363
and O 0 0.023099442943930626
HFE O 1 0.9999984502792358
bind O 0 0.03049824759364128
tightly O 0 0.023521224036812782
at O 0 0.008862990885972977
the O 0 0.006142640486359596
basic O 0 0.01054023951292038
pH O 0 0.04256225377321243
of O 0 0.006122145336121321
the O 0 0.008237640373408794
cell O 0 0.0445299968123436
surface O 0 0.00941589754074812
, O 0 0.0053681847639381886
but O 0 0.0038895902689546347
not O 0 0.004018823616206646
at O 0 0.00855171773582697
the O 0 0.01098140049725771
acidic O 1 0.9923627376556396
pH O 1 0.9935817718505859
of O 0 0.03148869052529335
intracellular O 1 0.9988701939582825
vesicles O 1 0.9939630627632141
. O 0 0.04885402321815491

TfR O 1 0.9998736381530762
HFE O 1 0.9999816417694092
stoichiometry O 0 0.3565932512283325
( O 0 0.02154368907213211
2 O 0 0.024340389296412468
1 O 0 0.019119644537568092
) O 0 0.010955825448036194
differs O 0 0.013723358511924744
from O 0 0.013152321800589561
TfR O 1 0.9982580542564392
transferrin O 1 0.9975305199623108
stoichiometry O 0 0.0944959744811058
( O 0 0.01859663426876068
2 O 0 0.021743711084127426
2 O 0 0.01810377836227417
) O 0 0.008556821383535862
, O 0 0.007754913065582514
implying O 0 0.013586072251200676
a O 0 0.006764564663171768
different O 0 0.003836780320852995
mode O 0 0.010418347083032131
of O 0 0.006933534052222967
binding O 0 0.010290203616023064
for O 0 0.010972934775054455
HFE O 1 0.9999983310699463
and O 0 0.014761103317141533
transferrin O 1 0.9974220991134644
to O 0 0.016081100329756737
TfR O 1 0.9996359348297119
, O 0 0.010970219038426876
consistent O 0 0.010084673762321472
with O 0 0.0060760765336453915
our O 0 0.00877890083938837
demonstration O 0 0.01733384281396866
that O 0 0.009512096643447876
HFE O 1 0.9999891519546509
, O 0 0.01996743306517601
transferrin O 1 0.9996720552444458
, O 0 0.0159860048443079
and O 0 0.014920590445399284
TfR O 1 0.9996482133865356
form O 0 0.018206415697932243
a O 0 0.022417904809117317
ternary O 0 0.1458570510149002
complex O 0 0.05375516787171364
. O 0 0.043404094874858856

Identification O 0 0.03207341209053993
of O 0 0.014045351184904575
three O 0 0.00977951567620039
novel O 0 0.017368890345096588
mutations O 0 0.009893201291561127
and O 0 0.0051417057402431965
a O 0 0.006649157498031855
high O 0 0.0076890443451702595
frequency O 0 0.006848189514130354
of O 0 0.0057676248252391815
the O 0 0.00889408215880394
Arg778Leu O 1 0.9952751398086548
mutation O 0 0.010584361851215363
in O 0 0.00765672093257308
Korean O 1 0.9976813793182373
patients O 1 0.999312162399292
with O 0 0.02119212970137596
Wilson B-Disease 1 0.9999878406524658
disease I-Disease 1 0.9999997615814209
. O 0 0.03371076658368111

Four O 0 0.03198673948645592
mutations O 0 0.03276168182492256
- O 1 0.9999473094940186
- O 1 0.9999589920043945
R778L O 1 0.9965389966964722
, O 0 0.014986573718488216
A874V O 1 0.7410854697227478
, O 0 0.011150257661938667
L1083F O 0 0.21437302231788635
, O 0 0.008733012713491917
and O 0 0.008471482433378696
2304delC O 1 0.9999260902404785
- O 1 0.9999579191207886
- O 1 0.568124532699585
in O 0 0.0076322429813444614
the O 0 0.010714763775467873
copper O 1 0.8965249061584473
- O 1 0.8690015077590942
transporting O 0 0.024575043469667435
enzyme O 0 0.016498995944857597
, O 0 0.012208551168441772
P O 1 0.9947569370269775
- O 1 0.9999711513519287
type O 1 0.8740297555923462
ATPase O 1 0.9999561309814453
( O 0 0.019392104819417
ATP7B O 1 0.9999591112136841
) O 0 0.010179406963288784
, O 0 0.006245276890695095
were O 0 0.0038943064864724874
identified O 0 0.00654953857883811
in O 0 0.0060332114808261395
Korean O 1 0.982181191444397
Patients O 1 0.9994832277297974
with O 0 0.04146164655685425
Wilson B-Disease 1 0.9999990463256836
disease I-Disease 1 1.0
. O 0 0.04617302119731903

Arg778Leu O 1 0.9850867986679077
, O 0 0.015775561332702637
the O 0 0.009895148687064648
most O 0 0.0066562858410179615
frequently O 0 0.006244303658604622
reported O 0 0.008065100759267807
mutation O 0 0.007556793745607138
of O 0 0.004782290663570166
this O 0 0.005040248855948448
enzyme O 0 0.00865061953663826
, O 0 0.0054462081752717495
was O 0 0.007333823014050722
found O 0 0.0038099451921880245
in O 0 0.0032521963585168123
six O 0 0.0049021197482943535
of O 0 0.005722998175770044
eight O 0 0.010014554485678673
unrelated O 0 0.016887729987502098
patients O 1 0.8891232013702393
studied O 0 0.012015839107334614
, O 0 0.007987857796251774
an O 0 0.007725432515144348
allele O 0 0.022151339799165726
frequency O 0 0.012075820006430149
of O 0 0.014834248460829258
37 O 0 0.04058780148625374
. O 0 0.031054997816681862

5 O 0 0.031509190797805786
% O 0 0.017054976895451546
, O 0 0.008910298347473145
which O 0 0.005709344055503607
is O 0 0.005304541438817978
considerably O 0 0.008614037185907364
higher O 0 0.0058295466005802155
than O 0 0.003701593028381467
those O 0 0.0030516176484525204
in O 0 0.004857578780502081
other O 0 0.006311612669378519
Asian O 0 0.02200949750840664
populations O 0 0.014459195546805859
. O 0 0.024978306144475937

The O 0 0.03636038303375244
novel O 0 0.04125146567821503
single O 0 0.022843675687909126
nucleotide O 0 0.030162764713168144
deletion O 0 0.0326884463429451
, O 0 0.01614340953528881
2304delC O 1 0.9805750846862793
, O 0 0.010332725942134857
was O 0 0.011283955536782742
found O 0 0.007083048578351736
in O 0 0.008062715642154217
one O 0 0.012166948989033699
patient O 1 0.9696778059005737
. O 0 0.029535379260778427

Since O 0 0.028163166716694832
a O 0 0.019992735236883163
mutation O 0 0.01983465999364853
at O 0 0.017732389271259308
cDNA O 0 0.04295053333044052
nucleotide O 0 0.03809674084186554
2302 O 1 0.9999372959136963
( O 0 0.018449364230036736
2302insC O 1 0.9340959191322327
) O 0 0.008553181774914265
had O 0 0.00700330501422286
been O 0 0.005440410226583481
previously O 0 0.008158925920724869
described O 0 0.0077402787283062935
, O 0 0.004568927921354771
this O 0 0.00308598717674613
region O 0 0.005251806695014238
of O 0 0.004572262056171894
the O 0 0.007781824562698603
ATP7B O 1 0.9999998807907104
gene O 0 0.011402853764593601
may O 0 0.0060096788220107555
be O 0 0.004848817829042673
susceptible O 0 0.01307407021522522
to O 0 0.008675648830831051
gene O 0 0.0170656219124794
rearrangements O 1 0.9912418127059937
causing O 1 0.9996634721755981
Wilson B-Disease 1 0.9999960660934448
disease I-Disease 1 1.0
. O 0 0.041309040039777756

Disruption O 0 0.07419484853744507
of O 0 0.025892464444041252
splicing O 0 0.03569537773728371
regulated O 0 0.01947088912129402
by O 0 0.008299113251268864
a O 0 0.015623586252331734
CUG O 1 0.9999967813491821
- O 1 0.9999061822891235
binding O 0 0.023964934051036835
protein O 0 0.02602526545524597
in O 0 0.02785920724272728
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.33551573753356934

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.04850834608078003
is O 0 0.010379631072282791
caused O 0 0.011197923682630062
by O 0 0.006597432773560286
a O 0 0.012073202058672905
CTG O 1 0.999880313873291
expansion O 0 0.017887121066451073
in O 0 0.007416340988129377
the O 0 0.00887280609458685
3 O 0 0.014855126850306988
untranslated O 0 0.043025244027376175
region O 0 0.015015254728496075
of O 0 0.011480030603706837
the O 0 0.03931828588247299
DM B-Disease 1 1.0
gene O 0 0.05661936104297638
. O 0 0.03837252035737038

One O 0 0.02596287801861763
model O 0 0.0324203260242939
of O 0 0.03220634534955025
DM B-Disease 1 1.0
pathogenesis O 1 1.0
suggests O 0 0.02507796324789524
that O 0 0.009636973962187767
RNAs O 0 0.028673311695456505
from O 0 0.007020303048193455
the O 0 0.007824198342859745
expanded O 0 0.016334833577275276
allele O 0 0.01580454595386982
create O 0 0.008413398638367653
a O 0 0.007963734678924084
gain O 0 0.011507606133818626
- O 1 0.8877681493759155
of O 0 0.010718868114054203
- O 1 0.9996073842048645
function O 0 0.008459965698421001
mutation O 0 0.008272559382021427
by O 0 0.004339892417192459
the O 0 0.006453902926295996
inappropriate O 0 0.011416997760534286
binding O 0 0.009193885140120983
of O 0 0.0070978193543851376
proteins O 0 0.007439762353897095
to O 0 0.007577040698379278
the O 0 0.015179716050624847
CUG O 1 0.9999606609344482
repeats O 0 0.05807342752814293
. O 0 0.03664945065975189

Data O 0 0.026119763031601906
presented O 0 0.023809967562556267
here O 0 0.013257596641778946
indicate O 0 0.011061768978834152
that O 0 0.0054030525498092175
the O 0 0.008940075524151325
conserved O 0 0.018084753304719925
heterogeneous O 0 0.027157563716173172
nuclear O 0 0.025762658566236496
ribonucleoprotein O 1 0.9995637536048889
, O 0 0.019638793542981148
CUG O 1 0.9999762773513794
- O 1 0.965251088142395
binding O 0 0.015890583395957947
protein O 0 0.015383850783109665
( O 0 0.014031819067895412
CUG O 1 0.9999920129776001
- O 1 0.999972939491272
BP O 1 0.9404586553573608
) O 0 0.010211667977273464
, O 0 0.007430725265294313
may O 0 0.006300801876932383
mediate O 0 0.016904521733522415
the O 0 0.011863072402775288
trans O 1 0.9832994341850281
- O 1 0.9996761083602905
dominant O 0 0.022961409762501717
effect O 0 0.011286099441349506
of O 0 0.01071386318653822
the O 0 0.015702154487371445
RNA O 0 0.04366062581539154
. O 0 0.027401385828852654

CUG O 1 0.9999986886978149
- O 1 0.999943733215332
BP O 1 0.6063055396080017
was O 0 0.019257575273513794
found O 0 0.008576762862503529
to O 0 0.006562097929418087
bind O 0 0.010769260115921497
to O 0 0.005235231947153807
the O 0 0.0068627018481493
human O 0 0.013934439979493618
cardiac O 1 1.0
troponin O 1 1.0
T O 1 1.0
( O 0 0.022428754717111588
cTNT O 1 0.9791586399078369
) O 0 0.01462548691779375
pre O 0 0.2860473692417145
- O 1 0.995516836643219
messenger O 0 0.053369373083114624
RNA O 0 0.030846381559967995
and O 0 0.013709037564694881
regulate O 0 0.02043796516954899
its O 0 0.015561440028250217
alternative O 0 0.035100407898426056
splicing O 0 0.06220574304461479
. O 0 0.03966647386550903

Splicing O 0 0.060069065541028976
of O 0 0.02226901799440384
cTNT O 1 0.6181361675262451
was O 0 0.019899439066648483
disrupted O 0 0.032584868371486664
in O 0 0.053069405257701874
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999984502792358
and O 0 0.012663250789046288
in O 0 0.00890215765684843
normal O 0 0.012050723657011986
cells O 0 0.012182020582258701
expressing O 0 0.015448401682078838
transcripts O 0 0.016430703923106194
that O 0 0.009635668247938156
contain O 0 0.022187311202287674
CUG O 1 0.9995936751365662
repeats O 0 0.060986731201410294
. O 0 0.0415860079228878

Altered O 0 0.04569542035460472
expression O 0 0.020300136879086494
of O 0 0.012878566049039364
genes O 0 0.012581500224769115
regulated O 0 0.01639624312520027
posttranscriptionally O 0 0.353161096572876
by O 0 0.013933392241597176
CUG O 1 0.9999998807907104
- O 1 0.9999945163726807
BP O 1 0.7362945675849915
therefore O 0 0.01156396884471178
may O 0 0.009242940694093704
contribute O 0 0.01657399907708168
to O 0 0.02187448740005493
DM B-Disease 1 1.0
pathogenesis O 1 1.0
. O 0 0.03560938313603401
. O 0 0.039351120591163635

Identification O 0 0.036959972232580185
of O 0 0.014660540968179703
a O 0 0.016475481912493706
novel O 0 0.026789437979459763
nonsense O 0 0.16558371484279633
mutation O 0 0.014511829242110252
and O 0 0.008025101386010647
a O 0 0.010434002615511417
missense O 0 0.021282166242599487
substitution O 0 0.014120733365416527
in O 0 0.006848462857306004
the O 0 0.009166785515844822
vasopressin O 1 0.96219801902771
- O 1 0.999994158744812
neurophysin O 1 0.9999862909317017
II O 1 0.9999969005584717
gene O 0 0.011734985746443272
in O 0 0.00623833853751421
two O 0 0.005558057222515345
Spanish O 0 0.017323926091194153
kindreds O 0 0.04636361077427864
with O 0 0.018643436953425407
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 1 0.9375390410423279

Familial B-Disease 1 0.9999997615814209
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.999977707862854
FNDI B-Disease 1 1.0
) O 0 0.010270360857248306
is O 0 0.006391860079020262
an O 0 0.007479214109480381
autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9991100430488586
deficiency O 1 1.0
in O 1 0.7572662234306335
the O 1 0.9660999178886414
antidiuretic O 1 1.0
hormone O 1 0.9999735355377197
arginine O 1 0.9715914726257324
vasopressin O 1 0.9960777163505554
( O 0 0.028622252866625786
AVP O 1 0.9999649524688721
) O 0 0.011389738880097866
encoded O 0 0.008493366651237011
by O 0 0.005393978673964739
the O 0 0.010230055078864098
AVP O 1 0.9999988079071045
- O 1 0.999985933303833
neurophysin O 1 0.9999761581420898
II O 1 0.9999998807907104
( O 0 0.03186890110373497
AVP O 1 0.9999998807907104
- O 1 0.9999995231628418
NPII O 1 0.9999973773956299
) O 0 0.017459621652960777
gene O 0 0.015681399032473564
on O 0 0.015204234980046749
chromosome O 0 0.03382259979844093
20p13 O 1 0.9115378856658936
. O 0 0.03401447460055351

In O 0 0.018568092957139015
this O 0 0.009966373443603516
study O 0 0.009694293141365051
, O 0 0.006549410987645388
we O 0 0.004488356877118349
analyzed O 0 0.007348646875470877
two O 0 0.004403249826282263
families O 0 0.0059997327625751495
with O 0 0.006487657316029072
FNDI B-Disease 1 0.9999645948410034
using O 0 0.007368551567196846
direct O 0 0.008086425252258778
automated O 0 0.019048236310482025
fluorescent O 0 0.034041956067085266
, O 0 0.008923900313675404
solid O 0 0.01633763127028942
phase O 0 0.01981784962117672
, O 0 0.00884590856730938
single O 0 0.013556892983615398
- O 0 0.06114842742681503
stranded O 0 0.021774182096123695
DNA O 0 0.013492461293935776
sequencing O 0 0.01612277887761593
of O 0 0.013580002821981907
PCR O 0 0.056869324296712875
- O 1 0.9945833086967468
amplified O 1 0.519615888595581
AVP O 1 0.9999983310699463
- O 1 0.9999377727508545
NPII O 1 0.9996325969696045
DNA O 0 0.05481792241334915
. O 0 0.039808474481105804

In O 0 0.015852337703108788
one O 0 0.007671303115785122
of O 0 0.006652084644883871
the O 0 0.005684645380824804
families O 0 0.007559140212833881
, O 0 0.006568454205989838
affected O 0 0.00717055844143033
individuals O 0 0.004153965041041374
presented O 0 0.010650807060301304
a O 0 0.009873727336525917
novel O 0 0.017110545188188553
nonsense O 0 0.023007726296782494
mutation O 0 0.012233580462634563
in O 0 0.007664340082556009
exon O 0 0.024052603170275688
3 O 0 0.009398167952895164
of O 0 0.005897310096770525
the O 0 0.006910621654242277
gene O 0 0.007404148578643799
, O 0 0.005642234813421965
consisting O 0 0.007543801795691252
in O 0 0.0051492382772266865
a O 0 0.010694312863051891
G O 0 0.3208361566066742
to O 0 0.010210731066763401
T O 1 0.9229253530502319
transition O 0 0.020221741870045662
at O 0 0.015663515776395798
nucleotide O 0 0.023945970460772514
2101 O 1 0.9944736361503601
, O 0 0.010422330349683762
which O 0 0.006721836514770985
produces O 0 0.01015179231762886
a O 0 0.007332254201173782
stop O 0 0.009214600548148155
signal O 0 0.01122557558119297
in O 0 0.008503693155944347
codon O 0 0.02791745774447918
82 O 0 0.05242965742945671
( O 0 0.027141286060214043
Glu O 1 0.9999991655349731
) O 0 0.023716839030385017
of O 0 0.030085505917668343
NPII O 1 0.9996028542518616
. O 0 0.05800125375390053

The O 0 0.04451671987771988
premature O 0 0.30278539657592773
termination O 0 0.23319223523139954
eliminates O 0 0.053895529359579086
part O 0 0.01304554007947445
of O 0 0.009625311940908432
the O 0 0.013168292120099068
C O 1 0.9999209642410278
- O 1 0.9995253086090088
terminal O 0 0.030494242906570435
domain O 0 0.015584488399326801
of O 0 0.012054443359375
NPII O 1 0.9992595314979553
, O 0 0.00826580636203289
including O 0 0.0062576946802437305
a O 0 0.009276077151298523
cysteine O 0 0.015037747099995613
residue O 0 0.012310897931456566
in O 0 0.005922568030655384
position O 0 0.010709277354180813
85 O 0 0.017255064100027084
, O 0 0.005947899539023638
which O 0 0.003823738545179367
could O 0 0.003994582686573267
be O 0 0.003233524737879634
involved O 0 0.004296225029975176
in O 0 0.0051840683445334435
the O 0 0.007952426560223103
correct O 0 0.016905955970287323
folding O 1 0.9106003642082214
of O 0 0.015893908217549324
the O 0 0.02715228497982025
prohormone O 1 0.9999966621398926
. O 0 0.04668956622481346

In O 0 0.01939692720770836
the O 0 0.014910166151821613
second O 0 0.017473924905061722
family O 0 0.014141062274575233
, O 0 0.008218437433242798
a O 0 0.009883060120046139
G279A O 0 0.1336987018585205
substitution O 0 0.015026070177555084
at O 0 0.009332103654742241
position O 0 0.012332475744187832
- O 0 0.1309557557106018
1 O 0 0.010486888699233532
of O 0 0.006039024330675602
the O 0 0.007610978092998266
signal O 0 0.015449708327651024
peptide O 0 0.019886918365955353
was O 0 0.010594663210213184
observed O 0 0.007403756957501173
in O 0 0.006812156178057194
all O 0 0.007602792698889971
affected O 0 0.013999169692397118
individuals O 0 0.012098652310669422
. O 0 0.025662550702691078

This O 0 0.0239045899361372
missense O 0 0.049353428184986115
mutation O 0 0.022748466581106186
, O 0 0.011692139320075512
which O 0 0.009965111501514912
replaces O 1 0.9998942613601685
Ala O 1 1.0
with O 0 0.021130893379449844
Thr O 1 0.9999998807907104
, O 0 0.011190528981387615
is O 0 0.007290326524525881
frequent O 0 0.01193916890770197
among O 0 0.0167695302516222
FNDI B-Disease 1 1.0
patients O 1 0.9999992847442627
and O 0 0.008728176355361938
is O 0 0.005452198442071676
thought O 0 0.0062373001128435135
to O 0 0.00456508481875062
reduce O 0 0.00767588522285223
the O 0 0.006920924410223961
efficiency O 0 0.014954114332795143
of O 0 0.01009810995310545
cleavage O 0 0.19467604160308838
by O 0 0.01127179991453886
signal O 0 0.02905769646167755
peptidases O 1 0.5210710763931274
. O 0 0.022621525451540947
. O 0 0.031091252341866493

Genetic O 0 0.0370970256626606
heterogeneity O 0 0.04208972677588463
of O 0 0.021919112652540207
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.016507679596543312
due O 0 0.011307761073112488
to O 0 0.012301973067224026
TWIST O 1 0.9860608577728271
and O 0 0.024563832208514214
FGFR O 1 0.9999982118606567
mutations O 0 0.04397142305970192
. O 0 0.0379331149160862

Thirty O 0 0.0696181058883667
- O 1 0.5373963117599487
two O 0 0.012731826864182949
unrelated O 0 0.017177633941173553
patients O 0 0.013232960365712643
with O 0 0.005978062748908997
features O 0 0.008804223500192165
of O 0 0.009563960134983063
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.009835129603743553
a O 0 0.00938507728278637
common O 0 0.008850449696183205
autosomal B-Disease 1 0.9992325305938721
dominant I-Disease 1 0.997718870639801
condition I-Disease 1 0.9971924424171448
of O 1 0.9983459711074829
craniosynostosis B-Disease 1 1.0
and O 1 0.9999995231628418
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999995231628418
, O 0 0.01042410172522068
were O 0 0.005275745410472155
screened O 0 0.012573244981467724
for O 0 0.006747571751475334
mutations O 0 0.008412730880081654
in O 0 0.006868801079690456
TWIST O 1 0.9154658913612366
, O 0 0.01282611582428217
FGFR2 O 1 0.9999990463256836
, O 0 0.015372385270893574
and O 0 0.016304511576890945
FGFR3 O 1 0.9999825954437256
. O 0 0.037028443068265915

Nine O 0 0.038078680634498596
novel O 0 0.024755189195275307
and O 0 0.011846330948174
three O 0 0.01168789528310299
recurrent O 1 0.9999955892562866
TWIST O 1 0.9997574687004089
mutations O 0 0.0158477034419775
were O 0 0.005843848921358585
found O 0 0.006015119608491659
in O 0 0.0071027847006917
12 O 0 0.01521299872547388
families O 0 0.01731550507247448
. O 0 0.024684492498636246

Seven O 0 0.029424481093883514
families O 0 0.014963269233703613
were O 0 0.006410544738173485
found O 0 0.0042739431373775005
to O 0 0.004224215634167194
have O 0 0.0036030567716807127
the O 0 0.007924172095954418
FGFR3 O 1 0.9999986886978149
P250R O 1 0.9999699592590332
mutation O 0 0.014048018492758274
, O 0 0.006253535393625498
and O 0 0.0047008139081299305
one O 0 0.004798611160367727
individual O 0 0.0045915269292891026
was O 0 0.006314834579825401
found O 0 0.003890459192916751
to O 0 0.0033141765743494034
have O 0 0.0038145119324326515
an O 0 0.009613505564630032
FGFR2 O 1 0.9999874830245972
VV269 O 1 0.9998986721038818
- O 1 0.9996997117996216
270 O 0 0.08242534101009369
deletion O 0 0.07997924834489822
. O 0 0.04387558996677399

To O 0 0.018505528569221497
date O 0 0.013384892605245113
, O 0 0.008297787979245186
our O 0 0.008351512253284454
detection O 0 0.012867889367043972
rate O 0 0.006621857173740864
for O 0 0.005622637923806906
TWIST O 1 0.6847055554389954
or O 0 0.009577340446412563
FGFR O 1 0.9999912977218628
mutations O 0 0.009140567854046822
is O 0 0.006005884148180485
68 O 0 0.015740612521767616
% O 0 0.005695943720638752
in O 0 0.005218754056841135
our O 0 0.010027353651821613
Saethre B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999994039535522
, O 0 0.008240466006100178
including O 0 0.005590291228145361
our O 0 0.006843142211437225
five O 0 0.007984387688338757
patients O 1 0.9137718081474304
elsewhere O 0 0.008274066261947155
reported O 0 0.00852269772440195
with O 0 0.010021714493632317
TWIST O 1 0.9948824644088745
mutations O 0 0.027165254577994347
. O 0 0.025931542739272118

More O 0 0.014222659170627594
than O 0 0.00983179546892643
35 O 0 0.014640584588050842
different O 0 0.005633159540593624
TWIST O 0 0.03311986103653908
mutations O 0 0.009920462965965271
are O 0 0.004175025969743729
now O 0 0.007099614012986422
known O 0 0.007040879223495722
in O 0 0.006884047761559486
the O 0 0.011748619377613068
literature O 0 0.022553611546754837
. O 0 0.03024144470691681

The O 0 0.023731714114546776
most O 0 0.011233220808207989
common O 0 0.010851891711354256
phenotypic O 0 0.019530590623617172
features O 0 0.011278637684881687
, O 0 0.005123315844684839
present O 0 0.004176040180027485
in O 0 0.0031285732984542847
more O 0 0.0026883576065301895
than O 0 0.0027411438059061766
a O 0 0.004054626915603876
third O 0 0.0073979985900223255
of O 0 0.004845177289098501
our O 0 0.008143574930727482
patients O 1 0.6542595028877258
with O 0 0.007739924360066652
TWIST O 1 0.998499870300293
mutations O 0 0.013364387676119804
, O 0 0.008684610016644001
are O 0 0.0063286819495260715
coronal B-Disease 0 0.12167222052812576
synostosis I-Disease 1 0.9158762693405151
, O 0 0.014469853602349758
brachycephaly B-Disease 1 0.9580680131912231
, O 0 0.014372549951076508
low B-Disease 0 0.4346277117729187
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 1 0.9963610768318176
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 1 0.9995825886726379
ptosis B-Disease 1 1.0
, O 1 0.7188713550567627
hypertelorism B-Disease 1 0.9999995231628418
, O 0 0.01738855615258217
broad B-Disease 0 0.17656922340393066
great I-Disease 1 0.9908050298690796
toes I-Disease 1 0.9999830722808838
, O 0 0.016558371484279633
and O 0 0.018400603905320168
clinodactyly B-Disease 1 0.9999761581420898
. O 0 0.03384104371070862

Significant O 0 0.03544872999191284
intra O 1 0.9991950392723083
- O 1 0.9992873072624207
and O 0 0.017725493758916855
interfamilial O 1 0.9823572635650635
phenotypic O 0 0.031513918191194534
variability O 0 0.021252701058983803
is O 0 0.00740846386179328
present O 0 0.007380007766187191
for O 0 0.006523165851831436
either O 0 0.01016627810895443
TWIST O 0 0.4813952147960663
mutations O 0 0.021305985748767853
or O 0 0.017615938559174538
FGFR O 1 0.9999967813491821
mutations O 0 0.04217453673481941
. O 0 0.036345839500427246

The O 0 0.020923839882016182
overlap O 0 0.017322223633527756
in O 0 0.008404342457652092
clinical O 1 0.9045116901397705
features O 0 0.009736997075378895
and O 0 0.004895987920463085
the O 0 0.004831417463719845
presence O 0 0.005927308928221464
, O 0 0.004596563521772623
in O 0 0.0034898873418569565
the O 0 0.0048101479187607765
same O 0 0.004099502693861723
genes O 0 0.004857772495597601
, O 0 0.004597879480570555
of O 0 0.004798226524144411
mutations O 0 0.004822940565645695
for O 0 0.0028745129238814116
more O 0 0.0029186499305069447
than O 0 0.0033966400660574436
one O 0 0.0061965505592525005
craniosynostotic B-Disease 1 0.9989066123962402
condition I-Disease 1 0.6372003555297852
- O 1 0.9288384914398193
such O 0 0.00529774185270071
as O 0 0.009181652218103409
Saethre B-Disease 1 0.9999691247940063
- I-Disease 1 0.9999864101409912
Chotzen I-Disease 1 0.9992885589599609
, I-Disease 0 0.012000265531241894
Crouzon I-Disease 1 0.9808681607246399
, I-Disease 0 0.010537225753068924
and I-Disease 0 0.01508383173495531
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 0.9999994039535522
support O 0 0.009608689695596695
the O 0 0.008479713462293148
hypothesis O 0 0.013281108811497688
that O 0 0.00503030139952898
TWIST O 0 0.04064508154988289
and O 0 0.009014126844704151
FGFRs O 1 0.7365448474884033
are O 0 0.004884807392954826
components O 0 0.009434997104108334
of O 0 0.0051618898287415504
the O 0 0.005717476364225149
same O 0 0.005460820626467466
molecular O 0 0.012701856903731823
pathway O 0 0.010489269159734249
involved O 0 0.004897293634712696
in O 0 0.004529435653239489
the O 0 0.0059155006892979145
modulation O 0 0.019326459616422653
of O 0 0.021429220214486122
craniofacial O 1 1.0
and O 1 0.9997063279151917
limb O 1 1.0
development O 1 0.7728290557861328
in O 0 0.013113949447870255
humans O 0 0.014201275072991848
. O 0 0.015913013368844986
. O 0 0.02550659142434597

Mutation O 0 0.04256846383213997
analysis O 0 0.021364107728004456
of O 0 0.01912926323711872
UBE3A O 1 0.9999998807907104
in O 1 0.9999635219573975
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9952840209007263

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999569654464722
AS B-Disease 1 0.9999984502792358
) O 0 0.01164860650897026
is O 0 0.008196174167096615
caused O 0 0.010967430658638477
by O 0 0.009118974208831787
chromosome O 0 0.03680701181292534
15q11 O 1 0.9998949766159058
- O 1 0.9999593496322632
q13 O 1 0.7750508785247803
deletions O 0 0.03624771535396576
of O 0 0.015987079590559006
maternal O 0 0.02764660306274891
origin O 0 0.008472218178212643
, O 0 0.0068013411946594715
by O 0 0.00773507310077548
paternal O 1 0.9996527433395386
uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
( O 1 0.9704446792602539
UPD B-Disease 1 1.0
) O 0 0.013009610585868359
15 O 0 0.011561974883079529
, O 0 0.008154481649398804
by O 0 0.007830522954463959
imprinting O 1 0.9998910427093506
defects O 1 0.9999988079071045
, O 0 0.00880930945277214
and O 0 0.006455493625253439
by O 0 0.006435327231884003
mutations O 0 0.009433233179152012
in O 0 0.008456507697701454
the O 0 0.017206937074661255
UBE3A O 1 0.9999988079071045
gene O 0 0.03883757442235947
. O 0 0.03566636145114899

UBE3A O 1 0.9793771505355835
encodes O 0 0.0586962029337883
a O 0 0.026409056037664413
ubiquitin O 1 0.941975474357605
- O 1 0.9995656609535217
protein O 0 0.0200708769261837
ligase O 0 0.029774539172649384
and O 0 0.011059301905333996
shows O 0 0.01668611355125904
brain O 1 0.9772049784660339
- O 1 0.9992947578430176
specific O 0 0.019086915999650955
imprinting O 1 0.6971613764762878
. O 0 0.04105677083134651

Here O 0 0.024781793355941772
we O 0 0.014202630147337914
describe O 0 0.02441399358212948
UBE3A O 1 0.9999406337738037
coding O 1 0.956276535987854
- O 1 0.9991636276245117
region O 0 0.017081361263990402
mutations O 0 0.013612772338092327
detected O 0 0.012870252132415771
by O 0 0.007598577067255974
SSCP O 1 0.973391592502594
analysis O 0 0.008569873869419098
in O 0 0.0071471394039690495
13 O 0 0.011039002798497677
AS B-Disease 0 0.014000847935676575
individuals O 0 0.008550778962671757
or O 0 0.010398109443485737
families O 0 0.016145817935466766
. O 0 0.021016113460063934

Two O 0 0.02688455767929554
identical O 0 0.034738700836896896
de O 0 0.04997456446290016
novo O 0 0.07339943945407867
5 O 0 0.02951190061867237
- O 0 0.39702925086021423
bp O 0 0.05385903641581535
duplications O 0 0.05070926621556282
in O 0 0.017176320776343346
exon O 0 0.05179542303085327
16 O 0 0.02092224359512329
were O 0 0.013617056421935558
found O 0 0.01912909559905529
. O 0 0.029583483934402466

Among O 0 0.02311120554804802
the O 0 0.010996324941515923
other O 0 0.005887199193239212
11 O 0 0.009632478468120098
unique O 0 0.009451800025999546
mutations O 0 0.009255253709852695
, O 0 0.00611948873847723
8 O 0 0.008322757668793201
were O 0 0.004596225451678038
small O 0 0.0067375884391367435
deletions O 0 0.015043915249407291
or O 0 0.0062180208042263985
insertions O 0 0.019040370360016823
predicted O 0 0.008983335457742214
to O 0 0.006234702654182911
cause O 0 0.04137874394655228
frameshifts O 1 0.9999169111251831
, O 0 0.007077899295836687
1 O 0 0.009983268566429615
was O 0 0.006908430252224207
a O 0 0.006517122033983469
mutation O 0 0.007387224584817886
to O 0 0.004199074115604162
a O 0 0.0058219959028065205
stop O 0 0.00826175045222044
codon O 0 0.012847844511270523
, O 0 0.006366770248860121
1 O 0 0.010466250590980053
was O 0 0.009115230292081833
a O 0 0.008519821800291538
missense O 0 0.023875722661614418
mutation O 0 0.011467786505818367
, O 0 0.006341122556477785
and O 0 0.005618693772703409
1 O 0 0.00834774598479271
was O 0 0.009365029633045197
predicted O 0 0.010063255205750465
to O 0 0.007205413654446602
cause O 0 0.01071897428482771
insertion O 0 0.017845897004008293
of O 0 0.007347035687416792
an O 0 0.0099260238930583
isoleucine O 1 0.9975458979606628
in O 0 0.008396938443183899
the O 0 0.009679518640041351
hect O 0 0.2968907058238983
domain O 0 0.015198829583823681
of O 0 0.008159667253494263
the O 0 0.011865789070725441
UBE3A O 1 0.999996542930603
protein O 0 0.014989952556788921
, O 0 0.00817869883030653
which O 0 0.005346500780433416
functions O 0 0.00797261856496334
in O 0 0.009819984436035156
E2 O 1 0.9398329854011536
binding O 0 0.020913483574986458
and O 0 0.016333699226379395
ubiquitin O 0 0.06372085213661194
transfer O 0 0.028449570760130882
. O 0 0.037896040827035904

Eight O 0 0.022538932040333748
of O 0 0.010157247073948383
the O 0 0.008632335811853409
cases O 0 0.007494638673961163
were O 0 0.007297048810869455
familial O 1 0.9998944997787476
, O 0 0.006890361662954092
and O 0 0.005189306568354368
five O 0 0.00711085693910718
were O 0 0.007384857162833214
sporadic O 0 0.018513064831495285
. O 0 0.022410383448004723

In O 0 0.020114008337259293
two O 0 0.013012324459850788
familial O 1 0.9476620554924011
cases O 0 0.010240787640213966
and O 0 0.007438748609274626
one O 0 0.007451123092323542
sporadic O 0 0.01064631063491106
case O 0 0.009095598943531513
, O 0 0.009974685497581959
mosaicism O 1 0.9858010411262512
for O 0 0.014218568801879883
UBE3A O 1 0.9999996423721313
mutations O 0 0.01466948352754116
was O 0 0.011151689104735851
detected O 0 0.008691542781889439
in O 0 0.004557739943265915
the O 0 0.005573610309511423
mother O 0 0.009552340023219585
of O 0 0.0053121596574783325
three O 0 0.005743470508605242
AS B-Disease 0 0.434845507144928
sons O 0 0.08301158249378204
, O 0 0.0055061085149645805
in O 0 0.004994648043066263
the O 0 0.007247996050864458
maternal O 1 0.8559645414352417
grandfather O 0 0.27860885858535767
of O 0 0.006570322439074516
two O 0 0.0048611159436404705
AS B-Disease 0 0.010506199672818184
first O 0 0.00959885772317648
cousins O 0 0.015983110293745995
, O 0 0.005220928695052862
and O 0 0.0037960566114634275
in O 0 0.003919519484043121
the O 0 0.005400308407843113
mother O 0 0.01057569682598114
of O 0 0.00736925657838583
an O 0 0.009661661460995674
AS B-Disease 1 0.9975298047065735
daughter O 1 0.9955116510391235
. O 0 0.030592089518904686

The O 0 0.0177509356290102
frequencies O 0 0.014161156490445137
with O 0 0.0077590965665876865
which O 0 0.005285985302180052
we O 0 0.005788719747215509
detected O 0 0.009520641528069973
mutations O 0 0.0073773604817688465
were O 0 0.00411792891100049
5 O 0 0.008414307609200478
( O 0 0.006985945627093315
14 O 0 0.00928965862840414
% O 0 0.006036408245563507
) O 0 0.0051215956918895245
of O 0 0.005033481400460005
35 O 0 0.009124568663537502
in O 0 0.005073820240795612
sporadic O 0 0.009976323693990707
cases O 0 0.005625362973660231
and O 0 0.005474880337715149
8 O 0 0.00933872815221548
( O 0 0.0076848361641168594
80 O 0 0.011378775350749493
% O 0 0.006860125344246626
) O 0 0.005151782184839249
of O 0 0.005355282220989466
10 O 0 0.00792597234249115
in O 0 0.010035925544798374
familial O 1 0.9970844388008118
cases O 0 0.017883427441120148
. O 0 0.01608840562403202
. O 0 0.026434244588017464

The O 0 0.05265423655509949
hemochromatosis B-Disease 1 1.0
845 O 1 0.9999997615814209
G O 1 0.9999998807907104
- O 1 0.9999996423721313
- O 1 0.9993817806243896
> O 0 0.04490169137716293
A O 0 0.015877308323979378
and O 0 0.009260205551981926
187 O 0 0.02825755812227726
C O 1 0.9961045980453491
- O 1 0.9999891519546509
- O 1 0.9999632835388184
> O 1 0.9961286783218384
G O 1 0.9389230608940125
mutations O 0 0.019495146349072456
: O 0 0.015663553029298782
prevalence O 0 0.03553337603807449
in O 0 0.012859988026320934
non O 0 0.4177570343017578
- O 1 0.9999831914901733
Caucasian O 1 0.9909433722496033
populations O 0 0.026601528748869896
. O 0 0.03164134547114372

Hemochromatosis B-Disease 1 0.9999986886978149
, O 0 0.020260244607925415
the O 0 0.025568300858139992
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999990463256836
, O 0 0.021834777668118477
leads O 0 0.4485165476799011
, O 0 0.006988255772739649
if O 0 0.006136731244623661
untreated O 1 0.9995986819267273
, O 0 0.006993518676608801
to O 0 0.009135153144598007
progressive O 1 0.9999767541885376
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.9080429673194885
premature B-Disease 1 0.9999759197235107
death I-Disease 1 0.9484850764274597
. O 0 0.0342363677918911

The O 0 0.04840132221579552
hemochromatosis B-Disease 1 1.0
gene O 0 0.03509768843650818
, O 0 0.021981187164783478
HFE O 1 0.9999990463256836
, O 0 0.011557904072105885
recently O 0 0.011131673119962215
has O 0 0.0058054071851074696
been O 0 0.004300596192479134
identified O 0 0.004800688475370407
, O 0 0.003505808301270008
and O 0 0.0033823843114078045
characterization O 0 0.00775940902531147
of O 0 0.004193984903395176
this O 0 0.003731793025508523
gene O 0 0.005184913985431194
has O 0 0.0037757165264338255
shown O 0 0.0036398081574589014
that O 0 0.002488885773345828
it O 0 0.0033137579448521137
contains O 0 0.005070377141237259
two O 0 0.0037614183966070414
mutations O 0 0.005055360030382872
that O 0 0.003669129218906164
result O 0 0.005198686383664608
in O 0 0.006670994218438864
amino O 0 0.012884750962257385
acid O 0 0.01885245181620121
substitutions O 0 0.028605343773961067
- O 0 0.042505498975515366
cDNA O 0 0.04179331660270691
nucleotides O 0 0.029759163036942482
845 O 1 0.9765323400497437
G O 1 0.999836802482605
- O 1 0.9999634027481079
- O 1 0.9998302459716797
> O 1 0.551543653011322
A O 0 0.0183419119566679
( O 0 0.016280224546790123
C282Y O 0 0.0421714149415493
) O 0 0.008820809423923492
and O 0 0.008435415104031563
187 O 0 0.023530468344688416
C O 1 0.9751756191253662
- O 1 0.9999934434890747
- O 1 0.9999964237213135
> O 1 0.999896764755249
G O 1 0.9999388456344604
( O 0 0.027469759806990623
H63D O 1 0.9999393224716187
) O 0 0.02864786796271801
. O 0 0.03301791846752167

Although O 0 0.05141250044107437
hemochromatosis B-Disease 1 1.0
is O 0 0.016910027712583542
common O 0 0.011969790793955326
in O 0 0.010799135081470013
Caucasians O 1 0.8939753770828247
, O 0 0.011122574098408222
affecting O 0 0.02600572258234024
> O 1 0.9999351501464844
= O 1 0.6250147819519043
1 O 0 0.019148362800478935
/ O 0 0.025275925174355507
300 O 0 0.012787388637661934
individuals O 0 0.004495527595281601
of O 0 0.00489048520103097
northern O 0 0.007097194436937571
European O 0 0.006575260777026415
origin O 0 0.004906244110316038
, O 0 0.004862362053245306
it O 0 0.003721673274412751
has O 0 0.004345320630818605
not O 0 0.0033649331890046597
been O 0 0.0045427726581692696
recognized O 0 0.0070814588107168674
in O 0 0.005919520277529955
other O 0 0.006180711090564728
populations O 0 0.012878300622105598
. O 0 0.02146538719534874

The O 0 0.023799441754817963
present O 0 0.014158329926431179
study O 0 0.010770794935524464
used O 0 0.01000597607344389
PCR O 0 0.028693923726677895
and O 0 0.010930515825748444
restriction O 0 0.021856771782040596
- O 1 0.9999840259552002
enzyme O 0 0.02199210599064827
digestion O 0 0.024456264451146126
to O 0 0.00669403700158
analyze O 0 0.013285510241985321
the O 0 0.00714210607111454
frequency O 0 0.007023437414318323
of O 0 0.005727535579353571
the O 0 0.009332050569355488
845 O 1 0.9999607801437378
G O 1 0.9999983310699463
- O 1 0.9999985694885254
- O 1 0.9987057447433472
> O 0 0.03362485393881798
A O 0 0.014152979478240013
and O 0 0.009288684464991093
187 O 0 0.028496937826275826
C O 1 0.967930793762207
- O 1 0.9997116923332214
- O 1 0.9996374845504761
> O 1 0.9021459817886353
G O 1 0.6175932884216309
mutations O 0 0.01804475672543049
in O 0 0.01503506489098072
HLA O 1 1.0
- O 1 0.9964849948883057
typed O 0 0.03242964670062065
samples O 0 0.01078657153993845
from O 0 0.00873409491032362
non O 0 0.021580327302217484
- O 1 0.985007107257843
Caucasian O 0 0.10059668123722076
populations O 0 0.011697175912559032
, O 0 0.00957413762807846
comprising O 0 0.014130071736872196
Australian O 0 0.018889715895056725
Aboriginal O 0 0.02122834324836731
, O 0 0.009359912946820259
Chinese O 0 0.012231407687067986
, O 0 0.009785294532775879
and O 0 0.011122679337859154
Pacific O 0 0.04389578104019165
Islanders O 0 0.07219363749027252
. O 0 0.031538695096969604

Results O 0 0.022302888333797455
showed O 0 0.012916496954858303
that O 0 0.00604496942833066
the O 0 0.010619739070534706
845 O 1 0.9995119571685791
G O 1 0.9999964237213135
- O 1 0.9999980926513672
- O 1 0.9999862909317017
> O 1 0.6713719964027405
A O 0 0.017374498769640923
mutation O 0 0.01335033681243658
was O 0 0.009486788883805275
present O 0 0.006942450068891048
in O 0 0.0048048547469079494
these O 0 0.0034742546267807484
populations O 0 0.0052098301239311695
( O 0 0.006156705319881439
allele O 0 0.011427217163145542
frequency O 0 0.0073999096639454365
0 O 0 0.009827029891312122
. O 0 0.004641307983547449
32 O 0 0.009724828414618969
% O 0 0.00607307069003582
) O 0 0.0056213797070086
, O 0 0.004984099883586168
and O 0 0.004459022544324398
, O 0 0.005268763285130262
furthermore O 0 0.006518171634525061
, O 0 0.004601486027240753
it O 0 0.00411634799093008
was O 0 0.007324618753045797
always O 0 0.006371176335960627
seen O 0 0.006572575308382511
in O 0 0.005102666560560465
conjunction O 0 0.012524246238172054
with O 0 0.010617961175739765
HLA O 1 1.0
haplotypes O 1 0.8892532587051392
common O 0 0.009042061865329742
in O 0 0.009640556760132313
Caucasians O 0 0.04763629660010338
, O 0 0.0069963932037353516
suggesting O 0 0.006723196245729923
that O 0 0.0050112782046198845
845 O 1 0.9994841814041138
G O 1 0.9999992847442627
- O 1 0.9999998807907104
- O 1 0.9999992847442627
> O 1 0.996812641620636
A O 0 0.014344916678965092
may O 0 0.005853172857314348
have O 0 0.0035842168144881725
been O 0 0.004458218347281218
introduced O 0 0.0072595118544995785
into O 0 0.006395244039595127
these O 0 0.004238422028720379
populations O 0 0.008538257330656052
by O 0 0.011466575786471367
Caucasian O 1 0.9589591026306152
admixture O 1 0.9632052779197693
. O 0 0.040188875049352646

187 O 0 0.08447130769491196
C O 1 0.9970292448997498
- O 1 0.9999895095825195
- O 1 0.999983549118042
> O 1 0.997760534286499
G O 1 0.9182749390602112
was O 0 0.012837421149015427
present O 0 0.00850565917789936
at O 0 0.009002267383038998
an O 0 0.007951230742037296
allele O 0 0.01791977696120739
frequency O 0 0.012874959968030453
of O 0 0.014178522862493992
2 O 0 0.03255906328558922
. O 0 0.03036724217236042

68 O 0 0.06154531612992287
% O 0 0.01514881569892168
in O 0 0.00743910064920783
the O 0 0.006996248383074999
two O 0 0.005365496501326561
populations O 0 0.007984557189047337
analyzed O 0 0.013180617243051529
( O 0 0.009694256819784641
Australian O 0 0.018733303993940353
Aboriginal O 0 0.024530800059437752
and O 0 0.012732727453112602
Chinese O 0 0.025111863389611244
) O 0 0.021839618682861328
. O 0 0.030769189819693565

In O 0 0.024317527189850807
the O 0 0.01742166467010975
Australian O 0 0.02563754841685295
Aboriginal O 0 0.02594212256371975
samples O 0 0.012641972862184048
, O 0 0.008732516318559647
187 O 0 0.02365674264729023
C O 1 0.9902670979499817
- O 1 0.9999923706054688
- O 1 0.9999920129776001
> O 1 0.9997217059135437
G O 1 0.9203431010246277
was O 0 0.011322247795760632
found O 0 0.004833337385207415
to O 0 0.004486446268856525
be O 0 0.0042014517821371555
associated O 0 0.0074958582408726215
with O 0 0.008505533449351788
HLA O 1 1.0
haplotypes O 1 0.9201117157936096
common O 0 0.00937087181955576
in O 0 0.008624658919870853
Caucasians O 1 0.9986774325370789
, O 0 0.007769610267132521
suggesting O 0 0.006137134972959757
that O 0 0.003030810272321105
it O 0 0.004023783374577761
was O 0 0.00809764675796032
introduced O 0 0.009780652821063995
by O 0 0.0066153802908957005
recent O 0 0.014924852177500725
admixture O 0 0.06075403839349747
. O 0 0.030345458537340164

In O 0 0.01841741055250168
the O 0 0.012244712561368942
Chinese O 0 0.014652400277554989
samples O 0 0.00933142937719822
analyzed O 0 0.011583606712520123
, O 0 0.008838895708322525
187 O 0 0.02036179043352604
C O 1 0.9918032288551331
- O 1 0.9999909400939941
- O 1 0.9999828338623047
> O 1 0.9991494417190552
G O 1 0.9765384793281555
was O 0 0.012153753079473972
present O 0 0.007569385226815939
in O 0 0.006313276011496782
association O 0 0.008689003996551037
with O 0 0.004125527571886778
a O 0 0.00698844064027071
wide O 0 0.009174480102956295
variety O 0 0.009791520424187183
of O 0 0.013884094543755054
HLA O 1 1.0
haplotypes O 1 0.8645527958869934
, O 0 0.009357507340610027
showing O 0 0.010292059741914272
this O 0 0.004803728312253952
mutation O 0 0.007391939405351877
to O 0 0.0042982036247849464
be O 0 0.0038920079823583364
widespread O 0 0.006320273503661156
and O 0 0.0047106011770665646
likely O 0 0.005645622033625841
to O 0 0.005156791303306818
predate O 0 0.01551144476979971
the O 0 0.006274871993809938
more O 0 0.00480413855984807
genetically O 0 0.01049367431551218
restricted O 0 0.01255056168884039
845 O 1 0.9999274015426636
G O 1 0.9999990463256836
- O 1 0.9999998807907104
- O 1 0.9999961853027344
> O 1 0.914286732673645
A O 0 0.035628560930490494
mutation O 0 0.03764287382364273
. O 0 0.032587382942438126

Genotype O 1 0.9917781352996826
- O 1 0.999164342880249
phenotype O 0 0.28179672360420227
correlations O 0 0.04601949453353882
in O 0 0.027249353006482124
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 1 0.6691440939903259

Germ O 1 0.9999958276748657
- O 1 0.9992972612380981
line O 0 0.027419904246926308
mutations O 0 0.01561514101922512
of O 0 0.010310854762792587
the O 0 0.017949257045984268
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999992847442627
APC O 1 0.9999871253967285
are O 0 0.0087357172742486
implicated O 0 0.023007534444332123
in O 0 0.0164981447160244
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999943971633911
AAPC B-Disease 1 1.0
) O 0 0.015360089018940926
, O 0 0.010730504989624023
a O 0 0.01236986555159092
variant O 0 0.023861046880483627
of O 0 0.01785917393863201
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.12058870494365692
. O 0 0.04745810851454735

AAPC B-Disease 1 0.9999984502792358
is O 0 0.01888856291770935
recognized O 0 0.01420686487108469
by O 0 0.006246783304959536
the O 0 0.006720824167132378
occurrence O 0 0.010727284476161003
of O 0 0.009968114085495472
< O 1 0.9998544454574585
100 O 0 0.037654727697372437
colonic B-Disease 1 0.9999994039535522
adenomas I-Disease 1 0.9999887943267822
and O 0 0.008757367730140686
a O 0 0.007608255837112665
later O 0 0.011132302694022655
onset O 1 0.9999887943267822
of O 1 0.9994580149650574
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9004660248756409
age O 1 0.7396677732467651
> O 1 0.9968320727348328
40 O 0 0.019562359899282455
years O 0 0.013885777443647385
) O 0 0.01768709532916546
. O 0 0.023977238684892654

The O 0 0.024034084752202034
aim O 0 0.023652998730540276
of O 0 0.008499616757035255
this O 0 0.005139430984854698
study O 0 0.008444476872682571
was O 0 0.009320243261754513
to O 0 0.008621806278824806
assess O 0 0.025412695482373238
genotype O 1 0.9105386734008789
- O 1 0.9999433755874634
phenotype O 0 0.3216647505760193
correlations O 0 0.03765019029378891
in O 0 0.02523708902299404
AAPC B-Disease 1 0.9999997615814209
families O 0 0.03954406827688217
. O 0 0.03966754674911499

By O 0 0.0235731340944767
protein O 0 0.02955123968422413
- O 1 0.7436814308166504
truncation O 0 0.07188684493303299
test O 0 0.02781873568892479
( O 0 0.02036561258137226
PTT O 1 0.9538487792015076
) O 0 0.013959266245365143
assay O 0 0.01973419077694416
, O 0 0.006009024567902088
the O 0 0.00526652205735445
entire O 0 0.009973358362913132
coding O 0 0.012304035946726799
region O 0 0.007642065640538931
of O 0 0.005983488634228706
the O 0 0.008720999583601952
APC B-Disease 1 0.9999995231628418
gene O 0 0.011753370054066181
was O 0 0.01098304707556963
screened O 0 0.014407563954591751
in O 0 0.006941881496459246
affected O 0 0.0071504018269479275
individuals O 0 0.003537463955581188
from O 0 0.005555019713938236
11 O 0 0.023498659953475
AAPC B-Disease 1 1.0
kindreds O 1 0.9999490976333618
, O 0 0.009477656334638596
and O 0 0.006106005981564522
their O 0 0.005694956053048372
phenotypic O 0 0.016614673659205437
differences O 0 0.010559423826634884
were O 0 0.010404670611023903
examined O 0 0.03291131556034088
. O 0 0.027868641540408134

Five O 0 0.03731357678771019
novel O 0 0.04765002056956291
germ O 1 0.9999964237213135
- O 1 0.999994158744812
line O 0 0.0762077197432518
APC B-Disease 1 0.9998754262924194
mutations O 0 0.016678204759955406
were O 0 0.007358023896813393
identified O 0 0.009985145181417465
in O 0 0.01007990911602974
seven O 0 0.01947629824280739
kindreds O 1 0.8883020877838135
. O 0 0.03622616454958916

Mutations O 0 0.0325976200401783
were O 0 0.009401559829711914
located O 0 0.010670899413526058
in O 0 0.0050959414802491665
three O 0 0.003916426561772823
different O 0 0.002354756696149707
regions O 0 0.003640527371317148
of O 0 0.004826679360121489
the O 0 0.008151204325258732
APC B-Disease 1 0.9999997615814209
gene O 0 0.011909189634025097
( O 0 0.007195282727479935
1 O 0 0.009103694930672646
) O 0 0.005300321150571108
at O 0 0.006080899387598038
the O 0 0.005200279876589775
5 O 0 0.007970723323523998
end O 0 0.00842519011348486
spanning O 0 0.011657356284558773
exons O 0 0.01511912140995264
4 O 0 0.011605946347117424
and O 0 0.006854432635009289
5 O 0 0.010437017306685448
, O 0 0.007266539614647627
( O 0 0.007578604388982058
2 O 0 0.010685724206268787
) O 0 0.006105953827500343
within O 0 0.006835601292550564
exon O 0 0.02600504644215107
9 O 0 0.013205666095018387
, O 0 0.006833734456449747
and O 0 0.0059377471916377544
( O 0 0.0066943601705133915
3 O 0 0.009937882423400879
) O 0 0.005352858453989029
at O 0 0.0062676952220499516
the O 0 0.0062766531482338905
3 O 0 0.013062133453786373
distal O 0 0.16572293639183044
end O 0 0.010992913506925106
of O 0 0.00979862455278635
the O 0 0.01564529351890087
gene O 0 0.024205006659030914
. O 0 0.02645585685968399

Variability O 0 0.039573654532432556
in O 0 0.009053803980350494
the O 0 0.007932213135063648
number O 0 0.008576650172472
of O 0 0.2469765692949295
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9966021776199341
most O 0 0.008605965413153172
apparent O 0 0.011295313946902752
in O 0 0.0053743901662528515
individuals O 0 0.003639956470578909
with O 0 0.004362127743661404
mutations O 0 0.006276064086705446
in O 0 0.0043096840381622314
region O 0 0.0068885027430951595
1 O 0 0.0087190056219697
, O 0 0.005847016349434853
and O 0 0.007540333550423384
upper O 1 0.9999668598175049
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 0.9999983310699463
were O 0 0.008582457900047302
more O 0 0.00873158872127533
severe O 1 0.9999666213989258
in O 0 0.012132010422647
them O 0 0.014442802406847477
. O 0 0.028000451624393463

In O 0 0.018688421696424484
individuals O 0 0.007528502028435469
with O 0 0.007184871006757021
mutations O 0 0.008017430081963539
in O 0 0.005120338872075081
either O 0 0.005264921113848686
region O 0 0.007316392380744219
2 O 0 0.009353596717119217
or O 0 0.005271672736853361
region O 0 0.007128876633942127
3 O 0 0.00788370706140995
, O 0 0.004612332209944725
the O 0 0.004630729090422392
average O 0 0.006920905318111181
number O 0 0.004462940152734518
of O 0 0.007162842433899641
adenomas B-Disease 1 0.9999878406524658
tended O 0 0.01072675921022892
to O 0 0.004780360031872988
be O 0 0.003808756358921528
lower O 0 0.0052522351033985615
than O 0 0.003114393912255764
those O 0 0.0026636538095772266
in O 0 0.0034858547151088715
individuals O 0 0.0029288530349731445
with O 0 0.004135306924581528
mutations O 0 0.006599036511033773
in O 0 0.004295543301850557
region O 0 0.006462457124143839
1 O 0 0.008784753270447254
, O 0 0.006204819772392511
although O 0 0.005854665767401457
age O 0 0.010361656546592712
at O 0 0.014214920811355114
diagnosis O 1 0.9999327659606934
was O 0 0.02482513338327408
similar O 0 0.020473811775445938
. O 0 0.03129979968070984

In O 0 0.030250513926148415
all O 0 0.027084702625870705
AAPC B-Disease 1 0.9999997615814209
kindreds O 1 0.8675259351730347
, O 0 0.013618861325085163
a O 0 0.012645257636904716
predominance O 0 0.049163468182086945
of O 0 0.011861031875014305
right O 1 0.9781081676483154
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999986886978149
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999994039535522
was O 1 0.8197836875915527
observed O 0 0.029116693884134293
. O 0 0.030709421262145042

No O 0 0.05058484897017479
desmoid B-Disease 1 0.9999808073043823
tumors I-Disease 1 0.9999912977218628
were O 0 0.010725018568336964
found O 0 0.009384513832628727
in O 0 0.010722195729613304
these O 0 0.012632225640118122
kindreds O 1 0.546188235282898
. O 0 0.03475543484091759

Our O 0 0.02484307810664177
data O 0 0.010501153767108917
suggest O 0 0.009081538766622543
that O 0 0.00491844117641449
, O 0 0.007574552204459906
in O 0 0.008158061653375626
AAPC B-Disease 1 1.0
families O 0 0.010038522072136402
, O 0 0.005918627139180899
the O 0 0.0058858380652964115
location O 0 0.006799257360398769
of O 0 0.006329629570245743
the O 0 0.011514030396938324
APC B-Disease 1 0.9999995231628418
mutation O 0 0.056508440524339676
may O 0 0.012011470273137093
partially O 0 0.021758049726486206
predict O 0 0.01964917965233326
specific O 0 0.013103093020617962
phenotypic O 0 0.036556560546159744
expression O 0 0.028849853202700615
. O 0 0.030670955777168274

This O 0 0.014677840285003185
should O 0 0.009901540353894234
help O 0 0.00890601146966219
in O 0 0.005874252878129482
the O 0 0.0059182350523769855
design O 0 0.011316603049635887
of O 0 0.008636021986603737
tailored O 1 0.9966526627540588
clinical O 1 0.9999995231628418
- O 1 0.9999994039535522
management O 0 0.2904834449291229
protocols O 0 0.0157545804977417
in O 0 0.006154195871204138
this O 0 0.005516405683010817
subset O 0 0.019134417176246643
of O 0 0.018695788457989693
FAP B-Disease 1 1.0
patients O 1 0.9999995231628418
. O 0 0.020962340757250786
. O 0 0.03251698613166809

Wilms B-Disease 1 1.0
' I-Disease 1 0.9951449036598206
tumor I-Disease 1 0.9999816417694092
1 O 0 0.02855866029858589
and O 0 0.019490372389554977
Dax O 1 0.9999998807907104
- O 1 0.9998878240585327
1 O 0 0.02374226599931717
modulate O 0 0.033426787704229355
the O 0 0.01402994804084301
orphan O 1 0.9478134512901306
nuclear O 0 0.030192168429493904
receptor O 0 0.12798690795898438
SF O 1 0.9999998807907104
- O 1 0.9941996335983276
1 O 0 0.018407423049211502
in O 0 0.009191939607262611
sex O 0 0.014923246577382088
- O 1 0.5137112140655518
specific O 0 0.0107979541644454
gene O 0 0.016536526381969452
expression O 0 0.02218831330537796
. O 0 0.03043663501739502

Products O 0 0.035067927092313766
of O 0 0.020993413403630257
steroidogenic O 1 0.9999450445175171
factor O 0 0.025144150480628014
1 O 0 0.021814974024891853
( O 0 0.01711302250623703
SF O 1 1.0
- O 1 0.9999566078186035
1 O 0 0.013996221125125885
) O 0 0.008604851551353931
and O 0 0.010909410193562508
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999998807907104
1 O 1 0.7133468389511108
( O 0 0.027420058846473694
WT1 O 1 0.9999984502792358
) O 0 0.013043390586972237
genes O 0 0.00990312173962593
are O 0 0.003961306996643543
essential O 0 0.008402466773986816
for O 0 0.008256529457867146
mammalian O 0 0.02645060047507286
gonadogenesis O 1 0.8308197259902954
prior O 0 0.015087905339896679
to O 0 0.013245387934148312
sexual O 0 0.023306235671043396
differentiation O 0 0.0700061023235321
. O 0 0.033304400742053986

In O 0 0.02160605788230896
males O 0 0.021757258102297783
, O 0 0.020502539351582527
SF O 1 1.0
- O 1 0.9999911785125732
1 O 0 0.022477250546216965
participates O 0 0.019215872511267662
in O 0 0.008005550131201744
sexual O 0 0.008779383264482021
development O 0 0.0075973328202962875
by O 0 0.004702670965343714
regulating O 0 0.010583482682704926
expression O 0 0.00811175350099802
of O 0 0.007986092939972878
the O 0 0.015012702904641628
polypeptide O 1 0.9997960925102234
hormone O 1 0.9996520280838013
Mullerian O 1 0.9999997615814209
inhibiting O 1 0.9999216794967651
substance O 1 0.9998195767402649
( O 1 0.7131106853485107
MIS O 1 0.9999995231628418
) O 0 0.033012453466653824
. O 0 0.03829461336135864

Here O 0 0.03103506937623024
, O 0 0.015599214471876621
we O 0 0.00870782695710659
show O 0 0.012794457376003265
that O 0 0.011512327007949352
WT1 O 1 0.9999780654907227
- O 1 0.999954342842102
KTS O 1 0.9998949766159058
isoforms O 0 0.030346257612109184
associate O 0 0.025653276592493057
and O 0 0.014062258414924145
synergize O 1 0.9548213481903076
with O 0 0.020310061052441597
SF O 1 1.0
- O 1 0.9999569654464722
1 O 0 0.019305026158690453
to O 0 0.01289216335862875
promote O 0 0.031535226851701736
MIS O 1 0.999964714050293
expression O 0 0.03681264817714691
. O 0 0.036131538450717926

In O 0 0.030212925747036934
contrast O 0 0.03200024738907814
, O 0 0.025384945794939995
WT1 O 1 0.9999654293060303
missense O 0 0.06495054811239243
mutations O 0 0.01796954683959484
, O 0 0.008592712692916393
associated O 0 0.007461567874997854
with O 0 0.005510956980288029
male B-Disease 0 0.013991976156830788
pseudohermaphroditism I-Disease 1 0.999997615814209
in O 0 0.01674799434840679
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.016673684120178223
fail O 0 0.016469016671180725
to O 0 0.01107108499854803
synergize O 1 0.9992238283157349
with O 0 0.03245845437049866
SF O 1 1.0
- O 1 0.9999978542327881
1 O 0 0.04722189903259277
. O 0 0.041958410292863846

Additionally O 0 0.032670918852090836
, O 0 0.012062306515872478
the O 0 0.012604968622326851
X O 1 0.9730227589607239
- O 1 0.9966555833816528
linked O 0 0.016566284000873566
, O 0 0.008531599305570126
candidate O 0 0.014768197201192379
dosage O 1 0.9994377493858337
- O 1 0.9997102618217468
sensitive O 0 0.017912041395902634
sex O 0 0.013086707331240177
- O 0 0.47217750549316406
reversal O 0 0.019125064834952354
gene O 0 0.011665010824799538
, O 0 0.010985398665070534
Dax O 1 0.9999996423721313
- O 1 0.9997819066047668
1 O 0 0.017490800470113754
, O 0 0.011615149676799774
antagonizes O 0 0.11648272722959518
synergy O 0 0.10519706457853317
between O 0 0.015718264505267143
SF O 1 1.0
- O 1 0.9999947547912598
1 O 0 0.019716603681445122
and O 0 0.013094025664031506
WT1 O 1 0.99998939037323
, O 0 0.009078556671738625
most O 0 0.005673454608768225
likely O 0 0.005711905658245087
through O 0 0.004689035937190056
a O 0 0.005272043403238058
direct O 0 0.007795580197125673
interaction O 0 0.010306854732334614
with O 0 0.014859983697533607
SF O 1 1.0
- O 1 0.9999986886978149
1 O 0 0.042107030749320984
. O 0 0.033572763204574585

We O 0 0.02007962018251419
propose O 0 0.029230598360300064
that O 0 0.012177803553640842
WT1 O 1 0.9994730353355408
and O 0 0.023513654246926308
Dax O 1 1.0
- O 1 0.9999715089797974
1 O 0 0.022293003275990486
functionally O 0 0.026831652969121933
oppose O 0 0.013401975855231285
each O 0 0.00502885552123189
other O 0 0.0048355832695961
in O 0 0.007132786326110363
testis O 0 0.2498389184474945
development O 0 0.012021592818200588
by O 0 0.010345479473471642
modulating O 1 0.9999676942825317
SF O 1 1.0
- O 1 0.9999997615814209
1 O 0 0.23475100100040436
- O 1 0.999321699142456
mediated O 0 0.1646326333284378
transactivation O 1 0.9919420480728149
. O 0 0.026314126327633858
. O 0 0.03466469794511795

A O 0 0.04096892476081848
mouse O 0 0.04226024076342583
model O 0 0.025200337171554565
for O 0 0.022698044776916504
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9995948672294617
mutations O 0 0.05161086842417717
. O 0 0.04047742858529091

Imprinting O 0 0.09228389710187912
in O 0 0.018068334087729454
the O 0 0.022121291607618332
15q11 O 1 0.999462902545929
- O 1 0.9998807907104492
q13 O 1 0.5262323617935181
region O 0 0.01412077434360981
involves O 0 0.01091609988361597
an O 0 0.009059774689376354
imprinting O 1 0.9954262375831604
centre O 1 0.9985334873199463
( O 0 0.47104412317276
IC O 1 0.9999998807907104
) O 0 0.010950841009616852
, O 0 0.006725798361003399
mapping O 0 0.010196361690759659
in O 0 0.0052064647898077965
part O 0 0.0060758572071790695
to O 0 0.005532470066100359
the O 0 0.007348017301410437
promoter O 1 0.5774720907211304
and O 0 0.008677011355757713
first O 0 0.015438361093401909
exon O 0 0.0765933021903038
of O 0 0.026280168443918228
SNRPN O 1 0.9998229146003723
. O 0 0.045495618134737015

Deletion O 0 0.07249844074249268
of O 0 0.020255347713828087
this O 0 0.01691833697259426
IC O 1 0.9998725652694702
abolishes O 1 0.9402174353599548
local O 0 0.016337722539901733
paternally O 0 0.22988328337669373
derived O 0 0.013193339109420776
gene O 0 0.008689703419804573
expression O 0 0.00677043991163373
and O 0 0.004907780792564154
results O 0 0.006551841273903847
in O 0 0.012387785129249096
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999997615814209
PWS B-Disease 1 1.0
) O 0 0.08915085345506668
. O 0 0.0432899110019207

We O 0 0.01617044024169445
have O 0 0.007619677577167749
created O 0 0.012415099889039993
two O 0 0.00767748337239027
deletion O 0 0.02277446538209915
mutations O 0 0.009809200651943684
in O 0 0.005981112364679575
mice O 0 0.01198676135390997
to O 0 0.007167523726820946
understand O 0 0.014373409561812878
PWS B-Disease 1 1.0
and O 0 0.009046008810400963
the O 0 0.008362087421119213
mechanism O 0 0.011477680876851082
of O 0 0.01007852889597416
this O 0 0.013472521677613258
IC O 1 0.9999881982803345
. O 0 0.03656132519245148

Mice O 0 0.10979811102151871
harbouring O 0 0.4025712013244629
an O 0 0.02129645273089409
intragenic O 1 0.9957118034362793
deletion O 0 0.20465180277824402
in O 0 0.015330175869166851
Snrpn O 1 0.9996737241744995
are O 0 0.00737934373319149
phenotypically O 1 0.8163054585456848
normal O 0 0.008488047868013382
, O 0 0.006299697328358889
suggesting O 0 0.006065757945179939
that O 0 0.004037134349346161
mutations O 0 0.00697947246953845
of O 0 0.006736178416758776
SNRPN O 1 0.9999957084655762
are O 0 0.004695788491517305
not O 0 0.005485379137098789
sufficient O 0 0.014757566154003143
to O 0 0.019452780485153198
induce O 1 0.553856372833252
PWS B-Disease 1 0.9999998807907104
. O 0 0.05912826955318451

Mice O 0 0.052920710295438766
with O 0 0.014988472685217857
a O 0 0.013938503339886665
larger O 0 0.01834714785218239
deletion O 0 0.02651830017566681
involving O 0 0.013320083729922771
both O 0 0.009860088117420673
Snrpn O 1 0.6920226812362671
and O 0 0.009894213639199734
the O 0 0.013789761811494827
putative O 1 0.9999608993530273
PWS O 1 1.0
- O 1 1.0
IC O 1 0.9999967813491821
lack O 0 0.016293976455926895
expression O 0 0.010978220030665398
of O 0 0.008337701670825481
the O 0 0.011449528858065605
imprinted O 1 0.9988491535186768
genes O 0 0.01888587512075901
Zfp127 O 1 0.9997065663337708
( O 0 0.01601477339863777
mouse O 0 0.029196573421359062
homologue O 0 0.08813414722681046
of O 0 0.014851867221295834
ZNF127 O 1 0.9999996423721313
) O 0 0.014253056608140469
, O 0 0.013092410750687122
Ndn O 1 0.9999290704727173
and O 0 0.014928505755960941
Ipw O 1 0.9993022680282593
, O 0 0.01265968568623066
and O 0 0.008583205752074718
manifest O 0 0.01818278804421425
several O 0 0.009005467407405376
phenotypes O 0 0.03539332374930382
common O 0 0.015683703124523163
to O 0 0.045633215457201004
PWS B-Disease 1 1.0
infants O 1 0.9999980926513672
. O 0 0.053870461881160736

These O 0 0.013362149707973003
data O 0 0.009401881136000156
demonstrate O 0 0.010086347348988056
that O 0 0.004279624670743942
both O 0 0.0035373952705413103
the O 0 0.004553528502583504
position O 0 0.007648251485079527
of O 0 0.006097402889281511
the O 0 0.008534745313227177
IC O 1 0.9999988079071045
and O 0 0.006709463428705931
its O 0 0.006722403224557638
role O 0 0.007311227265745401
in O 0 0.004343534354120493
the O 0 0.005583868827670813
coordinate O 0 0.009618137031793594
expression O 0 0.008122303523123264
of O 0 0.006651779171079397
genes O 0 0.006602882873266935
is O 0 0.004614479839801788
conserved O 0 0.00808166153728962
between O 0 0.0052506509236991405
mouse O 0 0.01529698446393013
and O 0 0.00553015386685729
human O 0 0.005691349506378174
, O 0 0.004871971905231476
and O 0 0.0039111846126616
indicate O 0 0.004411798901855946
that O 0 0.0028245942667126656
the O 0 0.005126490723341703
mouse O 0 0.015165935270488262
is O 0 0.004354082979261875
a O 0 0.005741025786846876
suitable O 0 0.009886014275252819
model O 0 0.008616697043180466
system O 0 0.005383502691984177
in O 0 0.003773842705413699
which O 0 0.0031765911262482405
to O 0 0.0034320231061428785
investigate O 0 0.006654529832303524
the O 0 0.005893582012504339
molecular O 0 0.00820174254477024
mechanisms O 0 0.007185816764831543
of O 0 0.00697404844686389
imprinting O 0 0.3454480767250061
in O 0 0.006126685068011284
this O 0 0.004122392740100622
region O 0 0.007171060424298048
of O 0 0.007194782141596079
the O 0 0.010949399322271347
genome O 0 0.02639017626643181
. O 0 0.01593639701604843
. O 0 0.023087380453944206

Mutations O 0 0.03446223959326744
of O 0 0.013994017615914345
the O 0 0.01330486312508583
ATM O 0 0.06639843434095383
gene O 0 0.012452994473278522
detected O 0 0.010640506632626057
in O 0 0.008976911194622517
Japanese O 1 0.9804341197013855
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999918937683105
: O 0 0.014275236055254936
possible O 0 0.010222265496850014
preponderance O 0 0.03074158914387226
of O 0 0.0074070654809474945
the O 0 0.007290844339877367
two O 0 0.008343413472175598
founder O 1 0.9941943287849426
mutations O 0 0.021732425317168236
4612del165 O 1 0.9991433620452881
and O 0 0.02221270091831684
7883del5 O 1 0.9977461695671082
. O 0 0.034756649285554886

The O 0 0.027529222890734673
ATM O 0 0.06891483068466187
( O 0 0.015888547524809837
A O 1 0.9643197655677795
- O 1 0.9999998807907104
T O 1 0.9999998807907104
, O 0 0.014434725977480412
mutated O 0 0.025784457102417946
) O 0 0.008970138616859913
gene O 0 0.008471233770251274
on O 0 0.0075660827569663525
human O 0 0.012691720388829708
chromosome O 0 0.03551596775650978
11q22 O 1 0.9886406660079956
. O 0 0.03728030249476433

3 O 0 0.030616220086812973
has O 0 0.014383761212229729
recently O 0 0.013408124446868896
been O 0 0.006187293212860823
identified O 0 0.00594429112970829
as O 0 0.004730427637696266
the O 0 0.005668647587299347
gene O 0 0.00581726711243391
responsible O 0 0.004489313345402479
for O 0 0.0034930608235299587
the O 0 0.005462866276502609
human O 0 0.016378356143832207
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9920564293861389
A B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.026193125173449516
. O 0 0.0300547257065773

In O 0 0.015216954983770847
order O 0 0.010845771059393883
to O 0 0.005608541890978813
define O 0 0.008103408850729465
the O 0 0.005184958688914776
types O 0 0.0065230028703808784
of O 0 0.01587914116680622
disease O 1 1.0
- O 1 1.0
causing O 1 0.9986847043037415
ATM O 1 0.9885838031768799
mutations O 0 0.00759794469922781
in O 0 0.004320078995078802
Japanese O 0 0.020893655717372894
A B-Disease 1 0.9999934434890747
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9925829172134399
as O 0 0.006363850552588701
well O 0 0.004731868393719196
as O 0 0.004203024320304394
to O 0 0.00472219055518508
look O 0 0.007426347583532333
for O 0 0.005600242875516415
possible O 0 0.009729762561619282
mutational O 1 0.8806819915771484
hotspots O 1 0.8127997517585754
, O 0 0.012206141836941242
reverse O 0 0.026091044768691063
- O 1 0.9866828918457031
transcribed O 0 0.021268393844366074
RNA O 0 0.018887316808104515
derived O 0 0.009264913387596607
from O 0 0.005671459250152111
ten O 0 0.011577373370528221
patients O 0 0.011332537978887558
belonging O 0 0.008316892199218273
to O 0 0.004871382378041744
eight O 0 0.006765004247426987
unrelated O 0 0.0086582126095891
Japanese O 0 0.02204485982656479
A B-Disease 1 0.9994555115699768
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
families O 0 0.010080832056701183
was O 0 0.009963014163076878
analyzed O 0 0.010161329060792923
for O 0 0.007281490135937929
mutations O 0 0.009478726424276829
by O 0 0.0060875192284584045
the O 0 0.011354828253388405
restriction O 0 0.02785937301814556
endonuclease O 1 0.6533957123756409
fingerprinting O 0 0.057345401495695114
method O 0 0.035633575171232224
. O 0 0.03527439385652542

As O 0 0.018399052321910858
has O 0 0.009724416770040989
been O 0 0.006547727156430483
reported O 0 0.0067376201041042805
by O 0 0.003563287667930126
others O 0 0.004451092332601547
, O 0 0.0050866203382611275
mutations O 0 0.006719391327351332
that O 0 0.0037124487571418285
lead O 0 0.009498086757957935
to O 0 0.010302123613655567
exon O 0 0.056667208671569824
skipping O 0 0.034162770956754684
or O 0 0.01182803139090538
premature O 0 0.4188074767589569
protein O 0 0.016787268221378326
truncation O 0 0.02901269681751728
were O 0 0.007861398160457611
also O 0 0.01073834765702486
predominant O 0 0.020005591213703156
in O 0 0.012564640492200851
our O 0 0.0213973056524992
mutants O 0 0.06510338932275772
. O 0 0.033985380083322525

Six O 0 0.022639980539679527
different O 0 0.0075880419462919235
mutations O 0 0.009858318604528904
were O 0 0.004009965807199478
identified O 0 0.005321615841239691
on O 0 0.004116819240152836
12 O 0 0.006315232254564762
of O 0 0.005187167786061764
the O 0 0.0072436765767633915
16 O 0 0.01664191111922264
alleles O 0 0.024790015071630478
examined O 0 0.037828922271728516
. O 0 0.0260283462703228

Four O 0 0.02381007932126522
were O 0 0.010968858376145363
deletions O 0 0.023938659578561783
involving O 0 0.012431737966835499
a O 0 0.010814121924340725
loss O 0 0.017613396048545837
of O 0 0.009228603914380074
a O 0 0.012904687784612179
single O 0 0.017829908058047295
exon O 0 0.10739313066005707
exon O 0 0.06280538439750671
7 O 0 0.023203708231449127
, O 0 0.01583503745496273
exon O 0 0.04569897800683975
16 O 0 0.02105827070772648
, O 0 0.018210895359516144
exon O 0 0.057614684104919434
33 O 0 0.03508218005299568
or O 0 0.021533962339162827
exon O 0 0.06959120184183121
35 O 0 0.051077697426080704
. O 0 0.04054037854075432

The O 0 0.028924530372023582
others O 0 0.015177575871348381
were O 0 0.010622835718095303
minute O 0 0.023950081318616867
deletions O 0 0.03198809176683426
, O 0 0.013248846866190434
4649delA O 0 0.06042686849832535
in O 0 0.013650438748300076
exon O 0 0.0472383126616478
33 O 0 0.024942642077803612
and O 0 0.013562983833253384
7883del5 O 0 0.06798102706670761
in O 0 0.017282649874687195
exon O 0 0.07172801345586777
55 O 0 0.05603894591331482
. O 0 0.0371282696723938

The O 0 0.03164989501237869
mutations O 0 0.030162442475557327
4612del165 O 1 0.8842491507530212
and O 0 0.01233118586242199
7883del5 O 1 0.805480420589447
were O 0 0.0066346675157547
found O 0 0.004942568019032478
in O 0 0.0038349656388163567
more O 0 0.003114530351012945
than O 0 0.0038122807163745165
two O 0 0.0037357995752245188
unrelated O 0 0.007754010148346424
families O 0 0.005826905835419893
; O 0 0.005567265674471855
44 O 0 0.012019542045891285
% O 0 0.005869880318641663
( O 0 0.005691546946763992
7 O 0 0.008902906440198421
of O 0 0.005421268288046122
16 O 0 0.008288564160466194
) O 0 0.005640298128128052
of O 0 0.0060648065991699696
the O 0 0.008778100833296776
mutant O 0 0.020927688106894493
alleles O 0 0.013633564114570618
had O 0 0.007906828075647354
one O 0 0.005780939478427172
of O 0 0.005431366618722677
the O 0 0.00847235880792141
two O 0 0.011062944307923317
mutations O 0 0.021104304119944572
. O 0 0.022416232153773308

The O 0 0.03852362185716629
4612del165 O 1 0.9714308977127075
mutations O 0 0.018607070669531822
in O 0 0.0072546955198049545
three O 0 0.004943322855979204
different O 0 0.002763560973107815
families O 0 0.004361141473054886
were O 0 0.0029540660325437784
all O 0 0.0031549225095659494
ascribed O 0 0.008319641463458538
to O 0 0.003893801709637046
the O 0 0.00510722491890192
same O 0 0.00684392312541604
T O 1 1.0
- O 1 0.9999996423721313
- O 1 0.9999799728393555
> O 0 0.13547015190124512
A O 0 0.012845135293900967
substitution O 0 0.015006864443421364
at O 0 0.00955547671765089
the O 0 0.009976549074053764
splice O 0 0.03851064294576645
donor O 0 0.021631060168147087
site O 0 0.023708606138825417
in O 0 0.018062032759189606
intron O 1 0.992381751537323
33 O 0 0.057865209877491
. O 0 0.03836369514465332

Microsatellite O 1 0.8226231932640076
genotyping O 0 0.09256942570209503
around O 0 0.01817546784877777
the O 0 0.015881778672337532
ATM O 1 0.9881437420845032
locus O 1 0.7560591697692871
also O 0 0.008281566202640533
indicated O 0 0.007383823394775391
that O 0 0.0034616102930158377
a O 0 0.006523292977362871
common O 0 0.007251804694533348
haplotype O 0 0.07825851440429688
was O 0 0.010475766845047474
shared O 0 0.00941369216889143
by O 0 0.005426742602139711
the O 0 0.009984973818063736
mutant O 0 0.02691611833870411
alleles O 0 0.017935609444975853
in O 0 0.009258805774152279
both O 0 0.011382214725017548
mutations O 0 0.02269737794995308
. O 0 0.025857916101813316

This O 0 0.015042988583445549
suggests O 0 0.012479465454816818
that O 0 0.004199887625873089
these O 0 0.003452286124229431
two O 0 0.00628647580742836
founder O 1 0.9930221438407898
mutations O 0 0.011313092894852161
may O 0 0.00706671504303813
be O 0 0.005871613975614309
predominant O 0 0.020013049244880676
among O 0 0.012049134820699692
Japanese O 0 0.045468851923942566
ATM O 1 0.8659444451332092
mutant O 0 0.07894463837146759
alleles O 0 0.05736979469656944
. O 0 0.036427997052669525

W474C O 1 0.9906876683235168
amino O 0 0.051685210317373276
acid O 0 0.055759742856025696
substitution O 0 0.025511763989925385
affects O 0 0.017106231302022934
early O 0 0.009304859675467014
processing O 0 0.008516849018633366
of O 0 0.00639323890209198
the O 0 0.00818921159952879
alpha O 0 0.028647001832723618
- O 0 0.03855567425489426
subunit O 0 0.02042965404689312
of O 0 0.00989663414657116
beta O 0 0.030601024627685547
- O 1 0.9471310377120972
hexosaminidase O 0 0.11628413200378418
A O 0 0.012447607703506947
and O 0 0.006210835184901953
is O 0 0.004822928924113512
associated O 0 0.006702595856040716
with O 0 0.011173720471560955
subacute O 1 1.0
G B-Disease 1 1.0
( I-Disease 1 0.9873321652412415
M2 I-Disease 1 0.9999988079071045
) I-Disease 0 0.03336337208747864
gangliosidosis I-Disease 0 0.43603816628456116
. O 0 0.04623095691204071

Mutations O 0 0.04338560253381729
in O 0 0.015976525843143463
the O 0 0.020201757550239563
HEXA O 1 0.9999737739562988
gene O 0 0.017214452847838402
, O 0 0.009553694166243076
encoding O 0 0.011028191074728966
the O 0 0.00893789529800415
alpha O 0 0.02619047649204731
- O 0 0.03416341543197632
subunit O 0 0.019264191389083862
of O 0 0.009935499168932438
beta O 0 0.033931914716959
- O 1 0.998225748538971
hexosaminidase O 1 0.8206496238708496
A O 0 0.01629455015063286
( O 0 0.013625825755298138
Hex O 0 0.04257161170244217
A O 0 0.01785373128950596
) O 0 0.008952734060585499
, O 0 0.007139201741665602
that O 0 0.00543631985783577
abolish O 0 0.026322923600673676
Hex O 0 0.039309389889240265
A O 0 0.01818227581679821
enzyme O 0 0.017562666907906532
activity O 0 0.012849175371229649
cause O 1 0.9917437434196472
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9972188472747803
TSD B-Disease 1 1.0
) O 0 0.012468621134757996
, O 0 0.008086495101451874
the O 0 0.009867184795439243
fatal O 1 0.9994159936904907
infantile B-Disease 1 0.9999991655349731
form I-Disease 0 0.01615426503121853
of I-Disease 0 0.31501394510269165
G I-Disease 1 0.9999998807907104
( I-Disease 0 0.07949213683605194
M2 I-Disease 1 0.9999916553497314
) I-Disease 0 0.017539488151669502
gangliosidosis I-Disease 1 0.9486737847328186
, I-Disease 0 0.01692533679306507
Type I-Disease 0 0.030407166108489037
1 I-Disease 0 0.030790014192461967
. O 0 0.02985931932926178

Less O 0 0.0328105166554451
severe O 1 0.9998012185096741
, O 0 0.1694234013557434
subacute O 1 1.0
( O 1 0.9768728017807007
juvenile O 1 1.0
- O 1 1.0
onset O 1 1.0
) O 0 0.014624633826315403
and O 0 0.03267711400985718
chronic O 1 1.0
( O 1 0.8951608538627625
adult O 1 0.9995796084403992
- O 1 1.0
onset O 1 1.0
) O 0 0.010738271288573742
variants O 0 0.011320477351546288
are O 0 0.004335661418735981
characterized O 0 0.007551700342446566
by O 0 0.0035328767262399197
a O 0 0.006050825119018555
broad O 0 0.010026066564023495
spectrum O 0 0.014754834584891796
of O 0 0.009662473574280739
clinical O 1 0.9999991655349731
manifestations O 1 0.999977707862854
and O 0 0.008192774839699268
are O 0 0.004233585204929113
associated O 0 0.005944347474724054
with O 0 0.005661411210894585
residual O 1 0.953201949596405
levels O 0 0.011950593441724777
of O 0 0.011870083399116993
Hex O 1 0.5017192959785461
A O 0 0.034726954996585846
enzyme O 0 0.03485744073987007
activity O 0 0.024815602228045464
. O 0 0.033263541758060455

We O 0 0.01870894245803356
identified O 0 0.016506526619195938
a O 0 0.017056480050086975
1422 O 1 0.9999942779541016
G O 1 0.9999892711639404
- O 1 0.9999970197677612
- O 1 0.9999939203262329
> O 1 0.9995455145835876
C O 1 0.9703516960144043
( O 0 0.01771111972630024
amino O 0 0.025939904153347015
acid O 0 0.03408346325159073
W474C O 1 0.7201141715049744
) O 0 0.01312281470745802
substitution O 0 0.01654844358563423
in O 0 0.007269368506968021
the O 0 0.00688544288277626
first O 0 0.009195397607982159
position O 0 0.012130655348300934
of O 0 0.010859090834856033
exon O 0 0.03873973339796066
13 O 0 0.016840830445289612
of O 0 0.01418161578476429
HEXA O 1 0.9975507855415344
of O 0 0.011928524821996689
a O 0 0.013341100886464119
non O 0 0.02522207424044609
- O 1 0.9978548884391785
Jewish O 0 0.020908869802951813
proband O 1 0.920112133026123
who O 0 0.01881028711795807
manifested O 0 0.035290222615003586
a O 0 0.019483117386698723
subacute O 1 1.0
variant O 1 0.9883660078048706
of O 1 0.5774590969085693
G B-Disease 1 0.9999998807907104
( I-Disease 1 0.6657426953315735
M2 I-Disease 1 0.9999988079071045
) I-Disease 0 0.027390584349632263
gangliosidosis I-Disease 1 0.6695729494094849
. O 0 0.041492775082588196

On O 0 0.020625444129109383
the O 0 0.017290126532316208
second O 0 0.030025474727153778
maternally O 1 0.9992488026618958
inherited O 1 0.9999858140945435
allele O 0 0.033424798399209976
, O 0 0.007714254315942526
we O 0 0.004331785719841719
identified O 0 0.0050238571129739285
the O 0 0.005967044737190008
common O 0 0.0163632370531559
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999754428863525
4 O 0 0.46405017375946045
- O 1 0.9921051263809204
bp O 0 0.046398986130952835
insertion O 0 0.04183880239725113
, O 0 0.021719522774219513
+ O 0 0.18167497217655182
TATC O 1 0.999937891960144
1278 O 1 0.9999771118164062
, O 0 0.021227063611149788
in O 0 0.020427094772458076
exon O 0 0.0841321349143982
11 O 0 0.03702576458454132
. O 0 0.03519301116466522

Pulse O 1 0.9908913969993591
- O 1 0.8862184286117554
chase O 0 0.03943352401256561
analysis O 0 0.01426753494888544
using O 0 0.012987123802304268
proband O 1 0.9786590337753296
fibroblasts O 0 0.06825893372297287
revealed O 0 0.01364099234342575
that O 0 0.004647661466151476
the O 0 0.009575502946972847
W474C O 1 0.9909616112709045
- O 1 0.9727600812911987
containing O 0 0.01922878995537758
alpha O 0 0.035360682755708694
- O 1 0.852969765663147
subunit O 0 0.028565436601638794
precursor O 0 0.02316143736243248
was O 0 0.014327195473015308
normally O 0 0.012917578220367432
synthesized O 0 0.016431143507361412
, O 0 0.006904044188559055
but O 0 0.004273398779332638
not O 0 0.004629249684512615
phosphorylated O 0 0.021054301410913467
or O 0 0.007160286419093609
secreted O 0 0.015022429637610912
, O 0 0.006053506396710873
and O 0 0.004612294491380453
the O 0 0.006485817488282919
mature O 0 0.09984376281499863
lysosomal O 1 0.9999922513961792
alpha O 1 0.9719842672348022
- O 1 0.9995161294937134
subunit O 0 0.03105613961815834
was O 0 0.01547215785831213
not O 0 0.01149227749556303
detected O 0 0.02808082476258278
. O 0 0.02744220942258835

When O 0 0.02735111676156521
the O 0 0.021411579102277756
W474C O 1 0.8781962394714355
- O 1 0.8498274087905884
containing O 0 0.020828982815146446
alpha O 0 0.03564643859863281
- O 0 0.30990126729011536
subunit O 0 0.028849177062511444
was O 0 0.01742870919406414
transiently O 1 0.5749882459640503
co O 1 0.5936956405639648
- O 0 0.12910890579223633
expressed O 0 0.008753386326134205
with O 0 0.0053827883675694466
the O 0 0.009548506699502468
beta O 0 0.04108119010925293
- O 1 0.5471224188804626
subunit O 0 0.021110041067004204
to O 0 0.007171895820647478
produce O 0 0.010638649575412273
Hex O 0 0.038135118782520294
A O 0 0.017054682597517967
( O 0 0.012733007781207561
alphabeta O 1 0.6385927200317383
) O 0 0.010965599678456783
in O 0 0.012174447998404503
COS O 1 1.0
- O 1 0.9999837875366211
7 O 0 0.01848413050174713
cells O 0 0.010146447457373142
, O 0 0.006054539233446121
the O 0 0.007265820633620024
mature O 0 0.014285343699157238
alpha O 0 0.031544558703899384
- O 1 0.9878139495849609
subunit O 0 0.018207307904958725
was O 0 0.00842722225934267
present O 0 0.004793390166014433
, O 0 0.004421532154083252
but O 0 0.0026169230695813894
its O 0 0.00380857870914042
level O 0 0.004537460394203663
was O 0 0.005912246182560921
much O 0 0.004722267389297485
lower O 0 0.005239793565124273
than O 0 0.002592658158391714
that O 0 0.0023138897959142923
from O 0 0.0033406580332666636
normal O 0 0.006718548946082592
alpha O 0 0.023467158898711205
- O 1 0.8969839215278625
subunit O 0 0.025809897109866142
transfections O 0 0.20812909305095673
, O 0 0.007052031811326742
although O 0 0.004606120754033327
higher O 0 0.005153864622116089
than O 0 0.0037007948849350214
in O 0 0.0044725011102855206
those O 0 0.004762146156281233
cells O 0 0.010362155735492706
transfected O 0 0.033858444541692734
with O 0 0.006842568516731262
an O 0 0.009265825152397156
alpha O 0 0.1240689605474472
- O 1 0.9820997714996338
subunit O 0 0.03483186289668083
associated O 0 0.015660956501960754
with O 0 0.019583648070693016
infantile O 1 1.0
TSD B-Disease 1 1.0
. O 0 0.0595843605697155

Furthermore O 0 0.039029937237501144
, O 0 0.012381114065647125
the O 0 0.011084373109042645
precursor O 0 0.02006637305021286
level O 0 0.010065934620797634
of O 0 0.008719068020582199
the O 0 0.010855639353394508
W474C O 1 0.9097824096679688
alpha O 0 0.06218082830309868
- O 1 0.8857381343841553
subunit O 0 0.0210817102342844
was O 0 0.009913468733429909
found O 0 0.005222201347351074
to O 0 0.0058785597793757915
accumulate O 0 0.014073461294174194
in O 0 0.005356115289032459
comparison O 0 0.007610755041241646
to O 0 0.005977002903819084
the O 0 0.007954169064760208
normal O 0 0.014699552208185196
alpha O 0 0.042320333421230316
- O 1 0.9925411939620972
subunit O 0 0.05388358235359192
precursor O 0 0.05369894951581955
levels O 0 0.026118500158190727
. O 0 0.03193838521838188

We O 0 0.017658190801739693
conclude O 0 0.0186258964240551
that O 0 0.006217991001904011
the O 0 0.011695082299411297
1422 O 1 0.9999964237213135
G O 1 0.9999947547912598
- O 1 0.9999992847442627
- O 1 0.9999961853027344
> O 1 0.9990212917327881
C O 1 0.9247580766677856
mutation O 0 0.01314568892121315
is O 0 0.005321510136127472
the O 0 0.006455425638705492
cause O 0 0.008813975378870964
of O 0 0.008891276083886623
Hex B-Disease 1 0.9999414682388306
A I-Disease 1 0.9999666213989258
enzyme I-Disease 1 0.9999980926513672
deficiency I-Disease 1 1.0
in O 0 0.020666051656007767
the O 0 0.028722794726490974
proband O 1 0.9999582767486572
. O 0 0.03778155520558357

The O 0 0.0339231938123703
resulting O 0 0.03001801297068596
W474C O 1 0.9422885775566101
substitution O 0 0.029674362391233444
clearly O 0 0.01690436340868473
interferes O 0 0.02740393951535225
with O 0 0.010377167724072933
alpha O 0 0.10693761706352234
- O 1 0.9885603785514832
subunit O 0 0.021152062341570854
processing O 0 0.010006308555603027
, O 0 0.005735965445637703
but O 0 0.004175697918981314
because O 0 0.004029268864542246
the O 0 0.005525882821530104
base O 0 0.013761637732386589
substitution O 0 0.017300184816122055
falls O 0 0.02027171105146408
at O 0 0.009534614160656929
the O 0 0.007044619880616665
first O 0 0.008218083530664444
position O 0 0.010049075819551945
of O 0 0.009636040776968002
exon O 0 0.034969259053468704
13 O 0 0.014772688038647175
, O 0 0.01110115461051464
aberrant O 0 0.027325725182890892
splicing O 0 0.016705073416233063
may O 0 0.006289621815085411
also O 0 0.005549832712858915
contribute O 0 0.007604505401104689
to O 0 0.006754267029464245
Hex B-Disease 1 0.8423699736595154
A I-Disease 1 0.9953275918960571
deficiency I-Disease 1 1.0
in O 0 0.011309711262583733
this O 0 0.010556045919656754
proband O 1 0.9995052814483643
. O 0 0.017686067149043083
. O 0 0.02609947696328163

Two O 0 0.027801059186458588
frequent O 0 0.03437351435422897
missense O 0 0.0568121112883091
mutations O 0 0.028440820053219795
in O 0 0.03868572786450386
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9580239653587341

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.02954857051372528
an O 1 0.9943159222602844
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9661475419998169
early O 1 0.9999985694885254
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999998807907104
goiter B-Disease 1 1.0
. O 1 0.9989161491394043

A O 0 0.028640050441026688
century O 0 0.02106115221977234
after O 0 0.00950304139405489
its O 0 0.007065033074468374
recognition O 0 0.00941543560475111
as O 0 0.007520966697484255
a O 0 0.015535319223999977
syndrome O 1 1.0
by O 0 0.008945746347308159
Vaughan O 1 0.9999710321426392
Pendred O 1 0.9999842643737793
, O 0 0.008378417231142521
the O 0 0.011834118515253067
disease O 1 1.0
gene O 0 0.32798877358436584
( O 0 0.1045680046081543
PDS O 1 1.0
) O 0 0.01227826438844204
was O 0 0.013623128645122051
mapped O 0 0.022444285452365875
to O 0 0.012925862334668636
chromosome O 0 0.032051850110292435
7q22 O 1 0.9996850490570068
- O 1 0.9999673366546631
q31 O 1 0.996966540813446
. O 0 0.040096465498209

1 O 0 0.033626846969127655
and O 0 0.01438245177268982
, O 0 0.010842181742191315
recently O 0 0.012852865271270275
, O 0 0.007437100633978844
found O 0 0.005516738165169954
to O 0 0.006731374654918909
encode O 0 0.01846477761864662
a O 0 0.02116941101849079
putative O 1 0.9786016941070557
sulfate O 1 0.9999983310699463
transporter O 1 0.9995617270469666
. O 0 0.047706082463264465

We O 0 0.01963774673640728
performed O 0 0.019926298409700394
mutation O 0 0.013226281851530075
analysis O 0 0.007119577378034592
of O 0 0.007143796421587467
the O 0 0.010938488878309727
PDS B-Disease 1 0.9999998807907104
gene O 0 0.011996732093393803
in O 0 0.007784358225762844
patients O 0 0.19932234287261963
from O 0 0.007651588413864374
14 O 0 0.013303467072546482
Pendred B-Disease 1 0.9192973971366882
families O 0 0.010015301406383514
originating O 0 0.008862321265041828
from O 0 0.00534517178311944
seven O 0 0.006071827374398708
countries O 0 0.004031164105981588
and O 0 0.006176249124109745
identified O 0 0.009334668517112732
all O 0 0.008974234573543072
mutations O 0 0.020295262336730957
. O 0 0.02131347544491291

The O 0 0.029178384691476822
mutations O 0 0.016102192923426628
include O 0 0.009398186579346657
three O 0 0.008009688928723335
single O 0 0.010822954587638378
base O 0 0.01887986995279789
deletions O 0 0.020459158346056938
, O 0 0.008000821806490421
one O 0 0.008443507365882397
splice O 0 0.03197525069117546
site O 0 0.017014337703585625
mutation O 0 0.01444611418992281
and O 0 0.008909637108445168
10 O 0 0.018764937296509743
missense O 0 0.04732730984687805
mutations O 0 0.03165208548307419
. O 0 0.031157387420535088

One O 0 0.039201438426971436
missense O 0 0.06180538609623909
mutation O 0 0.031283050775527954
( O 0 0.017756182700395584
L236P O 1 0.99268639087677
) O 0 0.010585520416498184
was O 0 0.010485915467143059
found O 0 0.005506136454641819
in O 0 0.004884700756520033
a O 0 0.0059964885003864765
homozygous O 0 0.010145624168217182
state O 0 0.00488104484975338
in O 0 0.005070646293461323
two O 0 0.005308190360665321
consanguineous O 0 0.045218780636787415
families O 0 0.007571233436465263
and O 0 0.005307742394506931
in O 0 0.004303839989006519
a O 0 0.007058910559862852
heterozygous O 0 0.009968670085072517
state O 0 0.00413685105741024
in O 0 0.00458995345979929
five O 0 0.006134633906185627
additional O 0 0.009825475513935089
non O 0 0.02209407649934292
- O 1 0.9998977184295654
consanguineous O 1 0.912765622138977
families O 0 0.030340861529111862
. O 0 0.036195725202560425

Another O 0 0.046560563147068024
missense O 0 0.07778489589691162
mutation O 0 0.031803298741579056
( O 0 0.018153222277760506
T416P O 1 0.9987391829490662
) O 0 0.011006524786353111
was O 0 0.012372906319797039
found O 0 0.005349889397621155
in O 0 0.005373510532081127
a O 0 0.007325368467718363
homozygous O 0 0.01158592663705349
state O 0 0.004198725800961256
in O 0 0.004723092541098595
one O 0 0.005498098209500313
family O 0 0.007295443210750818
and O 0 0.005136427935212851
in O 0 0.005269543267786503
a O 0 0.007664783392101526
heterozygous O 0 0.012813272885978222
state O 0 0.006124351639300585
in O 0 0.00808024313300848
four O 0 0.01175488717854023
families O 0 0.016900256276130676
. O 0 0.026046492159366608

Pendred B-Disease 1 0.9995480179786682
patients O 0 0.08652440458536148
in O 0 0.010807360522449017
three O 0 0.009393543936312199
non O 0 0.024469474330544472
- O 1 0.9999585151672363
consanguineous O 1 0.8798502683639526
families O 0 0.00855952501296997
were O 0 0.004578373394906521
shown O 0 0.004889661446213722
to O 0 0.004856260493397713
be O 0 0.005184668581932783
compound O 0 0.024311712011694908
heterozygotes O 0 0.42205119132995605
for O 0 0.014252567663788795
L236P O 1 0.9953047037124634
and O 0 0.027949493378400803
T416P O 1 0.9709269404411316
. O 0 0.040852274745702744

In O 0 0.015597252175211906
total O 0 0.010884801857173443
, O 0 0.00696735130622983
one O 0 0.005693214014172554
or O 0 0.003824261948466301
both O 0 0.0029731490649282932
of O 0 0.003712973790243268
these O 0 0.003087797900661826
mutations O 0 0.004882754758000374
were O 0 0.003044763347133994
found O 0 0.0033595850691199303
in O 0 0.0030690403655171394
nine O 0 0.005494553595781326
of O 0 0.005245751701295376
the O 0 0.00829989556223154
14 O 0 0.015048756264150143
families O 0 0.014485176652669907
analyzed O 0 0.030867835506796837
. O 0 0.028245868161320686

The O 0 0.021457096561789513
identification O 0 0.01757851243019104
of O 0 0.00983739085495472
two O 0 0.008118140511214733
frequent O 0 0.020563215017318726
PDS B-Disease 1 0.9999998807907104
mutations O 0 0.01384352520108223
will O 0 0.007029892411082983
facilitate O 0 0.009120895527303219
the O 0 0.00933433324098587
molecular O 0 0.027614569291472435
diagnosis O 1 0.9999977350234985
of O 1 0.9993717074394226
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.992290198802948

Insertional O 1 0.947767436504364
mutation O 0 0.040424149483442307
by O 0 0.017995072528719902
transposable O 1 0.8051763772964478
element O 0 0.03144586458802223
, O 0 0.016759704798460007
L1 O 1 0.9999496936798096
, O 0 0.0076970672234892845
in O 0 0.006584697403013706
the O 0 0.011284323409199715
DMD B-Disease 1 1.0
gene O 0 0.012326228432357311
results O 0 0.00815634150058031
in O 0 0.009157841093838215
X B-Disease 1 0.9999605417251587
- I-Disease 1 0.9999996423721313
linked I-Disease 1 0.9985217452049255
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
. O 0 0.33584046363830566

X B-Disease 1 0.999722421169281
- I-Disease 1 0.9999971389770508
linked I-Disease 1 0.9996731281280518
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999823570251465
XLDCM B-Disease 1 1.0
) O 0 0.011017742566764355
is O 0 0.007164043374359608
a O 0 0.00910948310047388
clinical O 1 0.9868369102478027
phenotype O 1 0.908033549785614
of O 0 0.01698598638176918
dystrophinopathy B-Disease 1 0.999995231628418
which O 0 0.007052623201161623
is O 0 0.0065015279687941074
characterized O 0 0.010432161390781403
by O 0 0.0067769200541079044
preferential O 1 0.9997716546058655
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9114611148834229
without O 0 0.00760978227481246
any O 0 0.007126373238861561
overt O 0 0.38240477442741394
clinical O 1 0.9999834299087524
signs O 1 0.986817479133606
of O 1 0.99858558177948
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9530655145645142

To O 0 0.018093569204211235
date O 0 0.013833021745085716
, O 0 0.007633224129676819
several O 0 0.006013939622789621
mutations O 0 0.008067804388701916
in O 0 0.007004117127507925
the O 0 0.02339295484125614
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999780654907227
, O 1 0.998877227306366
DMD O 1 1.0
, O 0 0.009535864926874638
have O 0 0.004091186914592981
been O 0 0.0037228225264698267
identified O 0 0.004195805639028549
in O 0 0.004336938261985779
patients O 1 0.7378919720649719
with O 0 0.008727640844881535
XLDCM B-Disease 1 1.0
, O 0 0.006270425394177437
but O 0 0.004537337925285101
a O 0 0.006964339409023523
pathogenic O 0 0.011590974405407906
correlation O 0 0.008214004337787628
of O 0 0.005910475272685289
these O 0 0.005428090691566467
cardiospecific O 1 0.8985462188720703
mutations O 0 0.013868017122149467
in O 0 0.012462000362575054
DMD O 1 0.9999998807907104
with O 0 0.01251654140651226
the O 0 0.018681421875953674
XLDCM B-Disease 1 0.9999995231628418
phenotype O 1 0.96622234582901
has O 0 0.012208984233438969
remained O 0 0.01676672324538231
to O 0 0.009628303349018097
be O 0 0.011421186849474907
elucidated O 0 0.09256747364997864
. O 0 0.033034030348062515

We O 0 0.018947308883070946
report O 0 0.012790373526513577
here O 0 0.008036509156227112
the O 0 0.006383007857948542
identification O 0 0.008010250516235828
of O 0 0.006358238868415356
a O 0 0.00895063579082489
unique O 0 0.013625903986394405
de O 0 0.08423090726137161
novo O 1 0.9547441005706787
L1 O 1 0.9983822107315063
insertion O 0 0.028174495324492455
in O 0 0.009351343847811222
the O 0 0.011122982949018478
muscle O 1 0.8008515238761902
exon O 1 0.5414171814918518
1 O 0 0.015606105327606201
in O 0 0.011332212947309017
DMD O 1 0.9999992847442627
in O 0 0.010533548891544342
three O 0 0.012592262588441372
XLDCM B-Disease 1 0.9999972581863403
patients O 1 0.6098028421401978
from O 0 0.008542262949049473
two O 0 0.008557912893593311
unrelated O 0 0.018792446702718735
Japanese O 0 0.0375397652387619
families O 0 0.02492789551615715
. O 0 0.030112138018012047

The O 0 0.031462766230106354
insertion O 0 0.043789587914943695
was O 0 0.01762368157505989
a O 0 0.013234454207122326
5 O 0 0.017715906724333763
- O 1 0.7207896709442139
truncated O 0 0.022569965571165085
form O 0 0.007576624397188425
of O 0 0.0071403710171580315
human O 0 0.010177934542298317
L1 O 1 0.9999010562896729
inversely O 0 0.02723519690334797
integrated O 0 0.01841987669467926
in O 0 0.007108611520379782
the O 0 0.0079248808324337
5 O 0 0.014553874731063843
- O 1 0.9433683753013611
untranslated O 0 0.13047678768634796
region O 0 0.00988907739520073
in O 0 0.006594674661755562
the O 0 0.010430696420371532
muscle O 1 0.9984756112098694
exon O 1 0.9961287975311279
1 O 0 0.014044300653040409
, O 0 0.006225285120308399
which O 0 0.004159049596637487
affected O 0 0.0057174707762897015
the O 0 0.0055075837299227715
transcription O 0 0.008900622837245464
or O 0 0.003628574311733246
the O 0 0.004887464921921492
stability O 0 0.008893604390323162
of O 0 0.00579034723341465
the O 0 0.008809967897832394
muscle O 1 0.9986948370933533
form O 0 0.0073918309062719345
of O 0 0.010236690752208233
dystrophin O 1 0.9999934434890747
transcripts O 0 0.01500769704580307
but O 0 0.004049842711538076
not O 0 0.0022655243519693613
that O 0 0.002006364520639181
of O 0 0.0039327628910541534
the O 0 0.006115888245403767
brain O 1 0.9984279870986938
or O 0 0.028398998081684113
Purkinje O 1 1.0
cell O 1 0.9499555230140686
form O 0 0.008313128724694252
, O 0 0.00640169158577919
probably O 0 0.006635207217186689
due O 0 0.005075919907540083
to O 0 0.005007389932870865
its O 0 0.00672148959711194
unique O 0 0.009481215849518776
site O 0 0.013343478552997112
of O 0 0.010269382037222385
integration O 0 0.0322759710252285
. O 0 0.029753832146525383

We O 0 0.021923372521996498
speculate O 0 0.020298214629292488
that O 0 0.0064571877010166645
this O 0 0.005366622004657984
insertion O 0 0.015719370916485786
of O 0 0.006515504792332649
an O 0 0.009195171296596527
L1 O 1 0.9998538494110107
sequence O 0 0.013723964802920818
in O 0 0.011669558472931385
DMD O 1 1.0
is O 0 0.008729462511837482
responsible O 0 0.007785861846059561
for O 0 0.004357859492301941
some O 0 0.0030284856911748648
of O 0 0.0036543351598083973
the O 0 0.004469589330255985
population O 0 0.0038664955645799637
of O 0 0.006006476003676653
Japanese O 1 0.9482600688934326
patients O 1 0.9986276626586914
with O 0 0.018560852855443954
XLDCM B-Disease 1 0.999998927116394
. O 0 0.024282343685626984
. O 0 0.03666721656918526

Severe O 1 0.9998021721839905
early O 1 0.8327178359031677
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999996423721313
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999994039535522
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
caused O 1 0.9998235106468201
by O 0 0.022478878498077393
POMC O 1 1.0
mutations O 0 0.03004802204668522
in O 0 0.018358953297138214
humans O 0 0.02429346926510334
. O 0 0.032655537128448486

Sequential O 0 0.08162742853164673
cleavage O 0 0.058012209832668304
of O 0 0.014306051656603813
the O 0 0.012244981713593006
precursor O 0 0.023519208654761314
protein O 0 0.014284956268966198
pre O 0 0.1196143627166748
- O 1 0.9993708729743958
pro O 0 0.4257255494594574
- O 1 0.9999247789382935
opiomelanocortin O 1 0.999233603477478
( O 0 0.028480105102062225
POMC O 1 0.9997747540473938
) O 0 0.01998237706720829
generates O 0 0.027155207470059395
the O 0 0.01658601313829422
melanocortin O 1 0.9995216131210327
peptides O 0 0.08944962918758392
adrenocorticotrophin O 1 0.9999850988388062
( O 0 0.028301585465669632
ACTH O 1 0.9999876022338867
) O 0 0.01697121374309063
, O 0 0.018006805330514908
melanocyte O 1 0.9999996423721313
- O 1 0.9999992847442627
stimulating O 1 0.9998815059661865
hormones O 1 0.9575332403182983
( O 0 0.027569463476538658
MSH O 1 0.9999998807907104
) O 0 0.015943732112646103
alpha O 0 0.027809258550405502
, O 0 0.010550091043114662
beta O 0 0.02173103764653206
and O 0 0.00844006147235632
gamma O 0 0.018966054543852806
as O 0 0.006617899984121323
well O 0 0.004959171172231436
as O 0 0.005736637394875288
the O 0 0.008704518899321556
opioid O 1 0.9999126195907593
- O 1 0.9999918937683105
receptor O 0 0.049358706921339035
ligand O 1 0.6065006256103516
beta O 1 0.9614366888999939
- O 1 0.9999176263809204
endorphin O 1 0.9991500377655029
. O 0 0.048615287989377975

While O 0 0.020314455032348633
a O 0 0.011750148609280586
few O 0 0.009411285631358624
cases O 0 0.007551210001111031
of O 0 0.010315419174730778
isolated O 1 0.9998958110809326
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.007574703078716993
been O 0 0.00847399327903986
reported O 0 0.014267213642597198
( O 0 0.016757316887378693
OMIM O 1 1.0
201400 O 1 0.9998589754104614
) O 0 0.011002233251929283
, O 0 0.010015064850449562
an O 0 0.011328848078846931
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.9999997615814209
has O 0 0.012192364782094955
not O 0 0.0061258552595973015
been O 0 0.006522836163640022
described O 0 0.00994592159986496
so O 0 0.009022398851811886
far O 0 0.01406028214842081
. O 0 0.020604128018021584

Recent O 0 0.02592455968260765
studies O 0 0.015277059748768806
in O 0 0.010743166320025921
animal O 0 0.01322538498789072
models O 0 0.01570262387394905
elucidated O 0 0.029598930850625038
a O 0 0.007972185499966145
central O 0 0.007487150840461254
role O 0 0.008693721145391464
of O 0 0.009111522696912289
alpha O 1 0.9109784960746765
- O 1 0.9999939203262329
MSH O 1 0.999993085861206
in O 0 0.00923688244074583
the O 0 0.007307041902095079
regulation O 0 0.010036902502179146
of O 0 0.008000344969332218
food O 0 0.012140522710978985
intake O 0 0.018649721518158913
by O 0 0.006197481881827116
activation O 0 0.012614059261977673
of O 0 0.008048458024859428
the O 0 0.011865934357047081
brain O 1 0.9014126062393188
melanocortin O 1 0.999995231628418
- O 1 0.9999756813049316
4 O 0 0.030110470950603485
- O 1 0.9981250166893005
receptor O 0 0.02604955993592739
( O 0 0.019694119691848755
MC4 O 1 0.9999974966049194
- O 1 0.999790370464325
R O 1 0.5818317532539368
; O 0 0.0142364501953125
refs O 0 0.039820361882448196
3 O 0 0.019770406186580658
- O 1 0.7881438732147217
5 O 0 0.01110992580652237
) O 0 0.0052831824868917465
and O 0 0.004147023428231478
the O 0 0.005025382153689861
linkage O 0 0.011897866614162922
of O 0 0.006875908933579922
human O 0 0.013316481374204159
obesity B-Disease 1 1.0
to O 0 0.009457753039896488
chromosome O 0 0.014576480723917484
2 O 0 0.009873807430267334
in O 0 0.005875094328075647
close O 0 0.008877218700945377
proximity O 0 0.01175412442535162
to O 0 0.006961879786103964
the O 0 0.012369574047625065
POMC O 1 0.9999988079071045
locus O 1 0.8400554656982422
, O 0 0.010431935079395771
led O 0 0.010164273902773857
to O 0 0.005137631669640541
the O 0 0.005033438093960285
proposal O 0 0.00664020050317049
of O 0 0.004420184530317783
an O 0 0.005089835729449987
association O 0 0.012311908416450024
of O 0 0.014260172843933105
POMC O 1 1.0
with O 0 0.020097380504012108
human O 1 0.6142505407333374
obesity B-Disease 1 1.0
. O 0 0.04494951292872429

The O 0 0.03204379230737686
dual O 0 0.03470833599567413
role O 0 0.01944991759955883
of O 0 0.014871821738779545
alpha O 1 0.8691441416740417
- O 1 0.9999884366989136
MSH O 1 0.9999887943267822
in O 0 0.0133198332041502
regulating O 0 0.021611446514725685
food O 0 0.016995200887322426
intake O 0 0.028582192957401276
and O 0 0.010974524542689323
influencing O 0 0.038954105228185654
hair O 1 0.9996457099914551
pigmentation O 1 0.9999983310699463
predicts O 0 0.4904865324497223
that O 0 0.005820850376039743
the O 0 0.008289904333651066
phenotype O 0 0.05306442454457283
associated O 0 0.007514079101383686
with O 0 0.005720778834074736
a O 0 0.010748093016445637
defect O 1 0.9999443292617798
in O 0 0.014570782892405987
POMC O 1 0.9999997615814209
function O 0 0.009856224991381168
would O 0 0.008678766898810863
include O 0 0.01402151957154274
obesity B-Disease 1 0.9999998807907104
, O 0 0.011488085612654686
alteration O 1 0.985093355178833
in O 0 0.2255951315164566
pigmentation O 1 1.0
and O 1 0.9999924898147583
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.8290589451789856

The O 0 0.0228671133518219
observation O 0 0.029137233272194862
of O 0 0.01216270960867405
these O 0 0.009010319598019123
symptoms O 1 0.9997120499610901
in O 0 0.007575842551887035
two O 0 0.00817921757698059
probands O 1 0.9983022212982178
prompted O 0 0.01580190472304821
us O 0 0.009932281449437141
to O 0 0.006289961747825146
search O 0 0.009740053676068783
for O 0 0.007207928225398064
mutations O 0 0.011809052899479866
within O 0 0.008258547633886337
their O 0 0.013215245679020882
POMC O 1 0.9999983310699463
genes O 0 0.036946576088666916
. O 0 0.03230470046401024

Patient O 1 0.9995526671409607
1 O 0 0.026030009612441063
was O 0 0.014146407134830952
found O 0 0.005946157034486532
to O 0 0.004986001178622246
be O 0 0.004265496972948313
a O 0 0.008399177342653275
compound O 0 0.019730495288968086
heterozygote O 0 0.0400119423866272
for O 0 0.007588012609630823
two O 0 0.005957899149507284
mutations O 0 0.008257376030087471
in O 0 0.006507977843284607
exon O 0 0.06343381851911545
3 O 0 0.013342022895812988
( O 0 0.01118907704949379
G7013T O 1 0.9079155921936035
, O 0 0.014157922938466072
C7133delta O 1 0.9997910857200623
) O 0 0.008704198524355888
which O 0 0.006013489328324795
interfere O 0 0.010498171672224998
with O 0 0.006119848694652319
appropriate O 0 0.009431361220777035
synthesis O 0 0.01650906540453434
of O 0 0.015331989154219627
ACTH O 1 0.9999979734420776
and O 0 0.033103179186582565
alpha O 1 0.9952200055122375
- O 1 0.9999785423278809
MSH O 1 0.9999896287918091
. O 0 0.06151473522186279

Patient O 1 0.9916000366210938
2 O 0 0.027663933113217354
was O 0 0.01853848434984684
homozygous O 0 0.020596932619810104
for O 0 0.00725826108828187
a O 0 0.010879828594624996
mutation O 0 0.012314042076468468
in O 0 0.009250813163816929
exon O 0 0.38092026114463806
2 O 0 0.019781198352575302
( O 0 0.018779555335640907
C3804A O 1 0.6494718194007874
) O 0 0.018954452127218246
which O 0 0.023337222635746002
abolishes O 1 0.9961482286453247
POMC O 1 0.9999699592590332
translation O 0 0.06777448207139969
. O 0 0.052571240812540054

These O 0 0.01481540221720934
findings O 0 0.013728135265409946
represent O 0 0.00879431702196598
the O 0 0.006282172631472349
first O 0 0.007380541879683733
examples O 0 0.0072760675102472305
of O 0 0.005270183086395264
a O 0 0.009181826375424862
genetic B-Disease 1 0.8459450006484985
defect I-Disease 1 0.9999587535858154
within O 0 0.009971258230507374
the O 0 0.014112452045083046
POMC O 1 0.9999992847442627
gene O 0 0.013203112408518791
and O 0 0.007304537575691938
define O 0 0.012045747600495815
a O 0 0.00975382886826992
new O 0 0.01825629360973835
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.18836276233196259
in O 0 0.007621624507009983
early O 1 0.9725592136383057
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999856948852539
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999996423721313
red O 1 1.0
hair O 1 1.0
pigmentation O 1 1.0
. O 0 0.029554981738328934
. O 0 0.0359121710062027

A O 0 0.03558396175503731
European O 0 0.02612336538732052
multicenter O 0 0.45206132531166077
study O 0 0.016731753945350647
of O 0 0.01878918707370758
phenylalanine B-Disease 1 0.9999998807907104
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.027313653379678726
classification O 0 0.024912485852837563
of O 0 0.01075488980859518
105 O 0 0.09284493327140808
mutations O 0 0.009319283999502659
and O 0 0.004081400576978922
a O 0 0.005253585521131754
general O 0 0.007148377131670713
system O 0 0.005876592826098204
for O 0 0.006298034451901913
genotype O 0 0.4430944323539734
- O 1 0.8468537330627441
based O 0 0.011069373227655888
prediction O 0 0.027944786474108696
of O 0 0.02006702870130539
metabolic O 1 0.9999924898147583
phenotype O 1 0.9989745616912842
. O 0 0.03817976266145706

Phenylketonuria B-Disease 1 0.9999997615814209
( O 1 0.8075926899909973
PKU B-Disease 1 1.0
) O 0 0.021239005029201508
and O 0 0.016863850876688957
mild B-Disease 1 0.9999998807907104
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9999858140945435
MHP B-Disease 1 1.0
) O 0 0.016566425561904907
are O 0 0.009391866624355316
allelic B-Disease 1 0.9999940395355225
disorders I-Disease 1 1.0
caused O 1 0.9951465725898743
by O 0 0.008247674442827702
mutations O 0 0.00981533620506525
in O 0 0.006267006509006023
the O 0 0.00741576449945569
gene O 0 0.011198614723980427
encoding O 0 0.01925278827548027
phenylalanine O 1 0.996933102607727
hydroxylase O 1 0.9999847412109375
( O 1 0.8445854187011719
PAH O 1 1.0
) O 0 0.04203634709119797
. O 0 0.04074033349752426

Previous O 0 0.02521887794137001
studies O 0 0.013714906759560108
have O 0 0.005401397589594126
suggested O 0 0.005540663842111826
that O 0 0.0031867490615695715
the O 0 0.005365947261452675
highly O 0 0.011221474036574364
variable O 0 0.014375907368957996
metabolic O 1 0.9995700716972351
phenotypes O 1 0.9991576671600342
of O 1 0.9999803304672241
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999916553497314
with O 1 0.9987152814865112
PAH O 1 1.0
genotypes O 1 0.9999357461929321
. O 0 0.06626208126544952

We O 0 0.019682742655277252
identified O 0 0.015449339523911476
both O 0 0.009580913931131363
causative O 0 0.04600274935364723
mutations O 0 0.013445536606013775
in O 0 0.009294917806982994
686 O 1 0.9999994039535522
patients O 1 0.999028205871582
from O 0 0.008438306860625744
seven O 0 0.012900789268314838
European O 0 0.018683090806007385
centers O 0 0.028130345046520233
. O 0 0.02565431408584118

On O 0 0.018841732293367386
the O 0 0.010765822604298592
basis O 0 0.006761746481060982
of O 0 0.006428764201700687
the O 0 0.00778614915907383
phenotypic O 0 0.017617860808968544
characteristics O 0 0.013376993127167225
of O 0 0.012276576831936836
297 O 1 0.9987608194351196
functionally O 1 0.9998815059661865
hemizygous O 1 0.999997615814209
patients O 1 0.9636410474777222
, O 0 0.00954543985426426
105 O 0 0.018132176250219345
of O 0 0.007131415419280529
the O 0 0.007558721583336592
mutations O 0 0.008308546617627144
were O 0 0.004141328856348991
assigned O 0 0.008853022940456867
to O 0 0.004652207717299461
one O 0 0.004974895156919956
of O 0 0.005694334860891104
four O 0 0.008299209177494049
arbitrary O 0 0.013592240400612354
phenotype O 1 0.655187726020813
categories O 0 0.034906771034002304
. O 0 0.03305545449256897

We O 0 0.021339774131774902
proposed O 0 0.017424099147319794
and O 0 0.010875714011490345
tested O 0 0.015055463649332523
a O 0 0.00932165328413248
simple O 0 0.00883184652775526
model O 0 0.009828654117882252
for O 0 0.005893537309020758
correlation O 0 0.01248149760067463
between O 0 0.009971587918698788
genotype O 0 0.035805750638246536
and O 0 0.013721751980483532
phenotypic O 0 0.042429279536008835
outcome O 0 0.034771066159009933
. O 0 0.03454945608973503

The O 0 0.02957758679986
observed O 0 0.024298278614878654
phenotype O 0 0.03615986183285713
matched O 0 0.02282567135989666
the O 0 0.010809451341629028
predicted O 0 0.016551585868000984
phenotype O 0 0.019251609221100807
in O 0 0.006881185807287693
79 O 0 0.0188987385481596
% O 0 0.006206113379448652
of O 0 0.004978902637958527
the O 0 0.005427653435617685
cases O 0 0.00492828106507659
, O 0 0.004685272462666035
and O 0 0.0036066072061657906
in O 0 0.003388745943084359
only O 0 0.0033596870489418507
5 O 0 0.006881811656057835
of O 0 0.006549272686243057
184 O 1 0.8219067454338074
patients O 1 0.9747228622436523
was O 0 0.009096553549170494
the O 0 0.006834323052316904
observed O 0 0.007655036635696888
phenotype O 0 0.013747471384704113
more O 0 0.004703061189502478
than O 0 0.0044138771481812
one O 0 0.00508078932762146
category O 0 0.010214326903223991
away O 0 0.0077733551152050495
from O 0 0.005340279079973698
that O 0 0.0060391612350940704
expected O 0 0.016796739771962166
. O 0 0.024645894765853882

Among O 0 0.02189885824918747
the O 0 0.01264919899404049
seven O 0 0.011330883018672466
contributing O 0 0.011988732032477856
centers O 0 0.009168222546577454
, O 0 0.004592899698764086
the O 0 0.004654314368963242
proportion O 0 0.006266020238399506
of O 0 0.006319557782262564
patients O 1 0.9561811685562134
for O 0 0.00492449663579464
whom O 0 0.007248214911669493
the O 0 0.0060096485540270805
observed O 0 0.008432986214756966
phenotype O 0 0.016147803515195847
did O 0 0.005864206235855818
not O 0 0.003716210601851344
match O 0 0.006740460637956858
the O 0 0.005217145197093487
predicted O 0 0.012253539636731148
phenotype O 0 0.0177917517721653
was O 0 0.009973829612135887
4 O 0 0.010750115849077702
% O 0 0.009342707693576813
- O 0 0.050509437918663025
23 O 0 0.013095608912408352
% O 0 0.009196717292070389
( O 0 0.011963455006480217
P O 1 0.9577452540397644
< O 1 0.9284547567367554
. O 0 0.011262515559792519
0001 O 1 0.8275503516197205
) O 0 0.009058943949639797
, O 0 0.00651746429502964
suggesting O 0 0.007085309363901615
that O 0 0.002777850953862071
differences O 0 0.004010944627225399
in O 0 0.003134771715849638
methods O 0 0.0034735563676804304
used O 0 0.003326361533254385
for O 0 0.004186090547591448
mutation O 0 0.009443801827728748
detection O 0 0.05327073857188225
or O 0 0.007812547497451305
phenotype O 1 0.995063841342926
classification O 1 0.5716648101806641
may O 0 0.005751882214099169
account O 0 0.005164304748177528
for O 0 0.003993032965809107
a O 0 0.006118281744420528
considerable O 0 0.010282844305038452
proportion O 0 0.01202538050711155
of O 0 0.012087869457900524
genotype O 1 0.9986287355422974
- O 1 0.9999949932098389
phenotype O 1 0.9435567259788513
inconsistencies O 0 0.05791277438402176
. O 0 0.039127811789512634

Our O 0 0.023209450766444206
data O 0 0.011098789051175117
indicate O 0 0.008958464488387108
that O 0 0.0066016498021781445
the O 0 0.016492754220962524
PAH O 1 1.0
- O 1 0.9999996423721313
mutation O 0 0.02593686804175377
genotype O 0 0.02778884582221508
is O 0 0.008497270755469799
the O 0 0.008242129348218441
main O 0 0.014315442182123661
determinant O 0 0.16124820709228516
of O 0 0.013695323839783669
metabolic O 1 0.9999840259552002
phenotype O 1 0.9346950650215149
in O 0 0.008516527712345123
most O 0 0.011226678267121315
patients O 1 0.9999963045120239
with O 1 0.9999897480010986
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9627557396888733

In O 0 0.019459785893559456
the O 0 0.01214054599404335
present O 0 0.010073458775877953
study O 0 0.008672771044075489
, O 0 0.006014070473611355
the O 0 0.006354495417326689
classification O 0 0.011981379240751266
of O 0 0.011685593985021114
105 O 1 0.9999324083328247
PAH O 1 1.0
mutations O 0 0.02099979668855667
may O 0 0.007545997854322195
allow O 0 0.006238166708499193
the O 0 0.005811743438243866
prediction O 0 0.013789254240691662
of O 0 0.006906172726303339
the O 0 0.00952816754579544
biochemical O 0 0.02759646810591221
phenotype O 0 0.030294006690382957
in O 0 0.011480550281703472
> O 1 0.5500014424324036
10 O 0 0.011835908517241478
, O 0 0.009560699574649334
000 O 0 0.021505506709218025
genotypes O 0 0.21353866159915924
, O 0 0.007655362598598003
which O 0 0.004741467069834471
may O 0 0.003863260615617037
be O 0 0.002993832342326641
useful O 0 0.00445696571841836
for O 0 0.003388195065781474
the O 0 0.005911657586693764
management O 0 0.014264972880482674
of O 0 0.011557821184396744
hyperphenylalaninemia B-Disease 1 0.9999998807907104
in O 0 0.031954679638147354
newborns O 1 0.9992870688438416
. O 0 0.034823618829250336

Somatic O 0 0.10984731465578079
instability O 0 0.0491044856607914
of O 0 0.01974184438586235
the O 0 0.020701278001070023
CTG O 1 0.9999947547912598
repeat O 0 0.03561875969171524
in O 0 0.013136283494532108
mice O 0 0.01857903227210045
transgenic O 0 0.024751199409365654
for O 0 0.008116665296256542
the O 0 0.02840229868888855
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9970454573631287
is O 0 0.01546669751405716
age O 0 0.014496500603854656
dependent O 0 0.009322917088866234
but O 0 0.004503131378442049
not O 0 0.0036639070603996515
correlated O 0 0.007872393354773521
to O 0 0.004356622230261564
the O 0 0.00605374202132225
relative O 0 0.013584360480308533
intertissue O 1 0.9973272085189819
transcription O 0 0.0623030811548233
levels O 0 0.01840762421488762
and O 0 0.02394830994307995
proliferative O 1 0.9999992847442627
capacities O 1 0.9656378626823425
. O 0 0.060933008790016174

A O 0 0.055444248020648956
( O 0 0.040260858833789825
CTG O 1 0.9993150234222412
) O 0 0.02139202505350113
nexpansion O 0 0.04118646681308746
in O 0 0.009285000152885914
the O 0 0.010010894387960434
3 O 0 0.018803540617227554
- O 1 0.9988589286804199
untranslated O 1 0.9581729769706726
region O 0 0.018022872507572174
( O 0 0.016527945175766945
UTR O 1 0.7301816940307617
) O 0 0.009386127814650536
of O 0 0.007883111014962196
the O 0 0.013467224314808846
DM O 1 1.0
protein O 0 0.05824317783117294
kinase O 0 0.426357626914978
gene O 0 0.01516891922801733
( O 0 0.013703237287700176
DMPK O 1 0.9999470710754395
) O 0 0.00784932728856802
is O 0 0.0054046232253313065
responsible O 0 0.007162405177950859
for O 0 0.008759776130318642
causing O 1 0.9999995231628418
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.3756980001926422
. O 0 0.0447232648730278

Major O 0 0.16969288885593414
instability O 1 0.9558284878730774
, O 0 0.009081470780074596
with O 0 0.005850642453879118
very O 0 0.005764366127550602
large O 0 0.005953687243163586
expansions O 0 0.01341199316084385
between O 0 0.0059915026649832726
generations O 0 0.00940797571092844
and O 0 0.005531593691557646
high O 0 0.008997887372970581
levels O 0 0.007066122721880674
of O 0 0.008348495699465275
somatic O 1 0.6173276901245117
mosaicism O 1 0.9999845027923584
, O 0 0.012930541299283504
is O 0 0.009024541825056076
observed O 0 0.010680587962269783
in O 0 0.013569670729339123
patients O 1 0.5382035374641418
. O 0 0.03279920667409897

There O 0 0.019541412591934204
is O 0 0.010767112486064434
a O 0 0.01119193248450756
good O 0 0.011129163205623627
correlation O 0 0.010206191800534725
between O 0 0.006607966963201761
repeat O 0 0.014810420572757721
size O 0 0.010192102752625942
( O 0 0.006953818257898092
at O 0 0.006755981128662825
least O 0 0.004998860880732536
in O 0 0.006714590825140476
leucocytes O 1 0.9938071370124817
) O 0 0.008450141176581383
, O 0 0.010243862867355347
clinical O 1 0.975841760635376
severity O 1 0.9994327425956726
and O 0 0.010918295942246914
age O 0 0.04787715524435043
of O 0 0.04056856408715248
onset O 1 0.9999998807907104
. O 0 0.04281739145517349

The O 0 0.04222603514790535
trinucleotide O 1 0.9995816349983215
repeat O 0 0.1361919343471527
instability O 0 0.2164052277803421
mechanisms O 0 0.013562111184000969
involved O 0 0.008680863305926323
in O 0 0.013809864409267902
DM B-Disease 1 1.0
and O 0 0.013938450254499912
other O 0 0.005879591219127178
human O 0 0.3446069359779358
genetic B-Disease 1 0.9999994039535522
diseases I-Disease 1 1.0
are O 0 0.008905244991183281
unknown O 0 0.021757159382104874
. O 0 0.02211807481944561

We O 0 0.023745615035295486
studied O 0 0.03199658542871475
somatic O 0 0.04536792263388634
instability O 0 0.033057596534490585
by O 0 0.010900563560426235
measuring O 0 0.025006888434290886
the O 0 0.01597565785050392
CTG O 1 0.9999886751174927
repeat O 0 0.028394248336553574
length O 0 0.01140157412737608
at O 0 0.009033434092998505
several O 0 0.005124740302562714
ages O 0 0.008605990558862686
in O 0 0.0053811646066606045
various O 0 0.00534377247095108
tissues O 0 0.016344144940376282
of O 0 0.008827406913042068
transgenic O 1 0.5753707885742188
mice O 0 0.020784001797437668
carrying O 0 0.016203252598643303
a O 0 0.014742646366357803
( O 0 0.018687358126044273
CTG O 1 0.9997710585594177
) O 0 0.01868310011923313
55expansion O 0 0.055777933448553085
surrounded O 0 0.027799928560853004
by O 0 0.008294397965073586
45 O 0 0.017735451459884644
kb O 0 0.03390023857355118
of O 0 0.008410881273448467
the O 0 0.0090931486338377
human O 0 0.015466704964637756
DM B-Disease 1 1.0
region O 0 0.018636517226696014
, O 0 0.008661270141601562
using O 0 0.008735282346606255
small O 0 0.01446524541825056
- O 1 0.9956811666488647
pool O 0 0.10166027396917343
PCR O 0 0.07701196521520615
. O 0 0.034147679805755615

These O 0 0.017501315101981163
mice O 0 0.022226477041840553
have O 0 0.005872613750398159
been O 0 0.005705263465642929
shown O 0 0.0056803724728524685
to O 0 0.005352445878088474
reproduce O 0 0.012490293942391872
the O 0 0.008132463321089745
intergenerational O 1 0.7687750458717346
and O 0 0.010397220030426979
somatic O 0 0.028506530448794365
instability O 0 0.022689897567033768
of O 0 0.010286257602274418
the O 0 0.011825071647763252
55 O 0 0.04253871738910675
CTG O 1 0.9998924732208252
repeat O 0 0.02566874399781227
suggesting O 0 0.011992714367806911
that O 0 0.0048192162066698074
surrounding O 0 0.009609351865947247
sequences O 0 0.0075547704473137856
and O 0 0.005779580678790808
the O 0 0.0070898388512432575
chromatin O 0 0.019682209938764572
environment O 0 0.010203735902905464
are O 0 0.00432489812374115
involved O 0 0.006695970427244902
in O 0 0.009143151342868805
instability O 1 0.9242081046104431
mechanisms O 0 0.04804275557398796
. O 0 0.03230425342917442

As O 0 0.016848808154463768
observed O 0 0.008643212728202343
in O 0 0.004855120554566383
some O 0 0.0029479963704943657
of O 0 0.003862593090161681
the O 0 0.005800642538815737
tissues O 1 0.9890992641448975
of O 1 0.9988297820091248
DM B-Disease 1 1.0
patients O 1 1.0
, O 0 0.00897796731442213
there O 0 0.004468575585633516
is O 0 0.004971761256456375
a O 0 0.006379507016390562
tendency O 0 0.009113237261772156
for O 0 0.005971707869321108
repeat O 0 0.016227036714553833
length O 0 0.01103415247052908
and O 0 0.009314486756920815
somatic O 0 0.03071335144340992
mosaicism O 1 0.8480519652366638
to O 0 0.007550031412392855
increase O 0 0.0067186313681304455
with O 0 0.005260252859443426
the O 0 0.006398795172572136
age O 0 0.009577547200024128
of O 0 0.009951582178473473
the O 0 0.015569227747619152
mouse O 0 0.3529667854309082
. O 0 0.0317903570830822

Furthermore O 0 0.043596960604190826
, O 0 0.015564223751425743
we O 0 0.008243306539952755
observed O 0 0.007852916605770588
no O 0 0.006639854516834021
correlation O 0 0.008536158129572868
between O 0 0.004984492901712656
the O 0 0.007043160032480955
somatic O 0 0.024155467748641968
mutation O 0 0.015862422063946724
rate O 0 0.01146149542182684
and O 0 0.014088191092014313
tissue O 1 0.9999728202819824
proliferation O 1 0.9998998641967773
capacity O 0 0.23172791302204132
. O 0 0.03821549564599991

The O 0 0.03184335678815842
somatic O 0 0.05211599916219711
mutation O 0 0.023268450051546097
rates O 0 0.01011663954705
in O 0 0.006207334343343973
different O 0 0.004418157506734133
tissues O 0 0.013401155360043049
were O 0 0.0038616976235061884
also O 0 0.004644840490072966
not O 0 0.003024896839633584
correlated O 0 0.006897266488522291
to O 0 0.003438644576817751
the O 0 0.004605229012668133
relative O 0 0.00956006720662117
inter O 1 0.996977686882019
- O 1 0.9999967813491821
tissue O 0 0.4207765460014343
difference O 0 0.006908652372658253
in O 0 0.005211713723838329
transcriptional O 0 0.011378073133528233
levels O 0 0.0053014978766441345
of O 0 0.0036997715942561626
the O 0 0.004751599393785
three O 0 0.005135541316121817
genes O 0 0.007603504694998264
( O 0 0.00947257224470377
DMAHP O 1 0.9999226331710815
, O 0 0.011223415844142437
DMPK O 1 0.9998900890350342
and O 0 0.00846222322434187
59 O 0 0.020719312131404877
) O 0 0.007891357876360416
surrounding O 0 0.012197182513773441
the O 0 0.011835791170597076
repeat O 0 0.031100688502192497
. O 0 0.015350745990872383
. O 0 0.026515403762459755

A O 0 0.04685860499739647
novel O 0 0.037899572402238846
missense O 0 0.04398014023900032
mutation O 0 0.017283380031585693
in O 0 0.008653278462588787
patients O 0 0.14434294402599335
from O 0 0.006631367839872837
a O 0 0.013147068209946156
retinoblastoma B-Disease 1 0.9999988079071045
pedigree O 1 0.9748815298080444
showing O 0 0.012003142386674881
only O 0 0.00619640713557601
mild O 1 0.8942648768424988
expression O 0 0.010103778913617134
of O 0 0.01049111969769001
the O 1 0.6537878513336182
tumor B-Disease 1 1.0
phenotype O 1 0.9997959733009338
. O 0 0.03664955869317055

We O 0 0.015629351139068604
have O 0 0.0076490649953484535
used O 0 0.00899453368037939
single O 0 0.014046314172446728
strand O 0 0.0237444918602705
conformation O 0 0.02194640412926674
polymorphism O 0 0.0212861280888319
analysis O 0 0.007349569350481033
to O 0 0.005752964410930872
study O 0 0.0069731296971440315
the O 0 0.00697506545111537
27 O 0 0.012313148938119411
exons O 0 0.014805272221565247
of O 0 0.007555917836725712
the O 0 0.010169263929128647
RB1 O 1 0.9999988079071045
gene O 0 0.009835481643676758
in O 0 0.005312832538038492
individuals O 0 0.0032074344344437122
from O 0 0.0037030386738479137
a O 0 0.006293989717960358
family O 0 0.009983664378523827
showing O 0 0.010786033235490322
mild O 1 0.9956192374229431
expression O 0 0.008466280065476894
of O 0 0.01019793376326561
the O 0 0.25550389289855957
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.9999591112136841
. O 0 0.03871505707502365

In O 0 0.017496634274721146
this O 0 0.009881400503218174
family O 0 0.011740217916667461
affected O 0 0.009737158194184303
individuals O 0 0.005397230852395296
developed O 0 0.36858242750167847
unilateral B-Disease 1 0.999355137348175
tumors I-Disease 1 1.0
and O 0 0.014876075088977814
, O 0 0.006212175358086824
as O 0 0.004787329584360123
a O 0 0.0054500470869243145
result O 0 0.004539157263934612
of O 0 0.0060059926472604275
linkage O 0 0.012736216187477112
analysis O 0 0.007245474029332399
, O 0 0.008205369114875793
unaffected O 0 0.42650291323661804
mutation O 0 0.01379571296274662
carriers O 0 0.015208089724183083
were O 0 0.005214052740484476
also O 0 0.006216405890882015
identified O 0 0.006826663389801979
within O 0 0.007106312550604343
the O 0 0.014291536062955856
pedigree O 0 0.4192639887332916
. O 0 0.028897523880004883

A O 0 0.0378817543387413
single O 0 0.02438005618751049
band O 0 0.02259787544608116
shift O 0 0.01948283612728119
using O 0 0.012178732082247734
SSCP O 1 0.9914364218711853
was O 0 0.013601296581327915
identified O 0 0.00957563053816557
in O 0 0.008612706325948238
exon O 0 0.03181504085659981
21 O 0 0.014414334669709206
which O 0 0.006724161095917225
resulted O 0 0.010449967347085476
in O 0 0.006805884186178446
a O 0 0.010891539976000786
missense O 0 0.023715170100331306
mutation O 0 0.013199429027736187
converting O 0 0.015270022675395012
a O 0 0.01711941696703434
cys O 1 0.9999997615814209
- O 1 0.9999996423721313
- O 1 0.9999960660934448
> O 1 0.9795046448707581
arg O 1 0.6950804591178894
at O 0 0.021222025156021118
nucleotide O 0 0.022890159860253334
position O 0 0.016364917159080505
28 O 0 0.016793716698884964
in O 0 0.011489330790936947
the O 0 0.022410409525036812
exon O 0 0.1389218419790268
. O 0 0.03766850009560585

The O 0 0.03555157035589218
mutation O 0 0.032192811369895935
destroyed O 0 0.029535489156842232
an O 0 0.01710175722837448
NdeI O 1 0.9998898506164551
restriction O 0 0.049157191067934036
enzyme O 0 0.03849618509411812
site O 0 0.047156933695077896
. O 0 0.037024445831775665

Analysis O 0 0.02200337126851082
of O 0 0.012486930005252361
all O 0 0.008287223055958748
family O 0 0.011451796628534794
members O 0 0.005918246693909168
demonstrated O 0 0.009361587464809418
that O 0 0.004041722975671291
the O 0 0.007114257663488388
missense O 0 0.023014966398477554
mutation O 0 0.015617677010595798
co O 1 0.966850221157074
- O 1 0.9996864795684814
segregated O 0 0.028163153678178787
with O 0 0.006264577619731426
patients O 1 0.9988939166069031
with O 1 0.5101706981658936
tumors B-Disease 1 1.0
or O 0 0.013770047575235367
who O 0 0.01245754025876522
, O 0 0.004427791573107243
as O 0 0.003830509027466178
a O 0 0.004888499155640602
result O 0 0.00486025819554925
of O 0 0.00505862245336175
linkage O 0 0.01203359104692936
analysis O 0 0.006194052752107382
had O 0 0.006539956200867891
been O 0 0.005120157264173031
predicted O 0 0.009071203880012035
to O 0 0.0054303668439388275
carry O 0 0.009863649494946003
the O 0 0.015100864693522453
predisposing O 1 0.9859005808830261
mutation O 0 0.032764874398708344
. O 0 0.026697004213929176

These O 0 0.016323551535606384
observations O 0 0.020798496901988983
point O 0 0.00971281435340643
to O 0 0.006542118266224861
another O 0 0.007806476205587387
region O 0 0.008097387850284576
of O 0 0.006353233475238085
the O 0 0.01104806549847126
RB1 O 1 0.9999996423721313
gene O 0 0.013497158885002136
where O 0 0.00942795816808939
mutations O 0 0.007558224257081747
only O 0 0.004269373137503862
modify O 0 0.00945320539176464
the O 0 0.0049487510696053505
function O 0 0.005189138930290937
of O 0 0.004504555370658636
the O 0 0.00571028096601367
gene O 0 0.006132567301392555
and O 0 0.004397608805447817
raise O 0 0.006975061725825071
important O 0 0.0042028045281767845
questions O 0 0.005052410997450352
for O 0 0.004742115270346403
genetic O 0 0.008416996337473392
counseling O 0 0.3071858286857605
in O 0 0.0054565491154789925
families O 0 0.0070606013759970665
with O 0 0.005358564667403698
these O 0 0.005793796386569738
distinctive O 0 0.10277397185564041
phenotypes O 1 0.704207718372345
. O 0 0.017345786094665527
. O 0 0.02783956192433834

Maternal B-Disease 1 0.9623362421989441
disomy I-Disease 1 0.9992330074310303
and O 1 0.8571130037307739
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9985736608505249
with O 0 0.03757278993725777
gamete O 1 0.9999802112579346
complementation O 1 0.9999860525131226
in O 0 0.008922264911234379
a O 0 0.008803565986454487
case O 0 0.0080930907279253
of O 0 0.008428960107266903
familial O 1 0.9999810457229614
translocation O 1 0.9979521632194519
( O 0 0.009238313883543015
3 O 0 0.010966448113322258
; O 0 0.007497007958590984
15 O 0 0.009819270111620426
) O 0 0.008773251436650753
( O 0 0.010467860847711563
p25 O 1 0.6816599369049072
; O 0 0.01529015600681305
q11 O 1 0.5493139624595642
. O 0 0.012871633283793926
2 O 0 0.021472688764333725
) O 0 0.01787504553794861
. O 0 0.027259070426225662

Maternal B-Disease 1 0.9999750852584839
uniparental I-Disease 1 1.0
disomy I-Disease 1 0.9999998807907104
( I-Disease 1 0.9550955295562744
UPD I-Disease 1 1.0
) I-Disease 0 0.014188242144882679
for I-Disease 0 0.010019983164966106
chromosome I-Disease 0 0.014498231001198292
15 I-Disease 0 0.009616807103157043
is O 0 0.005297938361763954
responsible O 0 0.005335597787052393
for O 0 0.003465153742581606
an O 0 0.004627187270671129
estimated O 0 0.006451668683439493
30 O 0 0.007495262660086155
% O 0 0.004528494086116552
of O 0 0.004080280661582947
cases O 0 0.006263811606913805
of O 0 0.01788496971130371
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999997615814209
PWS B-Disease 1 1.0
) O 0 0.0995354950428009
. O 0 0.04328656196594238

We O 0 0.017710614949464798
report O 0 0.012871185317635536
on O 0 0.007765329908579588
an O 0 0.006329569965600967
unusual O 0 0.007744602393358946
case O 0 0.008635053411126137
of O 0 0.00852045789361
maternal B-Disease 1 0.999313473701477
disomy I-Disease 1 0.9999829530715942
15 I-Disease 0 0.014695629477500916
in O 0 0.012251426465809345
PWS B-Disease 1 1.0
that O 0 0.0061579421162605286
is O 0 0.00535722728818655
most O 0 0.003917502239346504
consistent O 0 0.00555406091734767
with O 0 0.004736411385238171
adjacent O 0 0.010120709426701069
- O 1 0.9786016941070557
1 O 0 0.010227433405816555
segregation O 0 0.012178720906376839
of O 0 0.005997765343636274
a O 0 0.009910596534609795
paternal O 1 0.995142936706543
t O 1 0.9999369382858276
( O 0 0.008127252571284771
3 O 0 0.01031033881008625
; O 0 0.00707813398912549
15 O 0 0.010115313343703747
) O 0 0.008826121687889099
( O 0 0.011702028103172779
p25 O 1 0.7447307109832764
; O 0 0.015452130697667599
q11 O 0 0.2300833910703659
. O 0 0.008956541307270527
2 O 0 0.012913590297102928
) O 0 0.007748344913125038
with O 0 0.007327726576477289
simultaneous O 0 0.01893516443669796
maternal O 1 0.9857332706451416
meiotic O 1 0.9999963045120239
nondisjunction O 1 0.9996734857559204
for O 0 0.020058756694197655
chromosome O 0 0.03606078028678894
15 O 0 0.02839539386332035
. O 0 0.03339976817369461

The O 0 0.03374628350138664
patient O 1 0.9927364587783813
( O 0 0.021951530128717422
J O 1 0.9999997615814209
. O 0 0.011890934780240059
B O 1 0.9991818070411682
. O 0 0.0049544270150363445
) O 0 0.004869191441684961
, O 0 0.003817247226834297
a O 0 0.005015745293349028
17 O 0 0.00899383146315813
- O 1 0.9696314930915833
year O 0 0.008625898510217667
- O 1 0.955137312412262
old O 0 0.017408790066838264
white O 0 0.014027755707502365
male O 0 0.012704649940133095
with O 0 0.0111226262524724
PWS B-Disease 1 1.0
, O 0 0.010352276265621185
was O 0 0.009855619631707668
found O 0 0.004994576796889305
to O 0 0.004235036671161652
have O 0 0.004258636850863695
47 O 0 0.013873063959181309
chromosomes O 0 0.00955374725162983
with O 0 0.005942727904766798
a O 0 0.010614355094730854
supernumerary O 1 0.9995406866073608
, O 0 0.0175905991345644
paternal O 1 0.9973783493041992
der O 1 0.9999300241470337
( O 0 0.010289296507835388
15 O 0 0.010048089548945427
) O 0 0.006248332094401121
consisting O 0 0.006465465296059847
of O 0 0.005235361400991678
the O 0 0.00624737236648798
short O 0 0.009749095886945724
arm O 1 0.6456262469291687
and O 0 0.00609917426481843
the O 0 0.008830268867313862
proximal O 1 0.9999643564224243
long O 0 0.021487342193722725
arm O 1 0.9044063091278076
of O 0 0.009401329793035984
chromosome O 0 0.016027042642235756
15 O 0 0.009917531162500381
, O 0 0.009805833920836449
and O 0 0.011254468001425266
distal O 1 0.9999727010726929
chromosome O 1 0.9649819135665894
arm O 1 0.9999856948852539
3p O 1 0.9999967813491821
. O 0 0.05394437536597252

The O 0 0.03349032253026962
t O 1 0.9865185618400574
( O 0 0.012471533380448818
3 O 0 0.012927517294883728
; O 0 0.007456446532160044
15 O 0 0.008851989172399044
) O 0 0.0062506175599992275
was O 0 0.00765669159591198
present O 0 0.005442226305603981
in O 0 0.0045348056592047215
the O 0 0.0051156217232346535
balanced O 0 0.008185718208551407
state O 0 0.004101940896362066
in O 0 0.004967983346432447
the O 0 0.008116565644741058
patients O 1 0.9991269707679749
father O 0 0.3044818341732025
and O 0 0.008981166407465935
a O 0 0.01838962733745575
sister O 0 0.27830371260643005
. O 0 0.027505744248628616

Fluorescent O 0 0.1555032730102539
in O 0 0.027495121583342552
situ O 0 0.0633237212896347
hybridization O 0 0.027011293917894363
analysis O 0 0.01218812633305788
demonstrated O 0 0.013072912581264973
that O 0 0.0073797074146568775
the O 0 0.012888391502201557
PWS B-Disease 1 1.0
critical O 0 0.027060186490416527
region O 0 0.012940386310219765
resided O 0 0.01711164228618145
on O 0 0.0061669666320085526
the O 0 0.007409568876028061
derivative O 0 0.020643040537834167
chromosome O 0 0.0119481161236763
3 O 0 0.007641833275556564
and O 0 0.004106612876057625
that O 0 0.0026957248337566853
there O 0 0.002706852275878191
was O 0 0.006016032304614782
no O 0 0.004859528969973326
deletion O 0 0.012629158794879913
of O 0 0.006860147230327129
the O 0 0.018223948776721954
PWS B-Disease 1 1.0
region O 0 0.012497730553150177
on O 0 0.007802358362823725
the O 0 0.008659162558615208
normal O 0 0.0097460662946105
pair O 0 0.016089696437120438
of O 0 0.01274321973323822
15s O 1 0.9987069368362427
present O 0 0.01973656564950943
in O 0 0.021903475746512413
J O 1 0.9999899864196777
. O 0 0.037810321897268295

B O 1 0.9966063499450684
. O 0 0.07825004309415817

Methylation O 0 0.05431798845529556
analysis O 0 0.021167267113924026
at O 0 0.020270053297281265
exon O 0 0.03957372531294823
alpha O 0 0.022642437368631363
of O 0 0.00873814057558775
the O 0 0.007847471162676811
small O 0 0.00917408149689436
nuclear O 0 0.020091217011213303
ribonucleoprotein O 1 0.999976634979248
- O 1 0.9998587369918823
associated O 0 0.01927878148853779
polypeptide O 1 0.8626517057418823
N O 0 0.07320468127727509
( O 0 0.016459273174405098
SNRPN O 1 0.999920129776001
) O 0 0.013220706954598427
gene O 0 0.011662916280329227
showed O 0 0.009069866500794888
a O 0 0.007755243685096502
pattern O 0 0.008734085597097874
characteristic O 0 0.008330789394676685
of O 0 0.005300330929458141
only O 0 0.005896097514778376
the O 0 0.008635364472866058
maternal O 1 0.9559239149093628
chromosome O 0 0.019192814826965332
15 O 0 0.015957241877913475
in O 0 0.02076820656657219
J O 1 0.9999856948852539
. O 0 0.038777172565460205

B O 1 0.9959368705749512
. O 0 0.07665632665157318

Maternal B-Disease 1 0.9995403289794922
disomy I-Disease 1 0.9981077909469604
was O 0 0.020726485177874565
confirmed O 0 0.013236397877335548
by O 0 0.009944174438714981
polymerase O 0 0.036075036972761154
chain O 0 0.019164230674505234
reaction O 0 0.010082188062369823
analysis O 0 0.008073871023952961
of O 0 0.010011481121182442
microsatellite O 0 0.06919101625680923
repeats O 0 0.018293635919690132
at O 0 0.010704590007662773
the O 0 0.011721593327820301
gamma O 0 0.2811128795146942
- O 1 0.999690055847168
aminobutyric O 1 0.9968528151512146
acid O 0 0.06905675679445267
receptor O 0 0.04375745356082916
beta3 O 1 0.8679093718528748
subunit O 0 0.05975811555981636
( O 0 0.03319188579916954
GABRB3 O 1 0.9997358918190002
) O 0 0.038568828254938126
locus O 0 0.11185768246650696
. O 0 0.04693444445729256

A O 0 0.049055833369493484
niece O 1 0.9998910427093506
( O 0 0.024448132142424583
B O 1 0.9996132254600525
. O 0 0.009408517740666866
B O 1 0.9328351616859436
. O 0 0.005272567737847567
) O 0 0.0045995404943823814
with O 0 0.004405494779348373
45 O 0 0.008798187598586082
chromosomes O 0 0.007308127824217081
and O 0 0.004584840498864651
the O 0 0.005156501196324825
derivative O 0 0.013350674882531166
3 O 0 0.008469587191939354
but O 0 0.004083535168319941
without O 0 0.0049522677436470985
the O 0 0.0077034542337059975
der O 1 0.9872756600379944
( O 0 0.007943583652377129
15 O 0 0.010762552730739117
) O 0 0.007510368246585131
demonstrated O 0 0.010093859396874905
a O 0 0.00937286764383316
phenotype O 0 0.03257645666599274
consistent O 0 0.009308578446507454
with O 0 0.004484236240386963
that O 0 0.003959511872380972
reported O 0 0.006956432014703751
for O 0 0.006698204204440117
haploinsufficiency O 1 0.9922933578491211
of O 0 0.015132654458284378
distal O 1 0.9999762773513794
3 O 0 0.09351951628923416
p O 0 0.15806834399700165
. O 0 0.03275429829955101

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999747276306152
associated O 0 0.025107242166996002
with O 0 0.013410666957497597
unbalanced O 0 0.1178281158208847
segregation O 0 0.037617530673742294
of O 0 0.012619303539395332
non O 1 0.9800389409065247
- O 1 0.9999998807907104
Robertsonian O 1 0.9999949932098389
translocations O 0 0.18532156944274902
has O 0 0.008028876036405563
been O 0 0.0052809882909059525
reported O 0 0.005744701251387596
previously O 0 0.006415069103240967
but O 0 0.0041002072393894196
has O 0 0.0037479500751942396
not O 0 0.0026016132906079292
, O 0 0.0035134863574057817
to O 0 0.003137964988127351
our O 0 0.005114369560033083
knowledge O 0 0.006948284804821014
, O 0 0.005269201006740332
been O 0 0.004723663441836834
observed O 0 0.005961566232144833
in O 0 0.005456761457026005
a O 0 0.008905254304409027
case O 0 0.014729318208992481
of O 0 0.02307414449751377
PWS B-Disease 1 1.0
. O 0 0.05018434673547745

Furthermore O 0 0.03398814797401428
, O 0 0.012063163332641125
our O 0 0.010093091987073421
findings O 0 0.010580227710306644
are O 0 0.004516639746725559
best O 0 0.010202161967754364
interpreted O 0 0.010031170211732388
as O 0 0.007844703271985054
true O 0 0.018135422840714455
gamete O 1 0.8971166610717773
complementation O 1 0.9999667406082153
resulting O 0 0.025724058970808983
in O 0 0.020908722653985023
maternal B-Disease 1 0.9999761581420898
UPD I-Disease 1 1.0
15 I-Disease 0 0.10055242478847504
and O 0 0.061970580369234085
PWS B-Disease 1 0.9999990463256836

Schwartz B-Disease 1 0.9998193383216858
- I-Disease 1 0.9999995231628418
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
type I-Disease 1 0.9552038908004761
2 I-Disease 0 0.02053879201412201
and O 0 0.015916993841528893
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.019422249868512154
a O 0 0.01152519229799509
case O 0 0.011346389539539814
for O 0 0.009356441907584667
" O 0 0.019022848457098007
lumping O 0 0.17730185389518738
" O 0 0.03142472356557846
. O 0 0.03572112321853638

Recent O 0 0.02904501184821129
studies O 0 0.013779232278466225
demonstrated O 0 0.016146214678883553
the O 0 0.007935719564557076
existence O 0 0.008850202895700932
of O 0 0.0062900991179049015
a O 0 0.008130674250423908
genetically O 0 0.012834112159907818
distinct O 0 0.008453122340142727
, O 0 0.00653754873201251
usually O 0 0.005654233042150736
lethal O 0 0.0076340483501553535
form O 0 0.004577076528221369
of O 0 0.00450787553563714
the O 0 0.00735281128436327
Schwartz B-Disease 1 0.9999979734420776
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9990431666374207
SJS B-Disease 1 1.0
) O 0 0.014238753356039524
of O 0 0.015972314402461052
myotonia B-Disease 1 1.0
and O 1 0.9864063858985901
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.1985759288072586
which O 0 0.00673611368983984
we O 0 0.007633420173078775
called O 0 0.023811597377061844
SJS B-Disease 1 1.0
type I-Disease 0 0.35064858198165894
2 I-Disease 0 0.03725366294384003
. O 0 0.031434979289770126

This O 0 0.031625647097826004
disorder O 1 0.9999942779541016
is O 0 0.011600903235375881
reminiscent O 0 0.028518233448266983
of O 0 0.0080659044906497
another O 0 0.010529926046729088
rare O 0 0.0392075777053833
condition O 0 0.14865054190158844
, O 0 0.005922629497945309
the O 0 0.010632768273353577
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9994040727615356
SWS B-Disease 1 1.0
) O 0 0.01302983146160841
, O 0 0.008113648742437363
which O 0 0.006552741397172213
comprises O 0 0.014257224276661873
campomelia B-Disease 0 0.338527113199234
at O 0 0.011034495197236538
birth O 0 0.015449832193553448
with O 0 0.014226604253053665
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999312162399292
contractures B-Disease 1 1.0
, O 0 0.13175374269485474
and O 0 0.009780061431229115
early B-Disease 0 0.015819445252418518
death I-Disease 0 0.02896624058485031
. O 0 0.026344574987888336

To O 0 0.016782136633992195
test O 0 0.014346763491630554
for O 0 0.006671986076980829
possible O 0 0.007774633821099997
nosologic O 1 0.504490315914154
identity O 0 0.006947012152522802
between O 0 0.005041152238845825
these O 0 0.005149803124368191
disorders O 1 1.0
, O 0 0.007419872563332319
we O 0 0.003985855728387833
reviewed O 0 0.00758786965161562
the O 0 0.005381501279771328
literature O 0 0.006671404466032982
and O 0 0.00381007743999362
obtained O 0 0.005451443139463663
a O 0 0.005558397620916367
follow O 0 0.007837432436645031
- O 0 0.017004963010549545
up O 0 0.006002918351441622
of O 0 0.003909635357558727
the O 0 0.0034448986407369375
only O 0 0.003617194015532732
two O 0 0.005029032006859779
surviving O 0 0.23251330852508545
patients O 0 0.1998104751110077
, O 0 0.004876164719462395
one O 0 0.005009437911212444
with O 0 0.006897263694554567
SJS B-Disease 1 1.0
type I-Disease 0 0.0177554152905941
2 I-Disease 0 0.011410520412027836
at O 0 0.007638095412403345
age O 0 0.007858253084123135
10 O 0 0.006717507727444172
years O 0 0.005379617679864168
and O 0 0.0043310741893947124
another O 0 0.006459250580519438
with O 0 0.006395104341208935
SWS B-Disease 1 0.9999923706054688
at O 0 0.013826850801706314
age O 0 0.015465637668967247
7 O 0 0.022959550842642784
years O 0 0.022246064618229866
. O 0 0.025255216285586357

Patients O 1 0.9851459264755249
reported O 0 0.012590104714035988
as O 0 0.0076166922226548195
having O 0 0.011180592700839043
either O 0 0.017151981592178345
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.1709885597229004
SWS B-Disease 1 0.9999886751174927
presented O 0 0.017451263964176178
a O 0 0.009310395456850529
combination O 0 0.009496535174548626
of O 0 0.0055211554281413555
a O 0 0.008170162327587605
severe O 1 0.9999796152114868
, O 1 0.9269545674324036
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9997866749763489
with O 1 0.9999383687973022
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999650716781616
feeding O 1 0.9995753169059753
difficulties O 1 0.9999176263809204
, O 0 0.012030390091240406
tendency O 0 0.019454173743724823
to O 0 0.009137718006968498
hyperthermia B-Disease 1 1.0
, O 0 0.008053839206695557
and O 0 0.006335906684398651
frequent O 0 0.009764565154910088
death O 0 0.01618327386677265
in O 0 0.007449652533978224
infancy O 1 0.9998741149902344
) O 0 0.005837425589561462
with O 0 0.0050190589390695095
a O 0 0.009051192551851273
distinct O 0 0.014279423281550407
campomelic B-Disease 1 0.9999966621398926
- I-Disease 1 1.0
metaphyseal I-Disease 1 0.9999998807907104
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.06950441747903824

The O 0 0.023357393220067024
similarity O 0 0.01762981526553631
of O 0 0.00898702535778284
the O 0 0.009905402548611164
clinical O 1 0.9990569949150085
and O 0 0.012177429161965847
radiographic O 1 0.999995231628418
findings O 0 0.009913408197462559
is O 0 0.005296736489981413
so O 0 0.003997275605797768
extensive O 0 0.005877066403627396
that O 0 0.0033768515568226576
these O 0 0.004151243716478348
disorders O 1 0.9999998807907104
appear O 0 0.005808834917843342
to O 0 0.004936272744089365
be O 0 0.004296963568776846
a O 0 0.01024245098233223
single O 0 0.016653088852763176
entity O 0 0.031766269356012344
. O 0 0.024985074996948242

The O 0 0.023428287357091904
follow O 0 0.020149754360318184
- O 0 0.03730853274464607
up O 0 0.011350402608513832
observation O 0 0.015260978601872921
of O 0 0.005967443343251944
an O 0 0.005009759217500687
identical O 0 0.0076494598761200905
and O 0 0.0042504677549004555
unique O 0 0.005713820457458496
pattern O 0 0.008112368173897266
of O 0 0.08947976678609848
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.008026479743421078
the O 0 0.006166948936879635
two O 0 0.0054579307325184345
patients O 1 0.8579504489898682
( O 0 0.004378901328891516
one O 0 0.005104659125208855
with O 0 0.006932641379535198
SJS B-Disease 1 1.0
type I-Disease 0 0.25463610887527466
2 I-Disease 0 0.009531008079648018
, O 0 0.005815557204186916
one O 0 0.005561542697250843
with O 0 0.00782928615808487
SWS B-Disease 1 0.9999934434890747
) O 0 0.013439174741506577
surviving O 0 0.031098345294594765
beyond O 0 0.017944062128663063
infancy O 1 0.5400516986846924
adds O 0 0.014071986079216003
to O 0 0.006013916805386543
the O 0 0.006304905284196138
evidence O 0 0.006343332584947348
in O 0 0.006748022045940161
favor O 0 0.010164791718125343
of O 0 0.010513662360608578
identity O 0 0.02149364911019802
. O 0 0.024962017312645912

The O 0 0.024538526311516762
hypothesis O 0 0.02539653144776821
that O 0 0.009982685558497906
SWS B-Disease 1 0.9999767541885376
and O 0 0.0634448379278183
SJS B-Disease 1 1.0
type I-Disease 0 0.2796064019203186
2 I-Disease 0 0.01110985316336155
are O 0 0.0033929322380572557
the O 0 0.006077098660171032
same O 0 0.007547215558588505
disorder O 1 0.9999971389770508
should O 0 0.00663115456700325
be O 0 0.006691988091915846
testable O 0 0.022195709869265556
by O 0 0.007734985090792179
molecular O 0 0.015455324202775955
methods O 0 0.012229195795953274
. O 0 0.01410435326397419
. O 0 0.023067735135555267

A O 0 0.03274240717291832
mouse O 0 0.034850429743528366
model O 0 0.018915770575404167
of O 0 0.015192894265055656
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999978542327881
defects O 1 1.0
in O 1 0.993419349193573
hemostasis O 1 1.0
and O 1 0.9995145797729492
thrombosis B-Disease 1 1.0
. O 0 0.488726943731308

von B-Disease 1 0.9997897744178772
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9468526840209961
( I-Disease 0 0.08607009798288345
vWf I-Disease 1 0.9999990463256836
) I-Disease 1 0.9724751710891724
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9972589015960693
humans O 0 0.037746936082839966
. O 0 0.03297371044754982

We O 0 0.02045997977256775
generated O 0 0.016546718776226044
a O 0 0.012042133137583733
mouse O 0 0.02121630683541298
model O 0 0.013254228979349136
for O 0 0.007982146926224232
this O 0 0.007889632135629654
disease O 1 0.9995362758636475
by O 0 0.005988484714180231
using O 0 0.010298662818968296
gene O 0 0.01610197313129902
targeting O 0 0.02487959712743759
. O 0 0.02589624561369419

vWf B-Disease 1 0.9999839067459106
- I-Disease 1 0.9999982118606567
deficient I-Disease 1 0.9999371767044067
mice O 0 0.028499916195869446
appeared O 0 0.012296152301132679
normal O 0 0.009451785124838352
at O 0 0.009992802515625954
birth O 0 0.011546846479177475
; O 0 0.005941868759691715
they O 0 0.003930290695279837
were O 0 0.005783592816442251
viable O 0 0.01880304515361786
and O 0 0.013860467821359634
fertile O 0 0.047499965876340866
. O 0 0.03136757016181946

Neither O 0 0.08704811334609985
vWf O 1 0.9619037508964539
nor O 0 0.05327737331390381
vWf O 1 0.9969052672386169
propolypeptide O 1 0.9989333748817444
( O 0 0.03373008593916893
von B-Disease 1 0.9999867677688599
Willebrand I-Disease 1 1.0
antigen O 1 1.0
II O 1 1.0
) O 0 0.013678845018148422
were O 0 0.009838427416980267
detectable O 0 0.022967707365751266
in O 0 0.010734726674854755
plasma O 0 0.03426444157958031
, O 0 0.01317200530320406
platelets O 1 0.9970719814300537
, O 0 0.011028492823243141
or O 0 0.010328220203518867
endothelial O 1 0.9992214441299438
cells O 0 0.015221020206809044
of O 0 0.01098807156085968
the O 0 0.01501605287194252
homozygous O 0 0.07555477321147919
mutant O 1 0.734901487827301
mice O 0 0.06345520913600922
. O 0 0.04306880384683609

The O 0 0.03786161169409752
mutant O 0 0.43199703097343445
mice O 0 0.3902158737182617
exhibited O 1 0.9848912358283997
defects O 1 0.9999955892562866
in O 0 0.013880542479455471
hemostasis O 1 0.9999998807907104
with O 0 0.008215224370360374
a O 0 0.011525172740221024
highly O 1 0.9439142942428589
prolonged O 1 0.9999998807907104
bleeding O 1 1.0
time O 0 0.010484241880476475
and O 0 0.010764786042273045
spontaneous O 0 0.07330809533596039
bleeding O 1 0.999998927116394
events O 0 0.009146362543106079
in O 0 0.006338951643556356
approximately O 0 0.0084540331736207
10 O 0 0.010552599094808102
% O 0 0.011736069805920124
of O 0 0.016360273584723473
neonates O 1 0.9841272234916687
. O 0 0.03739431872963905

As O 0 0.014921453781425953
in O 0 0.008025416173040867
the O 0 0.008319679647684097
human O 0 0.01088146585971117
disease O 1 0.9999994039535522
, O 0 0.006499492563307285
the O 0 0.007489971816539764
factor O 1 0.6893309950828552
VIII O 1 1.0
level O 0 0.010538975708186626
in O 0 0.006153467111289501
these O 0 0.005327566526830196
mice O 0 0.010728414170444012
was O 0 0.00843835063278675
reduced O 0 0.007875953800976276
strongly O 0 0.006375850643962622
as O 0 0.004823364317417145
a O 0 0.005501462146639824
result O 0 0.004624411929398775
of O 0 0.003972882870584726
the O 0 0.0052439263090491295
lack O 0 0.007015447597950697
of O 0 0.00869270134717226
protection O 1 0.9803665280342102
provided O 0 0.02205527387559414
by O 0 0.018125036731362343
vWf O 1 0.9597917795181274
. O 0 0.04236949235200882

Defective O 1 0.9999979734420776
thrombosis B-Disease 1 1.0
in O 0 0.03205372393131256
mutant O 1 0.9976119995117188
mice O 0 0.4535399079322815
was O 0 0.015660259872674942
also O 0 0.009455643594264984
evident O 0 0.012689391151070595
in O 0 0.005702505353838205
an O 0 0.00577084394171834
in O 0 0.007363706361502409
vivo O 0 0.02466939203441143
model O 0 0.018279364332556725
of O 0 0.08459446579217911
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.17578615248203278

In O 0 0.019491994753479958
this O 0 0.009640575386583805
model O 0 0.018192391842603683
, O 0 0.010860659182071686
the O 0 0.013246297836303711
exteriorized O 1 0.9970280528068542
mesentery O 1 0.9998465776443481
was O 0 0.04626348987221718
superfused O 1 0.9998797178268433
with O 0 0.021510520949959755
ferric O 1 1.0
chloride O 1 0.9995318651199341
and O 0 0.0104961097240448
the O 0 0.010442542843520641
accumulation O 0 0.024271998554468155
of O 0 0.0163137074559927
fluorescently O 1 1.0
labeled O 1 0.9999903440475464
platelets O 1 0.9999936819076538
was O 0 0.02157028205692768
observed O 0 0.01570012792944908
by O 0 0.014594491571187973
intravital O 1 0.647914469242096
microscopy O 0 0.07257727533578873
. O 0 0.04479868710041046

We O 0 0.020517492666840553
conclude O 0 0.02192871645092964
that O 0 0.00803753174841404
these O 0 0.005545129533857107
mice O 0 0.013100971467792988
very O 0 0.006495970766991377
closely O 0 0.010370340198278427
mimic O 1 0.7361915111541748
severe O 1 0.9999985694885254
human O 1 0.9997076392173767
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.8037779927253723
will O 0 0.007169968448579311
be O 0 0.004651337396353483
very O 0 0.0043379394337534904
useful O 0 0.005563465878367424
for O 0 0.003789361799135804
investigating O 0 0.006010685581713915
the O 0 0.004613753408193588
role O 0 0.007133306469768286
of O 0 0.006889578886330128
vWf O 1 0.9926536083221436
in O 0 0.007212385535240173
normal O 0 0.01004251278936863
physiology O 1 0.9874467253684998
and O 0 0.008725742809474468
in O 0 0.017825515940785408
disease O 1 1.0
models O 0 0.33972054719924927
. O 0 0.013945477083325386
. O 0 0.022336600348353386

Oral O 1 0.9860852956771851
contraceptives O 1 0.997309684753418
and O 0 0.01205776073038578
the O 0 0.010384236462414265
risk O 1 0.74322110414505
of O 1 0.999292254447937
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998775720596313

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.979206919670105
Group O 0 0.05954478308558464
. O 0 0.03018198162317276

BACKGROUND O 0 0.047052692621946335
Women O 0 0.02484416402876377
with O 0 0.009725729003548622
mutations O 0 0.008963477797806263
in O 0 0.004889932926744223
either O 0 0.0050421785563230515
the O 0 0.006970568094402552
BRCA1 O 1 0.999988317489624
or O 0 0.005715948063880205
the O 0 0.009257405996322632
BRCA2 O 1 0.9999744892120361
gene O 0 0.00737114017829299
have O 0 0.0030618528835475445
a O 0 0.005639330949634314
high O 0 0.010944608598947525
lifetime O 0 0.264845609664917
risk O 1 0.9932030439376831
of O 1 0.9996801614761353
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.962647020816803

Oral O 1 0.9870123267173767
contraceptives O 1 0.9999803304672241
protect O 1 0.9933584332466125
against O 1 0.999968409538269
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.44161322712898254
general O 1 0.8322844505310059
, O 0 0.0070348335430026054
but O 0 0.004278848879039288
it O 0 0.003457635175436735
is O 0 0.003580086398869753
not O 0 0.0028663610573858023
known O 0 0.0037932228296995163
whether O 0 0.002922358922660351
they O 0 0.002242075279355049
also O 0 0.004019947722554207
protect O 0 0.00672477250918746
against O 0 0.008375505916774273
hereditary B-Disease 1 0.9999997615814209
forms I-Disease 1 0.9351148009300232
of I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9755364656448364

METHODS O 0 0.030114009976387024
We O 0 0.014046804048120975
enrolled O 0 0.030862074345350266
207 O 0 0.04493303224444389
women O 0 0.015324066393077374
with O 0 0.02257450483739376
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9719519019126892
161 O 1 0.9706612825393677
of O 0 0.008682007901370525
their O 0 0.0067131188698112965
sisters O 0 0.015561207197606564
as O 0 0.005308961495757103
controls O 0 0.007908024825155735
in O 0 0.005003723315894604
a O 0 0.0067972284741699696
case O 0 0.01259028259664774
- O 1 0.999721348285675
control O 0 0.018363511189818382
study O 0 0.019081586971879005
. O 0 0.024617884308099747

All O 0 0.017057958990335464
the O 0 0.016830122098326683
patients O 0 0.09203389286994934
carried O 0 0.01161443255841732
a O 0 0.012700160034000874
pathogenic O 0 0.019469743594527245
mutation O 0 0.01162872277200222
in O 0 0.00652266014367342
either O 0 0.008933587931096554
BRCA1 O 1 0.997180700302124
( O 0 0.01101488433778286
179 O 0 0.08002821356058121
women O 0 0.013461771421134472
) O 0 0.009854437783360481
or O 0 0.01066870428621769
BRCA2 O 1 0.9998973608016968
( O 0 0.013616664335131645
28 O 0 0.02625829353928566
women O 0 0.024191541597247124
) O 0 0.022223887965083122
. O 0 0.030499683693051338

The O 0 0.02462102100253105
control O 0 0.018301891162991524
women O 0 0.012107576243579388
were O 0 0.006280009169131517
enrolled O 0 0.014039567671716213
regardless O 0 0.007679390721023083
of O 0 0.005394190549850464
whether O 0 0.0051358724012970924
or O 0 0.004338536411523819
not O 0 0.003548871725797653
they O 0 0.004205431789159775
had O 0 0.007725936360657215
either O 0 0.011642382480204105
mutation O 0 0.02001948468387127
. O 0 0.02227870561182499

Lifetime O 0 0.056831613183021545
histories O 0 0.028758930042386055
of O 0 0.01384931243956089
oral O 1 0.9999722242355347
- O 1 0.9999998807907104
contraceptive O 1 0.9999955892562866
use O 0 0.008642984554171562
were O 0 0.005364980548620224
obtained O 0 0.006040146574378014
by O 0 0.004503422416746616
interview O 0 0.009162204340100288
or O 0 0.004486098885536194
by O 0 0.0036158226430416107
written O 0 0.005654001608490944
questionnaire O 0 0.011907332576811314
and O 0 0.00471523916348815
were O 0 0.0034782374277710915
compared O 0 0.005708429031074047
between O 0 0.004461878910660744
patients O 1 0.757759153842926
and O 0 0.0057763815857470036
control O 0 0.13437041640281677
women O 0 0.013187329284846783
, O 0 0.005867816507816315
after O 0 0.006615877617150545
adjustment O 0 0.013236604630947113
for O 0 0.005591099616140127
year O 0 0.008987238630652428
of O 0 0.010234768502414227
birth O 0 0.02174007147550583
and O 0 0.013699634931981564
parity O 0 0.08647683262825012
. O 0 0.03179825469851494

RESULTS O 0 0.028348900377750397
The O 0 0.014102634973824024
adjusted O 0 0.02180706337094307
odds O 0 0.022866059094667435
ratio O 0 0.01936447247862816
for O 0 0.19781126081943512
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.12561294436454773
with O 0 0.005097317509353161
any O 0 0.004280353896319866
past O 0 0.005300899036228657
use O 0 0.0048158965073525906
of O 0 0.007665736135095358
oral O 1 0.9931738972663879
contraceptives O 1 0.9999982118606567
was O 0 0.45597994327545166
0 O 0 0.04018380120396614
. O 0 0.03067447617650032

5 O 0 0.03274678811430931
( O 0 0.016024259850382805
95 O 0 0.026309743523597717
percent O 0 0.014472207985818386
confidence O 0 0.019474785774946213
interval O 0 0.01880415342748165
, O 0 0.00980203878134489
0 O 0 0.012402262538671494
. O 0 0.005247538909316063
3 O 0 0.007950613275170326
to O 0 0.007055341731756926
0 O 0 0.014563219621777534
. O 0 0.009987547993659973
8 O 0 0.01917753554880619
) O 0 0.018159164115786552
. O 0 0.029641512781381607

The O 0 0.028538662940263748
risk O 0 0.34892573952674866
decreased O 0 0.015091371722519398
with O 0 0.006597448606044054
increasing O 0 0.008829844184219837
duration O 0 0.012208621017634869
of O 0 0.006446355022490025
use O 0 0.006831883452832699
( O 0 0.009359904564917088
P O 0 0.027939269319176674
for O 0 0.007410953752696514
trend O 0 0.013099036179482937
, O 0 0.009523655287921429
< O 0 0.17112870514392853
0 O 0 0.01902487501502037
. O 0 0.010409287177026272
001 O 1 0.9235072731971741
) O 0 0.00917748175561428
; O 0 0.005640557501465082
use O 0 0.004045788664370775
for O 0 0.004355302546173334
six O 0 0.005405641160905361
or O 0 0.0034276486840099096
more O 0 0.0033929292112588882
years O 0 0.004414401017129421
was O 0 0.006836533546447754
associated O 0 0.004324877168983221
with O 0 0.0033457993995398283
a O 0 0.005796197801828384
60 O 0 0.012126725167036057
percent O 0 0.011808001436293125
reduction O 0 0.015457761473953724
in O 0 0.013865558430552483
risk O 0 0.03508707135915756
. O 0 0.03165719285607338

Oral O 1 0.9983837604522705
- O 1 0.9999597072601318
contraceptive O 1 0.9999160766601562
use O 0 0.011843346059322357
protected O 0 0.39647093415260315
against O 1 0.9994935989379883
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.008020032197237015
for O 0 0.008406305685639381
carriers O 0 0.015228271484375
of O 0 0.008293025195598602
the O 0 0.012473742477595806
BRCA1 O 1 0.9999226331710815
mutation O 0 0.017794284969568253
( O 0 0.010950276628136635
odds O 0 0.022186225280165672
ratio O 0 0.014321204274892807
, O 0 0.008542642928659916
0 O 0 0.011525128968060017
. O 0 0.005667534656822681
5 O 0 0.007978565990924835
; O 0 0.005809154361486435
95 O 0 0.012753759510815144
percent O 0 0.009353759698569775
confidence O 0 0.011615489609539509
interval O 0 0.014164933003485203
, O 0 0.0067732431925833225
0 O 0 0.010751460678875446
. O 0 0.004937971476465464
3 O 0 0.007347864098846912
to O 0 0.005356699228286743
0 O 0 0.009925288148224354
. O 0 0.005649532191455364
9 O 0 0.009435790590941906
) O 0 0.0058522820472717285
and O 0 0.00477172015234828
for O 0 0.00476723862811923
carriers O 0 0.011493328027427197
of O 0 0.006044687703251839
the O 0 0.010983864776790142
BRCA2 O 1 0.9999722242355347
mutation O 0 0.015253126621246338
( O 0 0.009930453263223171
odds O 0 0.020712770521640778
ratio O 0 0.014428053051233292
, O 0 0.008316383697092533
0 O 0 0.011289308778941631
. O 0 0.005504620261490345
4 O 0 0.008394826203584671
; O 0 0.006158339325338602
95 O 0 0.01355989184230566
percent O 0 0.009489850141108036
confidence O 0 0.014131850562989712
interval O 0 0.014575165696442127
, O 0 0.007516903802752495
0 O 0 0.01184875424951315
. O 0 0.004972528200596571
2 O 0 0.007802658714354038
to O 0 0.005816301796585321
1 O 0 0.01252269558608532
. O 0 0.009545891545712948
1 O 0 0.018510673195123672
) O 0 0.01745796948671341
. O 0 0.025754589587450027

CONCLUSIONS O 0 0.05762285739183426
Oral O 1 0.9994372725486755
- O 1 0.9999972581863403
contraceptive O 1 0.9999945163726807
use O 0 0.009486322291195393
may O 0 0.007277995813637972
reduce O 0 0.009531619027256966
the O 0 0.006662240717560053
risk O 1 0.6940297484397888
of O 1 0.9990410208702087
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.834743082523346
women O 0 0.036341745406389236
with O 0 0.008319743908941746
pathogenic O 0 0.023136107251048088
mutations O 0 0.009202267974615097
in O 0 0.006940701510757208
the O 0 0.015525505878031254
BRCA1 O 1 0.999987006187439
or O 0 0.02905345894396305
BRCA2 O 1 0.9997153878211975
gene O 0 0.060655951499938965

A O 0 0.04104515165090561
Japanese O 0 0.04270937666296959
family O 0 0.02590402588248253
with O 0 0.015993809327483177
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.011572943069040775
a O 0 0.014845318160951138
codon O 0 0.028439659625291824
291 O 0 0.04583458602428436
deletion O 0 0.024856965988874435
: O 0 0.010254369117319584
a O 0 0.009188579395413399
clinical O 1 0.9872358441352844
, O 0 0.010544993914663792
biochemical O 0 0.40858498215675354
, O 0 0.011133687570691109
pathological O 1 0.9976444840431213
, O 0 0.011374818161129951
and O 0 0.00949251651763916
genetic O 0 0.015992607921361923
report O 0 0.017647473141551018
. O 0 0.027063628658652306

We O 0 0.017539523541927338
report O 0 0.011254416778683662
a O 0 0.00965040922164917
Japanese O 0 0.019207192584872246
family O 0 0.014810670167207718
with O 0 0.018408088013529778
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999932050704956
ALD B-Disease 1 1.0
) O 0 0.012165864929556847
with O 0 0.007019601762294769
a O 0 0.007877660915255547
three O 0 0.006842856295406818
base O 0 0.018957896158099174
pair O 0 0.01723337359726429
deletion O 0 0.031654439866542816
( O 0 0.013007762841880322
delGAG O 1 0.9712472558021545
291 O 0 0.10885453969240189
) O 0 0.008662937209010124
in O 0 0.008454028517007828
the O 0 0.017482522875070572
ALD B-Disease 1 1.0
gene O 0 0.046652454882860184
. O 0 0.035450439900159836

A O 0 0.03392842411994934
variety O 0 0.01805911771953106
of O 0 0.013716783374547958
phenotypes O 0 0.025620831176638603
were O 0 0.007589988876134157
observed O 0 0.008971291594207287
within O 0 0.008932816796004772
this O 0 0.010095318779349327
family O 0 0.024973880499601364
. O 0 0.028126360848546028

While O 0 0.0197449903935194
the O 0 0.014325607568025589
proband O 1 0.9998655319213867
( O 0 0.01369502954185009
patient O 1 0.998828113079071
1 O 0 0.064682736992836
) O 0 0.007754843682050705
was O 0 0.009065273217856884
classified O 0 0.009430043399333954
as O 0 0.0056519890204072
having O 0 0.006792912725359201
a O 0 0.006524269934743643
rare O 0 0.010035432875156403
intermediate O 0 0.01645410992205143
type O 0 0.009350239299237728
of O 0 0.007300652097910643
adult O 0 0.03656015172600746
cerebral O 1 0.9999943971633911
and O 0 0.474035382270813
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9985665678977966
stem O 0 0.013135435059666634
forms O 0 0.0063234539702534676
, O 0 0.006194660905748606
his O 0 0.009127366356551647
younger O 0 0.4359827935695648
brother O 1 0.5632514953613281
( O 0 0.008905322290956974
patient O 1 0.8832854628562927
2 O 0 0.011443549767136574
) O 0 0.0070912824012339115
and O 0 0.00862518884241581
nephew O 1 0.9991463422775269
( O 0 0.011454143561422825
patient O 1 0.9940744042396545
3 O 0 0.01408996619284153
) O 0 0.008668983355164528
had O 0 0.011188006959855556
a O 0 0.021746056154370308
childhood O 1 0.9999996423721313
ALD B-Disease 1 1.0
type O 1 0.9999572038650513
. O 0 0.04772968217730522

Another O 0 0.046683114022016525
nephew O 1 0.9999197721481323
( O 0 0.018577536568045616
patient O 1 0.956529438495636
4 O 0 0.015404297038912773
) O 0 0.008200562559068203
of O 0 0.007931173779070377
patient O 1 0.9769764542579651
1 O 0 0.015210675075650215
was O 0 0.013081719167530537
classified O 0 0.014177829958498478
as O 0 0.008028662763535976
having O 0 0.010393771342933178
an O 0 0.013586372137069702
adolescent O 1 0.9998086094856262
form O 0 0.026357682421803474
. O 0 0.032548051327466965

The O 0 0.03612954542040825
tau O 0 0.060611601918935776
level O 0 0.01597577892243862
in O 0 0.00975871179252863
the O 0 0.014506702311336994
cerebrospinal O 1 0.999998927116394
fluid O 1 0.9999830722808838
( O 1 0.9583654403686523
CSF O 1 1.0
) O 0 0.009208586998283863
in O 0 0.007839552126824856
patient O 1 0.8948292136192322
1 O 0 0.010096261277794838
was O 0 0.0077353003434836864
as O 0 0.004543149843811989
high O 0 0.006214567925781012
as O 0 0.003205137327313423
that O 0 0.0025578907225281
of O 0 0.005116971209645271
patients O 1 0.9990707635879517
with O 1 0.999825656414032
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9999213218688965
AD B-Disease 1 0.9999978542327881
) O 0 0.023628685623407364
. O 0 0.027022171765565872

His O 0 0.06609336286783218
brain O 1 0.6784512996673584
magnetic O 0 0.025632891803979874
resonance O 0 0.030388182029128075
image O 1 0.7688751816749573
( O 0 0.022487880662083626
MRI O 1 0.9999902248382568
) O 0 0.010868995450437069
showed O 0 0.012228055857121944
abnormalities B-Disease 0 0.03963479399681091
in I-Disease 0 0.00563569413498044
the I-Disease 0 0.008363756351172924
bilateral I-Disease 1 0.9874522089958191
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9998863935470581
and O 1 0.9640625715255737
brain O 1 0.9999964237213135
stem O 1 0.6786787509918213
, O 0 0.006030326243489981
but O 0 0.0032099063973873854
not O 0 0.0027471398934721947
in O 0 0.004164717625826597
the O 0 0.007532614748924971
cerebral O 1 0.9999978542327881
white O 1 0.6521095633506775
matter O 0 0.00879568513482809
, O 0 0.0064918240532279015
where O 0 0.0060781496576964855
marked O 0 0.008890115655958652
reductions O 0 0.011034714989364147
of O 0 0.007091322913765907
the O 0 0.011945407837629318
cerebral O 1 0.9999998807907104
blood O 1 0.9939852356910706
flow O 0 0.011478039436042309
and O 0 0.010862123221158981
oxygen O 1 0.992931604385376
metabolism O 0 0.08430866152048111
were O 0 0.0067362128756940365
clearly O 0 0.009247785434126854
demonstrated O 0 0.01097876951098442
by O 0 0.007948394864797592
positron O 0 0.1331777274608612
emission O 0 0.029440781101584435
tomography O 0 0.04773906245827675
( O 0 0.022928547114133835
PET O 1 0.9902685880661011
) O 0 0.026305656880140305
. O 0 0.035329535603523254

In O 0 0.021548526361584663
patients O 1 0.5969217419624329
2 O 0 0.01532100047916174
and O 0 0.007433025166392326
3 O 0 0.009571551345288754
, O 0 0.006467149127274752
the O 0 0.006417479831725359
autopsy O 0 0.015222407877445221
findings O 0 0.01002602931112051
showed O 0 0.010423880070447922
massive O 0 0.29479122161865234
demyelination B-Disease 1 0.9999998807907104
of I-Disease 0 0.05456927791237831
the I-Disease 1 0.9317032694816589
cerebral I-Disease 1 1.0
white I-Disease 1 0.5111665725708008
matter I-Disease 0 0.008221463300287724
with O 0 0.00617729127407074
sparing O 0 0.018576035276055336
of O 0 0.008031466044485569
the O 0 0.015807349234819412
U O 1 1.0
- O 1 0.9999998807907104
fibers O 1 0.9979044198989868
, O 0 0.010368380695581436
compatible O 0 0.016199976205825806
with O 0 0.006855711806565523
the O 0 0.009842989966273308
findings O 0 0.015086600556969643
of O 0 0.02053278312087059
childhood O 1 0.9999977350234985
ALD B-Disease 1 1.0
. O 0 0.07983986288309097

Oleic O 1 0.9908599853515625
and O 0 0.04333652928471565
erucic O 1 0.9999904632568359
acids O 0 0.03749347850680351
( O 0 0.0217890664935112
Lorenzos O 1 0.9952255487442017
Oil O 0 0.01876838132739067
) O 0 0.008114270865917206
were O 0 0.00465741753578186
administered O 0 0.008010486140847206
to O 0 0.006365437526255846
patients O 0 0.3298579454421997
1 O 0 0.009735479950904846
and O 0 0.0059028929099440575
4 O 0 0.009482764638960361
, O 0 0.005549085326492786
but O 0 0.004863330628722906
sufficient O 0 0.010232942178845406
effectiveness O 0 0.021679550409317017
was O 0 0.013323166407644749
not O 0 0.008907696232199669
obtained O 0 0.02267158031463623
. O 0 0.02779363840818405

The O 0 0.022065894678235054
findings O 0 0.01487642526626587
in O 0 0.00794905237853527
this O 0 0.005382274743169546
family O 0 0.008171763271093369
suggest O 0 0.0066105155274271965
that O 0 0.004567780997604132
delGAG291 O 1 0.5671270489692688
is O 0 0.004679578822106123
part O 0 0.006411528680473566
of O 0 0.004612128250300884
the O 0 0.006964916363358498
cause O 0 0.014694883488118649
of O 0 0.012807243503630161
Japanese O 1 0.9997499585151672
ALD B-Disease 1 1.0
with O 0 0.02424768917262554
phenotypic O 0 0.056700099259614944
variations O 0 0.041380103677511215
. O 0 0.03858727589249611

Moreover O 0 0.03456562012434006
, O 0 0.011080831289291382
although O 0 0.006489268504083157
the O 0 0.005920003168284893
scale O 0 0.008902384899556637
of O 0 0.005063938908278942
the O 0 0.005387170240283012
study O 0 0.00576662877574563
is O 0 0.004785839002579451
limited O 0 0.0058620888739824295
, O 0 0.004418129101395607
there O 0 0.002810346893966198
is O 0 0.0033148336224257946
a O 0 0.004937781020998955
possibility O 0 0.006394761614501476
that O 0 0.004209647420793772
PET O 0 0.30180874466896057
can O 0 0.005377108696848154
detect O 0 0.01230980921536684
an O 0 0.009806620888411999
insidious B-Disease 1 0.9999998807907104
lesion I-Disease 1 1.0
which O 0 0.007138319779187441
is O 0 0.00811746809631586
undetectable O 0 0.15743646025657654
by O 0 0.00588425574824214
computed O 0 0.016642402857542038
tomogram O 1 0.99962317943573
( O 0 0.017462696880102158
CT O 1 0.9999994039535522
) O 0 0.010197415947914124
or O 0 0.007804050575941801
MRI O 1 0.8811811804771423
analysis O 0 0.007751251570880413
, O 0 0.005986705422401428
and O 0 0.0040646749548614025
that O 0 0.003073096042498946
the O 0 0.004577461164444685
higher O 0 0.006878084037452936
level O 0 0.007796699646860361
of O 0 0.008753559552133083
tau O 0 0.07202569395303726
reflects O 0 0.01371064968407154
the O 0 0.0071070254780352116
process O 0 0.006972317583858967
of O 0 0.011742972768843174
neuronal B-Disease 1 0.9965478777885437
degeneration I-Disease 1 1.0
in O 1 0.9887912273406982
ALD B-Disease 1 1.0
. O 0 0.0738283097743988

Lorenzos O 1 0.9884424805641174
Oil O 0 0.03331875428557396
should O 0 0.01084804441779852
be O 0 0.0051167914643883705
given O 0 0.005623896140605211
in O 0 0.005463209003210068
the O 0 0.006970204412937164
early O 0 0.011631469242274761
stage O 0 0.02439291402697563
. O 0 0.018106764182448387
. O 0 0.026672707870602608

Nonsense O 0 0.09560095518827438
mutation O 0 0.03470315784215927
in O 0 0.015381770208477974
exon O 0 0.04015927389264107
4 O 0 0.015836887061595917
of O 0 0.010663481429219246
human O 0 0.011580604128539562
complement O 0 0.4225444495677948
C9 O 1 0.9999997615814209
gene O 0 0.015636812895536423
is O 0 0.007723063696175814
the O 0 0.00782164465636015
major O 0 0.012029635719954967
cause O 0 0.012898841872811317
of O 0 0.012701715342700481
Japanese O 1 0.998578667640686
complement B-Disease 1 0.9999865293502808
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.11129448562860489

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.020161844789981842
the I-Disease 0 0.017249219119548798
ninth I-Disease 1 0.9992097616195679
component I-Disease 0 0.02764999121427536
of I-Disease 0 0.008690237067639828
human I-Disease 0 0.008649572730064392
complement I-Disease 1 0.8582644462585449
( O 0 0.1081826463341713
C9 O 1 1.0
) O 0 0.007356035057455301
is O 0 0.004257590044289827
the O 0 0.003552529029548168
most O 0 0.004738795105367899
common O 0 0.008953173644840717
complement B-Disease 1 0.9999979734420776
deficiency I-Disease 1 1.0
in O 1 0.8678954839706421
Japan O 1 0.9961283206939697
but O 0 0.006144122686237097
is O 0 0.005471402313560247
rare O 0 0.008073092438280582
in O 0 0.005445965100079775
other O 0 0.006108773872256279
countries O 0 0.009801788255572319
. O 0 0.02023940347135067

We O 0 0.0192202590405941
studied O 0 0.017010614275932312
the O 0 0.009061264805495739
molecular O 0 0.01234800461679697
basis O 0 0.0075101121328771114
of O 0 0.013488983735442162
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.010403594933450222
four O 0 0.011643540114164352
Japanese O 1 0.9921566247940063
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999990463256836
patients O 1 0.9991177916526794
who O 0 0.019012335687875748
had O 0 0.4858037531375885
suffered O 1 1.0
from O 1 0.9998818635940552
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9950602650642395

Direct O 0 0.03997548669576645
sequencing O 0 0.03735723719000816
of O 0 0.022743217647075653
amplified O 0 0.062351860105991364
C9 O 1 0.9999508857727051
cDNA O 0 0.055839527398347855
and O 0 0.013252420350909233
DNA O 0 0.013574811629951
revealed O 0 0.01210774015635252
a O 0 0.011835480108857155
nonsense O 0 0.023741494864225388
substitution O 0 0.020196989178657532
( O 0 0.013320183381438255
CGA O 1 0.9149942994117737
- O 1 0.9999874830245972
- O 1 0.9999512434005737
> O 1 0.9945948719978333
TGA O 1 0.9997842907905579
) O 0 0.014011437073349953
at O 0 0.012037708424031734
codon O 0 0.022637294605374336
95 O 0 0.019697746261954308
in O 0 0.010083412751555443
exon O 0 0.02919013239443302
4 O 0 0.013472205027937889
in O 0 0.007095172069966793
the O 0 0.009226947091519833
four O 0 0.016865450888872147
C9 B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
deficient I-Disease 1 0.9996366500854492
individuals O 0 0.02208205685019493
. O 0 0.02882145345211029

An O 0 0.028624098747968674
allele O 0 0.048190243542194366
- O 1 0.6036556363105774
specific O 0 0.013888181187212467
polymerase O 0 0.05492469295859337
chain O 0 0.02121695876121521
reaction O 0 0.011270557530224323
system O 0 0.009380516596138477
designed O 0 0.012462000362575054
to O 0 0.0069715785793960094
detect O 0 0.011748509481549263
exclusively O 0 0.008700412698090076
only O 0 0.003967953845858574
one O 0 0.004306938964873552
of O 0 0.0041083176620304585
the O 0 0.005255546886473894
normal O 0 0.006883095484226942
and O 0 0.0065351310186088085
mutant O 0 0.022129172459244728
alleles O 0 0.012739214114844799
indicated O 0 0.0067983949556946754
that O 0 0.0028806657064706087
all O 0 0.002893482567742467
the O 0 0.004436927381902933
four O 0 0.006009158678352833
patients O 0 0.01801551692187786
were O 0 0.004447693005204201
homozygous O 0 0.00943690910935402
for O 0 0.004791129846125841
the O 0 0.006789768114686012
mutation O 0 0.008392970077693462
in O 0 0.006665235850960016
exon O 0 0.0338449664413929
4 O 0 0.008981973864138126
and O 0 0.004803742282092571
that O 0 0.003077545901760459
the O 0 0.004394644871354103
parents O 0 0.0061155688017606735
of O 0 0.00678648566827178
patient O 1 0.9986802935600281
2 O 0 0.017338113859295845
were O 0 0.014777615666389465
heterozygous O 0 0.03890946879982948
. O 0 0.030122185125947

The O 0 0.028564754873514175
common O 0 0.019825872033834457
mutation O 0 0.019975570961833
at O 0 0.013571682386100292
codon O 0 0.020752757787704468
95 O 0 0.020747032016515732
in O 0 0.011503496207296848
exon O 0 0.04175792261958122
4 O 0 0.013343052938580513
might O 0 0.006847105920314789
be O 0 0.004180060233920813
responsible O 0 0.006942844949662685
for O 0 0.005982972215861082
most O 0 0.01152962725609541
Japanese O 1 0.9995213747024536
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.032405342906713486
. O 0 0.035016220062971115

BRCA1 O 0 0.4500773251056671
required O 0 0.01498460117727518
for O 0 0.011755186133086681
transcription O 0 0.0390867255628109
- O 1 0.9997733235359192
coupled O 0 0.23959790170192719
repair O 1 0.9975814819335938
of O 0 0.022256644442677498
oxidative O 1 0.9995023012161255
DNA O 0 0.05157371982932091
damage O 1 0.8875871896743774
. O 0 0.039487674832344055

The O 0 0.045864854007959366
breast B-Disease 1 1.0
and I-Disease 1 0.9998940229415894
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.973097026348114
BRCA1 O 1 0.9999933242797852
encodes O 0 0.037459149956703186
a O 0 0.02570401504635811
zinc O 1 0.9999992847442627
finger O 1 0.9120885729789734
protein O 0 0.0159800723195076
of O 0 0.012220410630106926
unknown O 0 0.020428162068128586
function O 0 0.01996655762195587
. O 0 0.025920800864696503

Association O 0 0.032930824905633926
of O 0 0.015473997220396996
the O 0 0.01638467237353325
BRCA1 O 1 0.9997089505195618
protein O 0 0.011662565171718597
with O 0 0.006667635403573513
the O 0 0.008923344314098358
DNA O 0 0.0159499142318964
repair O 1 0.9998014569282532
protein O 0 0.023951532319188118
Rad51 O 1 0.9884933829307556
and O 0 0.007650183979421854
changes O 0 0.007363406475633383
in O 0 0.00521046994253993
the O 0 0.007024070248007774
phosphorylation O 0 0.012729285284876823
and O 0 0.006917628925293684
cellular O 0 0.01843249425292015
localization O 0 0.017795544117689133
of O 0 0.007921077311038971
the O 0 0.008100412786006927
protein O 0 0.009297718293964863
after O 0 0.008062799461185932
exposure O 0 0.01281845010817051
to O 0 0.008012386970221996
DNA O 0 0.015513643622398376
- O 1 0.9995583891868591
damaging O 0 0.028117487207055092
agents O 0 0.008149007335305214
are O 0 0.0030270430725067854
consistent O 0 0.006129003129899502
with O 0 0.004284613765776157
a O 0 0.006733473390340805
role O 0 0.00938393734395504
for O 0 0.009495225735008717
BRCA1 O 1 0.9996545314788818
in O 0 0.013974173925817013
DNA O 0 0.031081262975931168
repair O 1 0.9965896606445312
. O 0 0.03353603556752205

Here O 0 0.022064754739403725
, O 0 0.011432260274887085
it O 0 0.005713311024010181
is O 0 0.005588276777416468
shown O 0 0.005986381787806749
that O 0 0.00489087076857686
mouse O 0 0.02265879139304161
embryonic O 0 0.024693991988897324
stem O 0 0.03215344250202179
cells O 0 0.021064093336462975
deficient B-Disease 1 0.9945679903030396
in I-Disease 0 0.012862668372690678
BRCA1 I-Disease 1 0.999968409538269
are O 0 0.006722835823893547
defective O 1 0.6906893849372864
in O 0 0.00619149673730135
the O 0 0.0055846055038273335
ability O 0 0.006095406133681536
to O 0 0.004745951853692532
carry O 0 0.006312455981969833
out O 0 0.006861772853881121
transcription O 0 0.01648656651377678
- O 1 0.995368480682373
coupled O 0 0.02809056267142296
repair O 1 0.9646376967430115
of O 0 0.013039818964898586
oxidative O 1 0.998027503490448
DNA O 0 0.024317434057593346
damage O 1 0.8863241672515869
, O 0 0.007420421112328768
and O 0 0.007495368830859661
are O 0 0.006324301939457655
hypersensitive O 1 0.9902399778366089
to O 0 0.015513491816818714
ionizing O 1 0.9999730587005615
radiation O 1 0.9995694756507874
and O 0 0.021532025188207626
hydrogen O 0 0.06488567590713501
peroxide O 1 0.966759979724884
. O 0 0.04427307844161987

These O 0 0.014757954515516758
results O 0 0.012913930229842663
suggest O 0 0.010555069893598557
that O 0 0.008325709961354733
BRCA1 O 1 0.9990009665489197
participates O 0 0.03562464565038681
, O 0 0.007546877022832632
directly O 0 0.006799521390348673
or O 0 0.005485374014824629
indirectly O 0 0.008136582560837269
, O 0 0.005618394818156958
in O 0 0.00645808968693018
transcription O 0 0.022725285962224007
- O 1 0.9992165565490723
coupled O 0 0.1060490533709526
repair O 1 0.9885739088058472
of O 0 0.0165325328707695
oxidative O 1 0.9993289709091187
DNA O 0 0.032304808497428894
damage O 1 0.9328321814537048
. O 0 0.01765279844403267
. O 0 0.027840496972203255

Truncation O 0 0.21996313333511353
mutations O 0 0.033442072570323944
in O 0 0.013457508757710457
the O 0 0.016464615240693092
transactivation O 1 0.5970896482467651
region O 0 0.0158245749771595
of O 0 0.014055907726287842
PAX6 O 1 0.999998927116394
result O 0 0.01237604208290577
in O 0 0.012922612950205803
dominant O 1 0.9733032584190369
- O 1 0.9999808073043823
negative O 0 0.03283586725592613
mutants O 0 0.07703491300344467
. O 0 0.03884600102901459

PAX6 O 1 0.999724805355072
is O 0 0.018310846760869026
a O 0 0.01611386425793171
transcription O 0 0.021895287558436394
factor O 0 0.011295303702354431
with O 0 0.004789111204445362
two O 0 0.005197152495384216
DNA O 0 0.01050348300486803
- O 1 0.8402270078659058
binding O 0 0.012433073483407497
domains O 0 0.016111692413687706
( O 0 0.00955408625304699
paired O 0 0.024299079552292824
box O 0 0.05858885869383812
and O 0 0.013458396308124065
homeobox O 1 0.9989049434661865
) O 0 0.009382537566125393
and O 0 0.007395204156637192
a O 0 0.011330770328640938
proline O 1 0.8672716021537781
- O 1 0.9998787641525269
serine O 1 0.5821670293807983
- O 1 0.9997400641441345
threonine O 1 0.7270376682281494
( O 0 0.02054298110306263
PST O 1 0.9998769760131836
) O 0 0.023514071479439735
- O 1 0.8736436367034912
rich O 0 0.03978579118847847
transactivation O 1 0.9582774043083191
domain O 0 0.049195606261491776
. O 0 0.03757363185286522

PAX6 O 1 0.9999963045120239
regulates O 1 0.9466484785079956
eye O 1 0.9997617602348328
development O 0 0.019199900329113007
in O 0 0.010381150059401989
animals O 0 0.008604533970355988
ranging O 0 0.012531059794127941
from O 0 0.009652496315538883
jellyfish O 0 0.02803797833621502
to O 0 0.011851214803755283
Drosophila O 0 0.0332334041595459
to O 0 0.016277002170681953
humans O 0 0.02118070051074028
. O 0 0.027799025177955627

Heterozygous O 0 0.06405918300151825
mutations O 0 0.01830958016216755
in O 0 0.008495100773870945
the O 0 0.010296179912984371
human O 0 0.013066333718597889
PAX6 O 1 1.0
gene O 0 0.012867864221334457
result O 0 0.007028980180621147
in O 0 0.0061416104435920715
various O 0 0.005915946327149868
phenotypes O 0 0.01850445382297039
, O 0 0.007604706101119518
including O 0 0.009468989446759224
aniridia B-Disease 1 0.9999998807907104
, O 0 0.030466215685009956
Peters B-Disease 1 0.9999959468841553
anomaly I-Disease 1 0.9999701976776123
, O 0 0.019346045330166817
autosomal B-Disease 1 0.999963641166687
dominant I-Disease 1 0.9999908208847046
keratitis I-Disease 1 1.0
, O 1 0.5880388617515564
and O 1 0.871776819229126
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.8601006269454956

It O 0 0.01886008493602276
is O 0 0.010144880972802639
believed O 0 0.008265908807516098
that O 0 0.004453260451555252
the O 0 0.008034028112888336
mutated O 0 0.023811819031834602
allele O 0 0.02197304554283619
of O 0 0.011555295437574387
PAX6 O 1 0.9999982118606567
produces O 0 0.016321493312716484
an O 0 0.008912141434848309
inactive O 1 0.7893769145011902
protein O 0 0.010758933611214161
and O 0 0.008136346004903316
aniridia B-Disease 1 0.999998927116394
is O 0 0.008168185129761696
caused O 0 0.01678098924458027
due O 0 0.008725102990865707
to O 0 0.011807550676167011
genetic O 0 0.028567876666784286
haploinsufficiency O 1 0.9998446702957153
. O 0 0.03497365862131119

However O 0 0.018407074734568596
, O 0 0.010205470025539398
several O 0 0.006847559940069914
truncation O 0 0.08798123896121979
mutations O 0 0.009619318880140781
have O 0 0.003410183358937502
been O 0 0.003611983498558402
found O 0 0.0027479813434183598
to O 0 0.002723097801208496
occur O 0 0.0024881348945200443
in O 0 0.0033107823692262173
the O 0 0.006866758689284325
C O 1 0.9997366070747375
- O 1 0.9989031553268433
terminal O 0 0.017630161717534065
half O 0 0.007576975505799055
of O 0 0.008699582889676094
PAX6 O 1 0.9999469518661499
in O 0 0.010699107311666012
patients O 1 0.8037753105163574
with O 0 0.011872845701873302
Aniridia B-Disease 1 0.9999998807907104
resulting O 0 0.01222501415759325
in O 0 0.008595398627221584
mutant O 0 0.01927383989095688
proteins O 0 0.007740939036011696
that O 0 0.003952892031520605
retain O 0 0.011114774271845818
the O 0 0.007796657737344503
DNA O 0 0.01190546527504921
- O 1 0.9421424865722656
binding O 0 0.010079765692353249
domains O 0 0.009821486659348011
but O 0 0.0046776290982961655
have O 0 0.0038423172663897276
lost O 0 0.00932147167623043
most O 0 0.006500748451799154
of O 0 0.0086124949157238
the O 0 0.015488655306398869
transactivation O 1 0.9993911981582642
domain O 0 0.04772570729255676
. O 0 0.03730696067214012

It O 0 0.016766676679253578
is O 0 0.008696223609149456
not O 0 0.005003409460186958
clear O 0 0.00680548744276166
whether O 0 0.006431713234633207
such O 0 0.005968713667243719
mutants O 0 0.023970678448677063
really O 0 0.00953931175172329
behave O 0 0.009504944086074829
as O 0 0.0066658081486821175
loss O 0 0.053604260087013245
- O 1 0.9997343420982361
of O 0 0.012624877505004406
- O 1 0.9999920129776001
function O 0 0.011102704331278801
mutants O 0 0.022963061928749084
as O 0 0.011290756054222584
predicted O 0 0.019115231931209564
by O 0 0.014491542242467403
haploinsufficiency O 1 0.8638644814491272
. O 0 0.0344044528901577

Contrary O 0 0.026013657450675964
to O 0 0.009028876200318336
this O 0 0.006063260603696108
theory O 0 0.009479988366365433
, O 0 0.0060623204335570335
our O 0 0.006282651796936989
data O 0 0.006009887903928757
showed O 0 0.0063969651237130165
that O 0 0.003573616733774543
these O 0 0.004011680372059345
mutants O 0 0.01461130939424038
are O 0 0.004676899407058954
dominant O 0 0.029165610671043396
- O 1 0.9812085628509521
negative O 0 0.010459714569151402
in O 0 0.009475413709878922
transient O 1 0.5556062459945679
transfection O 1 0.9972929358482361
assays O 0 0.02132324129343033
when O 0 0.008451811037957668
they O 0 0.004261703696101904
are O 0 0.003924154210835695
coexpressed O 0 0.02727171778678894
with O 0 0.009468953125178814
wild O 0 0.02647273615002632
- O 1 0.9999958276748657
type O 1 0.9755444526672363
PAX6 O 1 0.9999954700469971
. O 0 0.04623963683843613

We O 0 0.01407009456306696
found O 0 0.005978482309728861
that O 0 0.0036548178177326918
the O 0 0.006565772462636232
dominant O 1 0.8429105877876282
- O 1 0.999984622001648
negative O 0 0.00993580836802721
effects O 0 0.009251752868294716
result O 0 0.004880137275904417
from O 0 0.0045099081471562386
the O 0 0.006754362490028143
enhanced O 0 0.017001895233988762
DNA O 0 0.012726529501378536
binding O 0 0.011207235045731068
ability O 0 0.010075000114738941
of O 0 0.009401613846421242
these O 0 0.010470344685018063
mutants O 0 0.04622893035411835
. O 0 0.0287702064961195

Kinetic O 0 0.07845190912485123
studies O 0 0.02187732793390751
of O 0 0.01677865907549858
binding O 0 0.01869511604309082
and O 0 0.013267486356198788
dissociation O 0 0.028622660785913467
revealed O 0 0.013202629052102566
that O 0 0.004924179054796696
various O 0 0.005279755685478449
truncation O 0 0.021865056827664375
mutants O 0 0.018516123294830322
have O 0 0.005215084180235863
3 O 0 0.012292140163481236
- O 1 0.8775233626365662
5 O 0 0.01411389745771885
- O 0 0.4195546805858612
fold O 0 0.019147444516420364
higher O 0 0.008668401278555393
affinity O 0 0.009051687084138393
to O 0 0.004131419118493795
various O 0 0.004396327305585146
DNA O 0 0.0097116120159626
- O 0 0.22929790616035461
binding O 0 0.00754025811329484
sites O 0 0.005666261073201895
when O 0 0.004803440999239683
compared O 0 0.004655587021261454
with O 0 0.00391763262450695
the O 0 0.006937980651855469
wild O 0 0.017776574939489365
- O 1 0.9999943971633911
type O 1 0.8571415543556213
PAX6 O 1 0.9999910593032837
. O 0 0.04611383378505707

These O 0 0.013602863997220993
results O 0 0.01250577624887228
provide O 0 0.00949172768741846
a O 0 0.008985170163214207
new O 0 0.009387609548866749
insight O 0 0.015964537858963013
into O 0 0.0068882121704518795
the O 0 0.006766080390661955
role O 0 0.009840043261647224
of O 0 0.009888843633234501
mutant O 1 0.731116771697998
PAX6 O 1 0.9999994039535522
in O 0 0.023342756554484367
causing O 1 0.995059609413147
aniridia B-Disease 1 0.9999990463256836
. O 0 0.024604400619864464
. O 0 0.033135317265987396

Reversal O 0 0.09064504504203796
of O 0 0.35398826003074646
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999927282333374
excellent O 1 0.999948263168335
neuropsychologic O 1 0.9998544454574585
outcome O 0 0.010566937737166882
in O 0 0.006168851628899574
very B-Disease 0 0.008001094684004784
- I-Disease 1 0.9919290542602539
long I-Disease 0 0.016525518149137497
- I-Disease 1 0.999649167060852
chain I-Disease 0 0.3909895718097687
acyl I-Disease 1 0.9996316432952881
- I-Disease 1 0.9999896287918091
coenzyme I-Disease 1 0.9989122152328491
A I-Disease 1 0.9995101690292358
dehydrogenase I-Disease 1 0.9999960660934448
deficiency I-Disease 1 1.0
. O 0 0.05347750335931778

Very B-Disease 0 0.0305766798555851
- I-Disease 1 0.9788163900375366
long I-Disease 0 0.026197366416454315
- I-Disease 1 0.9988368153572083
chain I-Disease 0 0.1208609789609909
acyl I-Disease 1 0.999277651309967
- I-Disease 1 0.9994298815727234
coenzyme I-Disease 1 0.6570568084716797
A I-Disease 0 0.08597416430711746
dehydrogenase I-Disease 1 0.9921107888221741
( I-Disease 0 0.023510120809078217
VLCAD I-Disease 1 1.0
) I-Disease 1 0.6331570744514465
deficiency I-Disease 1 1.0
is O 0 0.008384225890040398
a O 0 0.16412189602851868
disorder O 1 1.0
of O 1 0.9996310472488403
fatty O 1 1.0
acid O 1 0.9999911785125732
beta O 1 0.9620165228843689
oxidation O 0 0.0189568642526865
that O 0 0.005811016075313091
reportedly O 0 0.01212147157639265
has O 0 0.00797016080468893
high O 0 0.012378794141113758
rates O 0 0.011638559401035309
of O 0 0.012697779573500156
morbidity O 1 0.9999971389770508
and O 0 0.041403014212846756
mortality O 1 0.9999237060546875
. O 0 0.03750618174672127

We O 0 0.0164195504039526
describe O 0 0.01404346339404583
the O 0 0.007287400774657726
outcome O 0 0.007090819533914328
of O 0 0.0049737622030079365
a O 0 0.007206870708614588
5 O 0 0.011490943841636181
- O 0 0.49165186285972595
year O 0 0.010619163513183594
- O 1 0.903628945350647
old O 0 0.018798628821969032
girl O 0 0.02381305955350399
with O 0 0.01390392892062664
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.9657778143882751
was O 0 0.03988947346806526
first O 0 0.006534205283969641
seen O 0 0.005743322893977165
at O 0 0.005847235210239887
5 O 0 0.005655820015817881
months O 0 0.004932512529194355
of O 0 0.004311554599553347
age O 0 0.008284120820462704
with O 0 0.012871941551566124
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 1 0.9988524913787842
and O 1 0.7994959950447083
hypotonia B-Disease 1 0.9999984502792358
. O 0 0.05022862181067467

Biochemical O 0 0.08224023133516312
studies O 0 0.027486274018883705
indicated O 1 0.9126806259155273
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9997220635414124
by O 0 0.009313522838056087
a O 0 0.02292751707136631
stable O 1 0.8734418749809265
yet O 0 0.02523895725607872
inactive O 1 0.9360867142677307
enzyme O 0 0.04746274650096893
. O 0 0.036190394312143326

Molecular O 0 0.05832583084702492
genetic O 0 0.024098604917526245
analysis O 0 0.014520996250212193
of O 0 0.011577919125556946
her O 0 0.02146533690392971
VLCAD O 1 0.9999947547912598
gene O 0 0.01672445237636566
revealed O 0 0.015969017520546913
a O 0 0.016067255288362503
T1372C O 1 0.9981797933578491
( O 0 0.0176988635212183
F458L O 1 0.8688267469406128
) O 0 0.018472939729690552
missense O 0 0.0397178940474987
mutation O 0 0.02043215185403824
and O 0 0.012087179347872734
a O 0 0.022377509623765945
1668 O 1 0.9999990463256836
ACAG O 1 0.9999996423721313
1669 O 1 0.9999951124191284
splice O 1 0.8924385905265808
site O 0 0.05817664787173271
mutation O 0 0.05926879122853279
. O 0 0.040943942964076996

After O 0 0.030543426051735878
initial O 0 0.02440275065600872
treatment O 1 0.8004701137542725
with O 0 0.01647789403796196
intravenous O 1 1.0
glucose O 1 0.9996121525764465
and O 0 0.02196662686765194
carnitine O 1 0.9999996423721313
, O 0 0.009281200356781483
the O 0 0.008946060203015804
patient O 1 0.9745537638664246
has O 0 0.007479444611817598
thrived O 0 0.019916633144021034
on O 0 0.005565513391047716
a O 0 0.008938520215451717
low O 0 0.021245179697871208
- O 1 0.9997616410255432
fat O 0 0.0336838960647583
diet O 0 0.027675176039338112
supplemented O 0 0.020628180354833603
with O 0 0.010759060271084309
medium O 0 0.08903300762176514
- O 1 0.9995660185813904
chain O 0 0.043354108929634094
triglyceride O 0 0.0436849407851696
oil O 0 0.019116265699267387
and O 0 0.014714186079800129
carnitine O 1 0.9999641180038452
and O 0 0.017453620210289955
avoidance O 1 0.9999569654464722
of O 0 0.05426672101020813
fasting O 1 0.9328495860099792
. O 0 0.03978963941335678

Her O 1 0.9961931705474854
ventricular O 1 1.0
hypertrophy O 1 0.9999997615814209
resolved O 0 0.03178374096751213
significantly O 0 0.014840317890048027
over O 0 0.00998377799987793
1 O 0 0.012413603253662586
year O 0 0.008940717205405235
, O 0 0.008530414663255215
and O 0 0.009056809358298779
cognitively O 1 0.9985730648040771
, O 0 0.01011582836508751
she O 0 0.009429723024368286
is O 0 0.0050346278585493565
in O 0 0.005686402786523104
the O 0 0.008062624372541904
superior O 0 0.016889898106455803
range O 0 0.011672165244817734
for O 0 0.010318408720195293
age O 0 0.02263903059065342
. O 0 0.030888879671692848

Clinical O 0 0.2040385752916336
recognition O 0 0.029413286596536636
of O 1 0.9946715235710144
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.9474590420722961
important O 0 0.00970140565186739
because O 0 0.004814505111426115
it O 0 0.0039544072933495045
is O 0 0.003645770251750946
one O 0 0.0031416157726198435
of O 0 0.003252699738368392
the O 0 0.0035764228086918592
few O 0 0.005072354339063168
directly O 0 0.008651118725538254
treatable O 1 1.0
causes O 1 0.9999293088912964
of O 1 0.9998900890350342
cardiomyopathy B-Disease 1 1.0
in O 1 0.9991680383682251
children O 1 0.989429771900177
. O 0 0.015918681398034096
. O 0 0.027956867590546608

Cloning O 0 0.05186957120895386
of O 0 0.0164332315325737
a O 0 0.014303471893072128
novel O 0 0.01672935113310814
member O 0 0.008406265638768673
of O 0 0.006379950791597366
the O 0 0.00789492018520832
low O 0 0.46491700410842896
- O 1 0.9999829530715942
density O 0 0.036698564887046814
lipoprotein O 1 0.9999289512634277
receptor O 0 0.057676661759614944
family O 0 0.040700025856494904
. O 0 0.03643191605806351

A O 0 0.04052397236227989
gene O 0 0.023386867716908455
encoding O 0 0.019457712769508362
a O 0 0.013852459378540516
novel O 0 0.027710840106010437
transmembrane O 1 0.5678914785385132
protein O 0 0.015403232537209988
was O 0 0.010981275700032711
identified O 0 0.0073983860202133656
by O 0 0.004232523962855339
DNA O 0 0.007584659848362207
sequence O 0 0.0047712428495287895
analysis O 0 0.003840828314423561
within O 0 0.0039430949836969376
the O 0 0.006235400214791298
insulin B-Disease 1 0.9999979734420776
- I-Disease 1 1.0
dependent I-Disease 1 0.9996873140335083
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9990329742431641
IDDM B-Disease 1 1.0
) O 0 0.02311752364039421
locus O 1 0.9802408218383789
IDDM4 O 1 0.9999574422836304
on O 0 0.02412155270576477
chromosome O 0 0.05163544788956642
11q13 O 1 0.9275673031806946
. O 0 0.039061304181814194

Based O 0 0.02366943098604679
on O 0 0.011236738413572311
its O 0 0.011874389834702015
chromosomal O 0 0.026191312819719315
position O 0 0.01265238132327795
, O 0 0.007965875789523125
this O 0 0.005178879946470261
gene O 0 0.006869614589959383
is O 0 0.004677403252571821
a O 0 0.005916543770581484
candidate O 0 0.009046753868460655
for O 0 0.007514968980103731
conferring O 1 0.9698415994644165
susceptibility O 1 0.9999682903289795
to O 0 0.323736310005188
diabetes B-Disease 1 1.0
. O 0 0.06065059453248978

The O 0 0.027486175298690796
gene O 0 0.01808275282382965
, O 0 0.010947034694254398
termed O 0 0.02049717679619789
low O 0 0.026714688166975975
- O 1 0.9993129968643188
density O 0 0.024719636887311935
lipoprotein O 1 0.995537281036377
receptor O 0 0.028006885200738907
related O 0 0.01324186846613884
protein O 0 0.01214694045484066
5 O 0 0.016111375764012337
( O 0 0.014220960438251495
LRP5 O 1 0.9999650716781616
) O 0 0.011464910581707954
, O 0 0.009367569349706173
encodes O 0 0.01521785743534565
a O 0 0.009600289165973663
protein O 0 0.013126656413078308
of O 0 0.01333620585501194
1615 O 1 0.950689971446991
amino O 0 0.019739536568522453
acids O 0 0.012652511708438396
that O 0 0.007695660926401615
contains O 0 0.01215133536607027
conserved O 0 0.015638861805200577
modules O 0 0.016770528629422188
which O 0 0.005460503976792097
are O 0 0.0027842908166348934
characteristic O 0 0.005595674272626638
of O 0 0.0039550238288939
the O 0 0.005758182145655155
low O 0 0.3281153440475464
- O 1 0.9999929666519165
density O 0 0.029452351853251457
lipoprotein O 1 0.9999983310699463
( O 0 0.07561914622783661
LDL O 1 0.9999988079071045
) O 0 0.024190733209252357
receptor O 0 0.044503357261419296
family O 0 0.035672660917043686
. O 0 0.033842071890830994

These O 0 0.01900968886911869
modules O 0 0.03948519751429558
include O 0 0.015473929233849049
a O 0 0.015465041622519493
putative O 0 0.05974370986223221
signal O 0 0.0206010602414608
peptide O 0 0.022838754579424858
for O 0 0.009024201892316341
protein O 0 0.009908064268529415
export O 0 0.009730336256325245
, O 0 0.008393795229494572
four O 0 0.009327122941613197
epidermal O 1 0.9960081577301025
growth O 0 0.03057916834950447
factor O 0 0.06657209247350693
( O 0 0.019116971641778946
EGF O 1 0.9999750852584839
) O 0 0.012000689283013344
repeats O 0 0.018406854942440987
with O 0 0.007468733470886946
associated O 0 0.012240871787071228
spacer O 0 0.03851424530148506
domains O 0 0.01704486273229122
, O 0 0.010194546543061733
three O 0 0.012485625222325325
LDL O 1 0.9999998807907104
- O 1 0.9999991655349731
receptor O 0 0.18729938566684723
( O 0 0.016068512573838234
LDLR O 1 0.9998786449432373
) O 0 0.011883814819157124
repeats O 0 0.017218375578522682
, O 0 0.00884269829839468
a O 0 0.010175361298024654
single O 0 0.014191098511219025
transmembrane O 0 0.04489187151193619
spanning O 0 0.02066572569310665
domain O 0 0.017270993441343307
, O 0 0.009561436250805855
and O 0 0.009970692917704582
a O 0 0.017768217250704765
cytoplasmic O 0 0.053837038576602936
domain O 0 0.041257742792367935
. O 0 0.0346926711499691

The O 0 0.027449103072285652
encoded O 0 0.02233615517616272
protein O 0 0.015594945289194584
has O 0 0.007344831712543964
a O 0 0.007492780219763517
unique O 0 0.008346183225512505
organization O 0 0.009558207355439663
of O 0 0.010513434186577797
EGF O 1 0.9999998807907104
and O 0 0.03658914938569069
LDLR O 1 0.9999998807907104
repeats O 0 0.07682371884584427
; O 0 0.009912092238664627
therefore O 0 0.008620331063866615
, O 0 0.009258745238184929
LRP5 O 1 0.9979058504104614
likely O 0 0.009376618079841137
represents O 0 0.008777888491749763
a O 0 0.006617599166929722
new O 0 0.007678678724914789
category O 0 0.01203568372875452
of O 0 0.0069617475382983685
the O 0 0.01123860850930214
LDLR O 1 0.9999969005584717
family O 0 0.03310837969183922
. O 0 0.029193073511123657

Both O 0 0.016636604443192482
human O 0 0.012097233906388283
and O 0 0.012282995507121086
mouse O 1 0.9950388073921204
LRP5 O 1 0.9999998807907104
cDNAs O 1 0.9996904134750366
have O 0 0.006274987943470478
been O 0 0.006199003662914038
isolated O 0 0.008088720962405205
and O 0 0.004857952240854502
the O 0 0.006460345350205898
encoded O 0 0.01045447401702404
mature O 0 0.014093106612563133
proteins O 0 0.007426045835018158
are O 0 0.0037169521674513817
95 O 0 0.014188122935593128
% O 0 0.007649033330380917
identical O 0 0.008440360426902771
, O 0 0.006126691121608019
indicating O 0 0.007086282595992088
a O 0 0.0069127753376960754
high O 0 0.009505536407232285
degree O 0 0.010445265099406242
of O 0 0.00853510107845068
evolutionary O 0 0.018250582739710808
conservation O 0 0.022064372897148132
. O 0 0.016342496499419212
. O 0 0.023719465360045433

The O 0 0.04761318489909172
APC B-Disease 1 0.9990631937980652
variants O 0 0.04196071997284889
I1307K O 1 0.735377311706543
and O 0 0.01215977594256401
E1317Q O 0 0.09708968549966812
are O 0 0.0042809052392840385
associated O 0 0.009518420323729515
with O 1 0.9867854714393616
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.8885713219642639
but O 0 0.006183333694934845
not O 0 0.003968417644500732
always O 0 0.007413554470986128
with O 0 0.005705463699996471
a O 0 0.010774032212793827
family O 0 0.015390003100037575
history O 0 0.02355949766933918
. O 0 0.0273407232016325

Classical O 0 0.11363716423511505
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999990463256836
FAP B-Disease 1 1.0
) O 0 0.014272820204496384
is O 0 0.0078594870865345
a O 0 0.009876394644379616
high O 0 0.018228650093078613
- O 1 0.9999768733978271
penetrance O 1 0.9999982118606567
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999992847442627
disease I-Disease 1 1.0
that O 0 0.007138275541365147
predisposes O 1 0.99985671043396
to O 0 0.006192644126713276
hundreds O 0 0.006377297453582287
or O 0 0.004343023058027029
thousands O 0 0.008058537729084492
of O 1 0.9521050453186035
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
and O 0 0.13828061521053314
that O 0 0.006203161086887121
results O 0 0.008663331158459187
from O 0 0.007761851418763399
truncating O 0 0.03721240907907486
mutations O 0 0.014313221909105778
in O 0 0.010202142409980297
the O 0 0.01737840101122856
APC B-Disease 1 0.9999979734420776
gene O 0 0.031247690320014954
. O 0 0.032080844044685364

A O 0 0.04024842008948326
variant O 0 0.04645739495754242
of O 0 0.023672735318541527
FAP B-Disease 1 1.0
is O 0 0.31267061829566956
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.012117840349674225
which O 0 0.005041080992668867
results O 0 0.006340296473354101
from O 0 0.007326196879148483
germ O 1 0.9999990463256836
- O 1 0.9999810457229614
line O 0 0.01525755226612091
mutations O 0 0.007531923707574606
in O 0 0.004519149195402861
the O 0 0.004566402640193701
5 O 0 0.00823400728404522
and O 0 0.006017007399350405
3 O 0 0.0076265595853328705
regions O 0 0.005275124683976173
of O 0 0.007278310135006905
the O 0 0.013998538255691528
APC B-Disease 1 0.9999995231628418
gene O 0 0.02853401191532612
. O 0 0.02913396619260311

Attenuated B-Disease 1 0.9999991655349731
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999998807907104
have O 0 0.007496767211705446
" O 0 0.010713591240346432
multiple O 0 0.016878556460142136
" O 1 0.9977800250053406
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.03896542638540268
typically O 0 0.00938855018466711
fewer O 0 0.008579341694712639
than O 0 0.0057996828109025955
100 O 0 0.009291572496294975
) O 0 0.006015308201313019
without O 0 0.005647625308483839
the O 0 0.010546278208494186
florid O 1 0.995253324508667
phenotype O 0 0.22702686488628387
of O 0 0.017468048259615898
classical O 0 0.11961105465888977
FAP B-Disease 1 0.9999998807907104
. O 0 0.05261849984526634

Another O 0 0.027482230216264725
group O 0 0.01972426474094391
of O 0 0.012249257415533066
patients O 1 0.8365623354911804
with O 0 0.008193542249500751
multiple O 0 0.2752687335014343
adenomas B-Disease 1 1.0
has O 0 0.009397298097610474
no O 0 0.00652920501306653
mutations O 0 0.006999819539487362
in O 0 0.004823086783289909
the O 0 0.007745401468127966
APC B-Disease 1 0.999998927116394
gene O 0 0.009267366491258144
, O 0 0.005716771353036165
and O 0 0.004339156206697226
their O 0 0.004519918467849493
phenotype O 0 0.02185620181262493
probably O 0 0.007434865925461054
results O 0 0.005058661103248596
from O 0 0.0038727708160877228
variation O 0 0.00661864597350359
at O 0 0.006041737738996744
a O 0 0.008504142984747887
locus O 1 0.6552868485450745
, O 0 0.0075974916107952595
or O 0 0.007624810095876455
loci O 0 0.01503828540444374
, O 0 0.00805381964892149
elsewhere O 0 0.009615208953619003
in O 0 0.007790297269821167
the O 0 0.014857986941933632
genome O 0 0.03495736047625542
. O 0 0.029988229274749756

Recently O 0 0.03840160742402077
, O 0 0.012938656844198704
however O 0 0.007081368938088417
, O 0 0.007397403009235859
a O 0 0.008990997448563576
missense O 0 0.024107351899147034
variant O 0 0.021130654960870743
of O 0 0.013799439184367657
APC B-Disease 1 1.0
( O 0 0.03141086921095848
I1307K O 1 0.999942421913147
) O 0 0.010261471383273602
was O 0 0.0102463960647583
described O 0 0.008199566043913364
that O 0 0.004347503650933504
confers O 0 0.02155132405459881
an O 0 0.005830342881381512
increased O 0 0.008720440790057182
risk O 1 0.6602807641029358
of O 1 0.999811589717865
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.38438528776168823
including O 0 0.011491334065794945
multiple O 1 0.5017179250717163
adenomas B-Disease 1 1.0
, O 0 0.019842546433210373
in O 0 0.019126620143651962
Ashkenazim O 1 0.9780105948448181
. O 0 0.040202509611845016

We O 0 0.015159320086240768
have O 0 0.006365093402564526
studied O 0 0.009306077845394611
a O 0 0.006152368150651455
set O 0 0.005558669567108154
of O 0 0.0056907557882368565
164 O 0 0.01962778903543949
patients O 0 0.3287797272205353
with O 0 0.006748089101165533
multiple O 1 0.9987051486968994
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
/ I-Disease 1 1.0
or I-Disease 1 0.9712153077125549
carcinoma I-Disease 1 1.0
and O 0 0.015388631261885166
analyzed O 0 0.02569401077926159
codons O 0 0.04479433596134186
1263 O 1 0.9999696016311646
- O 1 0.9999514818191528
1377 O 1 0.9998281002044678
( O 0 0.03664034977555275
exon O 0 0.23663641512393951
15G O 0 0.46623966097831726
) O 0 0.013135133311152458
of O 0 0.011903613805770874
the O 0 0.014227419160306454
APC B-Disease 1 0.9987599849700928
gene O 0 0.01590203307569027
for O 0 0.014762640930712223
germ O 1 0.9999998807907104
- O 1 0.9999936819076538
line O 0 0.04003452509641647
variants O 0 0.03861193731427193
. O 0 0.03460107371211052

Three O 0 0.023410936817526817
patients O 0 0.024862445890903473
with O 0 0.009057758376002312
the O 0 0.01273493841290474
I1307K O 1 0.9988216757774353
allele O 0 0.01949615776538849
were O 0 0.0070488909259438515
detected O 0 0.010776989161968231
, O 0 0.006942516192793846
each O 0 0.005694653373211622
of O 0 0.011730649508535862
Ashkenazi O 1 0.8511971831321716
descent O 0 0.03736966848373413
. O 0 0.03073282167315483

Four O 0 0.030716469511389732
patients O 0 0.030490422621369362
had O 0 0.011630202643573284
a O 0 0.015999263152480125
germ O 1 0.9999998807907104
- O 1 0.9999960660934448
line O 0 0.021443577483296394
E1317Q O 0 0.2777020037174225
missense O 0 0.030997322872281075
variant O 0 0.019344525411725044
of O 0 0.010153906419873238
APC O 1 0.9999562501907349
that O 0 0.004782547242939472
was O 0 0.006324838846921921
not O 0 0.0029018137138336897
present O 0 0.004023624584078789
in O 0 0.004163973964750767
controls O 0 0.007857454009354115
; O 0 0.00441379938274622
one O 0 0.0037566160317510366
of O 0 0.0037197466008365154
these O 0 0.002389008877798915
individuals O 0 0.002490958198904991
had O 0 0.0037145549431443214
an O 0 0.004141549114137888
unusually O 0 0.009369135834276676
large O 0 0.0054896133951842785
number O 0 0.0048041981644928455
of O 0 0.008520175702869892
metaplastic B-Disease 1 0.9999505281448364
polyps I-Disease 1 0.9996480941772461
of I-Disease 0 0.014235541224479675
the I-Disease 0 0.022009579464793205
colorectum I-Disease 1 0.9994200468063354
. O 0 0.04008965194225311

There O 0 0.01637297123670578
is O 0 0.00864176731556654
increasing O 0 0.008361129090189934
evidence O 0 0.005626659374684095
that O 0 0.003508127760142088
there O 0 0.003757783677428961
exist O 0 0.007567258086055517
germ O 1 0.9999743700027466
- O 1 0.999479353427887
line O 0 0.014368586242198944
variants O 0 0.010863312520086765
of O 0 0.007836705073714256
the O 0 0.010505872778594494
APC B-Disease 1 0.9999706745147705
gene O 0 0.01002420112490654
that O 0 0.005056082271039486
predispose O 0 0.01531114149838686
to O 0 0.004428443033248186
the O 0 0.004316175356507301
development O 0 0.006919273175299168
of O 0 0.008711590431630611
multiple O 1 0.9979760050773621
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.28795403242111206
but O 0 0.005913291592150927
without O 0 0.005408404860645533
the O 0 0.00934518687427044
florid O 1 0.9985320568084717
phenotype O 0 0.07630037516355515
of O 0 0.01041155681014061
classical O 0 0.3859652578830719
FAP B-Disease 1 1.0
, O 0 0.009988845326006413
and O 0 0.006913129240274429
possibly O 0 0.0069170682691037655
with O 0 0.004571580793708563
importance O 0 0.00918613187968731
for O 1 0.9961310625076294
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999983310699463
in O 0 0.008221485652029514
the O 0 0.007616015151143074
general O 0 0.014432664960622787
population O 0 0.009251652285456657
. O 0 0.012987623922526836
. O 0 0.020664803683757782

Genomic O 0 0.051824841648340225
structure O 0 0.02064470574259758
of O 0 0.00979948416352272
the O 0 0.012195137329399586
human O 1 0.9986656904220581
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.3086289167404175
gene O 0 0.03883952274918556
. O 0 0.034026119858026505

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.07640760391950607
is O 0 0.008868669159710407
caused O 0 0.009635817259550095
by O 0 0.005579391028732061
mutations O 0 0.006001678295433521
in O 0 0.004343683365732431
a O 0 0.006834226194769144
gene O 0 0.008075441233813763
which O 0 0.006679888349026442
encodes O 0 0.019898807629942894
an O 0 0.021538274362683296
intestinal O 1 1.0
anion O 1 0.9999996423721313
transporter O 1 0.9999470710754395
. O 0 0.05257720127701759

We O 0 0.018647603690624237
report O 0 0.011795304715633392
here O 0 0.008865989744663239
the O 0 0.007736120373010635
complete O 0 0.011927401646971703
genomic O 0 0.016612734645605087
organization O 0 0.008267855271697044
of O 0 0.0062765576876699924
the O 0 0.008996033109724522
human O 0 0.01465036440640688
CLD B-Disease 1 1.0
gene O 0 0.015292215161025524
which O 0 0.009346246719360352
spans O 0 0.021298401057720184
approximately O 0 0.013860967010259628
39kb O 1 0.6147539615631104
, O 0 0.011065072380006313
and O 0 0.011254383251070976
comprises O 0 0.02962736412882805
21 O 0 0.030707228928804398
exons O 0 0.05388607084751129
. O 0 0.03681105002760887

All O 0 0.04016495496034622
exon O 0 0.36728012561798096
/ O 1 0.829022228717804
intron O 0 0.2272772639989853
boundaries O 0 0.018288129940629005
conform O 0 0.017769625410437584
to O 0 0.010020172223448753
the O 0 0.016126219183206558
GT O 1 0.9999998807907104
/ O 1 0.9999972581863403
AG O 1 0.9999988079071045
rule O 0 0.04361358657479286
. O 0 0.040671516209840775

An O 0 0.019360633566975594
analysis O 0 0.014165718108415604
of O 0 0.01134457252919674
the O 0 0.013637988828122616
putative O 1 0.7226078510284424
promoter O 1 0.9654093384742737
region O 0 0.012817955575883389
sequence O 0 0.00921695213764906
shows O 0 0.009131473489105701
a O 0 0.014172977767884731
putative O 1 0.9625117182731628
TATA O 1 1.0
box O 1 0.8259837031364441
and O 0 0.013441994786262512
predicts O 0 0.03010822832584381
multiple O 0 0.016571396961808205
transcription O 0 0.02586837112903595
factor O 0 0.02437232807278633
binding O 0 0.022755317389965057
sites O 0 0.02344234474003315
. O 0 0.03164944052696228

The O 0 0.024972207844257355
genomic O 0 0.03202264755964279
structure O 0 0.014821243472397327
was O 0 0.010239880532026291
determined O 0 0.008341645821928978
using O 0 0.0053826854564249516
DNA O 0 0.006906636990606785
from O 0 0.003245133440941572
several O 0 0.0031089361291378736
sources O 0 0.0031832673121243715
including O 0 0.004056691192090511
multiple O 0 0.006437684874981642
large O 0 0.009577222168445587
- O 1 0.999966025352478
insert O 1 0.9781127572059631
libaries O 1 0.6835193037986755
and O 0 0.010376967489719391
genomic O 0 0.018018586561083794
DNA O 0 0.01236284151673317
from O 0 0.009826087392866611
Finnish O 1 0.9999860525131226
CLD B-Disease 1 1.0
patients O 1 0.9999477863311768
and O 0 0.02306399680674076
controls O 0 0.045404717326164246
. O 0 0.03738511726260185

Exon O 1 0.957280158996582
- O 1 0.8860197067260742
specific O 0 0.015977201983332634
primers O 0 0.035615306347608566
developed O 0 0.012261713854968548
in O 0 0.006051200442016125
this O 0 0.004014985170215368
study O 0 0.005436489824205637
will O 0 0.005282751750200987
facilitate O 0 0.00943406205624342
mutation O 0 0.008809485472738743
screening O 0 0.010335124097764492
studies O 0 0.006393583491444588
of O 0 0.0071754176169633865
patients O 1 0.9898204803466797
with O 0 0.009840293787419796
the O 1 0.6381258964538574
disease O 1 1.0
. O 0 0.03549681231379509

Genomic O 0 0.06862743943929672
sequencing O 0 0.03371585160493851
of O 0 0.015951799228787422
a O 0 0.02259966731071472
BAC O 1 0.9999964237213135
clone O 1 0.999947190284729
H O 1 0.9999985694885254
_ O 0 0.023465590551495552
RG364P16 O 0 0.17404307425022125
revealed O 0 0.012759006582200527
the O 0 0.005743225570768118
presence O 0 0.005979785230010748
of O 0 0.005109858233481646
another O 0 0.006560835521668196
, O 0 0.005951412953436375
highly O 0 0.008993559516966343
homologous O 0 0.012107488699257374
gene O 0 0.006808621808886528
3 O 0 0.00796898826956749
of O 0 0.00625198008492589
the O 0 0.010210894979536533
CLD B-Disease 1 1.0
gene O 0 0.013117442838847637
, O 0 0.006617093924432993
with O 0 0.004788390826433897
a O 0 0.006549470126628876
similar O 0 0.006817526649683714
genomic O 0 0.015369851142168045
structure O 0 0.008898759260773659
, O 0 0.005571168847382069
recently O 0 0.008018369786441326
identified O 0 0.0048915920779109
as O 0 0.004529023077338934
the O 0 0.011114154942333698
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999692440032959
( O 1 0.9981227517127991
PDS B-Disease 1 1.0
) O 0 0.024216311052441597
. O 0 0.0207565575838089
. O 0 0.03013482317328453

The O 0 0.036884985864162445
APCI1307K O 1 0.9999845027923584
allele O 0 0.42036619782447815
and O 0 0.026407036930322647
cancer B-Disease 1 1.0
risk O 1 0.9474079608917236
in O 0 0.006311133969575167
a O 0 0.008176189847290516
community O 0 0.008950301446020603
- O 1 0.862209141254425
based O 0 0.008726600557565689
study O 0 0.008740123361349106
of O 0 0.010756289586424828
Ashkenazi O 0 0.29329103231430054
Jews O 0 0.03470716252923012
. O 0 0.03420267254114151

Mutations O 0 0.05504561588168144
in O 0 0.023602919653058052
APC O 1 0.9992583394050598
are O 0 0.00943614263087511
classically O 1 0.8193808197975159
associated O 0 0.01183661725372076
with O 0 0.0145586421713233
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.016147639602422714
, O 0 0.00883321650326252
a O 0 0.009086724370718002
highly O 0 0.039479661732912064
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999988079071045
by O 1 0.8266868591308594
multiple O 1 0.9999988079071045
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9894266128540039
, O 0 0.013489732518792152
without O 0 0.008764125406742096
surgical O 1 1.0
intervention O 0 0.4902832806110382
, O 0 0.006277895998209715
the O 0 0.006004602648317814
development O 0 0.011043938808143139
of O 1 0.9913449287414551
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999986886978149
CRC B-Disease 1 1.0
) O 0 0.03477393090724945
. O 0 0.03501836583018303

APC B-Disease 1 0.9831086993217468
is O 0 0.023289168253540993
a O 0 0.034109849482774734
tumour O 1 1.0
- O 1 1.0
suppressor O 1 0.9999829530715942
gene O 0 0.01543183159083128
, O 0 0.009553419426083565
and O 0 0.008317681960761547
somatic O 0 0.23990045487880707
loss O 1 0.9894934892654419
occurs O 0 0.018877478316426277
in O 0 0.02517029643058777
tumours B-Disease 1 1.0
. O 0 0.04245441406965256

The O 0 0.042853944003582
germline O 1 0.9963905215263367
T O 1 0.9999961853027344
- O 1 0.9831945300102234
to O 0 0.014517449773848057
- O 1 0.8340193033218384
A O 0 0.01740872673690319
transversion O 0 0.04959530010819435
responsible O 0 0.01000802218914032
for O 0 0.007032649125903845
the O 0 0.012669194489717484
APC O 1 0.9999802112579346
I1307K O 1 0.9911102056503296
allele O 0 0.025400886312127113
converts O 0 0.016960296779870987
the O 0 0.009276282973587513
wild O 0 0.012513924390077591
- O 1 0.8099911212921143
type O 0 0.010000777430832386
sequence O 0 0.00525709567591548
to O 0 0.004830519203096628
a O 0 0.010474144481122494
homopolymer O 1 0.9999995231628418
tract O 1 1.0
( O 1 0.9992551207542419
A8 O 1 1.0
) O 0 0.009287227876484394
that O 0 0.005610461812466383
is O 0 0.007415927015244961
genetically O 0 0.014881499111652374
unstable O 1 0.8954406380653381
and O 0 0.015380057506263256
prone O 1 0.999610960483551
to O 0 0.016562214121222496
somatic O 1 0.8350284099578857
mutation O 0 0.04758108779788017
. O 0 0.03526308760046959

The O 0 0.04267055168747902
I1307K O 1 0.9699816703796387
allele O 0 0.04683850333094597
was O 0 0.020186295732855797
found O 0 0.011193135753273964
in O 0 0.013354462571442127
6 O 0 0.03193505480885506
. O 0 0.029443781822919846

1 O 0 0.04298406466841698
% O 0 0.019627321511507034
of O 0 0.016283990815281868
unselected O 1 0.9848524928092957
Ashkenazi O 1 0.7786138653755188
Jews O 0 0.015709709376096725
and O 0 0.008753419853746891
higher O 0 0.00945307221263647
proportions O 0 0.015194562263786793
of O 0 0.008597743697464466
Ashkenazim O 1 0.9968380928039551
with O 0 0.00759460125118494
family O 0 0.012001005001366138
or O 0 0.006110186222940683
personal O 0 0.011928907595574856
histories O 0 0.01563306339085102
of O 0 0.018894508481025696
CRC B-Disease 1 1.0
( O 0 0.23683448135852814
ref O 1 0.9999637603759766
. O 0 0.018316883593797684
2 O 0 0.0259411558508873
) O 0 0.021484123542904854
. O 0 0.029875854030251503

To O 0 0.019509242847561836
evaluate O 0 0.025466613471508026
the O 0 0.009539829567074776
role O 0 0.012031256221234798
of O 0 0.009487729519605637
I1307K O 1 0.9997116923332214
in O 0 0.015883060172200203
cancer B-Disease 1 0.9999998807907104
, O 0 0.009787782095372677
we O 0 0.008196448907256126
genotyped O 0 0.20448075234889984
5 O 0 0.019683612510561943
, O 0 0.019204990938305855
081 O 1 0.9969083666801453
Ashkenazi O 1 0.5466902852058411
volunteers O 0 0.02617025002837181
in O 0 0.011719686910510063
a O 0 0.0132597042247653
community O 0 0.017165852710604668
survey O 0 0.029801398515701294
. O 0 0.0321989431977272

Risk O 0 0.03298041224479675
of O 0 0.016503067687153816
developing O 1 0.9996582269668579
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999560117721558
breast I-Disease 1 1.0
and I-Disease 0 0.20537438988685608
other I-Disease 0 0.009801678359508514
cancers I-Disease 1 0.9998921155929565
were O 0 0.005828551948070526
compared O 0 0.00881775002926588
between O 0 0.008619124069809914
genotyped O 1 0.9826013445854187
I1307K O 1 0.9922274351119995
carriers O 0 0.02759404666721821
and O 0 0.007146229036152363
non O 0 0.01929360069334507
- O 1 0.9996316432952881
carriers O 0 0.016041409224271774
and O 0 0.005246222019195557
their O 0 0.004496932495385408
first O 0 0.010328463278710842
- O 1 0.9970621466636658
degree O 0 0.020006325095891953
relatives O 0 0.02646823227405548
. O 0 0.024158021435141563

Sperm O 0 0.05010147765278816
DNA O 0 0.025533011183142662
analysis O 0 0.012300513684749603
in O 0 0.0129184415563941
a O 0 0.027148624882102013
Friedreich B-Disease 1 0.9999995231628418
ataxia I-Disease 1 1.0
premutation O 1 0.9999994039535522
carrier O 1 0.9996203184127808
suggests O 0 0.027538888156414032
both O 0 0.01591946743428707
meiotic O 1 0.996605634689331
and O 0 0.016552524641156197
mitotic O 0 0.13968303799629211
expansion O 0 0.026433654129505157
in O 0 0.01421717181801796
the O 0 0.021604623645544052
FRDA B-Disease 1 0.9999631643295288
gene O 0 0.040983617305755615
. O 0 0.03981740400195122

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.022378824651241302
usually O 0 0.012123538181185722
caused O 0 0.010055264458060265
by O 0 0.00475723622366786
an O 0 0.0060238102450966835
expansion O 0 0.012204986996948719
of O 0 0.008535505272448063
a O 0 0.015155945904552937
GAA O 1 0.9954665899276733
trinucleotide O 1 0.9980607628822327
repeat O 0 0.032522592693567276
in O 0 0.01536122988909483
intron O 1 0.8946642279624939
1 O 0 0.018518410623073578
of O 0 0.013135467655956745
the O 0 0.017335280776023865
FRDA B-Disease 1 0.9999722242355347
gene O 0 0.036315370351076126
. O 0 0.035777498036623

Occasionally O 0 0.03379731625318527
, O 0 0.013011466711759567
a O 0 0.010071337223052979
fully O 0 0.015282080508768559
expanded O 0 0.015936993062496185
allele O 0 0.017517851665616035
has O 0 0.0064760842360556126
been O 0 0.005165383219718933
found O 0 0.004421970807015896
to O 0 0.00477442005649209
arise O 0 0.006780632305890322
from O 0 0.004316606093198061
a O 0 0.007164009381085634
premutation O 0 0.20143698155879974
of O 0 0.007694743573665619
100 O 0 0.014381896704435349
or O 0 0.008819458074867725
less O 0 0.015895579010248184
triplet O 0 0.4909803867340088
repeats O 0 0.051671698689460754
. O 0 0.03791791945695877

We O 0 0.019311103969812393
have O 0 0.0090299341827631
examined O 0 0.018769646063447
the O 0 0.01012977585196495
sperm O 0 0.014856877736747265
DNA O 0 0.012850518338382244
of O 0 0.00973806343972683
a O 0 0.018951507285237312
premutation O 1 0.9997302889823914
carrier O 1 0.9931294322013855
. O 0 0.03838053345680237

This O 0 0.02605513110756874
mans O 0 0.10675400495529175
leucocyte O 0 0.29290369153022766
DNA O 0 0.02042720839381218
showed O 0 0.012626055628061295
one O 0 0.007767912931740284
normal O 0 0.00938364677131176
allele O 0 0.014685938134789467
and O 0 0.005745742004364729
one O 0 0.0069790491834282875
allele O 0 0.0158262699842453
of O 0 0.008677929639816284
approximately O 0 0.012023556977510452
100 O 0 0.024873200803995132
repeats O 0 0.044909313321113586
. O 0 0.03435944765806198

His O 0 0.03668753057718277
sperm O 0 0.024483947083353996
showed O 0 0.014570379629731178
an O 0 0.009400726296007633
expanded O 0 0.018840357661247253
allele O 0 0.019113615155220032
in O 0 0.006819308735430241
a O 0 0.009509209543466568
tight O 0 0.016989974305033684
range O 0 0.012108619324862957
centering O 0 0.020468607544898987
on O 0 0.006314110476523638
a O 0 0.007753167301416397
size O 0 0.010936548002064228
of O 0 0.009574897587299347
approximately O 0 0.01962920092046261
320 O 0 0.06934264302253723
trinucleotide O 1 0.9964367151260376
repeats O 0 0.06142951548099518
. O 0 0.04059671238064766

His O 0 0.044163208454847336
affected O 0 0.03059125319123268
son O 1 0.8888298273086548
has O 0 0.014900771901011467
repeat O 0 0.02217259258031845
sizes O 0 0.019159726798534393
of O 0 0.014309058897197247
1040 O 1 0.9865865707397461
and O 0 0.02317488193511963
540 O 1 0.6167256832122803
. O 0 0.04361680522561073

These O 0 0.01419045776128769
data O 0 0.009647374972701073
suggest O 0 0.009608144871890545
that O 0 0.004737958312034607
expansion O 0 0.010799074545502663
occurs O 0 0.00635911850258708
in O 0 0.004953597206622362
two O 0 0.004414740484207869
stages O 0 0.008721107617020607
, O 0 0.005402626935392618
the O 0 0.004875274375081062
first O 0 0.0071234856732189655
during O 0 0.009505092166364193
meiosis O 0 0.0351172611117363
followed O 0 0.00949423760175705
by O 0 0.006263853516429663
a O 0 0.01255031954497099
second O 0 0.025494683533906937
mitotic O 0 0.20583397150039673
expansion O 0 0.052286162972450256
. O 0 0.04055839031934738

We O 0 0.019083207473158836
also O 0 0.011474134400486946
show O 0 0.008949557319283485
that O 0 0.003858946729451418
in O 0 0.005221614148467779
all O 0 0.0054401494562625885
informative O 0 0.021398821845650673
carrier O 0 0.3292337656021118
father O 0 0.011588498950004578
to O 0 0.006418276112526655
affected O 0 0.008560406044125557
child O 0 0.014887548051774502
transmissions O 0 0.011863227933645248
, O 0 0.0048576826229691505
with O 0 0.0033258656039834023
the O 0 0.004655927419662476
notable O 0 0.00631420873105526
exception O 0 0.006930776871740818
of O 0 0.006041512358933687
the O 0 0.009512824937701225
premutation O 1 0.9998996257781982
carrier O 1 0.9793269634246826
, O 0 0.008351702243089676
the O 0 0.008267519064247608
expansion O 0 0.019581185653805733
size O 0 0.02061210758984089
decreases O 0 0.02599875070154667
. O 0 0.015896452590823174
. O 0 0.02601001039147377

The O 0 0.03427359089255333
R496H O 0 0.201285719871521
mutation O 0 0.02419338747859001
of O 0 0.01396199781447649
arylsulfatase O 1 0.9997636675834656
A O 0 0.029856884852051735
does O 0 0.01023663766682148
not O 0 0.01039474830031395
cause O 1 0.9730197787284851
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.06441884487867355

Deficiency B-Disease 1 1.0
of I-Disease 0 0.0329001359641552
arylsulfatase I-Disease 1 0.9999809265136719
A I-Disease 1 0.9707338213920593
( O 0 0.35543936491012573
ARSA O 1 0.9999998807907104
) O 0 0.021417295560240746
enzyme O 0 0.02688034251332283
activity O 0 0.017754901200532913
causes O 1 0.9778947234153748
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999572038650513
MLD B-Disease 1 1.0
) O 0 0.04910746589303017
. O 0 0.04298717528581619

A O 0 0.031072035431861877
number O 0 0.015511874109506607
of O 0 0.019044438377022743
ARSA O 1 0.9999978542327881
gene O 0 0.021664556115865707
mutations O 0 0.014729422517120838
responsible O 0 0.012257348746061325
for O 0 0.012922042049467564
MLD B-Disease 1 1.0
have O 0 0.010004366748034954
been O 0 0.012542298063635826
identified O 0 0.019336175173521042
. O 0 0.02269580215215683

Recently O 0 0.03860143572092056
, O 0 0.014811971224844456
the O 0 0.015214048326015472
R496H O 1 0.6933333873748779
mutation O 0 0.01824624091386795
of O 0 0.012092338874936104
ARSA O 1 0.9999997615814209
was O 0 0.014071007259190083
proposed O 0 0.00839936826378107
to O 0 0.005095600616186857
be O 0 0.0040889219380915165
a O 0 0.006821524817496538
cause O 0 0.010379739105701447
of O 0 0.014852195046842098
MLD B-Disease 1 1.0
( O 0 0.1119411438703537
Draghia O 1 0.9999746084213257
et O 0 0.07607812434434891
al O 0 0.03353681415319443
. O 0 0.011643447913229465
, O 0 0.012607300654053688
1997 O 0 0.02933078445494175
) O 0 0.021779567003250122
. O 0 0.031078316271305084

We O 0 0.014776048250496387
have O 0 0.007075346074998379
investigated O 0 0.011816209182143211
the O 0 0.009888675063848495
R496H O 1 0.996832549571991
mutation O 0 0.013076788745820522
and O 0 0.006373706739395857
found O 0 0.004714523442089558
this O 0 0.0043437425047159195
mutation O 0 0.007131999358534813
at O 0 0.005366521887481213
a O 0 0.00584379630163312
relatively O 0 0.005783801898360252
high O 0 0.006858393084257841
frequency O 0 0.005840417463332415
in O 0 0.0032634467352181673
an O 0 0.004068831447511911
African O 0 0.006834239233285189
American O 0 0.007191049866378307
population O 0 0.004909508395940065
( O 0 0.008266588672995567
f O 0 0.02869436889886856
= O 0 0.022694887593388557
0 O 0 0.016801968216896057
. O 0 0.009504054673016071
09 O 0 0.04504123330116272
, O 0 0.014508698135614395
n O 0 0.025342296808958054
= O 0 0.034052979201078415
61 O 0 0.03885487839579582
subjects O 0 0.0313955694437027
) O 0 0.02415931411087513
. O 0 0.03200088441371918

The O 0 0.06191331148147583
ARSA O 1 0.9999955892562866
enzyme O 0 0.03758886083960533
activity O 0 0.012277953326702118
in O 0 0.007973807863891125
subjects O 0 0.009047342464327812
with O 0 0.004594556521624327
and O 0 0.004753097426146269
without O 0 0.004792795982211828
the O 0 0.0079417759552598
R496H O 1 0.9999370574951172
mutation O 0 0.012852247804403305
was O 0 0.009786144830286503
determined O 0 0.009362119249999523
and O 0 0.006270803045481443
found O 0 0.005440476816147566
to O 0 0.006833727937191725
be O 0 0.007675311993807554
normal O 0 0.014825094491243362
. O 0 0.023518560454249382

It O 0 0.02140771970152855
is O 0 0.013195621781051159
therefore O 0 0.008307846263051033
concluded O 0 0.00937690120190382
that O 0 0.004840335343033075
the O 0 0.008825213648378849
R496H O 1 0.9289115071296692
mutation O 0 0.01813819259405136
of O 0 0.014337554574012756
ARSA O 1 1.0
does O 0 0.010668417438864708
not O 0 0.005415645893663168
negatively O 0 0.009868769906461239
influence O 0 0.007643323391675949
the O 0 0.007104947231709957
activity O 0 0.008656633086502552
of O 0 0.010538951493799686
ARSA O 1 0.9999995231628418
and O 0 0.010908011347055435
is O 0 0.007496405392885208
not O 0 0.0060586389154195786
a O 0 0.01335713267326355
cause O 0 0.04372930899262428
of O 0 0.04942503198981285
MLD B-Disease 1 1.0

Down O 0 0.0555788017809391
- O 0 0.09830030053853989
regulation O 0 0.0236162431538105
of O 0 0.018657326698303223
transmembrane O 0 0.26298245787620544
carbonic O 1 0.9977394342422485
anhydrases O 1 0.9999432563781738
in O 1 0.8865827918052673
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9878826141357422
lines O 0 0.015848424285650253
by O 0 0.008061598055064678
wild O 0 0.01736103929579258
- O 1 0.9989789724349976
type O 0 0.08602888882160187
von B-Disease 1 0.9985515475273132
Hippel I-Disease 1 0.999997615814209
- I-Disease 1 0.9999926090240479
Lindau I-Disease 1 0.9997583031654358
transgenes O 0 0.4394952356815338
. O 0 0.05692256987094879

To O 0 0.02347400039434433
discover O 0 0.02885059267282486
genes O 0 0.010400517843663692
involved O 0 0.00789070688188076
in O 0 0.008706634864211082
von B-Disease 1 0.995502769947052
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999997615814209
( O 0 0.028891898691654205
VHL B-Disease 1 0.9999996423721313
) O 0 0.020284291356801987
- O 1 0.9997738003730774
mediated O 1 0.7069067358970642
carcinogenesis O 1 0.999940037727356
, O 0 0.008259735070168972
we O 0 0.00661064637824893
used O 0 0.0120216254144907
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9971729516983032
lines O 0 0.024885034188628197
stably O 1 0.5221384167671204
transfected O 0 0.13096153736114502
with O 0 0.010413363575935364
wild O 0 0.020747127011418343
- O 1 0.9999748468399048
type O 1 0.9878794550895691
VHL O 1 0.9999998807907104
- O 1 0.9999879598617554
expressing O 0 0.09043314307928085
transgenes O 1 0.6734049320220947
. O 0 0.05208738520741463

Large O 0 0.03363965451717377
- O 0 0.32177290320396423
scale O 0 0.021928731352090836
RNA O 0 0.02569257654249668
differential O 0 0.019939105957746506
display O 0 0.014813710935413837
technology O 0 0.013415373861789703
applied O 0 0.008177638053894043
to O 0 0.005400114227086306
these O 0 0.004012491554021835
cell O 0 0.009826435707509518
lines O 0 0.006880143191665411
identified O 0 0.00581294484436512
several O 0 0.0044520762749016285
differentially O 0 0.019850125536322594
expressed O 0 0.008631005883216858
genes O 0 0.007096999790519476
, O 0 0.00572230014950037
including O 0 0.006467493716627359
an O 0 0.010025329887866974
alpha O 1 0.5329244136810303
carbonic O 1 0.9990742206573486
anhydrase O 1 0.9998341798782349
gene O 0 0.027032142505049706
, O 0 0.020580481737852097
termed O 0 0.07848391681909561
CA12 O 1 0.9998799562454224
. O 0 0.050765279680490494

The O 0 0.031624723225831985
deduced O 0 0.04536570981144905
protein O 0 0.018688950687646866
sequence O 0 0.011016765609383583
was O 0 0.010151711292564869
classified O 0 0.009862769395112991
as O 0 0.005151068326085806
a O 0 0.006684762891381979
one O 0 0.009440605528652668
- O 1 0.9870542883872986
pass O 0 0.019497450441122055
transmembrane O 1 0.669730007648468
CA O 0 0.03329179808497429
possessing O 0 0.015066682361066341
an O 0 0.011452756822109222
apparently O 0 0.016326110810041428
intact O 0 0.026678459718823433
catalytic O 0 0.026584001258015633
domain O 0 0.016111677512526512
in O 0 0.010836833156645298
the O 0 0.018921557813882828
extracellular O 0 0.37144261598587036
CA O 1 0.6487076282501221
module O 1 0.7996975183486938
. O 0 0.04189122095704079

Reintroduced O 0 0.07860314100980759
wild O 0 0.04123440012335777
- O 1 0.9999452829360962
type O 1 0.7264187932014465
VHL B-Disease 1 0.9999852180480957
strongly O 0 0.02470669522881508
inhibited O 0 0.030049873515963554
the O 0 0.011634659953415394
overexpression O 0 0.030574416741728783
of O 0 0.008730091154575348
the O 0 0.010769519954919815
CA12 O 1 0.9998406171798706
gene O 0 0.009137929417192936
in O 0 0.006548992358148098
the O 0 0.010612576268613338
parental O 1 0.9999862909317017
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999961853027344
lines O 0 0.06751267611980438
. O 0 0.03626753389835358

Similar O 0 0.025827137753367424
results O 0 0.015085708349943161
were O 0 0.007521511986851692
obtained O 0 0.012699943967163563
with O 0 0.010920622386038303
CA9 O 1 0.9998728036880493
, O 0 0.013826525770127773
encoding O 0 0.01733587309718132
another O 0 0.017979204654693604
transmembrane O 1 0.8586857318878174
CA O 0 0.027248919010162354
with O 0 0.010793879628181458
an O 0 0.01306855771690607
intact O 0 0.07730816304683685
catalytic O 0 0.06361661106348038
domain O 0 0.03782806545495987
. O 0 0.029444653540849686

Although O 0 0.02007296122610569
both O 0 0.010344844311475754
domains O 0 0.018696455284953117
of O 0 0.01018704753369093
the O 0 0.016228172928094864
VHL B-Disease 1 0.9999997615814209
protein O 0 0.016319837421178818
contribute O 0 0.012702289037406445
to O 0 0.007039725314825773
regulation O 0 0.011000163853168488
of O 0 0.008742643520236015
CA12 O 1 0.9999855756759644
expression O 0 0.01118806004524231
, O 0 0.008319065906107426
the O 0 0.009285205975174904
elongin O 1 0.9387741684913635
binding O 0 0.016194438561797142
domain O 0 0.01745266281068325
alone O 0 0.013575519435107708
could O 0 0.01038588397204876
effectively O 0 0.02160930074751377
regulate O 0 0.03348596766591072
CA9 O 1 0.9999394416809082
expression O 0 0.045767419040203094
. O 0 0.044997863471508026

We O 0 0.03276079148054123
mapped O 0 0.0671439990401268
CA12 O 1 0.9991022348403931
and O 0 0.028102008625864983
CA9 O 1 0.9998561143875122
loci O 0 0.04633781686425209
to O 0 0.019826563075184822
chromosome O 0 0.03283371403813362
bands O 0 0.032363127917051315
15q22 O 1 0.9871542453765869
and O 0 0.025537759065628052
17q21 O 1 0.9774008393287659
. O 0 0.040177345275878906

2 O 0 0.039355549961328506
respectively O 0 0.025589076802134514
, O 0 0.013713770546019077
regions O 0 0.011739189736545086
prone O 0 0.11293565481901169
to O 0 0.00852930173277855
amplification O 0 0.020889636129140854
in O 0 0.007998441345989704
some O 0 0.008222064934670925
human O 0 0.01926318183541298
cancers B-Disease 1 0.9999949932098389
. O 0 0.03267049789428711

Additional O 0 0.030382433906197548
experiments O 0 0.020569711923599243
are O 0 0.004637862555682659
needed O 0 0.0091022327542305
to O 0 0.005405397154390812
define O 0 0.007137075997889042
the O 0 0.004864173475652933
role O 0 0.007946598343551159
of O 0 0.007555956952273846
CA O 1 0.999448835849762
IX O 1 1.0
and O 0 0.016890928149223328
CA O 1 0.9790776371955872
XII O 1 0.9999991655349731
enzymes O 0 0.013147569261491299
in O 0 0.005634198430925608
the O 0 0.005602547898888588
regulation O 0 0.0089661730453372
of O 0 0.007439920678734779
pH O 1 0.6467998623847961
in O 0 0.007997136563062668
the O 0 0.010795682668685913
extracellular O 0 0.04882660508155823
microenvironment O 1 0.5986670851707458
and O 0 0.007603937294334173
its O 0 0.007074220571666956
potential O 0 0.010109474882483482
impact O 0 0.012356439605355263
on O 0 0.0139074195176363
cancer B-Disease 1 1.0
cell O 1 0.9683770537376404
growth O 0 0.03430846333503723
. O 0 0.030257243663072586

A O 0 0.035143520683050156
gene O 0 0.01993582397699356
encoding O 0 0.01855623535811901
a O 0 0.015064467675983906
transmembrane O 0 0.19664758443832397
protein O 0 0.014145861379802227
is O 0 0.007216449826955795
mutated O 0 0.013960566371679306
in O 0 0.006841311696916819
patients O 1 0.9858821630477905
with O 1 0.9820469617843628
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.941096842288971
. O 0 0.0408613383769989

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9993876218795776
WFS B-Disease 1 1.0
; O 1 0.9397713541984558
OMIM O 1 1.0
222300 O 1 0.9999896287918091
) O 0 0.009803120978176594
is O 0 0.0070167044177651405
an O 0 0.010022242553532124
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9970167875289917
by O 0 0.012134886346757412
young O 1 0.9997994303703308
- O 1 1.0
onset O 1 1.0
non O 1 0.9998005032539368
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.9999983310699463
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999971389770508
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.912956714630127

Linkage O 0 0.059900324791669846
to O 0 0.01948772743344307
markers O 0 0.028803780674934387
on O 0 0.01526253204792738
chromosome O 0 0.03837059438228607
4p O 1 0.9999991655349731
was O 0 0.018358351662755013
confirmed O 0 0.012799300253391266
in O 0 0.010513398796319962
five O 0 0.012780667282640934
families O 0 0.020294377580285072
. O 0 0.028023675084114075

On O 0 0.014760367572307587
the O 0 0.008360307663679123
basis O 0 0.006898938678205013
of O 0 0.010215898044407368
meiotic O 1 0.9999947547912598
recombinants O 1 0.9999994039535522
and O 1 0.9364315271377563
disease O 1 1.0
- O 1 0.9999998807907104
associated O 0 0.01717754639685154
haplotypes O 0 0.030920028686523438
, O 0 0.009377566166222095
the O 0 0.012439848855137825
WFS B-Disease 1 1.0
gene O 0 0.01290928851813078
was O 0 0.011794926598668098
localized O 0 0.016789991408586502
to O 0 0.008607284165918827
a O 0 0.0158847589045763
BAC O 1 0.9999997615814209
/ O 1 0.9999415874481201
P1 O 1 0.9998338222503662
contig O 0 0.09194266051054001
of O 0 0.01181885413825512
less O 0 0.011364484205842018
than O 0 0.011974439024925232
250 O 0 0.03874436393380165
kb O 1 0.6468170881271362
. O 0 0.035507068037986755

Mutations O 0 0.037068624049425125
in O 0 0.013238053768873215
a O 0 0.01571042463183403
novel O 0 0.02334682270884514
gene O 0 0.013740872032940388
( O 0 0.014005931094288826
WFS1 O 1 0.9978273510932922
) O 0 0.011116188019514084
encoding O 0 0.012496870942413807
a O 0 0.014034128747880459
putative O 0 0.052423518151044846
transmembrane O 0 0.3049522936344147
protein O 0 0.013211949728429317
were O 0 0.004976604599505663
found O 0 0.004178804345428944
in O 0 0.003670255420729518
all O 0 0.0034944091457873583
affected O 0 0.004964369349181652
individuals O 0 0.0030186250805854797
in O 0 0.004175096750259399
six O 0 0.010381747037172318
WFS B-Disease 1 1.0
families O 0 0.010703761130571365
, O 0 0.006175827234983444
and O 0 0.004200370516628027
these O 0 0.0032318837475031614
mutations O 0 0.005343813449144363
were O 0 0.002911617513746023
associated O 0 0.004925666842609644
with O 0 0.005924685392528772
the O 1 0.6236059069633484
disease O 1 1.0
phenotype O 1 0.9999988079071045
. O 0 0.05265773832798004

WFS1 O 1 0.9997298121452332
appears O 0 0.028897952288389206
to O 0 0.011489948257803917
function O 0 0.01002001017332077
in O 0 0.007142315153032541
survival O 0 0.021615048870444298
of O 0 0.009526322595775127
islet O 1 0.999941349029541
beta O 1 0.9999831914901733
- O 1 0.9999996423721313
cells O 0 0.021900124847888947
and O 0 0.013804021291434765
neurons O 0 0.026989396661520004
. O 0 0.018022039905190468
. O 0 0.029142651706933975

Stable O 0 0.050551120191812515
interaction O 0 0.016828257590532303
between O 0 0.008334233425557613
the O 0 0.007493922952562571
products O 0 0.011636419221758842
of O 0 0.00823295209556818
the O 0 0.013773965649306774
BRCA1 O 1 0.9999994039535522
and O 1 0.6624486446380615
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999676942825317
genes O 0 0.01777256466448307
in O 0 0.014948545023798943
mitotic O 1 0.9825117588043213
and O 0 0.02683013305068016
meiotic O 1 0.9999951124191284
cells O 0 0.04861466586589813
. O 0 0.04402782395482063

BRCA1 O 1 0.9999758005142212
and O 0 0.02494504116475582
BRCA2 O 1 0.9832273721694946
account O 0 0.010361348278820515
for O 0 0.0057671875692903996
most O 0 0.00523248640820384
cases O 0 0.005477908067405224
of O 0 0.006233261898159981
familial O 1 0.9972419738769531
, O 0 0.007511783391237259
early O 0 0.08519137650728226
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9970442652702332
/ I-Disease 1 1.0
or I-Disease 1 0.9998579025268555
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.2800111472606659
encode O 0 0.017680278047919273
products O 0 0.014273343607783318
that O 0 0.005677560809999704
each O 0 0.0066399043425917625
interact O 0 0.01465125847607851
with O 0 0.01586059108376503
hRAD51 O 1 0.9116695523262024
. O 0 0.04288717359304428

Results O 0 0.028239326551556587
presented O 0 0.02001131698489189
here O 0 0.010393919423222542
show O 0 0.011170390993356705
that O 0 0.00848018191754818
BRCA1 O 1 0.9990410208702087
and O 0 0.011505051515996456
BRCA2 O 1 0.9999600648880005
coexist O 0 0.01730143278837204
in O 0 0.0068468633107841015
a O 0 0.009365856647491455
biochemical O 0 0.022492000833153725
complex O 0 0.01254633255302906
and O 0 0.008325401693582535
colocalize O 1 0.8841438889503479
in O 0 0.01207190565764904
subnuclear O 1 0.9999219179153442
foci O 1 0.9876697659492493
in O 0 0.01022308599203825
somatic O 0 0.07650447636842728
cells O 0 0.011038778349757195
and O 0 0.0063912998884916306
on O 0 0.006841800641268492
the O 0 0.008056899532675743
axial O 0 0.02094433270394802
elements O 0 0.012402968481183052
of O 0 0.01158744003623724
developing O 0 0.11255313456058502
synaptonemal O 1 0.9999632835388184
complexes O 1 0.7102976441383362
. O 0 0.04362647607922554

Like O 0 0.05189497396349907
BRCA1 O 1 0.9994254112243652
and O 0 0.028683779761195183
RAD51 O 1 0.9999955892562866
, O 0 0.02799517847597599
BRCA2 O 1 0.9995142221450806
relocates O 1 0.6836525201797485
to O 0 0.019304141402244568
PCNA O 1 0.9999516010284424
+ O 0 0.03973930701613426
replication O 0 0.01950107328593731
sites O 0 0.008653736673295498
following O 0 0.00891058798879385
exposure O 0 0.015278119593858719
of O 0 0.009296920150518417
S O 1 0.9999083280563354
phase O 0 0.06827867776155472
cells O 0 0.01541979517787695
to O 0 0.014532992616295815
hydroxyurea O 1 0.9998331069946289
or O 0 0.030946213752031326
UV O 1 0.9999997615814209
irradiation O 1 0.9958654642105103
. O 0 0.05753913149237633

Thus O 0 0.03937024995684624
, O 0 0.024090463295578957
BRCA1 O 1 0.9961071610450745
and O 0 0.017051707953214645
BRCA2 O 1 0.999488115310669
participate O 0 0.010553909465670586
, O 0 0.006752922665327787
together O 0 0.005869199056178331
, O 0 0.0044411043636500835
in O 0 0.003634959226474166
a O 0 0.006484977900981903
pathway O 0 0.1565961241722107
( O 0 0.009535460732877254
s O 1 0.9765644073486328
) O 0 0.005616586655378342
associated O 0 0.004990190267562866
with O 0 0.003520108526572585
the O 0 0.005344847217202187
activation O 0 0.010353010147809982
of O 0 0.006896962411701679
double O 0 0.19778522849082947
- O 1 0.9999234676361084
strand O 0 0.02042549103498459
break O 0 0.016962310299277306
repair O 1 0.9946827292442322
and O 0 0.015372160822153091
/ O 1 0.9851609468460083
or O 0 0.017663361504673958
homologous O 0 0.041364170610904694
recombination O 0 0.0497366301715374
. O 0 0.03496250882744789

Dysfunction O 1 0.9999955892562866
of O 0 0.0184921957552433
this O 0 0.010614641010761261
pathway O 0 0.023659832775592804
may O 0 0.006757184863090515
be O 0 0.004252656362950802
a O 0 0.0064017013646662235
general O 0 0.009001178666949272
phenomenon O 0 0.008651708252727985
in O 0 0.00450070621445775
the O 0 0.00446014478802681
majority O 0 0.003921959549188614
of O 0 0.0035541346296668053
cases O 0 0.00428153108805418
of O 0 0.007864768616855145
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999978542327881
/ I-Disease 1 1.0
or I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7654271125793457
. O 0 0.033640097826719284

A O 0 0.053877588361501694
novel O 0 0.0506519116461277
Arg362Ser O 1 0.7266887426376343
mutation O 0 0.021444734185934067
in O 0 0.008815544657409191
the O 0 0.01100433524698019
sterol O 0 0.3348705470561981
27 O 0 0.04022183269262314
- O 1 0.9999682903289795
hydroxylase O 1 0.9981154203414917
gene O 0 0.016224710270762444
( O 0 0.014879556372761726
CYP27 O 1 0.9999817609786987
) O 0 0.01046083029359579
: O 0 0.008387747220695019
its O 0 0.007611086126416922
effects O 0 0.009798652492463589
on O 0 0.00841671321541071
pre O 0 0.25270503759384155
- O 1 0.9635462760925293
mRNA O 0 0.02865973673760891
splicing O 0 0.030675971880555153
and O 0 0.017759207636117935
enzyme O 0 0.02755061164498329
activity O 0 0.021483447402715683
. O 0 0.030824236571788788

A O 0 0.04752262309193611
novel O 0 0.04353579133749008
C O 0 0.043732594698667526
to O 0 0.010195373557507992
A O 0 0.014524449594318867
mutation O 0 0.012028684839606285
in O 0 0.006161521188914776
the O 0 0.008846527896821499
sterol O 0 0.3417796790599823
27 O 0 0.031334370374679565
- O 1 0.9999568462371826
hydroxylase O 1 0.9696866273880005
gene O 0 0.01903497241437435
( O 0 0.015228306874632835
CYP27 O 1 0.999958872795105
) O 0 0.012303435243666172
was O 0 0.012048998847603798
identified O 0 0.008467208594083786
by O 0 0.006118421442806721
sequencing O 0 0.019652752205729485
amplified O 0 0.03675458952784538
CYP27 O 1 0.9999101161956787
gene O 0 0.013452773913741112
products O 0 0.011977643705904484
from O 0 0.006483426783233881
a O 0 0.00902505498379469
patient O 0 0.4301817715167999
with O 0 0.01333780586719513
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 1 0.9807876348495483
CTX B-Disease 1 1.0
) O 0 0.04311617091298103
. O 0 0.043556977063417435

The O 0 0.03702452406287193
mutation O 0 0.03033224307000637
changed O 0 0.018554845824837685
the O 0 0.016261357814073563
adrenodoxin O 1 0.998214602470398
cofactor O 1 0.9987710118293762
binding O 0 0.026249058544635773
residue O 0 0.04425658658146858
362Arg O 1 0.5761594772338867
to O 0 0.01753978617489338
362Ser O 1 0.9798177480697632
( O 0 0.023075059056282043
CGT O 1 0.9882701635360718
362Arg O 1 0.9113871455192566
to O 0 0.023672359064221382
AGT O 1 1.0
362Ser O 1 0.999982476234436
) O 0 0.012140373699367046
, O 0 0.00743935676291585
and O 0 0.005126686301082373
was O 0 0.008183387108147144
responsible O 0 0.008172120898962021
for O 0 0.010442681610584259
deficiency O 1 1.0
in O 0 0.007343893405050039
the O 0 0.009687624871730804
sterol O 1 0.9984014630317688
27 O 0 0.4259888529777527
- O 1 0.9999357461929321
hydroxylase O 1 0.7299654483795166
activity O 0 0.009945470839738846
, O 0 0.005627166014164686
as O 0 0.004828713368624449
confirmed O 0 0.005874187219887972
by O 0 0.0036144996993243694
expression O 0 0.006757632363587618
of O 0 0.0071709551848471165
mutant O 0 0.02462971955537796
cDNA O 0 0.032508376985788345
into O 0 0.021223705261945724
COS O 1 0.9999998807907104
- O 1 0.9999833106994629
1 O 0 0.03750227391719818
cells O 0 0.03425823152065277
. O 0 0.033404286950826645

Quantitative O 0 0.03770239278674126
analysis O 0 0.013689342886209488
showed O 0 0.010680070146918297
that O 0 0.004444814287126064
the O 0 0.0058201998472213745
expression O 0 0.00828468520194292
of O 0 0.009798225946724415
CYP27 O 1 0.999990701675415
gene O 0 0.013439648784697056
mRNA O 0 0.01464078389108181
in O 0 0.008559135720133781
the O 0 0.011410639621317387
patient O 0 0.027173573151230812
represented O 0 0.01981980912387371
52 O 0 0.043468523770570755
. O 0 0.03121083416044712

5 O 0 0.03221721574664116
% O 0 0.01368251908570528
of O 0 0.009530988521873951
the O 0 0.01187512930482626
normal O 0 0.017070742323994637
level O 0 0.02151888608932495
. O 0 0.027129262685775757

As O 0 0.02325025014579296
the O 0 0.015606625936925411
mutation O 0 0.019392933696508408
occurred O 0 0.011191468685865402
at O 0 0.010332939215004444
the O 0 0.010079947300255299
penultimate O 0 0.11835653334856033
nucleotide O 0 0.01757979765534401
of O 0 0.009633674286305904
exon O 0 0.045344673097133636
6 O 0 0.017270725220441818
( O 0 0.012019852176308632
- O 0 0.05137057974934578
2 O 0 0.01059042476117611
position O 0 0.009758556261658669
of O 0 0.009028637781739235
exon O 0 0.03809843957424164
6 O 0 0.02340840734541416
- O 1 0.9028054475784302
intron O 1 0.9530017375946045
6 O 0 0.023473292589187622
splice O 0 0.03408721834421158
site O 0 0.014641127549111843
) O 0 0.0058607193641364574
of O 0 0.005184653680771589
the O 0 0.0063245357014238834
gene O 0 0.007408405188471079
, O 0 0.005010170396417379
we O 0 0.004537518601864576
hypothesized O 0 0.008982236497104168
that O 0 0.0033842173870652914
the O 0 0.006376869045197964
mutation O 0 0.010187298059463501
may O 0 0.0072530340403318405
partially O 0 0.013030542992055416
affect O 0 0.008143443614244461
the O 0 0.006898736115545034
normal O 0 0.008578404784202576
splicing O 0 0.01646704040467739
efficiency O 0 0.016140367835760117
in O 0 0.009972765110433102
exon O 0 0.04782605916261673
6 O 0 0.017032258212566376
and O 0 0.010012166574597359
cause O 0 0.01157769002020359
alternative O 0 0.012938193045556545
splicing O 0 0.01855473406612873
elsewhere O 0 0.009392869658768177
, O 0 0.006565154530107975
which O 0 0.004306172486394644
resulted O 0 0.006725062150508165
in O 0 0.006099597085267305
decreased O 0 0.013050083070993423
transcript O 0 0.0161771010607481
in O 0 0.008756501600146294
the O 0 0.014756596647202969
patient O 1 0.9516693949699402
. O 0 0.028214434161782265

Transfection O 0 0.4416508674621582
of O 0 0.024914877489209175
constructed O 0 0.04367988929152489
minigenes O 1 0.9903995394706726
, O 0 0.00894777663052082
with O 0 0.005838421173393726
or O 0 0.004637116100639105
without O 0 0.004741189070045948
the O 0 0.006119146477431059
mutation O 0 0.007678319234400988
, O 0 0.00585648138076067
into O 0 0.009182215668261051
COS O 1 1.0
- O 1 0.9999935626983643
1 O 0 0.01654570922255516
cells O 0 0.008632850833237171
confirmed O 0 0.006330862641334534
that O 0 0.003491260576993227
the O 0 0.007349200081080198
mutant O 0 0.02700899913907051
minigene O 1 0.9724618792533875
was O 0 0.011551297269761562
responsible O 0 0.008763247169554234
for O 0 0.005966660566627979
a O 0 0.009293490089476109
mRNA O 0 0.01591973379254341
species O 0 0.007771500386297703
alternatively O 0 0.016075555235147476
spliced O 0 0.0211205892264843
at O 0 0.011543492786586285
an O 0 0.01080711092799902
activated O 0 0.42654654383659363
cryptic O 0 0.04333283379673958
5 O 0 0.025173917412757874
splice O 0 0.047443605959415436
site O 0 0.026163186877965927
88 O 0 0.038146644830703735
bp O 0 0.034251194447278976
upstream O 0 0.018633412197232246
from O 0 0.006651665084064007
the O 0 0.00801132619380951
3 O 0 0.012054924853146076
end O 0 0.011141571216285229
of O 0 0.014181527309119701
exon O 0 0.33997687697410583
6 O 0 0.038032855838537216
. O 0 0.03023955039680004

Our O 0 0.025529293343424797
data O 0 0.01239759661257267
suggest O 0 0.008754287846386433
that O 0 0.005142898298799992
the O 0 0.008440542034804821
C O 0 0.025015689432621002
to O 0 0.007810610346496105
A O 0 0.01323557086288929
mutation O 0 0.014340587891638279
at O 0 0.010375771671533585
the O 0 0.01043777447193861
penultimate O 0 0.051521241664886475
nucleotide O 0 0.01688074879348278
of O 0 0.010179069824516773
exon O 0 0.030198073014616966
6 O 0 0.011634967289865017
of O 0 0.007449613884091377
the O 0 0.00976849626749754
CYP27 O 1 0.9999316930770874
gene O 0 0.008243673481047153
not O 0 0.0037503293715417385
only O 0 0.005159026011824608
causes O 0 0.010021714493632317
the O 0 0.009649096056818962
deficiency B-Disease 1 1.0
in I-Disease 0 0.00782223790884018
the I-Disease 0 0.011435537599027157
sterol I-Disease 1 0.9991611242294312
27 I-Disease 0 0.4120047390460968
- I-Disease 1 0.9999715089797974
hydroxylase I-Disease 1 0.6070389151573181
activity I-Disease 0 0.010088857263326645
, O 0 0.006971617694944143
but O 0 0.00541957700625062
also O 0 0.007632943335920572
partially O 0 0.014432420954108238
leads O 0 0.010018914006650448
to O 0 0.0066035836935043335
alternative O 0 0.01525926310569048
pre O 0 0.029688308015465736
- O 0 0.053063176572322845
mRNA O 0 0.01932213269174099
splicing O 0 0.020728129893541336
of O 0 0.009557968936860561
the O 0 0.014583036303520203
gene O 0 0.02138127014040947
. O 0 0.02513948455452919

To O 0 0.01982305571436882
our O 0 0.015275150537490845
knowledge O 0 0.01304148230701685
, O 0 0.0076136402785778046
this O 0 0.00404747761785984
is O 0 0.004168377723544836
the O 0 0.0046243201941251755
first O 0 0.006044177804142237
report O 0 0.005204605869948864
regarding O 0 0.005908894818276167
effects O 0 0.007136191241443157
on O 0 0.007162639405578375
pre O 1 0.5778276920318604
- O 0 0.38451194763183594
mRNA O 0 0.015047264285385609
splicing O 0 0.01161836925894022
of O 0 0.005052183289080858
a O 0 0.006918267346918583
mutation O 0 0.007792704738676548
at O 0 0.006413072347640991
the O 0 0.007616999093443155
- O 1 0.9062594175338745
2 O 0 0.011063006706535816
position O 0 0.00920905265957117
of O 0 0.007158604916185141
a O 0 0.011479305103421211
5 O 0 0.022777292877435684
splice O 0 0.0580005906522274
site O 0 0.036189962178468704
. O 0 0.03197786584496498

ATM O 0 0.2700510323047638
germline O 0 0.08882646262645721
mutations O 0 0.025437980890274048
in O 0 0.012388043105602264
classical O 0 0.07628493756055832
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999744892120361
in O 0 0.0129556218162179
the O 0 0.01576554961502552
Dutch O 0 0.04726741462945938
population O 0 0.01936393789947033
. O 0 0.030862465500831604

Germline O 0 0.20124682784080505
mutations O 0 0.0250033438205719
in O 0 0.010363958775997162
the O 0 0.011262509971857071
ATM O 1 0.6505602598190308
gene O 0 0.0077765146270394325
are O 0 0.0022128280252218246
responsible O 0 0.004785727709531784
for O 0 0.0037685702554881573
the O 0 0.01047120988368988
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9989091157913208
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.028144052252173424
. O 0 0.03388127312064171

In O 0 0.01680399477481842
our O 0 0.012463420629501343
study O 0 0.008266597054898739
, O 0 0.005596630275249481
we O 0 0.0038374399300664663
have O 0 0.0027132583782076836
determined O 0 0.005976719781756401
the O 0 0.006685772445052862
ATM O 0 0.029410019516944885
mutation O 0 0.01005873829126358
spectrum O 0 0.009701483882963657
in O 0 0.004885734990239143
19 O 0 0.00822941679507494
classical O 0 0.010759425349533558
A B-Disease 1 0.9994864463806152
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9941360950469971
, O 0 0.005698435008525848
including O 0 0.00436768913641572
some O 0 0.0037545254454016685
immigrant O 0 0.00897879060357809
populations O 0 0.005061877891421318
, O 0 0.0046785189770162106
as O 0 0.004570370074361563
well O 0 0.005033586174249649
as O 0 0.005885820835828781
12 O 0 0.008462182246148586
of O 0 0.00977589562535286
Dutch O 0 0.026023704558610916
ethnic O 0 0.01555041316896677
origin O 0 0.01756025105714798
. O 0 0.026661572977900505

Both O 0 0.01712801121175289
the O 0 0.01633336953818798
protein O 0 0.019147809594869614
truncation O 0 0.05136153846979141
test O 0 0.02371079847216606
( O 0 0.016389604657888412
PTT O 1 0.9864584803581238
) O 0 0.008707968518137932
and O 0 0.0059105814434587955
the O 0 0.008035395294427872
restriction O 0 0.015279375948011875
endonuclease O 1 0.6704232692718506
fingerprinting O 0 0.08052501082420349
( O 0 0.018523382022976875
REF O 1 0.9999867677688599
) O 0 0.0103763397783041
method O 0 0.007255787495523691
were O 0 0.004556094296276569
used O 0 0.004288403317332268
and O 0 0.003751334035769105
compared O 0 0.004776990041136742
for O 0 0.004308583680540323
their O 0 0.005157026462256908
detection O 0 0.013143159449100494
efficiency O 0 0.012552730739116669
, O 0 0.00761156203225255
identifying O 0 0.012721270322799683
76 O 0 0.020046301186084747
% O 0 0.007099056150764227
and O 0 0.005196383688598871
60 O 0 0.008513177745044231
% O 0 0.0056818025186657906
of O 0 0.005986915435642004
the O 0 0.0091923912987113
mutations O 0 0.013594068586826324
, O 0 0.013203348033130169
respectively O 0 0.020409991964697838
. O 0 0.02386150136590004

Most O 0 0.028580576181411743
patients O 0 0.2539688050746918
were O 0 0.007544244639575481
found O 0 0.007516462821513414
to O 0 0.007767674513161182
be O 0 0.010102644562721252
compound O 0 0.05110226944088936
heterozygote O 1 0.8329378366470337
. O 0 0.0435815267264843

Seventeen O 0 0.07275325804948807
mutations O 0 0.022955959662795067
were O 0 0.0074712615460157394
distinct O 0 0.007577814161777496
, O 0 0.0058723995462059975
of O 0 0.004883929621428251
which O 0 0.0036362025421112776
10 O 0 0.0051493290811777115
were O 0 0.0035552172921597958
not O 0 0.004720515105873346
reported O 0 0.010284758172929287
previously O 0 0.018459869548678398
. O 0 0.021443204954266548

Mutations O 0 0.03761480003595352
are O 0 0.0093995975330472
small O 0 0.01278168335556984
deletions O 0 0.025291750207543373
or O 0 0.01001841202378273
point O 0 0.014272606000304222
mutations O 0 0.016276132315397263
frequently O 0 0.015864519402384758
affecting O 0 0.027936043217778206
splice O 0 0.07155564427375793
sites O 0 0.03435574099421501
. O 0 0.03494513779878616

Moreover O 0 0.04686099290847778
, O 0 0.01964511163532734
a O 0 0.025128526613116264
16 O 0 0.03614448755979538
. O 0 0.03462594747543335

7 O 0 0.07351935654878616
- O 1 0.8224630355834961
kb O 0 0.13516375422477722
genomic O 0 0.0431070551276207
deletion O 0 0.02856874279677868
of O 0 0.008884378708899021
the O 0 0.009060874581336975
3 O 0 0.009880824945867062
end O 0 0.007460724096745253
of O 0 0.00556948920711875
the O 0 0.006371638271957636
gene O 0 0.00633213110268116
, O 0 0.004709503147751093
most O 0 0.0034846458584070206
likely O 0 0.004093697294592857
a O 0 0.0051758321933448315
result O 0 0.00405370257794857
of O 0 0.0046354965306818485
recombination O 0 0.010088495910167694
between O 0 0.004441990051418543
two O 0 0.005329401232302189
LINE O 0 0.014354810118675232
elements O 0 0.00963571760803461
, O 0 0.008515649475157261
was O 0 0.01648852974176407
identified O 0 0.02048509195446968
. O 0 0.02564912848174572

The O 0 0.020941831171512604
most O 0 0.010234844870865345
frequently O 0 0.010858496651053429
found O 0 0.008394160307943821
mutation O 0 0.009476236999034882
, O 0 0.005393351893872023
identified O 0 0.004536951892077923
in O 0 0.003602841170504689
three O 0 0.0034671283792704344
unrelated O 0 0.00824751053005457
Turkish O 0 0.01278205681592226
A B-Disease 1 0.9998539686203003
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
individuals O 0 0.005047901067882776
, O 0 0.005899497307837009
was O 0 0.007374050561338663
previously O 0 0.006987170781940222
described O 0 0.0052637201733887196
to O 0 0.003673679893836379
be O 0 0.002840889384970069
a O 0 0.005517028272151947
Turkish O 0 0.01399691216647625
A B-Disease 1 0.9950413107872009
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 1 0.9996893405914307
mutation O 0 0.04141812026500702
. O 0 0.031450409442186356

The O 0 0.01926674135029316
presence O 0 0.015127872116863728
of O 0 0.00977284088730812
a O 0 0.011355658993124962
founder O 1 0.995572566986084
mutation O 0 0.014023998752236366
among O 0 0.007036546245217323
relatively O 0 0.007395855616778135
small O 0 0.005394661799073219
ethnic O 0 0.00454218965023756
population O 0 0.0031823518220335245
groups O 0 0.002691536210477352
in O 0 0.003861840581521392
Western O 0 0.006903311237692833
Europe O 0 0.00803341157734394
could O 0 0.005103729199618101
indicate O 0 0.005708483513444662
a O 0 0.0068589779548347
high O 0 0.012039318680763245
carrier O 1 0.7074989080429077
frequency O 0 0.01030628103762865
in O 0 0.008077037520706654
such O 0 0.00996590219438076
communities O 0 0.015627393499016762
. O 0 0.024455707520246506

In O 0 0.02537323348224163
patients O 0 0.029129987582564354
of O 0 0.010449493303894997
Dutch O 0 0.02515304647386074
ethnic O 0 0.007854936644434929
origin O 0 0.005829461384564638
, O 0 0.0057881358079612255
however O 0 0.004587039817124605
, O 0 0.004281331785023212
no O 0 0.004188353195786476
significant O 0 0.005958888214081526
founder O 1 0.9973898530006409
effect O 0 0.007449903525412083
could O 0 0.006464613601565361
be O 0 0.006913547404110432
identified O 0 0.015640337020158768
. O 0 0.02105839177966118

The O 0 0.026587072759866714
observed O 0 0.0197459664195776
genetic O 0 0.019780637696385384
heterogeneity O 0 0.025427542626857758
including O 0 0.00849777739495039
the O 0 0.007481069769710302
relative O 0 0.01010080985724926
high O 0 0.00983359757810831
percentage O 0 0.009374501183629036
of O 0 0.008953440003097057
splice O 1 0.9188225269317627
- O 1 0.9983413219451904
site O 0 0.014114554971456528
mutations O 0 0.010243465192615986
had O 0 0.006639435421675444
no O 0 0.006170141045004129
reflection O 0 0.01591108739376068
on O 0 0.01160595752298832
the O 0 0.01651756279170513
phenotype O 1 0.6408080458641052
. O 0 0.03709735721349716

All O 0 0.022765349596738815
patients O 0 0.05130736529827118
manifested O 0 0.03762652724981308
classical O 0 0.022978022694587708
A B-Disease 1 0.9999513626098633
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
and O 0 0.01335033681243658
increased O 0 0.01618311181664467
cellular O 0 0.20030736923217773
radioresistant O 1 0.9790356159210205
DNA O 0 0.04247620329260826
synthesis O 0 0.04824883118271828
. O 0 0.03590003401041031

Determination O 0 0.04446723312139511
of O 0 0.016034601256251335
the O 0 0.015137700363993645
genomic O 0 0.023788008838891983
structure O 0 0.012050020508468151
of O 0 0.00911970715969801
the O 0 0.011610772460699081
COL4A4 O 1 0.9999940395355225
gene O 0 0.01122981682419777
and O 0 0.006127823609858751
of O 0 0.007027216721326113
novel O 0 0.017727743834257126
mutations O 0 0.020192034542560577
causing O 1 0.9988961219787598
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.999937891960144

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.968853771686554
a O 1 0.9746914505958557
progressive O 1 0.9999998807907104
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9997814297676086
by O 0 0.026545315980911255
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999637603759766
abnormalities I-Disease 1 0.9999756813049316
and O 0 0.008241990581154823
associated O 0 0.006571744568645954
with O 0 0.005081883165985346
mutations O 0 0.006464739330112934
in O 0 0.004263492301106453
either O 0 0.004904539790004492
the O 0 0.006475329399108887
COL4A3 O 1 0.9999839067459106
or O 0 0.006274301093071699
the O 0 0.00831807591021061
COL4A4 O 1 0.9999985694885254
gene O 0 0.009975047782063484
, O 0 0.005946151912212372
which O 0 0.0038193929940462112
encode O 0 0.008168830536305904
the O 0 0.006414901465177536
alpha3 O 0 0.17458361387252808
and O 0 0.009665513411164284
alpha4 O 1 0.9999815225601196
type O 1 0.9999555349349976
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.999450147151947
, O 0 0.019873254001140594
respectively O 0 0.02660650573670864
. O 0 0.025430651381611824

To O 0 0.020764321088790894
date O 0 0.014784768223762512
, O 0 0.010036418214440346
mutation O 0 0.0126327620819211
screening O 0 0.010395916178822517
in O 0 0.004688417539000511
the O 0 0.005038538947701454
two O 0 0.004255663603544235
genes O 0 0.005620609037578106
has O 0 0.0048712436109781265
been O 0 0.004769402090460062
hampered O 0 0.017046939581632614
by O 0 0.004087652545422316
the O 0 0.0058813863433897495
lack O 0 0.00922992080450058
of O 0 0.01131371222436428
genomic O 0 0.03989703580737114
structure O 0 0.02310817874968052
information O 0 0.018608437851071358
. O 0 0.03035859391093254

We O 0 0.021417926996946335
report O 0 0.013911462388932705
here O 0 0.009090584702789783
the O 0 0.00824057124555111
complete O 0 0.013389800675213337
characterization O 0 0.016738668084144592
of O 0 0.007581624202430248
the O 0 0.008245806209743023
48 O 0 0.016423240303993225
exons O 0 0.018301188945770264
of O 0 0.008351397700607777
the O 0 0.011394287459552288
COL4A4 O 1 0.999970555305481
gene O 0 0.011367933824658394
, O 0 0.006069962400943041
a O 0 0.006894128397107124
comprehensive O 0 0.014611001126468182
gene O 0 0.009007262997329235
screen O 0 0.012364506721496582
, O 0 0.005500497296452522
and O 0 0.004026464652270079
the O 0 0.004765704739838839
subsequent O 0 0.007492163218557835
detection O 0 0.01181440707296133
of O 0 0.00651812506839633
10 O 0 0.008713353425264359
novel O 0 0.011663027107715607
mutations O 0 0.006160525139421225
in O 0 0.004731347784399986
eight O 0 0.009633360430598259
patients O 1 0.9999921321868896
diagnosed O 1 1.0
with O 1 0.9996765851974487
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999605417251587

Furthermore O 0 0.04565287381410599
, O 0 0.01631106063723564
we O 0 0.009013189934194088
identified O 0 0.010802442207932472
a O 0 0.012652548030018806
glycine O 0 0.02413332462310791
to O 0 0.010810164734721184
alanine O 0 0.034632157534360886
substitution O 0 0.01625409908592701
in O 0 0.008329777978360653
the O 0 0.012329746037721634
collagenous O 1 0.9999794960021973
domain O 0 0.014132275246083736
that O 0 0.0051518771797418594
is O 0 0.006763441022485495
apparently O 0 0.008911079727113247
silent O 0 0.012532733380794525
in O 0 0.005248400382697582
the O 0 0.008512155152857304
heterozygous O 0 0.018634362146258354
carriers O 0 0.021821483969688416
, O 0 0.008482038043439388
in O 0 0.010709710419178009
11 O 0 0.02238188125193119
. O 0 0.02678011916577816

5 O 0 0.028439253568649292
% O 0 0.011062526144087315
of O 0 0.00671909935772419
all O 0 0.00536652747541666
control O 0 0.007778423838317394
individuals O 0 0.0038081970997154713
, O 0 0.004670406691730022
and O 0 0.00449921702966094
in O 0 0.004644290078431368
one O 0 0.00543257175013423
control O 0 0.009159521199762821
individual O 0 0.007905720733106136
homozygous O 0 0.01555041316896677
for O 0 0.008815986104309559
this O 0 0.01076234970241785
glycine O 0 0.04347772151231766
substitution O 0 0.04257901757955551
. O 0 0.033309370279312134

There O 0 0.014842277392745018
has O 0 0.01053391583263874
been O 0 0.006926738191395998
no O 0 0.004939540755003691
previous O 0 0.005852706730365753
finding O 0 0.006464105099439621
of O 0 0.005810795817524195
a O 0 0.007719005458056927
glycine O 0 0.02290765754878521
substitution O 0 0.011560088954865932
that O 0 0.0041209617629647255
is O 0 0.00440046563744545
not O 0 0.003308037994429469
associated O 0 0.004307266790419817
with O 0 0.004126387648284435
any O 0 0.007116346154361963
obvious O 0 0.021386360749602318
phenotype O 1 0.5445765256881714
in O 0 0.011381962336599827
homozygous O 0 0.03145594522356987
individuals O 0 0.016277750954031944
. O 0 0.026306238025426865

Founder O 1 0.9996991157531738
BRCA1 O 1 0.99994957447052
and O 0 0.02662273310124874
BRCA2 O 1 0.9964823722839355
mutations O 0 0.01413401123136282
in O 0 0.008570359088480473
French O 0 0.045118547976017
Canadian O 1 0.995016872882843
breast B-Disease 1 1.0
and I-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9910337328910828
. O 0 0.03312993794679642

We O 0 0.014338351786136627
have O 0 0.006256769876927137
identified O 0 0.007613449357450008
four O 0 0.00652519054710865
mutations O 0 0.006019226741045713
in O 0 0.0032197681721299887
each O 0 0.002561180153861642
of O 0 0.0043444023467600346
the O 0 0.014055101200938225
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999818801879883
genes O 0 0.012792247347533703
, O 0 0.011100725270807743
BRCA1 O 1 0.9985826015472412
and O 0 0.009734146296977997
BRCA2 O 1 0.9969846606254578
, O 0 0.0058291153982281685
in O 0 0.005089338403195143
French O 0 0.01340402476489544
Canadian O 1 0.9314092397689819
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999963045120239
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03927271068096161
from O 0 0.019037840887904167
Quebec O 1 0.5607209801673889
. O 0 0.030076052993535995

To O 0 0.025108981877565384
identify O 0 0.027571959421038628
founder O 1 0.991651713848114
effects O 0 0.05103500559926033
, O 0 0.00790448673069477
we O 0 0.006741264835000038
examined O 0 0.014553874731063843
independently O 0 0.010524834506213665
ascertained O 0 0.022808510810136795
French O 0 0.02188820205628872
Canadian O 0 0.3129710555076599
cancer B-Disease 1 0.9999923706054688
families O 0 0.008852197788655758
for O 0 0.005905075464397669
the O 0 0.006397716235369444
distribution O 0 0.007033734582364559
of O 0 0.005998225882649422
these O 0 0.006149310618638992
eight O 0 0.014846972189843655
mutations O 0 0.023220304399728775
. O 0 0.026555893942713737

Mutations O 0 0.034719474613666534
were O 0 0.009469244629144669
found O 0 0.007220106199383736
in O 0 0.006916508078575134
41 O 0 0.015241162851452827
of O 0 0.011413258500397205
97 O 0 0.0755278691649437
families O 0 0.024354321882128716
. O 0 0.02689186856150627

Six O 0 0.02352125570178032
of O 0 0.013983533717691898
eight O 0 0.01523115299642086
mutations O 0 0.01118176244199276
were O 0 0.0055636451579630375
observed O 0 0.007620188873261213
at O 0 0.009487729519605637
least O 0 0.00936951581388712
twice O 0 0.02265446074306965
. O 0 0.027463851496577263

The O 0 0.05084092915058136
BRCA1 O 1 0.9999332427978516
C4446T O 1 0.9991703033447266
mutation O 0 0.01958181895315647
was O 0 0.01223613228648901
the O 0 0.006285409908741713
most O 0 0.005378123372793198
common O 0 0.006541861686855555
mutation O 0 0.00824668351560831
found O 0 0.004430392757058144
, O 0 0.0048124101012945175
followed O 0 0.006924547720700502
by O 0 0.006194533780217171
the O 0 0.0141526460647583
BRCA2 O 1 0.9999985694885254
8765delAG O 1 0.9999942779541016
mutation O 0 0.04742737114429474
. O 0 0.03198431432247162

Together O 0 0.027149925008416176
, O 0 0.011245133355259895
these O 0 0.0059309788048267365
mutations O 0 0.00703622680157423
were O 0 0.003809724235907197
found O 0 0.0039328159764409065
in O 0 0.004121842328459024
28 O 0 0.007893997244536877
of O 0 0.005937403999269009
41 O 0 0.01328541524708271
families O 0 0.006699022836983204
identified O 0 0.006038251332938671
to O 0 0.004765626043081284
have O 0 0.004864244721829891
a O 0 0.01157313957810402
mutation O 0 0.02130080759525299
. O 0 0.023224590346217155

The O 0 0.02628217078745365
odds O 0 0.027933649718761444
of O 0 0.010134562849998474
detection O 0 0.012878584675490856
of O 0 0.0054879081435501575
any O 0 0.00439035426825285
of O 0 0.005626653786748648
the O 0 0.007454318925738335
four O 0 0.010323503986001015
BRCA1 O 1 0.9995751976966858
mutations O 0 0.01554667018353939
was O 0 0.019300557672977448
18 O 0 0.026219334453344345
. O 0 0.02579529955983162

7x O 1 0.9991881251335144
greater O 0 0.021538574248552322
if O 0 0.009142844937741756
one O 0 0.0061930394731462
or O 0 0.003489542054012418
more O 0 0.003114060964435339
cases O 0 0.004956832621246576
of O 1 0.996152937412262
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.010924510657787323
also O 0 0.005795502569526434
present O 0 0.00636172853410244
in O 0 0.007054492831230164
the O 0 0.01074314583092928
family O 0 0.022174401208758354
. O 0 0.024562351405620575

The O 0 0.027218060567975044
odds O 0 0.028811993077397346
of O 0 0.01113086473196745
detection O 0 0.01674475707113743
of O 0 0.006431883201003075
any O 0 0.004772768821567297
of O 0 0.00571270938962698
the O 0 0.007299808319658041
four O 0 0.013324570842087269
BRCA2 O 1 0.9999406337738037
mutations O 0 0.01811813749372959
was O 0 0.01917215809226036
5 O 0 0.02715259976685047
. O 0 0.026208650320768356

3x O 1 0.8099210858345032
greater O 0 0.021369893103837967
if O 0 0.00889180600643158
there O 0 0.0040910313837230206
were O 0 0.00343809905461967
at O 0 0.004905190784484148
least O 0 0.0032568906899541616
five O 0 0.0037889836821705103
cases O 0 0.004751423839479685
of O 0 0.041613876819610596
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.061213698238134384
the O 0 0.018129795789718628
family O 0 0.025653056800365448
. O 0 0.025220435112714767

Interestingly O 0 0.06169775128364563
, O 0 0.014417405240237713
the O 0 0.007969019003212452
presence O 0 0.008615180850028992
of O 0 0.008163168095052242
a O 0 0.197532519698143
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.6164811849594116
< O 1 0.9979289770126343
36 O 0 0.012856011278927326
years O 0 0.006335997022688389
of O 0 0.005322656128555536
age O 0 0.007284862920641899
was O 0 0.008216188289225101
strongly O 0 0.007316164672374725
predictive O 0 0.010799736715853214
of O 0 0.00518403947353363
the O 0 0.005005354061722755
presence O 0 0.005580486264079809
of O 0 0.004729229025542736
any O 0 0.004498694092035294
of O 0 0.006220897659659386
the O 0 0.009497683495283127
eight O 0 0.016563203185796738
mutations O 0 0.023079831153154373
screened O 0 0.04311574622988701
. O 0 0.028598487377166748

Carriers O 0 0.04267748072743416
of O 0 0.011904449202120304
the O 0 0.00917839165776968
same O 0 0.007873990572988987
mutation O 0 0.00953756459057331
, O 0 0.004770561121404171
from O 0 0.003430307609960437
different O 0 0.002526288153603673
families O 0 0.004047074355185032
, O 0 0.004382481798529625
shared O 0 0.007024096790701151
similar O 0 0.00655374163761735
haplotypes O 0 0.017633697018027306
, O 0 0.006379022728651762
indicating O 0 0.007553569506853819
that O 0 0.003956245258450508
the O 0 0.006648004520684481
mutant O 0 0.020386191084980965
alleles O 0 0.011011592112481594
were O 0 0.004556362517178059
likely O 0 0.005517881363630295
to O 0 0.004033067263662815
be O 0 0.0038589343894273043
identical O 0 0.006060615181922913
by O 0 0.0035480086226016283
descent O 0 0.00790884718298912
for O 0 0.00497582508251071
a O 0 0.007721247151494026
mutation O 0 0.010603263974189758
in O 0 0.006649614777415991
the O 0 0.01126150693744421
founder O 1 0.8949914574623108
population O 0 0.014689505100250244
. O 0 0.02378014847636223

The O 0 0.023144172504544258
identification O 0 0.018351787701249123
of O 0 0.014628015458583832
common O 0 0.017854973673820496
BRCA1 O 1 0.9999880790710449
and O 0 0.027368592098355293
BRCA2 O 1 0.999994158744812
mutations O 0 0.012120808474719524
will O 0 0.007069388870149851
facilitate O 0 0.011655125766992569
carrier O 0 0.05020788311958313
detection O 0 0.011124243028461933
in O 0 0.0057981270365417
French O 0 0.014855769462883472
Canadian O 1 0.5784469246864319
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999995231628418
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.8574845194816589
. O 0 0.034112535417079926

Are O 0 0.02527528628706932
Dp71 O 1 0.9782417416572571
and O 0 0.026035964488983154
Dp140 O 1 0.9999788999557495
brain O 1 0.9995463490486145
dystrophin O 1 0.9997724890708923
isoforms O 0 0.02616705186665058
related O 0 0.01272789016366005
to O 0 0.011051337234675884
cognitive B-Disease 1 0.9988396763801575
impairment I-Disease 1 1.0
in O 1 0.9999803304672241
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999977350234985

Molecular O 0 0.04784875735640526
study O 0 0.02058381587266922
and O 0 0.013880006968975067
neuropsychological O 0 0.04162660241127014
analysis O 0 0.01014401949942112
were O 0 0.005407427903264761
performed O 0 0.007840612903237343
concurrently O 0 0.009946208447217941
on O 0 0.006247428711503744
49 O 0 0.017024734988808632
patients O 0 0.49603983759880066
with O 1 0.7714229822158813
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.013713846914470196
in O 0 0.007805944886058569
order O 0 0.00690924096852541
to O 0 0.005614081397652626
find O 0 0.007648808415979147
a O 0 0.007539886981248856
molecular O 0 0.009671179577708244
explanation O 0 0.007428973447531462
for O 0 0.005293321330100298
the O 0 0.009422242641448975
cognitive B-Disease 1 0.9756770730018616
impairment I-Disease 1 0.9999983310699463
observed O 0 0.012057647109031677
in O 0 0.011334873735904694
most O 0 0.03440935164690018
DMD B-Disease 1 1.0
patients O 1 0.9999972581863403
. O 0 0.04387381672859192

Complete O 0 0.02510422095656395
analysis O 0 0.010526676662266254
of O 0 0.00851692259311676
the O 0 0.010278948582708836
dystrophin O 1 0.999992847442627
gene O 0 0.011370185762643814
was O 0 0.009142329916357994
performed O 0 0.00818839855492115
to O 0 0.005405382253229618
define O 0 0.009892962872982025
the O 0 0.007733484730124474
localization O 0 0.019406834617257118
of O 0 0.00961478054523468
deletions O 0 0.023524848744273186
and O 0 0.009139971807599068
duplications O 0 0.024569131433963776
in O 0 0.007188459858298302
relation O 0 0.009156924672424793
to O 0 0.0066057792864739895
the O 0 0.010444060899317265
different O 0 0.012136520817875862
DMD B-Disease 1 1.0
promoters O 1 0.992435872554779
. O 0 0.043466199189424515

Qualitative O 0 0.03693076968193054
analysis O 0 0.01312020793557167
of O 0 0.008951053954660892
the O 0 0.011736339889466763
Dp71 O 1 0.9985458850860596
transcript O 0 0.01953386701643467
and O 0 0.007824868895113468
testing O 0 0.01007932424545288
for O 0 0.005316060967743397
the O 0 0.006521788891404867
specific O 0 0.00540004950016737
first O 0 0.010680528357625008
exon O 0 0.030384570360183716
of O 0 0.011715016327798367
Dp140 O 0 0.41867971420288086
were O 0 0.00817303080111742
also O 0 0.010647778399288654
carried O 0 0.013470733538269997
out O 0 0.017643200233578682
. O 0 0.028270544484257698

Neuropsychological O 0 0.28726428747177124
analysis O 0 0.02148127742111683
assessed O 0 0.02575182542204857
verbal O 0 0.02823839895427227
and O 0 0.013973694294691086
visuospatial O 1 0.9980430603027344
intelligence O 0 0.017674317583441734
, O 0 0.01133886631578207
verbal O 0 0.4942588210105896
memory O 1 0.9990774393081665
, O 0 0.010740034282207489
and O 0 0.011163750663399696
reading O 0 0.02743775211274624
skills O 0 0.03940477967262268
. O 0 0.029429074376821518

Comparison O 0 0.038191791623830795
of O 0 0.016847331076860428
molecular O 0 0.0232008658349514
and O 0 0.012881366536021233
psychometric O 0 0.21498994529247284
findings O 0 0.013652109540998936
demonstrated O 0 0.012899884954094887
that O 0 0.006460691336542368
deletions O 0 0.01929645612835884
and O 0 0.008678923361003399
duplications O 0 0.02701624482870102
that O 0 0.005474480334669352
were O 0 0.005457876715809107
localized O 0 0.01266172993928194
in O 0 0.005959696136415005
the O 0 0.008026203140616417
distal O 1 0.701553463935852
part O 0 0.007673989050090313
of O 0 0.005207146983593702
the O 0 0.0065316795371472836
gene O 0 0.007192071061581373
seemed O 0 0.008152693510055542
to O 0 0.0044932602904737
be O 0 0.005193288438022137
preferentially O 0 0.015520979650318623
associated O 0 0.01002152357250452
with O 0 0.012162961065769196
cognitive B-Disease 1 0.9995986819267273
impairment I-Disease 1 0.9999998807907104
. O 0 0.04803233593702316

Two O 0 0.026811789721250534
altered O 0 0.03214890882372856
Dp71 O 0 0.42895790934562683
transcripts O 0 0.02568932995200157
and O 0 0.00965206604450941
two O 0 0.009043009020388126
deleted O 0 0.024776237085461617
Dp140 O 0 0.04397664591670036
DNA O 0 0.013206368312239647
sequences O 0 0.006702824961394072
were O 0 0.003418760374188423
found O 0 0.0033281357027590275
in O 0 0.0038921888917684555
four O 0 0.0061364020220935345
patients O 1 0.9962408542633057
with O 1 0.9781486988067627
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.999972939491272

These O 0 0.013551780954003334
findings O 0 0.013328546658158302
suggest O 0 0.007662625052034855
that O 0 0.003555925330147147
some O 0 0.0036757905036211014
sequences O 0 0.005355400964617729
located O 0 0.006367005407810211
in O 0 0.004481435753405094
the O 0 0.006591213867068291
distal O 0 0.14243961870670319
part O 0 0.006519725546240807
of O 0 0.005364985205233097
the O 0 0.005299013573676348
gene O 0 0.006164435762912035
and O 0 0.004550319630652666
, O 0 0.00395951746031642
in O 0 0.0038970913738012314
particular O 0 0.004480117000639439
, O 0 0.005025158170610666
some O 0 0.005256452597677708
DMD B-Disease 1 0.9999997615814209
isoforms O 0 0.012408009730279446
expressed O 0 0.007074401713907719
in O 0 0.006198533810675144
the O 0 0.010960331186652184
brain O 1 0.9929568767547607
may O 0 0.005552336107939482
be O 0 0.0035240009892731905
related O 0 0.0049102590419352055
to O 0 0.004316824954003096
the O 0 0.008387144654989243
cognitive B-Disease 1 0.9951575398445129
impairment I-Disease 1 1.0
associated O 1 0.9383394122123718
with O 1 0.9603976607322693
DMD B-Disease 1 1.0
. O 0 0.030337698757648468
. O 0 0.03420550748705864

I1307K O 1 0.9994910955429077
APC O 1 0.9999300241470337
and O 0 0.02445758879184723
hMLH1 O 1 0.9890718460083008
mutations O 0 0.015521672554314137
in O 0 0.006792022380977869
a O 0 0.008436977863311768
non O 0 0.01631552167236805
- O 1 0.9627450108528137
Jewish O 0 0.011577760800719261
family O 0 0.009380999021232128
with O 0 0.0080685680732131
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9869568347930908

We O 0 0.01747099682688713
describe O 0 0.01577799953520298
a O 0 0.00935716275125742
French O 0 0.016283418983221054
Canadian O 0 0.02061065472662449
hereditary B-Disease 1 0.9999974966049194
non I-Disease 1 0.9999986886978149
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.1595119833946228
kindred O 1 0.999643087387085
which O 0 0.011294557712972164
carries O 0 0.017793601378798485
a O 0 0.014632957987487316
novel O 0 0.032852333039045334
truncating O 1 0.6032498478889465
mutation O 0 0.028536589816212654
in O 0 0.021163316443562508
hMLH1 O 1 0.9948654770851135
. O 0 0.04002752900123596

Interestingly O 0 0.05986856669187546
, O 0 0.01758943498134613
the O 0 0.01829763501882553
I1307K O 1 0.9998818635940552
APC O 1 0.9999982118606567
polymorphism O 0 0.05209096148610115
, O 0 0.00844364520162344
associated O 0 0.005744025576859713
with O 0 0.0036701334174722433
an O 0 0.0040989285334944725
increased O 0 0.006244081538170576
risk O 1 0.9112929105758667
of O 1 0.9999939203262329
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9988524913787842
is O 0 0.00728373508900404
also O 0 0.005468040704727173
present O 0 0.006289109122008085
in O 0 0.007079306524246931
this O 0 0.007503085304051638
family O 0 0.02213752642273903
. O 0 0.023398132994771004

The O 0 0.03820154070854187
I1307K O 1 0.8648034334182739
polymorphism O 0 0.03137484937906265
has O 0 0.010789603926241398
previously O 0 0.009689085185527802
only O 0 0.004651717375963926
been O 0 0.004654544405639172
identified O 0 0.004750323481857777
in O 0 0.0035360187757760286
individuals O 0 0.0033650114201009274
of O 0 0.006244619842618704
self O 1 0.9976180195808411
- O 1 0.999997615814209
reported O 0 0.02379843220114708
Ashkenazi O 1 0.530039370059967
Jewish O 0 0.02828846499323845
origins O 0 0.04391589015722275
. O 0 0.033624906092882156

In O 0 0.017303258180618286
addition O 0 0.010775190778076649
, O 0 0.006090988405048847
in O 0 0.004525387659668922
this O 0 0.003897909540683031
family O 0 0.006620257161557674
, O 0 0.004376419819891453
there O 0 0.003101036651059985
appears O 0 0.004515443462878466
to O 0 0.0031523217912763357
be O 0 0.002650890266522765
no O 0 0.003398160682991147
relationship O 0 0.004392152652144432
between O 0 0.003553366754204035
the O 0 0.006189557258039713
I1307K O 1 0.9913663268089294
polymorphism O 0 0.014860828407108784
and O 0 0.005589081905782223
the O 0 0.0057349782437086105
presence O 0 0.007497061509639025
or O 0 0.0062128519639372826
absence O 0 0.016467411071062088
of O 0 0.32996493577957153
cancer B-Disease 1 1.0
. O 0 0.02206852100789547
. O 0 0.0286184623837471

Identification O 0 0.033662099391222
of O 0 0.01426593866199255
a O 0 0.014592626132071018
novel O 0 0.019136222079396248
mutation O 0 0.014070716686546803
of O 0 0.007766718044877052
the O 0 0.011414028704166412
CPO O 1 0.9958786964416504
gene O 0 0.012310667894780636
in O 0 0.008574464358389378
a O 0 0.013881208375096321
Japanese O 0 0.21805207431316376
hereditary B-Disease 1 0.9999984502792358
coproporphyria I-Disease 1 0.9999971389770508
family O 0 0.14748536050319672
. O 0 0.03787839785218239

Hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999998807907104
( O 1 0.9349862933158875
HCP B-Disease 1 0.9999998807907104
) O 0 0.011519263498485088
is O 0 0.007039211690425873
an O 0 0.008045862428843975
autosomal B-Disease 1 0.9999980926513672
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
characterized O 1 0.9997259974479675
by O 0 0.008131882175803185
a O 1 0.9759036302566528
deficiency B-Disease 1 1.0
of I-Disease 1 0.9997486472129822
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999998807907104
( O 1 0.5572186708450317
CPO O 1 0.9999873638153076
) O 0 0.012346782721579075
caused O 0 0.011039148084819317
by O 0 0.005286501720547676
a O 0 0.009676885791122913
mutation O 0 0.011945999227464199
in O 0 0.008291064761579037
the O 0 0.016662077978253365
CPO O 1 0.9999202489852905
gene O 0 0.031799256801605225
. O 0 0.030070185661315918

Only O 0 0.017457257956266403
11 O 0 0.01589825749397278
mutations O 0 0.009737813845276833
of O 0 0.005312215071171522
the O 0 0.00613916851580143
gene O 0 0.0062736026011407375
have O 0 0.003397532505914569
been O 0 0.005235170014202595
reported O 0 0.00914173386991024
in O 0 0.014337918721139431
HCP B-Disease 1 1.0
patients O 1 0.9999897480010986
. O 0 0.035293664783239365

We O 0 0.01948937028646469
report O 0 0.01394644845277071
another O 0 0.013292742893099785
mutation O 0 0.013968498446047306
in O 0 0.00757378526031971
a O 0 0.01314019039273262
Japanese O 0 0.042160551995038986
family O 0 0.030912520363926888
. O 0 0.026223402470350266

Polymerase O 0 0.23474842309951782
chain O 0 0.06448888033628464
reaction O 0 0.0333859845995903
- O 1 0.9104402661323547
single O 0 0.022507479414343834
strand O 0 0.029855160042643547
conformational O 0 0.030849382281303406
polymorphism O 0 0.02428634837269783
and O 0 0.00847349688410759
direct O 0 0.009089523926377296
sequence O 0 0.007651845924556255
analyses O 0 0.011211966164410114
demonstrated O 0 0.011082847602665424
a O 0 0.010594929568469524
C O 0 0.10815426707267761
to O 0 0.013570048846304417
T O 1 0.9708903431892395
substitution O 0 0.018128514289855957
in O 0 0.009870284236967564
exon O 0 0.03138822689652443
1 O 0 0.014006213285028934
of O 0 0.008769114501774311
the O 0 0.010467080399394035
CPO O 1 0.5315702557563782
gene O 0 0.01343951653689146
at O 0 0.011183639988303185
nucleotide O 0 0.015656422823667526
position O 0 0.01351451501250267
85 O 0 0.021625317633152008
, O 0 0.00874173454940319
which O 0 0.006004000548273325
lies O 0 0.010598643682897091
in O 0 0.005703172646462917
the O 0 0.00913848727941513
putative O 0 0.30712243914604187
presequence O 1 0.9713973999023438
for O 0 0.011381125077605247
targeting O 0 0.017130780965089798
to O 0 0.014996198005974293
mitochondria O 0 0.041469261050224304
. O 0 0.02878407947719097

This O 0 0.020720595493912697
mutation O 0 0.019835010170936584
changes O 0 0.009532961063086987
the O 0 0.010148085653781891
codon O 0 0.01931017078459263
for O 0 0.009454733692109585
glutamine O 0 0.02573956362903118
to O 0 0.00863712839782238
a O 0 0.012694361619651318
termination O 0 0.03266391158103943
codon O 0 0.03495828062295914
at O 0 0.021099472418427467
amino O 0 0.02382061444222927
acid O 0 0.027417287230491638
position O 0 0.024442782625555992
29 O 0 0.03950311988592148
. O 0 0.03131924942135811

MaeI O 1 0.9548888802528381
restriction O 0 0.02745731733739376
analysis O 0 0.012737791985273361
showed O 0 0.010943916626274586
two O 0 0.006073318421840668
other O 0 0.005624141078442335
carriers O 0 0.014794370159506798
in O 0 0.006930989678949118
the O 0 0.011694961227476597
family O 0 0.02175283245742321
. O 0 0.023860957473516464

The O 0 0.039537422358989716
C O 1 0.9999783039093018
- O 1 0.9999997615814209
T O 1 0.9999985694885254
mutation O 0 0.018769901245832443
is O 0 0.008509032428264618
located O 0 0.011197982355952263
within O 0 0.006122906226664782
a O 0 0.00791266467422247
recently O 0 0.012554764747619629
proposed O 0 0.011658146977424622
putative O 0 0.02840813808143139
alternative O 0 0.013600798323750496
translation O 0 0.015180113725364208
initiation O 0 0.022377904504537582
codon O 0 0.025603262707591057
( O 0 0.0189106035977602
TIC O 1 0.9999988079071045
- O 1 0.9998747110366821
1 O 0 0.019400741904973984
) O 0 0.009282139129936695
, O 0 0.007285669445991516
supporting O 0 0.008454548195004463
that O 0 0.007449042983353138
TIC O 1 0.9999997615814209
- O 1 0.9999655485153198
1 O 0 0.01405052188783884
is O 0 0.006329221185296774
the O 0 0.008440596051514149
real O 0 0.015275580808520317
TIC O 1 0.9795224666595459
rather O 0 0.00939807016402483
than O 0 0.009687795303761959
TIC O 1 0.9999998807907104
- O 1 0.9999886751174927
2 O 0 0.02551238238811493
. O 0 0.015266289003193378
. O 0 0.02639077417552471

Human B-Disease 0 0.02944914996623993
complement I-Disease 0 0.05670471489429474
factor I-Disease 1 0.9998596906661987
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9997506737709045
with O 1 0.9999996423721313
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.999997615814209

This O 0 0.01321058813482523
study O 0 0.00905972346663475
reports O 0 0.006778197828680277
on O 0 0.004322274122387171
six O 0 0.005907998885959387
cases O 0 0.005634364206343889
of O 0 0.037653516978025436
deficiency B-Disease 1 1.0
in I-Disease 0 0.007568261120468378
the I-Disease 0 0.006802648305892944
human I-Disease 0 0.006332320161163807
complement I-Disease 0 0.013443196192383766
regulatory I-Disease 0 0.013552774675190449
protein I-Disease 0 0.013766007497906685
Factor I-Disease 1 0.6232684254646301
H I-Disease 1 0.9999998807907104
( O 0 0.01994672790169716
FH O 1 0.9999996423721313
) O 0 0.007106810808181763
in O 0 0.00429470743983984
the O 0 0.0039268541149795055
context O 0 0.005487777758389711
of O 0 0.0078097982332110405
an O 1 0.999699592590332
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999979734420776

Five O 0 0.02205072157084942
of O 0 0.01265986543148756
the O 0 0.009791089221835136
cases O 0 0.006580332759767771
were O 0 0.004109115339815617
observed O 0 0.006114189513027668
in O 0 0.004848843906074762
children O 0 0.006410888861864805
presenting O 0 0.016530051827430725
with O 1 0.9663291573524475
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9942663311958313
. O 0 0.0460067056119442

Two O 0 0.014827475883066654
of O 0 0.010419528000056744
the O 0 0.009702472016215324
children O 0 0.010384098626673222
exhibited O 0 0.10943278670310974
a O 0 0.47350868582725525
homozygous O 1 0.9999949932098389
deficiency O 1 1.0
characterized O 1 0.9951624274253845
by O 0 0.006117314100265503
the O 0 0.006550413556396961
absence O 0 0.008210400119423866
of O 0 0.00584904570132494
the O 0 0.008156703785061836
150 O 0 0.01760459691286087
- O 1 0.9893295168876648
kD O 1 0.9275237321853638
form O 0 0.009447893127799034
of O 0 0.00893864780664444
Factor O 1 0.6572673916816711
H O 1 0.9999973773956299
and O 0 0.007162680383771658
the O 0 0.007026432082056999
presence O 0 0.008762394078075886
, O 0 0.007406115531921387
upon O 0 0.00888126902282238
immunoblotting O 0 0.03493979573249817
, O 0 0.005943142343312502
of O 0 0.0056778923608362675
the O 0 0.007735369727015495
42 O 0 0.02261657826602459
- O 1 0.999661922454834
kD O 1 0.9999436140060425
Factor O 0 0.3796350359916687
H O 1 0.9999957084655762
- O 1 0.814551830291748
like O 0 0.010572678409516811
protein O 0 0.00952252559363842
1 O 0 0.012492639943957329
( O 0 0.01100622396916151
FHL O 1 0.999997615814209
- O 1 0.9996435642242432
1 O 0 0.01356495637446642
) O 0 0.006136163603514433
and O 0 0.005047741811722517
other O 0 0.006630180403590202
FH O 1 0.9999997615814209
- O 1 0.999984622001648
related O 0 0.016925407573580742
protein O 0 0.017346931621432304
( O 0 0.018592022359371185
FHR O 1 0.9999922513961792
) O 0 0.020282793790102005
bands O 0 0.036265499889850616
. O 0 0.031971525400877

Southern O 0 0.05808380991220474
blot O 1 0.9348758459091187
and O 0 0.016545671969652176
PCR O 0 0.031851667910814285
analysis O 0 0.008998889476060867
of O 0 0.005945692304521799
DNA O 0 0.008199580945074558
of O 0 0.0053510237485170364
one O 0 0.006155042443424463
patient O 1 0.68658846616745
with O 0 0.010295527055859566
homozygous O 1 0.9998862743377686
deficiency O 1 1.0
ruled O 0 0.41504546999931335
out O 0 0.007797081954777241
the O 0 0.005828137509524822
presence O 0 0.005816517397761345
of O 0 0.004498503636568785
a O 0 0.005590408109128475
large O 0 0.006247837096452713
deletion O 0 0.010356572456657887
of O 0 0.005156271159648895
the O 0 0.00872283149510622
FH O 1 1.0
gene O 0 0.008475091308355331
as O 0 0.005153500009328127
the O 0 0.0066276779398322105
underlying O 1 0.9568219184875488
defect O 1 0.999985933303833
for O 0 0.02632540464401245
the O 1 0.9921255707740784
deficiency O 1 1.0
. O 0 0.21530665457248688

The O 0 0.02097218856215477
other O 0 0.009052466601133347
four O 0 0.009370958432555199
children O 0 0.00945950299501419
presented O 0 0.011846269480884075
with O 0 0.01101603265851736
heterozygous O 1 0.9985974431037903
deficiency O 1 1.0
and O 0 0.2654884457588196
exhibited O 1 0.9558228254318237
a O 0 0.014068309217691422
normal O 0 0.014236518181860447
immunoblotting O 1 0.8037322163581848
pattern O 0 0.014673006720840931
of O 0 0.010131540708243847
proteins O 0 0.011198880150914192
of O 0 0.012411773204803467
the O 0 0.024487966671586037
FH O 1 0.9999998807907104
family O 0 0.07778438180685043
. O 0 0.041686564683914185

Factor B-Disease 1 0.9999775886535645
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.01039502676576376
the O 0 0.008999820798635483
only O 0 0.010833226144313812
complement B-Disease 1 0.9999822378158569
deficiency I-Disease 1 1.0
associated O 1 0.998284637928009
with O 1 0.9868671894073486
HUS B-Disease 1 1.0
. O 0 0.17430171370506287

These O 0 0.01703571528196335
observations O 0 0.01800381951034069
suggest O 0 0.009499194100499153
a O 0 0.007731004152446985
role O 0 0.00940043292939663
for O 0 0.009011763148009777
FH O 1 1.0
and O 0 0.21541181206703186
/ O 1 0.999988317489624
or O 0 0.017067259177565575
FH O 1 0.9999998807907104
receptors O 0 0.021542200818657875
in O 0 0.010201454162597656
the O 0 0.015163863077759743
pathogenesis O 1 0.9999982118606567
of O 1 0.994515597820282
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.9155604839324951
. O 0 0.04401584714651108

Further O 0 0.0203684214502573
evidence O 0 0.009254843927919865
for O 0 0.005682546179741621
a O 0 0.007637719623744488
major O 0 0.00936166476458311
ancient O 0 0.01563660055398941
mutation O 0 0.14305749535560608
underlying O 1 0.9999946355819702
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9989514350891113
linkage O 1 0.9999915361404419
disequilibrium O 1 0.9999985694885254
studies O 0 0.016258306801319122
in O 0 0.010434819385409355
the O 0 0.014910775236785412
Japanese O 0 0.030847996473312378
population O 0 0.018502583727240562
. O 0 0.030754605308175087

The O 1 0.9112693667411804
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 0.02871791459619999
mutation O 0 0.016520138829946518
is O 0 0.006768837571144104
an O 0 0.007658166810870171
unstable O 1 0.9997629523277283
( O 0 0.11664415895938873
CTG O 1 0.9999998807907104
) O 0 0.013608373701572418
n O 0 0.01873842254281044
repeat O 0 0.016726437956094742
, O 0 0.006637549493461847
present O 0 0.005757996812462807
at O 0 0.006051728036254644
a O 0 0.005577201023697853
copy O 0 0.009570986963808537
number O 0 0.0035899572540074587
of O 0 0.004609506577253342
5 O 0 0.011191057041287422
- O 0 0.28947925567626953
37 O 0 0.014834200032055378
repeats O 0 0.012030689977109432
on O 0 0.0067884717136621475
normal O 0 0.009339891374111176
chromosomes O 0 0.010539424605667591
but O 0 0.005525689572095871
amplified O 0 0.01571253500878811
to O 0 0.008052071556448936
50 O 0 0.01787368208169937
- O 1 0.5748794078826904
3000 O 0 0.039657287299633026
copies O 0 0.024639558047056198
on O 0 0.025597911328077316
DM B-Disease 1 1.0
chromosomes O 0 0.0654764249920845
. O 0 0.043572798371315

Previous O 0 0.028798088431358337
findings O 0 0.0195519607514143
in O 0 0.012074454687535763
Caucasian O 0 0.03253035619854927
populations O 0 0.00949963927268982
of O 0 0.009806769900023937
a O 0 0.32622385025024414
DM B-Disease 1 1.0
founder O 1 0.9999994039535522
chromosome O 0 0.032192111015319824
raise O 0 0.01633421890437603
a O 0 0.008589309640228748
question O 0 0.007571370340883732
about O 0 0.006029043346643448
the O 0 0.006792402360588312
molecular O 0 0.010332047939300537
events O 0 0.007578997872769833
involved O 0 0.005867190193384886
in O 0 0.006798574235290289
the O 0 0.01048898696899414
expansion O 0 0.03036937490105629
mutation O 0 0.0368204191327095
. O 0 0.03189622238278389

To O 0 0.020782312378287315
investigate O 0 0.019462870433926582
whether O 0 0.011667435988783836
a O 0 0.011987348087131977
founder O 0 0.05597546324133873
chromosome O 0 0.01435079611837864
for O 0 0.006969498470425606
the O 0 0.025743916630744934
DM B-Disease 1 1.0
mutation O 0 0.07128286361694336
exists O 0 0.009324065409600735
in O 0 0.005245675332844257
the O 0 0.006910372991114855
Japanese O 0 0.014514175243675709
population O 0 0.006011095829308033
, O 0 0.006395870354026556
we O 0 0.0064324685372412205
genotyped O 0 0.026081601157784462
families O 0 0.008276516571640968
using O 0 0.007644561119377613
polymorphic O 0 0.026417434215545654
markers O 0 0.016374900937080383
near O 0 0.012813781388103962
the O 0 0.009595030918717384
( O 0 0.014579946175217628
CTG O 1 0.9999771118164062
) O 0 0.01550502423197031
n O 0 0.02688748762011528
repeat O 0 0.024147963151335716
region O 0 0.017763201147317886
and O 0 0.01687253639101982
constructed O 0 0.04473595693707466
haplotypes O 0 0.07566468417644501
. O 0 0.042677365243434906

Six O 0 0.028590545058250427
different O 0 0.011260072700679302
haplotypes O 0 0.03091001883149147
were O 0 0.007653405889868736
found O 0 0.008857187815010548
and O 0 0.01353512704372406
DM B-Disease 1 1.0
alleles O 0 0.04223070293664932
were O 0 0.01233264897018671
always O 0 0.019952164962887764
haplotype O 0 0.04653140529990196
A O 0 0.03885052725672722
. O 0 0.03213499113917351

To O 0 0.016883043572306633
find O 0 0.01093581598252058
an O 0 0.006076785270124674
origin O 0 0.005164895672351122
of O 0 0.005739093292504549
the O 0 0.0075293248519301414
( O 0 0.012854437343776226
CTG O 1 0.9999995231628418
) O 0 0.011966215446591377
n O 0 0.01957085356116295
repeat O 0 0.018324168398976326
mutation O 0 0.010282029397785664
and O 0 0.00459396792575717
to O 0 0.004590602591633797
investigate O 0 0.007438303902745247
the O 0 0.0055808089673519135
mechanism O 0 0.006613073870539665
of O 0 0.005095938686281443
the O 0 0.005825328174978495
expansion O 0 0.012089964933693409
mutation O 0 0.00891242828220129
in O 0 0.004927408415824175
the O 0 0.005952936597168446
Japanese O 0 0.012957492843270302
population O 0 0.004318549297749996
we O 0 0.003798512974753976
have O 0 0.003478205995634198
studied O 0 0.00873108021914959
90 O 0 0.01219999324530363
Japanese O 0 0.052083972841501236
DM B-Disease 1 1.0
families O 0 0.01820453442633152
comprising O 0 0.021160293370485306
190 O 0 0.02998780831694603
affected O 0 0.014210055582225323
and O 0 0.010925432667136192
130 O 0 0.02850911393761635
unaffected O 0 0.04606534540653229
members O 0 0.022298449650406837
. O 0 0.03068557195365429

The O 0 0.022917700931429863
results O 0 0.012935027480125427
suggest O 0 0.008083726279437542
that O 0 0.0037230507005006075
a O 0 0.005314052104949951
few O 0 0.005301595665514469
common O 0 0.006473688408732414
ancestral O 0 0.02370200678706169
mutations O 0 0.007497249636799097
in O 0 0.004784468095749617
both O 0 0.0051117525435984135
Caucasian O 1 0.9864429235458374
and O 0 0.006721056066453457
Japanese O 0 0.017310351133346558
populations O 0 0.005963238887488842
have O 0 0.003533272771164775
originated O 0 0.00696005392819643
by O 0 0.0035516147036105394
expansion O 0 0.008180470205843449
of O 0 0.005548641085624695
an O 0 0.006857471074908972
ancestral O 0 0.03399001434445381
n O 0 0.0202522873878479
= O 0 0.021915029734373093
5 O 0 0.013075841590762138
repeat O 0 0.015481282956898212
to O 0 0.009284717962145805
n O 0 0.020783556625247
= O 0 0.027159640565514565
19 O 0 0.025482844561338425
- O 0 0.24307000637054443
37 O 0 0.03062397986650467
copies O 0 0.02941320464015007
. O 0 0.030127784237265587

These O 0 0.014454704709351063
data O 0 0.011733424849808216
support O 0 0.014320549555122852
multistep O 0 0.035802580416202545
models O 0 0.01886577717959881
of O 0 0.014317366294562817
triplet O 1 0.8171461820602417
repeat O 0 0.02629759907722473
expansion O 0 0.015753982588648796
that O 0 0.00490493094548583
have O 0 0.0033030686900019646
been O 0 0.003428851254284382
proposed O 0 0.004956663120537996
for O 0 0.005466577596962452
both O 0 0.010575427673757076
DM B-Disease 1 1.0
and O 1 0.8340603113174438
Friedreichs B-Disease 1 1.0
ataxia I-Disease 1 0.9999998807907104
. O 0 0.029647722840309143
. O 0 0.038833219558000565

The O 0 0.02513844333589077
molecular O 0 0.02241288125514984
basis O 0 0.012125039473176003
of O 0 0.061462100595235825
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.019133171066641808
the O 0 0.013565976172685623
western O 0 0.020808501169085503
Cape O 1 0.6590380668640137
, O 0 0.01791093498468399
South O 0 0.025576381012797356
Africa O 0 0.03632062301039696
. O 0 0.02960372529923916

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.020523173734545708
the I-Disease 0 0.01718694344162941
sixth I-Disease 1 0.9234663844108582
component I-Disease 0 0.030491506680846214
of I-Disease 0 0.009572894312441349
human I-Disease 0 0.008736290968954563
complement I-Disease 1 0.8208737969398499
( O 0 0.4224895238876343
C6 O 1 1.0
) O 0 0.010341886430978775
has O 0 0.006569020915776491
been O 0 0.004619305953383446
reported O 0 0.004534254316240549
in O 0 0.003365712007507682
a O 0 0.00406385725364089
number O 0 0.0032495229970663786
of O 0 0.004130516201257706
families O 0 0.004793986212462187
from O 0 0.004189399071037769
the O 0 0.006728729233145714
western O 0 0.01219883281737566
Cape O 0 0.3214326500892639
, O 0 0.014770482666790485
South O 0 0.02767828106880188
Africa O 0 0.03680437058210373
. O 0 0.03257780149579048

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.02141883783042431
endemic O 1 0.9746472835540771
in O 0 0.00850232969969511
the O 0 0.01039194781333208
Cape O 1 0.5150353908538818
and O 0 0.00569146778434515
almost O 0 0.0049107251688838005
all O 0 0.004049526993185282
pedigrees O 0 0.014144963584840298
of O 0 0.007895861752331257
total O 1 0.8425852656364441
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9999597072601318
C6Q0 O 1 1.0
) O 0 0.010040787048637867
have O 0 0.005248865578323603
been O 0 0.006665931083261967
ascertained O 0 0.01880354806780815
because O 0 0.009109861217439175
of O 0 0.01829664222896099
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.9790024757385254

We O 0 0.0173635371029377
have O 0 0.0077608004212379456
sequenced O 0 0.015535849146544933
the O 0 0.0069027128629386425
expressed O 0 0.008403833955526352
exons O 0 0.015653837472200394
of O 0 0.008203062228858471
the O 0 0.011684207245707512
C6 O 1 0.9999997615814209
gene O 0 0.01198050007224083
from O 0 0.005932587198913097
selected O 0 0.00957609061151743
cases O 0 0.005661024712026119
and O 0 0.004571129102259874
have O 0 0.0026904214173555374
found O 0 0.0035909840371459723
three O 0 0.004162676632404327
molecular O 0 0.013232182711362839
defects O 1 0.9969486594200134
leading O 0 0.022980207577347755
to O 0 0.008087978698313236
total O 0 0.07654505223035812
deficiency O 1 1.0
879delG O 1 0.9999998807907104
, O 0 0.009206616319715977
which O 0 0.004521229770034552
is O 0 0.004352979362010956
the O 0 0.005665484815835953
common O 0 0.007328086998313665
defect O 1 0.9531698822975159
in O 0 0.006662897299975157
the O 0 0.008421674370765686
Cape O 1 0.7412222027778625
and O 0 0.009425482712686062
hitherto O 0 0.025637643411755562
unreported O 0 0.01668691821396351
, O 0 0.008038030005991459
and O 0 0.007115194108337164
1195delC O 1 0.9988793730735779
and O 0 0.010101133026182652
1936delG O 1 0.9995786547660828
, O 0 0.00822793785482645
which O 0 0.004525320138782263
have O 0 0.002881260123103857
been O 0 0.003682957496494055
previously O 0 0.005619631614536047
reported O 0 0.006505946163088083
in O 0 0.006172948516905308
African O 0 0.06623665988445282
- O 1 0.9999440908432007
Americans O 0 0.025084493681788445
. O 0 0.025467488914728165

We O 0 0.019499514251947403
also O 0 0.00974410679191351
show O 0 0.007198966108262539
that O 0 0.004350896459072828
the O 0 0.007476839702576399
879delG O 1 0.9890239238739014
and O 0 0.014341154135763645
1195delC O 1 0.9999994039535522
defects O 1 0.9999518394470215
are O 0 0.004729515872895718
associated O 0 0.007958161644637585
with O 0 0.008727408945560455
characteristic O 1 0.9995177984237671
C6 O 1 1.0
/ O 1 1.0
C7 O 1 0.9999998807907104
region O 0 0.021820828318595886
DNA O 0 0.022159075364470482
marker O 0 0.11421710252761841
haplotypes O 0 0.03644070029258728
, O 0 0.011175775900483131
although O 0 0.010292564518749714
small O 0 0.010749852284789085
variations O 0 0.014276187866926193
were O 0 0.008573788218200207
observed O 0 0.017138207331299782
. O 0 0.026865988969802856

The O 0 0.0428285077214241
1936delG O 1 0.9999761581420898
defect O 1 0.9995195865631104
was O 0 0.0167060736566782
observed O 0 0.008353415876626968
only O 0 0.00470903143286705
once O 0 0.006724747363477945
in O 0 0.004296103026717901
the O 0 0.005779854487627745
Cape O 0 0.12691935896873474
, O 0 0.005614565685391426
but O 0 0.003788695437833667
its O 0 0.006289598066359758
associated O 0 0.008894342929124832
haplotype O 0 0.0313088521361351
could O 0 0.012244516052305698
be O 0 0.012814998626708984
deduced O 0 0.04783898964524269
. O 0 0.03301214799284935

The O 0 0.01633887179195881
data O 0 0.008687238208949566
from O 0 0.005783813074231148
the O 0 0.007224585395306349
haplotypes O 0 0.016818929463624954
indicate O 0 0.006840267684310675
that O 0 0.0034221799578517675
these O 0 0.002964874729514122
three O 0 0.005630737170577049
molecular O 0 0.013727954588830471
defects O 1 0.9402807950973511
account O 0 0.006331213749945164
for O 0 0.006369126960635185
the O 0 0.00862996093928814
defects O 1 0.9953372478485107
in O 0 0.0048051741905510426
all O 0 0.004067784175276756
the O 0 0.006126284599304199
38 O 0 0.015316938050091267
unrelated O 0 0.018238389864563942
C6Q0 O 1 0.9998949766159058
individuals O 0 0.005050589796155691
we O 0 0.004191807471215725
have O 0 0.0039452603086829185
studied O 0 0.00943716336041689
from O 0 0.007324456702917814
the O 0 0.013967971317470074
Cape O 0 0.09707404673099518
. O 0 0.031679313629865646

We O 0 0.017093975096940994
have O 0 0.007151748985052109
also O 0 0.008235611021518707
observed O 0 0.006842341739684343
the O 0 0.01059679314494133
879delG O 1 0.9940150380134583
defect O 1 0.6588072180747986
in O 0 0.007277186494320631
two O 0 0.009057805873453617
Dutch O 1 0.9998761415481567
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999995231628418
kindreds O 1 0.975583553314209
, O 0 0.010469253174960613
but O 0 0.005851136054843664
the O 0 0.009011264890432358
879delG O 1 0.9997387528419495
defect O 1 0.9947949051856995
in O 0 0.009027579799294472
the O 0 0.011297347955405712
Cape O 1 0.9650057554244995
probably O 0 0.009956173598766327
did O 0 0.006432211957871914
not O 0 0.004116566386073828
come O 0 0.006160358898341656
from O 0 0.006989856716245413
The O 0 0.013130029663443565
Netherlands O 0 0.031043708324432373
. O 0 0.018351273611187935
. O 0 0.02799226902425289

Complement B-Disease 1 0.9999817609786987
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.020783886313438416
seven O 0 0.013023676350712776
further O 0 0.013066381216049194
molecular O 0 0.13590092957019806
defects O 1 0.9994753003120422
and O 0 0.009474501013755798
their O 0 0.008219110779464245
associated O 0 0.017685603350400925
marker O 1 0.9963537454605103
haplotypes O 0 0.2759510278701782
. O 0 0.045259829610586166

Seven O 0 0.023747120052576065
further O 0 0.011651983484625816
molecular O 0 0.018591267988085747
bases O 0 0.022305455058813095
of O 1 0.9155750274658203
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.017559148371219635
described O 0 0.04950714856386185
. O 0 0.03198562562465668

All O 0 0.014234431087970734
these O 0 0.007878231815993786
new O 0 0.014736774377524853
molecular O 0 0.02469785138964653
defects O 1 0.9915211200714111
involve O 0 0.012339243665337563
single O 0 0.014861785806715488
- O 1 0.9992333650588989
nucleotide O 0 0.015499158762395382
events O 0 0.009179653599858284
, O 0 0.007884014397859573
deletions O 0 0.016772549599409103
and O 0 0.007107880432158709
substitutions O 0 0.01305492501705885
, O 0 0.004764412064105272
some O 0 0.0032695201225578785
of O 0 0.004902152810245752
which O 0 0.004902739077806473
alter O 0 0.0148713244125247
splice O 0 0.033015407621860504
sites O 0 0.010544279590249062
, O 0 0.009314552880823612
and O 0 0.010047297924757004
others O 0 0.013266632333397865
codons O 0 0.04027395695447922
. O 0 0.031121525913476944

They O 0 0.015000727027654648
are O 0 0.006451989058405161
distributed O 0 0.010066590271890163
along O 0 0.009156210348010063
the O 0 0.01251255627721548
C7 O 1 1.0
gene O 0 0.013161739334464073
, O 0 0.007129116449505091
but O 0 0.005506312474608421
predominantly O 0 0.007087972946465015
towards O 0 0.008507328107953072
the O 0 0.009098694659769535
3 O 0 0.017044734209775925
end O 0 0.025256643071770668
. O 0 0.03029404766857624

All O 0 0.017897486686706543
were O 0 0.009026359766721725
found O 0 0.008159218356013298
in O 0 0.009541834704577923
compound O 0 0.02828872576355934
heterozygous O 0 0.03164003789424896
individuals O 0 0.017876049503684044
. O 0 0.029937971383333206

The O 0 0.06033293157815933
C6 O 1 0.9999997615814209
/ O 1 0.9999967813491821
C7 O 1 0.9999998807907104
marker O 1 0.963750958442688
haplotypes O 0 0.04699558764696121
associated O 0 0.012758389115333557
with O 0 0.010736661031842232
most O 0 0.030939999967813492
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
are O 0 0.010344122536480427
tabulated O 0 0.029273737221956253
. O 0 0.017182819545269012
. O 0 0.028405847027897835

A O 0 0.040102358907461166
genome O 0 0.04101637750864029
- O 0 0.07777504622936249
wide O 0 0.014330723322927952
search O 0 0.01255396194756031
for O 0 0.008869284763932228
chromosomal O 0 0.03372407332062721
loci O 0 0.020528508350253105
linked O 0 0.013499807566404343
to O 0 0.010310854762792587
mental O 1 0.9999998807907104
health O 1 0.9999998807907104
wellness O 1 1.0
in O 0 0.009606030769646168
relatives O 0 0.01098835188895464
at O 0 0.008462878875434399
high O 0 0.01272190548479557
risk O 1 0.7062241435050964
for O 1 0.9616931676864624
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9925324320793152
the O 0 0.4544288218021393
Old O 1 0.9729624390602112
Order O 0 0.03352497145533562
Amish O 0 0.09281647205352783
. O 0 0.039068371057510376

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999788999557495
BPAD B-Disease 1 1.0
; O 1 0.9999972581863403
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.4370894730091095
is O 0 0.0076094805262982845
characterized O 0 0.009760693646967411
by O 0 0.00479663023725152
episodes O 0 0.010518543422222137
of O 0 0.011618463322520256
mania B-Disease 1 1.0
and O 1 0.9610974192619324
/ O 1 0.9999990463256836
or O 0 0.02950095571577549
hypomania B-Disease 1 0.9999996423721313
interspersed O 0 0.025810640305280685
with O 0 0.010510160587728024
periods O 0 0.0172394011169672
of O 0 0.021958205848932266
depression B-Disease 1 1.0
. O 0 0.04976233094930649

Compelling O 0 0.04822806268930435
evidence O 0 0.01464009564369917
supports O 0 0.015457253903150558
a O 0 0.00922244880348444
significant O 0 0.008823956362903118
genetic O 0 0.010752621106803417
component O 0 0.017303580418229103
in O 0 0.007242436055094004
the O 0 0.009731195867061615
susceptibility O 1 0.8687987327575684
to O 0 0.012679249979555607
develop O 1 0.9665303826332092
BPAD B-Disease 1 0.9999998807907104
. O 0 0.043303828686475754

To O 0 0.019778529182076454
date O 0 0.014390941709280014
, O 0 0.009125076234340668
however O 0 0.007130315061658621
, O 0 0.0072152335196733475
linkage O 0 0.01325229648500681
studies O 0 0.006071312353014946
have O 0 0.002960268873721361
attempted O 0 0.007254022639244795
only O 0 0.003727891016751528
to O 0 0.004953985568135977
identify O 0 0.009909557178616524
chromosomal O 0 0.0720006451010704
loci O 0 0.015749966725707054
that O 0 0.0055755674839019775
cause O 0 0.02402057684957981
or O 0 0.005326712504029274
increase O 0 0.006601881235837936
the O 0 0.009283419698476791
risk O 0 0.027016757056117058
of O 0 0.015705041587352753
developing O 1 0.9858148097991943
BPAD B-Disease 1 1.0
. O 0 0.0459359772503376

To O 0 0.01512090303003788
determine O 0 0.010066147893667221
whether O 0 0.005703452043235302
there O 0 0.004370132461190224
could O 0 0.004782102536410093
be O 0 0.004936319310218096
protective O 1 0.9785799980163574
alleles O 0 0.010419509373605251
that O 0 0.0039970059879124165
prevent O 0 0.006536279339343309
or O 0 0.00367756187915802
reduce O 0 0.006791597697883844
the O 0 0.005358829163014889
risk O 0 0.011668073013424873
of O 0 0.0063104708679020405
developing O 1 0.9882959723472595
BPAD B-Disease 1 1.0
, O 0 0.006694885902106762
similar O 0 0.004428338259458542
to O 0 0.004263595677912235
what O 0 0.003811693750321865
is O 0 0.0031957838218659163
observed O 0 0.0036312148440629244
in O 0 0.0034603094682097435
other O 0 0.004260485991835594
genetic B-Disease 1 0.9999027252197266
disorders I-Disease 1 1.0
, O 0 0.34304627776145935
we O 0 0.005754689686000347
used O 0 0.008920527063310146
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
( O 0 0.011372340843081474
absence O 0 0.010567576624453068
of O 0 0.007118138950318098
any O 0 0.01981595903635025
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 1 0.6822757124900818
as O 0 0.006628720555454493
the O 0 0.006941494066268206
phenotype O 0 0.015507236123085022
in O 0 0.005152820609509945
our O 0 0.008265776559710503
genome O 0 0.017901834100484848
- O 1 0.8591066002845764
wide O 0 0.01400530431419611
linkage O 0 0.02113606035709381
scan O 0 0.018057359382510185
of O 0 0.007024011109024286
several O 0 0.005829176399856806
large O 0 0.009509973227977753
multigeneration O 1 0.8560193777084351
Old O 0 0.02382807433605194
Order O 0 0.018021119758486748
Amish O 0 0.04605964198708534
pedigrees O 0 0.035075593739748
exhibiting O 0 0.023358728736639023
an O 0 0.011167516000568867
extremely O 0 0.017935125157237053
high O 0 0.1294763833284378
incidence O 1 0.9998481273651123
of O 0 0.2423000931739807
BPAD B-Disease 1 1.0
. O 0 0.04346350580453873

We O 0 0.01718086376786232
have O 0 0.008485781028866768
found O 0 0.006870518438518047
strong O 0 0.007777073420584202
evidence O 0 0.00661485968157649
for O 0 0.006221887655556202
a O 0 0.010870206169784069
locus O 0 0.03519872948527336
on O 0 0.012995651923120022
chromosome O 0 0.02635422721505165
4p O 1 0.9999904632568359
at O 0 0.019717762246727943
D4S2949 O 1 0.6766111850738525
( O 0 0.013018638826906681
maximum O 0 0.01924074813723564
GENEHUNTER O 1 0.9999428987503052
- O 1 0.9790730476379395
PLUS O 0 0.03472631424665451
nonparametric O 0 0.04759470000863075
linkage O 0 0.029816478490829468
score O 0 0.017775367945432663
= O 0 0.026478774845600128
4 O 0 0.017706135287880898
. O 0 0.009644202888011932
05 O 0 0.3063143193721771
, O 0 0.013928479515016079
P O 0 0.36851367354393005
= O 0 0.019114404916763306
5 O 0 0.008940810337662697
. O 0 0.004506784025579691
22 O 0 0.009638708084821701
x O 0 0.014182602055370808
10 O 0 0.009893513284623623
( O 0 0.009652531705796719
- O 1 0.8427391052246094
4 O 0 0.01561584323644638
) O 0 0.010210972279310226
; O 0 0.011514877900481224
SIBPAL O 1 0.8637603521347046
Pempirical O 0 0.31991538405418396
value O 0 0.013218958862125874
< O 0 0.0351557731628418
3 O 0 0.013008913956582546
x O 0 0.019191302359104156
10 O 0 0.011276031844317913
( O 0 0.011437338776886463
- O 1 0.9939700365066528
5 O 0 0.014377246610820293
) O 0 0.009409668855369091
) O 0 0.008583062328398228
and O 0 0.008132698014378548
suggestive O 0 0.01602695882320404
evidence O 0 0.0054168119095265865
for O 0 0.00599880563095212
a O 0 0.009883745573461056
locus O 0 0.031458862125873566
on O 0 0.013563896529376507
chromosome O 0 0.02998911589384079
4q O 1 0.9999039173126221
at O 0 0.01991264708340168
D4S397 O 1 0.8186635375022888
( O 0 0.01636972464621067
maximum O 0 0.023717200383543968
GENEHUNTER O 1 0.9998636245727539
- O 1 0.9714788198471069
PLUS O 0 0.04927771911025047
nonparametric O 0 0.058910999447107315
linkage O 0 0.03202786296606064
score O 0 0.0186469629406929
= O 0 0.024638131260871887
3 O 0 0.012790253385901451
. O 0 0.0068937502801418304
29 O 0 0.014435025863349438
, O 0 0.010868790559470654
P O 0 0.11586537212133408
= O 0 0.019814297556877136
2 O 0 0.011611377820372581
. O 0 0.006022263318300247
57 O 0 0.014578686095774174
x O 0 0.01443722378462553
10 O 0 0.009032093919813633
( O 0 0.009360571391880512
- O 1 0.8869101405143738
3 O 0 0.013960015028715134
) O 0 0.00996914878487587
; O 0 0.01218467764556408
SIBPAL O 1 0.7590775489807129
Pempirical O 0 0.12566256523132324
value O 0 0.015319150872528553
< O 0 0.03688248246908188
1 O 0 0.015956973657011986
x O 0 0.0183294415473938
10 O 0 0.010735237039625645
( O 0 0.009469177573919296
- O 1 0.9892274141311646
3 O 0 0.012712721712887287
) O 0 0.007404808420687914
) O 0 0.0048787896521389484
that O 0 0.003104506991803646
are O 0 0.003007841296494007
linked O 0 0.009322639554738998
to O 0 0.009760582819581032
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
. O 1 0.6195173263549805

These O 0 0.01514067966490984
findings O 0 0.012087828479707241
are O 0 0.004030716139823198
consistent O 0 0.007038899231702089
with O 0 0.004325739573687315
the O 0 0.006558903492987156
hypothesis O 0 0.009115743450820446
that O 0 0.0032446985132992268
certain O 0 0.004170707426965237
alleles O 0 0.008525785990059376
could O 0 0.0052980687469244
prevent O 0 0.006586420349776745
or O 0 0.004487510770559311
modify O 0 0.010667526163160801
the O 0 0.00766045693308115
clinical O 1 0.9975246787071228
manifestations O 1 0.9986316561698914
of O 1 0.8601053357124329
BPAD B-Disease 1 1.0
and O 0 0.011571088805794716
perhaps O 0 0.012421474792063236
other O 0 0.008020191453397274
related O 1 0.8862754702568054
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9826899766921997

Segregation O 1 0.9861538410186768
distortion O 1 0.9980524778366089
in O 1 0.8008793592453003
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9753418564796448

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999978542327881
DM B-Disease 1 1.0
) O 0 0.015426172874867916
is O 0 0.008104322478175163
an O 0 0.008936324156820774
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 0.007600563112646341
, O 0 0.005586599465459585
in O 0 0.005278774071484804
the O 0 0.00746625941246748
typical O 0 0.01592303067445755
pedigree O 0 0.03375982865691185
, O 0 0.007899776101112366
shows O 0 0.008347241207957268
a O 0 0.009186347015202045
three O 0 0.011991651728749275
generation O 0 0.04395211115479469
anticipation O 0 0.06508633494377136
cascade O 1 0.801953136920929
. O 0 0.04049474745988846

This O 0 0.01645052805542946
results O 0 0.015111404471099377
in O 0 0.013814099133014679
infertility B-Disease 1 1.0
and O 1 0.9999946355819702
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.01260907668620348
with O 0 0.007513382006436586
the O 0 0.008049233816564083
disappearance O 0 0.018172651529312134
of O 0 0.016196109354496002
DM B-Disease 1 1.0
in O 0 0.017104780301451683
that O 0 0.014209755696356297
pedigree O 0 0.1532556116580963
. O 0 0.02818269655108452

The O 0 0.021374551579356194
concept O 0 0.018951119855046272
of O 0 0.01374940574169159
segregation O 1 0.9228165149688721
distortion O 1 0.9911879301071167
, O 0 0.010163486003875732
where O 0 0.00651160441339016
there O 0 0.00394805520772934
is O 0 0.004887578077614307
preferential O 0 0.011250860057771206
transmission O 0 0.009621670469641685
of O 0 0.005326596088707447
the O 0 0.006081797648221254
larger O 0 0.00865259114652872
allele O 0 0.013579588383436203
at O 0 0.009720146656036377
the O 0 0.013173605315387249
DM B-Disease 1 1.0
locus O 1 0.9999194145202637
, O 0 0.009471557103097439
has O 0 0.005952367093414068
been O 0 0.0049477675929665565
put O 0 0.007437997963279486
forward O 0 0.006804476026445627
to O 0 0.004284169990569353
explain O 0 0.007433025166392326
partially O 0 0.01077777799218893
the O 0 0.007037036120891571
maintenance O 1 0.6591604948043823
of O 0 0.11409537494182587
DM B-Disease 1 1.0
in O 0 0.013363419100642204
the O 0 0.014706149697303772
population O 0 0.015782533213496208
. O 0 0.027985472232103348

In O 0 0.01726607419550419
a O 0 0.013506177812814713
survey O 0 0.017113743349909782
of O 0 0.01331046037375927
DM B-Disease 1 1.0
in O 0 0.011593044735491276
Northern O 0 0.015162752009928226
Ireland O 0 0.015222758986055851
, O 0 0.011584359221160412
59 O 0 0.026470553129911423
pedigrees O 0 0.039290428161621094
were O 0 0.01297019049525261
ascertained O 0 0.04691752791404724
. O 0 0.03065338544547558

Sibships O 1 0.8664092421531677
where O 0 0.016234613955020905
the O 0 0.009789078496396542
status O 0 0.009783829562366009
of O 0 0.006229611579328775
all O 0 0.004322350025177002
the O 0 0.005341221112757921
members O 0 0.00508755212649703
had O 0 0.005211194045841694
been O 0 0.004397775512188673
identified O 0 0.0049531771801412106
were O 0 0.0030383954290300608
examined O 0 0.007049505598843098
to O 0 0.003975495230406523
determine O 0 0.004365011118352413
the O 0 0.004621665459126234
transmission O 0 0.00917370431125164
of O 0 0.005476515740156174
the O 0 0.013322748243808746
DM B-Disease 1 1.0
expansion O 0 0.35386204719543457
from O 0 0.010670285671949387
affected O 0 0.01290473248809576
parents O 0 0.011170159094035625
to O 0 0.009451981633901596
their O 0 0.012685219757258892
offspring O 0 0.03661579266190529
. O 0 0.030355028808116913

Where O 0 0.02617514133453369
the O 0 0.018621163442730904
transmitting O 0 0.04073542729020119
parent O 0 0.03787394240498543
was O 0 0.020927898585796356
male O 0 0.02217627502977848
, O 0 0.015357039868831635
58 O 0 0.04192805290222168
. O 0 0.029236597940325737

3 O 0 0.0337868295609951
% O 0 0.012201348319649696
of O 0 0.007794135250151157
the O 0 0.007978704757988453
offspring O 0 0.01116413064301014
were O 0 0.005672378931194544
affected O 0 0.007368385326117277
, O 0 0.004964306019246578
and O 0 0.0038200204726308584
in O 0 0.004218118730932474
the O 0 0.004817510023713112
case O 0 0.00586684001609683
of O 0 0.0052855792455375195
a O 0 0.0077969166450202465
female O 0 0.017517147585749626
transmitting O 1 0.8443199992179871
parent O 1 0.5036278963088989
, O 0 0.017299769446253777
68 O 0 0.0475531741976738
. O 0 0.03394084796309471

7 O 0 0.05261852592229843
% O 0 0.024526793509721756
were O 0 0.015738075599074364
affected O 0 0.023939110338687897
. O 0 0.028300708159804344

Studies O 0 0.03179193288087845
on O 0 0.01959148794412613
meiotic O 1 0.9828112125396729
drive O 0 0.030248215422034264
in O 0 0.016509074717760086
DM B-Disease 1 1.0
have O 0 0.008991630747914314
shown O 0 0.0073047177866101265
increased O 0 0.008373490534722805
transmission O 0 0.009554768912494183
of O 0 0.005298722069710493
the O 0 0.0058348714374005795
larger O 0 0.008159543387591839
allele O 0 0.015183692798018456
at O 0 0.009540450759232044
the O 0 0.012407846748828888
DM B-Disease 1 1.0
locus O 1 0.8199339509010315
in O 0 0.015601161867380142
non O 1 0.9865047335624695
- O 1 1.0
DM O 1 1.0
heterozygotes O 1 0.9997766613960266
for O 0 0.03472910448908806
CTGn O 1 0.9952774047851562
. O 0 0.0519925095140934

This O 0 0.015125172212719917
study O 0 0.010913815349340439
provides O 0 0.009614931419491768
further O 0 0.0063706934452056885
evidence O 0 0.005319905932992697
that O 0 0.004321319982409477
the O 0 0.010964705608785152
DM B-Disease 1 1.0
expansion O 1 0.725700855255127
tends O 0 0.022492755204439163
to O 0 0.011692260392010212
be O 0 0.012320377863943577
transmitted O 0 0.035716500133275986
preferentially O 0 0.06272704899311066
. O 0 0.03286544606089592

Diagnosis O 1 0.9999921321868896
of O 1 0.7645832896232605
hemochromatosis B-Disease 1 1.0
. O 0 0.4337778687477112

If O 0 0.029637238010764122
untreated O 1 0.9999986886978149
, O 1 0.9724575877189636
hemochromatosis B-Disease 1 1.0
can O 0 0.47036030888557434
cause O 1 0.9999958276748657
serious O 1 1.0
illness O 1 1.0
and O 1 0.9937022924423218
early B-Disease 0 0.3833344578742981
death I-Disease 1 0.660936176776886
, O 0 0.0047288741916418076
but O 0 0.004103211220353842
the O 0 0.007729614619165659
disease O 1 0.9999958276748657
is O 0 0.005255988799035549
still O 0 0.007072154898196459
substantially O 0 0.0195798110216856
under O 1 0.6714459657669067
- O 1 1.0
diagnosed O 1 1.0
. O 0 0.036747802048921585

The O 0 0.0317792072892189
cornerstone O 1 0.957410991191864
of O 0 0.017564890906214714
screening O 0 0.024147668853402138
and O 0 0.010450361296534538
case O 0 0.011066710576415062
detection O 0 0.016092609614133835
is O 0 0.006554808933287859
the O 0 0.007862938567996025
measurement O 0 0.016308030113577843
of O 0 0.013091247528791428
serum O 1 0.9999518394470215
transferrin O 1 0.9999842643737793
saturation O 1 0.9592353105545044
and O 0 0.016496645286679268
the O 0 0.0242986511439085
serum O 1 0.999963641166687
ferritin O 1 0.9999470710754395
level O 0 0.04145646467804909
. O 0 0.034723181277513504

Once O 0 0.03383854776620865
the O 0 0.020253783091902733
diagnosis O 1 0.9999293088912964
is O 0 0.009767296724021435
suspected O 0 0.012990265153348446
, O 0 0.00779273035004735
physicians O 0 0.21489213407039642
must O 0 0.0076741925440728664
use O 0 0.010334398597478867
serum O 1 0.9999809265136719
ferritin O 1 0.9999954700469971
levels O 0 0.017443718388676643
and O 0 0.01396198384463787
hepatic O 1 0.9999998807907104
iron O 1 0.9999997615814209
stores O 0 0.03400399908423424
on O 0 0.014119021594524384
liver O 1 0.9999995231628418
biopsy O 1 0.9998592138290405
specimens O 0 0.014395543374121189
to O 0 0.007563948631286621
assess O 0 0.018702641129493713
patients O 0 0.014230763539671898
for O 0 0.0055528548546135426
the O 0 0.007584653329104185
presence O 0 0.013323204591870308
of O 0 0.03024342469871044
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
. O 0 0.04264109209179878

Liver O 1 1.0
biopsy O 1 0.9999969005584717
is O 0 0.011311733163893223
also O 0 0.0071517424657940865
used O 0 0.004111289978027344
to O 0 0.0036008271854370832
establish O 0 0.006089042406529188
the O 0 0.004635535646229982
presence O 0 0.0058187018148601055
or O 0 0.0041793654672801495
absence O 0 0.010032459162175655
of O 0 0.36344149708747864
cirrhosis B-Disease 1 1.0
, O 0 0.12490116059780121
which O 0 0.005161339417099953
can O 0 0.005369335878640413
affect O 0 0.011907468549907207
prognosis O 1 1.0
and O 0 0.020147614181041718
management O 1 0.9629181623458862
. O 0 0.027506520971655846

A O 0 0.03230700269341469
DNA O 0 0.02669381909072399
- O 0 0.050188831984996796
based O 0 0.009353878907859325
test O 0 0.009422197937965393
for O 0 0.00635876227170229
the O 0 0.010926886461675167
HFE O 1 0.9999985694885254
gene O 0 0.012814890593290329
is O 0 0.0071538588963449
commercially O 0 0.012873431667685509
available O 0 0.007059625815600157
, O 0 0.0047415439039468765
but O 0 0.003043446457013488
its O 0 0.003653553780168295
place O 0 0.004839033354073763
in O 0 0.003485199296846986
the O 0 0.006871586199849844
diagnosis O 1 0.9999978542327881
of O 1 0.9908289909362793
hemochromatosis B-Disease 1 1.0
is O 1 0.7269113659858704
still O 0 0.013781514018774033
being O 0 0.01535178441554308
evaluated O 0 0.0336490273475647
. O 0 0.02711673267185688

Currently O 0 0.026743754744529724
, O 0 0.011319014243781567
the O 0 0.009051773697137833
most O 0 0.0062502240762114525
useful O 0 0.007272678427398205
role O 0 0.006617624778300524
for O 0 0.004640784114599228
this O 0 0.0037443190813064575
test O 0 0.006441257428377867
is O 0 0.0031433007679879665
in O 0 0.0033619008027017117
the O 0 0.004537525121122599
detection O 0 0.011957727372646332
of O 0 0.009279267862439156
hemochromatosis B-Disease 1 1.0
in O 0 0.006843715440481901
the O 0 0.006545285694301128
family O 0 0.007069704122841358
members O 0 0.004254323896020651
of O 0 0.0057027083821594715
patients O 0 0.4405820071697235
with O 0 0.004455116577446461
a O 0 0.007317162584513426
proven O 0 0.01722049154341221
case O 0 0.008701063692569733
of O 0 0.008976325392723083
the O 0 0.05000251531600952
disease O 1 0.9999996423721313
. O 0 0.03439183533191681

It O 0 0.015916874632239342
is O 0 0.008909118361771107
crucial O 0 0.014641237445175648
to O 0 0.013008398935198784
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999985694885254
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 1.0
because O 1 0.9637112021446228
phlebotomy O 1 1.0
therapy O 1 0.999995231628418
can O 0 0.009095839224755764
avert O 1 0.9999997615814209
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9999691247940063
can O 0 0.006079515442252159
even O 0 0.005043540149927139
lead O 0 0.007293958216905594
to O 0 0.006515695713460445
normal O 0 0.009929628111422062
life O 0 0.015188341960310936
expectancy O 1 0.5957841277122498
. O 0 0.017184382304549217
. O 0 0.02497931569814682

Prevalence O 0 0.2865796983242035
of O 0 0.017092350870370865
the O 0 0.016178445890545845
I1307K O 1 0.9999938011169434
APC B-Disease 1 0.9999998807907104
gene O 0 0.019522419199347496
variant O 0 0.01612384431064129
in O 0 0.007274579256772995
Israeli O 0 0.009412313811480999
Jews O 0 0.008091234602034092
of O 0 0.0048756287433207035
differing O 0 0.0065901209600269794
ethnic O 0 0.0060252780094742775
origin O 0 0.005192815791815519
and O 0 0.006545023061335087
risk O 1 0.995266318321228
for O 1 0.9999628067016602
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.996482253074646

BACKGROUND O 0 0.07048823684453964
& O 1 0.5401764512062073
AIMS O 0 0.03614574298262596
Israeli O 0 0.013411038555204868
Jews O 0 0.009998559951782227
of O 0 0.005891504697501659
European O 0 0.008995547890663147
birth O 0 0.06826724112033844
, O 0 0.006633686367422342
i O 0 0.008966248482465744
. O 0 0.0060633099637925625
e O 0 0.012016495689749718
. O 0 0.005751647986471653
, O 0 0.006858516484498978
Ashkenazim O 0 0.02285979501903057
, O 0 0.004841102287173271
have O 0 0.003264290513470769
the O 0 0.006503520533442497
highest O 1 0.9999977350234985
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 0 0.019708359614014626
any O 0 0.008069515228271484
Israeli O 0 0.013729749247431755
ethnic O 0 0.013596626929938793
group O 0 0.024658633396029472
. O 0 0.02738993801176548

The O 0 0.04510961100459099
I1307K O 1 0.9993234872817993
APC B-Disease 1 0.9999270439147949
gene O 0 0.02969793602824211
variant O 0 0.034938208758831024
was O 0 0.018962984904646873
found O 0 0.01085925567895174
in O 0 0.013949556276202202
6 O 0 0.030398940667510033
. O 0 0.03211429715156555

1 O 0 0.03359642252326012
% O 0 0.014702369458973408
of O 0 0.00926634855568409
American O 0 0.01219475269317627
Jews O 0 0.011106929741799831
, O 0 0.006715049035847187
28 O 0 0.008335687220096588
% O 0 0.004963799379765987
of O 0 0.005448114592581987
their O 0 0.008413550443947315
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999872446060181
, O 0 0.015718575567007065
but O 0 0.004586875904351473
not O 0 0.0038571329787373543
in O 0 0.006934598088264465
non O 0 0.018626786768436432
- O 1 0.9964481592178345
Jews O 0 0.027675727382302284
. O 0 0.027992626652121544

We O 0 0.019610345363616943
assessed O 0 0.024065880104899406
the O 0 0.014505392871797085
I1307K O 1 0.9683733582496643
prevalence O 1 0.5009341239929199
in O 0 0.007048684172332287
Israeli O 0 0.010280408896505833
Jews O 0 0.007866390980780125
of O 0 0.0052422997541725636
differing O 0 0.005763649940490723
ethnic O 0 0.005083166062831879
origin O 0 0.005775246769189835
and O 0 0.006861154921352863
risk O 1 0.9975698590278625
for O 1 0.9999548196792603
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9909809231758118

METHODS O 0 0.03608004376292229
DNA O 0 0.019002865999937057
samples O 0 0.013017131946980953
from O 0 0.007935704663395882
500 O 0 0.01722586527466774
unrelated O 0 0.013756701722741127
Jews O 0 0.0076171462424099445
of O 0 0.005528273992240429
European O 0 0.008111831732094288
or O 0 0.006615587044507265
non O 0 0.015527895651757717
- O 1 0.9894792437553406
European O 0 0.008720353245735168
origin O 0 0.005638985428959131
, O 0 0.005211248528212309
with O 0 0.003987389151006937
or O 0 0.0038250796496868134
without O 0 0.0035575563088059425
a O 0 0.005578422453254461
personal O 0 0.035225383937358856
and O 0 0.00762990303337574
/ O 1 0.9941668510437012
or O 0 0.0055689737200737
family O 0 0.007590361405164003
history O 0 0.008384615182876587
of O 0 0.010523304343223572
neoplasia B-Disease 1 1.0
, O 0 0.009133686311542988
were O 0 0.0054643042385578156
examined O 0 0.01153674814850092
for O 0 0.007023324724286795
the O 0 0.011009027250111103
I1307K O 0 0.19252780079841614
variant O 0 0.018292509019374847
by O 0 0.006450087763369083
the O 0 0.009736573323607445
allele O 0 0.023656567558646202
- O 1 0.7020167112350464
specific O 0 0.01436188817024231
oligonucleotide O 1 0.8670795559883118
( O 0 0.021519239991903305
ASO O 1 0.9999994039535522
) O 0 0.023773731663823128
method O 0 0.027170997112989426
. O 0 0.0266074538230896

RESULTS O 0 0.025990283116698265
In O 0 0.010667729191482067
persons O 0 0.008114885538816452
at O 0 0.009463328868150711
average O 0 0.012219545431435108
risk O 0 0.034676168113946915
for O 1 0.915755033493042
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9976894855499268
I1307K O 1 0.9999818801879883
was O 0 0.015264144167304039
found O 0 0.008472606539726257
in O 0 0.01073107123374939
5 O 0 0.02166641876101494
. O 0 0.023462427780032158

0 O 0 0.042613375931978226
% O 0 0.015325339511036873
of O 0 0.009210353717207909
120 O 0 0.018052395433187485
European O 0 0.014571569859981537
and O 0 0.014179976657032967
1 O 0 0.029987698420882225
. O 0 0.03079972416162491

6 O 0 0.040608566254377365
% O 0 0.015228420495986938
of O 0 0.012605727650225163
188 O 0 0.029990527778863907
non O 0 0.020334351807832718
- O 1 0.8717193007469177
European O 0 0.012531294487416744
Jews O 0 0.0140198590233922
( O 0 0.014616706408560276
P O 1 0.9185904860496521
= O 0 0.03777020052075386
0 O 0 0.026379335671663284
. O 0 0.016907840967178345
08 O 0 0.27576857805252075
) O 0 0.02671593427658081
. O 0 0.033743683248758316

It O 0 0.026604505255818367
occurred O 0 0.026326455175876617
in O 0 0.018455885350704193
15 O 0 0.037112750113010406
. O 0 0.037838973104953766

4 O 0 0.0359223373234272
% O 0 0.014847577549517155
of O 0 0.0108890226110816
52 O 0 0.0220467671751976
Ashkenazi O 0 0.033477816730737686
Israelis O 0 0.013801595196127892
with O 0 0.011039555072784424
familial O 1 0.9999998807907104
cancer B-Disease 1 1.0
( O 1 0.9791383147239685
P O 1 0.9999959468841553
= O 0 0.061572570353746414
0 O 0 0.017921362072229385
. O 0 0.010591734200716019
02 O 1 0.9999326467514038
) O 0 0.008087053894996643
and O 0 0.005652860272675753
was O 0 0.00666568148881197
not O 0 0.0035173208452761173
detected O 0 0.006247686222195625
in O 0 0.004926957190036774
51 O 0 0.014523296616971493
non O 0 0.011708138510584831
- O 0 0.0997900739312172
European O 0 0.009466861374676228
Jews O 0 0.010920045897364616
at O 0 0.013058881275355816
increased O 0 0.09104913473129272
cancer B-Disease 1 1.0
risk O 1 0.9990459084510803
. O 0 0.031036917120218277

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 0 0.43490785360336304
personally O 1 0.8518595695495605
or O 0 0.008171159774065018
in O 0 0.005562811624258757
the O 0 0.0067128390073776245
families O 0 0.00554622570052743
of O 0 0.004895806312561035
13 O 0 0.006968014407902956
of O 0 0.006187581457197666
20 O 0 0.01252343226224184
Ashkenazi O 1 0.9479366540908813
I1307K O 1 0.9975423812866211
carriers O 0 0.02279498614370823
, O 0 0.00851602852344513
8 O 0 0.010357758961617947
of O 0 0.006477735470980406
whom O 0 0.008906735107302666
also O 0 0.005236523691564798
had O 0 0.005510486662387848
a O 0 0.0060536619275808334
personal O 0 0.010948407463729382
or O 0 0.005935054272413254
family O 0 0.009868945926427841
history O 0 0.012363971211016178
of O 0 0.02246180549263954
noncolonic O 1 0.9999998807907104
neoplasia B-Disease 1 0.9999998807907104
. O 0 0.045407410711050034

CONCLUSIONS O 0 0.05269823223352432
The O 0 0.03590428829193115
I1307K O 1 0.9998207688331604
APC O 1 0.9999971389770508
variant O 0 0.2221679538488388
may O 0 0.010967859998345375
represent O 0 0.009337464347481728
a O 0 0.009921194054186344
susceptibility O 1 0.6684597134590149
gene O 0 0.010265955701470375
for O 0 0.010744008235633373
colorectal B-Disease 1 1.0
, I-Disease 0 0.008736670948565006
or I-Disease 0 0.0044803256168961525
other I-Disease 0 0.004173752851784229
, I-Disease 0 0.0077523342333734035
cancers I-Disease 1 0.9998608827590942
in O 0 0.006291689816862345
Ashkenazi O 1 0.9961254000663757
Jews O 0 0.010372349061071873
, O 0 0.00631839269772172
and O 0 0.005846924614161253
partially O 0 0.012752463109791279
explains O 0 0.009482218883931637
the O 0 0.005391214042901993
higher O 0 0.010225960984826088
incidence O 1 0.9996204376220703
of O 1 0.999933123588562
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.09994451701641083
European O 0 0.02114022523164749
Israelis O 0 0.03105633705854416
. O 0 0.03503567352890968

Systematic O 0 0.034506820142269135
analysis O 0 0.018342427909374237
of O 0 0.014717856422066689
coproporphyrinogen O 1 0.9999004602432251
oxidase O 1 0.9981586337089539
gene O 0 0.02601524069905281
defects O 1 0.9992521405220032
in O 0 0.01725119724869728
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 1 0.7389713525772095
mutation O 0 0.31539347767829895
update O 1 0.7830150723457336
. O 0 0.03437020257115364

Hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 1.0
( O 1 0.9837397933006287
HC B-Disease 1 1.0
) O 0 0.013571005314588547
is O 0 0.009630149230360985
an O 0 0.020417915657162666
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9996422529220581
autosomal O 1 1.0
dominant O 1 0.9999998807907104
inheritance O 1 0.9999957084655762
caused O 1 0.999313235282898
by O 0 0.009460648521780968
deficient B-Disease 1 0.9998334646224976
activity I-Disease 0 0.010116564109921455
of I-Disease 0 0.013274461962282658
coproporphyrinogen I-Disease 1 0.9999998807907104
III I-Disease 1 1.0
oxidase I-Disease 1 0.9999830722808838
( O 0 0.03796811029314995
CPO O 1 0.9988849759101868
) O 0 0.034899722784757614
. O 0 0.03667494282126427

Clinical O 1 0.9990068078041077
manifestations O 1 0.9131461381912231
of O 0 0.01949903927743435
the O 1 0.977637529373169
disease O 1 1.0
are O 0 0.0047570038586854935
characterized O 0 0.21506068110466003
by O 0 0.0056727854534983635
acute O 1 1.0
attacks O 1 0.9991783499717712
of O 1 0.9999991655349731
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9995168447494507
precipitated O 1 1.0
by O 0 0.009086234495043755
drugs O 1 0.8200936317443848
, O 0 0.008052753284573555
fasting O 0 0.019891342148184776
, O 0 0.010444996878504753
cyclical O 1 0.9999936819076538
hormonal O 1 0.999981164932251
changes O 0 0.01139063574373722
, O 0 0.0774611234664917
or O 1 0.9369434118270874
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.9776974320411682

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.039952125400304794
also O 0 0.01582164317369461
be O 0 0.010490283370018005
present O 0 0.017783213406801224
. O 0 0.026854610070586205

The O 0 0.031081244349479675
seven O 0 0.02337229996919632
exons O 0 0.038308411836624146
, O 0 0.01563994213938713
the O 0 0.017180031165480614
exon O 1 0.738315999507904
/ O 1 0.987256646156311
intron O 1 0.9002660512924194
boundaries O 0 0.01283126138150692
and O 0 0.007659637834876776
part O 0 0.008560750633478165
of O 0 0.008188390173017979
3 O 0 0.013446724973618984
noncoding O 0 0.027216089889407158
sequence O 0 0.009663752280175686
of O 0 0.008446049876511097
the O 0 0.010899628512561321
CPO O 1 0.9961017370223999
gene O 0 0.01340292114764452
were O 0 0.007260062266141176
systematically O 0 0.014014284126460552
analyzed O 0 0.009979767724871635
by O 0 0.005428706295788288
an O 0 0.00803202111274004
exon O 0 0.15600109100341797
- O 1 0.9347053170204163
by O 0 0.010789889842271805
- O 1 0.9644262790679932
exon O 0 0.22592473030090332
denaturing O 1 0.9945631623268127
gradient O 0 0.4688113033771515
gel O 1 0.9999794960021973
electrophoresis O 1 0.998400866985321
( O 0 0.03211125731468201
DGGE O 1 0.9999901056289673
) O 0 0.015186830423772335
strategy O 0 0.019580554217100143
followed O 0 0.009950755164027214
by O 0 0.0052918377332389355
direct O 0 0.0074265762232244015
sequencing O 0 0.014295311644673347
in O 0 0.007919090799987316
seven O 0 0.011266423389315605
unrelated O 0 0.01878828927874565
heterozygous O 0 0.03785352036356926
HC B-Disease 1 1.0
patients O 1 0.9994482398033142
from O 0 0.01098676212131977
France O 0 0.08999999612569809
, O 0 0.010462961159646511
Holland O 0 0.407896488904953
, O 0 0.00934016052633524
and O 0 0.010827708058059216
Czech O 0 0.22332483530044556
Republic O 0 0.04375561699271202
. O 0 0.034358732402324677

Seven O 0 0.036044418811798096
novel O 0 0.03343556821346283
mutations O 0 0.015649136155843735
and O 0 0.008071431890130043
two O 0 0.006359185092151165
new O 0 0.011589744128286839
polymorphisms O 0 0.02362951636314392
were O 0 0.01216819230467081
detected O 0 0.025691993534564972
. O 0 0.02476484514772892

Among O 0 0.024004394188523293
these O 0 0.008253689855337143
mutations O 0 0.009585177525877953
two O 0 0.0048702615313231945
are O 0 0.0037855582777410746
missense O 0 0.017251070588827133
( O 0 0.01011913362890482
G197W O 1 0.9969615340232849
, O 0 0.011835851706564426
W427R O 1 0.9972435235977173
) O 0 0.007832006551325321
, O 0 0.006027248688042164
two O 0 0.0040889219380915165
are O 0 0.0038925660774111748
nonsense O 0 0.014736379496753216
( O 0 0.009903074242174625
Q306X O 1 0.9907111525535583
, O 0 0.011538129299879074
Q385X O 1 0.9968796968460083
) O 0 0.008354166522622108
, O 0 0.005820351652801037
two O 0 0.003542345017194748
are O 0 0.003364160656929016
small O 0 0.0072715082205832005
deletions O 0 0.01802634447813034
( O 0 0.013227487914264202
662de14bp O 1 0.9450444579124451
; O 0 0.015031052753329277
1168del3bp O 0 0.11406416445970535
removing O 0 0.01870104856789112
a O 0 0.011438470333814621
glycine O 0 0.021800097078084946
at O 0 0.010034414939582348
position O 0 0.012013755738735199
390 O 1 0.5751501321792603
) O 0 0.007214113604277372
, O 0 0.006264453288167715
and O 0 0.004350590519607067
one O 0 0.004043400753289461
is O 0 0.004267705138772726
a O 0 0.007333548739552498
splicing O 0 0.016418427228927612
mutation O 0 0.013793159276247025
( O 0 0.012484888546168804
IVS1 O 1 0.9998672008514404
- O 1 0.9998756647109985
15c O 1 0.9999814033508301
- O 1 0.9999972581863403
- O 1 0.9999827146530151
> O 1 0.9995461106300354
g O 0 0.15652865171432495
) O 0 0.010562431998550892
which O 0 0.00742087047547102
creates O 0 0.014501453377306461
a O 0 0.01032920554280281
new O 0 0.01668480597436428
acceptor O 0 0.046056561172008514
splice O 0 0.19938677549362183
site O 0 0.03834719955921173
. O 0 0.03550296649336815

The O 0 0.027712149545550346
pathological O 0 0.03095727600157261
significance O 0 0.01469050720334053
of O 0 0.007642177399247885
the O 0 0.008105947636067867
point O 0 0.010993525385856628
mutations O 0 0.01339060626924038
G197W O 1 0.9584552049636841
, O 0 0.010899761691689491
W427R O 1 0.8728976845741272
, O 0 0.007161910180002451
and O 0 0.005460483953356743
the O 0 0.005871233064681292
in O 0 0.00870381947606802
- O 1 0.9996601343154907
frame O 0 0.03457209840416908
deletion O 0 0.03628097474575043
390delGly O 0 0.34602972865104675
were O 0 0.00705323088914156
assessed O 0 0.010566359385848045
by O 0 0.004695175681263208
their O 0 0.004875329323112965
respective O 0 0.008022529073059559
expression O 0 0.007050950545817614
in O 0 0.004873273428529501
a O 0 0.007466853130608797
prokaryotic O 0 0.01964215189218521
system O 0 0.008838636800646782
using O 0 0.008981782011687756
site O 0 0.020133933052420616
- O 1 0.8183348178863525
directed O 0 0.03090711124241352
mutagenesis O 0 0.07207366824150085
. O 0 0.030692208558321

These O 0 0.01866460032761097
mutations O 0 0.01727837324142456
resulted O 0 0.012771633453667164
in O 0 0.007095333654433489
the O 0 0.00834690872579813
absence O 0 0.014049762859940529
or O 0 0.0064805797301232815
a O 0 0.009315313771367073
dramatic O 0 0.020065074786543846
decrease O 0 0.01891779713332653
of O 0 0.019270481541752815
CPO O 1 0.9996905326843262
activity O 0 0.030078252777457237
. O 0 0.03357880190014839

The O 0 0.026339145377278328
two O 0 0.014160891994833946
polymorphisms O 0 0.023418936878442764
were O 0 0.00952813122421503
localized O 0 0.02054271660745144
in O 0 0.00984176341444254
noncoding O 0 0.025635531172156334
part O 0 0.010030402801930904
of O 0 0.006238192785531282
the O 0 0.00730896508321166
gene O 0 0.009000335820019245
1 O 0 0.010824165306985378
) O 0 0.007343079429119825
a O 0 0.012236064299941063
C O 1 0.9964678287506104
/ O 1 0.9967092275619507
G O 1 0.6126475930213928
polymorphism O 0 0.02411583438515663
in O 0 0.009801492094993591
the O 0 0.013480769470334053
promotor O 1 0.9995170831680298
region O 0 0.018604237586259842
, O 0 0.01339274737983942
142 O 0 0.03570215031504631
bp O 0 0.03494774550199509
upstream O 0 0.017967892810702324
from O 0 0.006776407361030579
the O 0 0.007704937364906073
transcriptional O 0 0.017555052414536476
initiation O 0 0.017865322530269623
site O 0 0.013447054661810398
( O 0 0.01205021794885397
- O 1 0.9919227361679077
142C O 1 0.9996166229248047
/ O 1 0.999384880065918
G O 1 0.9880945086479187
) O 0 0.0098249651491642
, O 0 0.007361803203821182
and O 0 0.005871628411114216
2 O 0 0.010772994719445705
) O 0 0.007252776063978672
a O 0 0.009568216279149055
6 O 0 0.018961526453495026
bp O 0 0.03737974539399147
deletion O 0 0.030499910935759544
polymorphism O 0 0.022981898859143257
in O 0 0.00866600964218378
the O 0 0.009369276463985443
3 O 0 0.014458216726779938
noncoding O 0 0.023966919630765915
part O 0 0.01020309142768383
of O 0 0.008251473307609558
the O 0 0.012096942402422428
CPO O 1 0.9986652135848999
gene O 0 0.019617075100541115
, O 0 0.012847540900111198
574 O 0 0.08137449622154236
bp O 0 0.035067830234766006
downstream O 0 0.019124655053019524
of O 0 0.00812718365341425
the O 0 0.007007776293903589
last O 0 0.009557674638926983
base O 0 0.013376212678849697
of O 0 0.006982308346778154
the O 0 0.007967706769704819
normal O 0 0.010963402688503265
termination O 0 0.3932805359363556
codon O 0 0.03651714697480202
( O 0 0.021450629457831383
+ O 0 0.27161145210266113
574 O 1 0.9861933588981628
delATTCTT O 1 0.9900127649307251
) O 0 0.039885036647319794
. O 0 0.04282674565911293

Five O 0 0.03974134102463722
intragenic O 1 0.9843270182609558
dimorphisms O 1 0.8822153210639954
are O 0 0.008114696480333805
now O 0 0.009973861277103424
well O 0 0.0072575462982058525
characterized O 0 0.010607607662677765
and O 0 0.005398457404226065
the O 0 0.005947498604655266
high O 0 0.009429811500012875
degree O 0 0.009919095784425735
of O 0 0.00988776981830597
allelic O 1 0.9822642207145691
heterogeneity O 1 0.8919897675514221
in O 0 0.0177273228764534
HC B-Disease 1 1.0
is O 0 0.010668423026800156
demonstrated O 0 0.011133215390145779
with O 0 0.005511123687028885
seven O 0 0.00677677895873785
new O 0 0.006367898546159267
different O 0 0.0034241387620568275
mutations O 0 0.005737146362662315
making O 0 0.005132009740918875
a O 0 0.005650282837450504
total O 0 0.006233728025108576
of O 0 0.008093687705695629
nineteen O 0 0.34859925508499146
CPO O 1 0.9999983310699463
gene B-Disease 0 0.21016548573970795
defects I-Disease 1 0.9999747276306152
reported O 0 0.013540094718337059
so O 0 0.008390477858483791
far O 0 0.010844238102436066
. O 0 0.011859539896249771
. O 0 0.020362142473459244

Coincidence O 0 0.056246671825647354
of O 0 0.015085841529071331
two O 0 0.011533007957041264
novel O 0 0.025020575150847435
arylsulfatase O 1 0.827351987361908
A O 0 0.018863754346966743
alleles O 0 0.019346388056874275
and O 0 0.011363155208528042
mutation O 0 0.023448288440704346
459 O 1 0.9999562501907349
+ O 1 0.9994819760322571
1G O 1 0.9999899864196777
> O 0 0.08662206679582596
A O 0 0.014360255561769009
within O 0 0.00665796035900712
a O 0 0.008859807625412941
family O 0 0.01301677618175745
with O 0 0.012983247637748718
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 0.02011122927069664
molecular O 0 0.01766441948711872
basis O 0 0.010045764967799187
of O 0 0.015469485893845558
phenotypic O 0 0.051777299493551254
heterogeneity O 0 0.24338319897651672
. O 0 0.04376978427171707

In O 0 0.016679564490914345
a O 0 0.01406144630163908
family O 0 0.011625993996858597
with O 0 0.007260474376380444
three O 0 0.006560226436704397
siblings O 0 0.015052423812448978
, O 0 0.005246488377451897
one O 0 0.004921732936054468
developed O 0 0.007827459834516048
classical O 0 0.010526706464588642
late O 0 0.022602785378694534
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999061822891235
MLD B-Disease 1 1.0
) O 0 0.016194960102438927
, O 0 0.010419243015348911
fatal O 0 0.030588531866669655
at O 0 0.009055452421307564
age O 0 0.00928193423897028
5 O 0 0.008923406712710857
years O 0 0.006290808320045471
, O 0 0.0053788297809660435
with O 0 0.006121617741882801
deficient O 1 0.9999293088912964
arylsulfatase O 1 0.9999940395355225
A O 1 0.958350419998169
( O 0 0.04525782912969589
ARSA O 1 0.9999974966049194
) O 0 0.010776380077004433
activity O 0 0.0077004400081932545
and O 0 0.00697542168200016
increased O 0 0.012187684886157513
galactosylsulfatide O 1 0.9999936819076538
( O 1 0.7456148266792297
GS O 1 1.0
) O 0 0.03178440034389496
excretion O 0 0.10380368679761887
. O 0 0.03765728324651718

The O 0 0.020169276744127274
two O 0 0.00867445208132267
other O 0 0.007660108618438244
siblings O 0 0.017213955521583557
, O 0 0.007199103012681007
apparently O 0 0.008279412053525448
healthy O 0 0.010127313435077667
at O 0 0.006414548959583044
12 O 0 0.007647071033716202
( O 0 0.0063009303994476795
1 O 0 0.013466203585267067
/ O 1 0.8961236476898193
2 O 0 0.010467090643942356
) O 0 0.004889441188424826
and O 0 0.004141387529671192
15 O 0 0.006239834241569042
years O 0 0.005455824546515942
, O 0 0.004617635160684586
respectively O 0 0.005811134818941355
, O 0 0.00435479823499918
and O 0 0.003806543769314885
their O 0 0.004204956348985434
father O 0 0.012394468300044537
, O 0 0.007122065871953964
apparently O 0 0.0075956652872264385
healthy O 0 0.011770653538405895
as O 0 0.0052674091421067715
well O 0 0.005865730345249176
, O 0 0.006973592098802328
presented O 0 0.01779293641448021
ARSA O 1 0.9999985694885254
and O 0 0.017930446192622185
GS O 1 1.0
values O 0 0.01334840152412653
within O 0 0.00784317497164011
the O 0 0.009524086490273476
range O 0 0.01572038233280182
of O 0 0.021900778636336327
MLD B-Disease 1 1.0
patients O 1 0.9999855756759644
. O 0 0.045515693724155426

Mutation O 0 0.05421716347336769
screening O 0 0.027951056137681007
and O 0 0.010025111958384514
sequence O 0 0.008134178817272186
analysis O 0 0.007638969924300909
disclosed O 0 0.013102870434522629
the O 0 0.006098446436226368
involvement O 0 0.009920832701027393
of O 0 0.006097492761909962
three O 0 0.005883882287889719
different O 0 0.006551685743033886
ARSA O 1 0.9999943971633911
mutations O 0 0.011657497845590115
being O 0 0.006461790297180414
the O 0 0.007315759547054768
molecular O 0 0.012858153320848942
basis O 0 0.008198798634111881
of O 0 0.012855049222707748
intrafamilial O 1 0.9919346570968628
phenotypic O 0 0.06584517657756805
heterogeneity O 1 0.548831045627594
. O 0 0.04556826874613762

The O 0 0.032507359981536865
late O 0 0.09102892130613327
infantile O 1 1.0
patient O 1 0.999998927116394
inherited O 1 0.9999978542327881
from O 0 0.008851001039147377
his O 0 0.022368552163243294
mother O 0 0.017048034816980362
the O 0 0.00801797304302454
frequent O 0 0.012496459297835827
0 O 0 0.020925400778651237
- O 1 0.834433376789093
type O 0 0.019612865522503853
mutation O 0 0.021047992631793022
459 O 1 0.9924734830856323
+ O 1 0.9247981309890747
1G O 1 0.9999725818634033
> O 1 0.8627405762672424
A O 0 0.015267464332282543
, O 0 0.007186184171587229
and O 0 0.0047790720127522945
from O 0 0.004584310110658407
his O 0 0.008881456218659878
father O 0 0.06945296376943588
a O 0 0.010122601874172688
novel O 0 0.015394081361591816
, O 0 0.008114447817206383
single O 0 0.014375145547091961
basepair O 1 0.6929339170455933
microdeletion O 0 0.0808653011918068
of O 0 0.012114563956856728
guanine O 0 0.037900179624557495
at O 0 0.013019092381000519
nucleotide O 0 0.018543856218457222
7 O 0 0.014686684124171734
in O 0 0.01161261647939682
exon O 0 0.05505644157528877
1 O 0 0.02586382068693638
( O 0 0.02423732914030552
7delG O 1 0.8492063283920288
) O 0 0.031339481472969055
. O 0 0.03645195811986923

The O 0 0.0293350201100111
two O 0 0.019400762394070625
clinically O 1 0.9874891638755798
unaffected O 0 0.4702439606189728
siblings O 0 0.03234131634235382
carried O 0 0.015531234443187714
the O 0 0.011394460685551167
maternal O 1 0.9757484793663025
mutation O 0 0.08055023849010468
459 O 1 0.9999991655349731
+ O 1 0.9999706745147705
1G O 1 0.9999983310699463
> O 1 0.9046044945716858
A O 0 0.017270449548959732
and O 0 0.00792860146611929
, O 0 0.006680451333522797
on O 0 0.005671545397490263
their O 0 0.006736893206834793
paternal O 0 0.05876341834664345
allele O 0 0.02129473350942135
, O 0 0.008813295513391495
a O 0 0.012321701273322105
novel O 0 0.02350534312427044
cytosine O 0 0.03203392028808594
to O 0 0.0130836833268404
thymidine O 0 0.04659389331936836
transition O 0 0.02515748143196106
at O 0 0.02152317389845848
nucleotide O 0 0.039107535034418106
2435 O 0 0.4937328100204468
in O 0 0.017051853239536285
exon O 0 0.050058700144290924
8 O 0 0.020614221692085266
, O 0 0.01042590755969286
resulting O 0 0.010540342889726162
in O 0 0.007912896573543549
substitution O 0 0.01717035099864006
of O 0 0.013195957988500595
alanine O 0 0.05379347503185272
464 O 1 0.9829683899879456
by O 0 0.016025658696889877
valine O 1 0.999873161315918
( O 0 0.030145633965730667
A464V O 1 0.9994780421257019
) O 0 0.028052637353539467
. O 0 0.0355895459651947

The O 0 0.040187641978263855
fathers O 0 0.052987486124038696
genotype O 0 0.05863285809755325
thus O 0 0.022181550040841103
was O 0 0.044198084622621536
7delG O 1 0.9999805688858032
/ O 1 0.9998527765274048
A464V O 1 0.9983072280883789
. O 0 0.049879033118486404

Mutation O 0 0.0826965942978859
A464V O 1 0.9675856828689575
was O 0 0.017034893855452538
not O 0 0.006368450820446014
found O 0 0.006785585079342127
in O 0 0.006807125173509121
18 O 0 0.015118603594601154
unrelated O 0 0.4100992977619171
MLD B-Disease 1 1.0
patients O 1 0.9999850988388062
and O 0 0.016654392704367638
50 O 0 0.029103191569447517
controls O 0 0.03816162794828415
. O 0 0.0374564491212368

A464V O 1 0.789012610912323
, O 0 0.019688120111823082
although O 0 0.010505672544240952
clearly O 0 0.013353060930967331
modifying O 0 0.03219633921980858
ARSA O 1 0.9999996423721313
and O 0 0.09671095758676529
GS O 1 1.0
levels O 0 0.01756391115486622
, O 0 0.00968099944293499
apparently O 0 0.011116701178252697
bears O 0 0.011647817678749561
little O 0 0.008939103223383427
significance O 0 0.01209645252674818
for O 0 0.008831638842821121
clinical O 1 0.9987627267837524
manifestation O 1 0.999987006187439
of O 1 0.9712018966674805
MLD B-Disease 1 1.0
, O 0 0.026990383863449097
mimicking O 0 0.12555889785289764
the O 0 0.02242974378168583
frequent O 0 0.06337135285139084
ARSA O 1 0.9999994039535522
pseudodeficiency O 1 0.999890923500061
allele O 0 0.09236247092485428
. O 0 0.04970661550760269

Our O 0 0.026104331016540527
results O 0 0.01257124450057745
demonstrate O 0 0.010754725895822048
that O 0 0.004149532876908779
in O 0 0.004694478120654821
certain O 0 0.005021183285862207
genetic O 0 0.008945408277213573
conditions O 0 0.42799854278564453
MLD B-Disease 1 1.0
- O 1 1.0
like O 0 0.4041801691055298
ARSA O 1 1.0
and O 0 0.022636910900473595
GS O 1 1.0
values O 0 0.012090754695236683
need O 0 0.007515839301049709
not O 0 0.0037458976730704308
be O 0 0.004257064312696457
paralleled O 0 0.015099046751856804
by O 0 0.007835779339075089
clinical O 1 1.0
disease O 1 1.0
, O 0 0.009640405885875225
a O 0 0.007808149792253971
finding O 0 0.009980577975511551
with O 0 0.007322303485125303
serious O 1 0.9578379988670349
diagnostic O 1 0.9999984502792358
and O 0 0.18352630734443665
prognostic O 1 0.9999998807907104
implications O 1 0.9387245774269104
. O 0 0.037833746522665024

Moreover O 0 0.05136927589774132
, O 0 0.020087935030460358
further O 0 0.025110073387622833
ARSA O 1 0.9999837875366211
alleles O 0 0.03747812286019325
functionally O 0 0.028589578345417976
similar O 0 0.008671811781823635
to O 0 0.008917044848203659
A464V O 1 0.8919014930725098
might O 0 0.008290452882647514
exist O 0 0.004404114559292793
which O 0 0.0033717891201376915
, O 0 0.003984265960752964
together O 0 0.003954888321459293
with O 0 0.004455829504877329
0 O 0 0.014138017781078815
- O 1 0.9999585151672363
type O 0 0.12438392639160156
mutations O 0 0.00872847344726324
, O 0 0.006733996327966452
may O 0 0.006756902206689119
cause O 0 0.02730613574385643
pathological O 1 0.9999620914459229
ARSA O 1 1.0
and O 1 0.9986674785614014
GS O 1 1.0
levels O 0 0.013230742886662483
, O 0 0.005986415781080723
but O 0 0.003928223624825478
not O 0 0.004684222862124443
clinical O 1 0.578443706035614
outbreak O 1 0.9979555606842041
of O 0 0.0746411681175232
the O 1 0.995427131652832
disease O 1 1.0
. O 0 0.021970108151435852
. O 0 0.026224059984087944

Human O 1 0.8079187273979187
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999998807907104
to O 0 0.49851930141448975
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9999886751174927
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999960660934448
1 I-Disease 0 0.49136316776275635
. O 0 0.03697279095649719

Heterozygous O 0 0.13524843752384186
germ O 1 0.999991774559021
- O 1 0.9995532631874084
line O 0 0.027202360332012177
mutations O 0 0.013021385297179222
in O 0 0.006607337389141321
the O 0 0.00903769489377737
DNA O 0 0.016645319759845734
mismatch O 1 0.9998196959495544
repair O 1 0.9988201260566711
genes O 0 0.011008964851498604
lead O 0 0.010501333512365818
to O 0 0.014576735906302929
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9692695140838623

The O 0 0.24732626974582672
disease O 1 0.9999998807907104
susceptibility O 1 0.99981290102005
of O 0 0.012514112517237663
individuals O 0 0.0069522433914244175
who O 0 0.009315995499491692
constitutionally O 0 0.024265743792057037
lack O 0 0.007504981476813555
both O 0 0.005972251296043396
wild O 0 0.016265850514173508
- O 1 0.9999904632568359
type O 0 0.4164362847805023
alleles O 0 0.021003488451242447
is O 0 0.013962733559310436
unknown O 0 0.022778823971748352
. O 0 0.026660213246941566

We O 0 0.018378710374236107
have O 0 0.00819405261427164
identified O 0 0.009212477132678032
three O 0 0.005966003984212875
offspring O 0 0.010241900570690632
in O 0 0.00565713457763195
a O 0 0.011651808395981789
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999386072158813
who O 1 0.8791625499725342
developed O 1 0.9964902997016907
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.032759133726358414
a O 0 0.007444217801094055
very O 0 0.005101473536342382
early O 0 0.007352932821959257
age O 0 0.007880493998527527
, O 0 0.004827018361538649
and O 0 0.004476482048630714
at O 0 0.005070251878350973
least O 0 0.0031597171910107136
two O 0 0.002984421793371439
of O 0 0.003770626150071621
them O 0 0.003830796107649803
displayed O 0 0.010265108197927475
signs O 0 0.011341427452862263
of O 0 0.012862657196819782
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9998987913131714
1 I-Disease 1 0.7753876447677612
( O 0 0.024525050073862076
NF1 B-Disease 1 0.9999679327011108
) O 0 0.0328541062772274
. O 0 0.038836754858493805

DNA O 0 0.030400369316339493
sequence O 0 0.012074664235115051
analysis O 0 0.010334665887057781
and O 0 0.010691693983972073
allele O 0 0.02623741514980793
- O 1 0.8045738339424133
specific O 0 0.008877630345523357
amplification O 0 0.022836580872535706
in O 0 0.008111824281513691
two O 0 0.007738880347460508
siblings O 0 0.01814192906022072
revealed O 0 0.013616555370390415
a O 0 0.012609967030584812
homozygous O 0 0.036227528005838394
MLH1 O 1 0.9999979734420776
mutation O 0 0.021859439089894295
( O 0 0.016060328111052513
C676T O 1 0.9999788999557495
- O 1 0.9999998807907104
- O 1 0.9999996423721313
> O 1 0.9999328851699829
Arg226Stop O 1 0.999812662601471
) O 0 0.030851563438773155
. O 0 0.03345789015293121

Thus O 0 0.02809653989970684
, O 0 0.014638473279774189
a O 0 0.014861778356134892
homozygous O 0 0.04124046862125397
germ O 1 0.9999996423721313
- O 1 0.9999983310699463
line O 0 0.21852688491344452
MLH1 O 1 0.9999985694885254
mutation O 0 0.021023651584982872
and O 0 0.01161161344498396
consequent O 1 0.9999997615814209
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.017622359097003937
in O 0 0.008969083428382874
a O 0 0.015222038142383099
mutator O 1 0.9999977350234985
phenotype O 1 0.8896158933639526
characterized O 0 0.10324911028146744
by O 0 0.009262174367904663
leukemia B-Disease 1 1.0
and O 1 0.9998787641525269
/ O 1 1.0
or O 1 0.9997097849845886
lymphoma B-Disease 1 1.0
associated O 1 0.9882370829582214
with O 1 0.9547398686408997
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999791383743286
1 I-Disease 0 0.08902306854724884
. O 0 0.019082389771938324
. O 0 0.028233949095010757

Missense O 0 0.0861515998840332
mutations O 0 0.020468592643737793
in O 0 0.008286310359835625
the O 0 0.007637212984263897
most O 0 0.006285793147981167
ancient O 0 0.010328533127903938
residues O 0 0.010772420093417168
of O 0 0.008182289078831673
the O 0 0.012923062779009342
PAX6 O 1 0.9999994039535522
paired O 0 0.09779049456119537
domain O 0 0.021023528650403023
underlie O 0 0.023988960310816765
a O 0 0.010035139508545399
spectrum O 0 0.018527278676629066
of O 0 0.030069934204220772
human O 1 0.9999759197235107
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9996552467346191

Mutations O 0 0.031208693981170654
of O 0 0.011011498048901558
the O 0 0.009511607699096203
human O 0 0.013660727068781853
PAX6 O 1 0.9999997615814209
gene O 0 0.23801001906394958
underlie O 1 0.9999966621398926
aniridia B-Disease 1 1.0
( O 1 0.998256266117096
congenital B-Disease 1 1.0
absence I-Disease 1 0.9776802659034729
of I-Disease 0 0.14332298934459686
the I-Disease 1 0.9525794386863708
iris I-Disease 1 0.999998927116394
) O 0 0.006238970439881086
, O 0 0.00538218580186367
a O 0 0.007348198443651199
rare O 0 0.015489236451685429
dominant O 1 0.9816046953201294
malformation B-Disease 1 0.999998927116394
of I-Disease 0 0.05285882577300072
the I-Disease 1 0.8470007181167603
eye I-Disease 1 0.9999995231628418
. O 0 0.042366862297058105

The O 0 0.02415112592279911
spectrum O 0 0.033246155828237534
of O 0 0.017648009583353996
PAX6 O 1 0.9999998807907104
mutations O 0 0.02614143304526806
in O 0 0.014442136511206627
aniridia B-Disease 1 1.0
patients O 1 0.9998905658721924
is O 0 0.009488705545663834
highly O 0 0.011535345576703548
biased O 0 0.010684700682759285
, O 0 0.0063542211428284645
with O 0 0.005782227497547865
92 O 0 0.016731150448322296
% O 0 0.005731061566621065
of O 0 0.004216047935187817
all O 0 0.004271447658538818
reported O 0 0.008010175079107285
mutations O 0 0.007666596211493015
leading O 0 0.00710573373362422
to O 0 0.006024084519594908
premature O 0 0.03698747232556343
truncation O 0 0.030187271535396576
of O 0 0.00712958537042141
the O 0 0.010211204178631306
protein O 0 0.012210985645651817
( O 0 0.008181191049516201
nonsense O 0 0.020050086081027985
, O 0 0.008224484510719776
splicing O 0 0.015639090910553932
, O 0 0.009709961712360382
insertions O 0 0.02608906850218773
and O 0 0.009061808697879314
deletions O 0 0.017727794125676155
) O 0 0.006805858109146357
and O 0 0.0044999560341238976
just O 0 0.006721173878759146
2 O 0 0.008529163897037506
% O 0 0.005877133458852768
leading O 0 0.008744115009903908
to O 0 0.005429018288850784
substitution O 0 0.009920588694512844
of O 0 0.00663747126236558
one O 0 0.008264017291367054
amino O 0 0.01293492317199707
acid O 0 0.012368316762149334
by O 0 0.0063605112954974174
another O 0 0.01125380489975214
( O 0 0.015809819102287292
missense O 0 0.044806621968746185
) O 0 0.020436666905879974
. O 0 0.02741454914212227

The O 0 0.024174978956580162
extraordinary O 0 0.0251940730959177
conservation O 0 0.017642399296164513
of O 0 0.01009158231317997
the O 0 0.013684314675629139
PAX6 O 1 0.9999799728393555
protein O 0 0.014237522147595882
at O 0 0.009466677904129028
the O 0 0.00813095923513174
amino O 0 0.011805880814790726
acid O 0 0.017651697620749474
level O 0 0.010187448002398014
amongst O 0 0.015236460603773594
vertebrates O 0 0.023658089339733124
predicts O 0 0.02536272443830967
that O 0 0.007908623665571213
pathological O 1 0.6961331963539124
missense O 0 0.1536271572113037
mutations O 0 0.010235743597149849
should O 0 0.005343471188098192
in O 0 0.0040872287936508656
fact O 0 0.004604232497513294
be O 0 0.0032100165262818336
common O 0 0.004002731293439865
even O 0 0.004022741690278053
though O 0 0.0036118701100349426
they O 0 0.002788167679682374
are O 0 0.0027855823282152414
hardly O 0 0.009896651841700077
ever O 0 0.009722285903990269
seen O 0 0.010508167557418346
in O 0 0.01243098359555006
aniridia B-Disease 1 0.9999995231628418
patients O 1 0.9996352195739746
. O 0 0.03144907206296921

This O 0 0.015814561396837234
indicates O 0 0.014474058523774147
that O 0 0.004616810940206051
there O 0 0.004217800684273243
is O 0 0.004630540497601032
a O 0 0.007800233084708452
heavy O 1 0.9481641054153442
ascertainment O 1 0.9999947547912598
bias O 0 0.01447917241603136
in O 0 0.005901348311454058
the O 0 0.006201047915965319
selection O 0 0.010514521040022373
of O 0 0.007920694537460804
patients O 1 0.5423641800880432
for O 0 0.010760501027107239
PAX6 O 1 0.9999998807907104
mutation O 0 0.01531680766493082
analysis O 0 0.007773684803396463
and O 0 0.005428188946098089
that O 0 0.004092485178261995
the O 0 0.00872645154595375
missing O 0 0.022260384634137154
PAX6 O 1 0.9999986886978149
missense O 0 0.45609477162361145
mutations O 0 0.020395440980792046
frequently O 0 0.013292736373841763
may O 0 0.013940823264420033
underlie O 0 0.4266209006309509
phenotypes O 0 0.09147214144468307
distinct O 0 0.017538299784064293
from O 0 0.023316940292716026
textbook O 1 0.9999969005584717
aniridia B-Disease 1 0.9999990463256836
. O 0 0.048066120594739914

Here O 0 0.021999649703502655
we O 0 0.008927704766392708
present O 0 0.011834308505058289
four O 0 0.011890525929629803
novel O 0 0.026105253025889397
PAX6 O 1 0.9999971389770508
missense O 0 0.3698481023311615
mutations O 0 0.01384599320590496
, O 0 0.00624920753762126
two O 0 0.004095472861081362
in O 0 0.004697009921073914
association O 0 0.009147861041128635
with O 0 0.007279712241142988
atypical O 1 0.9999988079071045
phenotypes O 1 0.9999939203262329
ectopia B-Disease 1 1.0
pupillae I-Disease 1 0.9999990463256836
( O 0 0.01410833839327097
displaced B-Disease 0 0.020149385556578636
pupils I-Disease 0 0.1351228803396225
) O 0 0.012120123952627182
and O 0 0.2612760365009308
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 0.2423395812511444
searching B-Disease 0 0.07782434672117233
gaze I-Disease 1 0.9983142614364624
) O 0 0.007480039726942778
, O 0 0.005893610417842865
and O 0 0.004397984594106674
two O 0 0.0036332150921225548
in O 0 0.0049263546243309975
association O 0 0.008492961525917053
with O 0 0.006422900594770908
more O 0 0.010645297355949879
recognizable O 1 0.9961078763008118
aniridia B-Disease 1 0.999998927116394
phenotypes O 1 0.9794443845748901
. O 0 0.0470723956823349

Strikingly O 0 0.05961555987596512
, O 0 0.01275609526783228
all O 0 0.00687075313180685
four O 0 0.007803622633218765
mutations O 0 0.007513332646340132
are O 0 0.003085671691223979
located O 0 0.007153946906328201
within O 0 0.0054012020118534565
the O 0 0.010044911876320839
PAX6 O 1 0.9999977350234985
paired O 0 0.3927340805530548
domain O 0 0.015893148258328438
and O 0 0.009119645692408085
affect O 0 0.011377953924238682
amino O 0 0.01259013544768095
acids O 0 0.01003784965723753
which O 0 0.004855007398873568
are O 0 0.003691979218274355
highly O 0 0.008975312113761902
conserved O 0 0.009942237287759781
in O 0 0.006072990130633116
all O 0 0.007107275538146496
known O 0 0.013312489725649357
paired O 0 0.033369384706020355
domain O 0 0.029195411130785942
proteins O 0 0.028669342398643494
. O 0 0.02969968132674694

Our O 0 0.02477995865046978
results O 0 0.014048243872821331
support O 0 0.010553804226219654
the O 0 0.007815348915755749
hypothesis O 0 0.009441746398806572
that O 0 0.0035834340378642082
the O 0 0.004972695838660002
under O 0 0.007968227379024029
- O 1 0.572516143321991
representation O 0 0.008376301266252995
of O 0 0.008665960282087326
missense O 0 0.037772297859191895
mutations O 0 0.010655415244400501
is O 0 0.006389924790710211
caused O 0 0.010545959696173668
by O 0 0.007578948512673378
ascertainment O 1 0.9999998807907104
bias O 0 0.24778404831886292
and O 0 0.007748883217573166
suggest O 0 0.006858182139694691
that O 0 0.00347236474044621
a O 0 0.005433863028883934
substantial O 0 0.008543652482330799
burden O 0 0.06305188685655594
of O 0 0.015970738604664803
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.9998798370361328
disease I-Disease 1 1.0
remains O 0 0.16506977379322052
to O 0 0.006945199333131313
be O 0 0.007314911112189293
uncovered O 0 0.026350580155849457
. O 0 0.013743980787694454
. O 0 0.022624526172876358

The O 0 0.031940609216690063
chromosomal O 0 0.031103763729333878
order O 0 0.011427552439272404
of O 0 0.009069359861314297
genes O 0 0.009951891377568245
controlling O 0 0.013303129002451897
the O 0 0.00965835154056549
major O 1 0.839540421962738
histocompatibility O 1 1.0
complex O 0 0.08617653697729111
, O 0 0.012259415350854397
properdin O 1 0.9999229907989502
factor O 1 0.6664745211601257
B O 1 0.9998979568481445
, O 0 0.010213743895292282
and O 0 0.010754539631307125
deficiency B-Disease 1 1.0
of I-Disease 0 0.00903761014342308
the I-Disease 0 0.009706688113510609
second I-Disease 0 0.02398623712360859
component I-Disease 0 0.041358355432748795
of I-Disease 0 0.017538808286190033
complement I-Disease 0 0.045796334743499756
. O 0 0.028466902673244476

The O 0 0.02186073176562786
relationship O 0 0.012829551473259926
of O 0 0.007638189010322094
the O 0 0.00906308926641941
genes O 0 0.01030529011040926
coding O 0 0.017888914793729782
for O 0 0.010313345119357109
HLA O 1 0.9999978542327881
to O 0 0.007778537459671497
those O 0 0.0052885934710502625
coding O 0 0.012545617297291756
for O 0 0.008387288078665733
properdin O 1 0.9994113445281982
Factor O 1 0.7049793004989624
B O 1 0.998618483543396
allotypes O 1 0.8102046847343445
and O 0 0.010032926686108112
for O 0 0.010661710985004902
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.008296363987028599
the I-Disease 0 0.007816080935299397
second I-Disease 0 0.01111067645251751
component I-Disease 0 0.017385175451636314
of I-Disease 0 0.009266634471714497
complement I-Disease 0 0.09007390588521957
( O 0 0.024787932634353638
C2 O 1 1.0
) O 0 0.009676813147962093
was O 0 0.009435522370040417
studied O 0 0.0078021264635026455
in O 0 0.0042806691490113735
families O 0 0.004911363590508699
of O 0 0.005664493422955275
patients O 1 0.9999531507492065
with O 1 0.9963701963424683
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9998878240585327

Patients O 1 0.8918308019638062
were O 0 0.011575726792216301
selected O 0 0.014836031943559647
because O 0 0.006039363797754049
they O 0 0.0044674999080598354
were O 0 0.0053375158458948135
heterozygous O 0 0.014242650009691715
or O 0 0.008372856304049492
homozygous O 0 0.03575187548995018
for O 1 0.985852837562561
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9792145490646362

12 O 0 0.02817867137491703
families O 0 0.013202840462327003
with O 0 0.01058575976639986
15 O 0 0.01814103312790394
matings O 0 0.042364537715911865
informative O 0 0.03912073373794556
for O 0 0.4619826376438141
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.023034922778606415
found O 0 0.022776128724217415
. O 0 0.02793043665587902

Of O 0 0.03628479689359665
57 O 0 0.05287698283791542
informative O 0 0.048251207917928696
meioses O 1 0.5841819047927856
, O 0 0.011824321001768112
two O 0 0.006669319700449705
crossovers O 0 0.01675477996468544
were O 0 0.005203956738114357
noted O 0 0.007062487304210663
between O 0 0.0058815982192754745
the O 0 0.06060278043150902
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.023780135437846184
and O 0 0.007901114411652088
the O 0 0.058696944266557693
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999537467956543
gene O 0 0.011408282443881035
, O 0 0.006582770496606827
with O 0 0.00497490493580699
a O 0 0.009585575200617313
recombinant O 0 0.028251301497220993
fraction O 0 0.021684082224965096
of O 0 0.014500336721539497
0 O 0 0.038042910397052765
. O 0 0.030720099806785583

035 O 1 0.9930248260498047
. O 0 0.09711957722902298

A O 0 0.052179113030433655
lod O 1 0.8047873377799988
score O 0 0.0200954657047987
of O 0 0.01117192953824997
13 O 0 0.013011584058403969
was O 0 0.01053647045046091
calculated O 0 0.00892559066414833
for O 0 0.006259883753955364
linkage O 0 0.019370023161172867
between O 0 0.020271027460694313
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999996423721313
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999359846115112
at O 0 0.010812479071319103
a O 0 0.007389140781015158
maximum O 0 0.009765824303030968
likelihood O 0 0.0102699538692832
value O 0 0.007274951785802841
of O 0 0.00636897049844265
the O 0 0.008695291355252266
recombinant O 0 0.02807350642979145
fraction O 0 0.023479314520955086
of O 0 0.017447177320718765
0 O 0 0.035317957401275635
. O 0 0.03038732521235943

04 O 1 0.9968773126602173
. O 0 0.08729919791221619

18 O 0 0.03530130535364151
families O 0 0.0188017338514328
with O 0 0.011880903504788876
21 O 0 0.01928502880036831
informative O 0 0.03022873029112816
matings O 0 0.029937902465462685
for O 0 0.008836372755467892
both O 0 0.010068163275718689
properdin O 1 0.936344563961029
Factor O 0 0.050867605954408646
B O 1 0.9956940412521362
allotype O 1 0.9938066005706787
and O 0 0.03301198408007622
HLA O 1 1.0
- O 1 0.9999997615814209
B O 1 0.9975259900093079
were O 0 0.016409680247306824
found O 0 0.018771156668663025
. O 0 0.026692526414990425

Of O 0 0.03840336576104164
72 O 0 0.05581515654921532
informative O 0 0.05365285277366638
meioses O 1 0.7724675536155701
, O 0 0.012241926975548267
three O 0 0.008548209443688393
recombinants O 1 0.8024286031723022
were O 0 0.006064964924007654
found O 0 0.005752495490014553
, O 0 0.006702647544443607
giving O 0 0.008146610110998154
a O 0 0.01160496287047863
recombinant O 0 0.03157680854201317
fraction O 0 0.024363026022911072
of O 0 0.016911575570702553
0 O 0 0.03769237920641899
. O 0 0.029401445761322975

042 O 1 0.9735227227210999
. O 0 0.0878935381770134

A O 0 0.04532305523753166
lod O 0 0.15458671748638153
score O 0 0.01576918177306652
of O 0 0.00828850083053112
16 O 0 0.013364878483116627
between O 0 0.012316965498030186
HLA O 1 1.0
- O 1 0.9999998807907104
B O 1 0.9999467134475708
and O 0 0.011456170119345188
Factor O 0 0.19151300191879272
B O 1 0.9994945526123047
allotypes O 1 0.7896162271499634
was O 0 0.012892249040305614
calculated O 0 0.010590455494821072
at O 0 0.008154693990945816
a O 0 0.007450558710843325
maximum O 0 0.010912425816059113
likelihood O 0 0.011292215436697006
value O 0 0.007503950968384743
of O 0 0.006860323250293732
the O 0 0.010640396736562252
recombinant O 0 0.0352795273065567
fraction O 0 0.023749815300107002
of O 0 0.018228380009531975
0 O 0 0.03918040543794632
. O 0 0.034587159752845764

04 O 1 0.9984694123268127
. O 0 0.08506351709365845

A O 0 0.03898485749959946
crossover O 0 0.04353270307183266
was O 0 0.015867698937654495
shown O 0 0.008276758715510368
to O 0 0.005735448561608791
have O 0 0.003999440465122461
occurred O 0 0.0070641967467963696
between O 0 0.004389516077935696
genes O 0 0.005170898977667093
for O 0 0.005759339779615402
Factor O 0 0.01587837189435959
B O 1 0.9899837970733643
and O 0 0.013271688483655453
HLA O 1 1.0
- O 1 0.9999998807907104
D O 1 0.999455988407135
, O 0 0.007878703996539116
in O 0 0.0072589414194226265
which O 0 0.009425136260688305
HLA O 1 1.0
- O 1 0.9999988079071045
D O 1 0.9999825954437256
segregared O 1 0.9862601161003113
with O 0 0.01590077206492424
HLA O 1 1.0
- O 1 0.9999918937683105
A O 0 0.12919899821281433
and O 0 0.021522480994462967
B O 1 0.9949306845664978
. O 0 0.03202896565198898

These O 0 0.01572321727871895
studies O 0 0.012565539218485355
suggest O 0 0.008377347141504288
that O 0 0.00364908529445529
the O 0 0.00581559119746089
genes O 0 0.006231651641428471
for O 0 0.0063070328906178474
Factor O 0 0.21152256429195404
B O 1 0.9999986886978149
and O 1 0.996896505355835
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00562209403142333
located O 0 0.00823285710066557
outside O 0 0.0055721779353916645
those O 0 0.0039068288169801235
for O 0 0.007207825779914856
HLA O 1 1.0
, O 0 0.0068472037091851234
that O 0 0.0033342568203806877
the O 0 0.004515098873525858
order O 0 0.005344212055206299
of O 0 0.006173618137836456
genese O 1 0.9993784427642822
is O 0 0.012972468510270119
HLA O 1 1.0
- O 1 0.9994438290596008
A O 0 0.014271478168666363
, O 0 0.010908766649663448
- O 1 0.9968940019607544
B O 1 0.8638229370117188
, O 0 0.01230732910335064
- O 1 0.9986022114753723
D O 1 0.997945249080658
, O 0 0.011354576796293259
Factor O 0 0.022442644461989403
B O 1 0.9995562434196472
allotype O 1 0.999981164932251
, O 1 0.9990259408950806
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.009591964073479176
that O 0 0.0049498435109853745
the O 0 0.006254119332879782
genes O 0 0.009031753055751324
coding O 0 0.022108010947704315
for O 0 0.048689037561416626
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9086710810661316
Factor O 1 0.9995146989822388
B O 1 0.9998418092727661
allotypes O 0 0.03863849863409996
are O 0 0.004563233815133572
approximately O 0 0.008150005713105202
3 O 0 0.013598929159343243
- O 1 0.966359555721283
- O 0 0.3765594959259033
5 O 0 0.013606551103293896
centimorgans O 0 0.02599957399070263
from O 0 0.008439009077847004
the O 0 0.012365450151264668
HLA O 1 1.0
- O 1 0.9798325300216675
A O 0 0.016325511038303375
and O 0 0.019078006967902184
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999713897705078
loci O 0 0.0192565880715847
, O 0 0.007044706493616104
and O 0 0.004187792539596558
that O 0 0.0032789907418191433
the O 0 0.005226790904998779
apparent O 0 0.009915940463542938
lack O 0 0.008344336412847042
of O 0 0.007832220755517483
recombinants O 1 0.932348370552063
between O 0 0.0064500607550144196
the O 0 0.0073274485766887665
Factor O 0 0.022841742262244225
B O 1 0.997028648853302
gene O 0 0.01424025185406208
and O 1 0.6807259321212769
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.13524273037910461
suggests O 0 0.007891185581684113
that O 0 0.003374398685991764
these O 0 0.0027738092467188835
two O 0 0.003616010071709752
genes O 0 0.00604982441291213
lie O 0 0.007784498855471611
in O 0 0.004640601109713316
close O 0 0.007099405396729708
proximity O 0 0.010205528698861599
to O 0 0.007187027484178543
one O 0 0.009153299033641815
another O 0 0.017081914469599724
. O 0 0.025127898901700974

Distribution O 0 0.029494812712073326
of O 0 0.018318189308047295
emerin O 1 0.9573075175285339
and O 0 0.016140425577759743
lamins O 1 0.9925909042358398
in O 0 0.01017945446074009
the O 0 0.010834923014044762
heart O 1 0.9990148544311523
and O 0 0.007046635262668133
implications O 0 0.01674659550189972
for O 0 0.013497375883162022
Emery B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8629823923110962

Emerin O 1 0.9703360795974731
is O 0 0.016788344830274582
a O 0 0.013989096507430077
nuclear O 0 0.02256021276116371
membrane O 0 0.031221330165863037
protein O 0 0.012499159201979637
which O 0 0.005243232473731041
is O 0 0.005950516555458307
missing O 0 0.009836026467382908
or O 0 0.007619738113135099
defective O 1 0.6362135410308838
in O 0 0.01316961832344532
Emery B-Disease 1 0.9999991655349731
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999992847442627
EDMD B-Disease 1 1.0
) O 0 0.041258275508880615
. O 0 0.041451312601566315

It O 0 0.016577359288930893
is O 0 0.00965623464435339
one O 0 0.006674110423773527
member O 0 0.007229354232549667
of O 0 0.004964679945260286
a O 0 0.0068490589037537575
family O 0 0.009694834239780903
of O 0 0.013529348187148571
lamina O 1 1.0
- O 1 0.9999995231628418
associated O 0 0.013505720533430576
proteins O 0 0.010477032512426376
which O 0 0.006735316943377256
includes O 0 0.013742785900831223
LAP1 O 1 0.9922534823417664
, O 0 0.015492932870984077
LAP2 O 1 0.9999145269393921
and O 0 0.02256450615823269
lamin O 1 0.9999997615814209
B O 1 0.9999994039535522
receptor O 1 0.8649600148200989
( O 0 0.03923589736223221
LBR O 1 0.9999983310699463
) O 0 0.03851108253002167
. O 0 0.045794084668159485

A O 0 0.03136859089136124
panel O 0 0.02887980453670025
of O 0 0.014515266753733158
16 O 0 0.023263290524482727
monoclonal O 1 0.9769147634506226
antibodies O 1 0.9572516679763794
( O 0 0.02972441352903843
mAbs O 1 0.9998633861541748
) O 0 0.011287818662822247
has O 0 0.007316981442272663
been O 0 0.005239003803580999
mapped O 0 0.009996672160923481
to O 0 0.00411656079813838
six O 0 0.004777044989168644
specific O 0 0.004029621370136738
sites O 0 0.005057360976934433
throughout O 0 0.005120338872075081
the O 0 0.007509130984544754
emerin O 0 0.17737828195095062
molecule O 0 0.01795319654047489
using O 0 0.01133734267205
phage O 1 0.9947391152381897
- O 1 0.973874568939209
displayed O 0 0.02206551656126976
peptide O 0 0.021976355463266373
libraries O 0 0.011795715428888798
and O 0 0.006044258829206228
has O 0 0.004998668562620878
been O 0 0.0041420720517635345
used O 0 0.004652662202715874
to O 0 0.0073604099452495575
localize O 1 0.6119709610939026
emerin O 1 0.9163126945495605
in O 0 0.009031607769429684
human O 0 0.010587397962808609
and O 0 0.020731447264552116
rabbit O 1 0.999998927116394
heart O 1 0.9999991655349731
. O 0 0.03923828527331352

Several O 0 0.035242218524217606
mAbs O 0 0.12045447528362274
against O 0 0.0190325565636158
different O 0 0.010911225341260433
emerin O 1 0.9888074994087219
epitopes O 0 0.4552680253982544
did O 0 0.011381158605217934
not O 0 0.006376135163009167
recognize O 0 0.01565488800406456
intercalated O 1 0.995788037776947
discs O 0 0.027298245579004288
in O 0 0.008815182372927666
the O 0 0.010955494828522205
heart O 1 0.9999439716339111
, O 0 0.006817417219281197
though O 0 0.0050331298261880875
they O 0 0.004076710902154446
recognized O 0 0.01108568161725998
cardiomyocyte O 1 0.9881369471549988
nuclei O 0 0.01774062030017376
strongly O 0 0.009749049320816994
, O 0 0.00541739771142602
both O 0 0.004246748052537441
at O 0 0.006724371109157801
the O 0 0.007600448094308376
rim O 0 0.47614380717277527
and O 0 0.00764663377776742
in O 0 0.00973080936819315
intranuclear O 1 0.9994925260543823
spots O 0 0.029420653358101845
or O 0 0.0150216119363904
channels O 0 0.02225506864488125
. O 0 0.028179511427879333

A O 0 0.07165908068418503
polyclonal O 1 0.995402455329895
rabbit O 1 0.9837802052497864
antiserum O 1 0.9959818124771118
against O 0 0.026729272678494453
emerin O 1 0.9986292123794556
did O 0 0.011434266343712807
recognize O 0 0.012340225279331207
both O 0 0.007902998477220535
nuclear O 0 0.017705289646983147
membrane O 0 0.026176150888204575
and O 0 0.011313839815557003
intercalated O 1 0.9999834299087524
discs O 0 0.25453418493270874
but O 0 0.008825412951409817
, O 0 0.007515957113355398
after O 0 0.010004999116063118
affinity O 0 0.013844318687915802
purification O 0 0.030042873695492744
against O 0 0.009636919014155865
a O 0 0.011216973885893822
pure O 1 0.5280435085296631
- O 1 0.9999916553497314
emerin O 1 0.9893297553062439
band O 0 0.013249900192022324
on O 0 0.006505151279270649
a O 0 0.007984533905982971
western O 0 0.01106169167906046
blot O 1 0.9818664193153381
, O 0 0.009064177051186562
it O 0 0.007591263856738806
stained O 1 0.9998199343681335
only O 0 0.007847616448998451
the O 0 0.0123791778460145
nuclear O 0 0.028815649449825287
membrane O 0 0.05318237096071243
. O 0 0.031324733048677444

These O 0 0.013622411526739597
results O 0 0.009476515464484692
would O 0 0.005816457327455282
not O 0 0.003689319361001253
be O 0 0.0034980387426912785
expected O 0 0.00621240446344018
if O 0 0.006578249856829643
immunostaining O 0 0.1346772313117981
at O 0 0.016952380537986755
intercalated O 1 0.9986423850059509
discs O 0 0.0276937372982502
were O 0 0.006272561848163605
due O 0 0.005751939956098795
to O 0 0.004898167680948973
a O 0 0.006054609082639217
product O 0 0.007679495960474014
of O 0 0.005310789681971073
the O 0 0.007354098837822676
emerin O 1 0.9997217059135437
gene O 0 0.009381713345646858
and O 0 0.0062450929544866085
, O 0 0.005698932334780693
therefore O 0 0.0056300777941942215
, O 0 0.004826610442250967
cast O 0 0.005844217259436846
some O 0 0.003105730516836047
doubt O 0 0.006519993767142296
upon O 0 0.004619047045707703
the O 0 0.004727325867861509
hypothesis O 0 0.010380551218986511
that O 0 0.006448765750974417
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9971131086349487
EDMD B-Disease 1 1.0
are O 0 0.006284950766712427
caused O 0 0.010706184431910515
by O 0 0.006127991713583469
absence O 0 0.014035330154001713
of O 0 0.012753902934491634
emerin O 1 0.999880313873291
from O 0 0.021724114194512367
intercalated O 1 0.9998611211776733
discs O 0 0.32105162739753723
. O 0 0.04311751946806908

Although O 0 0.03216680511832237
emerin O 1 0.8737730383872986
was O 0 0.018239516764879227
abundant O 0 0.01423477940261364
in O 0 0.007121266797184944
the O 0 0.008747910149395466
membranes O 0 0.022421101108193398
of O 0 0.010782135650515556
cardiomyocyte O 1 0.9999921321868896
nuclei O 0 0.02188599668443203
, O 0 0.006793559994548559
it O 0 0.0050173732452094555
was O 0 0.00774787925183773
absent O 0 0.009004934690892696
from O 0 0.004229940008372068
many O 0 0.00459925876930356
non O 0 0.028139084577560425
- O 1 0.9999961853027344
myocyte O 1 0.9999955892562866
cells O 0 0.016927970573306084
in O 0 0.011702567338943481
the O 0 0.019116738811135292
heart O 1 0.9991773962974548
. O 0 0.034931447356939316

This O 0 0.0179978609085083
distribution O 0 0.014699826948344707
of O 0 0.012365001253783703
emerin O 1 0.9865180850028992
was O 0 0.011998596601188183
similar O 0 0.005841735750436783
to O 0 0.004681462422013283
that O 0 0.0044396729208528996
of O 0 0.007256084121763706
lamin O 1 0.99960857629776
A O 0 0.013903222046792507
, O 0 0.0067606959491968155
a O 0 0.006218492519110441
candidate O 0 0.01033944170922041
gene O 0 0.008143852464854717
for O 0 0.005151061341166496
an O 0 0.00914632249623537
autosomal O 1 0.9225825071334839
form O 0 0.014049512334167957
of O 0 0.04747109115123749
EDMD B-Disease 1 1.0
. O 0 0.0468464232981205

In O 0 0.030759720131754875
contrast O 0 0.033518899232149124
, O 0 0.02858416922390461
lamin O 1 0.9999984502792358
B1 O 1 1.0
was O 0 0.04107888787984848
absent O 0 0.027925461530685425
from O 0 0.014712153933942318
cardiomyocyte O 1 0.989534318447113
nuclei O 0 0.026100877672433853
, O 0 0.01191031839698553
showing O 0 0.014311696402728558
that O 0 0.010245796293020248
lamin O 1 0.9999997615814209
B1 O 1 1.0
is O 0 0.008637560531497002
not O 0 0.0057599893771111965
essential O 0 0.00994841568171978
for O 0 0.006790561601519585
localization O 0 0.020078415051102638
of O 0 0.010138227604329586
emerin O 1 0.9103454947471619
to O 0 0.011318481527268887
the O 0 0.016211790964007378
nuclear O 0 0.03872203081846237
lamina O 1 0.9999688863754272
. O 0 0.047416314482688904

Lamin O 1 0.9999998807907104
B1 O 1 1.0
is O 0 0.01603725738823414
also O 0 0.009666097350418568
almost O 0 0.008771294727921486
completely O 0 0.013971520587801933
absent O 0 0.026036294177174568
from O 0 0.019081125035881996
skeletal O 1 0.9999998807907104
muscle O 1 0.9999994039535522
nuclei O 1 0.771494448184967
. O 0 0.04227058216929436

In O 0 0.03639970347285271
EDMD B-Disease 1 0.9999879598617554
, O 0 0.01300920732319355
the O 0 0.007934990338981152
additional O 0 0.010647275485098362
absence O 0 0.01623913086950779
of O 0 0.014969082549214363
lamin O 1 0.9999998807907104
B1 O 1 1.0
from O 0 0.06013137474656105
heart O 1 0.9999997615814209
and O 1 0.6484102606773376
skeletal O 1 1.0
muscle O 1 0.9999986886978149
nuclei O 0 0.0801023542881012
which O 0 0.007347144652158022
already O 0 0.010091619566082954
lack O 0 0.020305773243308067
emerin O 1 0.9999614953994751
may O 0 0.006289818789809942
offer O 0 0.0070121269673109055
an O 0 0.004979599267244339
alternative O 0 0.007427398581057787
explanation O 0 0.007560270838439465
of O 0 0.005452986806631088
why O 0 0.007485663518309593
these O 0 0.005550737958401442
tissues O 0 0.08268315345048904
are O 0 0.00420849584043026
particularly O 0 0.010732448659837246
affected O 0 0.015770122408866882
. O 0 0.015971709042787552
. O 0 0.02848915196955204

Genetic O 0 0.03504316881299019
mapping O 0 0.03155001252889633
of O 0 0.014842105098068714
the O 0 0.020071543753147125
copper B-Disease 1 0.9999544620513916
toxicosis I-Disease 1 0.9999982118606567
locus O 1 0.9320796728134155
in O 0 0.021590564399957657
Bedlington O 1 0.999699592590332
terriers O 0 0.17338179051876068
to O 0 0.014367458410561085
dog O 0 0.027243638411164284
chromosome O 0 0.015470430254936218
10 O 0 0.009164854884147644
, O 0 0.0064095184206962585
in O 0 0.005172692704945803
a O 0 0.007804102264344692
region O 0 0.009856932796537876
syntenic O 1 0.579762876033783
to O 0 0.007361129857599735
human O 0 0.010231290943920612
chromosome O 0 0.022552233189344406
region O 0 0.024546710774302483
2p13 O 1 0.9999837875366211
- O 1 0.9999964237213135
p16 O 1 0.9893190264701843
. O 0 0.04816815257072449

Abnormal O 1 0.9999675750732422
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999985694885254
accumulation I-Disease 1 0.9916449189186096
is O 0 0.00936693511903286
recognized O 0 0.00881111714988947
as O 0 0.006511597894132137
an O 0 0.013675423339009285
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9723437428474426
man O 1 0.9999405145645142
, O 0 0.2369282990694046
mouse O 1 0.9955288767814636
, O 0 0.014939287677407265
rat O 1 0.9992697834968567
and O 0 0.01768849417567253
dog O 0 0.10979847609996796
. O 0 0.027362940832972527

The O 0 0.02623843401670456
major O 0 0.023423893377184868
cause O 0 0.13634632527828217
of O 1 0.6059231758117676
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.999955415725708
in O 0 0.010231115855276585
man O 0 0.013562849722802639
is O 0 0.006419072858989239
a O 0 0.008389964699745178
dysfunctional O 1 0.9128366112709045
ATP7B O 1 0.9999984502792358
gene O 0 0.011377030983567238
, O 0 0.008774836547672749
causing O 1 0.9944363832473755
Wilson B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 1 0.9999854564666748
WD B-Disease 1 1.0
) O 0 0.038015734404325485
. O 0 0.03784903883934021

Mutations O 0 0.03197340667247772
in O 0 0.012139000929892063
the O 0 0.013338043354451656
ATP7B O 1 0.9999781847000122
genes O 0 0.010679108090698719
have O 0 0.004688924644142389
also O 0 0.005618666764348745
been O 0 0.006016282364726067
demonstrated O 0 0.010246459394693375
in O 0 0.010328981094062328
mouse O 1 0.5118309855461121
and O 0 0.020612414926290512
rat O 1 0.9946422576904297
. O 0 0.03759719431400299

The O 0 0.040854211896657944
ATP7B O 1 0.9999462366104126
gene O 0 0.019443297758698463
has O 0 0.009520664811134338
been O 0 0.006485048681497574
excluded O 0 0.010008982382714748
in O 0 0.00481537077575922
the O 0 0.005455436185002327
much O 0 0.007040318567305803
rarer O 1 0.9342907667160034
human O 0 0.016812337562441826
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9999909400939941
- I-Disease 1 0.9999998807907104
Indian I-Disease 1 0.9313291907310486
childhood I-Disease 1 0.9999996423721313
cirrhosis I-Disease 1 1.0
, O 0 0.021894272416830063
indicating O 0 0.028026998043060303
genetic O 0 0.028657760471105576
heterogeneity O 0 0.3539637625217438
. O 0 0.03906383365392685

By O 0 0.01972290873527527
investigating O 0 0.022378752008080482
the O 0 0.013344389386475086
common O 0 0.015776563435792923
autosomal O 1 0.999993085861206
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9996175765991211
CT B-Disease 1 1.0
) O 0 0.0127128716558218
in O 0 0.011919570155441761
Bedlington O 1 0.9999638795852661
terriers O 1 0.713316023349762
, O 0 0.00859756488353014
we O 0 0.004885358735918999
have O 0 0.0032945494167506695
identified O 0 0.00469157425686717
a O 0 0.0045579830184578896
new O 0 0.0071935527957975864
locus O 0 0.022094372659921646
involved O 0 0.008189111016690731
in O 0 0.01812843792140484
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9960812926292419

We O 0 0.016546081751585007
examined O 0 0.02151038497686386
whether O 0 0.011173172853887081
the O 0 0.016272200271487236
WD B-Disease 1 0.9999998807907104
gene O 0 0.0310192983597517
ATP7B O 1 0.9999886751174927
was O 0 0.020772190764546394
also O 0 0.011211537756025791
causative O 0 0.029016561806201935
for O 0 0.0100156981498003
CT B-Disease 1 0.9983505010604858
by O 0 0.006217496935278177
investigating O 0 0.010195344686508179
the O 0 0.009298966266214848
chromosomal O 1 0.5276640057563782
co O 1 0.9955440163612366
- O 1 0.9998736381530762
localization O 0 0.040403928607702255
of O 0 0.015168064273893833
ATP7B O 1 0.9999910593032837
and O 0 0.0137415062636137
C04107 O 1 0.7514572739601135
, O 0 0.009357692673802376
using O 0 0.007376173045486212
fluorescence O 0 0.020652825012803078
in O 0 0.012629158794879913
situ O 0 0.1432713270187378
hybridization O 0 0.0323789156973362
( O 0 0.02170523628592491
FISH O 0 0.03326866403222084
) O 0 0.024820655584335327
. O 0 0.031754862517118454

C04107 O 1 0.7468354105949402
is O 0 0.01659083552658558
an O 0 0.012755775824189186
anonymous O 0 0.025025228038430214
microsatellite O 1 0.9736906886100769
marker O 0 0.18271683156490326
closely O 0 0.018916867673397064
linked O 0 0.023702170699834824
to O 0 0.021887749433517456
CT B-Disease 1 0.9999722242355347
. O 0 0.039830200374126434

However O 0 0.037540141493082047
, O 0 0.03655880689620972
BAC O 1 0.9985338449478149
clones O 0 0.1252257376909256
containing O 0 0.0404709056019783
ATP7B O 1 0.9990761280059814
and O 0 0.01787286065518856
C04107 O 0 0.1722564697265625
mapped O 0 0.024269988760352135
to O 0 0.009728902950882912
the O 0 0.01124530378729105
canine O 1 0.9882968068122864
chromosome O 0 0.020275168120861053
regions O 0 0.011898762546479702
CFA22q11 O 1 0.9998996257781982
and O 0 0.010872908867895603
CFA10q26 O 1 0.9999830722808838
, O 0 0.008901753462851048
respectively O 0 0.008050460368394852
, O 0 0.0064813075587153435
demonstrating O 0 0.011702589690685272
that O 0 0.007184034679085016
WD B-Disease 1 0.9999991655349731
cannot O 0 0.011002674698829651
be O 0 0.00920508150011301
homologous O 0 0.02410195581614971
to O 0 0.019772198051214218
CT B-Disease 1 0.9999121427536011
. O 0 0.04090486466884613

The O 0 0.042132388800382614
copper O 1 0.717806339263916
transport O 0 0.039443910121917725
genes O 0 0.026361502707004547
CTR1 O 1 0.9999263286590576
and O 0 0.017272992059588432
CTR2 O 1 0.9996665716171265
were O 0 0.008912419900298119
also O 0 0.007874984294176102
excluded O 0 0.012191974557936192
as O 0 0.0066545926965773106
candidate O 0 0.012204153463244438
genes O 0 0.007646666374057531
for O 0 0.007834244519472122
CT B-Disease 1 0.9999833106994629
since O 0 0.007165880873799324
they O 0 0.00446186400949955
both O 0 0.005929309409111738
mapped O 0 0.018711410462856293
to O 0 0.012669172137975693
canine O 1 0.9983068704605103
chromosome O 0 0.035432927310466766
region O 0 0.03286333009600639
CFA11q22 O 1 0.9998959302902222
. O 0 0.03988523781299591

2 O 0 0.07858745753765106
- O 1 0.8819659948348999
22 O 0 0.06331165879964828
. O 0 0.04772334545850754

5 O 0 0.09387481957674026
. O 0 0.07085379958152771

A O 0 0.044203020632267
transcribed O 0 0.030507385730743408
sequence O 0 0.012954973615705967
identified O 0 0.00853669922798872
from O 0 0.00581471947953105
the O 0 0.009224426932632923
C04107 O 1 0.9983848333358765
- O 1 0.9997542500495911
containing O 0 0.023393403738737106
BAC O 1 0.9999351501464844
was O 0 0.012074705213308334
found O 0 0.005155861843377352
to O 0 0.005116660613566637
be O 0 0.00422643544152379
homologous O 0 0.008711293339729309
to O 0 0.004183769691735506
a O 0 0.006649157498031855
gene O 0 0.006601778324693441
expressed O 0 0.006083529908210039
from O 0 0.004834284540265799
human O 0 0.008129236288368702
chromosome O 0 0.02857072651386261
2p13 O 1 0.9999746084213257
- O 1 0.9999967813491821
p16 O 1 0.981480062007904
, O 0 0.009261894039809704
a O 0 0.0099160335958004
region O 0 0.013458077795803547
devoid O 0 0.021798795089125633
of O 0 0.00934691820293665
any O 0 0.011735676787793636
positional O 0 0.11577171832323074
candidate O 0 0.034134041517972946
genes O 0 0.029710980132222176
. O 0 0.02924797683954239

Molecular O 0 0.03573906794190407
analysis O 0 0.014424832537770271
of O 0 0.011543428525328636
the O 0 0.014953377656638622
APC B-Disease 1 0.9999165534973145
gene O 0 0.013459275476634502
in O 0 0.009049412794411182
205 O 0 0.02849249728024006
families O 0 0.009472792036831379
: O 0 0.010512248612940311
extended O 0 0.018631406128406525
genotype O 0 0.49619460105895996
- O 1 0.9985982775688171
phenotype O 0 0.063486248254776
correlations O 0 0.02211933583021164
in O 0 0.01274979766458273
FAP B-Disease 1 0.9999998807907104
and O 0 0.0079124104231596
evidence O 0 0.0056938002817332745
for O 0 0.004397663287818432
the O 0 0.005438397638499737
role O 0 0.007999027147889137
of O 0 0.010046087205410004
APC B-Disease 1 0.9999988079071045
amino O 0 0.016277600079774857
acid O 0 0.019434109330177307
changes O 0 0.01030315924435854
in O 0 0.3415567874908447
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.5561138987541199

BACKGROUND O 0 0.06894970685243607
/ O 0 0.38137832283973694
AIMS O 0 0.030329309403896332
The O 0 0.010526681318879128
development O 0 0.014158009551465511
of O 1 0.9891660809516907
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.041672319173812866
a O 0 0.00949571467936039
variable O 0 0.011159305460751057
range O 0 0.008492853492498398
of O 0 0.007903394289314747
extracolonic O 1 0.9521024227142334
manifestations O 1 0.6539595127105713
in O 0 0.021935606375336647
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.01606830209493637
is O 0 0.007513126358389854
the O 0 0.0060629709623754025
result O 0 0.005032005254179239
of O 0 0.0048552281223237514
the O 0 0.006665074732154608
dominant O 0 0.021390391513705254
inheritance O 0 0.07890699803829193
of O 1 0.8264310956001282
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.999993085861206
APC B-Disease 1 1.0
) O 0 0.028416726738214493
gene O 0 0.02753896266222
mutations O 0 0.028469132259488106
. O 0 0.02680635266005993

In O 0 0.018135543912649155
this O 0 0.008537999354302883
study O 0 0.010605224408209324
, O 0 0.007197112776339054
direct O 0 0.006741839926689863
mutation O 0 0.0077433339320123196
analysis O 0 0.004904753528535366
of O 0 0.0060362485237419605
the O 0 0.008736121468245983
APC B-Disease 1 0.9999994039535522
gene O 0 0.01144556887447834
was O 0 0.009279574267566204
performed O 0 0.008431870490312576
to O 0 0.0064917742274701595
determine O 0 0.01021043211221695
genotype O 0 0.19967786967754364
- O 1 0.998688280582428
phenotype O 0 0.03384081646800041
correlations O 0 0.018102576956152916
for O 0 0.008222655393183231
nine O 0 0.01570235937833786
extracolonic O 1 0.999692440032959
manifestations O 1 0.5389509797096252
and O 0 0.00720712635666132
to O 0 0.006130228750407696
investigate O 0 0.012422180734574795
the O 0 0.008944435976445675
incidence O 1 0.8068708181381226
of O 0 0.011588739231228828
APC B-Disease 1 0.9999985694885254
mutations O 0 0.012878991663455963
in O 0 0.010211106389760971
non O 1 0.9996147155761719
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7592797875404358

METHODS O 0 0.04054655134677887
The O 0 0.02650073729455471
APC B-Disease 1 0.999972939491272
gene O 0 0.01876920647919178
was O 0 0.01692304201424122
analysed O 0 0.021723225712776184
in O 0 0.01103453803807497
190 O 0 0.03220183029770851
unrelated O 0 0.02424362488090992
FAP B-Disease 1 0.9999902248382568
and O 0 0.01017908938229084
15 O 0 0.01794959232211113
non O 1 0.9907622933387756
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999985694885254
using O 0 0.0222146175801754
denaturing O 1 0.9999783039093018
gradient O 1 0.9785230755805969
gel O 1 0.9999581575393677
electrophoresis O 0 0.35130658745765686
, O 0 0.012184624560177326
the O 0 0.010249240323901176
protein O 0 0.015239086002111435
truncation O 0 0.032480813562870026
test O 0 0.015348793007433414
, O 0 0.010921059176325798
and O 0 0.009475181810557842
direct O 0 0.015335474163293839
sequencing O 0 0.03043247014284134
. O 0 0.030161872506141663

RESULTS O 0 0.0538453683257103
Chain O 0 0.05196692422032356
terminating O 0 0.02906283736228943
signals O 0 0.013831180520355701
were O 0 0.005317423492670059
only O 0 0.004455954302102327
identified O 0 0.005388258956372738
in O 0 0.004971426445990801
patients O 0 0.09959261864423752
belonging O 0 0.00723554752767086
to O 0 0.005676436237990856
the O 0 0.010881290771067142
FAP B-Disease 1 1.0
group O 0 0.047770675271749496
( O 0 0.0166468508541584
105 O 1 0.549994707107544
patients O 1 0.9975874423980713
) O 0 0.021882951259613037
. O 0 0.03127238526940346

Amino O 0 0.04844612255692482
acid O 0 0.026685332879424095
changes O 0 0.009007586166262627
were O 0 0.005358927883207798
identified O 0 0.006147885695099831
in O 0 0.004447036422789097
four O 0 0.006979558616876602
patients O 0 0.41560328006744385
, O 0 0.004192587453871965
three O 0 0.004184437450021505
of O 0 0.005083754193037748
whom O 0 0.0068820626474916935
belonged O 0 0.009056000038981438
to O 0 0.004088031128048897
the O 0 0.006017475388944149
non O 0 0.07928265631198883
- O 1 0.9999990463256836
FAP O 1 1.0
group O 0 0.2691775858402252
of O 1 0.9999003410339355
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.5571935772895813

Genotype O 1 0.9984973669052124
- O 1 0.9999624490737915
phenotype O 1 0.7525650262832642
correlations O 0 0.02815365232527256
identified O 0 0.011048928834497929
significant O 0 0.007637351285666227
differences O 0 0.00686288345605135
in O 0 0.005182131193578243
the O 0 0.005112191662192345
nature O 0 0.00684033939614892
of O 0 0.0062376051209867
certain O 0 0.008115553297102451
extracolonic O 1 0.999980092048645
manifestations O 1 0.9995965361595154
in O 1 0.650955855846405
FAP B-Disease 1 1.0
patients O 1 0.9999439716339111
belonging O 0 0.019944332540035248
to O 0 0.011469094082713127
three O 0 0.01592176780104637
mutation O 0 0.03258524835109711
subgroups O 0 0.04850897192955017
. O 0 0.033870160579681396

CONCLUSIONS O 0 0.05124673992395401
Extended O 0 0.04669974744319916
genotype O 1 0.9010171294212341
- O 1 0.9999196529388428
phenotype O 0 0.3999311923980713
correlations O 0 0.020770924165844917
made O 0 0.009356933645904064
in O 0 0.00596527149900794
this O 0 0.004294964950531721
study O 0 0.005896265152841806
may O 0 0.004738408140838146
have O 0 0.002959722653031349
the O 0 0.004603089764714241
potential O 0 0.006210720632225275
to O 0 0.004186376463621855
determine O 0 0.004528808407485485
the O 0 0.004076451528817415
most O 0 0.004064181353896856
appropriate O 0 0.006404209416359663
surveillance O 0 0.012380625121295452
and O 0 0.007907276973128319
prophylactic O 1 0.9999986886978149
treatment O 1 0.9999988079071045
regimens O 1 0.9999991655349731
for O 0 0.007167231757193804
those O 0 0.005541333928704262
patients O 1 0.8335012793540955
with O 0 0.005358213558793068
mutations O 0 0.008195406757295132
associated O 0 0.006775489542633295
with O 0 0.006947672925889492
life O 1 0.5351366996765137
threatening O 1 0.9961349964141846
conditions O 0 0.4755401313304901
. O 0 0.028441479429602623

This O 0 0.017147978767752647
study O 0 0.012000201269984245
also O 0 0.007986857555806637
provided O 0 0.008803599514067173
evidence O 0 0.005411599762737751
for O 0 0.004656789358705282
the O 0 0.007274558302015066
pathological O 0 0.0272525604814291
nature O 0 0.010425371117889881
of O 0 0.010558576323091984
amino O 0 0.013888350687921047
acid O 0 0.015985846519470215
changes O 0 0.00707604642957449
in O 0 0.007847939617931843
APC O 1 0.9996378421783447
associated O 0 0.007477292791008949
with O 0 0.005102008581161499
both O 0 0.006195531692355871
FAP B-Disease 1 0.9999998807907104
and O 0 0.012838122434914112
non O 1 0.999925971031189
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.11110461503267288
. O 0 0.030091797932982445

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999971389770508
cancer B-Disease 1 1.0
risk O 1 0.9999799728393555
of O 0 0.3594054579734802
the O 1 0.9583069682121277
APC O 1 1.0
I1307K O 1 0.9999850988388062
polymorphism O 0 0.1594126969575882
. O 0 0.04836704954504967

Germ O 1 0.9999990463256836
- O 1 0.9997424483299255
line O 0 0.03155875578522682
and O 0 0.01705424301326275
somatic O 0 0.04116828367114067
truncating O 0 0.05433810129761696
mutations O 0 0.015080240555107594
of O 0 0.008961115032434464
the O 0 0.012351086363196373
APC B-Disease 1 0.9999983310699463
gene O 0 0.009948162361979485
are O 0 0.003318178001791239
thought O 0 0.006025848910212517
to O 0 0.007398334331810474
initiate O 1 0.8049910664558411
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.7705252170562744
in O 0 0.44699954986572266
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 1.0
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9443782567977905
respectively O 0 0.04397639259696007
. O 0 0.03647715225815773

Recently O 0 0.0449526384472847
, O 0 0.017089953646063805
an O 0 0.016412382945418358
isoleucine O 1 0.9999970197677612
- O 1 0.9999997615814209
- O 1 0.999990701675415
> O 1 0.9365926384925842
lysine O 0 0.051157135516405106
polymorphism O 0 0.03575392812490463
at O 0 0.019332850351929665
codon O 0 0.040533024817705154
1307 O 1 0.9864029288291931
( O 0 0.01925661414861679
I1307K O 0 0.0703403502702713
) O 0 0.009649861603975296
of O 0 0.008850653655827045
the O 0 0.012099677696824074
APC B-Disease 1 0.99997878074646
gene O 0 0.01040868740528822
has O 0 0.006223492324352264
been O 0 0.004907878581434488
identified O 0 0.005172449629753828
in O 0 0.004477269947528839
6 O 0 0.009315076284110546
% O 0 0.006851777900010347
- O 0 0.22305715084075928
7 O 0 0.011703241616487503
% O 0 0.00625836756080389
of O 0 0.006101927254348993
the O 0 0.008473528549075127
Ashkenazi O 0 0.21829719841480255
Jewish O 0 0.018648577854037285
population O 0 0.0152679942548275
. O 0 0.027691850438714027

To O 0 0.019158869981765747
assess O 0 0.02679150179028511
the O 0 0.01273746881633997
risk O 0 0.011370131745934486
of O 0 0.006091293878853321
this O 0 0.005426603369414806
common O 0 0.009540118277072906
APC B-Disease 1 0.9999988079071045
allelic O 1 0.9999511241912842
variant O 1 0.9986830353736877
in O 1 0.9564554691314697
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.01231186743825674
we O 0 0.006386087276041508
have O 0 0.0053033786825835705
analyzed O 0 0.010018195025622845
a O 0 0.007878949865698814
large O 0 0.008760563097894192
cohort O 0 0.02821064367890358
of O 0 0.010110634379088879
unselected O 1 0.9978869557380676
Ashkenazi O 1 0.6547988057136536
Jewish O 0 0.014780107885599136
subjects O 0 0.01584845595061779
with O 0 0.012198342941701412
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999996423721313
and O 0 0.0322582870721817
. O 0 0.011630652472376823
or O 1 0.9970167875289917
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.3291966915130615
for O 0 0.01075281947851181
the O 0 0.02037953771650791
APC O 1 0.9999977350234985
I1307K O 1 0.9992020726203918
polymorphism O 0 0.07494369149208069
. O 0 0.03937007859349251

The O 0 0.05641312524676323
APC O 1 0.9998196959495544
I1307K O 1 0.9724379777908325
allele O 0 0.03952284902334213
was O 0 0.014744427055120468
identified O 0 0.008105878718197346
in O 0 0.005792305339127779
48 O 0 0.010601658374071121
( O 0 0.005836000666022301
10 O 0 0.006037475541234016
. O 0 0.004700278863310814
1 O 0 0.00922814104706049
% O 0 0.007142065092921257
) O 0 0.00889370497316122
of O 0 0.012788929045200348
476 O 1 0.999568521976471
patients O 1 0.999613344669342
. O 0 0.03427013382315636

Compared O 0 0.026284413412213326
with O 0 0.00937366858124733
the O 0 0.00838683545589447
frequency O 0 0.0068666026927530766
in O 0 0.004557441454380751
two O 0 0.003758272621780634
separate O 0 0.004081616178154945
population O 0 0.0032305694185197353
control O 0 0.005776009056717157
groups O 0 0.003379157977178693
, O 0 0.006028331350535154
the O 0 0.00958878081291914
APC O 1 0.9999998807907104
I1307K O 1 0.9999905824661255
allele O 0 0.02781158871948719
is O 0 0.007372183725237846
associated O 0 0.006609485484659672
with O 0 0.004532571882009506
an O 0 0.005788465030491352
estimated O 0 0.009729183278977871
relative O 0 0.01315990649163723
risk O 0 0.014837285503745079
of O 0 0.012477071955800056
1 O 0 0.02771368995308876
. O 0 0.02730848267674446

5 O 0 0.06977242231369019
- O 1 0.9963950514793396
1 O 0 0.04737043008208275
. O 0 0.043648939579725266

7 O 0 0.043295565992593765
for O 0 0.029167447239160538
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.01981142908334732
both O 0 0.017448771744966507
P O 1 0.9998407363891602
= O 1 0.6116365790367126
. O 0 0.019451336935162544
01 O 1 0.9999558925628662
) O 0 0.0276279728859663
. O 0 0.0340547189116478

Furthermore O 0 0.03698132559657097
, O 0 0.01421153824776411
compared O 0 0.012460109777748585
with O 0 0.010218989104032516
noncarriers O 1 0.9997184872627258
, O 0 0.019802965223789215
APC O 1 0.9999988079071045
I1307K O 1 0.999723494052887
carriers O 0 0.022519610822200775
had O 0 0.008977747522294521
increased O 0 0.007382732816040516
numbers O 0 0.0068597812205553055
of O 0 0.009811578318476677
adenomas B-Disease 1 0.9999992847442627
and O 1 0.9927500486373901
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.01678561419248581
patient O 1 0.999586284160614
( O 0 0.015661943703889847
P O 1 0.9996204376220703
= O 0 0.06080982834100723
. O 0 0.009342843666672707
03 O 1 0.9998360872268677
) O 0 0.007646731100976467
, O 0 0.0061025433242321014
as O 0 0.004349213559180498
well O 0 0.004240026697516441
as O 0 0.004703563638031483
a O 0 0.008022713474929333
younger O 0 0.017877399921417236
age O 0 0.015244183130562305
at O 0 0.022532830014824867
diagnosis O 1 0.99993896484375
. O 0 0.03126585856080055

We O 0 0.02052382379770279
conclude O 0 0.021907631307840347
that O 0 0.008046098053455353
the O 0 0.013815860264003277
APC O 1 0.9999061822891235
I1307K O 1 0.9991031885147095
variant O 0 0.03633616864681244
leads O 0 0.01664537563920021
to O 0 0.010090467520058155
increased O 0 0.041278138756752014
adenoma B-Disease 1 1.0
formation O 0 0.06639567017555237
and O 0 0.0077481684274971485
directly O 0 0.007391288410872221
contributes O 0 0.01046183705329895
to O 0 0.005384325049817562
3 O 0 0.009622739627957344
% O 0 0.0073127360083162785
- O 0 0.052967824041843414
4 O 0 0.009215869009494781
% O 0 0.0053184423595666885
of O 0 0.005075098946690559
all O 0 0.007655210327357054
Ashkenazi O 1 0.9983994364738464
Jewish O 1 0.9987027645111084
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8795642256736755

The O 0 0.02492474392056465
estimated O 0 0.01787281408905983
relative O 0 0.014974363148212433
risk O 0 0.012349446304142475
for O 0 0.0074053057469427586
carriers O 0 0.458038330078125
may O 0 0.006454600021243095
justify O 0 0.012119791470468044
specific O 0 0.006850337143987417
clinical O 1 0.9172684550285339
screening O 0 0.014275141060352325
for O 0 0.007328912615776062
the O 0 0.008242737501859665
360 O 0 0.024656176567077637
, O 0 0.01105846930295229
000 O 0 0.01944996602833271
Americans O 0 0.00967493001371622
expected O 0 0.009224793873727322
to O 0 0.007444975432008505
harbor O 0 0.018601559102535248
this O 0 0.006715614814311266
allele O 0 0.014982616528868675
, O 0 0.006548205390572548
and O 0 0.004791836719959974
genetic O 0 0.005670179612934589
testing O 0 0.00591213908046484
in O 0 0.0030248684342950583
the O 0 0.0029795519076287746
setting O 0 0.004665266256779432
of O 0 0.003696117550134659
long O 0 0.007497221231460571
- O 1 0.998985230922699
term O 0 0.01145749818533659
- O 1 0.585044801235199
outcome O 0 0.007401206064969301
studies O 0 0.005168951582163572
may O 0 0.004705213475972414
impact O 0 0.007478690706193447
significantly O 0 0.009641922079026699
on O 0 0.2863641381263733
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.015492727048695087
this O 0 0.009505239315330982
population O 0 0.013239368796348572
. O 0 0.025712791830301285

Localization O 0 0.06096527352929115
of O 0 0.020002184435725212
human O 0 0.016044856980443
BRCA1 O 1 0.9977660179138184
and O 0 0.006102644372731447
its O 0 0.006762118078768253
loss O 0 0.02402726374566555
in O 0 0.006599705666303635
high O 0 0.09146365523338318
- O 1 0.9999387264251709
grade O 0 0.05712214857339859
, O 0 0.010068102739751339
non B-Disease 0 0.07168351858854294
- I-Disease 1 0.9999998807907104
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.24177603423595428

Although O 0 0.018493257462978363
the O 0 0.012162433937191963
link O 0 0.015058666467666626
between O 0 0.007648069877177477
the O 0 0.011870644055306911
BRCA1 O 1 0.9999998807907104
tumour B-Disease 1 1.0
- O 1 1.0
suppressor O 1 0.9999641180038452
gene O 0 0.011230302974581718
and O 0 0.008938613347709179
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9609867334365845
established O 0 0.01756546087563038
, O 0 0.004527540411800146
the O 0 0.0048177000135183334
role O 0 0.006393128540366888
, O 0 0.004422598518431187
if O 0 0.003091252176091075
any O 0 0.0030499654822051525
, O 0 0.0033842911943793297
of O 0 0.00473896786570549
BRCA1 O 1 0.9921833872795105
in O 0 0.006412592250853777
non B-Disease 1 0.9974669218063354
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.015773490071296692
unclear O 0 0.02337328903377056
. O 0 0.029537810012698174

BRCA1 O 1 0.9999203681945801
mutations O 0 0.021875571459531784
are O 0 0.005140557419508696
rare O 0 0.00873783603310585
in O 0 0.007755570113658905
sporadic B-Disease 1 0.9879180788993835
cancers I-Disease 1 0.9999998807907104
, O 0 0.006188553757965565
but O 0 0.004891125950962305
loss O 0 0.03346649557352066
of O 0 0.01068307738751173
BRCA1 O 1 0.9999842643737793
resulting O 0 0.009847205132246017
from O 0 0.006271997932344675
reduced O 0 0.010684661567211151
expression O 0 0.009403674863278866
or O 0 0.0077162254601716995
incorrect O 0 0.015236368402838707
subcellular O 0 0.03764019533991814
localization O 0 0.03480462357401848
is O 0 0.008380112238228321
postulated O 0 0.014546307735145092
to O 0 0.00449575437232852
be O 0 0.003525999141857028
important O 0 0.004588757175952196
in O 0 0.005130792502313852
non B-Disease 0 0.02185332030057907
- I-Disease 1 0.9999998807907104
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.8327044248580933

Epigenetic O 0 0.3830309510231018
loss O 0 0.48124000430107117
, O 0 0.012100545689463615
however O 0 0.007817339152097702
, O 0 0.0062816631980240345
has O 0 0.005073876120150089
not O 0 0.0032703778706490993
received O 0 0.006176483351737261
general O 0 0.009555038996040821
acceptance O 0 0.011322676204144955
due O 0 0.006700488738715649
to O 0 0.0074059925973415375
controversy O 0 0.015003059059381485
regarding O 0 0.00959144439548254
the O 0 0.010866181924939156
subcellular O 0 0.031196922063827515
localization O 0 0.026145989075303078
of O 0 0.014210148714482784
BRCA1 O 1 0.9999532699584961
proteins O 0 0.010927144438028336
, O 0 0.006848481483757496
reports O 0 0.006222217809408903
of O 0 0.00512590492144227
which O 0 0.004064304754137993
have O 0 0.003438863204792142
ranged O 0 0.008505260571837425
from O 0 0.005013142712414265
exclusively O 0 0.008528380654752254
nuclear O 0 0.010829649865627289
, O 0 0.0069276755675673485
to O 0 0.006718863267451525
conditionally O 0 0.02462332881987095
nuclear O 0 0.01287560909986496
, O 0 0.007090309169143438
to O 0 0.0064186714589595795
the O 0 0.012843247503042221
ER O 1 1.0
/ O 1 0.9999880790710449
golgi O 1 0.9992710947990417
, O 0 0.012438051402568817
to O 0 0.011408800259232521
cytoplasmic O 0 0.03548021242022514
invaginations O 0 0.45769765973091125
into O 0 0.016256285831332207
the O 0 0.019874947145581245
nucleus O 0 0.0490264818072319
. O 0 0.031590536236763

In O 0 0.013843230903148651
an O 0 0.007923811674118042
attempt O 0 0.011345972307026386
to O 0 0.006449801381677389
resolve O 0 0.010994002223014832
this O 0 0.004806487821042538
issue O 0 0.007780645973980427
, O 0 0.005098930560052395
we O 0 0.003470487892627716
have O 0 0.003466288559138775
comprehensively O 0 0.04438590258359909
characterized O 0 0.01525752991437912
19 O 0 0.033109936863183975
anti O 1 0.9999384880065918
- O 1 1.0
BRCA1 O 1 0.9999982118606567
antibodies O 1 0.6267209053039551
. O 0 0.038442160934209824

These O 0 0.02610974758863449
reagents O 0 0.05704868584871292
detect O 0 0.032985612750053406
a O 0 0.018253998830914497
220 O 0 0.05408402159810066
- O 1 0.9999496936798096
kD O 1 0.9997316002845764
protein O 0 0.023789627477526665
localized O 0 0.023593274876475334
in O 0 0.010097900405526161
discrete O 0 0.018505441024899483
nuclear O 0 0.02116970904171467
foci O 0 0.037948887795209885
in O 0 0.00952235423028469
all O 0 0.009539834223687649
epithelial O 1 0.999921441078186
cell O 0 0.038457613438367844
lines O 0 0.011795109137892723
, O 0 0.006483294535428286
including O 0 0.004476863890886307
those O 0 0.004898446146398783
derived O 0 0.008772841654717922
from O 0 0.013800873421132565
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9999998807907104
. O 0 0.045724499970674515

Immunohistochemical O 1 0.9995781779289246
staining O 0 0.32388433814048767
of O 0 0.019924812018871307
human O 0 0.032139137387275696
breast O 1 1.0
specimens O 0 0.050604190677404404
also O 0 0.012165057472884655
revealed O 0 0.024091023951768875
BRCA1 O 1 0.999945878982544
nuclear O 0 0.021418176591396332
foci O 1 0.9130712151527405
in O 0 0.014141213148832321
benign O 1 0.9999998807907104
breast O 1 1.0
, O 1 0.984473466873169
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.3914361298084259
low B-Disease 1 0.9997063279151917
- I-Disease 1 1.0
grade I-Disease 1 0.9999966621398926
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.07323139160871506

Conversely O 0 0.07647804915904999
, O 0 0.027000995352864265
BRCA1 O 1 0.9977176189422607
expression O 0 0.01371900923550129
was O 0 0.016113130375742912
reduced O 0 0.016037460416555405
or O 0 0.00803535059094429
undetectable O 0 0.4739939868450165
in O 0 0.005202386993914843
the O 0 0.005122018046677113
majority O 0 0.004670162685215473
of O 0 0.005425610113888979
high O 1 0.500686764717102
- O 1 0.9999995231628418
grade O 1 0.9993880987167358
, O 0 0.06476783007383347
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.012205574661493301
suggesting O 0 0.009722184389829636
that O 0 0.004831110592931509
absence O 0 0.012496870942413807
of O 0 0.010999520309269428
BRCA1 O 1 0.9999955892562866
may O 0 0.008249699138104916
contribute O 0 0.00874177273362875
to O 0 0.006362421438097954
the O 0 0.009069274179637432
pathogenesis O 1 0.99852055311203
of O 0 0.006541665643453598
a O 0 0.0066909994930028915
significant O 0 0.005422883667051792
percentage O 0 0.008227662183344364
of O 0 0.010100885294377804
sporadic B-Disease 1 0.9999008178710938
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.022687580436468124
. O 0 0.03154603764414787

